PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Autier, P; Dore, JF; Breitbart, E; Greinert, R; Pasterk, M; Boniol, M				Autier, Philippe; Dore, Jean Francois; Breitbart, Eckhard; Greinert, Ruediger; Pasterk, Markus; Boniol, Mathieu			The indoor tanning industry's double game	LANCET			English	Editorial Material									[Autier, Philippe; Pasterk, Markus; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Dore, Jean Francois] INSERM, U590, F-69008 Lyon, France; [Breitbart, Eckhard; Greinert, Ruediger] Elbekliniken Klinikum Buxtehude, EUROSKIN, Buxtehude, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm)	Autier, P (corresponding author), Int Prevent Res Inst, F-69006 Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014; Ferris, Laura/I-7689-2012; Boniol, Mathieu/F-9623-2011; Pasterk, Markus/A-6588-2011	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; Pasterk, Markus/0000-0002-6127-3323				El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; *EUROSKIN, 2008, PROP COD PRACT ART T; *FTC, 2010, FTC CONS AL; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Greenman J, 2010, J AM ACAD DERMATOL, V62, P685; Greinert R, 2001, EUR J CANCER PREV, V10, P157, DOI 10.1097/00008469-200104000-00007; International Agency for Research on Cancer, 2008, IARC WORK GROUP REP, V5; International Agency for Research on Cancer, 2006, IARC WORK GROUP REP, V1; Levine JA, 2005, J AM ACAD DERMATOL, V53, P1038, DOI 10.1016/j.jaad.2005.07.066; *PROS, 2010, NEWSL; *PROS, 2009, JOINT ACT SUNB 2008; *US FDA, 2010, FDA CONS HLTH INF IN; IS SUNLIGHT GOOD YOU; VITAMIN D IS ESSENTI	14	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1299	1301		10.1016/S0140-6736(10)61966-6	http://dx.doi.org/10.1016/S0140-6736(10)61966-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21324519				2022-12-24	WOS:000289962900009
J	Drucker, DJ; Goldfine, AB				Drucker, Daniel J.; Goldfine, Allison B.			Cardiovascular safety and diabetes drug development	LANCET			English	Editorial Material							EXENATIDE TWICE; OPEN-LABEL; TYPE-2; LIRAGLUTIDE; THERAPIES; OUTCOMES; WEIGHT; RISK		[Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Drucker, DJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada.	d.drucker@utoronto.ca	Drucker, Daniel J/A-4092-2010	Goldfine, Allison/0000-0002-0345-1048				Ban K, 2009, J AM SOC HYPERTENS, V3, P245, DOI 10.1016/j.jash.2009.04.001; Best JH, 2009, DIABETIC MED, V26, P722, DOI 10.1111/j.1464-5491.2009.02752.x; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chatterjee DJ, 2009, J CLIN PHARMACOL, V49, P1353, DOI 10.1177/0091270009339189; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Orexigen, 2011, FDA ISS COMPL RESP N; US Food and Drug Administration, 2008, GUID IND DIAB MELL E	14	30	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					977	979		10.1016/S0140-6736(10)62299-4	http://dx.doi.org/10.1016/S0140-6736(10)62299-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21316097				2022-12-24	WOS:000288775800009
J	Mair, W; Morantte, I; Rodrigues, APC; Manning, G; Montminy, M; Shaw, RJ; Dillin, A				Mair, William; Morantte, Ianessa; Rodrigues, Ana P. C.; Manning, Gerard; Montminy, Marc; Shaw, Reuben J.; Dillin, Andrew			Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; C-ELEGANS; INSULIN-RESISTANCE; COACTIVATOR CRTC2; GENE-REGULATION; ER STRESS; PATHWAY; KINASE; TORC2	Activating AMPK or inactivating calcineurin slows ageing in Caenorhabditis elegans(1,2) and both have been implicated as therapeutic targets for age-related pathology in mammals(3-5). However, the direct targets that mediate their effects on longevity remain unclear. In mammals, CREB-regulated transcriptional coactivators (CRTCs)(6) are a family of cofactors involved in diverse physiological processes including energy homeostasis(7-9), cancer(10) and endoplasmic reticulum stress(11). Here we show that both AMPK and calcineurin modulate longevity exclusively through post-translational modification of CRTC-1, the sole C. elegans CRTC. We demonstrate that CRTC-1 is a direct AMPK target, and interacts with the CREB homologue-1 (CRH-1) transcription factor in vivo. The pro-longevity effects of activating AMPK or deactivating calcineurin decrease CRTC-1 and CRH-1 activity and induce transcriptional responses similar to those of CRH-1 null worms. Downregulation of crtc-1 increases lifespan in a crh-1-dependent manner and directly reducing crh-1 expression increases longevity, substantiating a role for CRTCs and CREB in ageing. Together, these findings indicate a novel role for CRTCs and CREB in determining lifespan downstream of AMPK and calcineurin, and illustrate the molecular mechanisms by which an evolutionarily conserved pathway responds to low energy to increase longevity.	[Mair, William; Morantte, Ianessa; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Mair, William; Morantte, Ianessa; Montminy, Marc; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Glenn Fdn Med Res, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu; dillin@salk.edu	Rodrigues, Ana/B-7446-2011; Manning, Gerard/C-8308-2009	Mair, William/0000-0002-0661-1342; Grant, Ana/0000-0002-5439-9331; Manning, Gerard/0000-0002-5087-9151	George E. Hewitt Foundation for Medical Research; American Federation for Aging Research; Glenn Foundation for Medical Research; National Institutes of Health (NIH) [R01 DK080425, P01 CA120964, R01 HG004164, AG031097, CA14195, R01 DK070696, AG027463]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425, R01DK070696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463, P01AG031097] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; American Federation for Aging Research; Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	W.M. is funded by the George E. Hewitt Foundation for Medical Research, the American Federation for Aging Research and the Glenn Foundation for Medical Research. R.J.S. is funded by National Institutes of Health (NIH) R01 DK080425 and P01 CA120964. A.P.C.R. and G.M. are funded by NIH R01 HG004164, AG031097 and CA14195. A.D. is supported by NIH R01 DK070696 and AG027463. We thank the Caenorhabditis Genetics Center, the National Bioresource Project for the Nematode and Mark Alkema for providing worm strains. We are grateful to M. Raices and M. D'Angelo for critical analysis of the manuscript, DAPI images and the NUP-160::GFP construct. We also thank members of the A.D. laboratory and M. Hansen for comments on the manuscript and discussion and K. Butler for technical assistance in the early stages of this project.	*AFF, 2004, GENECHIP EXPR AN; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hope IA., 1999, C ELEGANS PRACTICAL; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Komiya T, 2010, ONCOGENE, V29, P1672, DOI 10.1038/onc.2009.453; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; MAIR W, 2009, WORM BREED GAZ, V18, P33; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535	41	264	279	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					404	U179		10.1038/nature09706	http://dx.doi.org/10.1038/nature09706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331044	Green Accepted			2022-12-24	WOS:000287409100044
J	Kavalier, F				Kavalier, Fred			Personal View Why do pharmacists sell homoeopathic remedies?	BRITISH MEDICAL JOURNAL			English	Editorial Material												kavalier@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d349	10.1136/bmj.d349	http://dx.doi.org/10.1136/bmj.d349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248013				2022-12-24	WOS:000286602400025
J	Mor, V; Besdine, RW				Mor, Vincent; Besdine, Richard W.			Policy Options to Improve Discharge Planning and Reduce Rehospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL; CARE; HOSPITALISTS		[Mor, Vincent; Besdine, Richard W.] Brown Univ, Sch Med, Dept Community Hlth, Providence, RI 02912 USA; [Mor, Vincent; Besdine, Richard W.] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Besdine, Richard W.] Brown Univ, Sch Med, Dept Med, Div Geriatr, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Mor, V (corresponding author), Brown Univ, Sch Med, Dept Community Hlth, Box G-S121, Providence, RI 02912 USA.	vincent_mor@brown.edu			NIA NIH HHS [P0-1 AG027296, P01 AG027296] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; *COMM MP, 2008, DAT BOOK HEALTHC SPE; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Hamel MB, 2009, NEW ENGL J MED, V360, P1141, DOI 10.1056/NEJMe0900796; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7	9	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					302	303		10.1001/jama.2010.2006	http://dx.doi.org/10.1001/jama.2010.2006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707YY	21245187	Green Accepted			2022-12-24	WOS:000286328700029
J	Durieux, J; Wolff, S; Dillin, A				Durieux, Jenni; Wolff, Suzanne; Dillin, Andrew			The Cell-Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity	CELL			English	Article							ELEGANS LIFE-SPAN; GENE-EXPRESSION; ENDOCRINE REGULATION; OXIDATIVE STRESS; DROSOPHILA; IDENTIFICATION; REQUIREMENTS; DETERMINANT; MUTANTS; DAF-16	The life span of C. elegans can be increased via reduced function of the mitochondria; however, the extent to which mitochondrial alteration in a single, distinct tissue may influence aging in the whole organism remains unknown. We addressed this question by asking whether manipulations to ETC function can modulate aging in a cell-non-autonomous fashion. We report that the alteration of mitochondrial function in key tissues is essential for establishing and maintaining a prolongevity cue. We find that regulators of mitochondrial stress responses are essential and specific genetic requirements for the electron transport chain (ETC) longevity pathway. Strikingly, we find that mitochondrial perturbation in one tissue is perceived and acted upon by the mitochondrial stress response pathway in a distal tissue. These results suggest that mitochondria may establish and perpetuate the rate of aging for the whole organism independent of cell-autonomous functions.	[Durieux, Jenni; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, La Jolla, CA 92037 USA; [Wolff, Suzanne] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Wolff, Suzanne/A-2839-2012		NIA [R01 AG024365]; NIH; HHMI; NATIONAL INSTITUTE ON AGING [R01AG024365] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. W. Mair, S. Panowski, M. Raices, P. Douglas, and N. Baird for thoughtful editing and scientific insight. We thank Z. Liu for cloning and strain integration. We are grateful to Drs. C. Hunter, C. Haynes, D. Ron, and K. Shen for strains and reagents; and anonymous reviewers for their insight. This work was supported by NIA R01 AG024365, NIH Developmental Biology Training Grant, and HHMI. A.D. is cofounder of Proteostasis Therapeutics, Inc. and declares no financial interest related to this work.	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; COPELAND JM, 2009, CURRENT BIOL; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gems David, 2008, P81, DOI 10.1007/978-1-59745-420-9_6; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kirchman PA, 1999, GENETICS, V152, P179; LAPOINTE J, 2009, J BIOL CHEM, pM109; LARSEN PL, 1995, GENETICS, V139, P1567; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu XF, 2005, FASEB J, V19, pA1391; MADURO M, 1995, GENETICS, V141, P977; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Nonet ML, 1997, J NEUROSCI, V17, P8061; OKKEMA PG, 1993, GENETICS, V135, P385; PEARL R, 2007, GENE, V400, P166; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubner M, 1908, PROBLEM LEBENSDAUER; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; VANRAAMSDONK JM, 2009, PLOS GENET, P5; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	54	682	694	5	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					79	91		10.1016/j.cell.2010.12.016	http://dx.doi.org/10.1016/j.cell.2010.12.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215371	Green Accepted, Bronze			2022-12-24	WOS:000285993600009
J	Sillanpaa, M; Shinnar, S				Sillanpaa, Matti; Shinnar, Shlomo			Long-Term Mortality in Childhood-Onset Epilepsy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN UNEXPECTED DEATH; UNEXPLAINED DEATH; RISK-FACTORS; CHILDREN; SEIZURE; PROGNOSIS; COHORT; TERMINOLOGY; DUTCH	Background: There are few studies on long-term mortality in prospectively followed, well-characterized cohorts of children with epilepsy. We report on long-term mortality in a Finnish cohort of subjects with a diagnosis of epilepsy in childhood. Methods: We assessed seizure outcomes and mortality in a population-based cohort of 245 children with a diagnosis of epilepsy in 1964; this cohort was prospectively followed for 40 years. Rates of sudden, unexplained death were estimated. The very high autopsy rate in the cohort allowed for a specific diagnosis in almost all subjects. Results: Sixty subjects died (24%); this rate is three times as high as the expected age- and sex-adjusted mortality in the general population. The subjects who died included 51 of 107 subjects (48%) who were not in 5-year terminal remission (i.e., greater/equal 5 years seizure-free at the time of death or last follow-up). A remote symptomatic cause of epilepsy (i.e., a major neurologic impairment or insult) was also associated with an increased risk of death as compared with an idiopathic or cryptogenic cause (37% vs. 12%, P<0.001). Of the 60 deaths, 33 (55%) were related to epilepsy, including sudden, unexplained death in 18 subjects (30%), definite or probable seizure in 9 (15%), and accidental drowning in 6 (10%). The deaths that were not related to epilepsy occurred primarily in subjects with remote symptomatic epilepsy. The cumulative risk of sudden, unexplained death was 7% at 40 years overall and 12% in an analysis that was limited to subjects who were not in long-term remission and not receiving medication. Among subjects with idiopathic or cryptogenic epilepsy, there were no sudden, unexplained deaths in subjects younger than 14 years of age. Conclusions: Childhood-onset epilepsy was associated with a substantial risk of epilepsy-related death, including sudden, unexplained death. The risk was especially high among children who were not in remission. (Funded by the Finnish Epilepsy Research Foundation.) N Engl J Med 2010;363:2522-9.	[Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Comprehens Epilepsy Management Ctr, Bronx, NY 10467 USA; [Sillanpaa, Matti] Univ Turku, Dept Pediat Neurol, Turku, Finland; [Sillanpaa, Matti] Univ Turku, Dept Publ Hlth, Turku, Finland; [Sillanpaa, Matti] Turku Univ Hosp, FIN-20520 Turku, Finland; [Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Neurol Pediat & Epidemiol, Bronx, NY 10467 USA; [Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Turku; University of Turku; University of Turku; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Shinnar, S (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Comprehens Epilepsy Management Ctr, 111 E 210th St, Bronx, NY 10467 USA.	sshinnar@montefiore.org	Sillanpaa, Matti L/G-4708-2015	Sillanpaa, Matti L/0000-0003-4190-3698; Sillanpaa, Matti/0000-0002-1521-3602	Finnish Epilepsy Research Foundation	Finnish Epilepsy Research Foundation	Supported by a grant from the Finnish Epilepsy Research Foundation.	Annegers JF, 1997, EPILEPSIA, V38, pS9, DOI 10.1111/j.1528-1157.1997.tb06137.x; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berg AT, 2004, ARCH PEDIAT ADOL MED, V158, P1147, DOI 10.1001/archpedi.158.12.1147; BRORSON LO, 1987, EPILEPSIA, V28, P324, DOI 10.1111/j.1528-1157.1987.tb03651.x; Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259; Camfield CS, 2002, LANCET, V359, P1891, DOI 10.1016/S0140-6736(02)08779-2; Central Statistical Office of Finland, 2003, STAT YB FINL; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; COX DR, 1972, J R STAT SOC B, V34, P187; Derby LE, 1996, EPILEPSIA, V37, P931, DOI 10.1111/j.1528-1157.1996.tb00529.x; Donner EJ, 2001, NEUROLOGY, V57, P430, DOI 10.1212/WNL.57.3.430; Elandt-Johnson RC, 1980, SURVIVAL MODELS DATA, P150; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; Fleiss J, 2003, STAT METHODS RATES P, P638; Foreman AJ, 2003, SAS STAT USERS GUIDE; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Lhatoo SD, 2001, ANN NEUROL, V49, P336; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Shackleton DP, 1999, J NEUROL NEUROSUR PS, V66, P636, DOI 10.1136/jnnp.66.5.636; Shinnar S, 2005, NEUROLOGY, V64, P880, DOI 10.1212/01.WNL.0000152893.72146.92; Sillanpaa M, 1999, PEDIATR NEUROL, V21, P533, DOI 10.1016/S0887-8994(99)00031-4; Sillanpaa M, 2002, ANN NEUROL, V52, P303, DOI 10.1002/ana.10286; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; TENNIS P, 1995, EPILEPSIA, V36, P29, DOI 10.1111/j.1528-1157.1995.tb01661.x; Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; ZIELINSKI JJ, 1974, EPILEPSIA, V15, P191, DOI 10.1111/j.1528-1157.1974.tb04941.x	36	249	254	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2522	2529		10.1056/NEJMoa0911610	http://dx.doi.org/10.1056/NEJMoa0911610			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175314				2022-12-24	WOS:000285555600007
J	Halpern, SD; Barnes, B; Hasz, RD; Abt, PL				Halpern, Scott D.; Barnes, Barbara; Hasz, Richard D.; Abt, Peter L.			Estimated Supply of Organ Donors After Circulatory Determination of Death: A Population-Based Cohort Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CARDIAC DEATH; TRANSPLANTATION; DONATION		[Halpern, Scott D.] Univ Penn, Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA; [Barnes, Barbara; Hasz, Richard D.] Gift Life Donor Program, Philadelphia, PA USA; [Abt, Peter L.] Univ Penn, Sch Med, Div Transplant Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu	Abt, Peter/AAD-6856-2019		AHRQ HHS [K08 HS018406, K08HS018406] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018406] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Campbell GMD, 1999, CAN MED ASSOC J, V160, P1573; Durall AL, 2007, PEDIATRICS, V119, pE219, DOI 10.1542/peds.2006-0375; Childress James F., 2006, ORG DON OPP ACT; Koogler T, 1998, PEDIATRICS, V101, P1049, DOI 10.1542/peds.101.6.1049; Lacroix JD, 2004, CAN J SURG, V47, P10; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x	6	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2592	2594		10.1001/jama.2010.1824	http://dx.doi.org/10.1001/jama.2010.1824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156947	Bronze			2022-12-24	WOS:000285303400021
J	Hughes, JM				Hughes, James M.			Preserving the Lifesaving Power of Antimicrobial Agents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTIOUS-DISEASES SOCIETY; AMERICA		[Hughes, James M.] Infect Dis Soc Amer, Arlington, VA USA; [Hughes, James M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Hughes, James M.] Emory Univ, Hubert Dept Global Hlth, Sch Med, Atlanta, GA 30322 USA; [Hughes, James M.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health	Hughes, JM (corresponding author), Emory Univ, Dept Med, 1462 Clifton Rd,Ste 446 Mailstop 1370-004-1AD, Atlanta, GA 30322 USA.	jmhughe@emory.edu						Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891	7	71	72	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1027	1028		10.1001/jama.2011.279	http://dx.doi.org/10.1001/jama.2011.279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21343545				2022-12-24	WOS:000288129600022
J	Kamiya, D; Banno, S; Sasai, N; Ohgushi, M; Inomata, H; Watanabe, K; Kawada, M; Yakura, R; Kiyonari, H; Nakao, K; Jakt, LM; Nishikawa, S; Sasai, Y				Kamiya, Daisuke; Banno, Satoe; Sasai, Noriaki; Ohgushi, Masatoshi; Inomata, Hidehiko; Watanabe, Kiichi; Kawada, Masako; Yakura, Rieko; Kiyonari, Hiroshi; Nakao, Kazuki; Jakt, Lars Martin; Nishikawa, Shin-ichi; Sasai, Yoshiki			Intrinsic transition of embryonic stem-cell differentiation into neural progenitors	NATURE			English	Article							ZINC-FINGER PROTEIN; IN-VITRO; DIRECTED DIFFERENTIATION; NERVOUS-SYSTEM; MOTOR-NEURONS; MOUSE EMBRYO; ES CELLS; INDUCTION; EXPRESSION; SIGNALS	The neural fate is generally considered to be the intrinsic direction of embryonic stem (ES) cell differentiation. However, little is known about the intracellular mechanism that leads undifferentiated cells to adopt the neural fate in the absence of extrinsic inductive signals. Here we show that the zinc-finger nuclear protein Zfp521 is essential and sufficient for driving the intrinsic neural differentiation of mouse ES cells. In the absence of the neural differentiation inhibitor BMP4, strong Zfp521 expression is intrinsically induced in differentiating ES cells. Forced expression of Zfp521 enables the neural conversion of ES cells even in the presence of BMP4. Conversely, in differentiation culture, Zfp521-depleted ES cells do not undergo neural conversion but tend to halt at the epiblast state. Zfp521 directly activates early neural genes by working with the co-activator p300. Thus, the transition of ES cell differentiation from the epiblast state into neuroectodermal progenitors specifically depends on the cell-intrinsic expression and activator function of Zfp521.	[Kamiya, Daisuke; Banno, Satoe; Sasai, Noriaki; Ohgushi, Masatoshi; Inomata, Hidehiko; Watanabe, Kiichi; Kawada, Masako; Yakura, Rieko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Kamiya, Daisuke; Sasai, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Med Embryol, Kyoto 6068501, Japan; [Kiyonari, Hiroshi; Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resource & Genet Engn, Kobe, Hyogo 6500047, Japan; [Jakt, Lars Martin; Nishikawa, Shin-ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Res, Kobe, Hyogo 6500047, Japan	RIKEN; Kyoto University; RIKEN; RIKEN	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Kiyonari, Hiroshi/N-7936-2015; Inomata, Hidehiko/N-7390-2015; Watanabe, Kiichi/ABA-4854-2020	Jakt, Lars Martin/0000-0002-3787-8138; Sasai, Noriaki/0000-0003-0360-1138; zhong wei, he gui/0000-0002-3066-3564	MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We are grateful to H. Niwa for comments; M. Okada for advice on the GeneChip study; Y. Toyooka-Kamiya for constant encouragement and technical advice; H. Akimaru for advice on the shRNA knockdown study; and members of the Sasai laboratory for discussion and advice. This work was supported by grants-in-aid from MEXT, the Kobe Cluster Project and the Leading Project (Y.S.).	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Brunelli S, 2003, GENESIS, V36, P12, DOI 10.1002/gene.10193; Chan HM, 2001, J CELL SCI, V114, P2363; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; JAKT LM, 2003, GENOME INFORM, V14, P276; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nagy A., 2003, MANIPULATING MOUSE E; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zwart R, 1996, MECH DEVELOP, V54, P185, DOI 10.1016/0925-4773(95)00472-6	38	159	168	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					503	U92		10.1038/nature09726	http://dx.doi.org/10.1038/nature09726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326203				2022-12-24	WOS:000287652900035
J	Olson, MV				Olson, Maynard V.			What Does a "Normal" Human Genome Look Like?	SCIENCE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Olson, MV (corresponding author), Univ Washington, Seattle, WA 98195 USA.								0	5	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					872	872		10.1126/science.1203236	http://dx.doi.org/10.1126/science.1203236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330527				2022-12-24	WOS:000287455100040
J	Gordon, LM; Joester, D				Gordon, Lyle M.; Joester, Derk			Nanoscale chemical tomography of buried organic-inorganic interfaces in the chiton tooth	NATURE			English	Article							SPECIMEN PREPARATION; RADULA TEETH; PROTEIN; MATRIX; BIOMINERALIZATION; CRYSTALS; BONE	Biological organisms possess an unparalleled ability to control the structure and properties of mineralized tissues. They are able, for example, to guide the formation of smoothly curving single crystals or tough, lightweight, self-repairing skeletal elements(1). In many biominerals, an organic matrix interacts with the mineral as it forms, controls its morphology and polymorph, and is occluded during mineralization(2-4). The remarkable functional properties of the resulting composites-such as outstanding fracture toughness and wear resistance-can be attributed to buried organic-inorganic interfaces at multiple hierarchical levels(5). Analysing and controlling such interfaces at the nanometre length scale is critical also in emerging organic electronic and photovoltaic hybrid materials(6). However, elucidating the structural and chemical complexity of buried organic-inorganic interfaces presents a challenge to state-of-the-art imaging techniques. Here we show that pulsed-laser atom-probe tomography reveals three-dimensional chemical maps of organic fibres with a diameter of 5-10 nm in the surrounding nano-crystalline magnetite (Fe3O4) mineral in the tooth of a marine mollusc, the chiton Chaetopleura apiculata. Remarkably, most fibres co-localize with either sodium or magnesium. Furthermore, clustering of these cations in the fibre indicates a structural level of hierarchy previously undetected. Our results demonstrate that in the chiton tooth, individual organic fibres have different chemical compositions, and therefore probably different functional roles in controlling fibre formation and matrix-mineral interactions. Atom-probe tomography is able to detect this chemical/structural heterogeneity by virtue of its high three-dimensional spatial resolution and sensitivity across the periodic table. We anticipate that the quantitative analysis and visualization of nanometre-scale interfaces by laser-pulsed atom-probe tomography will contribute greatly to our understanding not only of biominerals (such as bone, dentine and enamel), but also of synthetic organic-inorganic composites.	[Gordon, Lyle M.; Joester, Derk] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Joester, D (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	d-joester@northwestern.edu	Joester, Derk/B-7525-2009	Gordon, Lyle/0000-0001-8335-0126	Canadian National Sciences and Engineering Research Council; US National Science Foundation [DMR-0805313]; NSF-NSEC; NSF-MRSEC; Keck Foundation; State of Illinois; Northwestern University; NSF-MRI [DMR-0420532]; ONR-DURIP [N00014-0400798, N00014-0610539, N00014-0910781]; Division Of Materials Research [0805313] Funding Source: National Science Foundation	Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); NSF-NSEC(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University; NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); ONR-DURIP(Office of Naval Research); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the Canadian National Sciences and Engineering Research Council and the US National Science Foundation (DMR-0805313). FIB, SEM and (S) TEM work was performed in the Northwestern University Atomic and Nanoscale Characterization and Experimental Center (NUANCE) supported by NSF-NSEC, NSF-MRSEC, the Keck Foundation, the State of Illinois, and Northwestern University. APT measurements were performed at the Northwestern University Center for Atom Probe Tomography (NUCAPT) supported by NSF-MRI (DMR-0420532) and ONR-DURIP (N00014-0400798, N00014-0610539, N00014-0910781). We thank A. Tayi for help in preparing chitin thin film samples; B. Myers (NUANCE) for help with FIB; D. Isheim (NUCAPT), and D. Lawrence, R. Ulfig, T. Prosa and M. Greene (Cameca) for their assistance with APT; and D. Seidman for discussions.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 2006, Nanomechanics of Materials and Structures, P99, DOI 10.1007/1-4020-3951-4_10; BAS P, 1995, APPL SURF SCI, V87-8, P298, DOI 10.1016/0169-4332(94)00561-3; Chen YM, 2009, SCRIPTA MATER, V61, P693, DOI 10.1016/j.scriptamat.2009.05.043; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; EVANS LA, 1991, MAR BIOL, V109, P281, DOI 10.1007/BF01319396; EVANS LA, 1990, PHILOS T ROY SOC B, V329, P87, DOI 10.1098/rstb.1990.0153; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; FLEET ME, 1981, ACTA CRYSTALLOGR B, V37, P917, DOI 10.1107/S0567740881004597; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Koch N, 2007, CHEMPHYSCHEM, V8, P1438, DOI 10.1002/cphc.200700177; Kuhlman KR, 2001, ULTRAMICROSCOPY, V89, P169, DOI 10.1016/S0304-3991(01)00116-4; Larson DJ., 2008, MICROSC MICROANAL, V14, P1254, DOI DOI 10.1017/S1431927608083657; Law NA, 1999, ADV INORG CHEM, V46, P305; LEHN JM, 1994, P INDIAN AS-CHEM SCI, V106, P915; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Li J, 1997, J APPL POLYM SCI, V65, P373; Lowenstam HA, 1989, BIOMINERALIZATION; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Miller M. K., 2000, ATOM PROBE TOMOGRAPH, P139; Miller MK, 2007, MICROSC MICROANAL, V13, P428, DOI 10.1017/S1431927607070845; Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI [10.1016/j.ultramic.2004.10.011, 10.1016/J.ULTRAMIC.2004.10.011]; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Seidman D., 2009, MAT RES SOC B, V34, P717; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e; Tao JH, 2009, P NATL ACAD SCI USA, V106, P22096, DOI 10.1073/pnas.0909040106; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Tsai GJ, 2002, FISHERIES SCI, V68, P170, DOI 10.1046/j.1444-2906.2002.00404.x; van der Wal P, 2000, MAT SCI ENG C-BIO S, V7, P129, DOI 10.1016/S0928-4931(99)00129-0; Wang DB, 2009, P NATL ACAD SCI USA, V106, P21511, DOI 10.1073/pnas.0906741106; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001	40	182	185	8	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					194	197		10.1038/nature09686	http://dx.doi.org/10.1038/nature09686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228873				2022-12-24	WOS:000286143400034
J	Saraux, C; Le Bohec, C; Durant, JM; Viblanc, VA; Gauthier-Clerc, M; Beaune, D; Park, YH; Yoccoz, NG; Stenseth, NC; Le Maho, Y				Saraux, Claire; Le Bohec, Celine; Durant, Joel M.; Viblanc, Vincent A.; Gauthier-Clerc, Michel; Beaune, David; Park, Young-Hyang; Yoccoz, Nigel G.; Stenseth, Nils C.; Le Maho, Yvon			Reliability of flipper-banded penguins as indicators of climate change	NATURE			English	Article							POPULATION-DYNAMICS; KING PENGUIN; REPRODUCTION; SURVIVAL; BEHAVIOR	In 2007, the Intergovernmental Panel on Climate Change highlighted an urgent need to assess the responses of marine ecosystems to climate change(1). Because they lie in a high-latitude region, the Southern Ocean ecosystems are expected to be strongly affected by global warming. Using top predators of this highly productive ocean(2) (such as penguins) as integrative indicators may help us assess the impacts of climate change on marine ecosystems(3,4). Yet most available information on penguin population dynamics is based on the controversial use of flipper banding. Although some reports have found the effects of flipper bands to be deleterious(5-8), some short-term (one-year) studies have concluded otherwise(9-11), resulting in the continuation of extensive banding schemes and the use of data sets thus collected to predict climate impact on natural populations(12,13). Here we show that banding of free-ranging king penguins (Aptenodytes patagonicus) impairs both survival and reproduction, ultimately affecting population growth rate. Over the course of a 10-year longitudinal study, banded birds produced 39% fewer chicks and had a survival rate 16% lower than non-banded birds, demonstrating a massive long-term impact of banding and thus refuting the assumption that birds will ultimately adapt to being banded(6,12). Indeed, banded birds still arrived later for breeding at the study site and had longer foraging trips even after 10 years. One of our major findings is that responses of flipper-banded penguins to climate variability (that is, changes in sea surface temperature and in the Southern Oscillation index) differ from those of non-banded birds. We show that only long-term investigations may allow an evaluation of the impact of flipper bands and that every major life-history trait can be affected, calling into question the banding schemes still going on. In addition, our understanding of the effects of climate change on marine ecosystems based on flipper-band data should be reconsidered.	[Saraux, Claire; Le Bohec, Celine; Viblanc, Vincent A.; Beaune, David; Le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France; [Saraux, Claire; Le Bohec, Celine; Viblanc, Vincent A.; Beaune, David; Le Maho, Yvon] CNRS, UMR7178, F-67037 Strasbourg, France; [Saraux, Claire; Le Bohec, Celine; Durant, Joel M.; Stenseth, Nils C.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Saraux, Claire] ENGREF, AgroParisTech, F-75732 Paris, France; [Gauthier-Clerc, Michel] Ctr Rech Tour Valat, F-13200 Arles, France; [Park, Young-Hyang] Museum Natl Hist Nat, USM LOCEAN 0402, Dept Milieux & Peuplements Aquat, F-75231 Paris, France; [Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Stenseth, Nils C.] Inst Marine Res, Flodevigen Marine Res Stn, N-4817 His, Norway	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oslo; AgroParisTech; Museum National d'Histoire Naturelle (MNHN); UiT The Arctic University of Tromso; Institute of Marine Research - Norway	Saraux, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, 23 Rue Becquerel, F-67087 Strasbourg, France.	claire.saraux@c-strasbourg.fr; yvon.lemaho@iphc.cnrs.fr	saraux, claire/AAX-8709-2020; Yoccoz, Nigel/C-8561-2014; LE BOHEC, CELINE/AAD-3589-2022; Durant, Joël/D-3821-2013; Stenseth, Nils Christian/G-5212-2016	saraux, claire/0000-0001-5061-4009; Yoccoz, Nigel/0000-0003-2192-1039; Durant, Joël/0000-0002-1129-525X; LE BOHEC, Celine/0000-0003-0149-6477; Beaune, David/0000-0002-2329-1598; Viblanc, Vincent/0000-0002-4953-659X; Stenseth, Nils Christian/0000-0002-1591-5399	Institut Polaire Francais-Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique; European Commission; Norwegian Research Council; YGGDRASIL programme	Institut Polaire Francais-Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission); YGGDRASIL programme	We thank P. Trathan for his comments on the paper. We are grateful to C. Salmon for his help in pre-analysing data. We thank M. Ballesteros, C. Bricaud, N. Chatelain, G. Conan, S. Descamps, J. Dutel, C. Gilbert, S. Gravier, A. Hergott, G. Kuntz, N. Lambert, T. Lebard, N. Lecomte, J. Legrand, S. Mangin, V. Mosch, S. Quemeneur, A. Simon, E. Taquet and C. Villemin, for their help with field work. We also thank I. Durant for her help with chlorophyll data. This work was supported by the Institut Polaire Francais-Paul-Emile Victor, the Fondation Bettencourt-Schueller, the Fondation des Treilles and the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), and grants from the European Commission (Marie Curie, to C. L. B.), the Norwegian Research Council through the Match/Mismatch and Ecosystem project (to J. M. D.) and the YGGDRASIL programme (to C.S.).	Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bates D., 2009, CRAN PACKAGE LME4; Boersma PD, 2010, J FIELD ORNITHOL, V81, P195, DOI 10.1111/j.1557-9263.2010.00277.x; Boersma PD, 2009, J FIELD ORNITHOL, V80, P408, DOI 10.1111/j.1557-9263.2009.00248.x; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Caswell H., 2001, MATRIX POPULATION MO, P72; Croxall J.P., 1988, P261; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Descamps Sebastien, 2002, Avian Science, V2, P87; DESER C, 1987, J GEOPHYS RES-OCEANS, V92, P14189, DOI 10.1029/JC092iC13p14189; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Fallow PM, 2009, J WILDLIFE MANAGE, V73, P1348, DOI 10.2193/2008-146; Froget G, 1998, POLAR BIOL, V20, P409, DOI 10.1007/s003000050322; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Hindell MA, 1996, IBIS, V138, P557, DOI 10.1111/j.1474-919X.1996.tb08080.x; Jackson S, 2002, FUNCT ECOL, V16, P141, DOI 10.1046/j.0269-8463.2001.00606.x; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; KOZLOV AN, 1989, J ICHTHYOL, V29, P160; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; Lebreton J.-D., 1991, BIRD POPULATION STUD, P105; LEMAHO Y, 1993, MAR ECOL PROG SER, V95, P1, DOI 10.3354/meps095001; May RM, 2004, NATURE, V431, P403, DOI 10.1038/431403a; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Olsson O, 1996, J AVIAN BIOL, V27, P7, DOI 10.2307/3676955; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Stearns S.C., 1992, pi; Stonehouse B, 1960, SCI REPT FALKLAND IS, V23, P1; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Wolfaardt Anton C., 2003, P18	36	145	147	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					203	206		10.1038/nature09630	http://dx.doi.org/10.1038/nature09630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228875				2022-12-24	WOS:000286143400036
J	Zha, S; Guo, CG; Boboila, C; Oksenych, V; Cheng, HL; Zhang, Y; Wesemann, DR; Yuen, G; Patel, H; Goff, PH; Dubois, RL; Alt, FW				Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Dubois, Richard L.; Alt, Frederick W.			ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks	NATURE			English	Article							DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; V(D)J RECOMBINATION; HISTONE H2AX; TRANSLOCATIONS; LYMPHOCYTES; CERNUNNOS; MECHANISM; PATHWAY; MICE	Classical non-homologous DNA end-joining (NHEJ) is a major mammalian DNA double-strand-break (DSB) repair pathway. Deficiencies for classical NHEJ factors, such as XRCC4, abrogate lymphocyte development, owing to a strict requirement for classical NHEJ to join V(D) J recombination DSB intermediates(1,2). The XRCC4-like factor (XLF; also called NHEJ1) is mutated in certain immunodeficient human patients and has been implicated in classical NHEJ(3-6); however, XLF-deficient mice have relatively normal lymphocyte development and their lymphocytes support normal V(D) J recombination(5). The ataxia telangiectasia-mutated protein (ATM) detects DSBs and activates DSB responses by phosphorylating substrates including histone H2AX(7). However, ATM deficiency causes only modest V(D) J recombination and lymphocyte developmental defects, and H2AX deficiency does not have a measurable impact on these processes(7-9). Here we show that XLF, ATM and H2AX all have fundamental roles in processing and joining DNA ends during V(D) J recombination, but that these roles have been masked by unanticipated functional redundancies. Thus, combined deficiency of ATM and XLF nearly blocks mouse lymphocyte development due to an inability to process and join chromosomal V(D) J recombination DSB intermediates. Combined XLF and ATM deficiency also severely impairs classical NHEJ, but not alternative end-joining, during IgH class switch recombination. Redundant ATM and XLF functions in classical NHEJ are mediated by ATM kinase activity and are not required for extra-chromosomal V(D) J recombination, indicating a role for chromatin-associated ATM substrates. Correspondingly, conditional H2AX inactivation in XLF-deficient pro-B lines leads to V(D) J recombination defects associated with marked degradation of unjoined V(D) J ends, revealing that H2AX has a role in this process.	[Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA; [Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Alt, Frederick W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Dubois, Richard L.] Columbia Univ, Inst Canc Genet, Dept Pediat, Dept Pathol & Cell Biol, New York, NY 10032 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Columbia University	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Oksenych, Valentyn/J-6216-2019; Yuen, Grace/M-9383-2019	Oksenych, Valentyn/0000-0002-5088-3791; Yuen, Grace/0000-0002-3253-9575; Zha, Shan/0000-0002-6568-1818; Wesemann, Duane/0000-0002-6690-944X; Goff, Peter/0000-0002-3488-4997	NIH [AI076210, AI020047, AI007376]; Cancer Research Institute; AAAI/GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007376, P01AI076210, R01AI020047, R37AI020047, K08AI089972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; AAAI/GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Fujiwara and P. Huang for technical support. We thank B. Sleckman for advice, reagents and for critical review of this manuscript. This work is supported by NIH grant AI076210 and AI020047 to F. W. A. F. W. A. is an investigator of the Howard Hughes Medical Institute. S.Z. was a fellow, then senior fellow of Leukemia and Lymphomas Society of America and a St Baldrick Scholar. C. G. and Y.Z. are fellows of Cancer Research Institute. C. B. receives support from the pre-doctoral training program of Cancer Research Institute. D. R. W. is supported by a career development award from AAAI/GlaxoSmithKline and by NIH training grant AI007376.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GELLERT M, 1992, ANNU REV GENET, V26, P425, DOI 10.1146/annurev.ge.26.120192.002233; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	26	151	152	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					250	254		10.1038/nature09604	http://dx.doi.org/10.1038/nature09604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21160472	Green Accepted			2022-12-24	WOS:000286143400046
J	Eisenstein, M				Eisenstein, Michael			The first supper	NATURE			English	Editorial Material																		Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S8	S9		10.1038/468S8a	http://dx.doi.org/10.1038/468S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179084	Bronze			2022-12-24	WOS:000285553800003
J	Butler, CD				Butler, Colin D.			A stormy future for population health in southeast Asia?	LANCET			English	Editorial Material							CLIMATE-CHANGE		Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	Butler, CD (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	colin.butler@anu.edu.au	Butler, Colin D./H-2267-2019	Butler, Colin D./0000-0002-2942-5294				Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; Butler C. D., 2010, SCN News, P18; Butler CD, 2010, POSTGRAD MED J, V86, P230, DOI 10.1136/pgmj.2009.082727; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Dear K, 2005, ARCH ENVIRON OCCUP H, V60, P205, DOI 10.3200/AEOH.60.4.205-212; Hull TH, 2009, B INDONES ECON STUD, V45, P61, DOI 10.1080/00074910902836197; Owen NA, 2010, ENERG POLICY, V38, P4743, DOI 10.1016/j.enpol.2010.02.026; Pan CJ, 2010, ANN GEOPHYS-GERMANY, V28, P11, DOI 10.5194/angeo-28-11-2010; Pasricha SR, 2010, J PAEDIATR CHILD H, V46, P497, DOI 10.1111/j.1440-1754.2010.01839.x; Reuveny R, 2007, POLIT GEOGR, V26, P656, DOI 10.1016/j.polgeo.2007.05.001; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775	12	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					885	886		10.1016/S0140-6736(10)62140-X	http://dx.doi.org/10.1016/S0140-6736(10)62140-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21269679				2022-12-24	WOS:000288628800009
J	Solit, DB; Rosen, N				Solit, David B.; Rosen, Neal			Resistance to BRAF Inhibition in Melanomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RAF; PATHWAY; CRAF		[Solit, David B.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.		Rosen, Neal/ABF-2677-2020; Solit, David B./AAC-5309-2019					Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758	8	185	191	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					772	774		10.1056/NEJMcibr1013704	http://dx.doi.org/10.1056/NEJMcibr1013704			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345109				2022-12-24	WOS:000287652500016
J	Tutu, D				Tutu, Desmond			A Celebration of the Genome, Part II - My Genome	SCIENCE			English	Editorial Material																			0	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					689	689		10.1126/science.1203150	http://dx.doi.org/10.1126/science.1203150			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310994				2022-12-24	WOS:000287205700038
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Definitely not acceptable: drug company sues journal over review	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2011	342								d602	10.1136/bmj.d602	http://dx.doi.org/10.1136/bmj.d602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PR	21285186				2022-12-24	WOS:000287138000009
J	Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, YP; Colman, SM; Kempski, H; Moorman, AV; Titley, I; Swansbury, J; Kearney, L; Enver, T; Greaves, M				Anderson, Kristina; Lutz, Christoph; van Delft, Frederik W.; Bateman, Caroline M.; Guo, Yanping; Colman, Susan M.; Kempski, Helena; Moorman, Anthony V.; Titley, Ian; Swansbury, John; Kearney, Lyndal; Enver, Tariq; Greaves, Mel			Genetic variegation of clonal architecture and propagating cells in leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER STEM-CELLS; BREAST-CANCER; CHILDHOOD LEUKEMIA; INTRATUMORAL HETEROGENEITY; PROSTATE-CANCER; TUMOR-CELLS; PROGRESSION; EVOLUTION; DIVERSITY	Little is known of the genetic architecture of cancer at the subclonal and single-cell level or in the cells responsible for cancer clonemaintenance and propagation. Here we have examined this issue in childhood acute lymphoblastic leukaemia in which the ETV6-RUNX1 gene fusion is an early or initiating genetic lesion followed by a modest number of recurrent or 'driver' copy number alterations. By multiplexing fluorescence in situ hybridization probes for these mutations, up to eight genetic abnormalities can be detected in single cells, a genetic signature of subclones identified and a composite picture of subclonal architecture and putative ancestral trees assembled. Subclones in acute lymphoblastic leukaemia have variegated genetics and complex, nonlinear or branching evolutionary histories. Copy number alterations are independently and reiteratively acquired in subclones of individual patients, and in no preferential order. Clonal architecture is dynamic and is subject to change in the lead-upto a diagnosis and in relapse. Leukaemia propagating cells, assayed by serial transplantation in NOD/SCID IL2R gamma(null) mice, are also genetically variegated, mirroring subclonal patterns, and vary in competitive regenerative capacity in vivo. These data have implications for cancer genomics and for the targeted therapy of cancer.	[Anderson, Kristina; van Delft, Frederik W.; Bateman, Caroline M.; Colman, Susan M.; Titley, Ian; Swansbury, John; Kearney, Lyndal; Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Lutz, Christoph; Guo, Yanping; Enver, Tariq] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Kempski, Helena] Great Ormond St Hosp Sick Children, Paediat Malignancy Unit, London WC1N 3JH, England; [Kempski, Helena] UCL Inst Child Hlth, London WC1N 3JH, England; [Moorman, Anthony V.] Newcastle Univ, No Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; Institute of Cancer Research - UK; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Newcastle University - UK	Greaves, M (corresponding author), Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England.	mel.greaves@icr.ac.uk	Moorman, Anthony/F-5518-2010; Moorman, Anthony/G-1468-2014; Bateman, Caroline/AAE-6007-2022	Moorman, Anthony/0000-0002-9781-6107; Greaves, Melvyn/0000-0002-7239-1384; van Delft, Frederik Willem/0000-0002-3704-3720	Kay Kendall Leukaemia Fund; Leukaemia & Lymphoma Research; Deutsche Forschungsgemeinschaft [LU 1474/1-1]; Oxford BRC; MRC [MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817] Funding Source: researchfish	Kay Kendall Leukaemia Fund; Leukaemia & Lymphoma Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Oxford BRC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by specialist programme grants from The Kay Kendall Leukaemia Fund (M.G.) and Leukaemia & Lymphoma Research (M.G., T.E.) and a Deutsche Forschungsgemeinschaft fellowship LU 1474/1-1 (to C.L.). T. E. and C.L. acknowledge support from the Oxford BRC.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Aubele M, 1999, CANCER GENET CYTOGEN, V110, P94, DOI 10.1016/S0165-4608(98)00205-2; Barrett Paul H., 1987, C DARWINS NOTEBOOKS; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BOLAND CR, 1995, NAT MED, V1, P902, DOI 10.1038/nm0995-902; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cottu PH, 2008, ANN ONCOL, V19, P596, DOI 10.1093/annonc/mdn021; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Fox EJ, 2009, CANCER RES, V69, P4948, DOI 10.1158/0008-5472.CAN-09-1231; Gatenby RA, 2003, CANCER RES, V63, P6212; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Horsley SW, 2008, GENE CHROMOSOME CANC, V47, P333, DOI 10.1002/gcc.20537; Kearney Lyndal, 2009, V538, P57, DOI 10.1007/978-1-59745-418-6_4; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loncarevic IF, 1999, GENE CHROMOSOME CANC, V24, P272, DOI 10.1002/(SICI)1098-2264(199903)24:3<272::AID-GCC13>3.3.CO;2-L; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maenhaut C, 2010, CARCINOGENESIS, V31, P149, DOI 10.1093/carcin/bgp259; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Takahashi T, 1998, CANCER RES, V58, P5835; Teixeira MR, 1996, CANCER RES, V56, P855; Tsao JL, 1999, AM J PATHOL, V154, P1815, DOI 10.1016/S0002-9440(10)65437-5; van Dongen J. J. M, 2002, LEUKEMIA, P85; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	53	593	614	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					356	+		10.1038/nature09650	http://dx.doi.org/10.1038/nature09650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21160474				2022-12-24	WOS:000286385600043
J	Spence, D				Spence, Des			From the Frontline Overweening on weaning	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d334	10.1136/bmj.d334	http://dx.doi.org/10.1136/bmj.d334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248011				2022-12-24	WOS:000286602400016
J	Vergeer, M; Korporaal, SJA; Franssen, R; Meurs, I; Out, R; Hovingh, GK; Hoekstra, M; Sierts, JA; Dallinga-Thie, GM; Motazacker, MM; Holleboom, AG; Van Berkel, TJC; Kastelein, JJP; Van Eck, M; Kuivenhoven, JA				Vergeer, Menno; Korporaal, Suzanne J. A.; Franssen, Remco; Meurs, Illiana; Out, Ruud; Hovingh, G. Kees; Hoekstra, Menno; Sierts, Jeroen A.; Dallinga-Thie, Geesje M.; Motazacker, Mohammad Mahdi; Holleboom, Adriaan G.; Van Berkel, Theo J. C.; Kastelein, John J. P.; Van Eck, Miranda; Kuivenhoven, Jan Albert			Genetic Variant of the Scavenger Receptor BI in Humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MARROW-DERIVED CELLS; TRANSPORT IN-VIVO; SR-BI; CHOLESTEROL EFFLUX; FAMILIAL HYPERCHOLESTEROLEMIA; LIPID-METABOLISM; TRANSFER PROTEIN; RAISING HDL; DEFICIENCY	BACKGROUND In mice, the scavenger receptor class B type I (SR-BI) is essential for the delivery of high-density lipoprotein (HDL) cholesterol to the liver and steroidogenic organs. Paradoxically, elevated HDL cholesterol levels are associated with increased atherosclerosis in SR-BI-knockout mice. It is unclear what role SR-BI plays in human metabolism. METHODS We sequenced the gene encoding SR-BI in persons with elevated HDL cholesterol levels and identified a family with a new missense mutation (P297S). The functional effects of the P297S mutation on HDL binding, cellular cholesterol uptake and efflux, atherosclerosis, platelet function, and adrenal function were studied. RESULTS Cholesterol uptake from HDL by primary murine hepatocytes that expressed mutant SR-BI was reduced to half of that of hepatocytes expressing wild-type SR-BI. Carriers of the P297S mutation had increased HDL cholesterol levels (70.4 mg per deciliter [1.8 mmol per liter], vs. 53.4 mg per deciliter [1.4 mmol per liter] in noncarriers; P<0.001) and a reduced capacity for efflux of cholesterol from macrophages, but the carotid artery intima-media thickness was similar in carriers and in family noncarriers. Platelets from carriers had increased unesterified cholesterol content and impaired function. In carriers, adrenal steroidogenesis was attenuated, as evidenced by decreased urinary excretion of sterol metabolites, a decreased response to corticotropin stimulation, and symptoms of diminished adrenal function. CONCLUSIONS We identified a family with a functional mutation in SR-BI. The mutation carriers had increased HDL cholesterol levels and a reduction in cholesterol efflux from macrophages but no significant increase in atherosclerosis. Reduced SR-BI function was associated with altered platelet function and decreased adrenal steroidogenesis.	[Vergeer, Menno; Franssen, Remco; Hovingh, G. Kees; Sierts, Jeroen A.; Dallinga-Thie, Geesje M.; Motazacker, Mohammad Mahdi; Holleboom, Adriaan G.; Kastelein, John J. P.; Kuivenhoven, Jan Albert] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Korporaal, Suzanne J. A.; Meurs, Illiana; Out, Ruud; Hoekstra, Menno; Van Berkel, Theo J. C.; Van Eck, Miranda] Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC	Kuivenhoven, JA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,G1-113, NL-1105 AZ Amsterdam, Netherlands.	j.a.kuivenhoven@amc.uva.nl	Van Berkel, Theo/ABD-7677-2021; Kastelein, John/AAF-7950-2020	Holleboom, A.G. (Onno)/0000-0002-2911-2917; Hoekstra, Menno/0000-0001-7463-2893; dallinga-thie, geesje/0000-0001-5412-5923; van Eck, Miranda/0000-0003-3936-3194	European Community [037631]; Netherlands Heart Foundation [2006B107, 2007T056, 2008T070, 2009B027]; Netherlands Organization for Scientific Research [021.001.035, 917.66.301]	European Community(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by grants from the European Community (FP6-2005-LifeSciHealth-6; STREP contract number 037631), the Netherlands Heart Foundation (2006B107, 2007T056, 2008T070, and 2009B027), and the Netherlands Organization for Scientific Research (project numbers 021.001.035 and 917.66.301).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Covey SD, 2003, ARTERIOSCLER THROMB, V23, P1950; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hsu LA, 2003, ARTERIOSCL THROM VAS, V23, P1869, DOI 10.1161/01.ATV.0000082525.84814.A9; ILLINGWORTH DR, 1984, J CLIN ENDOCR METAB, V58, P206, DOI 10.1210/jcem-58-1-206; ILLINGWORTH DR, 1983, METABOLISM, V32, P1045, DOI 10.1016/0026-0495(83)90075-6; Imachi H, 2003, ARTERIOSCL THROM VAS, V23, P898, DOI 10.1161/01.ATV.0000067429.46333.7B; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Lange K, 2001, AM J HUM GENET, V69, P504; Masson D, 2009, ARTERIOSCL THROM VAS, V29, P2054, DOI 10.1161/ATVBAHA.109.191320; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; NORUM KR, 1967, SCAND J CLIN LAB INV, V20, P231, DOI 10.3109/00365516709076948; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Pirillo A, 2006, BBA-MOL CELL BIOL L, V1761, P292, DOI 10.1016/j.bbalip.2006.03.009; Rader DJ, 2009, CIRCULATION, V120, P549, DOI 10.1161/CIRCULATIONAHA.109.881979; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wild S, 2008, HEART, V94, P692, DOI 10.1136/hrt.2007.126326; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	39	246	253	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					136	145		10.1056/NEJMoa0907687	http://dx.doi.org/10.1056/NEJMoa0907687			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226579	Bronze			2022-12-24	WOS:000286142900007
J	Patel, V; Chatterji, S; Chisholm, D; Ebrahim, S; Gopalakrishna, G; Mathers, C; Mohan, V; Prabhakaran, D; Ravindran, RD; Reddy, KS				Patel, Vikram; Chatterji, Somnath; Chisholm, Dan; Ebrahim, Shah; Gopalakrishna, Gururaj; Mathers, Colin; Mohan, Viswanathan; Prabhakaran, Dorairaj; Ravindran, Ravilla D.; Reddy, K. Srinath			India: Towards Universal Health Coverage 3 Chronic diseases and injuries in India	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; COST-EFFECTIVENESS; MYOCARDIAL-INFARCTION; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; EDUCATIONAL STATUS; HEART-DISEASE; RISK-FACTORS; TOBACCO USE; ALCOHOL-USE	Chronic diseases (eg, cardiovascular diseases, mental health disorders, diabetes, and cancer) and injuries are the leading causes of death and disability in India, and we project pronounced increases in their contribution to the burden of disease during the next 25 years. Most chronic diseases are equally prevalent in poor and rural populations and often occur together. Although a wide range of cost-effective primary and secondary prevention strategies are available, their coverage is generally low, especially in poor and rural populations. Much of the care for chronic diseases and injuries is provided in the private sector and can be very expensive. Sufficient evidence exists to warrant immediate action to scale up interventions for chronic diseases and injuries through private and public sectors; improved public health and primary health-care systems are essential for the implementation of cost-effective interventions. We strongly advocate the need to strengthen social and policy frameworks to enable the implementation of interventions such as taxation on bidis (small hand-rolled cigarettes), smokeless tobacco, and locally brewed alcohols. We also advocate the integration of national programmes for various chronic diseases and injuries with one another and with national health agendas. India has already passed the early stages of a chronic disease and injury epidemic; in view of the implications for future disease burden and the demographic transition that is in progress in India, the rate at which effective prevention and control is implemented should be substantially increased. The emerging agenda of chronic diseases and injuries should be a political priority and central to national consciousness, if universal health care is to be achieved.	[Patel, Vikram; Ebrahim, Shah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Patel, Vikram] Sangath, Porvorim, Goa, India; [Chisholm, Dan] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Ebrahim, Shah; Prabhakaran, Dorairaj; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Gopalakrishna, Gururaj] WHO Collaborating Ctr Injury Prevent & Safety Pro, Natl Inst Mental Hlth & Neurosci, Dept Epidemiol, Bengaluru, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Madras, Tamil Nadu, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control India, New Delhi, India; [Ravindran, Ravilla D.] Aravind Eye Care Syst, Madurai, Tamil Nadu, India	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Public Health Foundation of India; National Institute of Mental Health & Neurosciences - India; Madras Diabetes Research Foundation	Patel, V (corresponding author), Sangath Ctr, Alto Porvorim 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Prabhakaran, Dorairaj/B-4147-2011; CHATTERJI, Somnath/ABE-6832-2020	Prabhakaran, Dorairaj/0000-0002-3172-834X; Patel, Vikram/0000-0003-1066-8584; Reddy, K Srinath/0000-0003-3416-3548; Mathers, Colin/0000-0002-0617-6731	Wellcome Trust; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	VP is supported by a Wellcome Trust Senior Clinical Research Fellowship in Tropical Medicine. We acknowledge the contribution of Krishna Rao who collated economic data for the cost-effectiveness estimates; the India World Health Survey team (P Arokiasamy) for doing the survey; and Emese Verdes for assisting with the World Health Survey analysis. The views expressed in this report are solely the responsibility of the named authors and do not necessarily reflect the decisions or stated policy of the WHO or its member states. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2000, TOB IND IND EC AN; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Baltussen R, 2009, INT J AUDIOL, V48, P144, DOI 10.1080/14992020802538081; Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Bang A, 1995, HLTH ACTION, V11, P2; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bidi Smoking and Public Health, 2008, BIDI SMOKING PUBLIC; BRILLIANT GE, 1991, ARCH OPHTHALMOL-CHIC, V109, P584, DOI 10.1001/archopht.1991.01080040152048; Cecchini M, 2010, LANCET          1111, DOI [10.1016/S0140-6736(10)61514-0, DOI 10.1016/50140-6736(10)61514-0]; Chang DF, 2005, BRIT J OPHTHALMOL, V89, P1073, DOI 10.1136/bjo.2005.068213; Chatterjee S, 2003, BRIT J PSYCHIAT, V182, P57, DOI 10.1192/bjp.182.1.57; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2008, ROAD TRAFFIC INJURY, P4; Chisholm D, 2008, B WORLD HEALTH ORGAN, V86, P542, DOI 10.2471/BLT.07.045377; Chow J, 2007, COST EFFECTIVENESS D; Crime National Records, 2007, ACC DEATHS SUIC IND, V11; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gill A, 2006, EC POLIT WKLY, V26, P27662; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Go R, 2005, STRIKING RIGHT BALAN; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Grover A, 2011, LANCET, V377, P976, DOI 10.1016/S0140-6736(10)62042-9; Gupta P. C., 2008, BIDI SMOKING PUBLIC; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Gupta R, 2006, INDIAN J MED RES, V124, P15; Gururaj G., 2006, ROAD TRAFFIC INJURY; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John R, EC TOBACCO TOBACCO T; John RM, 2008, HEALTH POLICY PLANN, V23, P200, DOI 10.1093/heapol/czn007; John TJ, 2011, LANCET          0112, DOI [10.1016/S0140-6736(10)61265-2, DOI 10.1016/50140-6736(10)61265-2]; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Jose R, 2008, COMMUNITY EYE HLTH, V21, ps103; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kapur A, 2007, INDIAN J MED RES, V125, P473; Karthikeyan G, 2007, HEART, V93, P1334, DOI 10.1136/hrt.2007.131193; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Leeder S, 2004, RACE TIME CHALLENGE; Levesque JF, 2007, INT J HEALTH PLAN M, V22, P159, DOI 10.1002/hpm.879; Levesque JF, 2006, FOR 9 M MUMB; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Maselko J, 2008, J EPIDEMIOL COMMUN H, V62, P817, DOI 10.1136/jech.2007.069351; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Ministry of Road Transport and Highways Government of India, 2007, REP COMM ROAD SAF TR; Ministry of Road Transport and Highways Government of India, 2007, NAT ROAD TRANSP POL; Ministry of Urban Development Government of India, NAT URB TRANSP POL; Mock C, 2003, J TRAUMA, V54, P1197, DOI 10.1097/01.TA.0000033492.48190.7A; Mock C., 2004, GUIDELINES ESSENTIAL; Mohan Dinesh, 2004, ROAD AHEAD TRAFFIC I; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Murray CJ, LANCET, V361, P717; Murthy RS, 2007, INDIAN J MED RES, V125, P707; Nagpal J, 2006, DIABETES CARE, V29, P2341, DOI 10.2337/dc06-0783; NATCHIAR G, 1994, ARCH OPHTHALMOL-CHIC, V112, P987, DOI 10.1001/archopht.1994.01090190135035; O'Heagarty M, 2008, BIDI SMOKING PUBLIC, P13; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Patel V, 2001, SOCIOECONOMIC FACTOR; Patel V, 2011, LANCET          1214; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2007, TROP MED INT HEALTH, V12, P130, DOI 10.1111/j.1365-3156.2006.01756.x; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Peden M., 2004, WORLD REPORT ROAD TR; Pednekar MS, 2008, BIDI SMOKING PUBLIC, P113; Planning Commission Government of India, 2007, 11 5 YEAR PLAN, VII; Prabhakaran Dorairaj, 2005, Indian Heart J, V57, P217; Purohit BC, 2001, HEALTH POLICY PLANN, V16, P87, DOI 10.1093/heapol/16.1.87; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2007, EPIDEMIOLOGY DIABETE; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Rastogi T, 2005, TOB CONTROL, V14, P356, DOI 10.1136/tc.2005.011965; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2006, LANCET, V367, P589, DOI 10.1016/S0140-6736(06)68225-1; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Rees K, 2004, COCHRANE DB SYST REV, V2; Rehm J, 1995, ALCOHOL CAPITA CONSU; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Sasser S, PREHOSPITAL TRAUMA C; Shastri SS, 2008, BIDI SMOKING PUBLIC, P143; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Singh RB, 2005, ACTA CARDIOL, V60, P611, DOI 10.2143/AC.60.6.2004933; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Sunley E., 2008, INDIA TAX TREATMENT; Tan-Torres Edejer T, 2003, MAKING CHOICE HLTH W; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thomas A, 2004, INVOLVEMENT IMPACT R; UNAIDS, 2007, AIDS EP UPD DEC 2007; Unwin N., 2009, INT DIABETES FEDERAT, V4; Ustun TB., 2003, WORLD HLTH SURVEYS H; Vijayakumar L, 2005, CRISIS, V26, P120, DOI 10.1027/0227-5910.26.3.120; WHO, 2005, CHRON DIS HLTH PROM; WHO Global Infobase Team, 2005, 2 WHO SURF GLOB INF; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1; World Health Organisation, 2008, CLOS GAP GEN; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, GLOB HLTH RISKS MORT; World Health Organization, GUID TRAUM QUAL IMPR; World Health Organization, 2004, GLOB BURD DIS 2004 U; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	122	220	222	3	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					413	428		10.1016/S0140-6736(10)61188-9	http://dx.doi.org/10.1016/S0140-6736(10)61188-9			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21227486				2022-12-24	WOS:000287337000031
J	Richly, H; Rocha-Viegas, L; Ribeiro, JD; Demajo, S; Gundem, G; Lopez-Bigas, N; Nakagawa, T; Rospert, S; Ito, T; Di Croce, L				Richly, Holger; Rocha-Viegas, Luciana; Domingues Ribeiro, Joana; Demajo, Santiago; Gundem, Gunes; Lopez-Bigas, Nuria; Nakagawa, Tekeya; Rospert, Sabine; Ito, Takashi; Di Croce, Luciano			Transcriptional activation of polycomb-repressed genes by ZRF1	NATURE			English	Article							RNA-POLYMERASE-II; H2A UBIQUITINATION; HISTONE H2B; PROTEIN; CHROMATIN; DIFFERENTIATION; MONOUBIQUITINATION; DEMETHYLATION; INITIATION; LEUKEMIA	Covalent modification of histones is fundamental in orchestrating chromatin dynamics and transcription(1-3). One example of such an epigenetic mark is the mono-ubiquitination of histones, which mainly occurs at histone H2A and H2B(4-6). Ubiquitination of histone H2A has been implicated in polycomb-mediated transcriptional silencing(7-9). However, the precise role of the ubiquitin mark during silencing is still elusive. Here we show in human cell lines that ZRF1 (zuotin-related factor 1) is specifically recruited to histone H2A when it is ubiquitinated at Lys 119 by means of a novel ubiquitin-interacting domain that is located in the evolutionarily conserved zuotin domain. At the onset of differentiation, ZRF1 specifically displaces polycomb-repressive complex 1 (PRC1) from chromatin and facilitates transcriptional activation. A genome-wide mapping of ZRF1, RING1B and H2A-ubiquitin targets revealed its involvement in the regulation of a large set of polycomb target genes, emphasizing the key role ZRF1 has in cell fate decisions. We provide here a model of the molecular mechanism of switching polycomb-repressed genes to an active state.	[Richly, Holger; Rocha-Viegas, Luciana; Domingues Ribeiro, Joana; Demajo, Santiago; Di Croce, Luciano] UPF, CRG, Barcelona 08003, Spain; [Gundem, Gunes; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Nakagawa, Tekeya; Ito, Takashi] Nagasaki Univ, Sch Med, Nagasaki 8528523, Japan; [Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol ZBMZ, D-79104 Freiburg, Germany; [Di Croce, Luciano] PRBB, CRG, ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Nagasaki University; University of Freiburg; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Di Croce, L (corresponding author), UPF, CRG, Barcelona 08003, Spain.	luciano.dicroce@crg.es	Lopez-Bigas, Nuria/F-6193-2011; Ribeiro, Joana/K-3357-2014; Demajo, Santiago/AAB-1999-2021; Di Croce, Luciano/E-7759-2015	Lopez-Bigas, Nuria/0000-0003-4925-8988; Ribeiro, Joana/0000-0003-2221-4002; Di Croce, Luciano/0000-0003-3488-6228; Rospert, Sabine/0000-0002-3089-9614; Rocha-Viegas, Luciana/0000-0001-7857-0212; Demajo Meseguer, Santiago/0000-0003-3998-8784	Spanish "Ministerio de Educacion y Ciencia'' [BFU2007-63059]; Association for International Cancer Research [10-0177]; AGAUR; Consolider; FEBS fellowship; Fundacao para a Ciencia e Tecnologia; Juan de la Cierva Fellowship; PFIS fellowship;  [FOR967]; ICREA Funding Source: Custom	Spanish "Ministerio de Educacion y Ciencia''(Spanish Government); Association for International Cancer Research; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEBS fellowship; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Juan de la Cierva Fellowship; PFIS fellowship; ; ICREA(ICREA)	We are indebted to S. Jentsch, S. Berger, K. Helin, J. Hasskarl, R. Shiekattar, T. Zimmermann and V. Raker for antibodies and plasmids and for discussions; and to the CRG Microarray facility and Light Microscopy Facility. This work was supported by the Spanish "Ministerio de Educacion y Ciencia'' (BFU2007-63059), the Association for International Cancer Research (10-0177), by the AGAUR and Consolider to L. D. C., and by FOR967 to S. R.; H. R. was supported by a FEBS fellowship; J. R. by a fellowship from Fundacao para a Ciencia e Tecnologia; L. R.-V. by a Juan de la Cierva Fellowship; S. D. by a PFIS fellowship.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Gibbons FD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r96; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue T, 1999, BIOCHEM BIOPH RES CO, V266, P147, DOI 10.1006/bbrc.1999.1779; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Resto VA, 2000, CANCER RES, V60, P5529; Saito S, 2008, INT J CANCER, V123, P633, DOI 10.1002/ijc.23490; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	33	103	105	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1124	U533		10.1038/nature09574	http://dx.doi.org/10.1038/nature09574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179169				2022-12-24	WOS:000285553800063
J	Verbrugge, I; Johnstone, RW; Smyth, MJ				Verbrugge, Inge; Johnstone, Ricky W.; Smyth, Mark J.			SnapShot: Extrinsic Apoptosis Pathways	CELL			English	Editorial Material							DEATH RECEPTORS; MITOCHONDRIA; INDUCTION; LIGAND; TRAIL		[Verbrugge, Inge; Johnstone, Ricky W.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Verbrugge, I (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.		Johnstone, Ricky w/H-3748-2014; Smyth, Mark J/H-8709-2014	Johnstone, Ricky w/0000-0001-7053-9237; Smyth, Mark J/0000-0001-7098-7240				ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386	10	50	53	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1192	+	1192.e1	10.1016/j.cell.2010.12.004	http://dx.doi.org/10.1016/j.cell.2010.12.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183080	Bronze			2022-12-24	WOS:000285625400016
J	Premaor, MO; Compston, JE				Premaor, Melissa O.; Compston, Juliet E.			Rational Testing Testing for secondary causes of osteoporosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							CELIAC-DISEASE; FRACTURE RISK; WOMEN		[Compston, Juliet E.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Premaor, Melissa O.] Univ Fed Santa Maria, Dept Clin Med, BR-97105900 Santa Maria, RS, Brazil	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade Federal de Santa Maria (UFSM)	Compston, JE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Box 157, Cambridge CB2 0QQ, England.	jec1001@cam.ac.uk	Premaor, Melissa/K-7401-2016	Premaor, Melissa/0000-0002-0770-9202				ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; CAPLAN GA, 1994, J ROY SOC MED, V87, P200; Francis RM, 2004, QJM-INT J MED, V97, P63, DOI 10.1093/qjmed/hch012; Jafri MR, 2008, DIGEST DIS SCI, V53, P964, DOI 10.1007/s10620-007-9976-0; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kristinsson SY, 2010, BLOOD, V116, P2651, DOI 10.1182/blood-2010-04-282848; Nolla JM, 2001, J RHEUMATOL, V28, P2289; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549	10	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 16	2010	341								c6959	10.1136/bmj.c6959	http://dx.doi.org/10.1136/bmj.c6959			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XM	21163836				2022-12-24	WOS:000285553100009
J	Song, Y; Altarejos, J; Goodarzi, MO; Inoue, H; Guo, XQ; Berdeaux, R; Kim, JH; Goode, J; Igata, M; Paz, JC; Hogan, MF; Singh, PK; Goebel, N; Vera, L; Miller, N; Cui, JR; Jones, MR; Chen, YDI; Taylor, KD; Hsueh, WA; Rotter, JI; Montminy, M				Song, Youngsup; Altarejos, Judith; Goodarzi, Mark O.; Inoue, Hiroshi; Guo, Xiuqing; Berdeaux, Rebecca; Kim, Jeong-Ho; Goode, Jason; Igata, Motoyuki; Paz, Jose C.; Hogan, Meghan F.; Singh, Pankaj K.; Goebel, Naomi; Vera, Lili; Miller, Nina; Cui, Jinrui; Jones, Michelle R.; Chen, Yii-Der I.; Taylor, Kent D.; Hsueh, Willa A.; Rotter, Jerome I.; Montminy, Marc		CHARGE Consortium; GIANT Consortium	CRTC3 links catecholamine signalling to energy balance	NATURE			English	Article							CREB COACTIVATOR CRTC2; BROWN ADIPOSE-TISSUE; ADENYLYL-CYCLASE; INSULIN-RESISTANCE; LIPOPROTEIN-LIPASE; MEXICAN-AMERICANS; OBESITY; GENE; TRANSCRIPTION; CELLS	The adipose-derived hormone leptin maintains energy balance in part through central nervous system-mediated increases in sympathetic outflow that enhance fat burning. Triggering of beta-adrenergic receptors in adipocytes stimulates energy expenditure by cyclic AMP (cAMP)-dependent increases in lipolysis and fatty-acid oxidation. Although the mechanism is unclear, catecholamine signalling is thought to be disrupted in obesity, leading to the development of insulin resistance. Here we show that the cAMP response element binding (CREB) coactivator Crtc3 promotes obesity by attenuating beta-adrenergic receptor signalling in adipose tissue. Crtc3 was activated in response to catecholamine signals, when it reduced adenyl cyclase activity by upregulating the expression of Rgs2, a GTPase-activating protein that also inhibits adenyl cyclase activity. As a common human CRTC3 variant with increased transcriptional activity is associated with adiposity in two distinct Mexican-American cohorts, these results suggest that adipocyte CRTC3 may play a role in the development of obesity in humans.	[Song, Youngsup; Altarejos, Judith; Inoue, Hiroshi; Berdeaux, Rebecca; Kim, Jeong-Ho; Goode, Jason; Igata, Motoyuki; Paz, Jose C.; Hogan, Meghan F.; Singh, Pankaj K.; Goebel, Naomi; Vera, Lili; Miller, Nina; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Goodarzi, Mark O.; Jones, Michelle R.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Guo, Xiuqing; Cui, Jinrui; Chen, Yii-Der I.; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Hsueh, Willa A.] Methodist Hosp, Res Inst, Diabet Res Ctr, Div Diabet Obes & Lipids, Houston, TX 77030 USA	Salk Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Paz, Jose Carlos/I-5783-2015; Rotter, Jerome/AAY-6598-2021; Goodarzi, Mark/AAH-7106-2021; Hogan, Meghan/AAD-4425-2020	Paz, Jose Carlos/0000-0001-9684-9735; Goodarzi, Mark/0000-0001-6364-5103; Singh, Pankaj/0000-0001-8903-0131; Hogan, Meghan/0000-0002-5767-1599; Berdeaux, Rebecca/0000-0002-9929-1711; Inoue, Hiroshi/0000-0002-7724-6637; Song, Youngsup/0000-0002-6268-5223	National Institutes of Health [R01-DK049777, R01-DK083834, P30-DK063491, R01-HL088457, R01-DK79888, R01-HL071205, N01-HC95159, N02-HL64278, M01-RR00425]; Cedars-Sinai Board of Governor's Chair in Medical Genetics; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071205, R01HL088457, R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R01DK049777, R37DK083834, P30DK063491, R01DK083834, R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Board of Governor's Chair in Medical Genetics; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-DK049777, R01-DK083834, P30-DK063491, R01-HL088457, R01-DK79888, R01-HL071205, N01-HC95159, N02-HL64278 and M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources, The J.W. Kieckhefer Foundation, The Clayton Medical Research Foundation, Inc., The Helmsley Foundation, the Cedars-Sinai Winnick Clinical Scholars Award (to M.O.G.) and the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). We thank B. Beutler and O. Siggs (The Scripps Research Institute) for help with macrophage studies.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Goodarzi MO, 2003, GENET MED, V5, P322, DOI 10.1097/01.GIM.0000076971.55421.AD; GRANNEMAN JG, 1995, ENDOCRINOLOGY, V136, P2007, DOI 10.1210/en.136.5.2007; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Landsberg L, 2006, CELL MOL NEUROBIOL, V26, P497, DOI 10.1007/s10571-006-9010-7; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; ROHLFS EM, 1995, J BIOL CHEM, V270, P10723, DOI 10.1074/jbc.270.18.10723; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	111	121	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					933	U329		10.1038/nature09564	http://dx.doi.org/10.1038/nature09564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164481	Green Accepted			2022-12-24	WOS:000285344600040
J	Gutierrez, NL; Hilborn, R; Defeo, O				Gutierrez, Nicolas L.; Hilborn, Ray; Defeo, Omar			Leadership, social capital and incentives promote successful fisheries	NATURE			English	Article							MANAGEMENT; COMANAGEMENT; PRINCIPLES; GOVERNANCE; QUOTAS	One billion people depend on seafood as their primary source of protein and 25% of the world's total animal protein comes from fisheries(1). Yet a third of fish stocks worldwide are overexploited or depleted(1,2). Using individual case studies, many have argued that community-based co-management(3) should prevent the tragedy of the commons(4) because cooperative management by fishers, managers and scientists often results in sustainable fisheries(3,5,6). However, general and multidisciplinary evaluations of co-management regimes and the conditions for social, economic and ecological success within such regimes are lacking. Here we examine 130 co-managed fisheries in a wide range of countries with different degrees of development, ecosystems, fishing sectors and type of resources. We identified strong leadership as the most important attribute contributing to success, followed by individual or community quotas, social cohesion and protected areas. Less important conditions included enforcement mechanisms, long-term management policies and life history of the resources. Fisheries were most successful when at least eight co-management attributes were present, showing a strong positive relationship between the number of these attributes and success, owing to redundancy in management regulations. Our results demonstrate the critical importance of prominent community leaders and robust social capital(7), combined with clear incentives through catch shares and conservation benefits derived from protected areas, for successfully managing aquatic resources and securing the livelihoods of communities depending on them. Our study offers hope that co-management, the only realistic solution for the majority of the world's fisheries, can solve many of the problems facing global fisheries.	[Gutierrez, Nicolas L.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Defeo, Omar] Fac Ciencias, UNDECIMAR, Montevideo 11400, Uruguay	University of Washington; University of Washington Seattle; Universidad de la Republica, Uruguay	Gutierrez, NL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	nicolasg@uw.edu	Gutierrez, Nicolas/D-4026-2009; Hilborn, Ray W/D-6332-2013	Defeo, Omar/0000-0001-8318-528X	National Science Foundation [0308440]; Fulbright-OAS Initiative in Ecology; Pew Charitable Trusts	National Science Foundation(National Science Foundation (NSF)); Fulbright-OAS Initiative in Ecology; Pew Charitable Trusts	N.L.G. was partially funded by the National Science Foundation (award 0308440) and a Fulbright-OAS Initiative in Ecology fellowship. O.D. acknowledges support by the Pew Charitable Trusts. We thank E. Ostrom, T. A. Branch, and X. Basurto for comments on the manuscript and A. E. Punt, W. N. Venables, R. Perera and S. Sethi for discussions on the methodological and statistical approach.	Basurto X., 2009, J NATURAL RESOURCES, V1, P255, DOI DOI 10.1080/19390450903040447; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Borrini-Feyerabend G., 2004, SHARING POWER LEARNI; Branch TA, 2009, FISH FISH, V10, P39, DOI 10.1111/j.1467-2979.2008.00294.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Castilla JC, 2005, SCIENCE, V309, P1324; Chetty RK, 2010, CLIN PHARMACOL THER, V88, P260, DOI 10.1038/clpt.2010.77; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Essington TE, 2010, P NATL ACAD SCI USA, V107, P754, DOI 10.1073/pnas.0907252107; Food and Agriculture Organization of the United Nations, 2009, FAO YB FISH AQ STAT; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Levin S, 2010, PHILOS T R SOC B, V365, P13, DOI 10.1098/rstb.2009.0197; Olsson P, 2004, ECOL SOC, V9; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; Ostrom E., 1990, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pollnac R., 2010, P NATL ACAD SCI US; Pomeroy R.S., 1994, FISHERIES COMANAGEME; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Stefansson G, 2005, PHILOS T R SOC B, V360, P133, DOI 10.1098/rstb.2004.1579; United Nations Development Program, 2009, HUM DEV IND; Wilson J, 2007, P NATL ACAD SCI USA, V104, P15212, DOI 10.1073/pnas.0702241104; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	30	829	844	12	574	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					386	389		10.1038/nature09689	http://dx.doi.org/10.1038/nature09689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21209616				2022-12-24	WOS:000287409100040
J	Clark, AL; Johnson, MJ; Squire, I				Clark, Andrew L.; Johnson, Miriam J.; Squire, Iain			Uncertainties Page Does home oxygen benefit people with chronic heart failure?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE CAPACITY; BREATHLESSNESS; THERAPY; DYSPNEA					a.l.clark@hull.ac.uk		Johnson, Miriam/0000-0001-6204-9158	National Institute for Health Research [06/80/01] Funding Source: researchfish; Department of Health [06/80/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Booth S, 2004, RESP MED, V98, P66, DOI 10.1016/j.rmed.2003.08.008; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; CLARK A, 1994, BRIT HEART J, V71, P528; Cranston JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001744.pub2; Cranston JM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004769.pub2; Currow DC, 2009, PALLIATIVE MED, V23, P309, DOI 10.1177/0269216309104058; Mak S, 2001, CHEST, V120, P467, DOI 10.1378/chest.120.2.467; MOORE DP, 1992, LANCET, V339, P850, DOI 10.1016/0140-6736(92)90288-E; Oldenburg O, 2007, EUR J HEART FAIL, V9, P251, DOI 10.1016/j.ejheart.2006.08.003; RUBIN SA, 1982, CIRCULATION, V66, P143, DOI 10.1161/01.CIR.66.1.143; Russell SD, 1999, AM J CARDIOL, V84, P1412, DOI 10.1016/S0002-9149(99)00587-1; Sasayama S, 2009, CIRC J, V73, P1255, DOI 10.1253/circj.CJ-08-1210; Scottish Intercollegiate Guidelines Network, 2003, 73 SCOTT INT GUID NE; THOMAS M, 1965, BRIT HEART J, V27, P401; Toyama T, 2009, CIRC J, V73, P299, DOI 10.1253/circj.CJ-07-0297	16	15	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2011	342								d234	10.1136/bmj.d234	http://dx.doi.org/10.1136/bmj.d234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PX	21296836				2022-12-24	WOS:000287138600005
J	Engineer, ND; Riley, JR; Seale, JD; Vrana, WA; Shetake, JA; Sudanagunta, SP; Borland, MS; Kilgard, MP				Engineer, Navzer D.; Riley, Jonathan R.; Seale, Jonathan D.; Vrana, Will A.; Shetake, Jai A.; Sudanagunta, Sindhu P.; Borland, Michael S.; Kilgard, Michael P.			Reversing pathological neural activity using targeted plasticity	NATURE			English	Article							VAGUS NERVE-STIMULATION; CORTICAL MAP REORGANIZATION; PHANTOM-LIMB PAIN; AUDITORY-CORTEX; HEARING-LOSS; ASSESSING TINNITUS; TRAUMA; HYPERACTIVITY; SELECTIVITY; NUCLEUS	Brain changes in response to nerve damage or cochlear trauma can generate pathological neural activity that is believed to be responsible for many types of chronic pain and tinnitus(1-3). Several studies have reported that the severity of chronic pain and tinnitus is correlated with the degree of map reorganization in somatosensory and auditory cortex, respectively(1,4). Direct electrical or transcranial magnetic stimulation of sensory cortex can temporarily disrupt these phantom sensations(5). However, there is as yet no direct evidence for a causal role of plasticity in the generation of pain or tinnitus. Here we report evidence that reversing the brain changes responsible can eliminate the perceptual impairment in an animal model of noise-induced tinnitus. Exposure to intense noise degrades the frequency tuning of auditory cortex neurons and increases cortical synchronization. Repeatedly pairing tones with brief pulses of vagus nerve stimulation completely eliminated the physiological and behavioural correlates of tinnitus in noise-exposed rats. These improvements persisted for weeks after the end of therapy. This method for restoring neural activity to normal may be applicable to a variety of neurological disorders.	[Engineer, Navzer D.; Riley, Jonathan R.; Seale, Jonathan D.; Vrana, Will A.; Shetake, Jai A.; Sudanagunta, Sindhu P.; Borland, Michael S.; Kilgard, Michael P.] Univ Texas Dallas, Cort Plast Lab, Richardson, TX 75080 USA; [Engineer, Navzer D.] MicroTransponder Inc, Austin, TX 78738 USA	University of Texas System; University of Texas Dallas	Engineer, ND (corresponding author), Univ Texas Dallas, Cort Plast Lab, Richardson, TX 75080 USA.	navzer@utdallas.edu		Riley, Jonathan/0000-0003-0129-3071; Kilgard, Michael/0000-0002-6699-1818	James S. McDonnell Foundation; Texas Advanced Research Program; National Institute for Deafness and other Communication Disorders; MicroTransponder Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R44DC010084, R43DC010084] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Texas Advanced Research Program; National Institute for Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MicroTransponder Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Kuzu, J. Omana, D. Vuppala, H. Rasul, M. Fink, E. Hanacik, R. Miller and C. Walker for help with rat behavioural training. We would also like to thank J. Eggermont, A. Moller, C. Bauer, J. Fritz, H. Reed, C. Engineer, A. Reed, M. Brosch, R. Rennaker, R. Beitel, V. Miller, C. McIntyre, G. White, P. Pandya, R. Tyler and D. deRidder for suggestions about earlier versions of the manuscript. This work was supported by the James S. McDonnell Foundation, the Texas Advanced Research Program, the National Institute for Deafness and other Communication Disorders, and MicroTransponder Inc.	Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Ben-Menachem E, 2001, J CLIN NEUROPHYSIOL, V18, P415, DOI 10.1097/00004691-200109000-00005; Bollinger J. J., 2006, THESIS U CALIFORNIA; BURNS EM, 1984, AUDIOLOGY, V23, P426; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; DAUMAN R, 1989, ARCH OTO-RHINO-LARYN, V246, P252, DOI 10.1007/BF00463566; De Ridder D, 2007, PROG BRAIN RES, V166, P377, DOI 10.1016/S0079-6123(07)66036-1; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2007, PROG BRAIN RES, V166, P19, DOI 10.1016/S0079-6123(07)66002-6; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kilgard MP, 2007, HEARING RES, V229, P171, DOI 10.1016/j.heares.2007.01.005; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Moore BCJ, 2010, HEARING RES, V261, P51, DOI 10.1016/j.heares.2010.01.003; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; MURPHY WJ, 2001, J ACOUST SOC AM, V109, P2373; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013	34	402	441	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					101	U114		10.1038/nature09656	http://dx.doi.org/10.1038/nature09656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21228773	Green Accepted			2022-12-24	WOS:000286886400042
J	Schmajuk, G; Trivedi, AN; Solomon, DH; Yelin, E; Trupin, L; Chakravarty, EF; Yazdany, J				Schmajuk, Gabriela; Trivedi, Amal N.; Solomon, Daniel H.; Yelin, Edward; Trupin, Laura; Chakravarty, Eliza F.; Yazdany, Jinoos			Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; HEALTH PLANS; DISPARITIES; OUTCOMES; DATABASE; COST; BENEFICIARIES; NEIGHBORHOOD; MEDICATIONS; AMERICAN	Context In 2005, the Healthcare Effectiveness Data and Information Set (HEDIS) introduced a quality measure to assess the receipt of disease-modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA). Objective To identify sociodemographic, community, and health plan factors associated with DMARD receipt among Medicare managed care enrollees. Design, Setting, and Participants We analyzed individual-level HEDIS data for 93 143 patients who were at least 65 years old with at least 2 diagnoses of RA within a measurement year (during 2005-2008). Logistic regression models with generalized estimating equations were used to determine factors associated with DMARD receipt and logistic regression was used to adjust health plan performance for case mix. Main Outcome Measures Receipt or nonreceipt of DMARD. Results The mean age of patients was 74 years; 75% were women and 82% were white. Overall performance on the HEDIS measure for RA was 59% in 2005, increasing to 67% in 2008 (P for trend <.001). The largest difference in performance was based on age: patients aged 85 years and older had a 30 percentage point lower rate of DMARD receipt (95% confidence interval [CI], -29 to -32 points; P<.001), compared with patients 65 to 69 years of age, even after adjusting for other factors. Lower percentage point rates were also found for patients who were men (-3 points; 95% CI, -5 to -2 points; P<.001), of black race (-4 points; 95% CI, -6 to -2 points; P<.001), with low personal income (-6 points; 95% CI, -8 to -5 points; P<.001), with the lowest zip code-based socioeconomic status (-4 points; 95% CI, -6 to 2 points; P<.001), or enrolled in for-profit health plans (-4 points; 95% CI, -7 to 0 points; P<.001); and in the Middle Atlantic region (-7 points; 95% CI, -13 to -2 points; P<.001) and South Atlantic regions (-11 points; 95% CI, -20 to -3 points; P<.001) as compared with the Pacific region. Performance varied widely by health plan, ranging from 16% to 87%. Conclusions Among Medicare managed care enrollees carrying a diagnosis of RA between 2005 and 2008, 63% received a DMARD. Receipt of DMARDs varied based on demographic factors, socioeconomic status, geographic location, and health plan. JAMA. 2011;305(5):480-486 www.jama.com	[Schmajuk, Gabriela; Chakravarty, Eliza F.] Stanford Univ, Dept Med, Div Rheumatol, Stanford, CA 94304 USA; [Trivedi, Amal N.] Brown Univ, Dept Community Hlth & Med, Providence, RI 02912 USA; [Solomon, Daniel H.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Yelin, Edward; Trupin, Laura; Yazdany, Jinoos] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA	Stanford University; Brown University; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Schmajuk, G (corresponding author), Stanford Univ, Dept Med, Div Rheumatol, 1000 Welch Rd,Ste 203, Stanford, CA 94304 USA.	schmajuk@gmail.com			Merck; Pzifer (Pzifer Foundation); American College of Rheumatology/Research and Education Foundation; National Center for Research Resources [5-M01-RR-00079]; Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health [R01-AR-44804]; State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1-R01-HS-013893, P60-AR-053308, K24-AR-AR055989, R01-AR-056215]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013893] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044804, P60AR053308, R01AR056215, R01AR056476, K24AR055989, K23AR060259] Funding Source: NIH RePORTER	Merck(Merck & Company); Pzifer (Pzifer Foundation); American College of Rheumatology/Research and Education Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trivedi reports receipt of compensation from Merck (for editing a chapter of the Merck Manual) and from the Pzifer (for receiving a Health Policy Scholars Award from the Pzifer Foundation). Other authors reported no potential conflicts.; Funding was provided by the American College of Rheumatology/Research and Education Foundation Physician-Scientist Development Award; National Center for Research Resources (5-M01-RR-00079); Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health (R01-AR-44804); State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; and National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant numbers: 1-R01-HS-013893, P60-AR-053308, K24-AR-AR055989, and R01-AR-056215).	Agency for Healthcare Research and Quality, RHEUM ARTHR PERC MEM; [Anonymous], 2001, INTERSTUDY COMPETITI; [Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Baker LC, 2010, INT J QUAL HEALTH C, V22, P210, DOI 10.1093/intqhc/mzq011; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Brown AF, 2007, AM J PUBLIC HEALTH, V97, P926, DOI 10.2105/AJPH.2005.069443; Bruce B, 2007, J RHEUMATOL, V34, P1475; Brunner HI, 2006, ARTHRIT RHEUM-ARTHR, V55, P378, DOI 10.1002/art.21991; Edwards CJ, 2005, RHEUMATOLOGY, V44, pI2; GABRIEL SE, 1994, ARTHRITIS RHEUM, V37, P821, DOI 10.1002/art.1780370607; Gleason PP, 2009, J MANAGE CARE PHARM, V15, P648, DOI 10.18553/jmcp.2009.15.8.648; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Groessl EJ, 2006, PHARMACOECONOMICS, V24, P109, DOI 10.2165/00019053-200624020-00002; Health Care Financing Administration, MED HE DIS DAT AUD M; Iren UT, 2005, J RHEUMATOL, V32, P602; Keenan PS, 2010, MED CARE, V48, P260, DOI 10.1097/MLR.0b013e3181ca410a; Khanna R, 2007, CLIN THER, V29, P2456, DOI 10.1016/j.clinthera.2007.11.009; Koroukian SM, 2010, HEALTH SERV RES, V45, P265, DOI 10.1111/j.1475-6773.2009.01051.x; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Pincus T, 1999, ANN INTERN MED, V131, P768, DOI 10.7326/0003-4819-131-10-199911160-00009; Pisetsky DS, 2001, JAMA-J AM MED ASSOC, V286, P2787, DOI 10.1001/jama.286.22.2787; Polinski JM, 2009, ARTHRIT RHEUM-ARTHR, V61, P745, DOI 10.1002/art.24560; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; Sequist TD, 2006, HEALTH SERV RES, V41, P1451, DOI 10.1111/j.1475-6773.2006.00549; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Strand V, 2008, AM J MANAG CARE, V14, P239; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Trupin L, 2008, J RHEUMATOL, V35, P1782; Tutuncu Z, 2006, ANN RHEUM DIS, V65, P1226, DOI 10.1136/ard.2005.051144; Widdifield J, 2011, ARTHRIT CARE RES, V63, P53, DOI 10.1002/acr.20304; Zaslavsky AM, 2005, INT J QUAL HEALTH C, V17, P67, DOI 10.1093/intqhc/mzi005; Ziegler S, 2010, ANN RHEUM DIS, V69, P1803, DOI 10.1136/ard.2009.122101; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	39	101	102	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					480	486		10.1001/jama.2011.67	http://dx.doi.org/10.1001/jama.2011.67			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714LI	21285425	Green Accepted, Bronze			2022-12-24	WOS:000286810700021
J	Sergio, F; Blas, J; Blanco, G; Tanferna, A; Lopez, L; Lemus, JA; Hiraldo, F				Sergio, F.; Blas, J.; Blanco, G.; Tanferna, A.; Lopez, L.; Lemus, J. A.; Hiraldo, F.			Raptor Nest Decorations Are a Reliable Threat Against Conspecifics	SCIENCE			English	Article							BOWERBIRDS; COST; REPEATABILITY; DISPLAY; BIRD	Individual quality is often signaled by phenotypic flags, such as bright plumage patches in birds. Extended phenotype signals can similarly show quality, but in these cases the signals are external to the individual, often taking the form of objects scavenged from the environment. Through multiple manipulative experiments, we showed that objects used for nest decoration by a territorial raptor, the black kite (Milvus migrans), act as reliable threats to conspecifics, revealing the viability, territory quality, and conflict dominance of the signaler. Our results suggest that animal-built structures may serve as signaling devices much more frequently than currently recognized.	[Sergio, F.; Blas, J.; Tanferna, A.; Lopez, L.; Lemus, J. A.; Hiraldo, F.] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville 41092, Spain; [Blanco, G.] CSIC, Museum Nat Sci, Dept Evolutionary Ecol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC)	Sergio, F (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, C Amer Vespucio, Seville 41092, Spain.	fsergio@ebd.csic.es	López, Lidia/HGE-0751-2022; Sergio, Fabrizio/B-3952-2015; Tanferna, Alessandro/L-6648-2015; Blanco, Guillermo/L-3170-2014; Hiraldo, Fernando/AAA-8314-2019; Blas, Julio/A-2487-2012	Sergio, Fabrizio/0000-0002-8024-1773; Tanferna, Alessandro/0000-0003-0799-301X; Blanco, Guillermo/0000-0001-5742-4929; Blas, Julio/0000-0003-0589-3322; Lopez-Jimenez, Lidia/0000-0002-4109-3034	Junta de Andalucia [CGL2008-01781, JA-58, RNM 1790, RNM 03822]; Ministerio de Ciencia e Innovacion; Natural Research Limited	Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Natural Research Limited	We thank F. J. Chicano, J. Giralt, and F. G. Vilches for help in the field. S. N. Vignieri and three anonymous reviewers greatly improved a previous draft of the manuscript. The study was funded by the research projects CGL2008-01781, JA-58, RNM 1790, and RNM 03822 granted by the Junta de Andalucia, Ministerio de Ciencia e Innovacion, and Natural Research Limited.	ADAMS ES, 1995, J THEOR BIOL, V175, P405, DOI 10.1006/jtbi.1995.0151; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; BORGIA G, 1993, AM NAT, V141, P729, DOI 10.1086/285502; Bradbury Jack W., 1998, pi; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; COLLIAS ELSIE C., 1964, AUK, V81, P42; DIAMOND J, 1986, P NATL ACAD SCI USA, V83, P3042, DOI 10.1073/pnas.83.9.3042; Doerr NR, 2010, ANIM BEHAV, V79, P747, DOI 10.1016/j.anbehav.2009.12.032; Enquist M, 1998, ANIM BEHAV, V56, P749, DOI 10.1006/anbe.1998.0820; Hansell M, 2005, OXF ANIMAL BIOL SER; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; JOHNSTONE RA, 1993, BEHAV ECOL SOCIOBIOL, V32, P127, DOI 10.1007/BF00164045; Levey DJ, 2004, NATURE, V431, P39, DOI 10.1038/431039a; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Madden JR, 2008, ANIM COGN, V11, P1, DOI 10.1007/s10071-007-0092-5; Madden JR, 2002, P ROY SOC B-BIOL SCI, V269, P1347, DOI 10.1098/rspb.2002.1988; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MORENO J, 1994, ANIM BEHAV, V47, P1297, DOI 10.1006/anbe.1994.1178; Ostlund-Nilsson S, 2003, BEHAV ECOL SOCIOBIOL, V53, P214, DOI 10.1007/s00265-002-0574-z; Rushbrook BJ, 2008, ANIM BEHAV, V75, P547, DOI 10.1016/j.anbehav.2007.06.011; Schaedelin FC, 2009, BIOL REV, V84, P293, DOI 10.1111/j.1469-185X.2008.00075.x; Schuetz JG, 2005, BEHAV ECOL, V16, P133, DOI 10.1093/beheco/arh139; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Walsh PT, 2010, BIOL LETTERS, V6, P149, DOI 10.1098/rsbl.2009.0664; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Wojcieszek JM, 2007, BEHAV ECOL, V18, P689, DOI 10.1093/beheco/arm031	28	97	104	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					327	330		10.1126/science.1199422	http://dx.doi.org/10.1126/science.1199422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252345	Green Submitted			2022-12-24	WOS:000286636300036
J	Gelstein, S; Yeshurun, Y; Rozenkrantz, L; Shushan, S; Frumin, I; Roth, Y; Sobel, N				Gelstein, Shani; Yeshurun, Yaara; Rozenkrantz, Liron; Shushan, Sagit; Frumin, Idan; Roth, Yehudah; Sobel, Noam			Human Tears Contain a Chemosignal	SCIENCE			English	Article							PULSATILE SECRETION; CHEMOSENSORY CUES; HORMONE; WOMEN; MOOD	Emotional tearing is a poorly understood behavior that is considered uniquely human. In mice, tears serve as a chemosignal. We therefore hypothesized that human tears may similarly serve a chemosignaling function. We found that merely sniffing negative-emotion-related odorless tears obtained from women donors induced reductions in sexual appeal attributed by men to pictures of women's faces. Moreover, after sniffing such tears, men experienced reduced self-rated sexual arousal, reduced physiological measures of arousal, and reduced levels of testosterone. Finally, functional magnetic resonance imaging revealed that sniffing women's tears selectively reduced activity in brain substrates of sexual arousal in men.	[Gelstein, Shani; Yeshurun, Yaara; Rozenkrantz, Liron; Shushan, Sagit; Frumin, Idan; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Shushan, Sagit; Roth, Yehudah] Edith Wolfson Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, IL-58100 Holon, Israel	Weizmann Institute of Science	Sobel, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	noam.sobel@weizmann.ac.il	Frumin, Idan/N-7049-2014	Frumin, Idan/0000-0002-6293-1586; Sobel, Noam/0000-0002-3232-9391; Yeshurun, Yaara/0000-0002-0843-6998; Rozenkrantz, Liron/0000-0002-6496-4592	Minerva Stiftung Foundation	Minerva Stiftung Foundation	This work was supported by a grant from the Minerva Stiftung Foundation.	Bensafi M, 2003, BEHAV NEUROSCI, V117, P1125, DOI 10.1037/0735-7044.117.6.1125; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; FREY WH, 1981, AM J OPHTHALMOL, V92, P559, DOI 10.1016/0002-9394(81)90651-6; Frey William H., 1985, CRYING MYSTERY TEARS; Frijda N.H.., 1986, REV PHILOS LOUVAIN; GROSS JJ, 1994, PSYCHOPHYSIOLOGY, V31, P460, DOI 10.1111/j.1469-8986.1994.tb01049.x; Hendriks MCP, 2008, J SOC PSYCHOL, V148, P22, DOI 10.3200/SOCP.148.1.22-42; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; McCarthy Susan, 1995, ELEPHANTS WEEP EMOTI; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; MONTAGU A, 1959, SCIENCE, V130, P1572, DOI 10.1126/science.130.3388.1572; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; Provine RR, 2009, EVOL PSYCHOL, V7, P52, DOI 10.1177/147470490900700107; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; STOLERU SG, 1993, PSYCHONEUROENDOCRINO, V18, P205, DOI 10.1016/0306-4530(93)90005-6; Thompson RN, 2007, PHYSIOL BEHAV, V90, P797, DOI 10.1016/j.physbeh.2007.01.008; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; Vingerhoets A.J.J.M., 2000, REV GEN PSYRCHOLOGY, V4, P354, DOI [https://doi.org/10.1037/1089-2680.4.4.354, DOI 10.1037/1089-2680.4.4.354, 10.1037/1089-2680.4.4.354]; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	30	136	139	1	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					226	230		10.1126/science.1198331	http://dx.doi.org/10.1126/science.1198331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21212322				2022-12-24	WOS:000286433100046
J	Eklind-Cervenka, M; Benson, L; Dahlstrom, U; Edner, M; Rosenqvist, M; Lund, LH				Eklind-Cervenka, Maria; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus; Rosenqvist, Marten; Lund, Lars H.			Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOTENSIN-RECEPTOR BLOCKERS; VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; RANDOMIZED-TRIAL; BLOOD-PRESSURE; TASK-FORCE; DIAGNOSIS; GUIDELINES; MANAGEMENT; BINDING	Context Angiotensin II receptor blockers (ARBs) reduce combined mortality and hospitalization in patients with heart failure (HF) with reduced left ventricular ejection fraction. Different agents have different affinity for the AT(1) receptor and may have different clinical effects, but have not been tested against each other in HF. Objective To assess the association of candesartan vs losartan with all-cause mortality in patients with HF. Design, Setting, and Patients An HF registry (the Swedish Heart Failure Registry) of 30 254 unique patients registered from 62 hospitals and 60 outpatient clinics between 2000 and 2009. A total of 5139 patients (mean [SD] age, 74 [11] years; 39% women) were treated with candesartan (n=2639) or losartan (n=2500). Survival as of December 14, 2009, by ARB agent was analyzed by Kaplan-Meier method and predictors of survival determined by univariate and multivariate proportional hazard regression models, with and without adjustment for propensity scores and interactions. Stratified analyses and quantification of residual confounding were also performed. Main Outcome Measures All-cause mortality at 1 and 5 years. Results One-year survival was 90% (95% confidence interval [CI], 89%-91%) for patients receiving candesartan and 83% (95% CI, 81%-84%) for patients receiving losartan, and 5-year survival was 61% (95% CI, 54%-68%) and 44% (95% CI, 41%-48%), respectively (log-rank P<.001). In multivariate analysis with adjustment for propensity scores, the hazard ratio for mortality for losartan compared with candesartan was 1.43 (95% CI, 1.23-1.65; P<.001). The results persisted in stratified analyses. Conclusion In this registry of patients with HF, the use of candesartan compared with losartan was associated with a lower mortality risk. JAMA. 2011; 305(2): 175-182	[Lund, Lars H.] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden; [Eklind-Cervenka, Maria; Rosenqvist, Marten] Soder Sjukhuset, Dept Cardiol, Stockholm, Sweden; [Eklind-Cervenka, Maria; Benson, Lina; Rosenqvist, Marten] Karolinska Inst, Dept Clin Sci & Educ, SoS, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Edner, Magnus] Danderyd Hosp, Div Cardiovasc Med, Stockholm, Sweden; [Edner, Magnus] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Lund, Lars H.] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital; Karolinska Institutet; Linkoping University; Linkoping University; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Lund, LH (corresponding author), Karolinska Univ Hosp, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055	Astra-Zeneca; Linkoping University; Research Foundation SouthEastern Sweden; Swedish Heart-Lung Foundation; Merck Sharp and Dohme; Karolinska Institutet; Stockholm County Council; Medtronic; St Jude; Boston Scientific; Vinnova; Swedish Order of Free Mason; Sanofi-Aventis; Boehringer Ingelheim; Orion Pharma; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Roche; Merck; ResMed	Astra-Zeneca(AstraZeneca); Linkoping University; Research Foundation SouthEastern Sweden; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Merck Sharp and Dohme(Merck & Company); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Medtronic(Medtronic); St Jude(St. Jude Medical); Boston Scientific(Boston Scientific); Vinnova(Vinnova); Swedish Order of Free Mason; Sanofi-Aventis(Sanofi-Aventis); Boehringer Ingelheim(Boehringer Ingelheim); Orion Pharma; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Roche(Roche Holding); Merck(Merck & Company); ResMed	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Eklind-Cervenka reported receiving speaker's fees from Astra-Zeneca. Dr Dahlstrom reported receiving speaker's fees from Astra-Zeneca and research grants from Linkoping University, Research Foundation SouthEastern Sweden, and Swedish Heart-Lung Foundation. Dr Edner reported receiving speaker's fees from Merck Sharp and Dohme, and research grants from Karolinska Institutet, Stockholm County Council, Medtronic, St Jude, Boston Scientific, and Merck Sharp and Dohme. Dr Rosenqvist reported receiving consulting fees from Merck Sharp and Dohme, speaker's fees from Astra-Zeneca and Merck Sharp and Dohme, and research grants from Karolinska Institutet, Stockholm County Council, Swedish Heart-Lung Foundation, Vinnova, Swedish Order of Free Mason, Sanofi-Aventis, and Boehringer Ingelheim. Dr Lund reported receiving consulting fees and speaker's fees from Astra-Zeneca, and research grants from Karolinska Institutet, Stockholm County Council, Swedish Heart-Lung Foundation, Astra-Zeneca, and Orion Pharma. Ms Benson reported no financial disclosures.; This study received no specific funding. However, establishment of the Swedish Heart Failure Registry was supported by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, AstraZeneca, Roche, Merck, Orion Pharma, and ResMed.	Bhuiyan MA, 2009, LIFE SCI, V85, P136, DOI 10.1016/j.lfs.2009.05.001; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fabiani ME, 2000, AM J HYPERTENS, V13, P1005, DOI 10.1016/S0895-7061(00)00286-7; Fierens F, 1999, EUR J PHARMACOL, V367, P413, DOI 10.1016/S0014-2999(98)00965-0; Fierens F L, 2000, J Renin Angiotensin Aldosterone Syst, V1, P283, DOI 10.3317/jraas.2000.044; Fridman KUB, 2002, BLOOD PRESSURE, V11, P244, DOI 10.1080/08037050213766; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hudson M, 2007, PHARMACOTHERAPY, V27, P526, DOI 10.1592/phco.27.4.526; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Koh KK, 2004, AM J CARDIOL, V93, P1432, DOI 10.1016/j.amjcard.2004.02.050; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lacourciere Y, 1999, AM J HYPERTENS, V12, P1181, DOI 10.1016/S0895-7061(99)00142-9; Lee VC, 2004, ANN INTERN MED, V141, P693, DOI 10.7326/0003-4819-141-9-200411020-00011; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2010, EUR J HEART FAIL, V12, P99, DOI 10.1093/eurjhf/hfp197; Meredith PA, 2010, J HUM HYPERTENS, V24, P525, DOI 10.1038/jhh.2009.99; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Van Liefde I, 2009, MOL CELL ENDOCRINOL, V302, P237, DOI 10.1016/j.mce.2008.06.006; Vanderheyden PML, 1999, BRIT J PHARMACOL, V126, P1057, DOI 10.1038/sj.bjp.0702398; Vauquelin G, 2006, J HYPERTENS, V24, pS23, DOI 10.1097/01.hjh.0000220403.61493.18; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	30	52	53	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					175	182		10.1001/jama.2010.1949	http://dx.doi.org/10.1001/jama.2010.1949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224459	Bronze			2022-12-24	WOS:000286103400023
J	Reddy, MM; Wilson, R; Wilson, J; Connell, S; Gocke, A; Hynan, L; German, D; Kodadek, T				Reddy, M. Muralidhar; Wilson, Rosemary; Wilson, Johnnie; Connell, Steven; Gocke, Anne; Hynan, Linda; German, Dwight; Kodadek, Thomas			Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening	CELL			English	Article							PROTEIN MICROARRAYS; MULTIPLE-SCLEROSIS; PEPTOID LIBRARIES; CANCER; AUTOIMMUNITY; DISCOVERY; LESSONS; ARRAY	The adaptive immune system is thought to be a rich source of protein biomarkers, but diagnostically useful antibodies remain unknown for a large number of diseases. This is, in part, because the antigens that trigger an immune response in many diseases remain unknown. We present here a general and unbiased approach to the identification of diagnostically useful antibodies that avoids the requirement for antigen identification. This method involves the comparative screening of combinatorial libraries of unnatural, synthetic molecules against serum samples obtained from cases and controls. Molecules that retain far more IgG antibodies from the case samples than the controls are identified and subsequently tested as capture agents for diagnostically useful antibodies. The utility of this method is demonstrated using a mouse model for multiple sclerosis and via the identification of two candidate IgG biomarkers for Alzheimer's disease.	[Reddy, M. Muralidhar; Kodadek, Thomas] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Reddy, M. Muralidhar; Kodadek, Thomas] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Reddy, M. Muralidhar; Wilson, Rosemary; Wilson, Johnnie] Opko Hlth Labs, Jupiter, FL 33458 USA; [Connell, Steven; Gocke, Anne] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Hynan, Linda] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [German, Dwight] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Scripps Research Institute; State University System of Florida; University of Florida; Scripps Research Institute; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Scripps Florida, Scripps Res Inst, Dept Chem, 130 Scripps Way,3A2, Jupiter, FL 33458 USA.	kodadek@scripps.edu	Hynan, Linda S/P-6473-2016	Hynan, Linda/0000-0002-4642-7769; Kodadek, Thomas/0000-0003-1930-4795	NIH [DP1OD000663, AG12300]; NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health [NO1-HV-28185]; NATIONAL INSTITUTE ON AGING [P30AG012300] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Mike Racke, Amy Lovett-Racke, and Ward Wakeland for contributing EAE and SLE samples in the early phase of this project. We thank Kristin Martin-Cook of the UT Southwestern Medical Center's Alzheimer's Disease Center for selecting the normal and AD serum samples for analysis and Dr. Padraig O'Suilleabhain for diagnosis and collection of the PD serum samples. This work was supported by an NIH Director Pioneer Award to T.K. (DP1OD000663) and the NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health (contract No. NO1-HV-28185). Human serum sample collection was supported by grant NIH grant AG12300.	Alluri PG, 2003, J AM CHEM SOC, V125, P13995, DOI 10.1021/ja036417x; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Figliozzi GM, 1996, METHOD ENZYMOL, V267, P437; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gibson DS, 2010, J PROTEOMICS, V73, P1045, DOI 10.1016/j.jprot.2009.11.013; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hauser SL, 2008, NEW ENGL J MED, V359, P1838, DOI 10.1056/NEJMe0806738; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386, 10.1517/14712590902870386 ]; Liu K, 2001, ADV EXP MED BIOL, V490, P1; Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T300001-MCP200; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Olivos HJ, 2002, ORG LETT, V4, P4057, DOI 10.1021/ol0267578; Ransohoff DF, 2005, J NATL CANCER I, V97, P315, DOI 10.1093/jnci/dji054; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; Robinson WH, 2002, BIOTECHNIQUES, P66; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Steller S, 2005, PROTEOMICS, V5, P2048, DOI 10.1002/pmic.200401097; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3	28	165	183	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					132	142		10.1016/j.cell.2010.11.054	http://dx.doi.org/10.1016/j.cell.2010.11.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215375	Green Accepted, Bronze			2022-12-24	WOS:000285993600013
J	Sare, J				Sare, Jeremy			Medicine and the Media How the media helped ban mephedrone	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeremysare@btinternet.com							0	4	4	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2011	342								d1138	10.1136/bmj.d1138	http://dx.doi.org/10.1136/bmj.d1138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729BE	21349891				2022-12-24	WOS:000287920900004
J	Breen, DP; Rowe, JB; Barker, RA				Breen, David P.; Rowe, James B.; Barker, Roger A.			Practice Rational Imaging Role of brain imaging in early parkinsonism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOPAMINE TRANSPORTERS; DISEASE; DIAGNOSIS; MOVEMENT; SPECT; DEMENTIA; MRI					davebreen@excite.co.uk	rowe, james B/C-3661-2013; Tick, Beata/ABA-1728-2020	rowe, james B/0000-0001-7216-8679; Barker, Roger Alistair/0000-0001-8843-7730	Medical Research Council [MC_U105597119] Funding Source: Medline; Wellcome Trust [088324] Funding Source: Medline; MRC [MC_U105597119] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, DIAGN PHARM MAN PARK, V113; Bohnen NI, 1999, NEUROLOGY, V52, P541, DOI 10.1212/WNL.52.3.541; Booij J, 1998, J NUCL MED, V39, P1879; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Kagi G, 2010, J NEUROL NEUROSUR PS, V81, P5, DOI 10.1136/jnnp.2008.157370; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; Seibyl JP, 1997, J NUCL MED, V38, P1453; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Vlaar AMM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-27; Yekhlef F, 2003, J NEURAL TRANSM, V110, P151, DOI 10.1007/s00702-002-0785-5	21	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2011	342								d638	10.1136/bmj.d638	http://dx.doi.org/10.1136/bmj.d638			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AZ	21345904				2022-12-24	WOS:000287920100018
J	Huang, WD; Ghisletti, S; Saijo, KR; Gandhi, M; Aouadi, M; Tesz, GJ; Zhang, DX; Yao, J; Czech, MP; Goode, BL; Rosenfeld, MG; Glass, CK				Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru; Gandhi, Meghal; Aouadi, Myriam; Tesz, Greg J.; Zhang, Dawn X.; Yao, Joyee; Czech, Michael P.; Goode, Bruce L.; Rosenfeld, Michael G.; Glass, Christopher K.			Coronin 2A mediates actin-dependent de-repression of inflammatory response genes	NATURE			English	Article							PPAR-GAMMA; NUCLEAR; RECEPTOR; PATHWAYS; TRANSREPRESSION; INTEGRATION; ACTIVATION; CHECKPOINT; EXPRESSION; ROLES	Toll-like receptors (TLRs) function as initiators of inflammation through their ability to sense pathogen-associated molecular patterns and products of tissue damage(1,2). Transcriptional activation of many TLR-responsive genes requires an initial de-repression step in which nuclear receptor co-repressor (NCoR) complexes are actively removed from the promoters of target genes to relieve basal repression(3,4). Ligand-dependent SUMOylation of liver X receptors (LXRs) has been found to suppress TLR4-induced transcription potently by preventing the NCoR clearance step(5-7), but the underlying mechanisms remain enigmatic. Here we provide evidence that coronin 2A (CORO2A), a component of the NCoR complex of previously unknown function(8,9), mediates TLR-induced NCoR turnover by a mechanism involving interaction with oligomeric nuclear actin. SUMOylated LXRs block NCoR turnover by binding to a conserved SUMO2/SUMO3-interaction motif in CORO2A and preventing actin recruitment. Intriguingly, the LXR transrepression pathway can itself be inactivated by inflammatory signals that induce calcium/calmodulin-dependent protein kinase II gamma (CaMKII gamma)-dependent phosphorylation of LXRs, leading to their deSUMOylation by the SUMO protease SENP3 and release from CORO2A. These findings uncover a CORO2A-actin-dependent mechanism for the de-repression of inflammatory response genes that can be differentially regulated by phosphorylation and by nuclear receptor signalling pathways that control immunity and homeostasis.	[Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru; Zhang, Dawn X.; Yao, Joyee; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Huang, Wendy; Zhang, Dawn X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Gandhi, Meghal; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA; [Aouadi, Myriam; Tesz, Greg J.; Czech, Michael P.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Czech, Michael P.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Ghisletti, Serena/AAO-6437-2021; Huang, Wendy Jia Men/AAF-2030-2021; Glass, Christopher/AAI-3933-2021	Huang, Wendy Jia Men/0000-0001-7425-8280; Glass, Christopher/0000-0003-4344-3592; Ghisletti, Serena/0000-0002-7087-5553	NRSA [1F31DK083913]; National Institutes of Health [CA52599, DK074868, HC088093, DK085853]; Leducq Foundation Transatlantic Network; NATIONAL CANCER INSTITUTE [R01CA097134, R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, P50HL056989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R37DK039949, F31DK083913, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation Transatlantic Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Amano for preparation of GeRP delivery spheres. We thank L. Bautista for assistance with preparation of the manuscript. W.H. was supported by NRSA 1F31DK083913. These studies were supported by National Institutes of Health grants CA52599, DK074868, HC088093 and DK085853 and a Leducq Foundation Transatlantic Network Grant. M.G.R. is an investigator of the Howard Hughes Medical Institute.	Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gandhi M, 2010, J BIOL CHEM, V285, P34899, DOI 10.1074/jbc.M110.171496; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gonsior SM, 1999, J CELL SCI, V112, P797; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	30	119	126	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					414	U25		10.1038/nature09703	http://dx.doi.org/10.1038/nature09703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331046	Green Accepted			2022-12-24	WOS:000287409100046
J	Pogach, L; Aron, DC				Pogach, Leonard; Aron, David C.			Sudden Acceleration of Diabetes Quality Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MELLITUS		[Aron, David C.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Educ Off 14W, Cleveland, OH 44106 USA; [Pogach, Leonard] Vet Affairs New Jersey Healthcare Syst, E Orange, NJ USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ USA; [Aron, David C.] Case Western Reserve Univ, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University	Aron, DC (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Educ Off 14W, 10701 E Blvd, Cleveland, OH 44106 USA.	david.aron@va.gov						Kerr EA, 2008, ASSESSING QUALITY CA; [Anonymous], 2010, AL FORC MINN COMM SN; Aron D, 2009, JAMA-J AM MED ASSOC, V301, P210, DOI 10.1001/jama.2008.930; Bridges to Excellence (BTE), 2010, BRIDG EXC BTE; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DeBord M, 2010, NY TIMES        0205; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Pogach L, 2007, JAMA-J AM MED ASSOC, V297, P520, DOI 10.1001/jama.297.5.520	8	32	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					709	710		10.1001/jama.2011.153	http://dx.doi.org/10.1001/jama.2011.153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325188				2022-12-24	WOS:000287361100023
J	Martyn, C				Martyn, Christopher			Out of Hours Lactation wars	BRITISH MEDICAL JOURNAL			English	Editorial Material												cmartyn@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d835	10.1136/bmj.d835	http://dx.doi.org/10.1136/bmj.d835			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307115				2022-12-24	WOS:000287402900008
J	Weatherall, DJ				Weatherall, David J.			Systems Biology and Red Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weatherall, David J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Weatherall, David J.] John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Weatherall, DJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.							Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; HORGAN J, 1996, END SCI LIMITS KNOWL; Ntaios G, 2007, ANN HEMATOL, V86, P487, DOI 10.1007/s00277-007-0302-x; WEATHERALL DJ, 2001, THALASSAEMIA SYNDROM, P345	5	14	14	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					376	377		10.1056/NEJMcibr1012683	http://dx.doi.org/10.1056/NEJMcibr1012683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268732				2022-12-24	WOS:000286592600016
J	Lu, JC; Unwin, DM; Deeming, DC; Jin, XS; Liu, YQ; Ji, QA				Lue, Junchang; Unwin, David M.; Deeming, D. Charles; Jin, Xingsheng; Liu, Yongqing; Ji, Qiang			An Egg-Adult Association, Gender, and Reproduction in Pterosaurs	SCIENCE			English	Article							EGGSHELL STRUCTURE; EVOLUTION; ONTOGENY	A sexually mature individual of Darwinopterus preserved together with an egg from the Jurassic of China provides direct evidence of gender in pterosaurs and insights into the reproductive biology of these extinct fliers. This new find and several other examples of Darwinopterus demonstrate that males of this pterosaur had a relatively small pelvis and a large cranial crest, whereas females had a relatively large pelvis and no crest. The ratio of egg mass to adult mass is relatively low, as in extant reptiles, and is comparable to values for squamates. A parchment-like eggshell points to burial and significant uptake of water after oviposition. This evidence for low parental investment contradicts the widespread assumption that reproduction in pterosaurs was like that of birds and shows that it was essentially like that of reptiles.	[Lue, Junchang; Liu, Yongqing; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Unwin, David M.] Univ Leicester, Sch Museum Studies, Leicester LE1 7LF, Leics, England; [Deeming, D. Charles] Lincoln Univ, Dept Biol Sci, Lincoln LN2 2LG, England; [Jin, Xingsheng] Zhejiang Museum Nat Hist, Hangzhou 310012, Zhejiang, Peoples R China	Chinese Academy of Geological Sciences; University of Leicester; University of Lincoln	Lu, JC (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China.	lujc2008@126.com; dmu1@le.ac.uk		Liu, Yongqing/0000-0002-9131-0172; Deeming, Denis Charles/0000-0002-9587-6149	National Natural Science Foundation of China [40872017, 90914003]; 973 Project [2006CB701405]; Ministry of Science and Technology [J1003, J0703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank X. M. Kang (Zhejiang Museum of Natural History, Hangzhou) for access to specimens and G. Birchard for access to his data set on reptile eggs. J.L. and Y.L. were supported by grants from the National Natural Science Foundation of China (40872017 and 90914003), the 973 Project (2006CB701405), and the Basic Outlay of Scientific Research Work from the Ministry of Science and Technology (J1003 and J0703); D.M.U. by the Royal Society and the University of Leicester; and D.C.D by the University of Lincoln.	Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S.C., 1992, Journal of Vertebrate Paleontology, V12, P422; Bennett S. Christopher, 2003, Palaeontologische Zeitschrift, V77, P61; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Chinsamy A, 2009, ANAT REC, V292, P1462, DOI 10.1002/ar.20990; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; Cogburn Larry A., 2000, P635, DOI 10.1016/B978-012747605-6/50026-2; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Deeming DC, 2007, J ZOOL, V271, P78, DOI 10.1111/j.1469-7998.2006.00219.x; [段冶 DUAN Ye], 2009, [世界地质, World Geology], V28, P143; Grellet-Tinner Gerald, 2007, Historical Biology, V19, P273, DOI 10.1080/08912960701189800; Kunz Thomas H., 2000, P415, DOI 10.1016/B978-012195670-7/50011-4; Lu Junchang, 2009, Acta Geologica Sinica English Edition, V83, P1; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; SHINE R, 1992, EVOLUTION, V46, P62, DOI 10.1111/j.1558-5646.1992.tb01985.x; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin D. M., 2006, 2005 HEYUAN INT DIN, P141; Unwin David M., 2008, Zitteliana Reihe B, V28, P199; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Xu L., 2010, ACTA GEOSCI SINICA S, V31, P82	27	81	89	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					321	324		10.1126/science.1197323	http://dx.doi.org/10.1126/science.1197323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252343				2022-12-24	WOS:000286636300034
J	Turner, K; Adams, E; Grant, A; Macleod, J; Bell, G; Clarke, J; Horner, P				Turner, Katy; Adams, Elisabeth; Grant, Arabella; Macleod, John; Bell, Gill; Clarke, Jan; Horner, Paddy			Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRACHOMATIS; INFECTION; POPULATION; PREVALENCE	Objectives To compare the cost, cost effectiveness, and sex equity of different intervention strategies within the English National Chlamydia Screening Programme. To develop a tool for calculating cost effectiveness of chlamydia control programmes at a local, national, or international level. Design An economic and mathematical modelling study with cost effectiveness analysis. Costs were restricted to those of screening and partner notification from the perspective of the NHS and excluded patient costs, the costs of reinfection, and costs of complications arising from initial infection. Setting England. Population Individuals eligible for the National Chlamydia Screening Programme. Main outcome measures Cost effectiveness of National Chlamydia Screening Programme in 2008-9 (as cost per individual tested, cost per positive diagnosis, total cost of screening, number screened, number infected, sex ratio of those tested and treated). Comparison of baseline programme with two different interventions-(i) increased coverage of primary screening in men and (ii) increased efficacy of partner notification. Results In 2008-9 screening was estimated to cost about 46.3m pound in total and 506 pound per infection treated. Provision for partner notification within the screening programme cost between 9 pound and 27 pound per index case, excluding treatment and testing. The model results suggest that increasing male screening coverage from 8% (baseline value) to 24% (to match female coverage) would cost an extra 22.9m pound and increase the cost per infection treated to 528 pound. In contrast, increasing partner notification efficacy from 0.4 (baseline value) to 0.8 partners per index case would cost an extra 3.3m pound and would reduce the cost per infection diagnosed to 449 pound. Increasing screening coverage to 24% in men would cost over six times as much as increasing partner notification to 0.8 but only treat twice as many additional infections. Conclusions In the English National Chlamydia Screening Programme increasing the effectiveness of partner notification is likely to cost less than increasing male coverage but also improve the ratio of women to men diagnosed. Further evaluation of the cost effectiveness of partner notification and screening is urgently needed. The spreadsheet tool developed in this study can be easily modified for use in other settings to evaluate chlamydia control programmes.	[Turner, Katy] Univ Bristol, Dept Social Med, NIHR, Bristol BS8 2PS, Avon, England; [Grant, Arabella] Pathway Analyt, London, England; [Bell, Gill] Royal Hallamshire Hosp, NHS Fdn Trust, Sheffield Teaching Hosp, Sheffield S10 2JF, S Yorkshire, England; [Clarke, Jan] Leeds Teaching Hosp Trust, Dept Genitourinary Med, Leeds LS1 3EX, W Yorkshire, England; [Horner, Paddy] Univ Hosp Bristol NHS Fdn Trust, Bristol Sexual Hlth Ctr, Bristol BS2 OJD, Avon, England	University of Bristol; Oxford University Hospitals NHS Foundation Trust; University of Sheffield; University of Leeds	Turner, K (corresponding author), Univ Bristol, Dept Social Med, NIHR, Bristol BS8 2PS, Avon, England.	katy.turner@bristol.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Macleod, John/0000-0001-8202-1144; Horner, Paddy/0000-0003-0411-8332	Bristol Sexual Health Centre; NIHR [07/42/02]; National Institute for Health Research [07/42/02, PDF-2009-02-55] Funding Source: researchfish	Bristol Sexual Health Centre; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a grant from the Bristol Sexual Health Centre Capacity Building Research Fund. KT is supported by an NIHR PDF fellowship. KT and GB also received funding from the NIHR Health Technology Assessment programme (project number 07/42/02). All authors in this paper are independent of their funders for publication purposes. The views and opinions expressed here are those of the authors and do not necessarily reflect those of the funders.; JC, PH, and JM are board members of the National Chlamydia Screening Advisory Group of the Department of Health and receive expenses for travel to meetings. JC also receives compensation for secondment as chair on NCSAG paid directly to Leeds Hospital Teaching Hospitals Trust. AG and EA received consultancy fees from Bristol Sexual Health Centre Capacity Building Research Fund for the additional cost data analysis and travel to a meeting with the other authors. EA and AG did consultancy work for the NCSP in spring 2009 on a project to estimate the cost of chlamydia screening. KT received consultancy fees from Bristol Sexual Health Centre Capacity Building Research Fund for additional days worked to develop the model and write the paper outside funded time. KT and EA were previously employed by the Health Protection Agency to work on economic and mathematical models of the impact of chlamydia screening. PH collaborated in a multicentre evaluation of a new molecular diagnostic test for chlamydia and gonorrhoea by Siemens Healthcare Diagnostics, for which his department received funding.	Apoola A, 2007, INT J STD AIDS, V18, P493, DOI 10.1258/095646207781147238; Bilardi JE, 2010, SEX TRANSM DIS, V37, P563, DOI 10.1097/OLQ.0b013e3181d707f1; Carre H, 2008, SEX TRANSM INFECT, V84, P239, DOI 10.1136/sti.2007.028068; Cassell JA, 2003, SEX TRANSM INFECT, V79, P264, DOI 10.1136/sti.79.3.264-a; Clarke J, 2009, PARTNER NOTIFICATION; European Centre for Disease Control and Prevention (ECDC), 2008, REV CHLAM CONTR ACT; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Kretzschmar M, 2009, SEX TRANSM INFECT, V85, P359, DOI 10.1136/sti.2009.036251; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; LaMontagne DS, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022053; Low N, 2009, INT J EPIDEMIOL, V38, P435, DOI 10.1093/ije/dyn222; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; National Audit Office, 2009, YOUNG PEOPL SEX HLTH; National Chlamydia Screening Programme, 2010, VSI DAT TABL 08 09 E; National Chlamydia Screening Programme, 2010, INV YOUNG MEN CHLAM; National Chlamydia Screening Programme, 2009, GUID COMM COSTS PROV; National Chlamydia Screening Programme, 2010, MEN TOO; National Chlamydia Screening Programme, 2009, NCSP ANN REPORT 2008; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173	22	35	35	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2011	342								c7250	10.1136/bmj.c7250	http://dx.doi.org/10.1136/bmj.c7250			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NF	21205807	hybrid, Green Submitted			2022-12-24	WOS:000286142400001
J	Nurok, M; Czeisler, CA; Lehmann, LS				Nurok, Michael; Czeisler, Charles A.; Lehmann, Lisa Soleymani			Sleep Deprivation, Elective Surgical Procedures, and Informed Consent.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nurok, Michael] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; [Nurok, Michael] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Czeisler, Charles A.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Ctr Bioeth, Boston, MA 02115 USA; [Nurok, Michael; Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Czeisler, Charles A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Div Med Eth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nurok, M (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.			Czeisler, Charles Andrew/0000-0002-7408-1849				Blum AB, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-33; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	5	59	59	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2577	2579		10.1056/NEJMp1007901	http://dx.doi.org/10.1056/NEJMp1007901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700SD	21190452				2022-12-24	WOS:000285763700001
J	Forneris, F; Ricklin, D; Wu, J; Tzekou, A; Wallace, RS; Lambris, JD; Gros, P				Forneris, Federico; Ricklin, Daniel; Wu, Jin; Tzekou, Apostolia; Wallace, Rachel S.; Lambris, John D.; Gros, Piet			Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation	SCIENCE			English	Article							ALTERNATIVE PATHWAY CONVERTASE; CONFORMATIONAL-CHANGES; SERINE-PROTEASE; PROVIDES INSIGHTS; ACTIVATION; SYSTEM; BINDING; DOMAIN; THERAPEUTICS; THIOESTER	Activation of the complement cascade induces inflammatory responses and marks cells for immune clearance. In the central complement-amplification step, a complex consisting of surface-bound C3b and factor B is cleaved by factor D to generate active convertases on targeted surfaces. We present crystal structures of the pro-convertase C3bB at 4 angstrom resolution and its complex with factor D at 3.5 angstrom resolution. Our data show how factor B binding to C3b forms an open "activation" state of C3bB. Factor D specifically binds the open conformation of factor B through a site distant from the catalytic center and is activated by the substrate, which displaces factor D's self-inhibitory loop. This concerted proteolytic mechanism, which is cofactor-dependent and substrate-induced, restricts complement amplification to C3b-tagged target cells.	[Ricklin, Daniel; Tzekou, Apostolia; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Forneris, Federico; Wu, Jin; Wallace, Rachel S.; Gros, Piet] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Pennsylvania; Utrecht University	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance, Philadelphia, PA 19104 USA.	lambris@upenn.edu; p.gros@uu.nl	Forneris, Federico/AAL-5361-2020; Mohammed, Imran/J-8271-2012; Gros, Piet/I-5569-2016; Forneris, Federico/B-1145-2011; Gros, Piet/AAD-6452-2019; Ricklin, Daniel/F-5104-2011; Lambris, John/Q-5633-2018	Forneris, Federico/0000-0002-7818-1804; Mohammed, Imran/0000-0002-8412-0768; Gros, Piet/0000-0002-7782-2585; Forneris, Federico/0000-0002-7818-1804; Gros, Piet/0000-0002-7782-2585; Ricklin, Daniel/0000-0001-6140-0233; Lambris, John/0000-0002-9370-5776	Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) [700.54.304]; NIH [AI030040, AI068730, AI072106, GM062134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030040, R01AI072106, N01AI030040, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Coordinates and structure factors of C3bB, C3bBD*, FD (S183A), and FD (R202A) have been deposited in the Protein Data Bank (PDB) with accession numbers 2XWJ, 2XWB, 2XW9, and 2XWA, respectively. We gratefully thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light source (SLS) for the provision of synchrotron radiation facilities and beamline scientists of the SLS, ESRF, and the European Molecular Biology Laboratory for assistance. This work was supported by a "Top" grant (700.54.304 to P.G.) by the Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) and NIH grants (AI030040, AI068730, AI072106, and GM062134 to J.D.L.). Author contributions: F.F. expressed and purified all FB and FD mutants, purified C3b, generated protein complexes, performed crystallization experiments, collected diffraction data, and solved the structures; F.F. and P.G. analyzed the structures; J.W. and R.S.W. helped with cloning and optimization of protein expression and purification; F.F. performed kinetic studies; D.R. and A.T. performed the SPR binding studies and hemolytic assays; F.F., D.R., J.D.L., and P.G. conceived the experiments; F. F. prepared the figures; and F.F., D.R., and P.G. wrote the manuscript. P.G. and J.D.L. co-supervised this work. Competing financial interests: P.G., F.F., D.R., and J.D.L. are co-inventors of a patent application titled "Structure of C3bB-factor D complex and use for rational drug design."	Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Jing H, 1999, EMBO J, V18, P804, DOI 10.1093/emboj/18.4.804; KAM CM, 1987, J BIOL CHEM, V262, P3444; KIM S, 1994, BIOCHEMISTRY-US, V33, P14393, DOI 10.1021/bi00252a004; Kim SG, 1999, JPN J APPL PHYS 2, V38, pL38; KIM SH, 1995, J IMMUNOL, V154, P6073; Law SKA, 1997, PROTEIN SCI, V6, P263; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Torreira E, 2009, J IMMUNOL, V183, P7347, DOI 10.4049/jimmunol.0902310; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x	36	183	184	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1816	1820		10.1126/science.1195821	http://dx.doi.org/10.1126/science.1195821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205667	Green Accepted			2022-12-24	WOS:000285603700039
J	Amstrup, SC; DeWeaver, ET; Douglas, DC; Marcot, BG; Durner, GM; Bitz, CM; Bailey, DA				Amstrup, Steven C.; DeWeaver, Eric T.; Douglas, David C.; Marcot, Bruce G.; Durner, George M.; Bitz, Cecilia M.; Bailey, David A.			Greenhouse gas mitigation can reduce sea-ice loss and increase polar bear persistence	NATURE			English	Article							CLIMATE-CHANGE; 21ST-CENTURY; SYSTEM; POLICY	On the basis of projected losses of their essential sea-ice habitats, a United States Geological Survey research team concluded in 2007 that two-thirds of the world's polar bears (Ursus maritimus) could disappear by mid-century if business-as-usual greenhouse gas emissions continue(1-3). That projection, however, did not consider the possible benefits of greenhouse gas mitigation. A key question is whether temperature increases lead to proportional losses of sea-ice habitat, or whether sea-ice cover crosses a tipping point and irreversibly collapses when temperature reaches a critical threshold(4-6). Such a tipping point would mean future greenhouse gas mitigation would confer no conservation benefits to polar bears. Here we show, using a general circulation model(7), that substantially more sea-ice habitat would be retained if greenhouse gas rise is mitigated. We also show, with Bayesian network model outcomes, that increased habitat retention under greenhouse gas mitigation means that polar bears could persist throughout the century in greater numbers and more areas than in the business-as-usual case(3). Our general circulation model outcomes did not reveal thresholds leading to irreversible loss of ice(6); instead, a linear relationship between global mean surface air temperature and sea-ice habitat substantiated the hypothesis that sea-ice thermodynamics can overcome albedo feedbacks proposed to cause sea-ice tipping points(5,6,8). Our outcomes indicate that rapid summer ice losses in models(9) and observations(6,10) represent increased volatility of a thinning sea-ice cover, rather than tipping-point behaviour. Mitigation-driven Bayesian network outcomes show that previously predicted declines in polar bear distribution and numbers(3) are not unavoidable. Because polar bears are sentinels of the Arctic marine ecosystem(11) and trends in their sea-ice habitats foreshadow future global changes, mitigating greenhouse gas emissions to improve polar bear status would have conservation benefits throughout and beyond the Arctic(12).	[Amstrup, Steven C.; Durner, George M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [DeWeaver, Eric T.] Natl Sci Fdn, Arlington, VA 22230 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK 99801 USA; [Marcot, Bruce G.] US Forest Serv, USDA, PNW Res Stn, Portland, OR 97205 USA; [Bitz, Cecilia M.] Univ Washington, Seattle, WA 98195 USA; [Bailey, David A.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	United States Department of the Interior; United States Geological Survey; National Science Foundation (NSF); United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of Washington; University of Washington Seattle; National Center Atmospheric Research (NCAR) - USA	Amstrup, SC (corresponding author), Polar Bears Int, 810 N Wallace,Suite E,POB 3008, Bozeman, MT 59772 USA.	samstrup@pbears.org	Bitz, Cecilia M/S-8423-2016; Douglas, David C./AAU-1087-2021; Daniel, Emily M/A-7387-2012	Bitz, Cecilia M/0000-0002-9477-7499; Douglas, David C./0000-0003-0186-1104; Bailey, David/0000-0002-6584-0663	USGS; USDA Forest Service, Pacific Northwest Research Station; Office of Science (BER), US Department of Energy [ER64735]; National Science Foundation (NSF); NSF Office of Polar Programs [0908675]; Directorate For Geosciences [0908675] Funding Source: National Science Foundation	USGS(United States Geological Survey); USDA Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Office of Polar Programs(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Principal funding for this project was provided by the USGS. B. G. M. acknowledges support from the USDA Forest Service, Pacific Northwest Research Station. E. T. D. acknowledges the support of the Office of Science (BER), US Department of Energy, under grant ER64735 to the University of Maryland. E.D.'s work also was supported by the National Science Foundation (NSF) during his employment there. The findings reported here, however, are not endorsed by and do not necessarily reflect the views of the NSF. CCSM3 simulations were performed using computing resources provided by the National Center for Atmospheric Research and the Earth Simulator in Japan. D. A. B. was supported under a grant from the NSF Office of Polar Programs, award number 0908675. M. Holland provided comments regarding model design and analysis. We acknowledge the Program for Climate Model Diagnosis and Intercomparison and the World Climate Research Programme's Working Group on Coupled Modeling for their roles in making available the Coupled Model Intercomparison Project phase 3 multi-model data set (support of this data set is provided by the Office of Science, US Department of Energy). We thank W. Washington and L. Buja for running the AS and providing us with the output from the CCSP integrations. We thank D. Vongraven and S. Vavrus for comments on earlier versions of this manuscript, and we thank N. Lunn and L. Peacock for providing the peer reviews necessary for the beta version of our Bayesian network model. Any use of trade names is for descriptive purposes only and does not represent endorsement by the US government.	Aars J., 2006, POL BEARS P 14 WORK, P189; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Amstrup SC, 2009, INTERFACES, V39, P353, DOI 10.1287/inte.1090.0444; [Anonymous], 2000, SPECIAL REPORT EMISS; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Deser C, 2008, GEOPHYS MONOGR SER, V180, P7, DOI 10.1029/180GM03; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Eisenman I, 2009, P NATL ACAD SCI USA, V106, P28, DOI 10.1073/pnas.0806887106; Grosell M., 2006, OCEANOGRAPHY WASH DC, V19, P127; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Holland MM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028024; Holland MM, 2008, GEOPHYS MONOGR SER, V180, P133, DOI 10.1029/180GM10; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Kerr RA, 2007, SCIENCE, V318, P33, DOI 10.1126/science.318.5847.33a; Kizzia T., 2007, ANCHORAGE DAILY 0908, pA1; Lawrence DM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033985; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Manly B.F.J., 2002, RESOURCE SELECTION A; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Meehl GA, 2006, J CLIMATE, V19, P2597, DOI 10.1175/JCLI3746.1; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; National Snow and Ice Data Center, 2009, 69 NSIDC, V69; Notz D, 2009, P NATL ACAD SCI USA, V106, P20590, DOI 10.1073/pnas.0902356106; Ramanathan V, 2008, P NATL ACAD SCI USA, V105, P14245, DOI 10.1073/pnas.0803838105; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Stirling I, 1999, ARCTIC, V52, P294; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; U.S. Climate Change Science Program, 2007, SCEN GREENH GAS EM A; Washington WM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037074; Wigley TML, 2005, SCIENCE, V307, P1766, DOI 10.1126/science.1103934; Winton M, 2008, GEOPHYS MONOGR SER, V180, P111, DOI 10.1029/180GM09	37	96	100	7	302	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					955	958		10.1038/nature09653	http://dx.doi.org/10.1038/nature09653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164484				2022-12-24	WOS:000285344600045
J	Booth, LN; Tuch, BB; Johnson, AD				Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.			Intercalation of a new tier of transcription regulation into an ancient circuit	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; YEAST CANDIDA-ALBICANS; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; GENE-EXPRESSION; EVOLUTION; PHEROMONE; IDENTIFICATION; MEIOSIS	Changes in gene regulatory networks are a major source of evolutionary novelty(1-3). Here we describe a specific type of network rewiring event, one that intercalates a new level of transcriptional control into an ancient circuit. We deduce that, over evolutionary time, the direct ancestral connections between a regulator and its target genes were broken and replaced by indirect connections, preserving the overall logic of the ancestral circuit but producing a new behaviour. The example was uncovered through a series of experiments in three ascomycete yeasts: the bakers' yeast Saccharomyces cerevisiae, the dairy yeast Kluyveromyces lactis and the human pathogen Candida albicans. All three species have three cell types: two mating-competent cell forms (a and alpha) and the product of their mating (a/alpha), which is mating-incompetent. In the ancestral mating circuit, two homeodomain proteins, Mata1 and Mat alpha 2, form a heterodimer that directly represses four genes that are expressed only in a and alpha cells and are required for mating(4-6). In a relatively recent ancestor of K. lactis, a reorganization occurred. The Mata1-Mat alpha 2 heterodimer represses the same four genes (known as the core haploid-specific genes) but now does so indirectly through an intermediate regulatory protein, Rme1. The overall logic of the ancestral circuit is preserved (haploid-specific genes ON in a and alpha cells and OFF in a/alpha cells), but a new phenotype was produced by the rewiring: unlike S. cerevisiae and C. albicans, K. lactis integrates nutritional signals, by means of Rme1, into the decision of whether or not to mate.	[Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	ajohnson@cgl.ucsf.edu			National Institutes of Health [RO1 GM037049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Mitrovich, O. Homann, A. Hernday, M. Miller, C. Cain, T. Sorrells and H. Madhani for helpful discussions and technical contributions; and S. Astrom for generously providing the K. lactis strains used in this study. The S. cerevisiae strains were a gift from the H. Madhani and J. Li laboratories. The work was funded by grant RO1 GM037049 from the National Institutes of Health. L.N.B. is a National Science Foundation Graduate Research Fellow.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barsoum E, 2010, GENETICS, V184, P999, DOI 10.1534/genetics.110.114678; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Coria R, 2006, FEMS YEAST RES, V6, P336, DOI 10.1111/j.1567-1364.2005.00022.x; Cote P, 2008, MOL MICROBIOL, V68, P392, DOI 10.1111/j.1365-2958.2008.06158.x; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dignard D, 2008, EUKARYOT CELL, V7, P1591, DOI 10.1128/EC.00077-08; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Falcone C., 2003, SPRINGER LAB MANUAL, P195; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gojkovic Z, 2000, J MOL BIOL, V295, P1073, DOI 10.1006/jmbi.1999.3393; GOUTTE C, 1994, EMBO J, V13, P1434, DOI 10.1002/j.1460-2075.1994.tb06397.x; HERMAN AI, 1970, ANTON VAN LEE J M S, V36, P421, DOI 10.1007/BF02069042; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hickman MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000710; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KASSIR Y, 1976, GENETICS, V82, P187; KURTZMAN CP, 2000, YEASTS TAXONOMIC STU; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Srikantha T, 2006, EUKARYOT CELL, V5, P1674, DOI 10.1128/EC.00252-06; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	43	57	65	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					959	U358		10.1038/nature09560	http://dx.doi.org/10.1038/nature09560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164485	Green Accepted			2022-12-24	WOS:000285344600046
J	Linsel-Nitschke, P; Samani, NJ; Schunkert, H				Linsel-Nitschke, Patrick; Samani, Nilesh J.; Schunkert, Heribert			Sorting Out Cholesterol and Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOCUS		[Linsel-Nitschke, Patrick; Schunkert, Heribert] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Univ Leicester, Leicester Natl Inst Hlth Res, Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Leicester; University of Leicester	Linsel-Nitschke, P (corresponding author), Univ Lubeck, Med Klin 2, Lubeck, Germany.							Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366	5	26	28	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2462	2463		10.1056/NEJMcibr1010765	http://dx.doi.org/10.1056/NEJMcibr1010765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158662	Green Published			2022-12-24	WOS:000285340200016
J	Rothberg, MB; Arora, A; Hermann, J; Kleppel, R; St Marie, P; Visintainer, P				Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul			CHRISTMAS 2010: THE LIVES OF DOCTORS Phantom vibration syndrome among medical staff: a cross sectional survey	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To describe the prevalence of and risk factors for experiencing "phantom vibrations," the sensory hallucination sometimes experienced by people carrying pagers or cell phones when the device is not vibrating. Design Cross sectional survey. Setting Academic medical centre. Participants 176 medical staff who responded to questionnaire (76% of the 232 people invited). Measurements Electronic survey consisting of 17 questions about demographics, device use, phantom vibrations experienced, and attempts to stop them. Results Of the 169 participants who answered the question, 115 (68%, 95% confidence interval 61% to 75%) reported having experienced phantom vibrations. Most (68/112) who experienced phantom vibrations did so after carrying the device between 1 month and 1 year, and 13% experienced them daily. Four factors were independently associated with phantom vibrations: occupation (resident v attending physician, prevalence ratio 1.47, 95% confidence interval 1.10 to 1.97), device location (breast pocket v belt, prevalence ratio 1.66, 1.29 to 2.14), hours carried (per 6 hour increment, prevalence ratio 1.30, 1.07 to 1.58), and more frequent use in vibrate mode (per frequency category, prevalence ratio 1.18, 1.03 to 1.34). Of those who experienced phantom vibrations, 43 (39%, 30% to 48%) were able to stop them. Strategies for stopping phantom vibrations included taking the device off vibrate mode, changing the location of the device, and using a different device (success rates 75% v 63% v 50%, respectively, P=0.217). However, 39% (30% to 49%) of respondents did not attempt any strategies. Conclusions Phantom vibration syndrome is common among those who use electronic devices.	[Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul] Baystate Med Ctr, Div Gen Med, Springfield, MA 01199 USA; [Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul] Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Baystate Med Ctr, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	Michael.Rothberg@bhs.org	ARORA, ASHISH/ABE-6212-2021	Visintainer, Paul/0000-0002-2491-1242; St. Marie, Peter/0000-0002-3567-2582				Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Goodman B, 2006, NY TIMES        0504; Haupt A., 2007, US TODAY        0612; Laramie D., 2007, THESIS ALLIANT INT U; Market Information and Statistics Division TDB International Telecommunication Union, 2009, WORLD 2009 ICT FACTS; PENNEBAKER JW, 1981, J PERS SOC PSYCHOL, V41, P213, DOI 10.1037/0022-3514.41.2.213	7	35	35	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6914	10.1136/bmj.c6914	http://dx.doi.org/10.1136/bmj.c6914			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XJ	21159761	hybrid			2022-12-24	WOS:000285552800008
J	Laurell, E; Beck, K; Krupina, K; Theerthagiri, G; Bodenmiller, B; Horvath, P; Aebersold, R; Antonin, W; Kutay, U				Laurell, Eva; Beck, Katja; Krupina, Ksenia; Theerthagiri, Gandhi; Bodenmiller, Bernd; Horvath, Peter; Aebersold, Ruedi; Antonin, Wolfram; Kutay, Ulrike			Phosphorylation of Nup98 by Multiple Kinases Is Crucial for NPC Disassembly during Mitotic Entry	CELL			English	Article							NUCLEAR-PORE COMPLEX; CYCLE-DEPENDENT PHOSPHORYLATION; NEK2 PROTEIN-KINASE; ENVELOPE BREAKDOWN; NIMA-FAMILY; NUCLEOPORIN; REVEALS; MITOSIS; ACTIVATION; DOMAINS	Disassembly of nuclear pore complexes (NPCs) is a decisive event during mitotic entry in cells undergoing open mitosis, yet the molecular mechanisms underlying NPC disassembly are unknown. Using chemical inhibition and depletion experiments we show that NPC disassembly is a phosphorylation-driven process, dependent on CDK1 activity and supported by members of the NIMA-related kinase (Nek) family. We identify phosphorylation of the GLFG-repeat nucleoporin Nup98 as an important step in mitotic NPC disassembly. Mitotic hyperphos-phorylation of Nup98 is accomplished by multiple kinases, including CDK1 and Neks. Nuclei carrying a phosphodeficient mutant of Nup98 undergo nuclear envelope breakdown slowly, such that both the dissociation of Nup98 from NPCs and the permeabilization of the nuclear envelope are delayed. Together, our data provide evidence for a phosphorylation-dependent mechanism underlying disintegration of NPCs during prophase. Moreover, we identify mitotic phosphorylation of Nup98 as a rate-limiting step in mitotic NPC disassembly.	[Laurell, Eva; Beck, Katja; Krupina, Ksenia; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Theerthagiri, Gandhi; Antonin, Wolfram] Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Horvath, Peter] ETH, Light Microscopy Ctr, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kutay, U (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	ulrike.kutay@bc.biol.ethz.ch	Antonin, Wolfram/A-8656-2014; Antonin, Wolfram/P-3648-2019	Antonin, Wolfram/0000-0003-4669-379X; Antonin, Wolfram/0000-0003-4669-379X; T. K. Boopathy, Gandhi/0000-0002-1821-9540	DFG [KN 938/1-1]; SNF [3100AO-133135]	DFG(German Research Foundation (DFG)); SNF	We thank C. Ashiono for excellent technical assistance, S. Giese for help automating image analysis, J. Ellenberg, P. Lidsky, K. S. Fields, and C. R. Mena for reagents, P. Meraldi and A. Rothballer for critical reading, and P. Meraldi, H. Meyer, D. Gerlich, and M. Held for discussion. Imaging was performed on instruments of the ETH Light Microscopy Center. This work was supported by the DFG (KN 938/1-1) to K. B. and the SNF (3100AO-133135) to U.K.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kiseleva E, 2001, J CELL SCI, V114, P3607; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li HC, 2010, P NATL ACAD SCI USA, V107, P14633, DOI 10.1073/pnas.1006615107; LU KP, 1994, EMBO J, V13, P2103, DOI 10.1002/j.1460-2075.1994.tb06486.x; LU KP, 1993, J BIOL CHEM, V268, P8769; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Onischenko EA, 2005, MOL BIOL CELL, V16, P5152, DOI 10.1091/mbc.E05-07-0642; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schultz C, 1999, J MED CHEM, V42, P2909, DOI 10.1021/jm9900570; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Wu WJ, 2007, J BIOL CHEM, V282, P26431, DOI 10.1074/jbc.M704969200; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598	48	173	177	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					539	550		10.1016/j.cell.2011.01.012	http://dx.doi.org/10.1016/j.cell.2011.01.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335236	Bronze			2022-12-24	WOS:000287473100009
J	Ali, K; Harnden, A; Edge, JA				Ali, Keya; Harnden, Anthony; Edge, Julie A.			Practice Easily Missed? Type 1 diabetes in children	BRITISH MEDICAL JOURNAL			English	Editorial Material							MELLITUS					julie.edge@paediatrics.ox.ac.uk						Ali K, 2009, DIABETIC MED S1, V26, P34; Bui H, 2010, J PEDIATR-US, V156, P472, DOI 10.1016/j.jpeds.2009.10.001; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; PALOWICZ MM, 2008, PEDIAT ENDOCRINOL DI, V14, P7; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Roche EF, 2005, PEDIATR DIABETES, V6, P75, DOI 10.1111/j.1399-543X.2005.00110.x; Royal College of Paediatrics and Child Health, 2009, GROW DIAB CHILDR YOU; Sundaram PCB, 2009, ARCH DIS CHILD, V94, P151, DOI 10.1136/adc.2007.133405; Vanelli M, 1999, DIABETES CARE, V22, P7, DOI 10.2337/diacare.22.1.7	10	12	12	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d294	10.1136/bmj.d294	http://dx.doi.org/10.1136/bmj.d294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325386				2022-12-24	WOS:000287656500023
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			Thirty-Day Readmission Rates for Medicare Beneficiaries by Race and Site of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; SAFETY-NET HOSPITALS; DUTY HOUR REFORM; BLACK PATIENTS; TRANSITIONS INTERVENTION; ADMINISTRATIVE DATA; RACIAL DISPARITIES	Context Understanding whether and why there are racial disparities in readmissions has implications for efforts to reduce readmissions. Objective To determine whether black patients have higher odds of readmission than white patients and whether these disparities are related to where black patients receive care. Design Using national Medicare data, we examined 30-day readmissions after hospitalization for acute myocardial infarction (MI), congestive heart failure (CHF), and pneumonia. We categorized hospitals in the top decile of proportion of black patients as minority-serving. We determined the odds of readmission for black patients compared with white patients at minority-serving vs non-minority-serving hospitals. Setting and Participants Medicare Provider Analysis Review files of more than 3.1 million Medicare fee-for-service recipients who were discharged from US hospitals in 2006-2008. Main Outcome Measure Risk-adjusted odds of 30-day readmission. Results Overall, black patients had higher readmission rates than white patients (24.8% vs 22.6%, odds ratio [OR], 1.13; 95% confidence interval [CI], 1.11-1.14; P<.001); patients from minority-serving hospitals had higher readmission rates than those from non-minority-serving hospitals (25.5% vs 22.0%, OR, 1.23; 95% CI, 1.20-1.27; P<.001). Among patients with acute MI and using white patients from non-minority-serving hospitals as the reference group (readmission rate 20.9%), black patients from minority-serving hospitals had the highest readmission rate (26.4%; OR, 1.35; 95% CI, 1.28-1.42), while white patients from minority-serving hospitals had a 24.6% readmission rate (OR, 1.23; 95% CI, 1.18-1.29) and black patients from non-minority-serving hospitals had a 23.3% readmission rate (OR, 1.20; 95% CI, 1.16-1.23; P<.001 for each); patterns were similar for CHF and pneumonia. The results were unchanged after adjusting for hospital characteristics including markers of caring for poor patients. Conclusion Among elderly Medicare recipients, black patients were more likely to be readmitted after hospitalization for 3 common conditions, a gap that was related to both race and to the site where care was received. JAMA. 2011;305(7):675-681 www.jama.com	[Joynt, Karen E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Institutes of Health, Brigham and Women's Hospital, Division of Cardiovascular Medicine [T32HL007604-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	National Institutes of Health, Brigham and Women's Hospital, Division of Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Joynt was supported by National Institutes of Health Training Grant T32HL007604-24, Brigham and Women's Hospital, Division of Cardiovascular Medicine.	Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; Baicker K, 2004, HLTH AFF MILLWOOD S, pVAR33; Benatar D, 2003, ARCH INTERN MED, V163, P347, DOI 10.1001/archinte.163.3.347; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Breslin TM, 2009, J CLIN ONCOL, V27, P3945, DOI 10.1200/JCO.2008.20.8546; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Culler SD, 2010, MED CARE, V48, P273, DOI 10.1097/MLR.0b013e3181c161ba; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Gaskin DJ, 2008, HEALTH AFFAIR, V27, P518, DOI 10.1377/hlthaff.27.2.518; Givens JL, 2010, ARCH INTERN MED, V170, P427, DOI 10.1001/archinternmed.2009.547; Halm EA, 2009, STROKE, V40, P2493, DOI 10.1161/STROKEAHA.108.544866; Han B, 2006, MED CARE, V44, P731, DOI 10.1097/01.mlr.0000215858.37118.65; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Healthcare Cost and Utilization Project (HCUP), COM SOFTW VERS 3 6; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; *I MED, 2002, UN TREATM CONFR RAC; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Jha AK, 2007, AM HEART J, V153, P785, DOI 10.1016/j.ahj.2007.02.014; Kahn CN, 2006, HEALTH AFFAIR, V25, P148, DOI 10.1377/hlthaff.25.1.148; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Parry Carla, 2009, Home Health Care Serv Q, V28, P84, DOI 10.1080/01621420903155924; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Tan EJ, 2003, J AM GERIATR SOC, V51, P246, DOI 10.1046/j.1532-5415.2003.51065.x; Trivedi AN, 2006, J AM COLL CARDIOL, V47, P417, DOI 10.1016/j.jacc.2005.08.068; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Weller WE, 2007, J AM COLL SURGEONS, V204, P383, DOI 10.1016/j.jamcollsurg.2006.12.031; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Zwanziger J, 2008, MED CARE RES REV, V65, P478, DOI 10.1177/1077558708315440	45	558	561	1	36	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					675	681		10.1001/jama.2011.123	http://dx.doi.org/10.1001/jama.2011.123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721NH	21325183	Green Accepted, Bronze			2022-12-24	WOS:000287361100018
J	Sabeti, P				Sabeti, Pardis			The Landscape of Human Evolution	SCIENCE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Sabeti, P (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.		Sabeti, Pardis/GQH-8610-2022						0	1	1	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	690		10.1126/science.1202570	http://dx.doi.org/10.1126/science.1202570			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310997	Green Submitted			2022-12-24	WOS:000287205700041
J	Santos, JM; Ferguson, DJP; Blackman, MJ; Soldati-Favre, D				Santos, Joana M.; Ferguson, David J. P.; Blackman, Michael J.; Soldati-Favre, Dominique			Intramembrane Cleavage of AMA1 Triggers Toxoplasma to Switch from an Invasive to a Replicative Mode	SCIENCE			English	Article							HOST-CELL INVASION; MICRONEME PROTEINS; GONDII; PROTEASES; MEMBRANE; PARASITE; SURFACE; CYCLE	Apicomplexan parasites invade host cells and immediately initiate cell division. The extracellular parasite discharges transmembrane proteins onto its surface to mediate motility and invasion. These are shed by intramembrane cleavage, a process associated with invasion but otherwise poorly understood. Functional analysis of Toxoplasma rhomboid 4, a surface intramembrane protease, by conditional overexpression of a catalytically inactive form produced a profound block in replication. This was completely rescued by expression of the cleaved cytoplasmic tail of Toxoplasma or Plasmodium apical membrane antigen 1 (AMA1). These results reveal an unexpected function for AMA1 in parasite replication and suggest that invasion proteins help to promote parasite switch from an invasive to a replicative mode.	[Santos, Joana M.; Soldati-Favre, Dominique] Univ Geneva, Fac Med, Dept Microbiol, CH-1211 Geneva 4, Switzerland; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Santos, Joana M.; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England	University of Geneva; University of Oxford; MRC National Institute for Medical Research	Soldati-Favre, D (corresponding author), Univ Geneva, Fac Med, Dept Microbiol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Dominique.Soldati-Favre@unige.ch	; M Santos, Joana/W-4149-2018	Ferguson, David/0000-0001-5045-819X; Soldati-Favre, Dominique/0000-0003-4156-2109; M Santos, Joana/0000-0002-5411-4439	Swiss National Foundation [FN3100A0-116722]; Medical Research Council, UK [U117532063]; MalParTraining [MEST-CT-2005-02049]; Wellcome Trust; Medical Research Council [MC_U117532063] Funding Source: researchfish; MRC [MC_U117532063] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MalParTraining; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Meissner for providing us with the dd system and G. Ward and F. Parussini for sharing unpublished data and inspiring discussions. We thank P. Bradley and M. Gubbels for sharing antibodies, L. Sheiner and T. Dowse for previous study of ROM4, J. Limenitakis for technical assistance, and L. Kemp for critical reading of the manuscript. This work was supported by the Swiss National Foundation (grant FN3100A0-116722) and the Medical Research Council, UK (grant U117532063). J.M.S. was funded by MalParTraining, an FP6-funded Marie Curie Initial Training Network (contract number MEST-CT-2005-020492, The Challenge of Malaria in the Post-Genomic Era). D.S.-F. is an international Howard Hughes Medical Institute scholar. D.J.P.F. is supported by an equipment grant from the Wellcome Trust.	Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3	24	75	85	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					473	477		10.1126/science.1199284	http://dx.doi.org/10.1126/science.1199284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21205639	Green Accepted			2022-12-24	WOS:000286635900056
J	Sundal, AV; Shepherd, A; Nienow, P; Hanna, E; Palmer, S; Huybrechts, P				Sundal, Aud Venke; Shepherd, Andrew; Nienow, Peter; Hanna, Edward; Palmer, Steven; Huybrechts, Philippe			Melt-induced speed-up of Greenland ice sheet offset by efficient subglacial drainage	NATURE			English	Article							MASS-BALANCE; SURFACE MELT; ACCELERATION; DYNAMICS; TRACKING; RUNOFF; MOTION	Fluctuations in surface melting are known to affect the speed of glaciers and ice sheets(1-7), but their impact on the Greenland ice sheet in a warming climate remains uncertain(8). Although some studies suggest that greater melting produces greater ice-sheet acceleration(7,9), others have identified a long-term decrease in Greenland's flow despite increased melting(3). Here we use satellite observations of ice motion recorded in a land-terminating sector of southwest Greenland to investigate the manner in which ice flow develops during years of markedly different melting. Although peak rates of ice speed-up are positively correlated with the degree of melting, mean summer flow rates are not, because glacier slowdown occurs, on average, when a critical run-off threshold of about 1.4 centimetres a day is exceeded. In contrast to the first half of summer, when flow is similar in all years, speed-up during the latter half is 62 +/- 16 per cent less in warmer years. Consequently, in warmer years, the period of fast ice flow is three times shorter and, overall, summer ice flow is slower. This behaviour is at odds with that expected from basal lubrication alone(7,9). Instead, it mirrors that of mountain glaciers(10-12), where melt-induced acceleration of flow ceases during years of high melting once subglacial drainage becomes efficient. A model of ice-sheet flow that captures switching between cavity and channel drainage modes(13) is consistent with the run-off threshold, fast-flow periods, and later-summer speeds we have observed. Simulations of the Greenland ice-sheet flow under climate warming scenarios should account for the dynamic evolution of subglacial drainage; a simple model of basal lubrication alone misses key aspects of the ice sheet's response to climate warming.	[Sundal, Aud Venke; Shepherd, Andrew; Palmer, Steven] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Nienow, Peter] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Hanna, Edward] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; [Huybrechts, Philippe] Vrije Univ Brussel, Dept Geog, B-1050 Brussels, Belgium	University of Leeds; University of Edinburgh; University of Sheffield; Vrije Universiteit Brussel	Shepherd, A (corresponding author), Univ Leeds, Sch Earth & Environm, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	a.shepherd@leeds.ac.uk	Hanna, Edward/H-2219-2016; Palmer, Steven/D-5170-2013; Hanna, Edward/W-5927-2019; Huybrechts, Philippe/J-5278-2013	Hanna, Edward/0000-0002-8683-182X; Hanna, Edward/0000-0002-8683-182X; Shepherd, Andrew/0000-0002-4914-1299; Huybrechts, Philippe/0000-0003-1406-0525; Palmer, Steven/0000-0003-3977-8509	UK NERC National Centre for Earth Observation; EU [026]; Natural Environment Research Council [cpom20001, earth010006] Funding Source: researchfish; NERC [cpom20001] Funding Source: UKRI	UK NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the UK NERC National Centre for Earth Observation, a Philip Leverhulme Prize to A.S. and by the EU FP7 Ice2Sea project (publ. no. 026). European Remote Sensing satellite synthetic aperture radar data were provided by the European Space Agency Vectra Consortium. We thank R. van de Wal for providing positive degree-day data.	Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Bingham RG, 2003, ANN GLACIOL, V37, P181, DOI 10.3189/172756403781815762; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Hanna E, 2008, J CLIMATE, V21, P331, DOI 10.1175/2007JCLI1964.1; Janssens I, 2000, ANN GLACIOL-SER, V31, P133, DOI 10.3189/172756400781819941; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mernild SH, 2010, J HYDROMETEOROL, V11, P3, DOI 10.1175/2009JHM1140.1; Palmer S.J., EARTH PLANE IN PRESS; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Price SF, 2008, J GLACIOL, V54, P213, DOI 10.3189/002214308784886117; Pritchard H, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000233; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Ru┬thlisberger H., 1972, J GLACIOL, V11, P177, DOI [10.3189/S0022143000022188, DOI 10.1017/S0022143000022188]; Schoof C, 2005, P ROY SOC A-MATH PHY, V461, P609, DOI 10.1098/rspa.2004.1350; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Shepherd A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035758; Steffen K, 2001, J GEOPHYS RES-ATMOS, V106, P33951, DOI 10.1029/2001JD900161; Strozzi T, 2002, IEEE T GEOSCI REMOTE, V40, P2384, DOI 10.1109/TGRS.2002.805079; Truffer M, 2005, J GLACIOL, V51, P663, DOI 10.3189/172756505781829016; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	26	234	238	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					522	U83		10.1038/nature09740	http://dx.doi.org/10.1038/nature09740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270891				2022-12-24	WOS:000286596500030
J	John, TJ; Dandona, L; Sharma, VP; Kakkar, M				John, T. Jacob; Dandona, Lalit; Sharma, Vinod P.; Kakkar, Manish			India: Towards Universal Health Coverage 1 Continuing challenge of infectious diseases in India	LANCET			English	Article							VIBRIO-CHOLERAE O1; SEXUALLY-TRANSMITTED INFECTIONS; ANDHRA-PRADESH STATE; PUBLIC-HEALTH; TYPHOID-FEVER; VIRAL-HEPATITIS; SCRUB TYPHUS; TAMIL-NADU; CHIKUNGUNYA EPIDEMIC; TUBERCULOSIS-CONTROL	In India, the range and burden of infectious diseases are enormous. The administrative responsibilities of the health system are shared between the central (federal) and state governments. Control of diseases and outbreaks is the responsibility of the central Ministry of Health, which lacks a formal public health department for this purpose. Tuberculosis, malaria, filariasis, visceral leishmaniasis, leprosy, HIV infection, and childhood duster of vaccine-preventable diseases are given priority for control through centrally managed vertical programmes. Control of HIV infection and leprosy, but not of tuberculosis, seems to be on track. Early success of malaria control was not sustained, and visceral leishmaniasis prevalence has increased. Inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of Chikungunya virus disease and typhus fever. Other infectious diseases caused by faecally transmitted pathogens (enteric fevers, cholera, hepatitis A and E viruses) and zoonoses (rabies, leptospirosis, anthrax) are not in the process of being systematically controlled. Big gaps in the surveillance and response system for infectious diseases need to be addressed. Replication of the model of vertical single-disease control for all infectious diseases will not be efficient or viable. India needs to rethink and revise its health policy to broaden the agenda of disease control. A comprehensive review and redesign of the health system is needed urgently to ensure equity and quality in health care. We recommend the creation of a functional public health infrastructure that is shared between central and state governments, with professional leadership and a formally trained public health cadre of personnel who manage an integrated control mechanism of diseases in districts that includes infectious and noninfectious diseases, and injuries.	[Dandona, Lalit; Kakkar, Manish] Publ Hlth Fdn India, New Delhi 110070, India; [John, T. Jacob] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [John, T. Jacob] Christian Med Coll & Hosp, Dept Virol, Vellore, Tamil Nadu, India; [Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Sharma, Vinod P.] Indian Inst Technol, Ctr Rural Dev & Technol, New Delhi, India	Public Health Foundation of India; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Dandona, L (corresponding author), Publ Hlth Fdn India, ISID Campus,4 Inst Area, New Delhi 110070, India.	lalit.dandona@phfi.org	Rivet, Catherine A/M-7978-2014		John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This report was prepared without any financial support. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Abraham M, 1999, Indian Pediatr, V36, P697; Acharya SK, 2006, NATL MED J INDIA, V19, P203; [Anonymous], HIST TB CONTR; [Anonymous], TB IND 2008RNTCP STA; [Anonymous], NAT VECT BORN DIS CO; Arankalle V A, 2006, Indian J Med Res, V123, P760; Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Bakshi D, 2007, ACTA TROP, V104, P63, DOI 10.1016/j.actatropica.2007.07.013; BALRAJ V, 1994, J TROP MED HYG, V97, P113; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bhore J, 1946, REPORT HLTH SURVEY D; BHUSHAN N, 1994, INDIAN J MED RES, V99, P195; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Chadha Mandeep S, 2003, Indian J Gastroenterol, V22, P11; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Chandy S, 2008, J BIOSCIENCES, V33, P495, DOI 10.1007/s12038-008-0068-x; Chowdhury A, 2005, J GASTROEN HEPATOL, V20, P1712, DOI 10.1111/j.1440-1746.2005.04070.x; Chu KM, 1998, J INFECT DIS, V177, P1314, DOI 10.1086/515273; Cooke FJ, 2007, T ROY SOC TROP MED H, V101, P398, DOI 10.1016/j.trstmh.2006.07.005; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Dandona L, 2009, AIDS, V23, P233, DOI 10.1097/QAD.0b013e328320accc; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; Dandona L, 2007, LANCET, V370, P1811, DOI 10.1016/S0140-6736(07)61756-5; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Das Gupta M, 2009, POLICY RES WORKING P; DASGUPTA PR, 1994, AIDS, V8, pS83; Datta M, 1999, INDIAN J MED RES, V110, P56; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; deBora D, 2005, J COMMUN DIS, V37, P1; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Government of India, E MAIL DIR; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; International Society for Infectious Diseases, 2009, MEN MEN IND 04 N E; International Society for Infectious Diseases, 2009, HEP B VIR IND 08 GUJ; JACOB M, 1989, INDIAN J MED RES-A, V89, P4; Jain NK, 1992, IND J TUBERC, V92, P145; Jesudason MV, 1996, LANCET, V347, P1493, DOI 10.1016/S0140-6736(96)91733-X; Jesudason MV, 2001, INDIAN J MED MICROBI, V19, P20; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; John T J, 2000, Indian Pediatr, V37, P9; John TJ, 2008, INDIAN PEDIATR, V45, P261; John TJ, 2010, INDIAN J MED RES, V132, P4; John TJ, 2010, INDIAN J MED RES, V131, P377; John TJ, 2009, INDIAN J MED RES, V130, P101; John TJ, 2009, INDIAN J MED RES, V130, P9; John TJ, 2008, INDIAN J MED RES, V128, P669; JOHN TJ, 1971, INDIAN J MED RES, V59, P1727; JOHN TJ, 1987, LANCET, V1, P160; John TJ, 2004, INDIAN J MED RES, V120, P86; JOHN TJ, 1993, INDIAN J MED RES-A, V97, P227; JOHN TJ, 1989, INDIAN J MED RES-A, V89, P1; John TJ, 1996, INDIAN J MED RES, V103, P4; John TJ, 1996, INDIAN J MED RES, V103, P62; JOHN TJ, 1974, B WORLD HEALTH ORGAN, V51, P617; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; JOHN TJ, 1993, AIDS, V7, P421, DOI 10.1097/00002030-199303000-00018; John TJ, 2003, GLOBAL PUBLIC HLTH N, P172; John TJ., 2008, P RANB SCI FDN ROUND, P3; John TJ, 2009, TROP MED INT HEALTH, V4, P1; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Keller A, 2008, J TRAVEL MED, V15, P248, DOI 10.1111/j.1708-8305.2008.00216.x; Khan AM, 2005, CURR SCI INDIA, V88, P1718; Khatri GR., 2000, P 7 ROUND TABL C SEP, P15; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kingston JJ, 2009, J MICROBIOL, V47, P110, DOI 10.1007/s12275-008-0162-7; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; Mahajan RC, 2005, INDIAN J MED RES, V121, P716; Mantur BG, 2008, J BIOSCIENCES, V33, P539, DOI 10.1007/s12038-008-0072-1; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; MATHAI R, 1990, INDIAN J MED RES-A, V91, P239; Mathew JL, 2009, INDIAN PEDIATR, V46, P304; Mathur P, 2008, INDIAN J MED RES, V128, P699; Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720; Ministry of Health and Family Welfare Government of India, 2009, OP MAN IMPL MAL PROG; Ministry of Health and Family Welfare Government of India, 2006, GUID SURV AC ENC SYN; Ministry of Health and Family Welfare Government of India, 1995, REP EXP COMM PLAG AU; Ministry of Health and Family Welfare Government of India, INT DIS SURV PROJ PR; Ministry of Health and Family Welfare Government of India, URB MAL SCHEM ACC UR; Mohapatra SS, 2007, J MED MICROBIOL, V56, P260, DOI 10.1099/jmm.0.46868-0; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Mukhopadhya Ashis, 2006, Trop Gastroenterol, V27, P105; Nandakumar A, 2005, INT J CANCER, V116, P740, DOI 10.1002/ijc.21109; Narain JP, 2008, INDIAN J MED RES, V128, P1; Narain KL, 2003, CURR SCI INDIA, V84, P985; Narang P, 2008, INDIAN J MED MICROBI, V26, P40; National Aids Control Organisation and Government of India Ministry of Health Family Welfare, 2007, HIV SENT SURV HIV ES; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, NAT AIDS CONTR PROGR; National AIDS Control Organization, 2021, SANK STAT NAT AIDS R, V3rd; National AIDS Control Organization (NACO), 2019, IND HIV EST 2019; National Institute of Malaria Research and National Vector Borne Disease Control Programme, 2007, IN DEPTH REV MAL NAT; National Vector Borne Disease Control Programme, CHIK FEV; National Vector Borne Disease Control Programme Government of India, STAT NOT DENG FEV DE; National Vector Rome Disease Control Programme, KAL AZ VISC LEISHM; Oberoi A, 2007, Indian J Med Microbiol, V25, P75; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Pandey A, 2009, INDIAN J MED RES, V129, P50; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Pattanayak S., 1994, Indian Journal of Malariology, V31, P141; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Radha Krishna Y, 2009, LIVER INT, V29, P392, DOI 10.1111/j.1478-3231.2008.01887.x; Rajendran R, 2004, T ROY SOC TROP MED H, V98, P174, DOI 10.1016/S0035-9203(03)00042-7; Rajendran R, MASS DRUG ADM; Rajshekhar V, 2006, NEUROLOGY, V67, P2135, DOI 10.1212/01.wnl.0000249113.11824.64; Ramachandran J, 2004, J GASTROEN HEPATOL, V19, P134, DOI 10.1111/j.1440-1746.2004.03188.x; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Ramasundaram S, 2001, WG523 COMM MACR HLTH, V23; Rao BL, 2003, NATL MED J INDIA, V16, P143; Rao G Raghu Rama, 2005, Indian J Dermatol Venereol Leprol, V71, P102; Rasheeda CA, 2008, EUR J GASTROEN HEPAT, V20, P362, DOI 10.1097/MEG.0b013e3282f246d6; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2006, NATL MED J INDIA, V19, P122; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Richard VS, 2001, J HOSP INFECT, V47, P243, DOI 10.1053/jhin.2000.0855; Roll Back Malaria, SIT AN MAL CONTR 5 S; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Satyanarayana, EVALUATION INTEGRATE; Schneider JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-59; Sebastian B, 1998, INDIAN J GASTROENTER, V17, pS10; Sehgal PN, 1993, J COMM DIS, V5, P175; SEHGAL SC, 1995, INDIAN J MED RES, V102, P9; Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579; Shah NK, LANCET INFE IN PRESS; Sharma NC, 2007, INDIAN J MED RES, V125, P633; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; Sharma R, 2000, BRIT MED J, V320, P668; Sharma VP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-281; Sharma VP, 1996, INDIAN J MED RES, V103, P26; Sharma VP., 2002, CONTEXTUAL DETERMINA; Sharma VP., 2005, GETTING GRIPS MALARI; Shetty PVD, 2008, INT J TUBERC LUNG D, V12, pS26; SIMOES EAF, 1993, J ACQ IMMUN DEF SYND, V6, P1030; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Somashekar HR, 2006, J TROP PEDIATRICS, V52, P228, DOI 10.1093/tropej/fmi096; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Sudarshan MK, 2005, INDIAN J COMMUN MED, V30, P100, DOI DOI 10.4103/0970-0218.42864; Sundaram SP, 2002, INDIAN J MED RES, V116, P258; Sur D, 2004, INDIAN J MED RES, V120, P454; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10; Tarantola A, 2008, J TRAVEL MED, V15, P273, DOI 10.1111/j.1708-8305.2008.00210.x; TBC India, DOTS EXP IND; Thakur CP, 2007, INDIAN J MED RES, V126, P447; Thakur CP, 2009, INDIAN J MED RES, V129, P102; UN Development Program, HUM DEV REP 2009 HDI; UNAIDS, 2010, REP GLOB AIDS EP 201; UNAIDS, 2006, REP GLOB AIDS EP; van den Ent M, 2009, INDIAN PEDIATR, V46, P933; VENKITARAMAN AR, 1986, INT J EPIDEMIOL, V15, P561, DOI 10.1093/ije/15.4.561; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; WHO, 1995, MAL COUNTR PROF IND; WHO, NEW CAS DET TRENDS L; WHO, 2004, REG STRAT FRAM EL KA; WHO, 2007, NEWS LETT        JUN; WHO, 2010, GLOB TUB CONTR 2010; WHO Regional Office for South East Asia, IMM VACC DEV; WHO SEARO, COMM DIS KAL AZ; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Bank, 2006, IMPL COMPL RES REP I; World Health Organization, 2008, GLOB BURD DIS 2004 U; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Young F, 2009, INDIAN J MED RES, V130, P1	174	122	125	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					252	269		10.1016/S0140-6736(10)61265-2	http://dx.doi.org/10.1016/S0140-6736(10)61265-2			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21227500				2022-12-24	WOS:000286696400033
J	Cocinero, EJ; Carcabal, P; Vaden, TD; Simons, JP; Davis, BG				Cocinero, Emilio J.; Carcabal, Pierre; Vaden, Timothy D.; Simons, John P.; Davis, Benjamin G.			Sensing the anomeric effect in a solvent-free environment	NATURE			English	Article							CONFORMATIONAL-ANALYSIS; GAS-PHASE; GLUCOSE; SYSTEMS; MODEL; BOND	The anomeric effect is a chemical phenomenon(1-9) that refers to an observed stabilization(10) of six-membered carbohydrate rings when they contain an electronegative substituent at the C1 position of the ring. This stereoelectronic effect influences the three-dimensional shapes of many biological molecules. It can be manifested not only in this classical manner involving interaction of the endocyclic oxygen atom (O5) found in such sugars with the C1 substituent (endo-anomeric effect) but also through a corresponding interaction of the electronegative exocyclic substituent with O5 (exoanomeric effect). However, the underlying physical origin(s) of this phenomenon is still not clear(1,3,4,11-14). Here we show, using a combination of laser spectroscopy and computational analysis, that a truncated peptide motif can engage the two anomers of an isolated sugar in the gas phase, an environment lacking extraneous factors which could confound the analysis. (Anomers are isomers that differ in the orientation of the substituent at C1.) Complexes formed between the peptide and the alpha- or beta-anomers of D-galactose are nearly identical structurally; however, the strength of the polarization of their interactions with the peptide differs greatly. Natural bond order calculations support this observation, and together they reveal the dominance of the exo- over the endo-anomeric effect. As interactions between oxygen atoms at positions C1 and C2 (O1 and O2, respectively) on the pyranose ring can alter the exo/endo ratio of a carbohydrate, our results suggest that it will be important to reevaluate the influence, and biological effects, of substituents at position C2 in sugars.	[Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Cocinero, Emilio J.; Carcabal, Pierre; Vaden, Timothy D.; Simons, John P.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Oxford; University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	John.Simons@chem.ox.ac.uk; Ben.Davis@chem.ox.ac.uk	Davis, Benjamin G/C-5281-2011; Cocinero, Emilio J./C-6497-2009	Davis, Benjamin G/0000-0002-5056-407X; Cocinero, Emilio J./0000-0001-7632-3728; Vaden, Timothy/0000-0002-2648-0300	EPSRC [GR/T26542]; Leverhulme Trust; Spanish Ministry (MCINN) for a Juan de la Cierva; Royal Society for a USA/Canada; Linacre College; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E004350/1, BB/C510824/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G026688/1, EP/D023335/1, EP/I500200/1, EP/G03088X/1, EP/E000614/1, GR/T26542/01, EP/D023343/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/I500200/1, EP/G026688/1, EP/E000614/1, EP/G03088X/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Spanish Ministry (MCINN) for a Juan de la Cierva(Spanish Government); Royal Society for a USA/Canada(Royal Society of London); Linacre College; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the EPSRC for funding (GR/T26542), the Leverhulme Trust for the award of an Emeritus Fellowship (J.P.S.), the Spanish Ministry (MCINN) for a Juan de la Cierva contract (E.J.C.), the Royal Society for a USA/Canada Research Fellowship and Linacre College for a Junior Research Fellowship (T.D.V.), the STFC for the provision of equipment from the Laser Loan Pool, and the Oxford Supercomputing Centre for their services. B.G.D. is a Royal Society Wolfson Research Merit Award recipient and is supported by an EPSRC LSI Platform grant.	BOX VGS, 1990, HETEROCYCLES, V31, P1157; BRIGGS AJ, 1984, J AM CHEM SOC, V106, P6200, DOI 10.1021/ja00333a014; Cramer CJ, 1997, CARBOHYD RES, V298, P1, DOI 10.1016/S0008-6215(96)00297-2; Deslongchamps P., 1983, STEREOELECTRONIC EFF; EDWARD JT, 1955, CHEM IND-LONDON, P1102; Eliel E. L., 1994, STEREOCHEMISTRY ORGA; ELIEL EL, 1968, J ORG CHEM, V33, P3754, DOI 10.1021/jo01274a015; Gerhards M, 2004, PHYS CHEM CHEM PHYS, V6, P2682, DOI 10.1039/b316001g; Gillespie RJ, 2010, CHEM-EUR J, V16, P3663, DOI 10.1002/chem.200902599; JUARISTI E, 1992, TETRAHEDRON, V48, P5019, DOI 10.1016/S0040-4020(01)90118-8; Jungius CL, 1905, Z PHYS CHEM-STOCH VE, V52, P97; Kirby A. J., 1983, ANOMERIC EFFECT RELA; Lemieux R.U., 1971, PURE APPL CHEM, V25, P527; LEMIEUX RU, 1979, ACS SYM SER, P17; Mo YR, 2010, NAT CHEM, V2, P666, DOI [10.1038/NCHEM.721, 10.1038/nchem.721]; Robertson EG, 2001, PHYS CHEM CHEM PHYS, V3, P1, DOI 10.1039/b008225m; Romers C., 1969, TOP STEREOCHEM, V4, P39; SALZNER U, 1994, J ORG CHEM, V59, P2138, DOI 10.1021/jo00087a035; Takahashi O, 2007, CARBOHYD RES, V342, P1202, DOI 10.1016/j.carres.2007.02.032; Thatcher G. R. J., 1993, ANOMERIC EFFECT ASS; Vila A, 2007, J COMPUT CHEM, V28, P1516, DOI 10.1002/jcc.20585; WIBERG KB, 1989, J AM CHEM SOC, V111, P4821, DOI 10.1021/ja00195a038	22	124	124	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					76	U1400		10.1038/nature09693	http://dx.doi.org/10.1038/nature09693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209661				2022-12-24	WOS:000285921600034
J	Lipska, KJ; Ross, JS				Lipska, Kasia J.; Ross, Joseph S.			Switching From Rosiglitazone Thinking Outside the Class	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TYPE-2 DIABETES-MELLITUS		[Lipska, Kasia J.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA	Yale University; Yale University	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, 333 Cedar St,SHM IE-60, New Haven, CT 06520 USA.	kasia.lipska@yale.edu		Ross, Joseph/0000-0002-9218-3320	NIA NIH HHS [K08 AG032886] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Cohen A, 2010, DIABETES CARE, V33, P823, DOI 10.2337/dc09-1834; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Erdmann E, 2010, J DIABETES, V2, P212, DOI 10.1111/j.1753-0407.2010.00082.x; McEvoy B, 2010, PIOGLITAZONE ROSIGLI; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; US Food and Drug Administration, 2008, GUID IND DIAB MELL E; WILSON D, ACTOS ADS JUMP AVAND	10	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					820	821		10.1001/jama.2011.193	http://dx.doi.org/10.1001/jama.2011.193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21304068				2022-12-24	WOS:000287594300026
J	Bredel, M; Scholtens, DM; Yadav, AK; Alvarez, AA; Renfrow, JJ; Chandler, JP; Yu, ILY; Carro, MS; Dai, FP; Tagge, MJ; Ferrarese, R; Bredel, C; Phillips, HS; Lukac, PJ; Robe, PA; Weyerbrock, A; Vogel, H; Dubner, S; Mobley, B; He, XL; Scheck, AC; Sikic, BI; Aldape, KD; Chakravarti, A; Harsh, GR				Bredel, Markus; Scholtens, Denise M.; Yadav, Ajay K.; Alvarez, Angel A.; Renfrow, Jaclyn J.; Chandler, James P.; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Tagge, Michael J.; Ferrarese, Roberto; Bredel, Claudia; Phillips, Heidi S.; Lukac, Paul J.; Robe, Pierre A.; Weyerbrock, Astrid; Vogel, Hannes; Dubner, Steven; Mobley, Bret; He, Xiaolin; Scheck, Adrienne C.; Sikic, Branimir I.; Aldape, Kenneth D.; Chakravarti, Arnab; Harsh, Griffith R.			NFKBIA Deletion in Glioblastomas.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KAPPA-B-ALPHA; INTEGRATED GENOMIC ANALYSIS; HODGKIN LYMPHOMA; ADJUVANT TEMOZOLOMIDE; MULTIPLE-MYELOMA; STERNBERG CELLS; EGF RECEPTOR; GENE; MUTATIONS; GROWTH	Background: Amplification and activating mutations of the epidermal growth factor receptor (EGFR) oncogene are molecular hallmarks of glioblastomas. We hypothesized that deletion of NFKBIA (encoding nuclear factor of (kappa)-light polypeptide gene enhancer in B-cells inhibitor-(alpha)), an inhibitor of the EGFR-signaling pathway, promotes tumorigenesis in glioblastomas that do not have alterations of EGFR. Methods: We analyzed 790 human glioblastomas for deletions, mutations, or expression of NFKBIA and EGFR. We studied the tumor-suppressor activity of NFKBIA in tumor-cell culture. We compared the molecular results with the outcome of glioblastoma in 570 affected persons. Results: NFKBIA is often deleted but not mutated in glioblastomas; most deletions occur in nonclassical subtypes of the disease. Deletion of NFKBIA and amplification of EGFR show a pattern of mutual exclusivity. Restoration of the expression of NFKBIA attenuated the malignant phenotype and increased the vulnerability to chemotherapy of cells cultured from tumors with NFKBIA deletion; it also reduced the viability of cells with EGFR amplification but not of cells with normal gene dosages of both NFKBIA and EGFR. Deletion and low expression of NFKBIA were associated with unfavorable outcomes. Patients who had tumors with NFKBIA deletion had outcomes that were similar to those in patients with tumors harboring EGFR amplification. These outcomes were poor as compared with the outcomes in patients with tumors that had normal gene dosages of NFKBIA and EGFR. A two-gene model that was based on expression of NFKBIA and O(sup 6)-methylguanine DNA methyltransferase was strongly associated with the clinical course of the disease. Conclusions: Deletion of NFKBIA has an effect that is similar to the effect of EGFR amplification in the pathogenesis of glioblastoma and is associated with comparatively short survival. N Engl J Med 2011;364:627-37.	[Bredel, Markus; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Ferrarese, Roberto; Bredel, Claudia; Weyerbrock, Astrid] Univ Freiburg, Dept Neurosurg, Neuroctr, Freiburg, Germany; [Bredel, Markus; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Ferrarese, Roberto; Bredel, Claudia; Weyerbrock, Astrid] Univ Freiburg, Ctr Comprehens Canc, Freiburg, Germany; [Bredel, Markus; Alvarez, Angel A.] Univ Alabama, UAB Comprehens Canc Ctr, Dept Radiat Oncol, Birmingham, AL USA; [Bredel, Markus; Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Tagge, Michael J.; Lukac, Paul J.] Northwestern Univ, Feinberg Sch Med, Lurie Ctr Canc Genet Res, NW Brain Tumor Inst,Dept Neurol Surg, Chicago, IL 60611 USA; [Bredel, Markus; Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Tagge, Michael J.; Lukac, Paul J.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Scholtens, Denise M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA; [Dubner, Steven] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Bredel, Markus; Harsh, Griffith R.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Vogel, Hannes; Mobley, Bret] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sikic, Branimir I.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Phillips, Heidi S.] Genentech Inc, San Francisco, CA 94080 USA; [Robe, Pierre A.] Univ Liege, Dept Neurosurg, Liege, Belgium; [Robe, Pierre A.] Univ Liege, Dept Human Genet, Liege, Belgium; [Robe, Pierre A.] Univ Utrecht, Dept Neurosurg, Utrecht, Netherlands; [Scheck, Adrienne C.] Barrow Neurol Inst, Ina Levine Brain Tumor Ctr, Phoenix, AZ 85013 USA; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Chakravarti, Arnab] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Chakravarti, Arnab] Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA	University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Stanford University; Roche Holding; Genentech; University of Liege; University of Liege; Utrecht University; Barrow Neurological Institute; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Bredel, M (corresponding author), Univ Freiburg, Dept Neurosurg, Neuroctr, Freiburg, Germany.	markus.bredel@uniklinik-freiburg.de	Weyerbrock, Astrid/AAI-1731-2020; Stella, Maria Stella/GVS-1585-2022; Scheck, Adrienne/AAH-5040-2020; Ferrarese, Roberto/GSJ-3449-2022; Weyerbrock, Astrid/E-8493-2014; Lukac, Pavel/P-4068-2017	Weyerbrock, Astrid/0000-0001-9060-4462; Ferrarese, Roberto/0000-0003-0625-3319; Lukac, Pavel/0000-0001-8412-1931; Yadav, Ajay/0000-0003-3321-4198; Carro, Maria Stella/0000-0002-8570-7691; Vogel, Otto Hannes/0000-0002-0960-3508; Scheck, Adrienne/0000-0003-3497-1895	Accelerate Brain Cancer Cure; Mike Gardner/American Brain Tumor Association; German Cancer Aid [107714]; State of Illinois Excellence in Academic Medicine Program Award [211]; State of Alabama Investment Pool for Action (IMPACT); National Cancer Institute [RO1CA108633, RC2CA148190, P50CA127001, RTOG U10CA21661, CCOP U10CA37422]; Goldhirsh Brain Tumor Research Award; Leach Foundation; Brain Tumor Funders' Collaborative; Lou Malnati's Cancer Benefit Committee; Mazza Foundation; NATIONAL CANCER INSTITUTE [RC2CA148190, R01CA108633, U10CA037422, U10CA021661, P50CA127001] Funding Source: NIH RePORTER	Accelerate Brain Cancer Cure; Mike Gardner/American Brain Tumor Association; German Cancer Aid(Deutsche Krebshilfe); State of Illinois Excellence in Academic Medicine Program Award; State of Alabama Investment Pool for Action (IMPACT); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Goldhirsh Brain Tumor Research Award; Leach Foundation; Brain Tumor Funders' Collaborative; Lou Malnati's Cancer Benefit Committee; Mazza Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Project Award of Accelerate Brain Cancer Cure, a Mike Gardner/American Brain Tumor Association Grant Award, a German Cancer Aid Grant Award (107714), a State of Illinois Excellence in Academic Medicine Program Award (211), State of Alabama Investment Pool for Action (IMPACT) funds, grants from the National Cancer Institute (RO1CA108633, RC2CA148190, P50CA127001, RTOG U10CA21661, and CCOP U10CA37422), a Goldhirsh Brain Tumor Research Award, a Leach Foundation Research Award, the Brain Tumor Funders' Collaborative, the Lou Malnati's Cancer Benefit Committee, and the Mazza Foundation.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Chakravarti A, 2002, CANCER RES, V62, P4307; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kapoor GS, 2004, MOL CELL BIOL, V24, P823, DOI 10.1128/MCB.24.2.823-836.2004; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lake A, 2009, INT J CANCER, V125, P1334, DOI 10.1002/ijc.24502; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Liu XJ, 2010, CANCER GENET CYTOGEN, V197, P152, DOI 10.1016/j.cancergencyto.2009.11.005; MIKESKA T, 1955, ANN HUM GENET, V19, P251; Nagai S, 2002, J NEUROSURG, V96, P909, DOI 10.3171/jns.2002.96.5.0909; Osborne J, 2005, INT J CANCER, V116, P646, DOI 10.1002/ijc.21036; Parker KM, 2002, CANCER GENET CYTOGEN, V137, P43, DOI 10.1016/S0165-4608(02)00541-1; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spink CF, 2007, CANCER LETT, V246, P92, DOI 10.1016/j.canlet.2006.02.001; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tsunoda Keishi, 2005, Brain Tumor Pathol, V22, P79, DOI 10.1007/s10014-005-0186-1; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wen PY, 2008, NEW ENGL J MED, V359, P877; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	181	186	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					627	637		10.1056/NEJMoa1006312	http://dx.doi.org/10.1056/NEJMoa1006312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21175304	Green Accepted			2022-12-24	WOS:000287406000008
J	Ding, ZH; Wu, CJ; Chu, GC; Xiao, YH; Ho, D; Zhang, JF; Perry, SR; Labrot, ES; Wu, XQ; Lis, R; Hoshida, Y; Hiller, D; Hu, BL; Jiang, S; Zheng, HW; Stegh, AH; Scott, KL; Signoretti, S; Bardeesy, N; Wang, YA; Hill, DE; Golub, TR; Stampfer, MJ; Wong, WH; Loda, M; Mucci, L; Chin, L; DePinho, RA				Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Zhang, Jingfang; Perry, Samuel R.; Labrot, Emma S.; Wu, Xiaoqiu; Lis, Rosina; Hoshida, Yujin; Hiller, David; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Signoretti, Sabina; Bardeesy, Nabeel; Wang, Y. Alan; Hill, David E.; Golub, Todd R.; Stampfer, Meir J.; Wong, Wing H.; Loda, Massimo; Mucci, Lorelei; Chin, Lynda; DePinho, Ronald A.			SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression	NATURE			English	Article							TGF-BETA; EXPRESSION; PTEN; SMAD4; INACTIVATION; OSTEOPONTIN; PROMOTER; ROLES; MODEL; LEADS	Effective clinical management of prostate cancer (PCA) has been challenged by significant intratumoural heterogeneity on the genomic and pathological levels and limited understanding of the genetic elements governing disease progression(1). Here, we exploited the experimental merits of the mouse to test the hypothesis that pathways constraining progression might be activated in indolent Pten-null mouse prostate tumours and that inactivation of such progression barriers in mice would engender a metastasis-prone condition. Comparative transcriptomic and canonical pathway analyses, followed by biochemical confirmation, of normal prostate epithelium versus poorly progressive Pten-null prostate cancers revealed robust activation of the TGF beta/BMP-SMAD4 signalling axis. The functional relevance of SMAD4 was further supported by emergence of invasive, metastatic and lethal prostate cancers with 100% penetrance upon genetic deletion of Smad4 in the Pten-null mouse prostate. Pathological and molecular analysis as well as transcriptomic knowledge-based pathway profiling of emerging tumours identified cell proliferation and invasion as two cardinal tumour biological features in the metastatic Smad4/Pten-null PCA model. Follow-on pathological and functional assessment confirmed cyclin D1 and SPP1 as key mediators of these biological processes, which together with PTEN and SMAD4, form a four-gene signature that is prognostic of prostate-specific antigen (PSA) biochemical recurrence and lethal metastasis in human PCA. This model-informed progression analysis, together with genetic, functional and translational studies, establishes SMAD4 as a key regulator of PCA progression in mice and humans.	[Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Perry, Samuel R.; Labrot, Emma S.; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Perry, Samuel R.; Labrot, Emma S.; Wu, Xiaoqiu; Lis, Rosina; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Wang, Y. Alan; Loda, Massimo; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Ho, Dennis; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Hill, David E.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Ho, Dennis; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chu, Gerald C.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhang, Jingfang] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Wu, Xiaoqiu; Lis, Rosina; Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Hoshida, Yujin; Golub, Todd R.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Hoshida, Yujin; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Hiller, David; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Signoretti, Sabina] Dana Farber Harvard Canc Ctr, Renal Canc Program, Boston, MA 02115 USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chin, Lynda] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Stampfer, Meir J.; Mucci, Lorelei] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stampfer, Meir J.; Mucci, Lorelei] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu; ron_depinho@dfci.harvard.edu	Hill, David E/B-6617-2011; Hoshida, Yujin/R-7513-2019	Zheng, Hongwu/0000-0002-5823-4913; DePinho, Ronald/0000-0002-5625-577X	Damon Runyon Cancer Research Foundation; National Science Foundation; Helen Hay Whitney Foundation; Multiple Myeloma Research Foundation; Belfer Institute for Applied Cancer Science (NCI) [U01-CA84313]; DF/HCC SPORE in Prostate Cancer [P50 CA090381-08]; National Cancer Institute [RO1CA131945, P50 CA90381, RO1 5R01CA136578, R01CA141298]; Linda and Arthur Gelb Center for Translational Research; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA141298, U01CA084313, R01CA136578, P50CA090381, R01CA131945] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; Multiple Myeloma Research Foundation; Belfer Institute for Applied Cancer Science (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DF/HCC SPORE in Prostate Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Linda and Arthur Gelb Center for Translational Research; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to the late W. Gerald for providing the primary gene expression data and clinical outcome files<SUP>13</SUP>. We thank S. Zhou for excellent mouse husbandry and care, B. Xiong and G. Tonon for bioinformatic assistance, and S. Jia, J. M. Stommel, J. Paik, M. Kim and A. C. Kimmelman for helpful discussion. We thank M. Vidal, the Ellison Foundation and DFCI ISR for support of ORF cloning efforts, R. Maser for MSCV-puro-v5 gateway vector, W. Hahn for shRNA constructs. We thank the DF/HCC Specialized Histopathology Core and the DF/HCC Tissue Microarray and Imaging core for the TMA IHC staining; the DFCI/BWH Center for Molecular Oncologic Pathology (CMOP) for the quantification of the IHC. Z.D was supported by the Damon Runyon Cancer Research Foundation. D. H. was supported by a graduate fellowship from the National Science Foundation. H.Z. was supported by the Helen Hay Whitney Foundation. Y.A.W. was supported by the Multiple Myeloma Research Foundation. This work is supported by the Belfer Institute for Applied Cancer Science, NCI U01-CA84313 (L. C. and R. A. D.), DF/HCC SPORE in Prostate Cancer P50 CA090381-08 (Z.D.), the National Cancer Institute (M. L. RO1CA131945 and P50 CA90381, L. M. RO1 5R01CA136578, M. S. R01CA141298), and the Linda and Arthur Gelb Center for Translational Research (M. L.). R. A. D. was supported by an American Cancer Society Research Professorship and L. M. was supported by the Prostate Cancer Foundation.	Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hullinger TG, 2001, EXP CELL RES, V262, P69, DOI 10.1006/excr.2000.5074; Jeet V, 2010, CANCER METAST REV, V29, P123, DOI 10.1007/s10555-010-9212-9; JEMAL A, 2010, CA CANC J CLIN; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Marino S, 2000, GENE DEV, V14, P994; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Packer L, 2006, CARCINOGENESIS, V27, P1778, DOI 10.1093/carcin/bgl016; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Rubin MA, 2008, MODERN PATHOL, V21, pS44, DOI 10.1038/modpathol.2008.11; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Shi XM, 2001, J BIOL CHEM, V276, P850, DOI 10.1074/jbc.M005955200; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang YZ, 2001, CANCER RES, V61, P6064; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zeng L, 2004, HUM PATHOL, V35, P290, DOI 10.1016/j.humpath.2003.11.001; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	33	373	389	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					269	+		10.1038/nature09677	http://dx.doi.org/10.1038/nature09677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21289624	Green Accepted			2022-12-24	WOS:000287144200046
J	Xian, Y; Holloway, RG; Noyes, K; Shah, MN; Friedman, B				Xian, Ying; Holloway, Robert G.; Noyes, Katia; Shah, Manish N.; Friedman, Bruce			Racial Differences in Mortality Among Patients With Acute Ischemic Stroke An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							COMORBIDITY ADJUSTMENT; TREATMENT INTENSITY; HOSPITAL MORTALITY; CARE; END; DISPARITIES; POPULATION; ADMISSION; SURVIVAL; OUTCOMES	Background: Black patients are commonly believed to have higher stroke mortality. However, several recent studies have reported better survival in black patients with stroke. Objective: To examine racial differences in stroke mortality and explore potential reasons for these differences. Design: Observational cohort study. Setting: 164 hospitals in New York. Participants: 5319 black and 18 340 white patients aged 18 years or older who were hospitalized with acute ischemic stroke between January 2005 and December 2006. Measurements: Influence of race on mortality, examined by using propensity score analysis. Secondary outcomes were selected aspects of end-of-life treatment, use of tissue plasminogen activator, hospital spending, and length of stay. Patients were followed for mortality for 1 year after admission. Results: Overall in-hospital mortality was lower for black patients than for white patients (5.0% vs. 7.4%; P < 0.001), as was all-cause mortality at 30 days (6.1% vs. 11.4%; P < 0.001) and 1 year (16.5% vs. 24.4%; P < 0.001). After propensity score adjustment, black race was independently associated with lower inhospital mortality (odds ratio [OR], 0.77 [95% CI, 0.61 to 0.98]) and all-cause mortality up to 1 year (OR, 0.86 [CI, 0.77 to 0.96]). The adjusted hazard ratio was 0.87 (CI, 0.79 to 0.96). After adjustment for the probability of dying in the hospital, black patients with stroke were more likely to receive life-sustaining interventions (OR, 1.22 [CI, 1.09 to 1.38]) but less likely to be discharged to hospice (OR, 0.25 [CI, 0.14 to 0.46]). Limitations: The study used hospital administrative data that lacked a stroke severity measure. The study design precluded determination of causality. Conclusion: Among patients with acute ischemic stroke, black patients had lower mortality than white patients. This could be the result of differences in receipt of life-sustaining interventions and end-of-life care.	[Holloway, Robert G.] Univ Rochester, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; Duke Clin Res Inst, Durham, NC USA	University of Rochester; Duke University	Holloway, RG (corresponding author), Univ Rochester, Dept Neurol, Sch Med & Dent, 601 Elmwood Ave,Box 673, Rochester, NY 14642 USA.	Robert_Holloway@URMC.Rochester.edu	Xian, Ying/O-1956-2019	Shah, Manish/0000-0001-6331-1074; Xian, Ying/0000-0002-1237-1162	American Heart Association [0815772D]; National Center for Research Resources; National Institutes of Health (NIH) and the NIH Roadmap for Medical Research [1 UL1 RR024160-01]; Paul B. Beeson Career Development Award [NIA 1K23AG028942]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028942] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH) and the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul B. Beeson Career Development Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By an American Heart Association Founders Affiliate Predoctoral Fellowship Award (0815772D) (Dr. Xian); the National Center for Research Resources, a component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research (1 UL1 RR024160-01) (Drs. Holloway and Noyes); and a Paul B. Beeson Career Development Award (NIA 1K23AG028942) (Dr. Shah).	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Dupreez AE, 2008, J PALLIAT MED, V11, P1249, DOI 10.1089/jpm.2008.0124; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellis C, 2009, ETHNIC DIS, V19, P161; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Feng WW, 2009, STROKE, V40, P3096, DOI 10.1161/STROKEAHA.109.554535; Gillum RF, 1996, NEW ENGL J MED, V335, P1597, DOI 10.1056/NEJM199611213352110; Gillum RF, 1999, STROKE, V30, P1711, DOI 10.1161/01.STR.30.8.1711; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Gorelick PB, 1998, STROKE, V29, P2656, DOI 10.1161/01.STR.29.12.2656; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Holloway RG, 2007, JAMA-J AM MED ASSOC, V298, P802, DOI 10.1001/jama.298.7.802; Holloway RG, 2010, J PALLIAT MED, V13, P407, DOI 10.1089/jpm.2009.0278; Iezzoni LI, 1996, MED DECIS MAKING, V16, P348, DOI 10.1177/0272989X9601600405; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Jones MR, 2000, STROKE, V31, P563, DOI 10.1161/01.STR.31.3.563; Kelly A, 2008, STROKE, V39, P3367, DOI 10.1161/STROKEAHA.108.518738; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; Kleindorfer D, 2006, STROKE, V37, P2473, DOI 10.1161/01.STR.0000242766.65550.92; KUHLEMEIER KV, 1994, STROKE, V25, P2126, DOI 10.1161/01.STR.25.11.2126; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Polsky D, 2007, MED CARE, V45, P1083, DOI 10.1097/MLR.0b013e3180ca960e; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Stukenborg GJ, 2007, CIRCULATION, V116, P2960, DOI 10.1161/CIRCULATIONAHA.107.712323; Tuhrim Stanley, 2008, J Stroke Cerebrovasc Dis, V17, P226, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.003; Volpp KG, 2007, HEALTH SERV RES, V42, P1613, DOI 10.1111/j.1475-6773.2006.00688.x; Wolfe CDA, 2005, BMJ-BRIT MED J, V331, P431, DOI 10.1136/bmj.38510.458218.8F; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zhu HF, 2008, NEUROLOGY, V71, P283, DOI 10.1212/01.wnl.0000318278.41347.94	45	42	42	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					152	+		10.7326/0003-4819-154-3-201102010-00004	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282694	Green Accepted			2022-12-24	WOS:000286729200002
J	Healey, F; Darowski, A; Lamont, T; Panesar, S; Poulton, S; Treml, J; Wiese, M				Healey, Frances; Darowski, Adam; Lamont, Tara; Panesar, Sukhmeet; Poulton, Susan; Treml, Jonathan; Wiese, Martin			Safety Alerts Essential care after an inpatient fall: summary of a safety report from the National Patient Safety Agency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITALS		[Healey, Frances; Lamont, Tara; Panesar, Sukhmeet] Natl Patient Safety Agcy, London W1T 5HD, England; [Darowski, Adam] John Radcliffe Hosp, Oxford OX3 9DU, England; [Poulton, Susan] Queen Alexandra Hosp, Portsmouth PO6 3LY, Hants, England; [Treml, Jonathan] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England; [Wiese, Martin] Leicester Royal Infirm, Leicester LE1 5WW, Leics, England	University of Oxford; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Birmingham; University of Leicester	Healey, F (corresponding author), Natl Patient Safety Agcy, London W1T 5HD, England.							British Orthopaedic Association British Geriatric Society, 2007, BLUE BOOK GUID TREAT; National Institute for Health and Clinical Excellence, 2007, 56 NAT I HLTH CLIN E; National Patient Safety Agency, 2010, SLIPS TRIPS FALLS DA; National Patient Safety Agency, 2010, NPSA2011RRR001; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Patient Safety First, 2009, GUID RED HARM FALLS; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Wiese MF, 2003, BMJ-BRIT MED J, V327, P782, DOI 10.1136/bmj.327.7418.782; Youde J, 2009, INJURY, V40, P1226, DOI 10.1016/j.injury.2009.06.167	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2011	342								d329	10.1136/bmj.d329	http://dx.doi.org/10.1136/bmj.d329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715MR	21278215				2022-12-24	WOS:000286889100002
J	Kaiser, JT; Hu, YL; Wiig, JA; Rees, DC; Ribbe, MW				Kaiser, Jens T.; Hu, Yilin; Wiig, Jared A.; Rees, Douglas C.; Ribbe, Markus W.			Structure of Precursor-Bound NifEN: A Nitrogenase FeMo Cofactor Maturase/Insertase	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; MOFE-PROTEIN	NifEN plays an essential role in the biosynthesis of the nitrogenase iron-molybdenum (FeMo) cofactor (M cluster). It is an alpha(2)beta(2) tetramer that is homologous to the catalytic molybdenum-iron (MoFe) protein (NifDK) component of nitrogenase. NifEN serves as a scaffold for the conversion of an iron-only precursor to a matured form of the M cluster before delivering the latter to its target location within NifDK. Here, we present the structure of the precursor-bound NifEN of Azotobacter vinelandii at 2.6 angstrom resolution. From a structural comparison of NifEN with des-M-cluster NifDK and holo NifDK, we propose similar pathways of cluster insertion for the homologous NifEN and NifDK proteins.	[Kaiser, Jens T.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hu, Yilin; Wiig, Jared A.; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Irvine; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu; mribbe@uci.edu			NIH [GM-67626, GM-45162]; U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045162, R01GM045162, R01GM067626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM-67626 (M.W.R.) and GM-45162 (D.C.R.) D.C.R. is an investigator of the Howard Hughes Medical Institute. We acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at California Institute of Technology. Operations at the Stanford Synchrotron Radiation Lightsource are supported by the U.S. Department of Energy and NIH. The coordinates and structure factors have been deposited with the Protein Data Bank (PDB), accession number 3PDI.	Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lee CC, 2009, P NATL ACAD SCI USA, V106, P18474, DOI 10.1073/pnas.0909149106; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302	17	77	79	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					91	94		10.1126/science.1196954	http://dx.doi.org/10.1126/science.1196954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212358	Green Accepted			2022-12-24	WOS:000285974000043
J	Eisenstein, M				Eisenstein, Michael			Of beans and genes	NATURE			English	Editorial Material																		Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; QIN J, NATURE, V464, P59	4	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S13	S15		10.1038/468S13a	http://dx.doi.org/10.1038/468S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179077	Bronze			2022-12-24	WOS:000285553800005
J	DePaolo, RW; Abadie, V; Tang, F; Fehlner-Peach, H; Hall, JA; Wang, W; Marietta, EV; Kasarda, DD; Waldmann, TA; Murray, JA; Semrad, C; Kupfer, SS; Belkaid, Y; Guandalini, S; Jabri, B				DePaolo, R. W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Hall, J. A.; Wang, W.; Marietta, E. V.; Kasarda, D. D.; Waldmann, T. A.; Murray, J. A.; Semrad, C.; Kupfer, S. S.; Belkaid, Y.; Guandalini, S.; Jabri, B.			Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; REGULATORY T-CELLS; GLUTEN SENSITIVITY; TRANSGENIC MICE; TGF-BETA; CLASS-I; DIFFERENTIATION; DISEASE; CYTOKINE; INTERLEUKIN-15	Under physiological conditions the gut-associated lymphoid tissues not only prevent the induction of a local inflammatory immune response, but also induce systemic tolerance to fed antigens(1,2). A notable exception is coeliac disease, where genetically susceptible individuals expressing human leukocyte antigen (HLA) HLA-DQ2 or HLA-DQ8 molecules develop inflammatory T-cell and antibody responses against dietary gluten, a protein present in wheat(3). The mechanisms underlying this dysregulated mucosal immune response to a soluble antigen have not been identified. Retinoic acid, a metabolite of vitamin A, has been shown to have a critical role in the induction of intestinal regulatory responses(4-6). Here we find in mice that in conjunction with IL-15, a cytokine greatly upregulated in the gut of coeliac disease patients(3,7), retinoic acid rapidly activates dendritic cells to induce JNK (also known as MAPK8) phosphorylation and release the proinflammatory cytokines IL-12p70 and IL-23. As a result, in a stressed intestinal environment, retinoic acid acted as an adjuvant that promoted rather than prevented inflammatory cellular and humoral responses to fed antigen. Altogether, these findings reveal an unexpected role for retinoic acid and IL-15 in the abrogation of tolerance to dietary antigens.	[DePaolo, R. W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Wang, W.; Semrad, C.; Kupfer, S. S.; Jabri, B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hall, J. A.; Belkaid, Y.] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Hall, J. A.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Marietta, E. V.] Mayo Clin, Dept Dermatol, Coll Med, Rochester, MN 55905 USA; [Marietta, E. V.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Kasarda, D. D.] ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA; [Waldmann, T. A.] NCI, Metab Branch, Bethesda, MD 20892 USA; [Murray, J. A.] Mayo Clin, Div Gastroenterol & Hepatol, Dept Med, Coll Med, Rochester, MN 55905 USA; [Guandalini, S.; Jabri, B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Jabri, B.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Mayo Clinic; Mayo Clinic; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Chicago; University of Chicago	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Kupfer, Sonia S/ABD-9416-2021; Guandalini, Stefano/G-8084-2011; Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Belkaid, Yasmine/0000-0001-9962-3571; DePaolo, William/0000-0002-3880-4544; murray, joseph/0000-0003-1941-9090	Digestive Disease Research Core Center at the University of Chicago [DK42086, R01 DK67180, R01DK71003]; Crohn's and Colitis Foundation; University of Chicago Celiac Disease Center; NATIONAL CANCER INSTITUTE [K08CA142892, ZIASC004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067180, R56DK071003, R01DK071003, P30DK042086] Funding Source: NIH RePORTER	Digestive Disease Research Core Center at the University of Chicago; Crohn's and Colitis Foundation; University of Chicago Celiac Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank coeliac disease patients and their family members as well as the University of Chicago Celiac Disease Center for supporting our research. We thank B. Sally, L. M. Sollid and M. Musch for critical reading of the manuscript. We thank C. Ciszewski, B. Uzunparmak, and N. Grandison for their help with the collection and analysis of human biopsies. We thank M. Constantinides for technical assistance with mice breeding. We also thank the University of Chicago flow cytometry facility for technical assistance. D<SUP>d</SUP>-IL-15 transgenic mice were a gift from M. Caligiuri. RAR alpha-deficient mice were provided by P. Chambon and C. Benoist. This work was supported by the Digestive Disease Research Core Center at the University of Chicago (DK42086), R01 DK67180 (for B.J.), R01DK71003 (for J.A.M.), and the Crohn's and Colitis Foundation (for V.A.).	BERNARDI.JE, 1967, J BIOL CHEM, V242, P445; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gao Y, 2007, LEUKEMIA RES, V31, P455, DOI 10.1016/j.leukres.2006.07.004; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mazzarella G, 2008, GASTROENTEROLOGY, V134, P1017, DOI 10.1053/j.gastro.2008.01.008; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mohty M, 2003, BRIT J HAEMATOL, V122, P829, DOI 10.1046/j.1365-2141.2003.04489.x; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Reddy D, 2006, AM J GASTROENTEROL, V101, P1569, DOI 10.1111/j.1572-0241.2006.00632.x; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Stephensen CB, 2009, AM J CLIN NUTR, V90, P457, DOI 10.3945/ajcn.2009.28343; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106	37	270	284	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					220	U110		10.1038/nature09849	http://dx.doi.org/10.1038/nature09849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21307853	Green Accepted			2022-12-24	WOS:000288170200038
J	Sackeyfio, A; Senthinathan, A; Kandaswamy, P; Barry, PW; Shaw, B; Baker, M				Sackeyfio, A.; Senthinathan, A.; Kandaswamy, P.; Barry, P. W.; Shaw, B.; Baker, M.		Guideline Dev Grp	Practice Guidelines Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Cianferoni Antonella, 2009, Allergology International, V58, P457, DOI 10.2332/allergolint.09-RAI-0138; *NAT I HLTH CLIN E, 2011, CLIN GUID, V116	2	22	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d747	10.1136/bmj.d747	http://dx.doi.org/10.1136/bmj.d747			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345912				2022-12-24	WOS:000287920100005
J	Kauppi, L; Barchi, M; Baudat, F; Romanienko, PJ; Keeney, S; Jasin, M				Kauppi, Liisa; Barchi, Marco; Baudat, Frederic; Romanienko, Peter J.; Keeney, Scott; Jasin, Maria			Distinct Properties of the XY Pseudoautosomal Region Crucial for Male Meiosis	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOME SYNAPSIS; MOUSE; RECOMBINATION; SPO11; SPERMATOCYTES; MICE; PROTEINS; PROPHASE; OOCYTES	Meiosis requires that each chromosome find its homologous partner and undergo at least one crossover. X-Y chromosome segregation hinges on efficient crossing-over in a very small region of homology, the pseudoautosomal region (PAR). We find that mouse PAR DNA occupies unusually long chromosome axes, potentially as shorter chromatin loops, predicted to promote double-strand break (DSB) formation. Most PARs show delayed appearance of RAD51/DMC1 foci, which mark DSB ends, and all PARs undergo delayed DSB-mediated homologous pairing. Analysis of Spo11 beta isoform-specific transgenic mice revealed that late RAD51/DMC1 foci in the PAR are genetically distinct from both early PAR foci and global foci and that late PAR foci promote efficient X-Y pairing, recombination, and male fertility. Our findings uncover specific mechanisms that surmount the unique challenges of X-Y recombination.	[Kauppi, Liisa; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Barchi, Marco; Baudat, Frederic; Romanienko, Peter J.; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Barchi, Marco] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Sect Anat, I-00133 Rome, Italy; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Rome Tor Vergata; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org; m-jasin@ski.mskcc.org	Barchi, Marco/Q-9378-2019; Kauppi, Liisa/H-5845-2012; Keeney, Scott/GVR-8515-2022	Barchi, Marco/0000-0003-1104-6234; Kauppi, Liisa/0000-0002-6759-8997; Romanienko, Peter/0000-0001-6586-3841; Baudat, Frederic/0000-0003-2415-8366; Keeney, Scott/0000-0002-1283-6417	NIH [R01 HD040916]; International Grants in Cancer Research (AIRC) [4765]; Italian Ministry for Education, University and Research (MIUR); Lalor Foundation; American-Italian Cancer Foundation (AICF); Charles H. Revson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Grants in Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Lalor Foundation; American-Italian Cancer Foundation (AICF); Charles H. Revson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant R01 HD040916 (M.J. and S.K); International Grants in Cancer Research (AIRC) [My First AIRC Grant (MFAG) grant 4765], Italian Ministry for Education, University and Research (MIUR), the Lalor Foundation, and the American-Italian Cancer Foundation (AICF) (M.B.); and the Charles H. Revson Foundation (F.B.). We thank M. Leversha [Memorial Sloan-Kettering Cancer Center (MSKCC)], P. Bois (Scripps Florida), and K. Manova (MSKCC) for valuable advice and protocols. We are grateful to Keeney and Jasin lab members, especially I. Roig, E. de Boer, and F. Cole, and to N. Hunter (University of California, Davis) for insightful comments.	Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Hall H, 2006, CURR OPIN GENET DEV, V16, P323, DOI 10.1016/j.gde.2006.04.011; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Romanienko P. J., 1997, THESIS CORNELL U ITH; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Shi QH, 2001, AM J MED GENET, V99, P34, DOI 10.1002/1096-8628(20010215)99:1<34::AID-AJMG1106>3.0.CO;2-D; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	27	170	174	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					916	920		10.1126/science.1195774	http://dx.doi.org/10.1126/science.1195774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330546	Green Accepted			2022-12-24	WOS:000287455100059
J	McCartney, M				McCartney, Margaret			Medicine and the Media How useful are lifetime risks of disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, COMP MATH MATH PHYS, V342, pD808, DOI DOI 10.1136/BMJ.D808	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1046	10.1136/bmj.d1046	http://dx.doi.org/10.1136/bmj.d1046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325383				2022-12-24	WOS:000287656500016
J	Stefansson, K				Stefansson, Kari			An Anniversary Party	SCIENCE			English	Editorial Material									deCode Genet, Reykjavik, Iceland		Stefansson, K (corresponding author), deCode Genet, Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019						0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					691	691		10.1126/science.1203016	http://dx.doi.org/10.1126/science.1203016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311000				2022-12-24	WOS:000287205700043
J	Worsdorfer, B; Woycechowsky, KJ; Hilvert, D				Woersdoerfer, Bigna; Woycechowsky, Kenneth J.; Hilvert, Donald			Directed Evolution of a Protein Container	SCIENCE			English	Article							LUMAZINE SYNTHASE; CONSTRAINED SYNTHESIS; CONTRAST AGENTS; IRON-OXIDE; NANOPARTICLES; CAGE; ENCAPSULATION; DELIVERY; INTERIOR; RELEASE	Confinement of enzymes in protein nanocompartments represents a potentially powerful strategy for controlling catalytic activity in cells. By using a simple electrostatically based tagging system for protein encapsulation, we successfully sequestered HIV protease, a toxic enzyme when produced cytoplasmically, within an engineered lumazine synthase capsid. The growth advantage resulting from protecting the Escherichia coli host from the protease enabled directed evolution of improved capsids. After four rounds of mutagenesis and selection, we obtained a variant with a 5- to 10-fold higher loading capacity than the starting capsid, which permitted efficient growth even at high intracellular concentrations of HIV protease. The superior properties of the evolved capsid can be ascribed to multiple mutations that increase the net negative charge on its luminal surface and thereby enhance engineered Coulombic interactions between host and guest. Such structures could be used for diverse biotechnological applications in living cells.	[Woersdoerfer, Bigna; Woycechowsky, Kenneth J.; Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Woycechowsky, Kenneth/K-5833-2015		Schweizerischer Nationalfond; ETH Zurich	Schweizerischer Nationalfond; ETH Zurich(ETH Zurich)	We thank B. Roschitzki at the Functional Genomics Center Zurich for collection of mass spectrometic data and assistance with data analysis; T. Ishikawa and M. Lucas at the Electron Microscopy Center of the ETH Zurich (EMEZ) for collecting the EM images and assistance with EM data analysis; H.-M. Fischer, F. Narberhaus, M. Neuenschwander, and F. Seebeck for contributive discussions; and P. Kast for careful reading of the manuscript. This work was supported in part by the Schweizerischer Nationalfond and the ETH Zurich. The supercharged GFP described in fig. S8 was obtained under a materials transfer agreement (MTA) with D. R. Liu at Harvard. An MTA would be required for sharing of materials used in the reported research.	Abbing A, 2004, J BIOL CHEM, V279, P27410, DOI 10.1074/jbc.M313612200; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Allen M, 2002, ADV MATER, V14, P1562, DOI 10.1002/1521-4095(20021104)14:21<1562::AID-ADMA1562>3.0.CO;2-D; de la Escosura A, 2009, J MATER CHEM, V19, P2274, DOI 10.1039/b815274h; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Hooker JM, 2007, NANO LETT, V7, P2207, DOI 10.1021/nl070512c; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; Klem MT, 2007, J AM CHEM SOC, V129, P197, DOI 10.1021/ja0667561; Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; McMillan RA, 2005, J AM CHEM SOC, V127, P2800, DOI 10.1021/ja043827s; Neuenschwander M, 2007, NAT BIOTECHNOL, V25, P1145, DOI [10.1038/nbt1341, 10.1038/nbtl341]; Rebek J, 2005, ANGEW CHEM INT EDIT, V44, P2068, DOI 10.1002/anie.200462839; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Schaffer DV, 2008, ANNU REV BIOMED ENG, V10, P169, DOI 10.1146/annurev.bioeng.10.061807.160514; Seebeck FP, 2006, J AM CHEM SOC, V128, P4516, DOI 10.1021/ja058363s; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Yamada T, 2003, NAT BIOTECHNOL, V21, P885, DOI 10.1038/nbt843; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zhang XF, 2006, J MOL BIOL, V362, P753, DOI 10.1016/j.jmb.2006.07.037; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	31	243	247	3	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					589	592		10.1126/science.1199081	http://dx.doi.org/10.1126/science.1199081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292977				2022-12-24	WOS:000286933600055
J	Kaplan, LJ; Shaw, AD				Kaplan, Lewis J.; Shaw, Andrew D.			Standards for Education and Credentialing in Critical Care Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNIT; ILL		[Kaplan, Lewis J.] Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, New Haven, CT 06520 USA; [Shaw, Andrew D.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Yale University; Duke University	Kaplan, LJ (corresponding author), Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, 330 Cedar St,BB-310, New Haven, CT 06520 USA.	lewis.kaplan@yale.edu		Shaw, Andrew/0000-0002-0566-8005				Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], GRADUATE MED ED DATA; Kleinpell RM, 2008, CRIT CARE MED, V36, P2888, DOI 10.1097/CCM.0b013e318186ba8c; Milbrandt EB, 2008, CRIT CARE MED, V36, P2504, DOI 10.1097/CCM.0b013e318183ef84; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; *US DEP HHS, NAT HEALTHC EXP AGGR; *US DEP HHS, CRIT CAR WORKF STUD; NEUROCRITICAL CARE C	8	23	24	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					296	297		10.1001/jama.2010.1997	http://dx.doi.org/10.1001/jama.2010.1997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21239762				2022-12-24	WOS:000286328700026
J	Zumla, A				Zumla, Alimuddin			The white plague returns to London-with a vengeance	LANCET			English	Editorial Material							TUBERCULOSIS		UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1T 4JF, England	University of London; University College London; UCL Medical School	Zumla, A (corresponding author), UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1T 4JF, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Anderson C, 2010, J EPIDEMIOL COMMUN H, V64, P373, DOI 10.1136/jech.2009.094375; Crofts JP, 2008, PUBLIC HEALTH, V122, P1302, DOI 10.1016/j.puhe.2008.04.011; DROBNIEWSKI F, 1995, LANCET, V346, P948, DOI 10.1016/S0140-6736(95)91562-1; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Hayward J, 2010, LONDON TB SERVICE RE; Health Protection Agency (UK), TUB UK ANN REP TUB S; Hollo V, 2009, EUROSURVEILLANCE, V14; Mitchell SL, 2011, THORAX, V66, P630, DOI 10.1136/thx.2010.148866; *NEW YORK CIT DEP, 2008, CLIN POL PROT; World Health Organization, GLOB TUB CONTR EP ST; Zumla, 2009, TUBERCULOSIS COMPREH, P1	12	23	23	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					10	11		10.1016/S0140-6736(10)62176-9	http://dx.doi.org/10.1016/S0140-6736(10)62176-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709MQ	21168203				2022-12-24	WOS:000286445200008
J	Fraser, AG; Dunstan, FD				Fraser, Alan G.; Dunstan, Frank D.			Christmas 2010: Reading between the Lines On the impossibility of being expert	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fraser, Alan G.] Cardiff Univ, Sch Med, Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales; [Dunstan, Frank D.] Cardiff Univ, Sch Med, Dept Primary Care & Public Hlth, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Fraser, AG (corresponding author), Cardiff Univ, Sch Med, Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales.	fraserag@cf.ac.uk						Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Cullis J, 2010, NEPHROLOGY, V15, P269, DOI 10.1111/j.1440-1797.2010.01282.x; Domain Tools Inc, 2010, TOT LIST 12 SEPT 201; Fraser AG, 2006, EUR HEART J, V27, P1750, DOI 10.1093/eurheartj/ehl031; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Porrino JA, 2008, J HAND SURG-AM, V33A, P2, DOI 10.1016/j.jhsa.2007.10.007; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Shortliffe EH, 2010, JAMA-J AM MED ASSOC, V304, P1227, DOI 10.1001/jama.2010.1262; Straus S, 2009, CAN MED ASSOC J, V180, P942, DOI 10.1503/cmaj.081697; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Tenopir C, 2004, J MED LIBR ASSOC, V92, P233; Toffler A., 1980, 3 WAVE; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Wager Elizabeth, 2008, COCHRANE DB SYST REV, V4; Ware M., 2009, STM REPORT OVERVIEW	19	53	54	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6815	10.1136/bmj.c6815	http://dx.doi.org/10.1136/bmj.c6815			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156739	Green Accepted			2022-12-24	WOS:000285552200012
J	Lebreton, A; Lakisic, G; Job, V; Fritsch, L; To, NT; Camejo, A; Mattei, PJ; Regnault, B; Nahori, MA; Cabanes, D; Gautreau, A; Ait-Si-Ali, S; Dessen, A; Cossart, P; Bierne, H				Lebreton, Alice; Lakisic, Goran; Job, Viviana; Fritsch, Lauriane; To Nam Tham; Camejo, Ana; Mattei, Pierre-Jean; Regnault, Beatrice; Nahori, Marie-Anne; Cabanes, Didier; Gautreau, Alexis; Ait-Si-Ali, Slimane; Dessen, Andrea; Cossart, Pascale; Bierne, Helene			A Bacterial Protein Targets the BAHD1 Chromatin Complex to Stimulate Type III Interferon Response	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; LAMBDA; INFECTION	Intracellular pathogens such as Listeria monocytogenes subvert cellular functions through the interaction of bacterial effectors with host components. Here we found that a secreted listerial virulence factor, LntA, could target the chromatin repressor BAHD1 in the host cell nucleus to activate interferon (IFN)-stimulated genes (ISGs). IFN-lambda expression was induced in response to infection of epithelial cells with bacteria lacking LntA; however, the BAHD1-chromatin associated complex repressed downstream ISGs. In contrast, in cells infected with lntA-expressing bacteria, LntA prevented BAHD1 recruitment to ISGs and stimulated their expression. Murine listeriosis decreased in BAHD1(+/-) mice or when lntA was constitutively expressed. Thus, the LntA-BAHD1 interplay may modulate IFN-lambda-mediated immune response to control bacterial colonization of the host.	[Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] INRA, USC2020, F-75015 Paris, France; [Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] INSERM, U604, F-75015 Paris, France; [Lakisic, Goran; Gautreau, Alexis] CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Job, Viviana; Mattei, Pierre-Jean; Dessen, Andrea] Inst Biol Struct, Bacterial Pathogenesis Grp, UMR 5075, CNRS CEA UJF, F-38027 Grenoble, France; [Fritsch, Lauriane; Ait-Si-Ali, Slimane] Univ Paris 07, CNRS, UMR7216, F-75013 Paris, France; [Camejo, Ana; Cabanes, Didier] Inst Mol & Cellular Biol, P-4150 Oporto, Portugal; [Regnault, Beatrice] Inst Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; hbierne@pasteur.fr	Lebreton, Alice/M-8764-2015; Gautreau, Alexis/AAT-2751-2020; Cabanes, Didier/K-3917-2013; Cabanes, Didier/P-3052-2019	Lebreton, Alice/0000-0002-6643-902X; Gautreau, Alexis/0000-0002-2369-4362; Cabanes, Didier/0000-0002-4001-1332; Cabanes, Didier/0000-0002-4001-1332; REGNAULT, Beatrice/0000-0002-3914-1914; LAKISIC, Goran/0000-0002-0079-5072; Job, Viviana/0000-0001-8421-5292; Dessen, Andrea/0000-0001-6487-4020; Marie-Anne, Nahori/0000-0002-4066-4528; Bierne, Helene/0000-0002-0525-0848	Pasteur Institute, French National Institute for Agricultural Research (INRA); INSERM; The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics [SPATELIS]; French Ligue Nationale Contre le Cancer [LNCC RS10/75-76]; European Research Council [233348]; Region Rhone Alpes; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC-SAU/MII/65406/2006, SFRH/BD/29314/2006]; ERANET-PathoGenomics [SPATELIS]	Pasteur Institute, French National Institute for Agricultural Research (INRA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics(French National Research Agency (ANR)); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Research Council(European Research Council (ERC)European Commission); Region Rhone Alpes(Region Auvergne-Rhone-Alpes); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ERANET-PathoGenomics	We are very grateful to O. Dussurget for help in virulence assays. We thank E. Gouin for antibodies against LntA; J.-Y. Coppee for microarrays facilities at the IP Genopole; S. Jacquot and M. C. Birling at the Targeted Mutagenesis and Transgenesis department of the Mouse Clinical Institute (MCI/ICS), where the BAHD1<SUP>+/-</SUP> mouse line was generated. Work in the Cossart laboratory received financial support from the Pasteur Institute, French National Institute for Agricultural Research (INRA), INSERM, The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics (grant SPATELIS), French Ligue Nationale Contre le Cancer (LNCC RS10/75-76 Bierne), and European Research Council (Advanced Grant 233348). P.-J. M. received a Ph. D. fellowship from Region Rhone Alpes. Work in the Cabanes laboratory was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (PTDC-SAU/MII/65406/2006; Ph. D. fellowship to A. C. SFRH/BD/29314/2006) and ERANET-PathoGenomics (grant SPATELIS). P. C. is an international research scholar of the Howard Hughes Medical Institute. The LntA molecular structure data are deposited at the Worldwide Protein Data Bank (http://www.wwpdb.org), ID no. 2xl4, structure factor file no. r2xl4sf.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bierne H, 2009, P NATL ACAD SCI USA, V106, P13826, DOI 10.1073/pnas.0901259106; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Dussurget O, 2008, INT REV CEL MOL BIO, V270, P1, DOI 10.1016/S1937-6448(08)01401-9; Gallagher G, 2010, J INTERF CYTOK RES, V30, P603, DOI 10.1089/jir.2010.0081; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Kamitani S, 2008, BIOCHEM BIOPH RES CO, V370, P366, DOI 10.1016/j.bbrc.2008.03.104; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952	18	126	135	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1319	1321		10.1126/science.1200120	http://dx.doi.org/10.1126/science.1200120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21252314	Green Submitted			2022-12-24	WOS:000288215200045
J	Addo, J; Bhalla, A; Crichton, S; Rudd, AG; McKevitt, C; Wolfe, CDA				Addo, Juliet; Bhalla, Ajay; Crichton, Siobhan; Rudd, Anthony G.; McKevitt, Christopher; Wolfe, Charles D. A.			Provision of acute stroke care and associated factors in a multiethnic population: prospective study with the South London Stroke Register	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-CARE; ISCHEMIC-STROKE; SEX-DIFFERENCES; EUROPEAN PERSPECTIVE; THROMBOLYTIC THERAPY; NORTHERN-IRELAND; RISK-FACTORS; OUTCOMES; MANAGEMENT; GUIDELINES	Objectives To investigate time trends in receipt of effective acute stroke care and to determine the factors associated with provision of care. Design Population based stroke register. Setting South London. Participants 3800 patients with first ever ischaemic stroke or primary intracerebral haemorrhage registered between January 1995 and December 2009. Main outcome measures Acute care interventions, admission to hospital, care on a stroke unit, acute drugs, and inequalities in access to care. Results Between 2007 and 2009, 5% (33/620) of patients were still not admitted to a hospital after an acute stroke, particularly those with milder strokes, and 21% (124/584) of patients admitted to hospital were not admitted to a stroke unit. Rates of admission to stroke units and brain imaging, between 1995 and 2009, and for thrombolysis, between 2005 and 2009, increased significantly (P<0.001). Black patients compared with white patients had a significantly increased odds of admission to a stroke unit (odds ratio 1.76, 95% confidence interval 1.35 to 2.29, P<0.001) and of receipt of occupational therapy or physiotherapy (1.90, 1.21 to 2.97, P=0.01), independent of age or stroke severity. Patients with motor or swallowing deficits were also more likely to be admitted to a stroke unit (1.52, 1.12 to 2.06, P=0.001 and 1.32, 1.02 to 1.72, P<0.001, respectively). Length of stay in hospital decreased significantly between 1995 and 2009 (P<0.001). The odds of brain imaging were lowest in patients aged 75 or more years (P=0.004) and those of lower socioeconomic status (P<0.001). The likelihood of those with a functional deficit receiving rehabilitation increased significantly over time (P<0.001). Patients aged 75 or more were more likely to receive occupational therapy or physiotherapy (P=0.002). Conclusion Although the receipt of effective acute stroke care improved between 1995 and 2009, inequalities in its provision were significant, and implementation of evidence based care was not optimal.				Juliet.addo@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Crichton, Siobhan/0000-0001-9962-083X; Wolfe, Charles/0000-0001-8264-0981	Guy's and St Thomas' Hospital Charity; Stroke Association; Department of Health, UK; National Institute for Health [RP-PG-0407-10184]; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre [PB-PG-0407-13228]; Guy's and St Thomas' NHS Trust; National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish	Guy's and St Thomas' Hospital Charity; Stroke Association; Department of Health, UK; National Institute for Health; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's and St Thomas' NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Guy's and St Thomas' Hospital Charity, The Stroke Association, Department of Health HQIP grants, UK, National Institute for Health Research programme grant (RP-PG-0407-10184). The authors (CW) acknowledge financial support from the Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and the NIHR research for patient benefit programme award (PB-PG-0407-13228). CDAW is a senior investigator for the NIHR. AR is funded by the Guy's and St Thomas' NHS Trust AHSC PA Scheme.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alter DA, 2003, CAN MED ASSOC J, V168, P261; Aly N, 2000, BRIT MED J, V320, P1511, DOI 10.1136/bmj.320.7248.1511; [Anonymous], 2008, NAT CLIN GUID STROK; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Beech R, 1996, STROKE, V27, P1958, DOI 10.1161/01.STR.27.11.1958; Bhalla A, 2004, AGE AGEING, V33, P618, DOI 10.1093/ageing/afh219; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bhalla A, 2001, AGE AGEING, V30, P197, DOI 10.1093/ageing/30.3.197; Bhalla A, 2010, J STROKE CEREBROVASC, V19, P357, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.005; Bray JE, 2006, INTERN MED J, V36, P483, DOI 10.1111/j.1445-5994.2006.01127.x; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2007, NAT STROK STRAT; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Eriksson M, 2009, STROKE, V40, P909, DOI 10.1161/STROKEAHA.108.517581; Farooq MU, 2008, CEREBROVASC DIS, V25, P12, DOI 10.1159/000111494; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Govan L, 2007, COCHRANE DB SYST REV, V4; Grieve R, 2001, STROKE, V32, P1684, DOI 10.1161/01.STR.32.7.1684; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heidrich J, 2007, EUR J NEUROL, V14, P255, DOI 10.1111/j.1468-1331.2006.01573.x; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Horner RD, 1997, STROKE, V28, P19, DOI 10.1161/01.STR.28.1.19; Irwin P, 2005, J EVAL CLIN PRACT, V11, P306, DOI 10.1111/j.1365-2753.2005.00529.x; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231; Lees KR, 2008, QJM-INT J MED, V101, P863, DOI 10.1093/qjmed/hcn102; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; *NAT STROK FDN, 2007, CLIN GUID AC STROK M; National Audit Office, 2005, RED BRAIN DAM FAST A; Quain DA, 2008, MED J AUSTRALIA, V189, P429, DOI 10.5694/j.1326-5377.2008.tb02114.x; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; *ROYAL COLL PHYS C, 2008, NAT SENT STROK AUD P; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174; Rudd AG, 2005, STROKE, V36, P103, DOI 10.1161/01.STR.0000149618.14922.8a; Saposnik G, 2009, STROKE, V40, P3328, DOI 10.1161/STROKEAHA.109.558759; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; TEASDALE G, 1974, LANCET, V2, P81; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Weir NU, 2001, STROKE, V32, P1370, DOI 10.1161/01.STR.32.6.1370; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; Wolfe C, 2001, BRIT MED J, V323, P5, DOI 10.1136/bmj.323.7303.5	49	36	36	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2011	342								d744	10.1136/bmj.d744	http://dx.doi.org/10.1136/bmj.d744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729BE	21349892	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000287920900009
J	Munk-Olsen, T; Laursen, TM; Pedersen, CB; Lidegaard, O; Mortensen, PB				Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten B.; Lidegaard, Ojvind; Mortensen, Preben Bo			Induced First-Trimester Abortion and Risk of Mental Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPRESSION; PREGNANCY; WOMEN; REGISTER; HOSPITALIZATION; FAMILY	BACKGROUND Concern has been expressed about potential harm to women's mental health in association with having an induced abortion, but it remains unclear whether induced abortion is associated with an increased risk of subsequent psychiatric problems. METHODS We conducted a population-based cohort study that involved linking information from the Danish Civil Registration system to the Danish Psychiatric Central Register and the Danish National Register of Patients. The information consisted of data for girls and women with no record of mental disorders during the 1995-2007 period who had a first-trimester induced abortion or a first childbirth during that period. We estimated the rates of first-time psychiatric contact (an inpatient admission or outpatient visit) for any type of mental disorder within the 12 months after the abortion or childbirth as compared with the 9-month period preceding the event. RESULTS The incidence rates of first psychiatric contact per 1000 person-years among girls and women who had a first abortion were 14.6 (95% confidence interval [CI], 13.7 to 15.6) before abortion and 15.2 (95% CI, 14.4 to 16.1) after abortion. The corresponding rates among girls and women who had a first childbirth were 3.9 (95% CI, 3.7 to 4.2) before delivery and 6.7 (95% CI, 6.4 to 7.0) post partum. The relative risk of a psychiatric contact did not differ significantly after abortion as compared with before abortion (P=0.19) but did increase after childbirth as compared with before childbirth (P<0.001). CONCLUSIONS The finding that the incidence rate of psychiatric contact was similar before and after a first-trimester abortion does not support the hypothesis that there is an increased risk of mental disorders after a first-trimester induced abortion.	[Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten B.; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Lidegaard, Ojvind] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Gynecol Clin, DK-2100 Copenhagen, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen	Munk-Olsen, T (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, Taasingegade 1, DK-8000 Aarhus C, Denmark.	tmo@ncrr.dk	Pedersen, Carsten Bøcker/B-8441-2013; Munk-olsen, Trine/AAS-3546-2021; Mortensen, Preben B/D-2358-2015; Laursen, Thomas Munk/AFQ-8066-2022	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Munk-olsen, Trine/0000-0002-0786-7147; Mortensen, Preben B/0000-0002-5230-9865; Laursen, Thomas Munk/0000-0001-6934-1784	Susan Thompson Buffett Foundation; Danish Medical Research Council [09-063642/FSS]; Bayer Schering Pharma	Susan Thompson Buffett Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bayer Schering Pharma(Bayer AG)	Supported by grants from the Susan Thompson Buffett Foundation (to Dr. Munk-Olsen and Dr. Laursen) and the Danish Medical Research Council (09-063642/FSS, to Dr. Munk-Olsen).; Dr. Lidegaard reports receiving lecture fees and research funding from Bayer Schering Pharma. No other potential conflict of interest relevant to this article was reported.	Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2007, LEGALT PROVOKEREDE A; Casey P, 2008, BRIT J PSYCHIAT, V193, P452, DOI 10.1192/bjp.bp.108.059550; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Coleman PK, 2009, J PSYCHIATR RES, V43, P770, DOI 10.1016/j.jpsychires.2008.10.009; DAGG PKB, 1991, AM J PSYCHIAT, V148, P578; Danish National Board of Health. Classification of Diseases, 1971, CLASS DIS EXT DAN LA; Dwyer Judith M, 2008, Aust New Zealand Health Policy, V5, P2, DOI 10.1186/1743-8462-5-2; Fergusson DM, 2009, BRIT J PSYCHIAT, V194, P377, DOI 10.1192/bjp.194.4.377b; Fergusson DM, 2008, BRIT J PSYCHIAT, V193, P444, DOI 10.1192/bjp.bp.108.056499; Fergusson DM, 2006, J CHILD PSYCHOL PSYC, V47, P16, DOI 10.1111/j.1469-7610.2005.01538.x; Gale S, 2003, J PSYCHOSOM OBST GYN, V24, P257, DOI 10.3109/01674820309074690; GILCHRIST AC, 1995, BRIT J PSYCHIAT, V167, P243, DOI 10.1192/bjp.167.2.243; Harlow BL, 2007, ARCH GEN PSYCHIAT, V64, P42, DOI 10.1001/archpsyc.64.1.42; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Jones I, 2008, ARCH GEN PSYCHIAT, V65, P356, DOI 10.1001/archpsyc.65.3.356-a; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; KENDELL RE, 1987, BRIT J PSYCHIAT, V151, P135; KENDLER KS, 1990, PSYCHOL MED, V20, P311, DOI 10.1017/S0033291700017621; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Laursen TM, 2005, ARCH GEN PSYCHIAT, V62, P841, DOI 10.1001/archpsyc.62.8.841; Lazzarini Z, 2008, NEW ENGL J MED, V359, P2189, DOI 10.1056/NEJMp0806742; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 2009, AM PSYCHOL, V64, P863, DOI 10.1037/a0017497; Munk-Olsen T, 2007, J CLIN PSYCHIAT, V68, P1947, DOI 10.4088/JCP.v68n1217; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Munk-Olsen T, 2009, ARCH GEN PSYCHIAT, V66, P189, DOI 10.1001/archgenpsychiatry.2008.528; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen W, 2008, SCAND J PUBLIC HEALT, V36, P424, DOI 10.1177/1403494807088449; Reardon DC, 2002, BRIT MED J, V324, P151, DOI 10.1136/bmj.324.7330.151; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schmiege S, 2005, BMJ-BRIT MED J, V331, P1303, DOI 10.1136/bmj.38623.532384.55; Steinberg JR, 2009, CONTRACEPTION, V79, P81, DOI 10.1016/j.contraception.2008.10.011; Thorp JM, 2003, OBSTET GYNECOL SURV, V58, P67, DOI 10.1097/00006254-200301000-00023; World Health Organization, 1994, WHO ICD 10 MENT BEH	41	108	109	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					332	339		10.1056/NEJMoa0905882	http://dx.doi.org/10.1056/NEJMoa0905882			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21268725				2022-12-24	WOS:000286592600008
J	Dwyer, T; Ponsonby, AL; Ukoumunne, OC; Pezic, A; Venn, A; Dunstan, D; Barr, E; Blair, S; Cochrane, J; Zimmet, P; Shaw, J				Dwyer, T.; Ponsonby, A-L; Ukoumunne, O. C.; Pezic, A.; Venn, A.; Dunstan, D.; Barr, E.; Blair, S.; Cochrane, J.; Zimmet, P.; Shaw, J.			Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; LIFE-STYLE; METABOLIC SYNDROME; SEDENTARY TIME; OBESITY; INTENSITY; PEDOMETER; MODERATE; RISK	Objectives To investigate the association between change in daily step count and both adiposity and insulin sensitivity and the extent to which the association between change in daily step count and insulin sensitivity may be mediated by adiposity. Design Population based cohort study. Setting Tasmania, Australia. Participants 592 adults (men (n=267), mean age 51.4 (SD 12.2) years; women (n=325), mean age 50.3 (12.3) years) who participated in the Tasmanian component of the national AusDiab Study in 2000 and 2005. Main outcome measures Body mass index, waist to hip ratio, and HOMA insulin sensitivity at follow-up in 2005. Results Over the five year period, the daily step count decreased for 65% (n=382) of participants. Having a higher daily step count in 2005 than in 2000 was independently associated with lower body mass index (0.08 (95% confidence interval 0.04 to 0.12) lower per 1000 steps), lower waist to hip ratio (0.15 (0.07 to 0.23) lower), and greater insulin sensitivity (1.38 (0.14 to 2.63) HOMA units higher) in 2005. The mean increase in HOMA units fell to 0.34 (-0.79 to 1.47) after adjustment for body mass index in 2005. Conclusions Among community dwelling, middle aged adults, a higher daily step count at five year follow-up than at baseline was associated with better insulin sensitivity. This effect seems to be largely mediated through lower adiposity.	[Dwyer, T.; Ponsonby, A-L; Ukoumunne, O. C.; Pezic, A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dwyer, T.; Ponsonby, A-L; Venn, A.; Cochrane, J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Dunstan, D.; Barr, E.; Zimmet, P.; Shaw, J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Blair, S.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Tasmania; Menzies Institute for Medical Research; Baker Heart and Diabetes Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dwyer, T (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	terry.dwyer@mcri.edu.au	Venn, Alison J/J-2803-2013; Zimmet, Paul/O-8486-2019; Dunstan, David Wayne/E-8473-2010; Shaw, Jonathan/E-7388-2010; Ponsonby, Anne-Louise/AAE-4351-2019	Zimmet, Paul/0000-0003-0627-0776; Dunstan, David Wayne/0000-0003-2629-9568; Shaw, Jonathan/0000-0002-6187-2203; Ponsonby, Anne-Louise/0000-0002-6581-3657	Commonwealth Department of Health and Aged Care; Abbott Australasia; Alphapharm; Aventis Pharmaceutical; AstraZeneca; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly (Australia); GlaxoSmithKline; Janssen-Cilag (Australia); Merck Lipha; Merck Sharp & Dohme (Australia); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical,; Pharmacia and Upjohn; Pfizer; Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; HITECH Pathology; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia (Northern Territory); Queensland Health; South Australian Department of Human Services; Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Health Department of Western Australia; Victorian Health Promotion Foundation; NHMRC [436914]	Commonwealth Department of Health and Aged Care; Abbott Australasia(Abbott Laboratories); Alphapharm; Aventis Pharmaceutical; AstraZeneca(AstraZeneca); Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly (Australia)(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag (Australia)(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Lipha; Merck Sharp & Dohme (Australia)(Merck & Company); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical,(Novo Nordisk); Pharmacia and Upjohn; Pfizer(Pfizer); Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; HITECH Pathology; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia (Northern Territory); Queensland Health; South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA)); Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Health Department of Western Australia; Victorian Health Promotion Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study received financial support from the Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp & Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, HITECH Pathology, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia (Northern Territory), Queensland Health, South Australian Department of Human Services, Tasmanian Department of Health and Human Services, Territory Health Services, Victorian Department of Human Services, and Health Department of Western Australia. DD is supported by a Victorian Health Promotion Foundation public health research fellowship. OCU is supported by NHMRC Population Health Capacity Building Grant 436914. JS is supported by an NHMRC senior research fellowship.	Ainsworth BE., 2002, COMPENDIUM PHYS ACTI; Australian Bureau of Statistics, 2001, SOC IND AR SEIFA; Australian Institute of Health and Welfare, 2003, ACT AUSTR SURV; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Coke LA, 2010, J CARDIOVASC NURS, V25, P238, DOI 10.1097/JCN.0b013e3181cec814; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Dwyer T, 2007, INT J OBESITY, V31, P797, DOI 10.1038/sj.ijo.0803472; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Hall AJ, 2002, INT J EPIDEMIOL, V31, P300, DOI 10.1093/ije/31.2.300; Hatano Y, 1993, INT COUNC HLTH PHYS, V29, P4; Hellie T, 2010, MEASURE YOUR STEP ST; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Little R.J., 2002, STAT ANAL MISSING DA; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Timperio A., 2002, VALIDATION ADULT PHY; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilkin TJ, 2004, J ROY SOC MED, V97, P511, DOI 10.1258/jrsm.97.11.511	30	52	52	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c7249	10.1136/bmj.c7249	http://dx.doi.org/10.1136/bmj.c7249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233153	hybrid, Green Submitted			2022-12-24	WOS:000286386600002
J	Stepney, R				Stepney, Rob			Christmas 2010: Reading Between the Lines A dose by any other name would not sell as sweet	BRITISH MEDICAL JOURNAL			English	Editorial Material												walcot2@freenetname.co.uk						*GLAXOSMITHKLINE, 2010, OUR HIST; HERPER M, 2004, FORBES          0316; Mills JG, 1997, ALIMENT PHARM THER, V11, P129, DOI 10.1046/j.1365-2036.1997.136312000.x; *WELLC TRUST, INV HIST; 2010, FASTEST CARS WORLD T	5	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6895	10.1136/bmj.c6895	http://dx.doi.org/10.1136/bmj.c6895			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159760				2022-12-24	WOS:000285552800001
J	Anderson, SH; Kelly, D; Ladley, JJ; Molloy, S; Terry, J				Anderson, Sandra H.; Kelly, Dave; Ladley, Jenny J.; Molloy, Sue; Terry, Jon			Cascading Effects of Bird Functional Extinction Reduce Pollination and Plant Density	SCIENCE			English	Article							POLLEN LIMITATION; DISPERSAL; CONSEQUENCES	Reductions in bird numbers could hamper ecosystem services such as pollination, but experimental proof is lacking. We show that functional extinction of bird pollinators has reduced pollination, seed production, and plant density in the shrub Rhabdothamnus solandri (Gesneriaceae) on the North Island ("mainland") of New Zealand but not on three nearby island bird sanctuaries where birds remain abundant. Pollen limitation of fruit set is strong [pollen limitation index (PLI) = 0.69] and significant on the mainland but small (PLI = 0.15) and nonsignificant on islands. Seed production per flower on the mainland is reduced 84%. Mainland sites have similar adult densities, but 55% fewer juvenile plants per adult, than island sites. Seed addition experiments near adult R. solandri plants on the mainland found strong seed limitation 5 years after sowing for R. solandri but not for two other co-occurring woody species. This demonstrates a terrestrial trophic cascade.	[Kelly, Dave; Ladley, Jenny J.; Molloy, Sue; Terry, Jon] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Anderson, Sandra H.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand	University of Canterbury; University of Auckland	Kelly, D (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand.	dave.kelly@canterbury.ac.nz	Kelly, Dave/A-6129-2013	Kelly, Dave/0000-0002-9469-2161; Anderson, Sandra/0000-0002-6164-7380	Foundation for Research, Science and Technology [CO9X0004, CO9X0503]	Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	W. Ji helped frequently with field work. Funding was provided by contracts (CO9X0004 and CO9X0503) from the Public Good Science Fund under the Foundation for Research, Science and Technology's Sustaining and Restoring Biodiversity program.	Allan H.H, 1961, FLORA NZ, VI; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Beever R. E., 1983, AUCKLAND BOT SOC NEW, V38, P24; Bell B.D., 1991, P195; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; CLOUT MN, 1989, NEW ZEAL J ECOL, V12, P27; DIAMOND JM, 1984, NEW ZEAL J ECOL, V7, P37; Driskell A, 2007, AUST J ZOOL, V55, P73, DOI 10.1071/ZO07007; Heather B.D., 1996, FIELD GUIDE BIRDS NZ; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; JANZEN DH, 1974, NAT HIST, V83, P48; Kelly D, 2006, ECOL STUD-ANAL SYNTH, V186, P227; Kelly D, 2004, NEW ZEAL J BOT, V42, P89, DOI 10.1080/0028825X.2004.9512892; Kelly D, 2010, NEW ZEAL J ECOL, V34, P66; King CM., 2005, HDB NZ MAMMALS; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Norton DA, 2009, SCIENCE, V325, P569, DOI 10.1126/science.1172978; Petrie D., 1902, T P R SOC NZ, V35, P321; Robertson AW, 1999, CONSERV BIOL, V13, P499, DOI 10.1046/j.1523-1739.1999.97471.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sharam GJ, 2009, SCIENCE, V325, P51, DOI 10.1126/science.1173805; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; [No title captured]	26	191	198	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1068	1071		10.1126/science.1199092	http://dx.doi.org/10.1126/science.1199092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21292938				2022-12-24	WOS:000287699000064
J	Godfray, HCJ; Pretty, J; Thomas, SM; Warham, EJ; Beddington, JR				Godfray, H. C. J.; Pretty, J.; Thomas, S. M.; Warham, E. J.; Beddington, J. R.			Linking Policy on Climate and Food	SCIENCE			English	Editorial Material									[Thomas, S. M.; Warham, E. J.; Beddington, J. R.] Foresight, Govt Off Sci, London, England; [Godfray, H. C. J.] Univ Oxford, Oxford Martin Sch, Dept Zool, Oxford OX1 3PS, England; [Godfray, H. C. J.] Univ Oxford, Oxford Martin Sch, Inst Biodivers, Oxford OX1 3PS, England; [Pretty, J.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Oxford; University of Oxford; University of Essex	Thomas, SM (corresponding author), Foresight, Govt Off Sci, London, England.	sandy.thomas@bis.gsi.gov.uk	Pretty, Jules/D-4071-2012	Pretty, Jules/0000-0002-3897-6581				[Anonymous], JOINT STAT GLOB FOOD; [Anonymous], 5 NATL COMMUNICATION; [Anonymous], KYOTO PROTOCOL; [Anonymous], FAOSTAT; Batjes N. H., 1999, 401200031 DUTCH NAT; Bellarby J., 2008, COOL FARMING CLIMATE; Evans L., 1998, FEEDING 10 BILLION P; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Government Office of Science, 2011, FOR MIGR GLOB ENV CH; REDD+, REDD; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497	11	100	104	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1013	1014		10.1126/science.1202899	http://dx.doi.org/10.1126/science.1202899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726DM	21273449				2022-12-24	WOS:000287699000036
J	Dermitzakis, ET				Dermitzakis, Emmanouil T.			Genome Literacy	SCIENCE			English	Editorial Material									Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	University of Geneva	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.		Dermitzakis, Emmanouil/B-7687-2013					DERMITZAKIS ET, GENOME LITERACY	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					689	690		10.1126/science.1203237	http://dx.doi.org/10.1126/science.1203237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310993	Green Published			2022-12-24	WOS:000287205700039
J	Capotosti, F; Guernier, S; Lammers, F; Waridel, P; Cai, Y; Jin, JJ; Conaway, JW; Conaway, RC; Herr, W				Capotosti, Francesca; Guernier, Sophie; Lammers, Fabienne; Waridel, Patrice; Cai, Yong; Jin, Jingji; Conaway, Joan W.; Conaway, Ronald C.; Herr, Winship			O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1	CELL			English	Article							N-ACETYLGLUCOSAMINE; COACTIVATOR HCF-1; TERMINAL SUBUNIT; PROTEINS; NUCLEAR; GLYCOSYLATION; COMPLEX; FAMILY; DOMAIN; VP16	The human epigenetic cell-cycle regulator HCF-1 undergoes an unusual proteolytic maturation process resulting in stably associated HCF-1(N) and HCF-1(C) subunits that regulate different aspects of the cell cycle. Proteolysis occurs at six centrally located HCF-1(PRO)-repeat sequences and is important for activation of HCF-1(C)-subunit functions in M phase progression. We show here that the HCF-1(PRO) repeat is recognized by O-linked beta-N-acetylglucosamine transferase (OGT), which both O-GlcNAcylates the HCF-1(N) subunit and directly cleaves the HCF-1(PRO) repeat. Replacement of the HCF-1(PRO) repeats by a heterologous proteolytic cleavage signal promotes HCF-1 proteolysis but fails to activate HCF-1(C)-subunit M phase functions. These results reveal an unexpected role of OGT in HCF-1 proteolytic maturation and an unforeseen nexus between OGT-directed O-GlcNAcylation and proteolytic maturation in HCF-1 cell-cycle regulation.	[Waridel, Patrice; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, CH-1015 Lausanne, Switzerland; [Cai, Yong; Jin, Jingji; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Lausanne; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, CH-1015 Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546; Conaway, Joan/0000-0002-2786-0663	Stowers Institute for Medical Research; Greater Kansas City Community Foundation; Swiss National Science Foundation; Oncosuisse; University of Lausanne	Stowers Institute for Medical Research; Greater Kansas City Community Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; University of Lausanne	We thank T. M. Kristie and J.A. Hanover for the HCF-1nc and the bacterial OGT expression vectors, respectively; M. Boutros and A. Wilson for the HCF-1<INF>Delta PROrep2</INF> construct; R. S. Haltiwanger for the alpha-OGT antibody; E. Julien and D.J. Aufiero for the N13 and C18 antibodies; S. S. Taylor for the Flp-In-HeLa cells; M. Quadroni for advice with the mass spectrometry analysis; L. Capponi, P. L'Hote, and M. McLaird for technical support; and J.H. Reina for art design. We thank N. Hernandez, J. Michaud, and S. H. Verhelst for critical reading of the manuscript; and V. Zoete, O. Michielin, N. Hernandez, J. Muller, P. Schneider, and K. Struhl for discussion. This study was supported by the Stowers Institute for Medical Research and the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation to J. W. C. and R. C. C. and by the Swiss National Science Foundation, Oncosuisse, and the University of Lausanne to W.H.	Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Nalivaeva NN, 2001, PROTEOMICS, V1, P735, DOI 10.1002/1615-9861(200106)1:6<735::AID-PROT735>3.0.CO;2-8; STARR CM, 1990, J BIOL CHEM, V265, P6868; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Vogel JL, 2000, P NATL ACAD SCI USA, V97, P9425, DOI 10.1073/pnas.160266697; Vogel JL, 2006, P NATL ACAD SCI USA, V103, P6817, DOI 10.1073/pnas.0602109103; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	46	164	164	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					376	388		10.1016/j.cell.2010.12.030	http://dx.doi.org/10.1016/j.cell.2010.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295698	Bronze			2022-12-24	WOS:000286973100010
J	Guaita, A; Jones, M				Guaita, Antonio; Jones, Marc			A "Prosthetic" Approach for Individuals With Dementia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; SYMPTOMS; MANAGEMENT		[Guaita, Antonio] Golgi Cenci Fdn, I-20081 Abbiategrasso, MI, Italy; [Jones, Marc] Moyra Jones Resources Ltd, New Westminster, BC, Canada		Guaita, A (corresponding author), Golgi Cenci Fdn, Piazza Golgi 11, I-20081 Abbiategrasso, MI, Italy.	a.guaita@golgiredaelli.it	Guaita, Antonio/Q-1787-2019	Guaita, Antonio/0000-0003-3954-5932				Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Colombo M, 2007, ARCH GERONTOL GERIAT, V44, P113, DOI 10.1016/j.archger.2007.01.017; Friedrich MJ, 2009, JAMA-J AM MED ASSOC, V301, P2430, DOI 10.1001/jama.2009.809; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Herrmann N, 2008, CAN MED ASSOC J, V179, P1279, DOI 10.1503/cmaj.070804; Jones M, 1999, GENTLECARE CHANGING; Rodda J, 2009, INT PSYCHOGERIATR, V21, P813, DOI 10.1017/S1041610209990354; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Trumble WR, 2007, OXFORD ENGLISH DICT	10	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					402	403		10.1001/jama.2011.28	http://dx.doi.org/10.1001/jama.2011.28			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266688				2022-12-24	WOS:000286595200026
J	Selyunin, AS; Sutton, SE; Weigele, BA; Reddick, LE; Orchard, RC; Bresson, SM; Tomchick, DR; Alto, NM				Selyunin, Andrey S.; Sutton, Sarah E.; Weigele, Bethany A.; Reddick, L. Evan; Orchard, Robert C.; Bresson, Stefan M.; Tomchick, Diana R.; Alto, Neal M.			The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold	NATURE			English	Article							STRUCTURAL BASIS; PROTEIN; ACTIVATION; SHIGELLA; MODEL; ARF; SECRETION; COATOMER; SOFTWARE; REVEALS	The fidelity and specificity of information flow within a cell is controlled by scaffolding proteins that assemble and link enzymes into signalling circuits(1,2). These circuits can be inhibited by bacterial effector proteins that post-translationally modify individual pathway components(3-6). However, there is emerging evidence that pathogens directly organize higher-order signalling networks through enzyme scaffolding(7,8), and the identity of the effectors and their mechanisms of action are poorly understood. Here we identify the enterohaemorrhagic Escherichia coli O157:H7 type III effector EspG as a regulator of endomembrane trafficking using a functional screen, and report ADP-ribosylation factor (ARF) GTPases and p21-activated kinases (PAKs) as its relevant host substrates. The 2.5 angstrom crystal structure of EspG in complex with ARF6 shows how EspG blocks GTPase-activating-protein-assisted GTP hydrolysis, revealing a potent mechanism of GTPase signalling inhibition at organelle membranes. In addition, the 2.8 angstrom crystal structure of EspG in complex with the autoinhibitory I alpha 3-helix of PAK2 defines a previously unknown catalytic site in EspG and provides an allosteric mechanism of kinase activation by a bacterial effector. Unexpectedly, ARF and PAKs are organized on adjacent surfaces of EspG, indicating its role as a 'catalytic scaffold' that effectively reprograms cellular events through the functional assembly of GTPase-kinase signalling complex.	[Selyunin, Andrey S.; Sutton, Sarah E.; Weigele, Bethany A.; Reddick, L. Evan; Orchard, Robert C.; Bresson, Stefan M.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Bresson, Stefan/0000-0002-0329-2243; Tomchick, Diana/0000-0002-7529-4643; Selyunin, Andrey/0000-0002-8980-0009	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NIH [5T32AI007520-12]; Welch Foundation [I-1704]; NIH (NIAID) [1RO1AI083359-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520, R01AI083359] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank our colleagues, specifically K. Orth, M. Rosen, M. Cobb, J. Seeman, C. Brautigam and T. Fox, for helpful discussions in preparation of this manuscript, and we are particularly indebted to members of the Structural Biology Lab and mass spectrometry facilities for their efforts on this project. We would also like to thank J. Goldberg and G. Bokoch for providing valuable reagents. We would particularly like to thank J. Cherfils for providing preliminary insights into this work and for key reagents. The structure shown in this report is derived from work performed on beamlines 19-BM and 19-ID at the Structural Biology Center, Advanced Photon Source, Argonne National Laboratory. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. R.C.O. was supported by a NIH Molecular Microbiology training grant (5T32AI007520-12). This work was supported by the Welch Foundation (#I-1704) and a grant from the NIH (NIAID; 1RO1AI083359-01) to N.M.A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis J, 2008, PROTEIN SCI, V17, P2167, DOI 10.1110/ps.037978.108; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Isabet T, 2009, EMBO J, V28, P2835, DOI 10.1038/emboj.2009.209; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shaw RK, 2005, INFECT IMMUN, V73, P4385, DOI 10.1128/IAI.73.7.4385-4390.2005; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tomson FL, 2005, MOL MICROBIOL, V56, P447, DOI 10.1111/j.1365-2958.2005.04571.x; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	39	85	88	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					107	U127		10.1038/nature09593	http://dx.doi.org/10.1038/nature09593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21170023	Green Accepted			2022-12-24	WOS:000285921600041
J	Long, EF; Brandeau, ML; Owens, DK				Long, Elisa F.; Brandeau, Margaret L.; Owens, Douglas K.			The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; QUALITY-OF-LIFE; HETEROSEXUAL TRANSMISSION; SEXUAL-BEHAVIOR; MALE CIRCUMCISION; CHILDBEARING AGE; RISK-REDUCTION; SAN-FRANCISCO; VIRAL LOAD	Background: Although recent guidelines call for expanded routine screening for HIV, resources for antiretroviral therapy (ART) are limited, and all eligible persons are not currently receiving treatment. Objective: To evaluate the effects on the U.S. HIV epidemic of expanded ART, HIV screening, or interventions to reduce risk behavior. Design: Dynamic mathematical model of HIV transmission and disease progression and cost-effectiveness analysis. Data Sources: Published literature. Target Population: High-risk (injection drug users and men who have sex with men) and low-risk persons aged 15 to 64 years in the United States. Time Horizon: Twenty years and lifetime (costs and quality-adjusted life-years [QALYs]). Perspective: Societal. Intervention: Expanded HIV screening and counseling, treatment with ART, or both. Outcome Measures: New HIV infections, discounted costs and QALYs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: One-time HIV screening of low-risk persons coupled with annual screening of high-risk persons could prevent 6.7% of a projected 1.23 million new infections and cost $22 382 per QALY gained, assuming a 20% reduction in sexual activity after screening. Expanding ART utilization to 75% of eligible persons prevents 10.3% of infections and costs $20 300 per QALY gained. A combination strategy prevents 17.3% of infections and costs $21 580 per QALY gained. Results of Sensitivity Analysis: With no reduction in sexual activity, expanded screening prevents 3.7% of infections. Earlier ART initiation when a CD4 count is greater than 0.350 x 10(9) cells/L prevents 20% to 28% of infections. Additional efforts to halve high-risk behavior could reduce infections by 65%. Limitation: The model of disease progression and treatment was simplified, and acute HIV screening was excluded. Conclusion: Expanding HIV screening and treatment simultaneously offers the greatest health benefit and is cost-effective. However, even substantial expansion of HIV screening and treatment programs is not sufficient to markedly reduce the U.S. HIV epidemic without substantial reductions in risk behavior.	[Long, Elisa F.] Yale Univ, Sch Management, New Haven, CT 06520 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Yale University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Long, EF (corresponding author), Yale Univ, Sch Management, 135 Prospect St, New Haven, CT 06520 USA.	elisa.long@yale.edu	Long, Elisa/AFQ-5915-2022		Department of Veterans Affairs; National Institutes of Health [R-01-DA-15612]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse, National Institutes of Health, and Department of Veterans Affairs.; By the National Institute on Drug Abuse, National Institutes of Health (R-01-DA-15612), and Department of Veterans Affairs.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], P 13 C RETR OPP INF; [Anonymous], CDCS HIV PREV PROGR; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bendavid E, 2009, JAIDS-J ACQ IMM DEF, V52, P106, DOI 10.1097/QAI.0b013e3181a4f9c4; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; BRANDEAU ML, 1993, MANAGE SCI, V39, P72, DOI 10.1287/mnsc.39.1.72; BRANDEAU ML, 1992, ARCH INTERN MED, V152, P2229, DOI 10.1001/archinte.152.11.2229; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brisson M, 1999, SEX TRANSM INFECT, V75, P296, DOI 10.1136/sti.75.5.296; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDCP, 2010, HIV AIDS US; *CDCP, CAS HIV INF AIDS US, V18; *CDCP, HIV AIDS GAY BISEX M; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; *CENSUSSCOPE, 2000, US AGE DISTR; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Centers for Medicare and Medicaid Services, MED FEE SCHED; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; DAVIS JO, GENERAL SOCIAL GENER; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Fryar Cheryl D, 2007, Adv Data, P1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Harris ZK, 2006, HEALTH ECON, V15, P147, DOI 10.1002/hec.1021; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Kelly JA, 2009, AIDS BEHAV, V13, P1068, DOI 10.1007/s10461-009-9579-1; Kerndt PR, 2009, AIDS BEHAV, V13, P1037, DOI 10.1007/s10461-009-9580-8; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; MacKellar DA, 2006, AIDS, V20, P1637, DOI 10.1097/01.aids.0000238410.67700.d1; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Taylor A, 2005, EPIDEMIOL INFECT, V133, P193, DOI 10.1017/S0950268804003504; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; TESHALE EH, 2005, P 12 C RETR OPP INF; Tyndall MW, 2002, SEX TRANSM INFECT, V78, pI170, DOI 10.1136/sti.78.suppl_1.i170; [U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents], 2009, GUID US ANT AG HIV 1; UNAIDS, 2008 REP GLOB AIDS E; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; WALL SD, 1991, AM J ROENTGENOL, V157, P911, DOI 10.2214/ajr.157.5.1927808; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, GLOB HLTH OBS; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; [No title captured]	104	133	136	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					778	+		10.7326/0003-4819-153-12-201012210-00004	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173412	Green Accepted			2022-12-24	WOS:000285453700027
J	Axelsson, J; Sundelin, T; Ingre, M; Van Someren, EJW; Olsson, A; Lekander, M				Axelsson, John; Sundelin, Tina; Ingre, Michael; Van Someren, Eus J. W.; Olsson, Andreas; Lekander, Mats			CHRISTMAS 2010: RESEARCH Beauty sleep: experimental study on the perceived health and attractiveness of sleep deprived people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEPRIVATION; DURATION; SYSTEM; IMPACT; BRAIN; HEART; FACE	Objective To investigate whether sleep deprived people are perceived as less healthy, less attractive, and more tired than after a normal night's sleep. Design Experimental study. Setting Sleep laboratory in Stockholm, Sweden. Participants 23 healthy, sleep deprived adults (age 1831) who were photographed and 65 untrained observers (age 18-61) who rated the photographs. Intervention Participants were photographed after a normal night's sleep (eight hours) and after sleep deprivation (31 hours of wakefulness after a night of reduced sleep). The photographs were presented in a randomised order and rated by untrained observers. Main outcome measure Difference in observer ratings of perceived health, attractiveness, and tiredness between sleep deprived and well rested participants using a visual analogue scale (100 mm). Results Sleep deprived people were rated as less healthy (visual analogue scale scores, mean 63 (SE 2) v 68 (SE 2), P<0.001), more tired (53 (SE 3) v 44 (SE 3), P<0.001), and less attractive (38 (SE 2) v 40 (SE 2), P<0.001) than after a normal night's sleep. The decrease in rated health was associated with ratings of increased tiredness and decreased attractiveness. Conclusion Our findings show that sleep deprived people appear less healthy, less attractive, and more tired compared with when they are well rested. This suggests that humans are sensitive to sleep related facial cues, with potential implications for social and clinical judgments and behaviour. Studies are warranted for understanding how these effects may affect clinical decision making and can add knowledge with direct implications in a medical context.	[Axelsson, John; Lekander, Mats] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, S-17177 Stockholm, Sweden; [Axelsson, John; Sundelin, Tina; Olsson, Andreas] Karolinska Inst, Dept Clin Neurosci, Div Psychol, S-17177 Stockholm, Sweden; [Ingre, Michael; Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Van Someren, Eus J. W.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Karolinska Institutet; Karolinska Institutet; Stockholm University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Axelsson, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, S-17177 Stockholm, Sweden.	john.axelsson@ki.se	Van Someren, Eus/AAA-6789-2020; Axelsson, John/AAH-5998-2019	Axelsson, John/0000-0003-3932-7310; Sundelin, Tina/0000-0002-7590-0826; Ingre, Michael/0000-0003-0678-4494	Swedish Society for Medical Research; Rut and Arvid Wolff's Memory Fund; Osher Center for Integrative Medicine	Swedish Society for Medical Research; Rut and Arvid Wolff's Memory Fund; Osher Center for Integrative Medicine	This study was funded by the Swedish Society for Medical Research, Rut and Arvid Wolff's Memory Fund, and the Osher Center for Integrative Medicine.	Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Doyle AC, 1993, CASE BOOK S HOLMES S; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Horne J., 1989, WHY WE SLEEP; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Lieberman MD, 2002, ADV EXP SOC PSYCHOL, V34, P199, DOI 10.1016/S0065-2601(02)80006-5; Olson LG, 2006, BRIT J HOSP MED, V67, P118, DOI 10.12968/hmed.2006.67.3.20610; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ranjbaran Z, 2007, INFLAMM RES, V56, P51, DOI 10.1007/s00011-006-6067-1; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; WIERWILLE WW, 1994, ACCIDENT ANAL PREV, V26, P571, DOI 10.1016/0001-4575(94)90019-1; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	23	65	65	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6614	10.1136/bmj.c6614	http://dx.doi.org/10.1136/bmj.c6614			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156746	Green Published, hybrid			2022-12-24	WOS:000285552200004
J	Encalada, SE; Szpankowski, L; Xia, CH; Goldstein, LSB				Encalada, Sandra E.; Szpankowski, Lukasz; Xia, Chun-hong; Goldstein, Lawrence S. B.			Stable Kinesin and Dynein Assemblies Drive the Axonal Transport of Mammalian Prion Protein Vesicles	CELL			English	Article							TUG-OF-WAR; HEAVY-CHAIN; CYTOPLASMIC DYNEIN; MOLECULAR MOTORS; TARGETED DISRUPTION; IN-VITRO; DYNACTIN; GENES; MITOCHONDRIA; REQUIRES	Kinesin and dynein are opposite-polarity microtubule motors that drive the tightly regulated transport of a variety of cargoes. Both motors can bind to cargo, but their overall composition on axonal vesicles and whether this composition directly modulates transport activity are unknown. Here we characterize the intracellular transport and steady-state motor subunit composition of mammalian prion protein (PrPC) vesicles. We identify Kinesin-1 and cytoplasmic dynein as major PrPC vesicle motor complexes and show that their activities are tightly coupled. Regulation of normal retrograde transport by Kinesin-1 is independent of dynein-vesicle attachment and requires the vesicle association of a complete Kinesin-1 heavy and light chain holoenzyme. Furthermore, motor subunits remain stably associated with stationary as well as with moving vesicles. Our data suggest a coordination model wherein PrPC vesicles maintain a stable population of associated motors whose activity is modulated by regulatory factors instead of by structural changes to motor-cargo associations.	[Encalada, Sandra E.; Szpankowski, Lukasz; Xia, Chun-hong; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Szpankowski, Lukasz] Univ Calif San Diego, Sch Med, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Szpankowski, Lukasz; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Encalada, SE (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sencalada@ucsd.edu; lgoldstein@ucsd.edu			UCSD [P30 NS047101]; NIH-NIA [AG032180]; Investigator of the Howard Hughes Medical Institute; NIH [T32 GM008806, AG000216]; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216, R01AG032180] Funding Source: NIH RePORTER	UCSD; NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ge Yang, Gaudenz Danuser, Khuloud Jaqaman, and Daniel Whisler for assistance with the development of software; Liz Roberts and Eileen Westerman for technical assistance; Jennifer Meerloo for assistance with imaging (UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101); Anne-Marie Craig (University of British Columbia) for the synaptophysin-mCherry construct; Anthony Williamson and Laura Solforosi (The Scripps Research Institute) for the HuM-D13 anti-PrP<SUP>C</SUP> antibody; Scott T. Brady for the KLC1/2 (63-90) antibody; Nancy Jenkins (Institute of Molecular and Cell Biology, Singapore) and Jiandong Huang (University of Hong Kong) for the Kinesin-1B mice; Tony Orth at the Genomics Institute of the Novartis Foundation for help with design and construction of shRNA lentiviral constructs; and Jeff W. Kelly (The Scripps Research Institute) for critical feedback on the manuscript. This work was supported in part by NIH-NIA grant AG032180 to L. S. B. G., who is an Investigator of the Howard Hughes Medical Institute. L. S. was supported by NIH Bioinformatics Training Grant T32 GM008806, and S. E. E. was supported by a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship and NIH Neuroplasticity Training Grant AG000216.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; [Anonymous], 2005, INTRO PRACTICE STAT; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BORCHELT DR, 1994, J BIOL CHEM, V269, P14711; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Butowt R, 2006, MOL CELL NEUROSCI, V31, P97, DOI 10.1016/j.mcn.2005.09.004; Butowt R, 2007, J NEUROSCI RES, V85, P2567, DOI 10.1002/jnr.21229; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HENDRICKS AG, 2010, CURR BIOL; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Howard J., 2001, MECH MOTOR PROTEINS; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Mazumdar M, 1996, P NATL ACAD SCI USA, V93, P6552, DOI 10.1073/pnas.93.13.6552; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Moya KL, 2004, J NEUROCHEM, V88, P155, DOI 10.1046/j.1471-4159.2003.02150.x; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Plitz T, 2001, MOL CELL BIOL, V21, P6044, DOI 10.1128/MCB.21.17.6044-6055.2001; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rodolfo K, 1999, NEUROREPORT, V10, P3639, DOI 10.1097/00001756-199911260-00032; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026	55	127	128	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					551	565		10.1016/j.cell.2011.01.021	http://dx.doi.org/10.1016/j.cell.2011.01.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335237	Bronze, Green Accepted			2022-12-24	WOS:000287473100010
J	Gagne, JJ; Choudhry, NK				Gagne, Joshua J.; Choudhry, Niteesh K.			How Many "Me-Too" Drugs Is Too Many?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRAND-NAME DRUGS		[Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	nchoudhry@partners.org	Mendoza, Elvia/A-9361-2012					Avorn J, 2005, POWERFUL MED BENEFIT; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Choudhry NK, 2009, CIRCULATION, V119, P365, DOI 10.1161/CIRCULATIONAHA.108.829655; Congressional Budget Office, 1998, INCR COMP GEN DRUGS; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Moran DW, 2000, HEALTH AFFAIR, V19, P63, DOI 10.1377/hlthaff.19.2.63; REDELMEIER DA, 1995, JAMA-J AM MED ASSOC, V273, P302, DOI 10.1001/jama.273.4.302; US Food and Drug Administration, 2010, FY 2009 PDUFA FIN RE	9	54	55	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					711	712		10.1001/jama.2011.152	http://dx.doi.org/10.1001/jama.2011.152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325189				2022-12-24	WOS:000287361100024
J	Sabatino, CP				Sabatino, Charles P.			Damage Prevention and Control for Financial Incapacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Bar Assoc, Commiss Law & Aging, Washington, DC 20005 USA		Sabatino, CP (corresponding author), Amer Bar Assoc, Commiss Law & Aging, 740 15th St NW, Washington, DC 20005 USA.	charles.sabatino@americanbar.org						American Bar Association American Psychological Association, ASS OLD AD DIM CAP H; *CA BANK ASS, SPOT ELD FIN AB; *FIN IND REG AUTH, ELELC158 FIN IND REG; STIEGEL LA, 2008, POWER ATTORNEY ABUSE, P8; *VA POL I STAT U C, 2009, BROK TRUST ELD FAM F	5	7	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					707	708		10.1001/jama.2011.187	http://dx.doi.org/10.1001/jama.2011.187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325187				2022-12-24	WOS:000287361100022
J	Rabl, J; Leibundgut, M; Ataide, SF; Haag, A; Ban, N				Rabl, Julius; Leibundgut, Marc; Ataide, Sandro F.; Haag, Andrea; Ban, Nenad			Crystal Structure of the Eukaryotic 40S Ribosomal Subunit in Complex with Initiation Factor 1	SCIENCE			English	Article							PROTEIN-KINASE-C; TRANSLATION INITIATION; MESSENGER-RNA; START CODON; IN-VIVO; 70S RIBOSOME; FACTOR EIF1; RACK1; S1; YEAST	Eukaryotic ribosomes are substantially larger and more complex than their bacterial counterparts. Although their core function is conserved, bacterial and eukaryotic protein synthesis differ considerably at the level of initiation. The eukaryotic small ribosomal subunit (40S) plays a central role in this process; it binds initiation factors that facilitate scanning of messenger RNAs and initiation of protein synthesis. We have determined the crystal structure of the Tetrahymena thermophila 40S ribosomal subunit in complex with eukaryotic initiation factor 1 (eIF1) at a resolution of 3.9 angstroms. The structure reveals the fold of the entire 18S ribosomal RNA and of all ribosomal proteins of the 40S subunit, and defines the interactions with eIF1. It provides insights into the eukaryotic-specific aspects of protein synthesis, including the function of eIF1 as well as signaling and regulation mediated by the ribosomal proteins RACK1 and rpS6e.	[Rabl, Julius; Leibundgut, Marc; Ataide, Sandro F.; Haag, Andrea; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch		F Ataide, Sandro/0000-0003-1807-5708; Rabl, Julius/0000-0001-6375-852X	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR); European Research Council [250071]; European Community	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR)(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission)	All data were collected at the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen). We thank C. Schulze-Briese, A. Pauluhn, R. Bingel-Erlenmeyer, M. Muller, and T. Tomizaki for their outstanding support at the SLS; B. Blattmann from the NCCR crystallization facility for screening; R. Brunisholz for help with mass spectroscopy; N. Katheder, D. Baretic, and M. Weisser for their work during the initial phase of the project; S. Arpagaus for preparation of the material; T. Maier for advice during phasing; D. Bohringer for critically reading the manuscript; all members of the Ban laboratory for suggestions and discussions; and A. Brunger for providing a prerelease version of the CNS 1.3 refinement program. Supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, and European Research Council grant 250071 under the European Community's Seventh Framework Programme (N.B.), and the Max Roessler prize to N.B. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession codes 2xzm and 2xzn. ETH Zurich has filed a patent application to use the crystals and the coordinates of the 40S ribosomal subunit for developing compounds that can interfere with eukaryotic translation.	Alkemar G, 2006, BIOCHEMISTRY-US, V45, P8067, DOI 10.1021/bi052149z; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CASTILHOVALAVICIUS B, 1990, GENETICS, V124, P483; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pachler K, 2004, FEMS YEAST RES, V5, P271, DOI 10.1016/j.femsyr.2004.07.009; PALM L, 1995, J BIOL CHEM, V270, P6000, DOI 10.1074/jbc.270.11.6000; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Sang NL, 2001, J BIOL CHEM, V276, P27026, DOI 10.1074/jbc.M010346200; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	54	349	354	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					730	736		10.1126/science.1198308	http://dx.doi.org/10.1126/science.1198308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21205638	Green Submitted			2022-12-24	WOS:000287205700060
J	Royal, CDM				Royal, Charmaine D. M.			My Genome, My Identity, My Health	SCIENCE			English	Editorial Material									[Royal, Charmaine D. M.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Royal, Charmaine D. M.] Duke Univ, Dept African & African Amer Studies, Durham, NC USA	Duke University; Duke University	Royal, CDM (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	691		10.1126/science.1203123	http://dx.doi.org/10.1126/science.1203123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310996				2022-12-24	WOS:000287205700042
J	Frey, BS				Frey, Bruno S.			Happy People Live Longer	SCIENCE			English	Editorial Material									[Frey, Bruno S.] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Frey, Bruno S.] Univ Zurich, Dept Econ, CH-8032 Zurich, Switzerland	University of Warwick; University of Zurich	Frey, BS (corresponding author), Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England.	bruno.frey@econ.uzh.ch	Frey, Bruno/AAW-9103-2021	tester22, sciencv/0000-0002-2791-7842; Holland, Sherri/0000-0003-2860-0668				Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; DIENER E, 2010, SSRN WORKING PAPER; Frey B, 2002, HAPPINESS EC; Frey B.S., 2008, HAPPINESS REVOLUTION; HOWELL RT, 2007, PSYCHOL REV, V1, P83; Layard R., 2005, PROSPECT, V108; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1	8	33	36	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					542	543		10.1126/science.1201060	http://dx.doi.org/10.1126/science.1201060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292959				2022-12-24	WOS:000286933600033
J	Venter, JC				Venter, J. Craig			The Human Genome at 10: Successes and Challenges	SCIENCE			English	Editorial Material									[Venter, J. Craig] J Craig Venter Inst, Rockville, MD USA; [Venter, J. Craig] J Craig Venter Inst, San Diego, CA USA; [Venter, J. Craig] Synthet Genom Inc, La Jolla, CA USA	J. Craig Venter Institute; J. Craig Venter Institute	Venter, JC (corresponding author), J Craig Venter Inst, Rockville, MD USA.								0	18	19	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	547		10.1126/science.1202812	http://dx.doi.org/10.1126/science.1202812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292962				2022-12-24	WOS:000286933600038
J	Crimmins, SM; Dobrowski, SZ; Greenberg, JA; Abatzoglou, JT; Mynsberge, AR				Crimmins, Shawn M.; Dobrowski, Solomon Z.; Greenberg, Jonathan A.; Abatzoglou, John T.; Mynsberge, Alison R.			Changes in Climatic Water Balance Drive Downhill Shifts in Plant Species' Optimum Elevations	SCIENCE			English	Article							VEGETATION DISTRIBUTION; CALIFORNIA; 20TH-CENTURY; PHENOLOGY; MIGRATION; USA	Uphill shifts of species' distributions in response to historical warming are well documented, which leads to widespread expectations of continued uphill shifts under future warming. Conversely, downhill shifts are often considered anomalous and unrelated to climate change. By comparing the altitudinal distributions of 64 plant species between the 1930s and the present day within California, we show that climate changes have resulted in a significant downward shift in species' optimum elevations. This downhill shift is counter to what would be expected given 20th-century warming but is readily explained by species' niche tracking of regional changes in climatic water balance rather than temperature. Similar downhill shifts can be expected to occur where future climate change scenarios project increases in water availability that outpace evaporative demand.	[Crimmins, Shawn M.; Dobrowski, Solomon Z.; Mynsberge, Alison R.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Greenberg, Jonathan A.] Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Abatzoglou, John T.] Univ Idaho, Dept Geog, Coll Sci, Moscow, ID 83844 USA	University of Montana System; University of Montana; University of California System; University of California Davis; Idaho; University of Idaho	Dobrowski, SZ (corresponding author), Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA.	solomon.dobrowski@cfc.umt.edu	Crimmins, Shawn/M-1809-2013; Abatzoglou, John T/ABE-6134-2020; Abatzoglou, John T/C-7635-2012; Dobrowski, Solomon Z/Q-7132-2019; Crimmins, Shawn/C-6972-2012	Abatzoglou, John T/0000-0001-7599-9750; Abatzoglou, John T/0000-0001-7599-9750; Dobrowski, Solomon Z/0000-0003-2561-3850; Greenberg, Jonathan/0000-0001-8435-9077	NSF [BCS-0819430, BCS-0819493, EPS-0814387]; U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station [JV11221635-201]	NSF(National Science Foundation (NSF)); U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	Supported by NSF (BCS-0819430 to S.Z.D. and BCS-0819493 to J.A.G.). J.T.A. was supported by NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) (EPS-0814387). A.R.M. was supported by U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station (JV11221635-201). We thank C. Daly for providing interpolated climate data; M. Kelly for Vegetation Type Mapping project data; C. Ramirez (Region 5 USFS Remote Sensing Lab) for the USFS Forest Inventory and Analysis data (plot locations were not provided to the authors); J. Thorne for compiling modern data sources; and S. Running for helpful comments on the manuscript.	Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Doi H, 2008, AGR FOREST METEOROL, V148, P512, DOI 10.1016/j.agrformet.2007.10.002; Eckert Andrew J., 2007, Madrono, V54, P117, DOI 10.3120/0024-9637(2007)54[117:EAEEOS]2.0.CO;2; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Oppel S, 2008, CONDOR, V110, P296, DOI 10.1525/cond.2008.8502; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wieslander A.E., 1935, MADRONO, V3, P140; Wieslander A. E, 1935, J FOREST, V33, P877, DOI DOI 10.1093/JOF/33.10.877; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047	24	386	399	6	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					324	327		10.1126/science.1199040	http://dx.doi.org/10.1126/science.1199040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252344				2022-12-24	WOS:000286636300035
J	Martinez, RN; Sereno, PC; Alcober, OA; Colombi, CE; Renne, PR; Montanez, IP; Currie, BS				Martinez, Ricardo N.; Sereno, Paul C.; Alcober, Oscar A.; Colombi, Carina E.; Renne, Paul R.; Montanez, Isabel P.; Currie, Brian S.			A Basal Dinosaur from the Dawn of the Dinosaur Era in Southwestern Pangaea	SCIENCE			English	Article							EARLY EVOLUTION; ORIGIN; ARGENTINA; SKELETON; SAURISCHIA	Upper Triassic rocks in northwestern Argentina preserve the most complete record of dinosaurs before their rise to dominance in the Early Jurassic. Here, we describe a previously unidentified basal theropod, reassess its contemporary Eoraptor as a basal sauropodomorph, divide the faunal record of the Ischigualasto Formation with biozones, and bracket the formation with 40Ar/39Ar ages. Some 230 million years ago in the Late Triassic (mid Carnian), the earliest dinosaurs were the dominant terrestrial carnivores and small herbivores in southwestern Pangaea. The extinction of nondinosaurian herbivores is sequential and is not linked to an increase in dinosaurian diversity, which weakens the predominant scenario for dinosaurian ascendancy as opportunistic replacement.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sereno, Paul C.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Martinez, Ricardo N.; Alcober, Oscar A.; Colombi, Carina E.] Univ Nacl San Juan, Inst Ciencias Nat, RA-5400 San Juan, Argentina; [Martinez, Ricardo N.; Alcober, Oscar A.; Colombi, Carina E.] Univ Nacl San Juan, Museo Ciencias Nat, RA-5400 San Juan, Argentina; [Colombi, Carina E.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Renne, Paul R.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Renne, Paul R.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Montanez, Isabel P.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Currie, Brian S.] Miami Univ, Dept Geol, Oxford, OH 45056 USA	University of Chicago; University of Chicago; Universidad Nacional de San Juan; Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Berkeley Geochronolgy Center; University of California System; University of California Berkeley; University of California System; University of California Davis; University System of Ohio; Miami University	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu		Currie, Brian/0000-0002-5759-3914; Montanez, Isabel/0000-0003-0492-3796; Renne, Paul/0000-0003-1769-5235	Whitten-Newman Foundation; New York Community Trust; Earthwatch Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Ann and Gordon Getty Foundation; National Geographic Society	Whitten-Newman Foundation; New York Community Trust; Earthwatch Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ann and Gordon Getty Foundation; National Geographic Society(National Geographic Society)	We thank C. Abraczinskas for final drafts of all figures, personnel of the Fossil Lab at the Univ. of Chicago for preparation of fossil material, personnel of the High-Resolution X-ray Computed Tomography Facility at The Univ. of Texas at Austin for assistance with computed tomography imaging, and S. Nesbitt and R. Irmis for examination of fossil material in their care. This work was supported by the Whitten-Newman Foundation, the Island Fund of the New York Community Trust, Earthwatch Institute, Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Ann and Gordon Getty Foundation, and the National Geographic Society.	Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Benton M. J., 2006, 3 JORN INT PAL DIN E, P11; BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Charig A. J., 1984, ZOOL SOC LONDON S, V57, P597; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Langer M. C., 2007, GLOBAL TRIASSIC; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer MC, 2005, J S AM EARTH SCI, V19, P219, DOI 10.1016/j.jsames.2005.04.002; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Santa Luca A.P., 1980, Annals of the South African Museum, V79, P159; Sereno Paul C., 2007, Historical Biology, V19, P145, DOI 10.1080/08912960601167435; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1992, SCIENCE, V258, P1137, DOI 10.1126/science.258.5085.1137; Tykoski R. S., 2005, THESIS U TEXAS AUSTI; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C	30	251	257	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					206	210		10.1126/science.1198467	http://dx.doi.org/10.1126/science.1198467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233386				2022-12-24	WOS:000286433100040
J	Helmink, BA; Tubbs, AT; Dorsett, Y; Bednarski, JJ; Walker, LM; Feng, ZH; Sharma, GG; McKinnon, PJ; Zhang, JR; Bassing, CH; Sleckman, BP				Helmink, Beth A.; Tubbs, Anthony T.; Dorsett, Yair; Bednarski, Jeffrey J.; Walker, Laura M.; Feng, Zhihui; Sharma, Girdhar G.; McKinnon, Peter J.; Zhang, Junran; Bassing, Craig H.; Sleckman, Barry P.			H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes	NATURE			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; GENOMIC STABILITY; HISTONE H2AX; MRN COMPLEX; MDC1; NBS1; CHROMATIN; DAMAGE; PROTEINS	DNA double-strand breaks (DSBs) are generated by the recombination activating gene (RAG) endonuclease in all developing lymphocytes as they assemble antigen receptor genes(1). DNA cleavage by RAG occurs only at the G1 phase of the cell cycle and generates two hairpin-sealed DNA (coding) ends that require nucleolytic opening before their repair by classical non-homologous end-joining (NHEJ)(1-3). Although there are several cellular nucleases that could perform this function, only the Artemis nuclease is able to do so efficiently(2,3). Here, in vivo, we show that in murine cells the histone protein H2AX prevents nucleases other than Artemis from processing hairpin-sealed coding ends; in the absence of H2AX, CtIP can efficiently promote the hairpin opening and resection of DNA ends generated by RAG cleavage. This CtIP-mediated resection is inhibited by gamma-H2AX and by MDC-1 (mediator of DNA damage checkpoint 1), which binds to gamma-H2AX in chromatin flanking DNA DSBs. Moreover, the ataxia telangiectasia mutated (ATM) kinase activates antagonistic pathways that modulate this resection. CtIP DNA end resection activity is normally limited to cells at post-replicative stages of the cell cycle, in which it is essential for homology-mediated repair(4,5). In G1-phase lymphocytes, DNA ends that are processed by CtIP are not efficiently joined by classical NHEJ and the joints that do form frequently use micro-homologies and show significant chromosomal deletions. Thus, H2AX preserves the structural integrity of broken DNA ends in G1-phase lymphocytes, thereby preventing these DNA ends from accessing repair pathways that promote genomic instability.	[Helmink, Beth A.; Tubbs, Anthony T.; Dorsett, Yair; Bednarski, Jeffrey J.; Walker, Laura M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bednarski, Jeffrey J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Feng, Zhihui; Sharma, Girdhar G.; Zhang, Junran] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; [McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Bassing, Craig H.] Univ Penn, Sch Med,Ctr Childhood Canc Res, Childrens Hosp Philadelphia,Dept Pathol & Lab Med, Abramson Family Canc Res Inst,Div Canc Pathobiol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	sleckman@wustl.edu	Bednarski, Jeff/GLN-6651-2022	Tubbs, Anthony/0000-0002-5605-8231; Helmink, Beth/0000-0002-8206-0351	National Institutes of Health (NIH) [AI074953, AI47829, CA136470, CA125195, CA21765, NS37956, T32 HD007499]; Children's Discovery Institute; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765, R01CA136470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953, R01AI047829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Oltz and F. Alt for critical review of the manuscript; R. Baer for providing us with the anti-CtIP antibodies; and G. Longmore and Y. Feng for pFLRU, pHR'Delta 8.2R and pCMV-VSVg. This work is supported by National Institutes of Health (NIH) grants AI074953(B. P. S.), AI47829 (B. P. S.), CA136470 (B. P. S. and C. H. B.), CA125195 (C. H. B.), CA21765 (P.J.McK.) and NS37956 (P.J.McK.). J.J.B. is supported by a NIH Ruth L. Kirschstein National Research Service Award (T32 HD007499) and a Children's Discovery Institute Fellows Award. C. H. B. was a Pew Scholar in the Biomedical Sciences program and is a Leukemia and Lymphoma Society Scholar.	Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Hegedus E, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp539; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; You ZS, 2010, TRENDS CELL BIOL, V20, P402, DOI 10.1016/j.tcb.2010.04.002	33	112	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					245	249		10.1038/nature09585	http://dx.doi.org/10.1038/nature09585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21160476	Green Accepted			2022-12-24	WOS:000286143400045
J	O'Shaughnessy, EC; Palani, S; Collins, JJ; Sarkar, CA				O'Shaughnessy, Ellen C.; Palani, Santhosh; Collins, James J.; Sarkar, Casim A.			Tunable Signal Processing in Synthetic MAP Kinase Cascades	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SWITCH-LIKE; CELL FATE; COMPUTATIONAL DESIGN; SCAFFOLD PROTEINS; MAMMALIAN-CELLS; GENE-EXPRESSION; GLOBAL ANALYSIS; YEAST; PATHWAYS	The flexibility of MAPK cascade responses enables regulation of a vast array of cell fate decisions, but elucidating the mechanisms underlying this plasticity is difficult in endogenous signaling networks. We constructed insulated mammalian MAPK cascades in yeast to explore how intrinsic and extrinsic perturbations affect the flexibility of these synthetic signaling modules. Contrary to biphasic dependence on scaffold concentration, we observe monotonic decreases in signal strength as scaffold concentration increases. We find that augmenting the concentration of sequential kinases can enhance ultrasensitivity and lower the activation threshold. Further, integrating negative regulation and concentration variation can decouple ultrasensitivity and threshold from the strength of the response. Computational analyses show that cascading can generate ultrasensitivity and that natural cascades with different kinase concentrations are innately biased toward their distinct activation profiles. This work demonstrates that tunable signal processing is inherent to minimal MAPK modules and elucidates principles for rational design of synthetic signaling systems.	[O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Palani, Santhosh; Sarkar, Casim A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Sarkar, Casim A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; University of Pennsylvania; University of Pennsylvania; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu; casarkar@seas.upenn.edu			National Institutes of Health (NIH) [DP1 OD00364]; Ellison Medical Foundation; Howard Hughes Medical Institute; American Heart Association [0835132N]; University of Pennsylvania; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); University of Pennsylvania; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) through the NIH Director's Pioneer Award Program, grant number DP1 OD00364, and by the Ellison Medical Foundation and the Howard Hughes Medical Institute (to J.J.C.); and by the American Heart Association, grant number 0835132N, and startup funds from the University of Pennsylvania (to C.A.S.). We also thank Natalie Ahn, Lloyd Cantley, Gerald Fink, Steen Hansen, and David Levin for kindly providing cDNA.	Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Chen RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-235; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Dwyer MA, 2003, P NATL ACAD SCI USA, V100, P11255, DOI 10.1073/pnas.2032284100; Elion EA, 2001, J CELL SCI, V114, P3967; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2645, DOI 10.1093/nar/gkq152; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kiel C, 2010, CELL, V140, P33, DOI 10.1016/j.cell.2009.12.028; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McMahon M, 2001, METHOD ENZYMOL, V332, P401; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Wu JJ, 2005, MOL CELL BIOL, V25, P4792, DOI 10.1128/MCB.25.11.4792-4803.2005; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	51	116	117	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					119	131		10.1016/j.cell.2010.12.014	http://dx.doi.org/10.1016/j.cell.2010.12.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215374	Green Accepted, Bronze			2022-12-24	WOS:000285993600012
J	Albanese, A				Albanese, Alberto			Terminology for Preparations of Botulinum Neurotoxins What a Difference a Name Makes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; CERVICAL DYSTONIA; THERAPEUTICS; DISORDERS; TOXIN		Univ Cattolica Sacro Cuore, Ist Neurol Carlo Besta, I-20133 Milan, Italy	Catholic University of the Sacred Heart; IRCCS Istituto Neurologico Besta	Albanese, A (corresponding author), Univ Cattolica Sacro Cuore, Ist Neurol Carlo Besta, Via G Celoria 11, I-20133 Milan, Italy.	alberto.albanese@unicatt.it	Albanese, Alberto/K-7396-2016	Albanese, Alberto/0000-0002-5864-0006				Albanese A, 2009, TOXICON, V54, P702, DOI 10.1016/j.toxicon.2009.02.003; Benecke R, 2005, NEUROLOGY, V64, P1949, DOI 10.1212/01.WNL.0000163767.99354.C3; Bentivoglio AR, 2009, NEUROTOX RES, V15, P224, DOI 10.1007/s12640-009-9023-3; Chapman MA, 2007, CLIN THER, V29, P1325, DOI 10.1016/j.clinthera.2007.07.020; Dressler D, 2006, EUR J NEUROL, V13, P11, DOI 10.1111/j.1468-1331.2006.01439.x; Naumann M, 2008, NEUROLOGY, V70, P1707, DOI 10.1212/01.wnl.0000311390.87642.d8; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; *US FDA, 2010, FDA GIV UPD BOT TOX; WHO, 1997, GUID US INT NONPR NA	10	44	49	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					89	90		10.1001/jama.2010.1937	http://dx.doi.org/10.1001/jama.2010.1937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205970				2022-12-24	WOS:000285924100029
J	Ahmed, F				Ahmed, Farooq			Tales of adversity	NATURE			English	Editorial Material																			0	23	23	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S20	S20		10.1038/468S20a	http://dx.doi.org/10.1038/468S20a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179081	Bronze			2022-12-24	WOS:000285553800008
J	Sheron, N; Hawkey, C; Gilmore, I				Sheron, Nick; Hawkey, Chris; Gilmore, Ian			Projections of alcohol deaths-a wake-up call	LANCET			English	Editorial Material							POLICY		[Sheron, Nick] Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England; [Hawkey, Chris] Univ Nottingham Hosp, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England; [Gilmore, Ian] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England; [Gilmore, Ian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Southampton; University of Nottingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Sheron, N (corresponding author), Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England.	Nick.Sheron@soton.ac.uk		Sheron, Nick/0000-0002-6156-8367; Sheron, Nick/0000-0001-5232-8292				Abel EL, 2001, ALCOHOL ALCOHOLISM, V36, P401, DOI 10.1093/alcalc/36.5.401; Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; BROWN RH, 2003, FORBIDDEN SUBSTANCES, pCH6; Department of Health, 2008, SAF SENS SOC CONS FU; DUFFY JC, 2010, J R STAT SOC, V149, P44; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009; Jernigan DH, 2000, B WORLD HEALTH ORGAN, V78, P491; Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259; JOLIFFE N, 1949, Q J STUD ALCOHOL, V2, P544; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; TERRIS M, 1967, AM J PUBLIC HEALTH, V57, P2067; The NHS Information Centre, 2009, STAT ALC ENGL 2009; WHO, 2004, GLOB STAT REP ALC 20; *WHO, 2008, HLTH STAT INF SYST G; World Health Organization, 2009, WHO EUR HLTH ALL DAT	15	35	36	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1297	1299		10.1016/S0140-6736(11)60022-6	http://dx.doi.org/10.1016/S0140-6736(11)60022-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21334738				2022-12-24	WOS:000289962900008
J	Sims, JK; Wade, PA				Sims, Jennifer K.; Wade, Paul A.			SnapShot: Chromatin Remodeling: CHD	CELL			English	Editorial Material							COMPLEXES; MI-2/NURD; CELLS		[Sims, Jennifer K.; Wade, Paul A.] Lab Mol Carcinogenesis, NIEHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X	Intramural Research Program of the National Institute of Environmental Health Science, NIH [Z01ES101965]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101965, Z01ES101965] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Science, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institute of Environmental Health Science, NIH (project number Z01ES101965 to PAW). We gratefully acknowledge helpful suggestions from S. Khorasanizadeh, T. Kutateladze, S. Venkatachalam, J. Wysocka, and members of the Wade laboratory.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Benayahu D, 2007, CRIT REV EUKAR GENE, V17, P103, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.20; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108	8	23	26	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					626	627		10.1016/j.cell.2011.02.019	http://dx.doi.org/10.1016/j.cell.2011.02.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335242	Bronze			2022-12-24	WOS:000287473100016
J	Ward, CV; Kimbel, WH; Johanson, DC				Ward, Carol V.; Kimbel, William H.; Johanson, Donald C.			Complete Fourth Metatarsal and Arches in the Foot of Australopithecus afarensis	SCIENCE			English	Article							HADAR FORMATION; EVOLUTION; JOINT; FOOTPRINTS; WALKING; TARSAL; FEET	The transition to full-time terrestrial bipedality is a hallmark of human evolution. A key correlate of human bipedalism is the development of longitudinal and transverse arches of the foot that provide a rigid propulsive lever and critical shock absorption during striding bipedal gait. Evidence for arches in the earliest well-known Australopithecus species, A. afarensis, has long been debated. A complete fourth metatarsal of A. afarensis was recently discovered at Hadar, Ethiopia. It exhibits torsion of the head relative to the base, a direct correlate of a transverse arch in humans. The orientation of the proximal and distal ends of the bone reflects a longitudinal arch. Further, the deep, flat base and tarsal facets imply that its midfoot had no ape-like midtarsal break. These features show that the A. afarensis foot was functionally like that of modern humans and support the hypothesis that this species was a committed terrestrial biped.	[Ward, Carol V.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Kimbel, William H.; Johanson, Donald C.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA	University of Missouri System; University of Missouri Columbia; Arizona State University; Arizona State University-Tempe	Ward, CV (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, M263 Med Sci Bldg, Columbia, MO 65212 USA.	wardcv@missouri.edu		Ward, Carol/0000-0001-6255-9668	NSF [NSF SBR-9601025, NSF BCS-0333296]; University of Missouri Research Board and University of Missouri Research Council; Institute of Human Origins at Arizona State University	NSF(National Science Foundation (NSF)); University of Missouri Research Board and University of Missouri Research Council; Institute of Human Origins at Arizona State University	The authors thank the members of the Hadar Research Project (1990-2004) and the Hadar Paleoanthropology Field School (2007 and 2009) for their dedication and hard work, and the directors and staff of the National Museum of Ethiopia, Cleveland Museum of Natural History, and National Museums of Kenya for facilitating the analytical research reported here. Fieldwork permissions were kindly granted by the Authority for Research and Conservation of Cultural Heritage, Ethiopian Ministry of Culture and Tourism, and the Culture and Tourism Bureau of the Afar Regional State government. We thank J. DeSilva, J. M. Plavcan, and G. Schwartz for helpful comments. The analytical research was supported by NSF (grants NSF SBR-9601025 and NSF BCS-0333296), the University of Missouri Research Board and University of Missouri Research Council, and the Institute of Human Origins at Arizona State University.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berillon G., 2003, Human Evolution, V18, P113, DOI 10.1007/BF02436280; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Deloison Yvette, 2003, Biometrie Humaine et Anthropologie, V21, P189; DeSilva J., 2009, AM J PHYS ANTHROPOL, V141, P1; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; GOMBERG DN, 1984, AM J PHYS ANTHROPOL, V63, P164; Hamrick MW, 1996, J MORPHOL, V230, P113; Harcourt-Smith W.E., 2002, THESIS U COLL LONDON; Harcourt-Smith WE, 2005, AM J PHYS ANTHROPOL, P112; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HICKS JH, 1953, J ANAT, V87, P345; Kapandji I. A., 1985, PHYSL JOINTS; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; KIDD RS, 1993, AUST PODIATR, V27, P35; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Klenerman L., 2006, HUMAN FOOT COMPANION; LAMY P, 1986, J HUM EVOL, V15, P31, DOI 10.1016/S0047-2484(86)80063-X; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; LEWIS OJ, 1980, J ANAT, V130, P833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Morton DJ, 1924, AM J PHYS ANTHROPOL, V7, P1, DOI 10.1002/ajpa.1330070114; SAMMARCO GJ, 1989, BASIC BIOMECHANICS M, P163; SARMIENTO E, 1991, AM J PHYS ANTHR S, V12, P157; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Tuttle R.H., 1991, Human Evolution, V6, P193, DOI 10.1007/BF02438142; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Vereecke EE, 2008, J EXP BIOL, V211, P3661, DOI 10.1242/jeb.018754; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Zipfel B, 2009, AM J PHYS ANTHROPOL, V140, P532, DOI 10.1002/ajpa.21103	36	118	122	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					750	753		10.1126/science.1201463	http://dx.doi.org/10.1126/science.1201463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311018				2022-12-24	WOS:000287205700065
J	Van Dover, CL				Van Dover, Cindy Lee			Tighten regulations on deep-sea mining	NATURE			English	Editorial Material									Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA	Duke University	Van Dover, CL (corresponding author), Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA.	clv3@duke.edu		Van Dover, Cindy/0000-0001-9845-8391				Coffey Natural Systems, 2008, ENV IMP STAT SOLW 1, P226; GJERDE KM, 2008, MARINE SERIES IUCN, V1; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Jankowski P, 2007, INDEPENDENT TECHNICA; SPIESS FN, 1980, SCIENCE, V207, P1421, DOI 10.1126/science.207.4438.1421; VANDOVER CL, 2011, ISA TECHNICAL STUDY, V8	6	97	98	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					31	33		10.1038/470031a	http://dx.doi.org/10.1038/470031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715LQ	21293351	Bronze			2022-12-24	WOS:000286886400013
J	Kendall, T; Cape, J; Chan, M; Taylor, C				Kendall, Tim; Cape, John; Chan, Melissa; Taylor, Clare		Guideline Dev Grp	Guidelines Management of generalised anxiety disorder in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; PREVALENCE		[Kendall, Tim; Chan, Melissa; Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim; Cape, John] UCL, London WC1E 7HB, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Cape, John] Camden & Islington NHS Fdn Trust, St Pancras Hosp, London NW1 0PE, England	University of London; University College London; University of London; University College London	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	tim.kendall@shsc.nhs.uk	John, Cape/B-9039-2009	John, Cape/0000-0003-3108-7228				Arroll B, 2009, PRIMARY CARE MENTAL, P147; Bitran S, 2009, NEW OXFORD TXB PSYCH, P729; Brugha T, 2009, ADULT PSYCHIAT MORBI; Culpepper L, 2009, J CLIN PSYCHIAT, V70, P20, DOI 10.4088/JCP.s.7002.04; Dugas M. J., 2007, COGNITIVE BEHAV TREA, P1; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; National Institute for Health and Clinical Excellence, 2009, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; National Institute for Health and Clinical Excellence, 2004, CLIN GUID; Rickels K, 2001, J CLIN PSYCHIAT, V62, P4; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Roy-Byrne PP, 2004, J CLIN PSYCHIAT, V65, P20; Sareen J, 2006, ARCH INTERN MED, V166, P2109, DOI 10.1001/archinte.166.19.2109; Tyrer P, 2006, LANCET, V368, P2156, DOI 10.1016/S0140-6736(06)69865-6; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	16	8	8	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2011	342								c7460	10.1136/bmj.c7460	http://dx.doi.org/10.1136/bmj.c7460			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270081	Green Published			2022-12-24	WOS:000286887800009
J	Rebbeck, CA; Leroi, AM; Burt, A				Rebbeck, Clare A.; Leroi, Armand M.; Burt, Austin			Mitochondrial Capture by a Transmissible Cancer	SCIENCE			English	Article							EVOLUTION; ORIGIN		[Rebbeck, Clare A.; Leroi, Armand M.; Burt, Austin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	Imperial College London	Burt, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	a.burt@imperial.ac.uk		rebbeck, clare/0000-0002-2502-9622; Burt, Austin/0000-0001-5146-9640	Natural Environmental Research Council (NERC); Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR)	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR)	We thank E. C. Yeoh, J. Gilchrist, A. Ortega-Pacheco, B. Rivera, N. Trakrantungsie, and H. Ververidis for providing CTVT samples and A. Ashworth and C. Isacke. Supported by the Natural Environmental Research Council (NERC) and the Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR). GenBank accession numbers for sequence data are given in table S1. Data were deposited at Dryad: DOI 10.5061/dryad.8081.	Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Mozos E, 1996, VET PATHOL, V33, P257, DOI 10.1177/030098589603300301; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103	8	74	78	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					303	303		10.1126/science.1197696	http://dx.doi.org/10.1126/science.1197696			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252340				2022-12-24	WOS:000286636300028
J	Driver, JA; Logroscino, G; Lu, LD; Gaziano, JM; Kurth, T				Driver, Jane A.; Logroscino, Giancarlo; Lu, Linda; Gaziano, J. Michael; Kurth, Tobias			Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PHYSICIANS HEALTH; BETA-CAROTENE; COMORBIDITY; PROTECT; CANCER; NEUROPROTECTION; SALICYLATE; ADJUSTMENT; MORTALITY	Objective To evaluate the relation between Parkinson's disease and prior use of non-steroidal anti-inflammatory drugs (NSAIDs) in a large cohort of men. Design Case-control analysis nested in the Physicians' Health Study. Participants 22 007 male physicians aged 40-84 years without indications for or contraindications to regular NSAID use and free of Parkinson's disease at baseline. Cases and controls were matched by age alone or by age and scores for confounders (comorbidity and indicators of NSAID use). Up to five controls were matched to each of 616 cases by age and 565 cases by age and confounder scores. Setting United States. Main outcome measures Odds of having been exposed to prior non-aspirin NSAID or aspirin use by participants with Parkinson's disease and by their controls in each case-control set. Results Participants who had ever used non-aspirin NSAIDs had an increased risk of Parkinson's disease (odds ratio 1.28 (95% CI 1.05 to 1.56) in the age matched group but not in the group also matched on confounder scores (odds ratio 1.17 (0.94 to 1.46)). There was an increased risk of Parkinson's disease in men who had 12 years of regular non-aspirin NSAID use (odds ratio 1.35 (1.07 to 1.70)), a finding that remained significant after matching for confounder scores as well (odds ratio 1.35 (1.05 to 1.75)). In contrast, the significant association of use of non-aspirin NSAIDs for >= 5 years (odds ratio 1.48 (1.05 to 2.09)) in the age matched group was entirely attenuated in the group also matched on confounder scores (1.03 (0.70 to 1.53)). There was also a suggestion that men who regularly used aspirin had an increased risk of Parkinson's disease. Positive associations between non-aspirin NSAID or aspirin and risk of Parkinson's disease tended to disappear when analyses were limited to drug use >= 5 years before the disease diagnosis. Conclusions This case-control study did not find evidence that NSAID use reduces Parkinson's disease risk. The positive associations observed between NSAID use and Parkinson's disease might have been due to confounding by indication as the use was clustered in the few years before disease diagnosis.	[Driver, Jane A.; Lu, Linda; Gaziano, J. Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02120 USA; [Driver, Jane A.; Gaziano, J. Michael] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Driver, Jane A.; Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res Informat Ctr, Boston, MA USA; [Logroscino, Giancarlo] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy; [Gaziano, J. Michael; Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, Paris, France; [Kurth, Tobias] Univ Paris 06, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Universita degli Studi di Bari Aldo Moro; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Driver, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, 1620 Tremont St, Boston, MA 02120 USA.	jdriver@partners.org	Kurth, Tobias/A-9243-2012; LOGROSCINO, GIANCARLO/K-5148-2016	Kurth, Tobias/0000-0001-7169-2620; LOGROSCINO, GIANCARLO/0000-0003-0423-3242	Parkinson's Disease Foundation; National Cancer Institute [CA-34944, CA-40360, CA-097193]; National Heart, Lung, and Blood Institute, Bethesda, MD [HL-26490, HL-34595]; Hartford Foundation; Harvard Medical School; Veteran's Administration; Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health; Apulia Region; Italian Ministry of Universities; National Institutes of Health; BASF; DSM Pharmaceuticals; Wyeth Pharmaceuticals; McNeil Consumer Products; Pliva; French National Research Agency; US National Institutes of Health; Merck; Migraine Research Foundation; Parkinson's Research Foundation; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hartford Foundation; Harvard Medical School; Veteran's Administration(US Department of Veterans Affairs); Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health(Ministry of Health, Italy); Apulia Region; Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF(BASF); DSM Pharmaceuticals; Wyeth Pharmaceuticals(Wyeth); McNeil Consumer Products; Pliva(Teva Pharmaceutical Industries); French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Migraine Research Foundation; Parkinson's Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is funded by a grant from the Parkinson's Disease Foundation. The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD. The study sponsor had no role in study design; data collection, analysis, or interpretation; writing the article; or the decision to submit it for publication. The researchers are independent from funders and sponsors.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JAD has support from the Parkinson's Disease Foundation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. We report a full disclosure for the past five years for each of the authors. JAD has a research grant from the Parkinson's Disease Foundation, the Hartford Foundation, Harvard Medical School, and a Career Development Award from the Veteran's Administration. LL has nothing to disclose. GL has received research funding from the Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health, the Apulia Region, and special funding from the Italian Ministry of Universities and has received honorariums from Pfizer, Novartis, Glaxo, and Lilly Pharmaceutical for speaking engagements. JMG has received investigator initiated research funding and support as principal investigator from National Institutes of Health, BASF, DSM Pharmaceuticals, Wyeth Pharmaceuticals, McNeil Consumer Products, and Pliva; received honoraria from Bayer and Pfizer for speaking engagements; and is a consultant for Bayer, McNeil Consumer Products, Wyeth Pharmaceuticals, Merck, Nutraquest, and GlaxoSmithKline. TK has received investigator initiated research funding from the French National Research Agency, the US National Institutes of Health, Merck, the Migraine Research Foundation, and the Parkinson's Research Foundation; is a consultant to i3 Drug Safety and World Health Information Science Consultants, LLC; and has received honoraria from the American Academy of Neurology, Genzyme, Merck, and Pfizer for educational lectures.	Administration on Aging, 2005, PROF OLD AM 2005; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Aubin N, 1998, J NEUROCHEM, V71, P1635, DOI 10.1046/j.1471-4159.1998.71041635.x; Bornebroek M, 2007, NEUROEPIDEMIOLOGY, V28, P193, DOI 10.1159/000108110; Bower JH, 2006, NEUROLOGY, V67, P494, DOI 10.1212/01.wnl.0000227906.99570.cc; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Driver JA, 2007, CANCER CAUSE CONTROL, V18, P705, DOI 10.1007/s10552-007-9005-9; Ford B, 2009, NAT REV NEUROL, V5, P242, DOI 10.1038/nrneurol.2009.50; Frigerio R, 2005, NEUROLOGY, V65, P1575, DOI 10.1212/01.wnl.0000184520.21744.a2; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Hancock DB, 2007, ARCH NEUROL-CHICAGO, V64, P576, DOI 10.1001/archneur.64.4.576; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hernan MA, 2006, NEUROLOGY, V66, P1097, DOI 10.1212/01.wnl.0000204446.82823.28; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; KOLLER WC, 1984, NEUROLOGY, V34, P957, DOI 10.1212/WNL.34.7.957; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; ROYER GL, 1984, AM J MED, V77, P25, DOI 10.1016/S0002-9343(84)80015-7; SANDYK R, 1982, S AFR MED J, V61, P3; Schiess M, 2003, ARCH NEUROL-CHICAGO, V60, P1043, DOI 10.1001/archneur.60.8.1043; Snider SR, 1987, HDB PARKINSON DISEAS, P171; Teismann P, 2001, SYNAPSE, V39, P167, DOI 10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U; Ton TG, 2006, MOVEMENT DISORD, V21, P964, DOI 10.1002/mds.20856; Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	36	50	52	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2011	342								d198	10.1136/bmj.d198	http://dx.doi.org/10.1136/bmj.d198			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PE	21252104	Green Published, hybrid			2022-12-24	WOS:000286603100002
J	Greely, HT				Greely, Henry T.			Get ready for the flood of fetal gene screening	NATURE			English	Editorial Material									Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA	Stanford University	Greely, HT (corresponding author), Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA.	hgreely@stanford.edu						Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Fan C, 2010, NATURE PRECEDINGS, DOI [10.1038/npre.2010.5373.1, DOI 10.1038/NPRE.2010.5373.1]; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; FUCHS F, 1956, NATURE, V177, P330, DOI 10.1038/177330a0; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Wright C., 2009, CELL FREE FETAL NUCL; RELIABLE ACCURATE PR; 2010, COM REV PREN GEN TES	10	71	85	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					289	291		10.1038/469289a	http://dx.doi.org/10.1038/469289a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248817				2022-12-24	WOS:000286385600018
J	Ross, J; Grahame, R				Ross, Juliette; Grahame, Rodney			Easily Missed? Joint hypermobility syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CRITERIA; POPULATION; TESTS; AGE					rodney.grahame@uclh.nhs.uk						Adib N, 2005, RHEUMATOLOGY, V44, P744, DOI 10.1093/rheumatology/keh557; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bravo JF, 2006, ARTHRITIS RHEUM, V54, P515, DOI 10.1002/art.21557; BRIDGES AJ, 1992, ANN RHEUM DIS, V51, P793, DOI 10.1136/ard.51.6.793; Coady D, 2004, RHEUMATOLOGY, V43, P633, DOI 10.1093/rheumatology/keh138; Daniel HC, 2010, HYPERMOBILITY FIBROM; DAVIDOVITCH M, 1994, J CHILD NEUROL, V9, P417, DOI 10.1177/088307389400900417; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; DIAZ MA, 1993, BRIT J RHEUMATOL, V32, P120; Ferrell WR, 2004, ARTHRITIS RHEUM-US, V50, P3323, DOI 10.1002/art.20582; Grahame R, 2006, ANN RHEUM DIS, V65, P263; Grahame R, 2000, J RHEUMATOL, V27, P1777; Grahame R, 2001, RHEUMATOLOGY, V40, P559, DOI 10.1093/rheumatology/40.5.559; Grahame R., 2010, HYPERMOBILITY FIBROM; Grahame R, 2009, CURR PAIN HEADACHE R, V13, P427, DOI 10.1007/s11916-009-0070-5; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Hudson N, 1995, BRIT J RHEUMATOL, V34, P1157; Juul-Kristensen B, 2007, RHEUMATOLOGY, V46, P1835, DOI 10.1093/rheumatology/kem290; Maillard S, 2010, HYPERMOBILITY FIBROM; McCulloch R, 2010, HYPERMOBILITY FIBROM; NORTON PA, 1995, OBSTET GYNECOL, V85, P225, DOI 10.1016/0029-7844(94)00386-R; Remvig L, 2007, J RHEUMATOL, V34, P804; Remvig L, 2007, J RHEUMATOL, V34, P798; RUNOW A, 1983, ACTA ORTHOP SCAND, V54, P1, DOI 10.3109/17453678309154170; Slmmonds JV, 2007, MANUAL THER, V12, P298, DOI 10.1016/j.math.2007.05.001; Tinkle BT, 2009, AM J MED GENET A, V149A, P2368, DOI 10.1002/ajmg.a.33070; WYNNEDAVIES R, 1971, P ROY SOC MED, V64, P689, DOI 10.1177/003591577106400649; Zarate N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01421.x	29	54	56	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2011	342								c7167	10.1136/bmj.c7167	http://dx.doi.org/10.1136/bmj.c7167			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PE	21252103				2022-12-24	WOS:000286603100008
J	Kurth, T; Mohamed, S; Maillard, P; Zhu, YC; Chabriat, H; Mazoyer, B; Bousser, MG; Dufouil, C; Tzourio, C				Kurth, Tobias; Mohamed, Shajahal; Maillard, Pauline; Zhu, Yi-Cheng; Chabriat, Hugues; Mazoyer, Bernard; Bousser, Marie-Germaine; Dufouil, Carole; Tzourio, Christophe			Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER HYPERINTENSITIES; CARDIOVASCULAR-DISEASE; RISK; PREVALENCE; STROKE; ABNORMALITIES; ASSOCIATION; DISABILITY; DECLINE; VOLUME	Objective To evaluate the association of overall and specific headaches with volume of white matter hyperintensities, brain infarcts, and cognition. Design Population based, cross sectional study. Setting Epidemiology of Vascular Ageing study, Nantes, France. Participants 780 participants (mean age 69, 58.5% women) with detailed headache assessment. Main outcome measures Brain scans were evaluated for volume of white matter hyperintensities (by fully automated imaging processing) and for classification of infarcts (by visual reading with a standardised assessment grid). Cognitive function was assessed by a battery of tests including the mini-mental state examination. Results 163 (20.9%) participants reported a history of severe headache and 116 had migraine, of whom 17 (14.7%) reported aura symptoms. An association was found between any history of severe headache and increasing volume of white matter hyperintensities. The adjusted odds ratio of being in the highest third for total volume of white matter hyperintensities was 2.0 (95% confidence interval 1.3 to 3.1, P for trend 0.002) for participants with any history of severe headache when compared with participants without severe headache being in the lowest third. The association pattern was similar for all headache types. Migraine with aura was the only headache type strongly associated with volume of deep white matter hyperintensities (highest third odds ratio 12.4, 1.6 to 99.4, P for trend 0.005) and with brain infarcts (3.4, 1.2 to 9.3). The location of infarcts was predominantly outside the cerebellum and brain stem. Evidence was lacking for cognitive impairment for any headache type with or without brain lesions. Conclusions In this population based study, any history of severe headache was associated with an increased volume of white matter hyperintensities. Migraine with aura was the only headache type associated with brain infarcts. Evidence that headache of any type by itself or in combination with brain lesions was associated with cognitive impairment was lacking.	[Kurth, Tobias; Mohamed, Shajahal; Zhu, Yi-Cheng; Dufouil, Carole; Tzourio, Christophe] Hop La Pitie Salpetriere, INSERM, Unit Neuroepidemiol 708, F-75651 Paris 13, France; [Kurth, Tobias; Zhu, Yi-Cheng; Dufouil, Carole; Tzourio, Christophe] Univ Paris 06, UMR S708, Paris, France; [Kurth, Tobias] Harvard Univ, Med Sch, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02215 USA; [Maillard, Pauline; Mazoyer, Bernard] CEA, CNRS, UMR 6194, Grp Imagerie Neurofonct, Caen, France; [Zhu, Yi-Cheng; Chabriat, Hugues; Bousser, Marie-Germaine; Tzourio, Christophe] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neurol, Paris, France; [Zhu, Yi-Cheng] Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Chabriat, Hugues; Bousser, Marie-Germaine] Univ Paris Denis Diderot, Paris, France; [Mazoyer, Bernard] Univ Caen Basse Normande, Caen, France; [Mazoyer, Bernard] Ctr Hosp & Univ Caen, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; CEA; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut Universitaire de France	Kurth, T (corresponding author), Hop La Pitie Salpetriere, INSERM, Unit Neuroepidemiol 708, 47 Blvd Hop, F-75651 Paris 13, France.	tobias.kurth@upmc.fr	Dufouil, Carole/J-4968-2012; Mazoyer, Bernard M/B-6303-2012; Zhu, Yi-Cheng/L-3890-2013; Maillard, Pauline/N-7600-2018; Dufouil, Carole/F-5751-2014; Tzourio, christophe/B-4015-2009; Kurth, Tobias/A-9243-2012; Tzourio, christophe/L-6344-2019; mazoyer, bernard m/A-5369-2009; Chabriat, Hugues/G-5699-2010	Mazoyer, Bernard M/0000-0003-0970-2837; Maillard, Pauline/0000-0003-3516-6345; Dufouil, Carole/0000-0003-2442-4476; Tzourio, christophe/0000-0002-6517-2984; Kurth, Tobias/0000-0001-7169-2620; Tzourio, christophe/0000-0002-6517-2984; mazoyer, bernard m/0000-0003-0970-2837; Chabriat, Hugues/0000-0001-8436-6074; Dichgans, Martin/0000-0002-0654-387X	French National Research Agency (ANR, Agence Nationale de la Recherche)	French National Research Agency (ANR, Agence Nationale de la Recherche)(French National Research Agency (ANR))	The Epidemiology of Vascular Ageing study was carried out under an agreement between INSERM (Institut National de la Sante et de la Recherche Medicale); Merck, Sharp, and Dohme-Chibret Laboratories (West Point, PA); and EISAI (Paris, France). This study was supported by a chair of excellence grant of the French National Research Agency (ANR, Agence Nationale de la Recherche) to TK. The sponsors were not involved in the design, data collection, analysis, or interpretation of the study nor were they involved in writing the manuscript.	Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cooney BS, 1996, HEADACHE, V36, P616, DOI 10.1046/j.1526-4610.1996.3610616.x; DEBENEDITTIS G, 1995, HEADACHE, V35, P264; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; FAZEKAS F, 1992, HEADACHE, V32, P287, DOI 10.1111/j.1526-4610.1992.hed3206287.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gruber HJ, 2010, EUR J NEUROL, V17, P419, DOI 10.1111/j.1468-1331.2009.02861.x; Gudmundsson Larus S, 2010, BMJ, V341, pc3966, DOI 10.1136/bmj.c3966; IGARASHI H, 1991, CEPHALALGIA, V11, P69, DOI 10.1046/j.1468-2982.1991.1102069.x; Intiso D, 2006, EUR J NEUROL, V13, P1364, DOI 10.1111/j.1468-1331.2006.01519.x; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jongen C, 2007, DIABETOLOGIA, V50, P1509, DOI 10.1007/s00125-007-0688-y; Kruit MC, 2006, STROKE, V37, P1109, DOI 10.1161/01.STR.0000206446.26702.e9; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3659; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; Martins KM, 2006, HEADACHE, V46, P312, DOI 10.1111/j.1526-4610.2006.00343.x; Napoli R, 2009, NEUROLOGY, V72, P2111, DOI 10.1212/WNL.0b013e3181aa53ce; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; Olesen J, 2004, J NEUROL NEUROSUR PS, V75, P808, DOI 10.1136/jnnp.2003.031286; Paemeleire K, 2009, J NEUROL SCI, V283, P134, DOI 10.1016/j.jns.2009.02.333; Rocca MA, 2000, NEUROLOGY, V54, P507, DOI 10.1212/WNL.54.2.507; Rozen TD, 1999, NEUROLOGY, V53, P1468, DOI 10.1212/WNL.53.7.1468; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schurks M, 2008, NEUROLOGY, V71, P505, DOI 10.1212/01.wnl.0000316198.34558.e5; Schwedt TJ, 2008, CEPHALALGIA, V28, P531, DOI 10.1111/j.1468-2982.2008.01554.x; SIBERT LC, 2008, NEUROLOGY, V71, P108; Soumare A, 2009, ANN NEUROL, V65, P706, DOI 10.1002/ana.21674; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Swartz RH, 2004, ARCH NEUROL-CHICAGO, V61, P1366, DOI 10.1001/archneur.61.9.1366; Tietjen GE, 2007, NEUROLOGY, V68, P134, DOI 10.1212/01.wnl.0000251195.55563.02; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Tzourio C, 2003, J NEUROL NEUROSUR PS, V74, P238, DOI 10.1136/jnnp.74.2.238; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	51	155	160	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2011	342								c7357	10.1136/bmj.c7357	http://dx.doi.org/10.1136/bmj.c7357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OH	21245119	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000286600800023
J	Bissiere, S; Zelikowsky, M; Ponnusamy, R; Jacobs, NS; Blair, HT; Fanselow, MS				Bissiere, Stephanie; Zelikowsky, Moriel; Ponnusamy, Ravikumar; Jacobs, Nathan S.; Blair, Hugh T.; Fanselow, Michael S.			Electrical Synapses Control Hippocampal Contributions to Fear Learning and Memory	SCIENCE			English	Article							BASOLATERAL AMYGDALA; MAMMALIAN BRAIN; THETA-RHYTHM; OSCILLATIONS; CONNEXIN36; SYNCHRONIZATION; INTERNEURONS; IMPAIRMENT; MODULATION; PLASTICITY	The role of electrical synapses in synchronizing neuronal assemblies in the adult mammalian brain is well documented. However, their role in learning and memory processes remains unclear. By combining Pavlovian fear conditioning, activity-dependent immediate early gene expression, and in vivo electrophysiology, we discovered that blocking neuronal gap junctions within the dorsal hippocampus impaired context-dependent fear learning, memory, and extinction. Theta rhythms in freely moving rats were also disrupted. Our results show that gap junction-mediated neuronal transmission is a prominent feature underlying emotional memories.	[Bissiere, Stephanie; Zelikowsky, Moriel; Ponnusamy, Ravikumar; Jacobs, Nathan S.; Blair, Hugh T.; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Fanselow, MS (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	fanselow@psych.ucla.edu	Zelikowsky, Moriel/GQI-0022-2022	Blair, Hugh/0000-0001-8256-5109; Jacobs, Nathan S/0000-0003-2175-6627; Zelikowsky, Moriel/0000-0002-0465-9027	NIMH [RO1-MH62122, P01NS35985, RO1-MH079511]; Swiss National Fund [PA00A-115367]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079511, R01MH062122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035985] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swiss National Fund(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIMH grant RO1-MH62122 and P01NS35985 (M.S.F.), Swiss National Fund grant PA00A-115367 (S.B.), and NIMH grant RO1-MH079511 (H.T.B.).	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Buhl DL, 2003, J NEUROSCI, V23, P1013; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2001, NEURON, V31, P342, DOI 10.1016/S0896-6273(01)00378-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Placantonakis DG, 2006, J NEUROSCI, V26, P5008, DOI 10.1523/JNEUROSCI.0146-06.2006; Quinn JJ, 2008, HIPPOCAMPUS, V18, P640, DOI 10.1002/hipo.20424; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sheth A, 2008, HIPPOCAMPUS, V18, P169, DOI 10.1002/hipo.20380; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	26	92	95	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					87	91		10.1126/science.1193785	http://dx.doi.org/10.1126/science.1193785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212357	Green Accepted			2022-12-24	WOS:000285974000042
J	Scheel, PJ; Feeley, N; Sozio, SM				Scheel, Paul J., Jr.; Feeley, Nancy; Sozio, Stephen M.			Combined Prednisone and Mycophenolate Mofetil Treatment for Retroperitoneal Fibrosis A Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							THERAPY	Background: Small case series suggest that a combination of mycophenolate mofetil and prednisone may be an effective treatment for patients with retroperitoneal fibrosis. Objective: To describe the outcomes of adults with retroperitoneal fibrosis who received a combination of prednisone and mycophenolate mofetil. Design: Prospective case series of patients followed between 1 April 2005 and 1 July 2009. Setting: Single tertiary care facility. Patients: 28 patients with retroperitoneal fibrosis. Intervention: Prednisone, 40 mg/d, tapered over 6 months, and mycophenolate mofetil, 1000 mg twice daily, for a mean of 24.3 months. Measurements: Clinical course, laboratory assessment, and measurement of periaortic mass. Mean follow-up was 1012 days, and no patients were lost to follow-up. Results: Systemic symptoms resolved in all patients; 89% had a 25% or greater reduction in periaortic mass. Elevated erythrocyte sedimentation rate and serum creatinine level and decreased hemoglobin level normalized in all patients. Disease recurred in 2 of 28 patients. Limitation: This was a small case series. Conclusion: Combined prednisone and mycophenolate mofetil therapy is a potentially effective treatment for retroperitoneal fibrosis that warrants evaluation in randomized trials.	[Scheel, Paul J., Jr.] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University	Scheel, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, 1830 E Monument St,Room 416, Baltimore, MD 21205 USA.	PScheel1@jhmi.edu	Sozio, Stephen M./H-1214-2018	Sozio, Stephen M./0000-0002-0099-0484				Adler S, 2008, RHEUMATOLOGY, V47, P1535, DOI 10.1093/rheumatology/ken291; Goncalves RG, 2004, AM J NEPHROL, V24, P527, DOI 10.1159/000081706; Jois RN, 2007, RHEUMATOLOGY, V46, P717, DOI 10.1093/rheumatology/kel417; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Khalil F, 2008, CLIN RHEUMATOL, V27, P679, DOI 10.1007/s10067-007-0826-4; Kramer S, 2005, AM J PHYSIOL-RENAL, V289, pF359, DOI 10.1152/ajprenal.00442.2004; Marcolongo R, 2004, AM J MED, V116, P194, DOI 10.1016/j.amjmed.2003.08.033; Marzano A, 2001, ANN RHEUM DIS, V60, P427, DOI 10.1136/ard.60.4.427; MCDOUGAL WS, 1991, J UROLOGY, V145, P112, DOI 10.1016/S0022-5347(17)38263-0; Moder KG, 2003, ANN ALLERG ASTHMA IM, V90, P15, DOI 10.1016/S1081-1206(10)63607-1; Morath C, 2006, CLIN TRANSPLANT, V20, P25, DOI 10.1111/j.1399-0012.2006.00597.x; Obrencevic Katarina, 2007, Vojnosanit Pregl, V64, P385, DOI 10.2298/VSP0706385O; Pescovitz MD, 2003, AM J TRANSPLANT, V3, P1581, DOI 10.1046/j.1600-6135.2003.00243.x; Plastiras SC, 2006, RHEUMATOLOGY, V45, P1572, DOI 10.1093/rheumatology/kel335; SCAVALLI AS, 1995, CLIN RHEUMATOL, V14, P481, DOI 10.1007/BF02207688; Scheel PJ, 2007, J UROLOGY, V178, P140, DOI 10.1016/j.juro.2007.03.057; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Swartz RD, 2008, CLIN NEPHROL, V69, P260; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; van Bommel EFH, 2006, ANN INTERN MED, V144, P101, DOI 10.7326/0003-4819-144-2-200601170-00007; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Warnatz K, 2005, ANN RHEUM DIS, V64, P828, DOI 10.1136/ard.2004.029793; Wu Jamie, 2002, Cancer Control, V9, P432	23	67	68	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					31	U163		10.7326/0003-4819-154-1-201101040-00005	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200036				2022-12-24	WOS:000285830900004
J	Bennett, KL; Mester, J; Eng, C				Bennett, Kristi L.; Mester, Jessica; Eng, Charis			Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HAMARTOMA-TUMOR-SYNDROME; PTEN; MUTATIONS; CANCER; DISEASE; INACTIVATION; BREAST; GENES; DNA	Context Germline loss-of-function phosphatase and tensin homolog gene (PTEN) mutations cause 80% of Cowden syndrome, a rare autosomal-dominant disorder (1 in 200 000 live births), characterized by high risks of breast, thyroid, and other cancers. A large heterogeneous group of individuals with Cowden-like syndrome, who have various combinations of Cowden syndrome features but who do not meet Cowden syndrome diagnostic criteria, have PTEN mutations less than 10% of the time, making molecular diagnosis, prediction, genetic counseling, and risk management challenging. Other mechanisms of loss of function such as hypermethylation, which should result in underexpression of PTEN or of KILLIN, a novel tumor suppressor transcribed in the opposite direction, may account for the remainder of Cowden syndrome and Cowden-like syndrome. Objective To determine whether germline methylation is found in Cowden syndrome or Cowden-like syndrome in individuals lacking germline PTEN mutations. Design, Setting, and Participants Nucleic acids from prospective nested series of 123 patients with Cowden syndrome or Cowden-like syndrome and 50 unaffected individuals without PTEN variants were analyzed for germline methylation and expression of PTEN and KILLIN at the Cleveland Clinic, August 2008-June 2010. Prevalence of component cancers between groups was compared using the Fisher exact test. Main Outcome Measures Frequency of germline methylation in PTEN mutation-negative Cowden syndrome and Cowden syndrome-like individuals. Prevalence of component cancers in methylation-positive and PTEN mutation-positive individuals. Results Of 123 patients with Cowden syndrome or Cowden-like syndrome, 45 (37%; 95% confidence interval [CI], 29%-45%) showed hypermethylation upstream of PTEN but no transcriptional repression. The germline methylation was found to transcriptionally down-regulate KILLIN by 250-fold (95% CI, 45-14 286; P=.007) and exclusively disrupted TP53 activation of KILLIN by 30% (95% CI, 7%-45%; P=.008). Demethylation treatment increased only KILLIN expression 4.88-fold (95% CI, 1.4-18.1; P=.05). Individuals with KILLIN-promoter methylation had a 3-fold increased prevalence of breast cancer (35/42 vs 24/64; P<.0001) and a greater than 2-fold increase of kidney cancer (4/45 vs 6/155; P=.004) over individuals with germline PTEN mutations. Conclusions Germline KILLIN methylation is common among patients with Cowden syndrome or Cowden-like syndrome and is associated with increased risks of breast and renal cancer over PTEN mutation-positive individuals. These observations need to be replicated. JAMA. 2010;304(24):2724-2732 www.jama.com	[Bennett, Kristi L.; Mester, Jessica; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Taussig Canc Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Nursing Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145	Breast Cancer Research Foundation; William Randolph Hearst Foundations; National Cancer Institute [P01CA124570]; FM Kirby Foundation; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; William Randolph Hearst Foundations; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FM Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Eng reports receipt of funding for this study, in part, by the Breast Cancer Research Foundation, the William Randolph Hearst Foundations, and the National Cancer Institute (P01CA124570). Dr Eng is the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic, was a Doris Duke Distinguished Clinical Scientist, and is an American Cancer Society Clinical Research Professor, which is funded, in part, by the FM Kirby Foundation.	Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; STARINK TM, 1986, CLIN GENET, V29, P222; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Zhou XP, 2003, AM J HUM GENET, V73, P1191, DOI 10.1086/379382	23	106	110	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2724	2731		10.1001/jama.2010.1877	http://dx.doi.org/10.1001/jama.2010.1877			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177507	Green Accepted, Bronze			2022-12-24	WOS:000285518000017
J	White, NJ				White, Nicholas J.			Artemisinin resistance-the clock is ticking	LANCET			English	Editorial Material							MALARIA; AFRICA		Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	Mahidol University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Wellcome Trust [093956] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2010, SCIENCE, V328, P846, DOI 10.1126/science.328.5980.846; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, ART RES CONT PROJ	9	77	81	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2051	2052		10.1016/S0140-6736(10)61963-0	http://dx.doi.org/10.1016/S0140-6736(10)61963-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21168039				2022-12-24	WOS:000285895000008
J	Yao, L; Schiavi, F; Cascon, A; Qin, YJ; Inglada-Perez, L; King, EE; Toledo, RA; Ercolino, T; Rapizzi, E; Ricketts, CJ; Mori, L; Giacche, M; Mendola, A; Taschin, E; Boaretto, F; Loli, P; Iacobone, M; Rossi, GP; Biondi, B; Lima, JV; Kater, CE; Bex, M; Vikkula, M; Grossman, AB; Gruber, SB; Barontini, M; Persu, A; Castellano, M; Toledo, SPA; Maher, ER; Mannelli, M; Opocher, G; Robledo, M; Dahia, PLM				Yao, Li; Schiavi, Francesca; Cascon, Alberto; Qin, Yuejuan; Inglada-Perez, Lucia; King, Elizabeth E.; Toledo, Rodrigo A.; Ercolino, Tonino; Rapizzi, Elena; Ricketts, Christopher J.; Mori, Luigi; Giacche, Mara; Mendola, Antonella; Taschin, Elisa; Boaretto, Francesca; Loli, Paola; Iacobone, Maurizio; Rossi, Gian-Paolo; Biondi, Bernadette; Lima-Junior, Jose Viana; Kater, Claudio E.; Bex, Marie; Vikkula, Miikka; Grossman, Ashley B.; Gruber, Stephen B.; Barontini, Marta; Persu, Alexandre; Castellano, Maurizio; Toledo, Sergio P. A.; Maher, Eamonn R.; Mannelli, Massimo; Opocher, Giuseppe; Robledo, Mercedes; Dahia, Patricia L. M.			Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-SUPPRESSOR; SUSCEPTIBILITY; 1P36	Context Pheochromocytomas and paragangliomas are genetically heterogeneous neural crest-derived neoplasms. We recently identified germline mutations of the novel transmembrane-encoding gene FP/TMEM127 in familial and sporadic pheochromocytomas consistent with a tumor suppressor effect. Objectives To examine the prevalence and spectrum of FP/TMEM127 mutations in pheochromocytomas and paragangliomas and to test the effect of mutations in vitro. Design, Setting, and Participants We sequenced the FP/TMEM127 gene in 990 individuals with pheochromocytomas and/or paragangliomas, including 898 previously unreported cases without mutations in other susceptibility genes from 8 independent worldwide referral centers between January 2009 and June 2010. A multiplex polymerase chain reaction-based method was developed to screen for large gene deletions in 545 of these samples. Confocal microscopy of 5 transfected mutant proteins was used to determine their subcellular localization. Main Outcome Measures The frequency and type of FP/TMEM127 mutation or deletion was assessed and correlated with clinical variables; the subcellular localization of 5 overexpressed mutants was compared with wild-type FP/TMEM127 protein. Results We identified 19 potentially pathogenic FP/TMEM127 germline mutations in 20 independent families, but no large deletions were detected. All mutation carriers had adrenal tumors, including 7 bilateral (P=2.7 x 10(-4)) and/or with familial disease (5 of 20 samples; P=.005). The median age at disease onset in the FP/TMEM127 mutation group was similar to that of patients without a mutation (41.5 vs 45 years, respectively; P=.54). The most common presentation was that of a single benign adrenal tumor in patients older than 40 years. Malignancy was seen in 1 mutation carrier (5%). Expression of 5 novel FP/TMEM127 mutations in cell lines revealed diffuse localization of the mutant proteins in contrast with the discrete multiorganelle distribution of wild-type TMEM127. Conclusions Germline mutations of FP/TMEM127 were associated with pheochromocytoma but not paraganglioma and occured in an age group frequently excluded from genetic screening algorithms. Disease-associated mutations disrupt intracellular distribution of the FP/TMEM127 protein. JAMA. 2010;304(23):2611-2619 www.jama.com	[Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Yao, Li; Qin, Yuejuan; King, Elizabeth E.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [King, Elizabeth E.] Univ Texas Hlth Sci Ctr San Antonio, Div Endocrinol, San Antonio, TX 78229 USA; [Yao, Li; Qin, Yuejuan; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Schiavi, Francesca; Taschin, Elisa; Boaretto, Francesca; Opocher, Giuseppe] Univ Padua, Veneto Inst Oncol, Familial Canc Clin, Padua, Italy; [Iacobone, Maurizio] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Rossi, Gian-Paolo] Univ Padua, Dept Internal Med 4, Padua, Italy; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Cascon, Alberto; Inglada-Perez, Lucia; Robledo, Mercedes] Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid, Spain; [Cascon, Alberto; Inglada-Perez, Lucia; Robledo, Mercedes] Inst Salud Carlos III, Ctr Biomed Res Rare Dis, Madrid, Spain; [Toledo, Rodrigo A.; Toledo, Sergio P. A.] Univ Sao Paulo, Sch Med, Dept Med, Div Endocrinol,Endocrine Genet Unit LIM 25, Sao Paulo, Brazil; [Lima-Junior, Jose Viana; Kater, Claudio E.] Univ Fed Sao Paulo, Dept Med, Div Endocrinol, Sao Paulo, Brazil; [Ercolino, Tonino; Rapizzi, Elena; Mannelli, Massimo] Univ Florence, Dept Clin Pathophysiol, Florence, Italy; [Mannelli, Massimo] Ist Toscano Tumori, Florence, Italy; [Ricketts, Christopher J.; Maher, Eamonn R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Ricketts, Christopher J.; Maher, Eamonn R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Birmingham, W Midlands, England; [Mori, Luigi; Giacche, Mara; Castellano, Maurizio] Univ Brescia, Endocrine & Metab Unit, Med Clin, Brescia, Italy; [Mendola, Antonella; Vikkula, Miikka] Catholic Univ Louvain, Clin Univ St Luc, Lab Human Mol Genet, de Duve Inst, B-1200 Brussels, Belgium; [Persu, Alexandre] Catholic Univ Louvain, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium; [Loli, Paola] Osped Niguarda Ca Granda, Dept Endocrinol, Milan, Italy; [Biondi, Bernadette] Univ Naples Federico II, Dept Clin & Mol Endocrinol & Oncol, Naples, Italy; [Bex, Marie] Katholieke Univ Leuven Hosp, Dept Endocrinol, Leuven, Belgium; [Grossman, Ashley B.] St Bartholomews Hosp, Barts & London Sch Med, Ctr Endocrinol, London, England; [Gruber, Stephen B.] Univ Michigan, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Barontini, Marta] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol, Buenos Aires, DF, Argentina	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; University of Padua; University of Padua; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Birmingham; University of Birmingham; University of Brescia; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Naples Federico II; KU Leuven; University Hospital Leuven; University of London; Queen Mary University London; University of Michigan System; University of Michigan; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Dahia, PLM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	dahia@uthscsa.edu	Robledo, Mercedes/O-2230-2013; Opocher, Giuseppe/F-3950-2014; Vikkula, Miikka/Q-1038-2018; Inglada-Perez, Lucia/Z-3020-2019; MAHER, EAMONN R/A-9507-2008; Toledo, Rodrigo/GQQ-1711-2022; Ricketts, Christopher/AAV-9580-2020; Biondi, Bernadette/AAH-7664-2020; Schiavi, Francesca/AAB-9908-2022; Castellano, Maurizio/C-1096-2011; Toledo, Rodrigo/N-4078-2013; Toledo, Rodrigo/ABH-5248-2020; boaretto, francesca/K-9811-2016; Qin, Yuejuan/F-6801-2010; Cascon, Alberto/G-3160-2014; Iacobone, Maurizio/K-8714-2016; inglada-perez, lucia/H-5378-2015; Toledo, Sergio P. A./S-9291-2018; taschin, elisa/K-3847-2016	Robledo, Mercedes/0000-0001-6256-5902; Opocher, Giuseppe/0000-0002-9845-9623; Vikkula, Miikka/0000-0002-6236-338X; MAHER, EAMONN R/0000-0002-6226-6918; Schiavi, Francesca/0000-0001-8529-4455; Castellano, Maurizio/0000-0002-4569-2659; Toledo, Rodrigo/0000-0003-3070-6795; Toledo, Rodrigo/0000-0003-3070-6795; boaretto, francesca/0000-0003-2015-929X; Cascon, Alberto/0000-0003-2119-891X; Toledo, Sergio P. A./0000-0002-2590-3519; taschin, elisa/0000-0001-9426-4071; ROSSI, GIAN PAOLO/0000-0002-7963-0931; Iacobone, Maurizio/0000-0002-6057-4642; Mannelli, Massimo/0000-0002-8001-9857; INGLADA, LUCIA/0000-0001-9523-2717; Inglada-Perez, Lucia/0000-0001-9814-4368; Persu, Alexandre/0000-0002-4007-9695; Biondi, Bernadette/0000-0001-8360-4464	University of Texas Health Science Center at San Antonio (UTHSCSA); National Cancer Institute (NCI) [P30 CA54174]; National Institute on Aging (NIA) [P30 AG013319, P01AG19316]; Department of Microbiology, UTHSCSA; Fundacao Faculdade de Medicina; Division of Endocrinology; Sao Paulo State Research Foundation (FAPESP) [2009/15386-6]; Cancer Research UK; Belgian Federal Science Policy, network [6/05]; Belgian French Community Ministry [07/12-005]; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale; FRS-FNRS (Fonds de la Recherche Scientifique), Belgium; NCI [5 P30 CA465920]; Italian University and Research Ministry [2006060473]; Fondazione della Comunita Bresciana; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fondo de Investigaciones Sanitarias [PI 08/080883]; Fundacion Mutua Madrilena [AP2775/2008]; Voelcker Fund; Alex's Lemonade Stand Foundation; Concern Foundation; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio (UTHSCSA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Microbiology, UTHSCSA; Fundacao Faculdade de Medicina; Division of Endocrinology; Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cancer Research UK(Cancer Research UK); Belgian Federal Science Policy, network(Belgian Federal Science Policy Office); Belgian French Community Ministry; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale; FRS-FNRS (Fonds de la Recherche Scientifique), Belgium(Fonds de la Recherche Scientifique - FNRS); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian University and Research Ministry(Ministry of Education, Universities and Research (MIUR)); Fondazione della Comunita Bresciana; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Voelcker Fund; Alex's Lemonade Stand Foundation; Concern Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cancer Therapy and Research Center Pathology Core and the Optical Imaging Core are supported by University of Texas Health Science Center at San Antonio (UTHSCSA) and National Cancer Institute (NCI) grant P30 CA54174 (Cancer Therapy and Research Center at UTHSCSA). The Optical Imaging Core is also supported by National Institute on Aging (NIA) grant P30 AG013319 (Nathan Shock Center) and NIA grant P01AG19316. The Nucleic Acids Core Facility receives the support of the Department of Microbiology, UTHSCSA. Funds from the Fundacao Faculdade de Medicina and the Division of Endocrinology provided support for the screening of the Brazilian cohort. Dr R. A. Toledo is supported by a Sao Paulo State Research Foundation (FAPESP grant 2009/15386-6) postdoctoral fellowship. Drs Ricketts and Maher are supported by Cancer Research UK. Dr Vikkula is supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05; Concerted Research Actions Convention No. 07/12-005 of the Belgian French Community Ministry; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale. Drs Vikkula and Persu are supported by the FRS-FNRS (Fonds de la Recherche Scientifique), Belgium. Dr Gruber is supported by NCI grant 5 P30 CA465920. Dr Castellano is supported by funds from the Italian University and Research Ministry (grant 2006060473) and by the Fondazione della Comunita Bresciana. Dr S. P. A. Toledo is supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant. Dr Robledo is supported by Fondo de Investigaciones Sanitarias grant PI 08/080883 and Fundacion Mutua Madrilena (reference AP2775/2008). Dr Dahia is supported by the Voelcker Fund, Alex's Lemonade Stand Foundation, Concern Foundation, and Clinical Translational and Science Awards (National Institutes of Health).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Cascon A, 2008, J MED GENET, V45, P233, DOI 10.1136/jmg.2007.054965; Cascon A, 2009, HORM METAB RES, V41, P672, DOI 10.1055/s-0029-1202814; Cascon A, 2009, J CLIN ENDOCR METAB, V94, P1701, DOI 10.1210/jc.2008-2756; Dahia PLM, 2005, CANCER RES, V65, P9651, DOI 10.1158/0008-5472.CAN-05-1427; Gimenez-Roqueplo AP, 2006, CLIN ENDOCRINOL, V65, P699, DOI 10.1111/j.1365-2265.2006.02714.x; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Manger WM, 2006, ANN NY ACAD SCI, V1073, P1, DOI 10.1196/annals.1353.001; Mannelli M, 2009, J CLIN ENDOCR METAB, V94, P1541, DOI 10.1210/jc.2008-2419; NEUMANN H, 2009, J CLIN ENDOCR METAB, V94, pA19; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Opocher G, 2003, HORM RES, V59, P56, DOI 10.1159/000067846; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Ya G, 2009, BIOL PHARM BULL, V32, P882, DOI 10.1248/bpb.32.882; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1	22	132	143	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2611	2619		10.1001/jama.2010.1830	http://dx.doi.org/10.1001/jama.2010.1830			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156949	Bronze			2022-12-24	WOS:000285303400024
J	Itzhaki, I; Maizels, L; Huber, I; Zwi-Dantsis, L; Caspi, O; Winterstern, A; Feldman, O; Gepstein, A; Arbel, G; Hammerman, H; Boulos, M; Gepstein, L				Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Hammerman, Haim; Boulos, Monther; Gepstein, Lior			Modelling the long QT syndrome with induced pluripotent stem cells	NATURE			English	Article							CARDIOMYOCYTES; INDUCTION; RANOLAZINE; MECHANISM; MYOCYTES; BLOCK	The ability to generate patient-specific human induced pluripotent stem cells (iPSCs)(1-3) offers a new paradigm for modelling human disease and for individualizing drug testing(4). Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death(5-7). Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I-Kr. Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K-ATP-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.	[Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, IL-31096 Haifa, Israel; [Hammerman, Haim; Boulos, Monther; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Gepstein, L (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, POB9649, IL-31096 Haifa, Israel.	mdlior@techunix.technion.ac.il	Gepstein, Lior/H-9458-2012	Maizels, Leonid/0000-0001-6993-2808	Israel Science Foundation; Legacy Heritage Foundation [1225/09]; Yad Hanadiv Foundation; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Foundation; Yad Hanadiv Foundation; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	This study was supported in part by the Israel Science Foundation and Legacy Heritage Foundation (no. 1225/09), by the Yad Hanadiv Foundation Bruno Award, by the Lorry Lokey research fund, and by the Nancy and Stephen Grand Philanthropic Fund. We thank E. Suss-Toby and O. Shenker (from the multidisciplinary laboratory unit) and M. Tzukerman for their valuable help, A. Zamir for writing the MEA analysis software and I. Laevsky and T. Falik-Zaccai for the karyotype analysis.	Antoons G, 2010, J AM COLL CARDIOL, V55, P801, DOI 10.1016/j.jacc.2009.10.033; Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Arbel G, 2010, METHODS MOL BIOL, V660, P85, DOI 10.1007/978-1-60761-705-1_6; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel C, 2008, PHARMACOL THERAPEUT, V118, P138, DOI 10.1016/j.pharmthera.2008.02.001; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tenenbaum M, 2008, ISR MED ASSOC J, V10, P809; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	28	727	750	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					225	U113		10.1038/nature09747	http://dx.doi.org/10.1038/nature09747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21240260				2022-12-24	WOS:000288170200039
J	den Camp, RO; Streng, A; De Mita, S; Cao, QQ; Polone, E; Liu, W; Ammiraju, JSS; Kudrna, D; Wing, R; Untergasser, A; Bisseling, T; Geurts, R				den Camp, Rik Op; Streng, Arend; De Mita, Stephane; Cao, Qingqin; Polone, Elisa; Liu, Wei; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod; Untergasser, Andreas; Bisseling, Ton; Geurts, Rene			LysM-Type Mycorrhizal Receptor Recruited for Rhizobium Symbiosis in Nonlegume Parasponia	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; NODULATION; EVOLUTION; LEGUME; BACTERIA; KINASES; CELLS	Rhizobium-root nodule symbiosis is generally considered to be unique for legumes. However, there is one exception, and that is Parasponia. In this nonlegume, the rhizobial nodule symbiosis evolved independently and is, as in legumes, induced by rhizobium Nod factors. We used Parasponia andersonii to identify genetic constraints underlying evolution of Nod factor signaling. Part of the signaling cascade, downstream of Nod factor perception, has been recruited from the more-ancient arbuscular endomycorrhizal symbiosis. However, legume Nod factor receptors that activate this common signaling pathway are not essential for arbuscular endomycorrhizae. Here, we show that in Parasponia a single Nod factor-like receptor is indispensable for both symbiotic interactions. Therefore, we conclude that the Nod factor perception mechanism also is recruited from the widespread endomycorrhizal symbiosis.	[den Camp, Rik Op; Streng, Arend; De Mita, Stephane; Cao, Qingqin; Polone, Elisa; Liu, Wei; Untergasser, Andreas; Bisseling, Ton; Geurts, Rene] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Polone, Elisa] Univ Padua, Dept Agr Biotechnol, I-35020 Padua, Italy; [Liu, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Ammiraju, Jetty S. S.; Wing, Rod] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Bisseling, Ton] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Wageningen University & Research; University of Padua; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Arizona; King Saud University	Bisseling, T (corresponding author), Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands.	ton.bisseling@wur.nl	Untergasser, Andreas/AAA-7452-2022; Wing, Rod A/Z-2885-2019; Op den Camp, Rik/F-4308-2011; cao, qingqin/W-5009-2019; Liu, Wei/J-6317-2013; Bisseling, Ton/A-2421-2013; poinssot, benoit/B-2569-2009	Wing, Rod A/0000-0001-6633-6226; Liu, Wei/0000-0003-4653-0448; poinssot, benoit/0000-0001-5890-4318	Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) [VIDI 864.06.007]	Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO))	We thank W. Broughton for NGR234; E. James, P. Hadobas, and T. J. Higgens for Parasponia seeds; P. van Dijk for flow cytometry; and J. Talag and W. Golser for BAC library construction. This research is funded by the Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) (VIDI 864.06.007).	AKKERMANS ADL, 1978, NATURE, V274, P190, DOI 10.1038/274190c0; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Pawlowski K, 1996, PLANT CELL, V8, P1899, DOI 10.1105/tpc.8.10.1899; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Sytsma KJ, 2002, AM J BOT, V89, P1531, DOI 10.3732/ajb.89.9.1531; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; WEBSTER G, 1995, J EXP BOT, V46, P1131, DOI 10.1093/jxb/46.9.1131; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zhu HY, 2006, GENETICS, V172, P2491, DOI 10.1534/genetics.105.051185	23	183	188	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					909	912		10.1126/science.1198181	http://dx.doi.org/10.1126/science.1198181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21205637				2022-12-24	WOS:000287455100057
J	Gibson, WT; Veldhuis, JH; Rubinstein, B; Cartwright, HN; Perrimon, N; Brodland, GW; Nagpal, R; Gibson, MC				Gibson, William T.; Veldhuis, James H.; Rubinstein, Boris; Cartwright, Heather N.; Perrimon, Norbert; Brodland, G. Wayne; Nagpal, Radhika; Gibson, Matthew C.			Control of the Mitotic Cleavage Plane by Local Epithelial Topology	CELL			English	Article							REGULATES SPINDLE ORIENTATION; ORIENTED CELL-DIVISION; MECHANICAL SIGNALS; 1ST CLEAVAGE; DROSOPHILA; SHAPE; POLARITY; NUCLEUS; MITOSIS; MICROTUBULES	For nearly 150 years, it has been recognized that cell shape strongly influences the orientation of the mitotic cleavage plane (e. g., Hofmeister, 1863). However, we still understand little about the complex interplay between cell shape and cleavage-plane orientation in epithelia, where polygonal cell geometries emerge from multiple factors, including cell packing, cell growth, and cell division itself. Here, using mechanical simulations, we show that the polygonal shapes of individual cells can systematically bias the long-axis orientations of their adjacent mitotic neighbors. Strikingly, analyses of both animal epithelia and plant epidermis confirm a robust and nearly identical correlation between local cell topology and cleavage-plane orientation in vivo. Using simple mathematics, we show that this effect derives from fundamental packing constraints. Our results suggest that local epithelial topology is a key determinant of cleavage-plane orientation, and that cleavage-plane bias may be a widespread property of polygonal cell sheets in plants and animals.	[Gibson, William T.; Rubinstein, Boris; Cartwright, Heather N.; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, William T.; Nagpal, Radhika] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gibson, William T.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Veldhuis, James H.; Brodland, G. Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Gibson, William T.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Gibson, Matthew C.] Kansas Univ Med Ctr, Dept Anat & Cell Biol, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; Harvard University; Harvard University; University of Waterloo; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Gibson, MC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	mg2@stowers.org		Gibson, Matthew/0000-0001-5588-8842; Cartwright, Heather/0000-0001-6639-5808; Perrimon, Norbert/0000-0001-7542-472X	Stowers Institute for Medical Research; Burroughs Wellcome Fund; National Science Foundation; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Institute; NIH/NIGMS [T32 GM008313, 1029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support for this research from the Stowers Institute for Medical Research and the Burroughs Wellcome Fund (to M. C. G.), from the National Science Foundation (to R.N.), from the Natural Sciences and Engineering Research Council of Canada (to G. W. B.), and from the Howard Hughes Medical Institute (to N.P.). W. T. G. was supported in part by NIH/NIGMS Molecular Biophysics Training Grant #T32 GM008313 and CTC grant 1029 to M.C.G.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; BLACK SD, 1988, DEV BIOL, V128, P65, DOI 10.1016/0012-1606(88)90267-9; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Buschmann H, 2006, CURR BIOL, V16, P1938, DOI 10.1016/j.cub.2006.08.028; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; COWAN R, 1988, J THEOR BIOL, V131, P33, DOI 10.1016/S0022-5193(88)80118-8; Dubertret B, 1998, PHYS REV E, V58, P6368, DOI 10.1103/PhysRevE.58.6368; Dubertret B, 1997, BIOPHYS J, V73, P38, DOI 10.1016/S0006-3495(97)78045-7; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; FLANDERS DJ, 1990, J CELL BIOL, V110, P1111, DOI 10.1083/jcb.110.4.1111; Gallagher K, 1999, DEVELOPMENT, V126, P4623; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; GOODBODY KC, 1991, DEVELOPMENT, V113, P931; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hofmeister W., 1863, JB WISSENSCHAFT BOT, V3, P259; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; KATSUTA J, 1990, J CELL SCI, V95, P413; KORN RW, 1973, NEW PHYTOL, V72, P1357, DOI 10.1111/j.1469-8137.1973.tb02114.x; Kost B, 2002, CELL, V108, P9, DOI 10.1016/S0092-8674(01)00634-1; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023; LINTILHAC PM, 1984, NATURE, V307, P363, DOI 10.1038/307363a0; LLOYD CW, 1991, DEVELOPMENT, P55; Lynch TM, 1997, DEV BIOL, V181, P246, DOI 10.1006/dbio.1996.8462; Miri MF, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031101; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; PALEVITZ BA, 1987, J CELL BIOL, V104, P1515, DOI 10.1083/jcb.104.6.1515; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; PESHKIN MA, 1991, PHYS REV LETT, V67, P1803, DOI 10.1103/PhysRevLett.67.1803; PICKETTHEAPS JD, 1966, J CELL SCI, V1, P109; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rivier N, 1995, ACTA BIOTHEOR, V43, P403, DOI 10.1007/BF00713562; RIVIER N, 1982, J PHYS A-MATH GEN, V15, pL143, DOI 10.1088/0305-4470/15/3/012; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sinnott EW, 1940, P NATL ACAD SCI USA, V26, P223, DOI 10.1073/pnas.26.4.223; Speicher S, 2008, CURR BIOL, V18, P831, DOI 10.1016/j.cub.2008.04.072; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; Vanstraelen M, 2006, CURR BIOL, V16, P308, DOI 10.1016/j.cub.2005.12.035; Walker KL, 2007, CURR BIOL, V17, P1827, DOI 10.1016/j.cub.2007.09.063; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Wright AJ, 2009, PLANT CELL, V21, P234, DOI 10.1105/tpc.108.062810	56	142	143	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					427	438		10.1016/j.cell.2010.12.035	http://dx.doi.org/10.1016/j.cell.2010.12.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295702	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000286973100014
J	Ampollini, L; Carbognani, P				Ampollini, Luca; Carbognani, Paolo			Madelung's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ampollini, Luca; Carbognani, Paolo] Univ Parma, I-43100 Parma, Italy	University of Parma	Ampollini, L (corresponding author), Univ Parma, I-43100 Parma, Italy.	lampollini@ao.pr.it		Ampollini, Luca/0000-0003-2225-299X					0	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					465	465		10.1056/NEJMicm1003531	http://dx.doi.org/10.1056/NEJMicm1003531			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288098				2022-12-24	WOS:000286885900012
J	Spence, D				Spence, Des			From the Frontline Bad medicine: cardiology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hingorani AD, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c6244; NHS Information Centre, PRESCR DISP COMM ENG; Office for National Statistics, MORT CIRC DIS LEAD C; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2011	342								d670	10.1136/bmj.d670	http://dx.doi.org/10.1136/bmj.d670			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PR	21285189				2022-12-24	WOS:000287138000005
J	Chen, DY; Stern, SA; Garcia-Osta, A; Saunier-Rebori, B; Pollonini, G; Bambah-Mukku, D; Blitzer, RD; Alberini, CM				Chen, Dillon Y.; Stern, Sarah A.; Garcia-Osta, Ana; Saunier-Rebori, Bernadette; Pollonini, Gabriella; Bambah-Mukku, Dhananjay; Blitzer, Robert D.; Alberini, Cristina M.			A critical role for IGF-II in memory consolidation and enhancement	NATURE			English	Article							GROWTH-FACTOR-II; LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; BINDING-PROTEIN; PERSISTENT DISRUPTION; RAT HIPPOCAMPUS; RECONSOLIDATION; RECEPTOR; GENE; MECHANISMS	We report that, in the rat, administering insulin-like growth factor II (IGF-II, also known as IGF2) significantly enhances memory retention and prevents forgetting. Inhibitory avoidance learning leads to an increase in hippocampal expression of IGF-II, which requires the transcription factor CCAAT enhancer binding protein beta and is essential for memory consolidation. Furthermore, injections of recombinant IGF-II into the hippocampus after either training or memory retrieval significantly enhance memory retention and prevent forgetting. To be effective, IGF-II needs to be administered within a sensitive period of memory consolidation. IGF-II-dependent memory enhancement requires IGF-II receptors, new protein synthesis, the function of activity-regulated cytoskeletal-associated protein and glycogen-synthase kinase 3 (GSK3). Moreover, it correlates with a significant activation of synaptic GSK3 beta and increased expression of GluR1 (also known as GRIA1) alpha-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid receptor subunits. In hippocampal slices, IGF-II promotes IGF-II receptor-dependent, persistent long-term potentiation after weak synaptic stimulation. Thus, IGF-II may represent a novel target for cognitive enhancement therapies.	[Chen, Dillon Y.; Stern, Sarah A.; Garcia-Osta, Ana; Pollonini, Gabriella; Bambah-Mukku, Dhananjay; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Saunier-Rebori, Bernadette; Blitzer, Robert D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Blitzer, Robert D.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Alberini, CM (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	Cristina.Alberini@mssm.edu	Stern, Sarah/AAV-6019-2021; Garcia-Osta, Ana/H-1139-2017	Stern, Sarah/0000-0002-3033-8251; Garcia-Osta, Ana/0000-0001-6326-9064; Bambah-Mukku, Dhananjay/0000-0001-5822-6326	NARSAD [R01-MH065635, R01-MH074736]; Hirschl Foundation; Philoctetes Foundation [F31-MH816213, T32-MH087004, R21-DA29298, R01-GM054508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635, T32MH087004, R01MH074736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029298] Funding Source: NIH RePORTER	NARSAD(NARSAD); Hirschl Foundation; Philoctetes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants R01-MH065635, R01-MH074736, NARSAD, the Hirschl Foundation and Philoctetes Foundation awarded to C.M.A., F31-MH816213 to D.Y.C., and T32-MH087004 to S.A.S.; R21-DA29298 and R01-GM054508 to R.D.B. We thank M. Baxter for assistance with statistical analyses. We thank J. Feng, J.-W. Koo and C.-Y. Lu for technical assistance. We thank A. Suzuki and A. Arguello for comments on the manuscript. We thank R. Miller and the Center for Comparative Medicine and Surgery Facility at Mount Sinai School of Medicine for technical support.	Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Elizalde PV, 1998, J STEROID BIOCHEM, V67, P305, DOI 10.1016/S0960-0760(98)00123-X; Elkobi A, 2008, NAT NEUROSCI, V11, P1149, DOI 10.1038/nn.2190; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KITRAKI E, 1993, INT J DEV NEUROSCI, V11, P1, DOI 10.1016/0736-5748(93)90029-D; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; Litvin O O, 2000, Neurosci Behav Physiol, V30, P671, DOI 10.1023/A:1026698700139; Lo JH, 2010, ENDOCRINOLOGY, V151, P2128, DOI 10.1210/en.2009-0960; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2007, LEARN MEMORY, V14, P504, DOI 10.1101/lm.598307; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nadel L, 2000, NAT REV NEUROSCI, V1, P209, DOI 10.1038/35044572; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NISSLEY SP, 1984, CLIN ENDOCRINOL META, V13, P43; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Quesada A, 2004, J NEUROSCI RES, V75, P107, DOI 10.1002/jnr.10833; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Scalia P, 2001, J CELL BIOCHEM, V82, P610, DOI 10.1002/jcb.1196; Shamblott MJ, 1998, MOL MAR BIOL BIOTECH, V7, P181; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; VANDIJK MA, 1992, NUCLEIC ACIDS RES, V20, P3099, DOI 10.1093/nar/20.12.3099; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu CM, 2009, J NEUROCHEM, V111, P1357, DOI 10.1111/j.1471-4159.2009.06414.x	50	289	297	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					491	U63		10.1038/nature09667	http://dx.doi.org/10.1038/nature09667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270887	Green Accepted			2022-12-24	WOS:000286596500024
J	Pinnock, H; Kendall, M; Murray, SA; Worth, A; Levack, P; Porter, M; MacNee, W; Sheikh, A				Pinnock, Hilary; Kendall, Marilyn; Murray, Scott A.; Worth, Allison; Levack, Pamela; Porter, Mike; MacNee, William; Sheikh, Aziz			Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							END-STAGE COPD; PALLIATIVE CARE; CHRONIC ILLNESS; BIOGRAPHICAL DISRUPTION; LUNG-CANCER; OLDER AGE; OF-LIFE; COMMUNITY	Objectives To understand the perspectives of people with severe chronic obstructive pulmonary disease (COPD) as their illness progresses, and of their informal and professional carers, to inform provision of care for people living and dying with COPD. Design Up to four serial qualitative interviews were conducted with each patient and nominated carer over 18 months. Interviews were transcribed and analysed both thematically and as narratives. Participants 21 patients, and 13 informal carers (a family member, friend, or neighbour) and 18 professional carers (a key health or social care professional) nominated by the patients. Setting Primary and secondary care in Lothian, Tayside, and Forth Valley, Scotland, during 2007-9. Results Eleven patients died during the study period. Our final dataset comprised 92 interviews (23 conducted with patient and informal carer together). Severe symptoms that caused major disruption to normal life were described, often in terms implying acceptance of the situation as a "way of life" rather than an "illness." Patients and their informal carers adapted to and accepted the debilitating symptoms of a lifelong condition. Professional carers' familiarity with the patients' condition, typically over many years, and prognostic uncertainty contributed to the difficulty of recognising and actively managing end stage disease. Overall, patients told a "chaos narrative" of their illness that was indistinguishable from their life story, with no clear beginning and an unanticipated end described in terms comparable with attitudes to death in a normal elderly population. Conclusions Our findings challenge current assumptions underpinning provision of end of life care for people with COPD. The policy focus on identifying a time point for transition to palliative care has little resonance for people with COPD or their clinicians and is counter productive if it distracts from early phased introduction of supportive care. Careful assessment of possible supportive and palliative care needs should be triggered at key disease milestones along a lifetime journey with COPD, in particular after hospital admission for an exacerbation.	[Pinnock, Hilary] Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, GP Sect,Med Sch, Edinburgh EH8 9AG, Midlothian, Scotland; [Kendall, Marilyn; Murray, Scott A.] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, GP Sect, Edinburgh EH8 9AG, Midlothian, Scotland; [Levack, Pamela] Ninewells Hosp, NHS Tayside, Dundee DD1 9SY, Scotland; [MacNee, William] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Pinnock, H (corresponding author), Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, GP Sect,Med Sch, Doorway 3,Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; MacNee, William/0000-0002-3692-1448	Chief Scientist's Office of the Scottish Government	Chief Scientist's Office of the Scottish Government	This study was supported by the Chief Scientist's Office of the Scottish Government. HP is supported by a primary care research career award from the Chief Scientist's Office of the Scottish Government.	Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; [Anonymous], 2004, SOL FACTS PALL CAR; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Centers for Medicare & Medicaid Services, 2008, PUBL US DEP HLTH HUM; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Cornwell Jocelyn, 1984, HARD EARNED LIVES AC; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, NHS END LIF CAR STRA; Department of Health, 2010, CONS STRAT SERV CHRO; Diffen E, 2010, BBC NEWS        0322; Elofsson LC, 2004, PALLIATIVE MED, V18, P611, DOI 10.1191/0269216304pm922oa; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Frank AW., 2013, WOUNDED STORYTELLER; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Habraken JM, 2007, PATIENT EDUC COUNS, V68, P121, DOI 10.1016/j.pec.2007.05.011; Habraken JM, 2008, BRIT J GEN PRACT, V58, P844, DOI 10.3399/bjgp08X376186; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; NHS End of Life Care Program, 2010, GOLD STAND FRAM; NHS Quality Improvement Scotland, 2010, CLIN STAND CHRON OBS; Pound P, 1998, SOCIOL HEALTH ILL, V20, P489, DOI 10.1111/1467-9566.00112; Reissman CatherineKohler., 1993, NARRATIVE ANAL; Rocker GM, 2007, J PALLIAT MED, V10, P783, DOI 10.1089/jpm.2007.9951; Sanders C, 2002, SOCIOL HEALTH ILL, V24, P227, DOI 10.1111/1467-9566.00292; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Williams B, 2009, QUAL HEALTH RES, V19, P1443, DOI 10.1177/1049732309348363; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	41	203	205	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2011	342								d142	10.1136/bmj.d142	http://dx.doi.org/10.1136/bmj.d142			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LP	21262897	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000286886300001
J	Khomyakova, M; Bukmez, O; Thomas, LK; Erb, TJ; Berg, IA				Khomyakova, Maria; Buekmez, Oezlem; Thomas, Lorenz K.; Erb, Tobias J.; Berg, Ivan A.			A Methylaspartate Cycle in Haloarchaea	SCIENCE			English	Article							HALOPHILIC ARCHAEON; ISOCITRATE LYASE; MALATE SYNTHASE; METABOLISM; GLUTAMATE; ENZYMES	Access to novel ecological niches often requires adaptation of metabolic pathways to cope with new environments. For conversion to cellular building blocks, many substrates enter central carbon metabolism via acetyl-coenzyme A (acetyl-CoA). Until now, only two such pathways have been identified: the glyoxylate cycle and the ethylmalonyl-CoA pathway. Prokaryotes in the haloarchaea use a third pathway by which acetyl-CoA is oxidized to glyoxylate via the key intermediate methylaspartate. Glyoxylate condensation with another acetyl-CoA molecule yields malate, the final assimilation product. This cycle combines reactions that originally belonged to different metabolic processes in different groups of prokaryotes, which suggests lateral gene transfer and evolutionary tinkering of acetate assimilation. Moreover, it requires elevated intracellular glutamate concentrations, as well as coupling carbon assimilation with nitrogen metabolism.	[Khomyakova, Maria; Buekmez, Oezlem; Thomas, Lorenz K.; Erb, Tobias J.; Berg, Ivan A.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Berg, IA (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	ivan.berg@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020; Erb, Tobias/J-5214-2013; Khomyakova, Maria/E-6912-2014	Erb, Tobias/0000-0003-3685-0894; Berg, Ivan/0000-0002-1864-4969	Deutscher Akademischer Austausch Dienst; Deutsche Forschungsgemeinschaft; Evonik-Degussa GmbH	Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa GmbH	The authors thank G. Fuchs, Freiburg, for his constant support and the innumerable discussions and suggestions during this work and for his critical reading of the manuscript and N. Gad'on and C. Ebenau-Jehle, Freiburg, for growing cells and maintaining the laboratory. The work of M.K. was supported by the Deutscher Akademischer Austausch Dienst. This work was supported by the Deutsche Forschungsgemeinschaft and Evonik-Degussa GmbH.	Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Brasen C, 2001, ARCH MICROBIOL, V175, P360, DOI 10.1007/s002030100273; Buckel W., 1999, Chemistry and biochemistry of B12., P757; BUCKEL W, 1987, EUR J BIOCHEM, V164, P565, DOI 10.1111/j.1432-1033.1987.tb11164.x; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Connaris H, 1999, BIOTECHNOL BIOENG, V64, P38, DOI 10.1002/(SICI)1097-0290(19990705)64:1<38::AID-BIT4>3.0.CO;2-7; Danson MJ, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P260; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Hezayen FF, 2000, APPL MICROBIOL BIOT, V54, P319, DOI 10.1007/s002530000394; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; LILLO JG, 1990, APPL ENVIRON MICROB, V56, P2517, DOI 10.1128/AEM.56.8.2517-2521.1990; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; OREN A, 1995, FEMS MICROBIOL LETT, V130, P91; Oren A., 2002, HALOPHILIC MICROORGA; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Serrano JA, 1998, FEBS LETT, V434, P13, DOI 10.1016/S0014-5793(98)00911-9; Serrano JA, 2001, BBA-GENE STRUCT EXPR, V1520, P154, DOI 10.1016/S0167-4781(01)00263-9; Shimizu S., 1984, MICROBIAL GROWTH C1, P113; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Zarzycki J, 2009, P NATL ACAD SCI USA, V106, P21317, DOI 10.1073/pnas.0908356106	28	71	82	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					334	337		10.1126/science.1196544	http://dx.doi.org/10.1126/science.1196544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252347				2022-12-24	WOS:000286636300038
J	Swing, K				Swing, Kelly			Day of reckoning for Ecuador's biodiversity	NATURE			English	Editorial Material									Univ San Francisco Quito, Tiputini Biodivers Stn, Quito, Ecuador		Swing, K (corresponding author), Univ San Francisco Quito, Tiputini Biodivers Stn, Quito, Ecuador.	kswing@usfq.edu.ec							0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					267	267		10.1038/469267a	http://dx.doi.org/10.1038/469267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248795	Bronze			2022-12-24	WOS:000286385600004
J	Marcovitch, H				Marcovitch, Harvey			MMR and scientific fraud Is research safe in their hands?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MISCONDUCT					h.marcovitch@btinternet.com						Angell M., NEW YORK REV BOOKS; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7001; Dillner L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d185; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Marcovitch H, 2006, MED J AUSTRALIA, V185, P616, DOI 10.5694/j.1326-5377.2006.tb00730.x; MARCUS A, FRAUD CASE ROCKS ANE; Nylenna M, 2006, LANCET, V367, P1882, DOI 10.1016/S0140-6736(06)68821-1; PINCOCK S, SCIENTIST; Shafer SL, 2010, ANESTH ANALG, V111, P1567, DOI [10.1213/ANE.0b013e3182040b99, 10.1213/ANE.0b013e3182009a22]; Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923; *UK RES INT OFF, PROC INV MISC RES	11	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d284	10.1136/bmj.d284	http://dx.doi.org/10.1136/bmj.d284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248020				2022-12-24	WOS:000286602400013
J	Kahn, BB; McGraw, TE				Kahn, Barbara B.; McGraw, Timothy E.			Rosiglitazone, PPAR(gamma), and Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GAMMA; DRUGS		[Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA USA; [McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052852, R37DK043051] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052852, R37 DK043051, R01 DK043051] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DeSouza C, 2009, NAT REV DRUG DISCOV, V8, P361, DOI 10.1038/nrd2872; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512	6	49	58	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2667	2669		10.1056/NEJMcibr1012075	http://dx.doi.org/10.1056/NEJMcibr1012075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190462	Green Accepted			2022-12-24	WOS:000285763700015
J	Ahmed, F				Ahmed, Farooq			Edible advice	NATURE			English	Editorial Material																		Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Matsuo T, 2009, OBESITY, V17, P1924, DOI 10.1038/oby.2009.199; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Wise Carolyn, 2009, J Diabetes Sci Technol, V3, P710	5	5	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					S10	S12		10.1038/468S10a	http://dx.doi.org/10.1038/468S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179076	Bronze			2022-12-24	WOS:000285553800004
J	Eisenstein, M				Eisenstein, Michael			More than meets the mouth	NATURE			English	Editorial Material																			0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S18	S19		10.1038/468S18a	http://dx.doi.org/10.1038/468S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179079	Bronze			2022-12-24	WOS:000285553800007
J	Chamot-Rooke, J; Mikaty, G; Malosse, C; Soyer, M; Dumont, A; Gault, J; Imhaus, AF; Martin, P; Trellet, M; Clary, G; Chafey, P; Camoin, L; Nilges, M; Nassif, X; Dumenil, G				Chamot-Rooke, Julia; Mikaty, Guillain; Malosse, Christian; Soyer, Magali; Dumont, Audrey; Gault, Joseph; Imhaus, Anne-Flore; Martin, Patricia; Trellet, Mikael; Clary, Guilhem; Chafey, Philippe; Camoin, Luc; Nilges, Michael; Nassif, Xavier; Dumenil, Guillaume			Posttranslational Modification of Pili upon Cell Contact Triggers N. meningitidis Dissemination	SCIENCE			English	Article							NEISSERIA-MENINGITIDIS; IV PILI; EPITHELIAL-CELLS; GONORRHOEAE; PHOSPHOETHANOLAMINE; PHOSPHOCHOLINE; GENE	The Gram-negative bacterium Neisseria meningitidis asymptomatically colonizes the throat of 10 to 30% of the human population, but throat colonization can also act as the port of entry to the blood (septicemia) and then the brain (meningitis). Colonization is mediated by filamentous organelles referred to as type IV pili, which allow the formation of bacterial aggregates associated with host cells. We found that proliferation of N. meningitidis in contact with host cells increased the transcription of a bacterial gene encoding a transferase that adds phosphoglycerol onto type IV pili. This unusual posttranslational modification specifically released type IV pili-dependent contacts between bacteria. In turn, this regulated detachment process allowed propagation of the bacterium to new colonization sites and also migration across the epithelium, a prerequisite for dissemination and invasive disease.	[Mikaty, Guillain; Soyer, Magali; Dumont, Audrey; Imhaus, Anne-Flore; Martin, Patricia; Clary, Guilhem; Chafey, Philippe; Camoin, Luc; Nassif, Xavier; Dumenil, Guillaume] Univ Paris 05, Fac Med Paris Descartes, F-75006 Paris, France; [Chamot-Rooke, Julia; Malosse, Christian; Gault, Joseph] Ecole Polytech, Lab Mecanismes React, F-91128 Palaiseau, France; [Chamot-Rooke, Julia; Malosse, Christian; Gault, Joseph] CNRS, UMR7651, F-91128 Palaiseau, France; [Mikaty, Guillain; Martin, Patricia; Nassif, Xavier] INSERM, U1002, F-75015 Paris, France; [Soyer, Magali; Dumont, Audrey; Imhaus, Anne-Flore; Dumenil, Guillaume] Paris Cardiovasc Res Ctr, INSERM, U970, F-75015 Paris, France; [Trellet, Mikael; Nilges, Michael] Inst Pasteur, Unite Rech Associee CNRS 2185, Unite Bioinformat Struct, F-75015 Paris, France; [Clary, Guilhem; Chafey, Philippe; Camoin, Luc] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Clary, Guilhem; Chafey, Philippe; Camoin, Luc] INSERM, U1016, F-75014 Paris, France; [Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Dumenil, G (corresponding author), Univ Paris 05, Fac Med Paris Descartes, F-75006 Paris, France.	guillaume.dumenil@inserm.fr	Camoin, Luc/AAB-3856-2019; Dumenil, Guillaume/N-3377-2019; Dumenil, Guillaume/F-7567-2015; Trellet, Mikael/A-9370-2017; Gault, Joseph/C-9623-2013; Nilges, Michael/E-4803-2011; Chamot-Rooke, Julia/F-3644-2014	Camoin, Luc/0000-0002-1230-4787; Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Trellet, Mikael/0000-0001-6337-581X; Gault, Joseph/0000-0001-7686-2983; Nilges, Michael/0000-0002-1451-8092; Nassif, Xavier/0000-0003-2855-3240; Chamot-Rooke, Julia/0000-0002-9427-543X	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche; Agence Nationale de la Recherche [PCV08_319010, FRM INE20100118195]	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Authors thank M.-C. Prevost, S. Guadagnini, D. Lankar, J.-L. Beretti, M. Dupuis, G. Guilbaud for help with experiments and A.-M. Lennon, E. Camerer, S. Silva, and K. Melican for critical reading of the manuscript. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche (including Avenir program), and Agence Nationale de la Recherche grants PCV08_319010 and FRM INE20100118195.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Deghmane AE, 2000, EMBO J, V19, P1068, DOI 10.1093/emboj/19.5.1068; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Ilver D, 1998, INFECT IMMUN, V66, P469, DOI 10.1128/IAI.66.2.469-473.1998; Jamet A, 2009, MICROBIOL-SGM, V155, P2288, DOI 10.1099/mic.0.027755-0; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Morelle S, 2003, J BACTERIOL, V185, P2618, DOI 10.1128/JB.185.8.2618-2627.2003; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Rusniok C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r110; Stimson E, 1996, BIOCHEM J, V316, P29, DOI 10.1042/bj3160029; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Warren MJ, 2003, INFECT IMMUN, V71, P6892, DOI 10.1128/IAI.71.12.6892-6898.2003	16	136	141	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					778	782		10.1126/science.1200729	http://dx.doi.org/10.1126/science.1200729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311024				2022-12-24	WOS:000287205700073
J	Tamura, K; Nomura, N; Seki, R; Yonei-Tamura, S; Yokoyama, H				Tamura, Koji; Nomura, Naoki; Seki, Ryohei; Yonei-Tamura, Sayuri; Yokoyama, Hitoshi			Embryological Evidence Identifies Wing Digits in Birds as Digits 1, 2, and 3	SCIENCE			English	Article							PENTADACTYL GROUND-STATE; CHICK LIMB-BUD; SONIC-HEDGEHOG; VERTEBRATE LIMB; POLARIZING ACTIVITY; GENE-EXPRESSION; AVIAN HAND; HOX GENES; EVOLUTION; ZPA	The identities of the digits of the avian forelimb are disputed. Whereas paleontological findings support the position that the digits correspond to digits one, two, and three, embryological evidence points to digit two, three, and four identities. By using transplantation and cell-labeling experiments, we found that the posteriormost digit in the wing does not correspond to digit four in the hindlimb; its progenitor segregates early from the zone of polarizing activity, placing it in the domain of digit three specification. We suggest that an avian-specific shift uncouples the digit anlagen from the molecular mechanisms that pattern them, resulting in the imposition of digit one, two, and three identities on the second, third, and fourth anlagens.	[Tamura, Koji; Nomura, Naoki; Seki, Ryohei; Yonei-Tamura, Sayuri; Yokoyama, Hitoshi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Tamura, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	tam@m.tohoku.ac.jp	Yokoyama, Hitoshi/F-5161-2015	Yokoyama, Hitoshi/0000-0003-4821-9506; Seki-Omura, Ryohei/0000-0002-3314-9237	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.)	We thank S. Kuratani for valuable discussions and comments on this study; R. Ladher, J. Fallon, H. Yajima, T. Suzuki, and D. Sipp for critical reading of this manuscript; and Y. Wakamatsu for supplying quail eggs. H.Y. was supported by Grant-in-Aid for Scientific Research on Innovative Areas. This work was supported by the Global Center of Excellence Program (J03) and grants from Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Toray Science Foundation.	Amano T, 2005, DEV DYNAM, V233, P326, DOI 10.1002/dvdy.20390; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cohn MJ, 2002, BIOESSAYS, V24, P460, DOI 10.1002/bies.10088; Galis F, 2005, J EXP ZOOL PART B, V304B, P198, DOI 10.1002/jez.b.21042; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hinchliffe J. R., 1977, VERTEBRATE LIMB SOMI, P293; HINCHLIFFE JR, 1985, J EMBRYOL EXP MORPH, V86, P169; HONIG LS, 1985, J EMBRYOL EXP MORPH, V87, P163; Larsson HCE, 2010, J EXP ZOOL PART B, V314B, P571, DOI 10.1002/jez.b.21362; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROWE DA, 1982, J EMBRYOL EXP MORPH, V68, P1; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; SUMMERBELL D, 1975, J EMBRYOL EXP MORPH, V33, P621; Summerbell D., 1977, VERTEBRATE LIMB SOMI, P41; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Uejima A, 2010, DEV GROWTH DIFFER, V52, P223, DOI 10.1111/j.1440-169X.2009.01161.x; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P206, DOI 10.1002/jez.b.21051; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; WILSON DJ, 1987, DEVELOPMENT, V99, P99; Wolpert L, 2007, PRINCIPLES DEV; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	29	46	49	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					753	757		10.1126/science.1198229	http://dx.doi.org/10.1126/science.1198229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311019				2022-12-24	WOS:000287205700066
J	Spiegel, D				Spiegel, David			Mind Matters in Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC BREAST-CANCER; TRIAL		Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Spiegel, D (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd,Off 2325, Stanford, CA 94305 USA.	dspiegel@stanford.edu		Spiegel, David/0000-0002-9476-9173	NATIONAL CANCER INSTITUTE [R01CA118567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P30AT005886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG018784] Funding Source: NIH RePORTER; NCCIH NIH HHS [1 P30 AT00 5886] Funding Source: Medline; NCI NIH HHS [1 R01 CA118567] Funding Source: Medline; NIA NIH HHS [P01 AG18784] Funding Source: Medline; NIMH NIH HHS [R01 MH47226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Giese-Davis J, 2011, J CLIN ONCOL, V29, P413, DOI 10.1200/JCO.2010.28.4455; Goodwin PJ, 2001, NEW ENGL J MED, V345, P1719, DOI 10.1056/NEJMoa011871; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; SPIEGEL D, 1989, LANCET, V2, P888; Spiegel D, 2007, CANCER-AM CANCER SOC, V110, P1130, DOI 10.1002/cncr.22890; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	10	44	44	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					502	503		10.1001/jama.2011.69	http://dx.doi.org/10.1001/jama.2011.69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285429	Green Accepted			2022-12-24	WOS:000286810700025
J	Miller, KM; Li, SR; Kaukinen, KH; Ginther, N; Hammill, E; Curtis, JMR; Patterson, DA; Sierocinski, T; Donnison, L; Pavlidis, P; Hinch, SG; Hruska, KA; Cooke, SJ; English, KK; Farrell, AP				Miller, Kristina M.; Li, Shaorong; Kaukinen, Karia H.; Ginther, Norma; Hammill, Edd; Curtis, Janelle M. R.; Patterson, David A.; Sierocinski, Thomas; Donnison, Louise; Pavlidis, Paul; Hinch, Scott G.; Hruska, Kimberly A.; Cooke, Steven J.; English, Karl K.; Farrell, Anthony P.			Genomic Signatures Predict Migration and Spawning Failure in Wild Canadian Salmon	SCIENCE			English	Article							SOCKEYE-SALMON; FRASER-RIVER; PHYSIOLOGICAL CONDITION; ONCORHYNCHUS-NERKA; TEMPERATURE; MORTALITY; SURVIVAL; BEHAVIOR	Long-term population viability of Fraser River sockeye salmon (Oncorhynchus nerka) is threatened by unusually high levels of mortality as they swim to their spawning areas before they spawn. Functional genomic studies on biopsied gill tissue from tagged wild adults that were tracked through ocean and river environments revealed physiological profiles predictive of successful migration and spawning. We identified a common genomic profile that was correlated with survival in each study. In ocean-tagged fish, a mortality-related genomic signature was associated with a 13.5-fold greater chance of dying en route. In river-tagged fish, the same genomic signature was associated with a 50% increase in mortality before reaching the spawning grounds in one of three stocks tested. At the spawning grounds, the same signature was associated with 3.7-fold greater odds of dying without spawning. Functional analysis raises the possibility that the mortality-related signature reflects a viral infection.	[Miller, Kristina M.; Li, Shaorong; Kaukinen, Karia H.; Ginther, Norma] Fisheries & Oceans Canada, Mol Genet Sect, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Miller, Kristina M.; Hinch, Scott G.; Hruska, Kimberly A.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; [Hammill, Edd; Curtis, Janelle M. R.] Fisheries & Oceans Canada, Conservat Biol Sect, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Fisheries & Oceans Canada, Cooperat Resource Management Inst, Burnaby, BC V5A 1S6, Canada; [Sierocinski, Thomas; Donnison, Louise; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [English, Karl K.] LGL Ltd Environm Res Associates, Sidney, BC V8L 3Y8, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada	Fisheries & Oceans Canada; University of British Columbia; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; Carleton University; University of British Columbia; University of British Columbia	Miller, KM (corresponding author), Fisheries & Oceans Canada, Mol Genet Sect, Pacific Biol Stn, 3190 Hammond Bay Rd, Nanaimo, BC V9T 6N7, Canada.	kristi.miller@dfo-mpo.gc.ca	Pavlidis, Paul/H-8406-2013; Cooke, Steven J/F-4193-2010; Hammill, Edd/F-9030-2013	Pavlidis, Paul/0000-0002-0426-5028; Cooke, Steven J/0000-0002-5407-0659; Hammill, Edd/0000-0001-8247-6106	Pacific Salmon Commission; Department of Fisheries and Oceans; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada	Pacific Salmon Commission; Department of Fisheries and Oceans; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Microarray data were deposited (according to Microarray Gene Expression Data Society Standard) in the National Center for Biotechnology Information Gene Expression Omnibus (GEO, www.ncbi.nlm.nih.gov/geo/) with the saltwater experimental accession number GSE22171, freshwater GSE22177, spawning GSE22347, and Superseries ID GSE22179. We thank the Pacific Salmon Commission Southern Endowment Fund, Department of Fisheries and Oceans Genomics Research and Development Fund, Genome British Columbia, and Natural Sciences and Engineering Research Council of Canada for research support. All procedures used were developed with approvals and guidance from the Canadian Council on Animal Care administered by the University of British Columbia and Fisheries and Oceans Canada. We thank M. Donaldson, I. Olsson, G. Crossin, K. Hanson, R. Alexander, D. Robichaud, S. Tyerman, D. Welch, and J. Hills for tagging and biopsies; L. Stenhouse and A. Schulze for RNA extractions; M. Shrimpton for gill Na<SUP>+</SUP>/K<SUP>+</SUP> ATPase activity levels; C. Wallace for figure preparation; M. Lapointe and C. McConnell for organizational assistance; and the skippers and crews of the ocean vessels Sunfisher and Belina.	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Cooke SJ, 2006, CAN J FISH AQUAT SCI, V63, P1469, DOI 10.1139/F06-042; Cooperman MS, 2010, PHYSIOL BIOCHEM ZOOL, V83, P459, DOI 10.1086/650473; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crossin GT, 2009, PHYSIOL BIOCHEM ZOOL, V82, P635, DOI 10.1086/605878; English KK, 2005, T AM FISH SOC, V134, P1342, DOI 10.1577/T04-119.1; HINCH SG, 2009, C EARL MIGR PREM MOR, P8; Irvine JR, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:CSARA]2.0.CO;2; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; MARTINS EG, GLOBAL CHAN IN PRESS, DOI DOI 10.1111/J.1365-2486.2010.02241.X; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Miller KM, 2009, COMP BIOCHEM PHYS D, V4, P75, DOI 10.1016/j.cbd.2008.11.002; Portner HO, 2009, SCIENCE, V323, P876; Rand P. S., IUCN 2010 IUCN RED L; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; Wagner GN, 2005, CAN J FISH AQUAT SCI, V62, P2124, DOI 10.1139/F05-126	18	146	153	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					214	217		10.1126/science.1196901	http://dx.doi.org/10.1126/science.1196901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233388				2022-12-24	WOS:000286433100042
J	Piscitelli, CL; Krishnamurthy, H; Gouaux, E				Piscitelli, Chayne L.; Krishnamurthy, Harini; Gouaux, Eric			Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site	NATURE			English	Article							BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; ACID TRANSPORTER; BINDING-SITE; MECHANISM; REVEALS; PROTEINS; NA+	Neurotransmitter/sodium symporters (NSSs) couple the uptake of neurotransmitter with one or more sodium ions(1-3), removing neurotransmitter from the synaptic cleft. NSSs are essential to the function of chemical synapses, are associated with multiple neurological diseases and disorders(4), and are the targets of therapeutic and illicit drugs(5). LeuT, a prokaryotic orthologue of the NSS family, is a model transporter for understanding the relationships between molecular mechanism and atomic structure in a broad range of sodium-dependent and sodium-independent secondary transporters(6-13). At present there is a controversy over whether there are one or two high-affinity substrate binding sites in LeuT. The first-reported crystal structure of LeuT, together with subsequent functional and structural studies, provided direct evidence for a single, high-affinity, centrally located substrate-binding site, defined as the S1 site(14,15). Recent binding, flux and molecular simulation studies, however, have been interpreted in terms of a model where there are two high-affinity binding sites: the central, S1, site and a second, the S2 site, located within the extracellular vestibule(16). Furthermore, it was proposed that the S1 and S2 sites are allosterically coupled such that occupancy of the S2 site is required for the cytoplasmic release of substrate from the S1 site(16). Here we address this controversy by performing direct measurement of substrate binding to wild-type LeuT and to S2 site mutants using isothermal titration calorimetry, equilibrium dialysis and scintillation proximity assays. In addition, we perform uptake experiments to determine whether the proposed allosteric coupling between the putative S2 site and the S1 site manifests itself in the kinetics of substrate flux. We conclude that LeuT harbours a single, centrally located, high-affinity substrate-binding site and that transport is well described by a simple, single-substrate kinetic mechanism.	[Piscitelli, Chayne L.; Krishnamurthy, Harini; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	ARCS foundation; NIH [T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	ARCS foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Pan and R. Hibbs for comments and L. Vaskalis for assistance with figures. C. L. P. was supported by the ARCS foundation and NIH training grant T32 DK007680. This work was supported by the NIH. E. G. is an investigator with the Howard Hughes Medical Institute.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; CHRISTENSEN JJ, 1971, SCIENCE, V174, P459, DOI 10.1126/science.174.4008.459; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; SEGEL IH, 1975, ENZYME KINETICS, P398; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	25	104	104	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1129	U538		10.1038/nature09581	http://dx.doi.org/10.1038/nature09581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179170	Green Accepted			2022-12-24	WOS:000285553800064
J	Jiang, H; Shukla, A; Wang, XL; Chen, WY; Bernstein, BE; Roeder, RG				Jiang, Hao; Shukla, Abhijit; Wang, Xiaoling; Chen, Wei-yi; Bernstein, Bradley E.; Roeder, Robert G.			Role for Dpy-30 in ES Cell-Fate Specification by Regulation of H3K4 Methylation within Bivalent Domains	CELL			English	Article							EMBRYONIC STEM-CELLS; ELEGANS DOSAGE COMPENSATION; HISTONE H3; DEVELOPMENTAL REGULATORS; CHROMATIN SIGNATURES; GROUP PROTEINS; POLYCOMB; PLURIPOTENT; DIFFERENTIATION; TRITHORAX	Histone H3K4 methylation is associated with active genes and, along with H3K27 methylation, is part of a bivalent chromatin mark that typifies poised developmental genes in embryonic stem cells (ESCs). However, its functional roles in ESC maintenance and differentiation are not established. Here we show that mammalian Dpy-30, a core subunit of the SET1/MLL histone methyltransferase complexes, modulates H3K4 methylation in vitro, and directly regulates chromosomal H3K4 trimethylation (H3K4me3) throughout the mammalian genome. Depletion of Dpy-30 does not affect ESC self-renewal, but significantly alters the differentiation potential of ESCs, particularly along the neural lineage. The differentiation defect is accompanied by defects in gene induction and in H3K4 methylation at key developmental loci. Our results strongly indicate an essential functional role for Dpy-30 and SET1/MLL complex-mediated H3K4 methylation, as a component of the bivalent mark, at developmental genes during the ESC fate transitions.	[Jiang, Hao; Wang, Xiaoling; Chen, Wei-yi; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Rockefeller University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Wang, Xiaoling/D-4208-2013	Chen, Wei-Yi/0000-0002-0661-6899	Tri-Institutional Starr Stem Cell Scholars fellowship; NIH [DK071900]; Starr Cancer Consortium [I2-A88]; Leukemia and Lymphoma Society [7132-08]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Tri-Institutional Starr Stem Cell Scholars fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Yali Dou for baculoviruses encoding RbBP5, WDR5 and Ash2L, Cristina Hughes (David Allis lab), and Eric McIntush (Bethyl Laboratories) for Dpy-30 antibody, Joanna Wysocka for WDR5 antibody, Aaron Goldberg (David Allis lab) for LIF, Shannon Lauberth and Zhanyun Tang for providing supporting data, Zheng-Yuan Fu for technical assistance, Esther Rheinbay, Jing Wang and Xiaojian Sun for data analyses, and Bing Ren (UCSD) and Xiangdong Lu for insightful discussions of the project. H.J. and W.-Y.C. are Leukemia and Lymphoma Society Fellows. X. W. is a recipient of a Tri-Institutional Starr Stem Cell Scholars fellowship. This work was supported by NIH (DK071900), Starr Cancer Consortium (I2-A88), and Leukemia and Lymphoma Society (7132-08) grants to R.G.R.	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang X, 2008, J VIS EXP; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	44	206	223	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					513	525		10.1016/j.cell.2011.01.020	http://dx.doi.org/10.1016/j.cell.2011.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335234	Green Accepted, Bronze			2022-12-24	WOS:000287473100007
J	Iglehart, JK				Iglehart, John K.			Bundled Payment for ESRD - Including ESAs in Medicare's Dialysis Package	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P49029; FIELDS R, 2010, PROPUBLICA      1109; *MED PAYM ADV COMM, 2001, REP C MED PAYM POL; ZHANG Y, 2010, HLTH SERV RES   1209, DOI DOI 10.1111/J.1475-6773.2010.01219.X	5	24	25	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					593	595		10.1056/NEJMp1014187	http://dx.doi.org/10.1056/NEJMp1014187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21323538	Bronze			2022-12-24	WOS:000287406000001
J	Baker, M				Baker, Monya			GENOMES IN THREE DIMENSIONS	NATURE			English	Editorial Material							CHROMATIN; ORGANIZATION											Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	20	19	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					289	294		10.1038/470289a	http://dx.doi.org/10.1038/470289a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307943	Bronze			2022-12-24	WOS:000287144200050
J	Howell, P				Howell, Peter			Listen to the lessons of The King's Speech	NATURE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Howell, P (corresponding author), UCL, London WC1E 6BT, England.	p.howell@ucl.ac.uk							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					7	7		10.1038/470007a	http://dx.doi.org/10.1038/470007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715LQ	21293331				2022-12-24	WOS:000286886400004
J	Seibert, MM; Ekeberg, T; Maia, FRNC; Svenda, M; Andreasson, J; Jonsson, O; Odic, D; Iwan, B; Rocker, A; Westphal, D; Hantke, M; DePonte, DP; Barty, A; Schulz, J; Gumprecht, L; Coppola, N; Aquila, A; Liang, MN; White, TA; Martin, A; Caleman, C; Stern, S; Abergel, C; Seltzer, V; Claverie, JM; Bostedt, C; Bozek, JD; Boutet, S; Miahnahri, AA; Messerschmidt, M; Krzywinski, J; Williams, G; Hodgson, KO; Bogan, MJ; Hampton, CY; Sierra, RG; Starodub, D; Andersson, I; Bajt, S; Barthelmess, M; Spence, JCH; Fromme, P; Weierstall, U; Kirian, R; Hunter, M; Doak, RB; Marchesini, S; Hau-Riege, SP; Frank, M; Shoeman, RL; Lomb, L; Epp, SW; Hartmann, R; Rolles, D; Rudenko, A; Schmidt, C; Foucar, L; Kimmel, N; Holl, P; Rudek, B; Erk, B; Homke, A; Reich, C; Pietschner, D; Weidenspointner, G; Struder, L; Hauser, G; Gorke, H; Ullrich, J; Schlichting, I; Herrmann, S; Schaller, G; Schopper, F; Soltau, H; Kuhnel, KU; Andritschke, R; Schroter, CD; Krasniqi, F; Bott, M; Schorb, S; Rupp, D; Adolph, M; Gorkhover, T; Hirsemann, H; Potdevin, G; Graafsma, H; Nilsson, B; Chapman, HN; Hajdu, J				Seibert, M. Marvin; Ekeberg, Tomas; Maia, Filipe R. N. C.; Svenda, Martin; Andreasson, Jakob; Joensson, Olof; Odic, Dusko; Iwan, Bianca; Rocker, Andrea; Westphal, Daniel; Hantke, Max; DePonte, Daniel P.; Barty, Anton; Schulz, Joachim; Gumprecht, Lars; Coppola, Nicola; Aquila, Andrew; Liang, Mengning; White, Thomas A.; Martin, Andrew; Caleman, Carl; Stern, Stephan; Abergel, Chantal; Seltzer, Virginie; Claverie, Jean-Michel; Bostedt, Christoph; Bozek, John D.; Boutet, Sebastien; Miahnahri, A. Alan; Messerschmidt, Marc; Krzywinski, Jacek; Williams, Garth; Hodgson, Keith O.; Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri; Andersson, Inger; Bajt, Sasa; Barthelmess, Miriam; Spence, John C. H.; Fromme, Petra; Weierstall, Uwe; Kirian, Richard; Hunter, Mark; Doak, R. Bruce; Marchesini, Stefano; Hau-Riege, Stefan P.; Frank, Matthias; Shoeman, Robert L.; Lomb, Lukas; Epp, Sascha W.; Hartmann, Robert; Rolles, Daniel; Rudenko, Artem; Schmidt, Carlo; Foucar, Lutz; Kimmel, Nils; Holl, Peter; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Reich, Christian; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Gorke, Hubert; Ullrich, Joachim; Schlichting, Ilme; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Soltau, Heike; Kuehnel, Kai-Uwe; Andritschke, Robert; Schroeter, Claus-Dieter; Krasniqi, Faton; Bott, Mario; Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais; Hirsemann, Helmut; Potdevin, Guillaume; Graafsma, Heinz; Nilsson, Bjoern; Chapman, Henry N.; Hajdu, Janos			Single mimivirus particles intercepted and imaged with an X-ray laser	NATURE			English	Article							FREE-ELECTRON LASER; DIFFRACTION MICROSCOPY; VIROPHAGE	X-ray lasers offer new capabilities in understanding the structure of biological systems, complex materials and matter under extreme conditions(1-4). Very short and extremely bright, coherent X-ray pulses can be used to outrun key damage processes and obtain a single diffraction pattern from a large macromolecule, a virus or a cell before the sample explodes and turns into plasma(1). The continuous diffraction pattern of non-crystalline objects permits oversampling and direct phase retrieval(2). Here we show that high-quality diffraction data can be obtained with a single X-ray pulse from a noncrystalline biological sample, a single mimivirus particle, which was injected into the pulsed beam of a hard-X-ray free-electron laser, the Linac Coherent Light Source(5). Calculations indicate that the energy deposited into the virus by the pulse heated the particle to over 100,000 K after the pulse had left the sample. The reconstructed exit wavefront (image) yielded 32-nm full-period resolution in a single exposure and showed no measurable damage. The reconstruction indicates inhomogeneous arrangement of dense material inside the virion. We expect that significantly higher resolutions will be achieved in such experiments with shorter and brighter photon pulses focused to a smaller area. The resolution in such experiments can be further extended for samples available in multiple identical copies.	[Seibert, M. Marvin; Ekeberg, Tomas; Maia, Filipe R. N. C.; Svenda, Martin; Andreasson, Jakob; Joensson, Olof; Odic, Dusko; Iwan, Bianca; Rocker, Andrea; Westphal, Daniel; Hantke, Max; Caleman, Carl; Hajdu, Janos] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [DePonte, Daniel P.; Barty, Anton; Schulz, Joachim; Gumprecht, Lars; Coppola, Nicola; Aquila, Andrew; Liang, Mengning; White, Thomas A.; Martin, Andrew; Caleman, Carl; Stern, Stephan; Chapman, Henry N.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Stern, Stephan; Chapman, Henry N.] Univ Hamburg, D-22607 Hamburg, Germany; [Abergel, Chantal; Seltzer, Virginie; Claverie, Jean-Michel] Aix Marseille Univ, CNRS, UPR2589, Inst Microbiol & Mediterranee, F-13288 Marseille 9, France; [Bostedt, Christoph; Bozek, John D.; Boutet, Sebastien; Miahnahri, A. Alan; Messerschmidt, Marc; Krzywinski, Jacek; Williams, Garth] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Hodgson, Keith O.; Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Andersson, Inger] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden; [Spence, John C. H.; Weierstall, Uwe; Kirian, Richard; Doak, R. Bruce] Arizona State Univ, Dept Phys, PSF470, Tempe, AZ 85287 USA; [Fromme, Petra; Hunter, Mark] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Marchesini, Stefano] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Shoeman, Robert L.; Lomb, Lukas; Rolles, Daniel; Foucar, Lutz; Schlichting, Ilme; Krasniqi, Faton; Bott, Mario] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Epp, Sascha W.; Rolles, Daniel; Rudenko, Artem; Schmidt, Carlo; Foucar, Lutz; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Strueder, Lothar; Ullrich, Joachim; Schlichting, Ilme; Krasniqi, Faton] Max Planck Adv Study Grp, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Epp, Sascha W.; Rudenko, Artem; Schmidt, Carlo; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Ullrich, Joachim; Kuehnel, Kai-Uwe; Schroeter, Claus-Dieter] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, Robert; Holl, Peter; Reich, Christian; Soltau, Heike] PNSensor GmbH, D-80803 Munich, Germany; [Kimmel, Nils; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Kimmel, Nils; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Strueder, Lothar] Univ Siegen, D-57068 Siegen, Germany; [Gorke, Hubert] Forschungszentrum Julich, Inst ZEL, D-52425 Julich, Germany; [Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany	Uppsala University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Swedish University of Agricultural Sciences; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Max Planck Society; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Universitat Siegen; Helmholtz Association; Research Center Julich; Technical University of Berlin	Hajdu, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, Husargatan 3,Box 596, SE-75124 Uppsala, Sweden.	chantal.abergel@igs.cnrs-mrs.fr; janos.hajdu@xray.bmc.uu.se	Bozek, John D/E-9260-2010; Frank, Matthias/O-9055-2014; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019; Rudenko, Artem/C-7412-2009; Gorkhover, Tais/K-8468-2012; Rupp, Daniela/AAD-7978-2021; Rudek, Benedikt/AAX-1278-2021; Bajt, Sasa/G-2228-2010; Bogan, Mike/I-6962-2012; Barty, Anton/K-5137-2014; Bajt, Sasa/O-4695-2019; Messerschmidt, Marc/F-3796-2010; FRS, Henry N Chapman/G-2153-2010; Jönsson, H Olof/O-8664-2017; Maia, Filipe R.N.C./C-3146-2014; Rupp, Daniela/P-7590-2016; Kirian, Richard/M-3750-2013; Marchesini, Stefano/GYR-1409-2022; Schlichting, Ilme/I-1339-2013; Marchesini, Stefano/A-6795-2009; Weierstall, Uwe/B-3568-2011; Williams, Garth/H-1606-2012; Rudek, Benedikt/A-5100-2017; Messerschmidt, Marc/Y-8929-2019	Bozek, John D/0000-0001-7486-7238; Claverie, Jean-Michel/0000-0003-1424-0315; Rudenko, Artem/0000-0002-9154-8463; Rupp, Daniela/0000-0002-6504-7956; Rudek, Benedikt/0000-0002-6404-4294; Bogan, Mike/0000-0001-9318-3333; Barty, Anton/0000-0003-4751-2727; Bajt, Sasa/0000-0002-7163-7602; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Jönsson, H Olof/0000-0002-2076-0918; Maia, Filipe R.N.C./0000-0002-2141-438X; Marchesini, Stefano/0000-0002-6798-2913; Messerschmidt, Marc/0000-0002-8641-3302; Stern, Stephan/0000-0001-9786-7513; Kirian, Richard/0000-0001-7197-3086; Frank, Matthias/0000-0002-5244-0791; Erk, Benjamin/0000-0001-8413-3588; MARTIN, ANDREW/0000-0003-3704-1829; Seibert, Mark Marvin/0000-0003-0251-0744; Aquila, Andrew/0000-0003-0358-2774; Abergel, Chantal/0000-0003-1875-4049; RUDENKO, Artem/0000-0001-6771-2510; Schulz, Joachim/0000-0002-9310-8832; Epp, Sascha/0000-0001-6366-9113; graafsma, heinz/0000-0003-2304-667X; Andreasson, Jakob/0000-0002-3202-2330	Swedish Research Councils; Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; Swedish University of Agricultural Sciences; Helmholtz Association [VH-VI-302]; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-BLAN08-0089]; Hamburg Ministry of Science and Research; Hamburg School for Structure and Dynamics; Max Planck Society; US National Science Foundation [MCB 0919195, MCB-1021557]; US Department of Energy through the PULSE Institute; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research (LEXI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021557] Funding Source: National Science Foundation	Swedish Research Councils(Swedish Research Council); Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Swedish University of Agricultural Sciences; Helmholtz Association(Helmholtz Association); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Hamburg Ministry of Science and Research; Hamburg School for Structure and Dynamics; Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); US Department of Energy through the PULSE Institute(United States Department of Energy (DOE)); Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research (LEXI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the following agencies: the Swedish Research Councils; the Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; the Swedish University of Agricultural Sciences; the Helmholtz Association (VH-VI-302); the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; the Centre National de la Recherche Scientifique; Agence Nationale de la Recherche (ANR-BLAN08-0089); the Hamburg Ministry of Science and Research and Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics; the Max Planck Society, the US National Science Foundation (grants MCB 0919195 and MCB-1021557); and the US Department of Energy, through the PULSE Institute. Portions of this research were carried out at the Linac Coherent Light Source, a National User Facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. We are grateful to B. Hedman and N. Timneanu for their help and to the scientific and technical staff of the LCLS for their outstanding facility and support.	Bergh M, 2008, Q REV BIOPHYS, V41, P181, DOI 10.1017/S003358350800471X; Bogan MJ, 2008, NANO LETT, V8, P310, DOI 10.1021/nl072728k; Bortel G, 2009, J STRUCT BIOL, V166, P226, DOI 10.1016/j.jsb.2009.01.005; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Hau-Riege SP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.064801; Huldt G, 2003, J STRUCT BIOL, V144, P219, DOI 10.1016/j.jsb.2003.09.025; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; Maia FRNC, 2010, J APPL CRYSTALLOGR, V43, P1535, DOI 10.1107/S0021889810036083; Maia FRNC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031905; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Nagler B, 2009, NAT PHYS, V5, P693, DOI 10.1038/NPHYS1341; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Seibert MM, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/19/194015; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Song CY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158101; Steinbrener J, 2010, OPT EXPRESS, V18, P18598, DOI 10.1364/OE.18.018598; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Thibault P, 2006, ACTA CRYSTALLOGR A, V62, P248, DOI 10.1107/S0108767306016515; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177	33	649	666	6	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					78	U86		10.1038/nature09748	http://dx.doi.org/10.1038/nature09748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293374	Green Accepted, Green Published			2022-12-24	WOS:000286886400037
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			The Association Between Hospital Volume and Processes, Outcomes, and Costs of Care for Congestive Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; PERCUTANEOUS CORONARY INTERVENTIONS; REGIONAL-VARIATIONS; MORTALITY; EXPERIENCE	Background: Congestive heart failure (CHF) is common and costly, and outcomes remain suboptimal despite pharmacologic and technical advances. Objective: To examine whether hospitals with more experience in caring for patients with CHF provide better, more efficient care. Design: Retrospective cohort study. Setting: 4095 hospitals in the United States. Patients: Medicare fee-for-service patients with a primary discharge diagnosis of CHF. Measurements: Hospital Quality Alliance CHF process measures; 30-day, risk-adjusted mortality rates; 30-day, risk-adjusted readmission rates; and costs per discharge. National Medicare claims data from 2006 to 2007 were used to examine the relationship between hospital case volume and quality, outcomes, and costs for patients with CHF. Results: Hospitals in the low-volume group had lower performance on the process measures (80.2%) than did medium-volume (87.0%) or high-volume (89.1%) hospitals (P < 0.001). In the low-volume group, being admitted to a hospital with a higher case volume was associated with lower mortality, lower readmission, and higher costs. Similar, though smaller, relationships were found between case volume and both mortality and costs in the medium- and high-volume hospital groups. Limitations: Analysis was limited to Medicare patients 65 years or older. Risk adjustment was performed by using administrative data. Conclusion: Experience with managing CHF, as measured by an institution's volume, is associated with higher quality of care and better outcomes for patients but a higher cost. Understanding which practices employed by high-volume institutions account for these advantages can help improve quality of care and clinical outcomes for all patients with CHF. Primary Funding Source: American Heart Association. Ann Intern Med. 2011;154:94-102.	[Joynt, Karen E.] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Vet Affairs Boston Hlth Care Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			American Heart Association [10CRP3780037]; National Institutes of Health [T32HL007604-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By an American Heart Association Clinical Research Program grant (10CRP3780037). Dr. Joynt was supported by a National Institutes of Health Training Grant (T32HL007604-24) held by Brigham and Women's Hospital Division of Cardiovascular Medicine.	Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Cunningham WE, 1999, AM J MED, V107, P137, DOI 10.1016/S0002-9343(99)00195-3; Desai MM, 2009, 2009 MEASURES MAINTE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATIONAHA.104.528455; Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B; Ho V, 2008, MED CARE, V46, P718, DOI 10.1097/MLR.0b013e3181653d6b; Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lindenauer PK, 2006, ANN INTERN MED, V144, P262, DOI 10.7326/0003-4819-144-4-200602210-00008; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Mechanic R, 1998, JAMA-J AM MED ASSOC, V280, P1015, DOI 10.1001/jama.280.11.1015; Medicare Payment Advisory Commission, 2009, DAT BOOK HEALTHC SPE; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; US Department of Health and Human Services, 2010, HOSP COMP; Ward MM, 2002, J RHEUMATOL, V29, P1198; Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566	39	124	125	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					94	+		10.7326/0003-4819-154-2-201101180-00008	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00008			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706MW	21242366	Green Accepted			2022-12-24	WOS:000286223500003
J	Lyall, J; Irvine, RM; Sherman, A; McKinley, TJ; Nunez, A; Purdie, A; Outtrim, L; Brown, IH; Rolleston-Smith, G; Sang, H; Tiley, L				Lyall, Jon; Irvine, Richard M.; Sherman, Adrian; McKinley, Trevelyan J.; Nunez, Alejandro; Purdie, Auriol; Outtrim, Linzy; Brown, Ian H.; Rolleston-Smith, Genevieve; Sang, Helen; Tiley, Laurence			Suppression of Avian Influenza Transmission in Genetically Modified Chickens	SCIENCE			English	Article							VIRUS; TRANSCRIPTION; POLYMERASE; SYSTEM; RNAS; H5N1	Infection of chickens with avian influenza virus poses a global threat to both poultry production and human health that is not adequately controlled by vaccination or by biosecurity measures. A novel alternative strategy is to develop chickens that are genetically resistant to infection. We generated transgenic chickens expressing a short-hairpin RNA designed to function as a decoy that inhibits and blocks influenza virus polymerase and hence interferes with virus propagation. Susceptibility to primary challenge with highly pathogenic avian influenza virus and onward transmission dynamics were determined. Although the transgenic birds succumbed to the initial experimental challenge, onward transmission to both transgenic and nontransgenic birds was prevented.	[Lyall, Jon; McKinley, Trevelyan J.; Tiley, Laurence] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Irvine, Richard M.; Nunez, Alejandro; Outtrim, Linzy; Brown, Ian H.] Vet Lab Agcy, Addlestone KT15 3NB, Surrey, England; [Sherman, Adrian; Purdie, Auriol; Rolleston-Smith, Genevieve; Sang, Helen] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9PS, Midlothian, Scotland; [Sherman, Adrian; Purdie, Auriol; Rolleston-Smith, Genevieve; Sang, Helen] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9PS, Midlothian, Scotland	University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Tiley, L (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	Lst21@cam.ac.uk	Castel, Alejandro Núñez/C-2560-2011; Irvine, Richard M/E-2556-2011; Brown, Ian H/E-1119-2011	Irvine, Richard M/0000-0002-1584-4076; Purdie, Auriol/0000-0003-1941-6658; Nunez, Alejandro/0000-0001-5926-7541	Biotechnology and Biological Sciences Research Council [BB/G00479X/1, BBS/B/00239, BBS/B/00301]; Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England [VT0105]; Cobb-Vantress Ltd.; BBSRC [BB/G00479X/1] Funding Source: UKRI; MRC [G0300009] Funding Source: UKRI; Medical Research Council [G0300009] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England; Cobb-Vantress Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Lillico, F. Song, and H. Gilhooley for advice on laboratory methods and technical support; R. Mitchell, F. Thomson, and M. Hutchison for assistance in production and breeding of transgenic birds; S. Essen and W. Cox for assistance with the in vivo challenge studies at the Veterinary Laboratories Agency, Weybridge; P. Digard and W. Barclay for providing the component plasmids of the minireplicon assays; and Cobb-Vantress Ltd. for supporting part of this work. This work was supported by the Biotechnology and Biological Sciences Research Council (grants BB/G00479X/1, BBS/B/00239, and BBS/B/00301) and by the Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England (grant VT0105). Crown Copyright 2010.	Biswas SK, 1996, J VIROL, V70, P6716, DOI 10.1128/JVI.70.10.6716-6722.1996; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Chen JZ, 2008, J INFECT DIS, V197, pS25, DOI 10.1086/524987; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Howard W, 2007, AVIAN DIS, V51, P393, DOI 10.1637/7645-050906R1.1; Hunter CV, 2005, TRENDS MOL MED, V11, P293, DOI 10.1016/j.molmed.2005.04.001; Luo GX, 1997, J GEN VIROL, V78, P2329, DOI 10.1099/0022-1317-78-9-2329; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Swayne DE, 2001, AVIAN DIS, V45, P355, DOI 10.2307/1592975; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; WEBSTER RG, 1995, AM J RESP CRIT CARE, V152, pS25, DOI 10.1164/ajrccm/152.4_Pt_2.S25	14	127	137	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					223	226		10.1126/science.1198020	http://dx.doi.org/10.1126/science.1198020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233391				2022-12-24	WOS:000286433100045
J	Silk, AW; McTigue, KM				Silk, Ann Willman; McTigue, Kathleen M.			Reexamining the Physical Examination for Obese Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; BREAST-CANCER; DIAGNOSIS; STAGE		[Silk, Ann Willman] Univ Pittsburgh, Sch Med, UPMC Montefiore Hosp, Internal Med Residency Program, Pittsburgh, PA 15213 USA; [McTigue, Kathleen M.] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Silk, AW (corresponding author), Univ Pittsburgh, Sch Med, UPMC Montefiore Hosp, Internal Med Residency Program, N-713,200 Lothrop St, Pittsburgh, PA 15213 USA.	awsilk@gmail.com	Silk, Ann/J-6752-2017	Silk, Ann/0000-0003-3877-3984				Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Chagpar AB, 2007, AM SURGEON, V73, P555; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; Ferrante JM, 2010, OBESITY, V18, P1153, DOI 10.1038/oby.2009.481; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; Hahn KME, 2007, AM J EPIDEMIOL, V166, P1035, DOI 10.1093/aje/kwm177; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; WILLIAMS JW, 1992, JAMA-J AM MED ASSOC, V267, P2645, DOI 10.1001/jama.267.19.2645	10	31	32	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					193	194		10.1001/jama.2010.1950	http://dx.doi.org/10.1001/jama.2010.1950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21191004				2022-12-24	WOS:000286103400026
J	Decramer, M; Sibille, Y				Decramer, Marc; Sibille, Yves			European conference on chronic respiratory disease	LANCET			English	Editorial Material							PULMONARY REHABILITATION; COPD; CHILDHOOD; IMPACT		[Decramer, Marc] Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium; [Sibille, Yves] Univ Louvain, Louvain, Belgium	KU Leuven	Decramer, M (corresponding author), Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium.	marc.decramer@uzleuven.be						Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Brooks D, 2007, CAN RESPIR J, V14, P87, DOI 10.1155/2007/951498; Bush A, 2008, COPD, V5, P53, DOI 10.1080/15412550701815965; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; Chronic Disease Alliance, UN PREV APPR; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; *EUR COMM, 2009, SURV TOB AN REP; Gibson J, 2013, EUROPEAN LUNG WHITE BOOK: RESPIRATORY HEALTH AND DISEASE IN EUROPE, P16; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Laurent GJ, 2004, THORAX, V59, P1010, DOI 10.1136/thx.2004.024182; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Munthe-Kaas MC, 2010, J ALLERGY CLIN IMMUN, V125, P1361, DOI 10.1016/j.jaci.2010.02.010; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; The Forum of International Respiratory Societies (FIRS), YEAR LUNG; Troosters T, 2005, AM J RESP CRIT CARE, V172, P19, DOI 10.1164/rccm.200408-1109SO; WHO, 2008, WORLD HLTH STAT	18	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					104	106		10.1016/S0140-6736(10)62239-8	http://dx.doi.org/10.1016/S0140-6736(10)62239-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21168909				2022-12-24	WOS:000286292800007
J	Bao, YH; Shen, XT				Bao, Yunhe; Shen, Xuetong			SnapShot: Chromatin Remodeling: INO80 and SWR1	CELL			English	Editorial Material							COMPLEXES; TRANSCRIPTION; REPAIR		[Bao, Yunhe; Shen, Xuetong] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bao, YH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA.			Shen, Xuetong/0000-0002-4267-5298	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093104] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM093104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	9	36	38	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					158	U165		10.1016/j.cell.2010.12.024	http://dx.doi.org/10.1016/j.cell.2010.12.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215376	Green Accepted, Bronze			2022-12-24	WOS:000285993600015
J	Pall, P; Aina, T; Stone, DA; Stott, PA; Nozawa, T; Hilberts, AGJ; Lohmann, D; Allen, MR				Pall, Pardeep; Aina, Tolu; Stone, Daithi A.; Stott, Peter A.; Nozawa, Toru; Hilberts, Arno G. J.; Lohmann, Dag; Allen, Myles R.			Anthropogenic greenhouse gas contribution to flood risk in England and Wales in autumn 2000	NATURE			English	Article							CLIMATE-CHANGE; PRECIPITATION EXTREMES; UK; ATTRIBUTION; EMISSIONS; RAINFALL; TRENDS; MODEL	Interest in attributing the risk of damaging weather-related events to anthropogenic climate change is increasing(1). Yet climate models used to study the attribution problem typically do not resolve the weather systems associated with damaging events(2) such as the UK floods of October and November 2000. Occurring during the wettest autumn in England and Wales since records began in 1766(3,4), these floods damaged nearly 10,000 properties across that region, disrupted services severely, and caused insured losses estimated at 1.3 pound billion (refs 5, 6). Although the flooding was deemed a 'wakeup call' to the impacts of climate change at the time(7), such claims are typically supported only by general thermodynamic arguments that suggest increased extreme precipitation under global warming, but fail(8,9) to account fully for the complex hydrometeorology(4,10) associated with flooding. Here we present a multi-step, physically based 'probabilistic event attribution' framework showing that it is very likely that global anthropogenic greenhouse gas emissions substantially increased the risk of flood occurrence in England and Wales in autumn 2000. Using publicly volunteered distributed computing(11,12), we generate several thousand seasonal-forecast-resolution climate model simulations of autumn 2000 weather, both under realistic conditions, and under conditions as they might have been had these greenhouse gas emissions and the resulting large-scale warming never occurred. Results are fed into a precipitation-runoff model that is used to simulate severe daily river runoff events in England and Wales (proxy indicators of flood events). The precise magnitude of the anthropogenic contribution remains uncertain, but in nine out of ten cases our model results indicate that twentieth-century anthropogenic greenhouse gas emissions increased the risk of floods occurring in England and Wales in autumn 2000 by more than 20%, and in two out of three cases by more than 90%.	[Pall, Pardeep] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Pall, Pardeep; Stone, Daithi A.; Allen, Myles R.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Aina, Tolu] Univ Oxford, Oxford E Res Ctr, Oxford OX1 3QG, England; [Stone, Daithi A.; Allen, Myles R.] Oxford Univ Ctr Environm, Tyndall Ctr Oxford, Oxford OX1 3QY, England; [Stott, Peter A.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Nozawa, Toru] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hilberts, Arno G. J.; Lohmann, Dag] Risk Management Solut Ltd, London EC3R 8NB, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; University of Oxford; University of Oxford; Met Office - UK; Hadley Centre; National Institute for Environmental Studies - Japan	Pall, P (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland.	pardeep.pall@env.ethz.ch	Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016; Allen, Myles R/A-5172-2012	Stott, Peter/0000-0003-4853-7686; Stone, Daithi/0000-0002-2518-100X	NERC; Risk Management Solutions Ltd; WWF International; UK Department for Environment, Food, and Rural Affairs; Joint DECC and Defra Integrated Climate Programme-DECC/Defra [GA01101]; Japanese Ministry of Education, Culture, Sports, Science and Technology; US National Oceanic and Atmospheric Administration's Office; US Department of Energy; European Union [036946]; Smith School of Enterprise and the Environment	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Risk Management Solutions Ltd; WWF International; UK Department for Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Joint DECC and Defra Integrated Climate Programme-DECC/Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Oceanic and Atmospheric Administration's Office; US Department of Energy(United States Department of Energy (DOE)); European Union(European Commission); Smith School of Enterprise and the Environment	We thank all members of the public who ran HadAM3-N144 climate model simulations using the BOINC open source computing platform, and the climateprediction. net team for their technical support; M. Collins, N. Rayner, A. Jones and C. Johnson for originally supplying the HadAM3-N144 model, observed SSTs and sea ice, sulphate fields, and ozone fields, respectively; G. Meehl and T. Knutson for permission to use NCARPCM1 and GFDLR30 temperature data, respectively; S. Hay and I. Tracey for assistance with beta tests; C. Lee for technical advice; and W. Ingram and D. Rowlands for scientific advice. P.P. was supported by a NERC CASE studentship with Risk Management Solutions Ltd, by WWF International, and by NCCR climate. D.A.S. and P.P. received partial support from the UK Department for Environment, Food, and Rural Affairs. P.A.S. was supported by the Joint DECC and Defra Integrated Climate Programme-DECC/Defra (GA01101). T.N. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology. D.A.S. and M.R.A. received additional support from the Climate Change Detection and Attribution Project jointly funded by the US National Oceanic and Atmospheric Administration's Office of Global Programs and the US Department of Energy. This research was also supported by the European Union (FP6) funded Integrated Project WATCH (contract number 036946) and the Smith School of Enterprise and the Environment.	Alexander LV, 2000, ATMOS SCI LETT, V1, P142, DOI 10.1006/asle.2001.0025; Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; [Anonymous], 2005, TRENDS COMPENDIUM DA; Association of British Insurers, 2001, FLOOD PARTN APPR PRO; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Blackburn M., 2001, ATMOSPHERIC VARIABIL; Department for Environment Food and Rural Affairs, 2001, FD2304 DEFRA; Environment Agency, 2001, LESS LEARN AUT 2000; Fowler HJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017327; Fowler HJ, 2003, INT J CLIMATOL, V23, P1313, DOI 10.1002/joc.943; Hannaford J, 2008, INT J CLIMATOL, V28, P1325, DOI 10.1002/joc.1643; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Lenderink G, 2008, NAT GEOSCI, V1, P511, DOI 10.1038/ngeo262; Lohmann D, 1996, TELLUS A, V48, P708, DOI 10.1034/j.1600-0870.1996.t01-3-00009.x; Maraun D, 2008, INT J CLIMATOL, V28, P833, DOI 10.1002/joc.1672; Marsh TJ, 2002, J CHART INST WATER E, V16, P180; Massacand A. C., 2003, 415 ECMWF; Massey N., 2006, ADV GEOSCI, V8, P49, DOI DOI 10.5194/ADGE0-8-49-2006); Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Natural Environmental Research Council - Centre for Ecology & Hydrology, 2010, NAT RIV FLOW ARCH; Nozawa T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023540; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Pitt M., 2008, PITT REV LESSONS LEA, VVolume 505; Pope VD, 2002, CLIM DYNAM, V19, P211, DOI 10.1007/s00382-001-0222-8; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Robson AJ, 2002, PHILOS T ROY SOC A, V360, P1327, DOI 10.1098/rsta.2002.1003; Sexton DMH, 2001, CLIM DYNAM, V17, P669, DOI 10.1007/s003820000141; Stone DA, 2005, CLIMATIC CHANGE, V71, P303, DOI 10.1007/s10584-005-6778-2; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Stott PA, 2006, J CLIMATE, V19, P3055, DOI 10.1175/JCLI3802.1; Stott PA, 2010, WIRES CLIM CHANGE, V1, P192, DOI 10.1002/wcc.34; United Nations Framework Convention on Climate Change (UNFCCC), 2007, FCCCKPCMP200610; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wilby RL, 2008, HYDROL PROCESS, V22, P2511, DOI 10.1002/hyp.6847	37	589	604	11	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					382	385		10.1038/nature09762	http://dx.doi.org/10.1038/nature09762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331040				2022-12-24	WOS:000287409100039
J	Stanescu, HC; Arcos-Burgos, M; Medlar, A; Bockenhauer, D; Kottgen, A; Dragomirescu, L; Voinescu, C; Patel, N; Pearce, K; Hubank, M; Stephens, HAF; Laundy, V; Padmanabhan, S; Zawadzka, A; Hofstra, JM; Coenen, MJH; den Heijer, M; Kiemeney, LALM; Bacq-Daian, D; Stengel, B; Powis, SH; Brenchley, P; Feehally, J; Rees, AJ; Debiec, H; Wetzels, JFM; Ronco, P; Mathieson, PW; Kleta, R				Stanescu, Horia C.; Arcos-Burgos, Mauricio; Medlar, Alan; Bockenhauer, Detlef; Kottgen, Anna; Dragomirescu, Liviu; Voinescu, Catalin; Patel, Naina; Pearce, Kerra; Hubank, Mike; Stephens, Henry A. F.; Laundy, Valerie; Padmanabhan, Sandosh; Zawadzka, Anna; Hofstra, Julia M.; Coenen, Marieke J. H.; den Heijer, Martin; Kiemeney, Lambertus A. L. M.; Bacq-Daian, Delphine; Stengel, Benedicte; Powis, Stephen H.; Brenchley, Paul; Feehally, John; Rees, Andrew J.; Debiec, Hanna; Wetzels, Jack F. M.; Ronco, Pierre; Mathieson, Peter W.; Kleta, Robert			Risk HLA-DQA1 and PLA(sub 2)R1 Alleles in Idiopathic Membranous Nephropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLASS-II GENES; GLOMERULONEPHRITIS; RECEPTOR; ANTIGEN; SUSCEPTIBILITY; DETERMINANTS; AUTOIMMUNITY; LOCI	Background: Idiopathic membranous nephropathy is a major cause of the nephrotic syndrome in adults, but its etiologic basis is not fully understood. We investigated the genetic basis of biopsy-proven cases of idiopathic membranous nephropathy in a white population. Methods: We performed independent genomewide association studies of single-nucleotide polymorphisms (SNPs) in patients with idiopathic membranous nephropathy from three populations of white ancestry (75 French, 146 Dutch, and 335 British patients). The patients were compared with racially matched control subjects; population stratification and quality controls were carried out according to standard criteria. Associations were calculated by means of a chi-square basic allele test; the threshold for significance was adjusted for multiple comparisons (with the Bonferroni method). Results: In a joint analysis of data from the 556 patients studied (398 men), we identified significant alleles at two genomic loci associated with idiopathic membranous nephropathy. Chromosome 2q24 contains the gene encoding M-type phospholipase A(sub 2) receptor (PLA(sub 2)R1) (SNP rs4664308, P=8.6 x 10(sup -29)), previously shown to be the target of an autoimmune response. Chromosome 6p21 contains the gene encoding HLA complex class II HLA-DQ alpha chain 1 (HLA-DQA1) (SNP rs2187668, P=8.0 x 10(sup -93)). The association with HLA-DQA1 was significant in all three populations (P=1.8 x 10(sup -9), P=5.6 x 10(sup -27), and P=5.2 x 10(sup -36) in the French, Dutch, and British groups, respectively). The odds ratio for idiopathic membranous nephropathy with homozygosity for both risk alleles was 78.5 (95% confidence interval, 34.6 to 178.2). Conclusions: An HLA-DQA1 allele on chromosome 6p21 is most closely associated with idiopathic membranous nephropathy in persons of white ancestry. This allele may facilitate an autoimmune response against targets such as variants of PLA2R1. Our findings suggest a basis for understanding this disease and illuminate how adaptive immunity is regulated by HLA. N Engl J Med 2011;364:616-26.	[Stanescu, Horia C.; Medlar, Alan; Bockenhauer, Detlef; Voinescu, Catalin; Patel, Naina; Stephens, Henry A. F.; Powis, Stephen H.; Kleta, Robert] UCL, Royal Free Hosp, Ctr Nephrol, London NW3 2PF, England; [Stanescu, Horia C.; Bockenhauer, Detlef; Patel, Naina; Pearce, Kerra; Hubank, Mike; Kleta, Robert] UCL, Inst Child Hlth, London NW3 2PF, England; [Kleta, Robert] UCL, Dept Physiol, London NW3 2PF, England; [Kleta, Robert] UCL, Genet Inst, London NW3 2PF, England; [Bockenhauer, Detlef; Kleta, Robert] Great Ormond St Hosp Sick Children, London, England; [Stephens, Henry A. F.] Anthony Nolan Trust, London, England; [Laundy, Valerie; Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Padmanabhan, Sandosh] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Zawadzka, Anna] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Brenchley, Paul] Univ Manchester, Sch Biomed, Manchester, Lancs, England; [Feehally, John] Univ Leicester, John Walls Renal Unit, Leicester, Leics, England; [Feehally, John] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Arcos-Burgos, Mauricio] NHGRI, NIH, Bethesda, MD 20892 USA; [Kottgen, Anna] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Kottgen, Anna] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Dragomirescu, Liviu] Univ Bucharest, Dept Syst Ecol, Bucharest, Romania; [Hofstra, Julia M.; Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Hubank, Mike; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Bacq-Daian, Delphine] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Stengel, Benedicte] Univ Paris Sud, INSERM, UMR S 1018, Villejuif, France; [Debiec, Hanna; Ronco, Pierre] Univ Paris 06, Tenon Hosp, AP HP, INSERM,UMR S 702, Paris, France; [Rees, Andrew J.] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Bristol; University of Glasgow; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; University of Leicester; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Freiburg; Johns Hopkins University; University of Bucharest; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Medical University of Vienna	Kleta, R (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	r.kleta@ucl.ac.uk	Padmanabhan, Sandosh/S-3963-2016; Ronco, Pierre/AAC-8390-2022; Coenen, Marieke/A-2159-2010; Hubank, Michael JF/C-1837-2008; Stengel, Benedicte/G-5730-2015; Bockenhauer, Detlef/C-5951-2008; Kiemeney, Lambertus A./D-3357-2009; Bockenhauer, Detlef/AAF-6495-2020; Kottgen, Anna/D-2920-2012; Hofstra, Julia/A-4171-2015; Vargas Alfonso, Alba Lucia/E-1581-2015; Debiec, Hanna/AAL-8144-2021; Wetzels, Jack F.M./A-1720-2014; den Heijer, Martin/J-8036-2015; Arcos-Burgos, Mauricio/H-1326-2017	Coenen, Marieke/0000-0001-8796-2031; Hubank, Michael JF/0000-0002-2901-0742; Stengel, Benedicte/0000-0001-9469-0804; Bockenhauer, Detlef/0000-0001-5878-941X; Kiemeney, Lambertus A./0000-0002-2368-1326; Bockenhauer, Detlef/0000-0001-5878-941X; Vargas Alfonso, Alba Lucia/0000-0001-7984-0560; Debiec, Hanna/0000-0002-8946-8245; Wetzels, Jack F.M./0000-0002-0650-6921; Padmanabhan, Sandosh/0000-0003-3869-5808; Brenchley, Paul/0000-0003-1290-9919; den Heijer, Martin/0000-0003-3620-5617; Voinescu, Catalin/0000-0002-3636-8689; Arcos-Burgos, Mauricio/0000-0002-8529-0574	David and Elaine Potter Charitable Foundation; St Peter's Trust for Kidney, Bladder and Prostate Research; Special Trustees of Great Ormond Street Hospital; Kids Kidney Research UK; Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester; MRC [G0000934]; Wellcome Trust [068545/Z/02]; National Institute for Health Research Manchester Biomedical Research Centre; Kidney Research UK; Dutch Kidney Foundation; French Ministry of Health [PHRC AOM 00022]; Ministry of Environment [EN00D08]; Ministry of Research [01P0513]; Biomedecine Agency; Agence Nationale pour la Recherche [ANR-07-Physio-016-01]; European Community [HEALTH-F2-2007-201590]; Fondation pour la Recherche Medicale; Association pour l'Utilisation du Rein Artificiel; Assistance Publique-Hopitaux de Paris; Medical Research Council [G9721265, G0000934] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish; MRC [G9721265] Funding Source: UKRI	David and Elaine Potter Charitable Foundation; St Peter's Trust for Kidney, Bladder and Prostate Research; Special Trustees of Great Ormond Street Hospital; Kids Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Kidney Research UK(Kidney Research UK (KRUK)); Dutch Kidney Foundation; French Ministry of Health; Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Biomedecine Agency; Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour l'Utilisation du Rein Artificiel; Assistance Publique-Hopitaux de Paris; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the David and Elaine Potter Charitable Foundation (to Drs. Powis and Kleta), St Peter's Trust for Kidney, Bladder and Prostate Research (to Drs. Bockenhauer, Powis, and Kleta), the Special Trustees of Great Ormond Street Hospital (to Dr. Bockenhauer), Kids Kidney Research UK (to Drs. Bockenhauer and Kleta), Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester; grants from the MRC (G0000934) and the Wellcome Trust (068545/Z/02); the National Institute for Health Research Manchester Biomedical Research Centre (to Dr. Brenchley); and the MRC and Kidney Research UK, as part of the MRC/Kidney Research UK National DNA Bank for Glomerulonephritis, for the collection of the British idiopathic membranous nephropathy DNA samples; grants from the Dutch Kidney Foundation (Nierstichting Nederland OW 08, to Drs. Wetzels and Hofstra); grants from the French Ministry of Health (PHRC AOM 00022), the Ministry of Environment (Decision d'aide EN00D08), the Ministry of Research (Decision d'aide 01P0513), and the Biomedecine Agency (AO Recherche et Greffes 2005); grants from the Agence Nationale pour la Recherche (ANR-07-Physio-016-01), Coordination Theme 1 (Health) of the European Community's 7th Framework Program (HEALTH-F2-2007-201590), Fondation pour la Recherche Medicale, and Association pour l'Utilisation du Rein Artificiel (to Drs. Ronco and Debiec), and a Contrat d'Interface from Assistance Publique-Hopitaux de Paris (to Dr. Debiec).	ABE S, 1986, J CLIN PATHOL, V39, P1193, DOI 10.1136/jcp.39.11.1193; AUSTIN HA, 1992, ANN INTERN MED, V116, P672, DOI 10.7326/0003-4819-116-8-672; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BERTHOUX FC, 1990, PRESSE MED, V19, P990; Bockenhauer D, 2008, NEPHRON CLIN PRACT, V108, pC10, DOI 10.1159/000112466; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; CAMERON J S, 1965, Guys Hosp Rep, V114, P101; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DYER PA, 1992, NEPHROL DIAL TRANSPL, V7, P42; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Glassock RJ, 2009, NEW ENGL J MED, V361, P81, DOI 10.1056/NEJMe0903343; Hofstra JM, 2010, NEPHROL DIAL TRANSPL, V25, P1760, DOI 10.1093/ndt/gfq017; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; KLOUDA PT, 1979, LANCET, V2, P770, DOI 10.1016/S0140-6736(79)92118-4; Lefaucheur C, 2006, KIDNEY INT, V70, P1510, DOI 10.1038/sj.ki.5001790; Li SJ, 2010, CLIN J AM SOC NEPHRO, V5, P439, DOI 10.2215/CJN.07571009; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; Moranne O, 2008, QJM-INT J MED, V101, P215, DOI 10.1093/qjmed/hcm142; OGAHARA S, 1992, KIDNEY INT, V41, P175, DOI 10.1038/ki.1992.24; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; PELLETIER L, 1987, SPRINGER SEMIN IMMUN, V9, P359; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Ponticelli C, 2007, J NEPHROL, V20, P268; Powis SH, 2003, OX MG MED G, V48, P417; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Rees A, 2009, NAT REV NEPHROL, V5, P617, DOI 10.1038/nrneph.2009.167; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Salant DJ, 2009, NEPHRON PHYSIOL, V112, pP11, DOI 10.1159/000212068; SHORT CD, 1984, BRIT MED J, V289, P1500, DOI 10.1136/bmj.289.6457.1500; SOLLID LM, 2002, COELIAC DIS DISSECTI; VAUGHAN RW, 1989, TISSUE ANTIGENS, V34, P261, DOI 10.1111/j.1399-0039.1989.tb01741.x; Waldman M, 2009, NAT REV NEPHROL, V5, P469, DOI 10.1038/nrneph.2009.101; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374	40	338	376	3	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					616	626		10.1056/NEJMoa1009742	http://dx.doi.org/10.1056/NEJMoa1009742			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323541	Green Published, Bronze			2022-12-24	WOS:000287406000007
J	Arie, S				Arie, Sophie			Vaccines Global HPV vaccination	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						Center for Disease Control, 2011, VACC IMM; World Health Organization/Information Commissioner's Office Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC SUM; World Health Organization (WHO), 2008, HUM PAP HPV VACC BAC	3	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1042	10.1136/bmj.d1042	http://dx.doi.org/10.1136/bmj.d1042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325382				2022-12-24	WOS:000287656500013
J	Sen Gupta, P; Green, AN; Chowdhury, TA				Sen Gupta, Piya; Green, Andrea N.; Chowdhury, Tahseen A.			Practice 10-Minute Consultation Hypoglycaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material												psengupta79@doctors.net.uk		Sen Gupta, Piya/0000-0002-2800-7365					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d567	10.1136/bmj.d567	http://dx.doi.org/10.1136/bmj.d567			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325388				2022-12-24	WOS:000287656500017
J	Glick, S				Glick, Shimon			Personal View Withholding versus withdrawal of life support: is there an ethical difference?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSISTED SUICIDE; EUTHANASIA; END; ATTITUDES		Ben Gurion Univ Negev, Joyce & Irving Goldman Sch Med, Lord Rabbi Immanuel Jakobovits Ctr Jewish Med Eth, IL-84105 Beer Sheva, Israel	Ben Gurion University	Glick, S (corresponding author), Ben Gurion Univ Negev, Joyce & Irving Goldman Sch Med, Lord Rabbi Immanuel Jakobovits Ctr Jewish Med Eth, IL-84105 Beer Sheva, Israel.	gshimon@bgu.ac.il						Abramson N, 1998, SOUTHERN MED J, V91, P637, DOI 10.1097/00007611-199807000-00006; Dickenson DL, 2000, J MED ETHICS, V26, P254, DOI 10.1136/jme.26.4.254; Elliott C, 1996, BRIT MED J, V313, P1088; Grossman D., 2000, PSYCHOL EFFECTS COMB; Hopkins PD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528666; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; Ravitsky V, 2005, BRIT MED J, V330, P415, DOI 10.1136/bmj.330.7488.415; RAVITSKY V, 2008, J JEWISH MED ETHICS, V6, P13; Rebagliato M, 2000, JAMA-J AM MED ASSOC, V284, P2451, DOI 10.1001/jama.284.19.2451	9	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d728	10.1136/bmj.d728	http://dx.doi.org/10.1136/bmj.d728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307111				2022-12-24	WOS:000287402900017
J	Hudson, T				Hudson, Tom			Genomics and Clinical Relevance	SCIENCE			English	Editorial Material									Ontario Inst Canc Res, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Hudson, T (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.								0	2	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					547	547		10.1126/science.1202572	http://dx.doi.org/10.1126/science.1202572			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292965				2022-12-24	WOS:000286933600040
J	Dowell, SF; Tappero, JW; Frieden, TR				Dowell, Scott F.; Tappero, Jordan W.; Frieden, Thomas R.			Public Health in Haiti - Challenges and Progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dowell, Scott F.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA; [Tappero, Jordan W.] Ctr Dis Control & Prevent, Hlth Syst Reconstruct Off, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dowell, SF (corresponding author), Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Rapid establishment of an internally displaced persons disease surveillance system after an earthquake-Haiti, 2010, MMWR MORB MORTAL WKL, V59, P939; *WHO UNICEF JMP WA, PROGR SAN DRINK WAT; 2010, MMWR MORB MORTAL WKL, V59, P1372; 2011, DONNEES PRELIMINAIRE; 2010, MMWR MORB MORTAL WKL, V59, P1637	5	40	40	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					300	301		10.1056/NEJMp1100118	http://dx.doi.org/10.1056/NEJMp1100118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21219131	Bronze			2022-12-24	WOS:000286592600004
J	Afek, Y; Alon, N; Barad, O; Hornstein, E; Barkai, N; Bar-Joseph, Z				Afek, Yehuda; Alon, Noga; Barad, Omer; Hornstein, Eran; Barkai, Naama; Bar-Joseph, Ziv			A Biological Solution to a Fundamental Distributed Computing Problem	SCIENCE			English	Article							LATERAL INHIBITION; PARALLEL ALGORITHM; PATTERN-FORMATION; SET; PATHWAY	Computational and biological systems are often distributed so that processors (cells) jointly solve a task, without any of them receiving all inputs or observing all outputs. Maximal independent set (MIS) selection is a fundamental distributed computing procedure that seeks to elect a set of local leaders in a network. A variant of this problem is solved during the development of the fly's nervous system, when sensory organ precursor (SOP) cells are chosen. By studying SOP selection, we derived a fast algorithm for MIS selection that combines two attractive features. First, processors do not need to know their degree; second, it has an optimal message complexity while only using one-bit messages. Our findings suggest that simple and efficient algorithms can be developed on the basis of biologically derived insights.	[Barad, Omer; Hornstein, Eran; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Afek, Yehuda; Alon, Noga] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Afek, Yehuda; Alon, Noga] Tel Aviv Univ, Sackler Sch Math, IL-69978 Tel Aviv, Israel; [Alon, Noga] Inst Adv Study, Princeton, NJ 08544 USA; [Bar-Joseph, Ziv] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA	Weizmann Institute of Science; Tel Aviv University; Tel Aviv University; Institute for Advanced Study - USA; Carnegie Mellon University	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il; zivbj@cs.cmu.edu	Bar-Joseph, Ziv/GWN-2754-2022; Alon, Noga/GOV-5970-2022; HORNSTEIN, ERAN/K-1340-2012	Alon, Noga/0000-0003-1332-4883; HORNSTEIN, ERAN/0000-0002-5534-1924; Bar-Joseph, Ziv/0000-0003-3430-6051	European Research Council (ERC); Oswald Veblen Fund; Bell Companies Fellowship; Azrieli Foundation; Israel Science Foundation; Hellen and Martin Kimmel award for innovative investigations; NIH [1RO1 GM085022]; NSF [0448453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085022] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)); Oswald Veblen Fund; Bell Companies Fellowship; Azrieli Foundation; Israel Science Foundation(Israel Science Foundation); Hellen and Martin Kimmel award for innovative investigations; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. W. Posakony for fly stock and D. Rosin for help in experiments. This work was supported by a European Research Council (ERC) Advanced grant, the Oswald Veblen Fund, and the Bell Companies Fellowship (N.A.), the Azrieli Foundation (O.B.), the Israel Science Foundation (E. H. and N.B.), ERC (IDEA), the Hellen and Martin Kimmel award for innovative investigations (N.B.), NIH grant 1RO1 GM085022, and NSF CAREER award 0448453 (Z.B.-J.).	ALON N, 1986, J ALGORITHM, V7, P567, DOI 10.1016/0196-6774(86)90019-2; Alon U., 2006, INTRO SYSTEMS BIOL D; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barad O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000857; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; COHEN S, 1984, THEOR COMPUT SCI, V34, P215, DOI 10.1016/0304-3975(84)90118-X; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; LUBY M, 1986, SIAM J COMPUT, V15, P1036, DOI 10.1137/0215074; Lynch N. A., 1996, DISTRIBUTED ALGORITH; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Moscibroda T., 2005, P 24 ANN ACM S PRINC, P148; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; RENDEL JM, 1965, GENETICS, V52, P1137; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Valiant Leslie G., 1982, P 7 IBM S MATH FDN C; Wan PJ, 2004, MOBILE NETW APPL, V9, P141, DOI 10.1023/B:MONE.0000013625.87793.13; Yves Metivier, 2009, Structural Information and Communication Complexity. 16th International Colloquium, SIROCCO 2009. Revised Selected Papers, P323	23	89	93	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					183	185		10.1126/science.1193210	http://dx.doi.org/10.1126/science.1193210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233379				2022-12-24	WOS:000286433100033
J	Mold, JE; Venkatasubrahmanyam, S; Burt, TD; Michaelsson, J; Rivera, JM; Galkina, SA; Weinberg, K; Stoddart, CA; McCune, JM				Mold, Jeff E.; Venkatasubrahmanyam, Shivkumar; Burt, Trevor D.; Michaelsson, Jakob; Rivera, Jose M.; Galkina, Sofiya A.; Weinberg, Kenneth; Stoddart, Cheryl A.; McCune, Joseph M.			Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans	SCIENCE			English	Article							MATERNAL HLA ANTIGENS; EARLY EVENTS; HUMAN FETUS; LONG-TERM; IN-UTERO; IDENTIFICATION; EXPRESSION; TOLERANCE; RESPONSES; ONTOGENY	Although the mammalian immune system is generally thought to develop in a linear fashion, findings in avian and murine species argue instead for the developmentally ordered appearance (or "layering") of distinct hematopoietic stem cells (HSCs) that give rise to distinct lymphocyte lineages at different stages of development. Here we provide evidence of an analogous layered immune system in humans. Our results suggest that fetal and adult T cells are distinct populations that arise from different populations of HSCs that are present at different stages of development. We also provide evidence that the fetal T cell lineage is biased toward immune tolerance. These observations offer a mechanistic explanation for the tolerogenic properties of the developing fetus and for variable degrees of immune responsiveness at birth.	[Mold, Jeff E.; Burt, Trevor D.; Rivera, Jose M.; Galkina, Sofiya A.; Stoddart, Cheryl A.; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA; [Venkatasubrahmanyam, Shivkumar] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; [Michaelsson, Jakob] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Weinberg, Kenneth] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; Karolinska Institutet; Stanford University	McCune, JM (corresponding author), Univ Calif San Francisco, Div Expt Med, Dept Med, UCSF Box 1234,SFGH Bldg 3, San Francisco, CA 94143 USA.	mike.mccune@ucsf.edu		Mold, Jeffrey/0000-0003-2195-2978; Burt, Trevor/0000-0001-7933-529X	NIH [OD000329, AI40312, CA049605, AG033314]; Harvey V. Berneking Living Trust; National Institute of Allergy and Infectious Diseases, NIH [N01-AI-70002]; Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology; Swedish Research Council; American Pediatric Society; American Academy of Pediatrics; March of Dimes; NIH, NIH Roadmap for Medical Research [DPI OD00329]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040312, P30AI027763, R01AI040312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey V. Berneking Living Trust; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology; Swedish Research Council(Swedish Research CouncilEuropean Commission); American Pediatric Society; American Academy of Pediatrics; March of Dimes(March of Dimes); NIH, NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all of the patients who generously donated tissue that was used in these studies. We also thank S. J. Fisher and D. F. Nixon for valuable discussions; A. J. Butte, M. E. Moreno, and G. Kosikova for technical support; and the Gladstone Genomics Core for microarray analysis. Support for this work was provided by grants from NIH to J. M. M. (OD000329 and AI40312) and to K. W. and A. J. Butte (CA049605 and AG033314) and from the Harvey V. Berneking Living Trust. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, under contract no. N01-AI-70002. S. V. is supported by the Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology. J. M. is supported by the Swedish Research Council. T. D. B. received funding from American Pediatric Society, the American Academy of Pediatrics, and the March of Dimes as a fellow of the Pediatric Scientist Development Program. J. M. M. is a recipient of the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant DPI OD00329. The microarray data have been deposited in the Gene Expression Omnibus with accession code GSE25119.	BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BRENT L, 1989, IMMUNOL LETT, V21, P55, DOI 10.1016/0165-2478(89)90012-6; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; BYRNE JA, 1994, J IMMUNOL, V152, P3098; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Harrison DE, 1997, EXP HEMATOL, V25, P293; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; LUCIVERO G, 1991, Fetal Diagnosis and Therapy, V6, P101; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Muench MO, 2003, DEV COMP IMMUNOL, V27, P899, DOI 10.1016/S0145-305X(03)00081-8; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Tavian M, 2005, EXP HEMATOL, V33, P1062, DOI 10.1016/j.exphem.2005.06.025; ZANJANI ED, 1993, BLOOD, V81, P399	26	282	285	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1695	1699		10.1126/science.1196509	http://dx.doi.org/10.1126/science.1196509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164017	Green Accepted			2022-12-24	WOS:000285390500072
J	Moon, JC; Flett, AS; Godman, BB; Grosso, AM; Wierzbicki, AS				Moon, James C.; Flett, Andrew S.; Godman, Brian B.; Grosso, Anthony M.; Wierzbicki, Anthony S.			Getting better value from the NHS drug budget	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWITCHING STATINS; INITIATIVES; SIMVASTATIN; EFFICIENCY; REFORMS; ENHANCE; IMPACT; COST		[Moon, James C.; Flett, Andrew S.] Univ Coll London Hosp, Heart Hosp, London W1M 8PH, England; [Godman, Brian B.] Mario Negri Inst Pharmacol Res, Milan, Italy; [Godman, Brian B.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Grosso, Anthony M.] Univ Coll London Hosp, Dept Pharm, London NW1 2PG, England; [Wierzbicki, Anthony S.] Guys & St Thomas NHS Trust, St Thomas Hosp, London SE1 7EH, England	University College London Hospitals NHS Foundation Trust; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Karolinska Institutet; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Moon, JC (corresponding author), Univ Coll London Hosp, Heart Hosp, London W1M 8PH, England.	james.moon@uclh.nhs.uk	Wierzbicki, Anthony/AAP-1735-2020; Godman, Brian/R-8897-2019; Moon, James/AAA-9905-2020; Moon, James C/F-1031-2014	Wierzbicki, Anthony/0000-0003-2756-372X; Moon, James/0000-0001-8071-1491; Moon, James C/0000-0001-8071-1491				British Hypertension Society, 2010, GUID MAN HYP; Erhardt LR, 2005, INT J CLIN PRACT, V59, P571, DOI 10.1111/j.1368-5031.2005.00513.x; Godman B, 2008, PHARMACOECONOMICS, V26, P91, DOI 10.2165/00019053-200826020-00001; Godman B, 2010, PHARMACEUTICALS, V3, P2470, DOI 10.3390/ph3082470; Godman B, 2010, EXPERT REV PHARM OUT, V10, P199, DOI [10.1586/erp.10.6, 10.1586/ERP.10.6]; Godman Brian, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P475, DOI 10.1586/erp.09.43; Gumbs PD, 2007, BRIT J CLIN PHARMACO, V64, P680, DOI 10.1111/j.1365-2125.2007.02958.x; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Light D., 2010, RISKS PRESCRIPTION D; McGinn D, 2010, EXPERT REV PHARM OUT, V10, P73, DOI [10.1586/erp.09.73, 10.1586/ERP.09.73]; Meredith PA, 2010, J HUM HYPERTENS, V24, P525, DOI 10.1038/jhh.2009.99; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; NHS Information Centre, 2010, PRESCR COST AN 2009; Prosser H, 2005, SOC SCI MED, V60, P1335, DOI 10.1016/j.socscimed.2004.07.013; Sakshaug S, 2007, BRIT J CLIN PHARMACO, V64, P476, DOI 10.1111/j.1365-2125.2007.02907.x; Sermet C, 2010, APPL HEALTH ECON HEA, V8, P7, DOI 10.2165/11313900-000000000-00000; Universtiy College London Hospital NHS Trust, 2010, UCLH GUID ANG 2 REC; Usher-Smith J, 2008, INT J CLIN PRACT, V62, P480, DOI 10.1111/j.1742-1241.2007.01690.x; Wettermark B, 2008, PHARMACOECONOMICS, V26, P537, DOI 10.2165/00019053-200826070-00001; Wright J.M, 2008, COCHRANE DB SYST REV, V2008, DOI [10.1002/14651858.CD003822.pub2., DOI 10.1002/14651858.CD003822.PUB2]	21	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2010	341								c6449	10.1136/bmj.c6449	http://dx.doi.org/10.1136/bmj.c6449			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XO	21169320				2022-12-24	WOS:000285553300006
J	Donnelly, P				Donnelly, Peter			Making Sense of the Data	SCIENCE			English	Editorial Material									Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.			Donnelly, Peter/0000-0001-9495-3408					0	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1024	1025		10.1126/science.1204089	http://dx.doi.org/10.1126/science.1204089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350160				2022-12-24	WOS:000287699000045
J	Al-Gazali, L				Al-Gazali, Lihadh			Human Genome Sequencing: Celebrating 10 years	SCIENCE			English	Editorial Material									United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates	United Arab Emirates University	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates.								0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	873		10.1126/science.1203266	http://dx.doi.org/10.1126/science.1203266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330531				2022-12-24	WOS:000287455100042
J	Lesburgueres, E; Gobbo, OL; Alaux-Cantin, S; Hambucken, A; Trifilieff, P; Bontempi, B				Lesburgueres, Edith; Gobbo, Oliviero L.; Alaux-Cantin, Stephanie; Hambucken, Anne; Trifilieff, Pierre; Bontempi, Bruno			Early Tagging of Cortical Networks Is Required for the Formation of Enduring Associative Memory	SCIENCE			English	Article							LONG-TERM-MEMORY; TRANSMITTED FOOD PREFERENCES; ORBITOFRONTAL CORTEX; SYNAPTIC PLASTICITY; REMOTE MEMORY; CONSOLIDATION; HIPPOCAMPUS; ACTIVATION; CASCADE; STORAGE	Although formation and stabilization of long-lasting associative memories are thought to require time-dependent coordinated hippocampal-cortical interactions, the underlying mechanisms remain unclear. Here, we present evidence that neurons in the rat cortex must undergo a "tagging process" upon encoding to ensure the progressive hippocampal-driven rewiring of cortical networks that support remote memory storage. This process was AMPA-and N-methyl-D-aspartate receptor-dependent, information-specific, and capable of modulating remote memory persistence by affecting the temporal dynamics of hippocampal-cortical interactions. Post-learning reinforcement of the tagging process via time-limited epigenetic modifications resulted in improved remote memory retrieval. Thus, early tagging of cortical networks is a crucial neurobiological process for remote memory formation whose functional properties fit the requirements imposed by the extended time scale of systems-level memory consolidation.	[Bontempi, Bruno] Univ Bordeaux 1, CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33405 Talence, France; Univ Bordeaux 2, CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bontempi, B (corresponding author), Univ Bordeaux 1, CNRS, UMR 5293, Inst Malad Neurodegenerat, Ave Fac, F-33405 Talence, France.	bruno.bontempi@u-bordeaux2.fr	Gobbo, Oliviero L/R-1763-2016; Gobbo, Oliviero/S-2043-2019; Trifilieff, Pierre/ABB-4317-2020	Gobbo, Oliviero L/0000-0003-4629-9485; Gobbo, Oliviero/0000-0003-4629-9485; Trifilieff, Pierre/0000-0002-7893-9697	CNRS, Fondation Simone et Cino del Duca; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (ANR) [09-MNPS-005-01]	CNRS, Fondation Simone et Cino del Duca(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	We thank T. Durkin for comments on earlier drafts of the manuscript and T. Maviel, L. Restivo, M. Ammassari-Teule, C. Saugier, L. Decorte, and A. Faugere for their experimental contribution or technical advice. This work was supported by the CNRS, Fondation Simone et Cino del Duca (B.B. and O.L.G.), Federation pour la Recherche sur le Cerveau (B.B.), and the Agence Nationale de la Recherche (ANR grant 09-MNPS-005-01 to B.B.).	Alvarez P, 2001, LEARN MEMORY, V8, P79, DOI 10.1101/lm.38201; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Galef BG, 2003, LEARN BEHAV, V31, P160; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Smith CA, 2010, BEHAV BRAIN RES, V208, P243, DOI 10.1016/j.bbr.2009.12.001; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2	28	216	218	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					924	928		10.1126/science.1196164	http://dx.doi.org/10.1126/science.1196164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330548				2022-12-24	WOS:000287455100061
J	Green, ED; Guyer, MS				Green, Eric D.; Guyer, Mark S.		Natl Human Genome Res Inst	Charting a course for genomic medicine from base pairs to bedside	NATURE			English	Article							ABL TYROSINE KINASE; AMERICAN SOCIETY; MYELOID-LEUKEMIA; WIDE ASSOCIATION; GENE-MUTATIONS; DISEASE; INFORMATION; AUTOPHAGY; CARE; RISK	There has been much progress in genomics in the ten years since a draft sequence of the human genome was published. Opportunities for understanding health and disease are now unprecedented, as advances in genomics are harnessed to obtain robust foundational knowledge about the structure and function of the human genome and about the genetic contributions to human health and disease. Here we articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine.	[Green, Eric D.; Guyer, Mark S.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, ED (corresponding author), NHGRI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov						Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Berg K, 2005, AM J HUM GENET, V77, P519; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P2028, DOI 10.1074/mcp.M800264-MCP200; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Brufsky A, 2010, AM J CLIN ONCOL-CANC, V33, P186, DOI 10.1097/COC.0b013e318191bfb0; Buntin MB, 2010, HEALTH AFFAIR, V29, P1214, DOI 10.1377/hlthaff.2010.0503; Burke W, 2010, PUBLIC HEALTH GENOM, V13, P215, DOI 10.1159/000279623; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caskey CT, 2010, ANNU REV MED, V61, P1, DOI 10.1146/annurev-med-011209-132719; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Couzin-Frankel J, 2010, SCIENCE, V328, P558, DOI 10.1126/science.328.5978.558; D'Hulst C, 2009, J MED GENET, V46, P577, DOI 10.1136/jmg.2008.064667; Del Fiol Guilherme, 2006, AMIA Annu Symp Proc, P904; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; Ewing SWF, 2009, ADDICT BIOL, V14, P356, DOI 10.1111/j.1369-1600.2009.00149.x; Feinberg AP, 2010, NAT BIOTECHNOL, V28, P1049, DOI 10.1038/nbt1010-1049; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Frueh FW, 2008, PHARMACOTHERAPY, V28, P992, DOI 10.1592/phco.28.8.992; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Grasemann H, 2010, EXPERT OPIN EMERG DR, V15, P653, DOI 10.1517/14728214.2010.517746; Gulcher JR, 2000, NEW ENGL J MED, V342, P1827, DOI 10.1056/NEJM200006153422411; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hiraki S, 2010, OBSTET GYN CLIN N AM, V37, P11, DOI 10.1016/j.ogc.2010.01.002; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jain KK, 2007, CLIN CHEM, V53, P2002, DOI 10.1373/clinchem.2007.090795; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kohane IS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000809; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Loukides G, 2010, P NATL ACAD SCI USA, V107, P7898, DOI 10.1073/pnas.0911686107; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; McBride CM, 2010, AM J PREV MED, V38, P556, DOI 10.1016/j.amepre.2010.01.027; McGuire AL, 2008, NAT REV GENET, V9, P152, DOI 10.1038/nrg2302; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Oita I, 2010, ANAL BIOANAL CHEM, V398, P239, DOI 10.1007/s00216-010-3857-7; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramos E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-29; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shiwaku K, 2003, INT J OBESITY, V27, P1028, DOI 10.1038/sj.ijo.0802375; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Smushkin G, 2010, CURR OPIN CLIN NUTR, V13, P471, DOI 10.1097/MCO.0b013e32833a558d; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Stover PJ, 2010, CURR OPIN LIPIDOL, V21, P136, DOI 10.1097/MOL.0b013e3283377395; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Thorisson GA, 2003, NUCLEIC ACIDS RES, V31, P124, DOI 10.1093/nar/gkg052; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	103	617	633	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					204	213		10.1038/nature09764	http://dx.doi.org/10.1038/nature09764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307933	Bronze			2022-12-24	WOS:000287144200034
J	Hansen, CJ; Bourke, M; Bridges, NT; Byrne, S; Colon, C; Diniega, S; Dundas, C; Herkenhoff, K; McEwen, A; Mellon, M; Portyankina, G; Thomas, N				Hansen, C. J.; Bourke, M.; Bridges, N. T.; Byrne, S.; Colon, C.; Diniega, S.; Dundas, C.; Herkenhoff, K.; McEwen, A.; Mellon, M.; Portyankina, G.; Thomas, N.			Seasonal Erosion and Restoration of Mars' Northern Polar Dunes	SCIENCE			English	Article							SUBLIMATION-DRIVEN ACTIVITY; HIRISE OBSERVATIONS; DEPOSITS	Despite radically different environmental conditions, terrestrial and martian dunes bear a strong resemblance, indicating that the basic processes of saltation and grainfall (sand avalanching down the dune slipface) operate on both worlds. Here, we show that martian dunes are subject to an additional modification process not found on Earth: springtime sublimation of Mars' CO2 seasonal polar caps. Numerous dunes in Mars' north polar region have experienced morphological changes within a Mars year, detected in images acquired by the High-Resolution Imaging Science Experiment on the Mars Reconnaissance Orbiter. Dunes show new alcoves, gullies, and dune apron extension. This is followed by remobilization of the fresh deposits by the wind, forming ripples and erasing gullies. The widespread nature of these rapid changes, and the pristine appearance of most dunes in the area, implicates active sand transport in the vast polar erg in Mars' current climate.	[Hansen, C. J.; Bourke, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Bourke, M.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Bridges, N. T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Byrne, S.; Dundas, C.; McEwen, A.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Colon, C.] Rutgers State Univ, Dept Earth & Environm Sci, Newark, NJ 07102 USA; [Diniega, S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Herkenhoff, K.] US Geol Survey, Flagstaff, AZ 86001 USA; [Mellon, M.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80309 USA; [Portyankina, G.; Thomas, N.] Univ Bern, Space Res & Planetol Div, CH-0132 Bern, Switzerland	University of Oxford; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; Rutgers State University Newark; Rutgers State University New Brunswick; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder; University of Bern	Hansen, CJ (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	cjhansen@psi.edu	Byrne, Shane/B-8104-2012; Bridges, Nathan T/D-6341-2016; Bourke, Mary/I-4387-2012; Mellon, Michael/C-3456-2016	Bourke, Mary/0000-0002-0424-0322; Dundas, Colin/0000-0003-2343-7224	Jet Propulsion Laboratory, California Institute of Technology; NASA	Jet Propulsion Laboratory, California Institute of Technology; NASA(National Aeronautics & Space Administration (NASA))	This work was partially supported by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Aharonson O., 2004, 35 LUN PLAN SCI C 15; Balme M, 2008, GEOMORPHOLOGY, V101, P703, DOI 10.1016/j.geomorph.2008.03.011; Bourke MC, 2008, GEOMORPHOLOGY, V94, P247, DOI 10.1016/j.geomorph.2007.05.012; Bourke M. C., 2009, P LUNAR PLANET SCI C, V40, P1748; CUTTS JA, 1973, J GEOPHYS RES, V78, P4139, DOI 10.1029/JB078i020p04139; Diniega S, 2010, GEOLOGY, V38, P1047, DOI 10.1130/G31287.1; Dundas C. M., 2009, GEOPHYS RES LETT, V37; Gardin E, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003515; Hansen C., 2010, P LUNAR PLANET SCI C, V41, P1533; Hansen CJ, 2010, ICARUS, V205, P283, DOI 10.1016/j.icarus.2009.07.021; Hansen C. J., 2008, B AM ASTRON SOC, V40, P409; Hayward RK, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002943; Kereszturi A, 2010, ICARUS, V207, P149, DOI 10.1016/j.icarus.2009.10.012; Kereszturi A, 2009, ICARUS, V201, P492, DOI 10.1016/j.icarus.2009.01.014; Kieffer H. H., 2000, LUNAR PLANETARY I CO, P1057; Kieffer HH, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002816; Malin M. C., 2005, NASA JPL PLANETARY P; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Matsuo K, 2009, ICARUS, V202, P90, DOI 10.1016/j.icarus.2009.02.023; MCCAULEY JF, 1972, ICARUS, V17, P289, DOI 10.1016/0019-1035(72)90003-6; McEwen AS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2005JE002605; Mellon MT, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003417; Mohlmann D, 2010, ICARUS, V207, P654, DOI 10.1016/j.icarus.2010.01.002; Piqueux S, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002007; Piqueux S, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003009; Portyankina G, 2010, ICARUS, V205, P311, DOI 10.1016/j.icarus.2009.08.029; Putzig N., 2010, P LUNAR PLANET SCI C, V41, P1533; Schatz V, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002514; Silvestro S., 2010, 2 INT DUN C LPI CONT, V1552, P65; Thomas N, 2010, ICARUS, V205, P296, DOI 10.1016/j.icarus.2009.05.030; TSOAR H, 1979, J GEOPHYS RES, V84, P8167, DOI 10.1029/JB084iB14p08167; WARD AW, 1983, ICARUS, V55, P420, DOI 10.1016/0019-1035(83)90112-4	32	117	118	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					575	578		10.1126/science.1197636	http://dx.doi.org/10.1126/science.1197636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292976				2022-12-24	WOS:000286933600051
J	Paul, VK; Sachdev, HS; Mavalankar, D; Ramachandran, P; Sankar, MJ; Bhandari, N; Sreenivas, V; Sundararaman, T; Govil, D; Osrin, D; Kirkwood, B				Paul, Vinod Kumar; Sachdev, Harshpal Singh; Mavalankar, Dileep; Ramachandran, Prema; Sankar, Mari Jeeva; Bhandari, Nita; Sreenivas, Vishnubhatla; Sundararaman, Thiagarajan; Govil, Dipti; Osrin, David; Kirkwood, Betty			India: Towards Universal Health Coverage 2 Reproductive health, and child health and nutrition in India: meeting the challenge	LANCET			English	Article							REDUCING MATERNAL MORTALITY; IMPAIRED GLUCOSE-TOLERANCE; SEVERE ACUTE MALNUTRITION; NEONATAL-MORTALITY; MANAGEMENT; PREVALENCE; SURVIVAL; DISEASES; NEWBORN	India, with a population of more than 1 billion people, has many challenges in improving the health and nutrition of its citizens. Steady declines have been noted in fertility, maternal, infant and child mortalities, and the prevalence of severe manifestations of nutritional deficiencies, but the pace has been slow and falls short of national and Millennium Development Goal targets. The likely explanations include social inequities, disparities in health systems between and within states, and consequences of urbanisation and demographic transition. In 2005, India embarked on the National Rural Health Mission, an extraordinary effort to strengthen the health systems. However, coverage of priority interventions remains insufficient, and the content and quality of existing interventions are suboptimum. Substantial unmet need for contraception remains, adolescent pregnancies are common, and access to safe abortion is inadequate. Increases in the numbers of deliveries in institutions have not been matched by improvements in the quality of intrapartum and neonatal care. Infants and young children do not get the health care they need; access to effective treatment for neonatal illness, diarrhoea, and pneumonia shows little improvement; and the coverage of nutrition programmes is inadequate. Absence of well functioning health systems is indicated by the inadequacies related to planning, financing, human resources, infrastructure, supply systems, governance, information, and monitoring. We provide a case for transformation of health systems through effective stewardship, decentralised planning in districts, a reasoned approach to financing that affects demand for health care, a campaign to create awareness and change health and nutrition behaviour, and revision of programmes for child nutrition on the basis of evidence. This agenda needs political commitment of the highest order and the development of a people's movement.	[Paul, Vinod Kumar] All India Inst Med Sci, Dept Paediat, New Delhi 110029, India; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Mavalankar, Dileep] Indian Inst Management, Ahmadabad 380015, Gujarat, India; [Ramachandran, Prema] Nutr Fdn India, New Delhi, India; [Bhandari, Nita] Soc Appl Studies, New Delhi, India; [Sundararaman, Thiagarajan] Natl Hlth Syst Resources Ctr, New Delhi, India; [Govil, Dipti] Inst Hlth Management & Res, Jaipur, Rajasthan, India; [Osrin, David] UCL, Ctr Int Hlth & Dev, London, England; [Kirkwood, Betty] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	All India Institute of Medical Sciences (AIIMS) New Delhi; Sitaram Bhartia Institute of Science & Research; Indian Institute of Management (IIM System); Indian Institute of Management Ahmedabad; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Paul, VK (corresponding author), All India Inst Med Sci, Dept Paediat, New Delhi 110029, India.	vinodkpaul@hotmail.com	Sankar, Jeeva/Q-1007-2019; Govil, Dipti/ABC-7928-2020; Mavalankar, Dileep/AAX-6931-2020	Sankar, Jeeva/0000-0003-1474-1451; Govil, Dipti/0000-0002-0599-0045; Mavalankar, Dileep/0000-0003-0498-3799; Kirkwood, Betty/0000-0001-5274-6072; Sachdev, Harshpal Singh/0000-0002-4956-9391; Osrin, David/0000-0001-9691-9684	University College London Institute of Child Health; Wellcome Trust [081052]; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	University College London Institute of Child Health; Wellcome Trust(Wellcome TrustEuropean Commission); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	DO was originally a reviewer of this report and was requested to join as a co-author after the first draft; he has received payment for employment from the University College London Institute of Child Health, grants from a Wellcome Trust Fellowship, and payment for visiting lectures at the London School of Hygiene and Tropical Medicine. The other authors declare that they have no conflicts of interest.; The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India. DO is supported by Wellcome Trust Fellowship (grant number 081052). We thank Shireen J Jejeebhoy for major inputs for sections about reproductive health and Rajiv Bahl for child health; S K Bhargava for providing access to the data for the New Delhi Birth Cohort; Pavitra Mohan for highly valuable comments about the report; Armida Fernandez, Thomas Cherian, Jose Martines, and Satish Gupta for suggestions and inputs; and Manju Saksena for assistance with the research.	Agarwal RK, 2008, INDIAN PEDIATR, V45, P625; [Anonymous], 2009, REP CAUS DEATH IND 2; Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; Arun Gupta, 2007, Economic and Political Weekly, V42, P87; BAJPAI N, 2009, IMPROVING ACCESS SER; BALARAJAN Y, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)618946; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARGE K, 1998, INT WORKSH AB FAC PO; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhatnagar S, 2007, INDIAN PEDIATR, V44, P443; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CHHABRA R, 1994, ABORTION INDIA OVERV; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; *DRUGS CONTR GEN I, 2006, NUMB PERM DAT ISS MF; ELUL B, 2003, UNINTENDED PREGNANCY; GANATRA B, 2000, WOMENS REPROD HLTH I; GANATRA BR, 2000, ASIA PAC POPUL J, V16, P109; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; *GOV IND, 2003, MED TERM PREGN RUL A; *GOV IND MIN HLTH, 2010, 3 COMM REV MISS REP; *GOV IND MIN WOM C, 2006, STRENGTH ICDS RED CH; Government of India Ministry of Women and Child Development, INT CHILD DEV SERV S; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *IHME, CHILD MORT GLOB; *IIPS, 2008, DISTR LEV HOUS SURV; *IIPS, 2005, IND FAC SURV; *IIPS MACR, 2007, NFHS3 IIPS MACR, V1; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; *INT I POP SCI POP, 2009, YOUTH IND SIT NEEDS; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; International Institute for Population Sciences (IIPS), 1995, NAT FAM HLTH SURV NF, P199293; Jain S, 2004, J TROP PEDIATRICS, V50, P170, DOI 10.1093/tropej/50.3.170; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Jones Gareth, 2006, Indian Journal of Pediatrics, V73, P479, DOI 10.1007/BF02759891; Kalyanwala S, 2010, INT PERSPECT SEX R H, V36, P62, DOI 10.1363/ipsrh.36.062.10; Kapil U, 2010, INDIAN PEDIATR, V47, P651, DOI 10.1007/s13312-010-0099-x; Kapil U, 2009, INDIAN PEDIATR, V46, P381; Khanna SK, 1997, SOC SCI MED, V44, P171, DOI 10.1016/S0277-9536(96)00144-X; KOSH JS, 2009, IND PARTN POP STAB; Krishna U R, 1995, J Indian Med Assoc, V93, P34; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; MALHOTRA A, 2003, REALIZING REPROD CHO; Mavalankar D, 2008, LANCET, V371, P631, DOI 10.1016/S0140-6736(08)60282-2; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; *MIN HLTH FAM WELF, 2009, NRHM PROGRE SO FAR; *MIN HUM RES DEV D, 2005, NAT PLAN ACT CHILDR; *MIN WOM CHILD DEV, INT CHILD DEV SERV; MOHAN P, 1999, THESIS U N CAROLINA; *MOHFW, 2008, NAT HLTH PROF 2008; *MOHFW, 2008, NAT TRAIN STRAT INS; *MOHFW, 2000, NAT POP POL 2000; *MOHFW, 2008, NAT COLD CHAIN ASS; *MOHFW STAT DIV, 2007, B RUR HLTH STAT IND; *MOHFW STAT DIV, 2008, B RUR HLTH STAT, P26; *NCEAR, 2001, CONC EV INT CHILD DE; *NHSRC, 2008, CHILD HLTH STAT PIPS; *NNBM, 2002, NNMB MICR SURV; *NRHM, 2008, KEY FIND 2 COMM REV; Oomman N, 2002, REPROD HEALTH MATTER, V10, P184, DOI 10.1016/S0968-8080(02)00029-0; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Paul VK, 2010, LANCET, V375, P1943, DOI 10.1016/S0140-6736(10)60901-4; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; *REG GEN IND, 2006, MAT MORT IND 1997 20; *REG GEN IND, 1999, COMP IND FERT MORT I; *REG GEN IND, POP PROJ 2001 26; *REG GEN IND, 2009, SAMPL REG SYST SRS S; *REG GEN IND, CENS IND 2001; Registrar General of India, 2009, SPEC B MAT MORT 2004; Sachdev HPS, 2010, INDIAN PEDIATR, V47, P661, DOI 10.1007/s13312-010-0097-z; Sachdev HPS, 2004, INDIAN J MED RES, V119, pIII; SACHDEV HPS, 2003, NFI B, V24, P6; Santhya K. G., 2003, Economic and Political Weekly, V38, P4370; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; SANTHYA KG, 2010, TIMING 1 SEX MARRIAG; SANTHYA KG, 2005, LOOKING BACK LOOKING; SHARMA BB, 1998, 18 ANN CONV NAT NEON; Shobha Malini, 2008, Health and Population - Perspectives and Issues, V31, P126; SNTHYA KG, 2009, UNDERSTANDING PREGNA; Sundararaman T, 2007, LANCET, V369, P2058, DOI 10.1016/S0140-6736(07)60326-2; *UNFPA, 2007, ASS ASHA JAN SUR YOJ; *UNFPA, ASS ASHA JAN SUR YOJ; *UNFPA, 2005, MISS MAPP ADV CHILD; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF/WHO, 2004, LOW BIRTHW COUNTR RE; *URB HLTH RES CTR, KEY IND URB POOR IND; W.H. Organization, 2009, WORLD HLTH STAT 2009; *WHO, 2009, HOME VIS NEWB CHILD; WHO, 2006, WORLD HLTH REPORT 20; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; *WORLD BANK, 2006, IND UND CHILDDR CALL; World Health Organization, 2000, WORLD HLTH REP 2000; 2010, INDIAN EXPRESS  0412, P5; NAT NEONATAL PERINAT	102	167	168	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					332	349		10.1016/S0140-6736(10)61492-4	http://dx.doi.org/10.1016/S0140-6736(10)61492-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21227494	Green Accepted			2022-12-24	WOS:000286850400030
J	Braun, S; Garcia, JF; Rowley, M; Rougemaille, M; Shankar, S; Madhani, HD				Braun, Sigurd; Garcia, Jennifer F.; Rowley, Margot; Rougemaille, Mathieu; Shankar, Smita; Madhani, Hiten D.			The Cul4-Ddb1(Cdt2) Ubiquitin Ligase Inhibits Invasion of a Boundary-Associated Antisilencing Factor into Heterochromatin	CELL			English	Article							JMJC DOMAIN PROTEIN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DNA-DAMAGE; S-PHASE; TRANSCRIPTION FACTOR; CHROMATIN DOMAINS; BINDING-PROTEIN; H3 METHYLATION; DDB1	Partitioning of chromosomes into euchromatic and heterochromatic domains requires mechanisms that specify boundaries. The S. pombe JmjC family protein Epe1 prevents the ectopic spread of heterochromatin and is itself concentrated at boundaries. Paradoxically, Epe1 is recruited to heterochromatin by HP1 silencing factors that are distributed throughout heterochromatin. We demonstrate here that the selective enrichment of Epe1 at boundaries requires its regulation by the conserved Cul4-Ddb1(Cdt2) ubiquitin ligase, which directly recognizes Epe1 and promotes its polyubiquitylation and degradation. Strikingly, in cells lacking the ligase, Epe1 persists in the body of heterochromatin thereby inducing a defect in gene silencing. Epe1 is the sole target of the Cul4-Ddb1(Cdt2) complex whose destruction is necessary for the preservation of heterochromatin. This mechanism acts parallel with phosphorylation of HP1/Swi6 by CK2 to restrict Epe1. We conclude that the ubiquitin-dependent sculpting of the chromosomal distribution of an antisilencing factor is critical for heterochromatin boundaries to form correctly.	[Braun, Sigurd; Garcia, Jennifer F.; Rowley, Margot; Rougemaille, Mathieu; Shankar, Smita; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH-N372C, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com	Garcia, Jennifer/HDN-4569-2022	Braun, Sigurd/0000-0001-6399-8574; Rougemaille, Mathieu/0000-0002-9675-3888; Garcia, Jennifer/0000-0002-0620-0594; Madhani, Hiten/0000-0001-7400-6657	German Research Foundation [BR 3511/1-1]; Human Frontier Science Program; Leukemia and Lymphoma Society; NIH/NIGMS IMSD [R25-GM56847]; National Institutes of Health [GM071801]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847, R01GM071801] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH/NIGMS IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Rape, Stefan Jentsch, Geeta Narlikar, David Morgan, members of their labs, and Ulrike Boettcher for critical reading of the manuscript. We are grateful to Danesh Moazed, Karl Ekwall, and Takashi Toda for strains, plasmids, and protocols. S.B., M. Rougemaille, and S.S. were supported by postdoctoral fellowships of the German Research Foundation (BR 3511/1-1), the Human Frontier Science Program, and the Leukemia and Lymphoma Society, respectively. J.F.G. was supported by an NIH/NIGMS IMSD predoctoral fellowship (R25-GM56847). This work was supported by a grant to H.D.M. from the National Institutes of Health (GM071801) and a scholar's award to H.D.M. from the Leukemia and Lymphoma Society.	Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Ekwall K, 1999, GENETICS, V153, P1153; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Golemis EA, 2009, CURR PROTOC PROTEIN; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Sacher M, 2005, METHOD ENZYMOL, V399, P392, DOI 10.1016/S0076-6879(05)99027-7; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	46	71	71	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					41	54		10.1016/j.cell.2010.11.051	http://dx.doi.org/10.1016/j.cell.2010.11.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215368	Bronze, Green Accepted			2022-12-24	WOS:000285993600006
J	Maiklem, A; Nicol, E				Maiklem, Andrew; Nicol, Ed			A Patient's Journey Heart transplant	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicol, Ed] Royal Brompton Hosp, Dept Cardiol & Radiol, London SW3 6NP, England	Royal Brompton Hospital	Nicol, E (corresponding author), Royal Brompton Hosp, Dept Cardiol & Radiol, Sydney St, London SW3 6NP, England.	amaiklem@caci.co.uk; cyprusdoc@doctors.org.uk							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2010	341								c4918	10.1136/bmj.c4918	http://dx.doi.org/10.1136/bmj.c4918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XO	21169319				2022-12-24	WOS:000285553300007
J	Moellering, RC				Moellering, Robert C., Jr.			NDM-1 - A Cause for Worldwide Concern	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		[Moellering, Robert C., Jr.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Moellering, Robert C., Jr.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Moellering, RC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	5	213	224	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2377	2379		10.1056/NEJMp1011715	http://dx.doi.org/10.1056/NEJMp1011715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158655				2022-12-24	WOS:000285340200001
J	Nadeau, JH; Dudley, AM				Nadeau, Joseph H.; Dudley, Aimee M.			Systems Genetics	SCIENCE			English	Editorial Material									[Nadeau, Joseph H.; Dudley, Aimee M.] Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Nadeau, JH (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jnadeau@systemsbiology.org; adudley@systemsbiology.org	Dudley, Aimee/K-3163-2019	Dudley, Aimee/0000-0003-3644-0625	NCRR NIH HHS [P40 RR012305, RR12305] Funding Source: Medline; NICHD NIH HHS [DP1 HD075624] Funding Source: Medline; NIGMS NIH HHS [R01 GM089978, P50 GM076547, R01GM089978, P50GM076547] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075624] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089978, P50GM076547] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Nadeau JH, 2003, GENOME RES, V13, P2082, DOI 10.1101/gr.1186603; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Newman M.E.J., 2010, NETWORKS INTRO; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shipley B., 2002, CAUSE CORRELATION US	12	58	61	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1015	1016		10.1126/science.1203869	http://dx.doi.org/10.1126/science.1203869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350153	Green Accepted			2022-12-24	WOS:000287699000037
J	Park-Wyllie, LY; Mamdani, MM; Juurlink, DN; Hawker, GA; Gunraj, N; Austin, PC; Whelan, DB; Weiler, PJ; Laupacis, A				Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Gunraj, Nadia; Austin, Peter C.; Whelan, Daniel B.; Weiler, Peter J.; Laupacis, Andreas			Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION ATTRIBUTABLE FRACTION; HIP FRACTURE; RANDOMIZED-TRIAL; DIAPHYSEAL FEMUR; ALENDRONATE; OSTEOPOROSIS; PERSISTENCE; MORTALITY; THERAPY; TRENDS	Context Osteoporosis is associated with significant morbidity and mortality. Oral bisphosphonates have become a mainstay of treatment, but concerns have emerged that long-term use of these drugs may suppress bone remodeling, leading to unusual fractures. Objective To determine whether prolonged bisphosphonate therapy is associated with an increased risk of subtrochanteric or femoral shaft fracture. Design, Setting, and Patients A population-based, nested case-control study to explore the association between bisphosphonate use and fractures in a cohort of women aged 68 years or older from Ontario, Canada, who initiated therapy with an oral bisphosphonate between April 1, 2002, and March 31, 2008. Cases were those hospitalized with a subtrochanteric or femoral shaft fracture and were matched to up to 5 controls with no such fracture. Study participants were followed up until March 31, 2009. Main Outcome Measures The primary analysis examined the association between hospitalization for a subtrochanteric or femoral shaft fracture and duration of bisphosphonate exposure. To test the specificity of the findings, the association between bisphosphonate use and fractures of the femoral neck or intertrochanteric region, which are characteristic of osteoporotic fractures, was also examined. Results We identified 716 women who sustained a subtrochanteric or femoral shaft fracture following initiation of bisphosphonate therapy and 9723 women who sustained a typical osteoporotic fracture of the intertrochanteric region or femoral neck. Compared with transient bisphosphonate use, treatment for 5 years or longer was associated with an increased risk of subtrochanteric or femoral shaft fracture (adjusted odds ratio, 2.74; 95% confidence interval, 1.25-6.02). A reduced risk of typical osteoporotic fractures occurred among women with more than 5 years of bisphosphonate therapy (adjusted odds ratio, 0.76; 95% confidence interval, 0.63-0.93). Among 52 595 women with at least 5 years of bisphosphonate therapy, a subtrochanteric or femoral shaft fracture occurred in 71 (0.13%) during the subsequent year and 117 (0.22%) within 2 years. Conclusion Among older women, treatment with a bisphosphonate for more than 5 years was associated with an increased risk of subtrochanteric or femoral shaft fractures; however, the absolute risk of these fractures is low. JAMA. 2011; 305(8): 783-789	[Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Laupacis, Andreas] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Gunraj, Nadia; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.; Hawker, Gillian A.; Laupacis, Andreas] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Whelan, Daniel B.; Weiler, Peter J.] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON M5B 1W8, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Mamdani, Muhammad M.; Laupacis, Andreas] King Saud Univ, Dept Med, Riyadh, Saudi Arabia	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; King Saud University	Park-Wyllie, LY (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	parkwylliel@smh.ca	Walter, Henrik/O-2612-2013	Austin, Peter/0000-0003-3337-233X	Novartis; Janssen-Ortho; Pfizer; Boehringer Ingelheim; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Novartis(Novartis); Janssen-Ortho; Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Dr Mamdani reported that he has has participated in paid advisory board meetings and received consulting fees from Novartis, Janssen-Ortho, Pfizer, and Boehringer Ingelheim. No other disclosures were reported.; This study was funded by the Ontario Ministry of Health and Long-Term Care. Dr Park-Wyllie was supported by a Fellowship Award from the Canadian Institutes of Health Research. Dr Austin was supported by a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Canadian Institute for Health Information, 2003, INT STAT CLASS DIS R; Colon-Emeric CS, 2006, JAMA-J AM MED ASSOC, V296, P2968, DOI 10.1001/jama.296.24.2968; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Curtis JR, 2008, OSTEOPOROSIS INT, V19, P1613, DOI 10.1007/s00198-008-0604-4; Evans JG, 1997, J EPIDEMIOL COMMUN H, V51, P424, DOI 10.1136/jech.51.4.424; Geusens Piet, 2009, Curr Osteoporos Rep, V7, P12; Glazier RH, 2003, CAN J PUBLIC HEALTH, V94, P140, DOI 10.1007/BF03404588; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Kelsey JL., 1996, METHODS OBSERVATIONA; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lofthus CM, 2005, J CLIN EPIDEMIOL, V58, P280, DOI 10.1016/j.jclinepi.2004.07.003; Mamdani M, 2007, OSTEOPOROSIS INT, V18, P1595, DOI 10.1007/s00198-007-0446-5; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Melo M, 2006, J AM GERIATR SOC, V54, P1015, DOI 10.1111/j.1532-5415.2006.00758.x; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Park-Wyllie LY, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000157; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider JP, 2009, GERIATRICS-US, V64, P18; Seeman E, 2009, OSTEOPOROSIS INT, V20, P187, DOI 10.1007/s00198-008-0813-x; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Shane Elizabeth, 2010, NEW ENGL J MED, V362, P1761; US Food and Drug Administration, 2010, ONG SAF REV OR BISPH; Wang MH, 2009, CANCER EPIDEM BIOMAR, V18, P706, DOI 10.1158/1055-9965.EPI-08-0839; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	41	313	331	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					783	789		10.1001/jama.2011.190	http://dx.doi.org/10.1001/jama.2011.190			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343577	Bronze			2022-12-24	WOS:000287594300021
J	Raby, AM				Raby, Adrian M.			Practice A Patient's Journey Alcoholism	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.raby@imperial.ac.uk						Kaner EFS, 1999, ALCOHOL ALCOHOLISM, V34, P559, DOI 10.1093/alcalc/34.4.559; National Audit Office, 2008, RED ALC HARM HLTH SE	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d956	10.1136/bmj.d956	http://dx.doi.org/10.1136/bmj.d956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345906				2022-12-24	WOS:000287920100002
J	Hoal, E				Hoal, Eileen			Famine in the Presence of the Genomic Data Feast	SCIENCE			English	Editorial Material									Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa	Stellenbosch University	Hoal, E (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa.								0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					874	874		10.1126/science.1203261	http://dx.doi.org/10.1126/science.1203261			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330533				2022-12-24	WOS:000287455100045
J	Smith, DM; Fraga, H; Reis, C; Kafri, G; Goldberg, AL				Smith, David M.; Fraga, Hugo; Reis, Christian; Kafri, Galit; Goldberg, Alfred L.			ATP Binds to Proteasomal ATPases in Pairs with Distinct Functional Effects, Implying an Ordered Reaction Cycle	CELL			English	Article							20S PROTEASOME; REGULATORY PARTICLE; CRYSTAL-STRUCTURE; 26S PROTEASOME; PROTEIN; HYDROLYSIS; MECHANISM; PAN; UBIQUITIN; GATE	In the eukaryotic 26S proteasome, the 20S particle is regulated by six AAA ATPase subunits and, in archaea, by a homologous ring complex, PAN. To clarify the role of ATP in proteolysis, we studied how nucleotides bind to PAN. Although PAN has six identical subunits, it binds ATPs in pairs, and its subunits exhibit three conformational states with high, low, or no affinity for ATP. When PAN binds two ATP gamma S molecules or two ATP gamma S plus two ADP molecules, it is maximally active in binding protein substrates, associating with the 20S particle, and promoting 20S gate opening. However, binding of four ATP gamma S molecules reduces these functions. The 26S proteasome shows similar nucleotide dependence. These findings imply an ordered cyclical mechanism in which two ATPase subunits bind ATP simultaneously and dock into the 20S. These results can explain how these hexameric ATPases interact with and "wobble'' on top of the heptameric 20S proteasome.	[Smith, David M.; Fraga, Hugo; Reis, Christian; Kafri, Galit; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Smith, DM (corresponding author), W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.	dsmith2@hsc.wvu.edu; alfred_goldberg@hms.harvard.edu	Smith, David/AAL-7662-2020; Fraga, Hugo/X-4850-2019	Smith, David/0000-0002-1502-676X; Fraga, Hugo/0000-0001-7677-4086	NIH [GM051923-09]; Multiple Myeloma Foundation; Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal [SFRH/26490/2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Foundation; Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by a grant from the NIH (GM051923-09) to A. L. G., by the Multiple Myeloma Foundation to A. L. G., and by a fellowship (SFRH/26490/2006) from Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal to H.F.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Fontes R, 1998, FEBS LETT, V438, P190, DOI 10.1016/S0014-5793(98)01301-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MENON AS, 1987, J BIOL CHEM, V262, P14921; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schumacher J, 2008, J MOL BIOL, V381, P1, DOI 10.1016/j.jmb.2008.05.075; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	43	151	153	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					526	538		10.1016/j.cell.2011.02.005	http://dx.doi.org/10.1016/j.cell.2011.02.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335235	Bronze, Green Accepted			2022-12-24	WOS:000287473100008
J	Vaccarella, M				Vaccarella, Maria			The art of medicine Narrative epileptology	LANCET			English	Editorial Material									Kings Coll London, Sch Arts & Humanities, Ctr Humanities & Hlth, London WC2R 2LS, England	University of London; King's College London; University College London	Vaccarella, M (corresponding author), Kings Coll London, Sch Arts & Humanities, Ctr Humanities & Hlth, London WC2R 2LS, England.	maria.vaccarella@kcl.ac.uk						Alcauskas M, 2008, NEUROLOGY, V70, P891, DOI 10.1212/01.wnl.0000304945.48551.13; Charon R., 2006, NARRATIVE MED HONORI; de Toffol B, 2008, PROUST IMPROVE YOUR; Frank AW., 2013, WOUNDED STORYTELLER; Gastaut H, 1978, EPILEPSIA, V78, P198; Heritage J, 2006, STUD INTERACT SOCIO, P1, DOI 10.1017/CBO9780511607172; Stirling J., 2010, REPRESENTING EPILEPS	7	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					460	461		10.1016/S0140-6736(11)60150-5	http://dx.doi.org/10.1016/S0140-6736(11)60150-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	721TX	21300595				2022-12-24	WOS:000287381800015
J	Jefferson, T; Doshi, P; Thompson, M; Heneghan, C				Jefferson, Tom; Doshi, Peter; Thompson, Matthew; Heneghan, Carl		Cochrane Acute Resp Infections Grp	Ensuring safe and effective drugs: who can do what it takes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE INFLUENZA; OSELTAMIVIR; EFFICACY; ROSIGLITAZONE		[Doshi, Peter] MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA; [Jefferson, Tom] Cochrane Collaborat, Acute Resp Infect Grp, Rome, Italy; [Thompson, Matthew; Heneghan, Carl] Univ Oxford, Dept Primary Hlth Care, Oxford, England; [Thompson, Matthew] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA	Massachusetts Institute of Technology (MIT); University of Oxford; Oregon Health & Science University	Doshi, P (corresponding author), MIT, Program Hist Anthropol Sci Technol & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pnd@mit.edu			National Institute for Health Research [10/80/01] Funding Source: researchfish; Department of Health [HTA/10/80/01, 10/80/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		COCHR ED UN, NEUR INH INFL HTA; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Godlee F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5405; Higgins JP., 2019, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1, DOI 10.1002/9781119536604]; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nissen S, 2010, ROSIGLITAZONE CRITIC; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; van Driel ML, 2009, J CLIN EPIDEMIOL, V62, P838, DOI 10.1016/j.jclinepi.2008.09.010	20	33	33	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c7258	10.1136/bmj.c7258	http://dx.doi.org/10.1136/bmj.c7258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SO	21224325				2022-12-24	WOS:000286384800009
J	Paradis-Bleau, C; Markovski, M; Uehara, T; Lupoli, TJ; Walker, S; Kahne, DE; Bernhardt, TG				Paradis-Bleau, Catherine; Markovski, Monica; Uehara, Tsuyoshi; Lupoli, Tania J.; Walker, Suzanne; Kahne, Daniel E.; Bernhardt, Thomas G.			Lipoprotein Cofactors Located in the Outer Membrane Activate Bacterial Cell Wall Polymerases	CELL			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; PEPTIDOGLYCAN BIOSYNTHESIS; PBP1B; IDENTIFICATION; MORPHOGENESIS; COMPLEXES; MUTANTS; DIMERS	Most bacteria surround themselves with a peptidoglycan (PG) exoskeleton synthesized by polysaccharide polymerases called penicillin-binding proteins (PBPs). Because they are the targets of penicillin and related antibiotics, the structure and biochemical functions of the PBPs have been extensively studied. Despite this, we still know surprisingly little about how these enzymes build the PG layer in vivo. Here, we identify the Escherichia coli outermembrane lipoproteins LpoA and LpoB as essential PBP cofactors. We show that LpoA and LpoB form specific trans-envelope complexes with their cognate PBP and are critical for PBP function in vivo. We further show that LpoB promotes PG synthesis by its partner PBP in vitro and that it likely does so by stimulating glycan chain polymerization. Overall, our results indicate that PBP accessory proteins play a central role in PG biogenesis, and like the PBPs they work with, these factors are attractive targets for antibiotic development.	[Paradis-Bleau, Catherine; Markovski, Monica; Uehara, Tsuyoshi; Walker, Suzanne; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Kahne, Daniel E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lupoli, Tania J.; Walker, Suzanne; Kahne, Daniel E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu		Uehara, Tsuyoshi/0000-0001-6994-4286	Massachusetts Life Science Center; Burroughs Wellcome Fund; National Institutes of Health [R01 AI083365-01A1, GM066174, GM076710]; FRSQ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174, R01GM076710] Funding Source: NIH RePORTER	Massachusetts Life Science Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRSQ(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank D. Rudner, M. Waldor, and members of our laboratories for critical reading of the manuscript. We would also like to thank A. Typas, C. Gross, W. Vollmer, and coworkers for communicating their results in advance of publication. Special thanks to K. Suefuji and J.T. Park for generously providing the UDP-M-pep5. This work was supported by the Massachusetts Life Science Center (T. G. B.), the Burroughs Wellcome Fund (T. G. B.), and the National Institutes of Health (R01 AI083365-01A1 for T. G. B, GM066174 for D. E. K., and GM076710 for D. E. K and S. W.). T. G. B. holds a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. C.P.-B. was supported in part by a fellowship from FRSQ.	Alaedini A, 1999, BIOCHEM BIOPH RES CO, V264, P191, DOI 10.1006/bbrc.1999.1509; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Charpentier X, 2002, J BACTERIOL, V184, P3749, DOI 10.1128/JB.184.13.3749-3752.2002; DELPORTILLO FG, 1990, J BACTERIOL, V172, P5863; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; DENBLAAUWEN T, 1990, J BACTERIOL, V172, P71, DOI 10.1128/JB.172.1.71-79.1990; Dougherty TJ, 1996, J BACTERIOL, V178, P6110, DOI 10.1128/jb.178.21.6110-6115.1996; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; GOODELL EW, 1975, J GEN MICROBIOL, V86, P201, DOI 10.1099/00221287-86-2-201; KATO J, 1985, MOL GEN GENET, V200, P272, DOI 10.1007/BF00425435; Lewenza S, 2006, J BACTERIOL, V188, P3516, DOI 10.1128/JB.188.10.3516-3524.2006; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; MIRELMAN D, 1976, BIOCHEMISTRY-US, V15, P1781, DOI 10.1021/bi00654a001; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHMIDT LS, 1981, J BACTERIOL, V145, P632, DOI 10.1128/JB.145.1.632-637.1981; SCHWARZ U, 1971, J BACTERIOL, V106, P588, DOI 10.1128/JB.106.2.588-595.1971; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; TAMAKI S, 1977, P NATL ACAD SCI USA, V74, P5472, DOI 10.1073/pnas.74.12.5472; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Vijayalakshmi J, 2008, PROTEINS, V73, P204, DOI 10.1002/prot.22033; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Wong SM, 2003, GENE, V316, P177, DOI 10.1016/S0378-1119(03)00762-5; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	32	222	227	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1110	1120		10.1016/j.cell.2010.11.037	http://dx.doi.org/10.1016/j.cell.2010.11.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183074	Green Accepted, Bronze			2022-12-24	WOS:000285625400009
J	Sury, M; Bullock, I; Rabar, S; DeMott, K				Sury, Mike; Bullock, Ian; Rabar, Silvia; DeMott, Kathleen			Guidelines Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sury, Mike] Great Ormond St Hosp Childrens NHS Trust, London WC1N 3JH, England; [Sury, Mike] UCL, Inst Child Hlth, PORTEX Unit Paediat Anaesthesia, London WC1N 1EH, England; [Bullock, Ian; Rabar, Silvia; DeMott, Kathleen] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Royal College of Physicians	Sury, M (corresponding author), Great Ormond St Hosp Childrens NHS Trust, London WC1N 3JH, England.	surym@gosh.nhs.uk						British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM CHILDR; National Institute for Health and Clinical Excellence, 2010, CLIN GUID, V112; Saklad M, 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004	3	35	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 16	2010	341								c6819	10.1136/bmj.c6819	http://dx.doi.org/10.1136/bmj.c6819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XM	21163835				2022-12-24	WOS:000285553100008
J	Behravesh, CB; Mody, RK; Jungk, J; Gaul, L; Redd, JT; Chen, S; Cosgrove, S; Hedican, E; Sweat, D; Chavez-Hauser, L; Snow, SL; Hanson, H; Nguyen, TA; Sodha, SV; Boore, AL; Russo, E; Mikoleit, M; Theobald, L; Gerner-Smidt, P; Hoekstra, RM; Angulo, FJ; Swerdlow, DL; Tauxe, RV; Griffin, PM; Williams, IT				Behravesh, Casey Barton; Mody, Rajal K.; Jungk, Jessica; Gaul, Linda; Redd, John T.; Chen, Sanny; Cosgrove, Shaun; Hedican, Erin; Sweat, David; Chavez-Hauser, Lina; Snow, Sandra L.; Hanson, Heather; Nguyen, Thai-An; Sodha, Samir V.; Boore, Amy L.; Russo, Elizabeth; Mikoleit, Matthew; Theobald, Lisa; Gerner-Smidt, Peter; Hoekstra, Robert M.; Angulo, Frederick J.; Swerdlow, David L.; Tauxe, Robert V.; Griffin, Patricia M.; Williams, Ian T.		Salmonella Saintpaul Outbreak Inve	2008 Outbreak of Salmonella Saintpaul Infections Associated with Raw Produce	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; FRESH PRODUCE; TOMATOES; ILLNESS; BURDEN	BACKGROUND Raw produce is an increasingly recognized vehicle for salmonellosis. We investigated a nationwide outbreak that occurred in the United States in 2008. METHODS We defined a case as diarrhea in a person with laboratory-confirmed infection with the outbreak strain of Salmonella enterica serotype Saintpaul. Epidemiologic, trace-back, and environmental studies were conducted. RESULTS Among the 1500 case subjects, 21% were hospitalized, and 2 died. In three case-control studies of cases not linked to restaurant clusters, illness was significantly associated with eating raw tomatoes (matched odds ratio, 5.6; 95% confidence interval [CI], 1.6 to 30.3); eating at a Mexican-style restaurant (matched odds ratio, 4.6; 95% CI, 2.1 to 8) and eating pico de gallo salsa (matched odds ratio, 4.0; 95% CI, 1.5 to 17.8), corn tortillas (matched odds ratio, 2.3; 95% CI, 1.2 to 5.0), or salsa (matched odds ratio, 2.1; 95% CI, 1.1 to 3.9); and having a raw jalape no pepper in the household (matched odds ratio, 2.9; 95% CI, 1.2 to 7.6). In nine analyses of clusters associated with restaurants or events, jalapeno peppers were implicated in all three clusters with implicated ingredients, and jalapeno or serrano peppers were an ingredient in an implicated item in the other three clusters. Raw tomatoes were an ingredient in an implicated item in three clusters. The outbreak strain was identified in jalapeno peppers collected in Texas and in agricultural water and serrano peppers on a Mexican farm. Tomato tracebacks did not converge on a source. CONCLUSIONS Although an epidemiologic association with raw tomatoes was identified early in this investigation, subsequent epidemiologic and microbiologic evidence implicated jalape o and serrano peppers. This outbreak highlights the importance of preventing raw-produce contamination.	[Behravesh, Casey Barton; Mody, Rajal K.; Nguyen, Thai-An; Sodha, Samir V.; Boore, Amy L.; Russo, Elizabeth; Mikoleit, Matthew; Theobald, Lisa; Gerner-Smidt, Peter; Hoekstra, Robert M.; Angulo, Frederick J.; Swerdlow, David L.; Tauxe, Robert V.; Griffin, Patricia M.; Williams, Ian T.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Mody, Rajal K.; Chen, Sanny; Boore, Amy L.; Russo, Elizabeth] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Jungk, Jessica] New Mexico Dept Hlth, Santa Fe, NM USA; [Gaul, Linda] Texas Dept State Hlth Serv, Austin, TX USA; [Chen, Sanny] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Redd, John T.] Indian Hlth Serv, Albuquerque, NM USA; [Cosgrove, Shaun] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Hedican, Erin] Minnesota Dept Hlth, St Paul, MN USA; [Sweat, David] N Carolina Div Publ Hlth, Raleigh, NC USA; [Chavez-Hauser, Lina] Missouri Dept Hlth & Senior Serv, Jefferson, AR USA; [Snow, Sandra L.] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Hanson, Heather] New York City Dept Hlth & Mental Hyg, New York, NY USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; New Mexico Department of Health; Texas Department of State Health Services; Arizona Department of Health Services; Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); New York City Department of Health & Mental Hygiene	Behravesh, CB (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE,MS A-38, Atlanta, GA 30333 USA.	cbartonbehravesh@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022; Jungk, Jessica/A-9958-2015; alzahrani, saud hamed/C-2014-2012	BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Jungk, Jessica/0000-0001-7087-7623; Ayers, Tracy/0000-0003-4140-3263; Biggerstaff, Matthew/0000-0001-5108-8311; Hoekstra, Robert Michael/0000-0002-0340-8015; Mikoleit, Matthew/0000-0002-4582-6733; Shanahan, Lisa/0000-0001-5048-9615				*C FOOD PROT, 2006, COUNC 3 ISS RES 3 00; *CDCP, 2008, SAL SURV ANN SUMM 20; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Gutierrez-Cogco E, 2000, SALUD PUBLICA MEXICO, V42, P490; Hedberg CW, 1999, EPIDEMIOL INFECT, V122, P385, DOI 10.1017/S0950268899002393; Kirkland E, 2009, J FOOD PROTECT, V72, P1692, DOI 10.4315/0362-028X-72.8.1692; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Ma L, 2010, J FOOD PROTECT, V73, P434, DOI 10.4315/0362-028X-73.3.434; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; *WHO COLL CTR REF, 2007, ANT FORM SALM SER; 2010, MMWR MORB MORTAL WKL, V59, P418	16	109	113	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					918	927		10.1056/NEJMoa1005741	http://dx.doi.org/10.1056/NEJMoa1005741			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21345092				2022-12-24	WOS:000288170300008
J	Lander, ES				Lander, Eric S.			GENOME-SEQUENCING ANNIVERSARY A Celebration of the Genome, Part IV	SCIENCE			English	Editorial Material									[Lander, Eric S.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Lander, Eric S.] Council Advisors Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02138 USA.								0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1024	1024		10.1126/science.1204037	http://dx.doi.org/10.1126/science.1204037			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350161				2022-12-24	WOS:000287699000044
J	Lazarus, MB; Nam, YS; Jiang, JY; Sliz, P; Walker, S				Lazarus, Michael B.; Nam, Yunsun; Jiang, Jiaoyang; Sliz, Piotr; Walker, Suzanne			Structure of human O-GlcNAc transferase and its complex with a peptide substrate	NATURE			English	Article							N-ACETYLGLUCOSAMINE; CRYSTAL-STRUCTURE; PROTEIN; GLYCOSYLATION; GLCNACYLATION; NUCLEAR; GENE; REPLACEMENT; PROMOTERS; MECHANISM	The essential mammalian enzyme O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, here OGT) couples metabolic status to the regulation of a wide variety of cellular signalling pathways by acting as a nutrient sensor(1). OGT catalyses the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine (UDP-GlcNAc) to serines and threonines of cytoplasmic, nuclear and mitochondrial proteins(2,3), including numerous transcription factors(4), tumour suppressors, kinases(5), phosphatases(1) and histone-modifying proteins(6). Aberrant glycosylation by OGT has been linked to insulin resistance(7), diabetic complications(8), cancer(9) and neurodegenerative diseases including Alzheimer's(10). Despite the importance of OGT, the details of how it recognizes and glycosylates its protein substrates are largely unknown. We report here two crystal structures of human OGT, as a binary complex with UDP (2.8 angstrom resolution) and as a ternary complex with UDP and a peptide substrate (1.95 angstrom). The structures provide clues to the enzyme mechanism, show how OGT recognizes target peptide sequences, and reveal the fold of the unique domain between the two halves of the catalytic region. This information will accelerate the rational design of biological experiments to investigate OGT's functions; it will also help the design of inhibitors for use as cellular probes and help to assess its potential as a therapeutic target.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Nam, Yunsun; Sliz, Piotr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nam, Yunsun; Sliz, Piotr] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	piotr_sliz@hms.harvard.edu; suzanne_walker@hms.harvard.edu		Lazarus, Michael/0000-0002-6738-2563; Sliz, Piotr/0000-0002-6522-0835; Nam, Yunsun/0000-0002-7939-8626	US National Institutes of Health; US National Science Foundation; Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263, R01GM078477, R01GM076710] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Gross and C. Drennan for advice. We also thank the US National Institutes of Health, the US National Science Foundation, and the Harvard Biomedical Accelerator Fund for financial support. This work is based on research conducted at the Advanced Photon Source (Northeastern Collaborative Access Team beamlines) and Brookhaven National Laboratory (X25 and X29 beamlines).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	48	312	326	7	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					564	U168		10.1038/nature09638	http://dx.doi.org/10.1038/nature09638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21240259	Green Accepted			2022-12-24	WOS:000286596500039
J	Gregory, SM; Davis, BK; West, JA; Taxman, DJ; Matsuzawa, S; Reed, JC; Ting, JPY; Damania, B				Gregory, Sean M.; Davis, Beckley K.; West, John A.; Taxman, Debra J.; Matsuzawa, Shu-ichi; Reed, John C.; Ting, Jenny P. Y.; Damania, Blossom			Discovery of a Viral NLR Homolog that Inhibits the Inflammasome	SCIENCE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; PATTERN-RECOGNITION RECEPTORS; KAPOSIS-SARCOMA; CASPASE-1 ACTIVATION; MURAMYL DIPEPTIDE; DNA-SEQUENCES; INFECTION; GENE; HUMAN-HERPESVIRUS-8; DISEASE	The NLR (nucleotide binding and oligomerization, leucine-rich repeat) family of proteins senses microbial infections and activates the inflammasome, a multiprotein complex that promotes microbial clearance. Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to several human malignancies. We found that KSHV Orf63 is a viral homolog of human NLRP1. Orf63 blocked NLRP1-dependent innate immune responses, including caspase-1 activation and processing of interleukins IL-1 beta and IL-18. KSHV Orf63 interacted with NLRP1, NLRP3, and NOD2. Inhibition of Orf63 expression resulted in increased expression of IL-1 beta during the KSHV life cycle. Furthermore, inhibition of NLRP1 was necessary for efficient reactivation and generation of progeny virus. The viral homolog subverts the function of cellular NLRs, which suggests that modulation of NLR-mediated innate immunity is important for the lifelong persistence of herpesviruses.	[Gregory, Sean M.; Davis, Beckley K.; West, John A.; Taxman, Debra J.; Ting, Jenny P. Y.; Damania, Blossom] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gregory, Sean M.; West, John A.; Taxman, Debra J.; Ting, Jenny P. Y.; Damania, Blossom] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Damania, Blossom] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill	Damania, B (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	damania@med.unc.edu			NIH [DE018281, CA096500, AI057157, AI077437, CA156330, AI56324, AI91967, T32-AI007419, T32-AI007001, 5R21CA131645, F32-AI78735]; American Heart Association [0640041N]; Burroughs Wellcome Fund; UNC; Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA096500, R01CA156330, R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI078735, U54AI057157, T32AI007419, R01AI091967, T32AI007001, R01AI056324, U19AI077437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Burroughs Wellcome Fund(Burroughs Wellcome Fund); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank S. Krall for assistance with tissue culture, Y. Matsuzawa for plasmid preparation, and D. Dittmer for proofreading. Supported by NIH grants DE018281 and CA096500, American Heart Association grant 0640041N, and a Burroughs Wellcome Fund grant (B.D.); NIH grants AI057157, AI077437, and CA156330 and the UNC University Cancer Research Fund (J.P.Y.T.); NIH grants AI56324 and AI91967 (J.C.R.); NIH training grants T32-AI007419 and T32-AI007001 (S.M.G.); the Crohn's & Colitis Foundation of America and NIH grant 5R21CA131645 (B.K.D.); and NIH grant F32-AI78735 (J.A.W.). B.D. is a Leukemia & Lymphoma Society Scholar and Burroughs Wellcome Fund Investigator in Infectious Disease. The NLRP1 and mutant NLRP1 expression plasmids as well as purified GST-NLRP1 protein were obtained from J.C.R. and require a material transfer agreement. The NLRP3, NOD1, NOD2, mutant NOD2, ASC, procaspase-1, and pro-IL-1 beta expression plasmids were obtained from J.P.Y.T. and also require a material transfer agreement. B.D., J.P.Y.T., and S.M.G. have filed a provisional patent on the KSHV Orf63 protein and/or any peptides derived from this protein in treatment for human disease.	Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997; Boschan C, 2006, AM J MED GENET A, V140A, P883, DOI 10.1002/ajmg.a.31148; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lequerre T, 2007, RHEUMATOLOGY, V46, P709, DOI 10.1093/rheumatology/kel399; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Monini P, 1999, BLOOD, V93, P4044; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07	29	155	168	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					330	334		10.1126/science.1199478	http://dx.doi.org/10.1126/science.1199478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252346	Green Accepted, Green Submitted			2022-12-24	WOS:000286636300037
J	Ambraseys, N; Bilham, R				Ambraseys, Nicholas; Bilham, Roger			Corruption kills	NATURE			English	Editorial Material							EARTHQUAKES		[Ambraseys, Nicholas] Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London SW5 2BU, England; [Bilham, Roger] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bilham, Roger] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	Imperial College London; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ambraseys, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London SW5 2BU, England.	n.ambraseys@imperial.ac.uk; rogerbilham@googlemail.com		Bilham, Roger/0000-0002-5547-4102				Allen TI, 2009, SEISMOL RES LETT, V80, P57, DOI 10.1785/gssrl.80.1.57; AMBRASEYS N, 2010, P ACAD ATHENS, V85; AMBRASEYS N, 1978, ASSESSMENT MITIGATIO, P140; Bilham R, 2009, B EARTHQ ENG, V7, P839, DOI 10.1007/s10518-009-9147-0; BURTON I, 1964, NAT RESOUR J, V3, P412; Escaleras M, 2007, PUBLIC CHOICE, V132, P209, DOI 10.1007/s11127-007-9148-y; *GLOB CONSTR PERSP, 2010, GLOB CONSTR 2020 GLO; Green P, 2005, BRIT J CRIMINOL, V45, P528, DOI 10.1093/bjc/azi036; JACKSON EL, 1978, ASSESSMENT MITIGATIO, P241; Kaufmann D., 1998, POLITICAL EC CORRUPT; LEWIS J, 2005, GLOBAL CORRUPTION RE, P23; LOMNITZ C, 1970, B SEISMOL SOC AM, V60, P1309; Marano KD, 2010, NAT HAZARDS, V52, P319, DOI 10.1007/s11069-009-9372-5; The World Bank, GNI PER CAP ATL METH; Transparency International, 2010, 2010 CORR PERC IND	15	96	96	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					153	155		10.1038/469153a	http://dx.doi.org/10.1038/469153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	705NO	21228851	Bronze			2022-12-24	WOS:000286143400014
J	Sedlak, DL; von Gunten, U				Sedlak, David L.; von Gunten, Urs			The Chlorine Dilemma	SCIENCE			English	Editorial Material							N-NITROSODIMETHYLAMINE NDMA; WATER-TREATMENT; CHEMICALS; TRICLOSAN; KINETICS		[Sedlak, David L.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [von Gunten, Urs] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [von Gunten, Urs] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Sedlak, DL (corresponding author), Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA.	sedlak@berkeley.edu; vongunten@eawag.ch	von Gunten, Urs/O-1637-2013	von Gunten, Urs/0000-0001-6852-8977				[Anonymous], 1998, FED REG, V40, P69390; Buth JM, 2010, ENVIRON SCI TECHNOL, V44, P4545, DOI 10.1021/es1001105; Deborde M, 2004, ENVIRON SCI TECHNOL, V38, P5577, DOI 10.1021/es040006e; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Edwards M, 2004, J AM WATER WORKS ASS, V96, P69; Lee BC, 2004, WATER RES, V38, P733, DOI 10.1016/j.watres.2003.10.010; Lee Y, 2008, ENVIRON SCI TECHNOL, V42, P6333, DOI 10.1021/es7023302; Liu HZ, 2009, ENVIRON SCI TECHNOL, V43, P3278, DOI 10.1021/es803179b; Mitch WA, 2002, ENVIRON SCI TECHNOL, V36, P588, DOI 10.1021/es010684q; Park SH, 2009, ENVIRON SCI TECHNOL, V43, P1360, DOI 10.1021/es802732z; Rule KL, 2005, ENVIRON SCI TECHNOL, V39, P3176, DOI 10.1021/es048943+; Sumpter JP, 2006, ENVIRON SCI TECHNOL, V40, P5478, DOI 10.1021/es052554d	12	270	276	19	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					42	43		10.1126/science.1196397	http://dx.doi.org/10.1126/science.1196397			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212347				2022-12-24	WOS:000285974000028
J	Chen, CA; Wang, TY; Varadharaj, S; Reyes, LA; Hemann, C; Talukder, MAH; Chen, YR; Druhan, LJ; Zweier, JL				Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.			S-glutathionylation uncouples eNOS and regulates its cellular and vascular function	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RELAXATION; SUPEROXIDE GENERATION; ENDOGENOUS METHYLARGININES; TETRAHYDROBIOPTERIN; REDUCTASE; OXIDATION; CELLS; PHOSPHORYLATION; GLUTATHIOLATION	Endothelial nitric oxide synthase (eNOS) is critical in the regulation of vascular function, and can generate both nitric oxide (NO) and superoxide (O-2(center dot-)), which are key mediators of cellular signalling. In the presence of Ca2+/calmodulin, eNOS produces NO, endothelial-derived relaxing factor, from L-arginine (L-Arg) by means of electron transfer from NADPH through a flavin containing reductase domain to oxygen bound at the haem of an oxygenase domain, which also contains binding sites for tetrahydrobiopterin (BH4) and L-Arg(1-3). In the absence of BH4, NO synthesis is abrogated and instead O-2(center dot-) is generated(4-7). While NOS dysfunction occurs in diseases with redox stress, BH4 repletion only partly restores NOS activity and NOS-dependent vasodilation(7). This suggests that there is an as yet unidentified redox-regulated mechanism controlling NOS function. Protein thiols can undergo S-glutathionylation, a reversible protein modification involved in cellular signalling and adaptation(8,9). Under oxidative stress, S-glutathionylation occurs through thiol-disulphide exchange with oxidized glutathione or reaction of oxidant-induced protein thiyl radicals with reduced glutathione(10,11). Cysteine residues are critical for the maintenance of eNOS function(12,13); we therefore speculated that oxidative stress could alter eNOS activity through S-glutathionylation. Here we show that S-glutathionylation of eNOS reversibly decreases NOS activity with an increase in O-2(center dot-) generation primarily from the reductase, in which two highly conserved cysteine residues are identified as sites of S-glutathionylation and found to be critical for redox-regulation of eNOS function. We show that eNOS S-glutathionylation in endothelial cells, with loss of NO and gain of O-2(center dot-) generation, is associated with impaired endothelium-dependent vasodilation. In hypertensive vessels, eNOS S-glutathionylation is increased with impaired endothelium-dependent vasodilation that is restored by thiol-specific reducing agents, which reverse this S-glutathionylation. Thus, S-glutathionylation of eNOS is a pivotal switch providing redox regulation of cellular signalling, endothelial function and vascular tone.	[Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.] Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	jay.zweier@osumc.edu	Druhan, Lawrence/E-2994-2011	Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [HL63744, HL65608, HL38324, HL83237, HL103846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, R00HL103846, R01HL083237, R01HL038324, R01HL063744, K99HL103846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank L. Zhang and K. Green-Church for support with mass spectrometric analysis. This work was supported by R01 grants HL63744, HL65608, HL38324 (J.L.Z.), HL83237 (Y.-R.C.) and HL103846 (C.-A. C.) from the National Institutes of Health.	Alzawahra WF, 2008, AM J PHYSIOL-HEART C, V295, pH499, DOI 10.1152/ajpheart.00374.2008; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Caruso RL, 2005, TOXICOL SCI, V86, P417, DOI 10.1093/toxsci/kfi208; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2006, BBA-GEN SUBJECTS, V1760, P1857, DOI 10.1016/j.bbagen.2006.08.002; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Giraldez RR, 1997, J BIOL CHEM, V272, P21420, DOI 10.1074/jbc.272.34.21420; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; Hill BG, 2007, IUBMB LIFE, V59, P21, DOI 10.1080/15216540701196944; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Huang AN, 2001, AM J PHYSIOL-CELL PH, V281, pC719, DOI 10.1152/ajpcell.2001.281.2.C719; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Kugiyama K, 1998, CIRCULATION, V97, P2299, DOI 10.1161/01.CIR.97.23.2299; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P707, DOI 10.1177/002215540305100602; Vanin AF, 2000, BBA-GEN SUBJECTS, V1474, P365, DOI 10.1016/S0304-4165(00)00033-7; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vita JA, 1998, J CLIN INVEST, V101, P1408, DOI 10.1172/JCI1155; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang YM, 2006, FREE RADICAL BIO MED, V41, P775, DOI 10.1016/j.freeradbiomed.2006.05.029; Xia Y, 2000, FREE RADICAL BIO MED, V29, P793, DOI 10.1016/S0891-5849(00)00427-5; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014	42	417	427	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1115	U521		10.1038/nature09599	http://dx.doi.org/10.1038/nature09599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179168	Green Accepted, Green Published			2022-12-24	WOS:000285553800061
J	Greaves, SJ; Rose, RA; Oliver, TAA; Glowacki, DR; Ashfold, MNR; Harvey, JN; Clark, IP; Greetham, GM; Parker, AW; Towrie, M; Orr-Ewing, AJ				Greaves, Stuart J.; Rose, Rebecca A.; Oliver, Thomas A. A.; Glowacki, David R.; Ashfold, Michael N. R.; Harvey, Jeremy N.; Clark, Ian P.; Greetham, Gregory M.; Parker, Anthony W.; Towrie, Michael; Orr-Ewing, Andrew J.			Vibrationally Quantum-State-Specific Reaction Dynamics of H Atom Abstraction by CN Radical in Solution	SCIENCE			English	Article							ROOM-TEMPERATURE LIQUIDS; BIMOLECULAR REACTIONS; HCN; RELAXATION; SPECTROSCOPY; COMPLEXES	Solvent collisions can often mask initial disposition of energy to the products of solution-phase chemical reactions. Here, we show with transient infrared absorption spectra obtained with picosecond time resolution that the nascent HCN products of reaction of CN radicals with cyclohexane in chlorinated organic solvents exhibit preferential excitation of one quantum of the C-H stretching mode and up to two quanta of the bending mode. On time scales of approximately 100 to 300 picoseconds, the HCN products undergo relaxation to the vibrational ground state by coupling to the solvent bath. Comparison with reactions of CN radicals with alkanes in the gas phase, known to produce HCN with greater C-H stretch and bending mode excitation (up to two and approximately six quanta, respectively), indicates partial damping of the nascent product vibrational motion by the solvent. The transient infrared spectra therefore probe solvent-induced modifications to the reaction free energy surface and chemical dynamics.	[Greaves, Stuart J.; Rose, Rebecca A.; Oliver, Thomas A. A.; Glowacki, David R.; Ashfold, Michael N. R.; Harvey, Jeremy N.; Orr-Ewing, Andrew J.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Clark, Ian P.; Greetham, Gregory M.; Parker, Anthony W.; Towrie, Michael] Rutherford Appleton Lab, Cent Laser Facil, Harwell Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Orr-Ewing, AJ (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	a.orr-ewing@bris.ac.uk	Greaves, Stuart/D-9213-2011; Harvey, Jeremy/AAC-6433-2019; Parker, Anthony W./G-5445-2011; Oliver, Tom/A-6432-2012; Harvey, Jeremy N/E-8848-2010	Greaves, Stuart/0000-0002-5238-7150; Harvey, Jeremy/0000-0002-1728-1596; Parker, Anthony W./0000-0003-3094-9762; Harvey, Jeremy N/0000-0002-1728-1596; Towrie, Mike/0000-0002-1305-701X; Orr-Ewing, Andrew/0000-0001-5551-9609; Oliver, Tom/0000-0003-3979-7857; Clark, Ian/0000-0002-0105-4743; ashfold, michael/0000-0001-5762-7048	Science and Technology Facilities Council (STFC); UK Biotechnology and Biological Sciences Research Council (STFC) [ST/501784]; Engineering and Physical Sciences Research Council [EP/G00224X]; Leverhulme Trust; Royal Society; Wolfson Foundation; EPSRC [EP/G00224X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G00224X/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); UK Biotechnology and Biological Sciences Research Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Wolfson Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Measurements were made at the Central Laser Facility, Rutherford Appleton Laboratory, with financial support for the ULTRA laser complex from the Science and Technology Facilities Council (STFC) and UK Biotechnology and Biological Sciences Research Council (STFC Facility Grant ST/501784). Funding for the Bristol group was provided by the Engineering and Physical Sciences Research Council Programme Grant EP/G00224X. We thank the Leverhulme Trust for an Early Career Research Fellowship (S.J.G.) and the Royal Society and the Wolfson Foundation for a Research Merit Award (A.J.O.E.).	Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Bethardy GA, 1996, J CHEM PHYS, V105, P4533, DOI 10.1063/1.472537; BETHARDY GA, 1995, J CHEM PHYS, V102, P7966, DOI 10.1063/1.468995; BOTSCHWINA P, 1983, CHEM PHYS, V81, P73, DOI 10.1016/0301-0104(83)85303-8; Bragg AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233005; Cahoon JF, 2008, SCIENCE, V319, P1820, DOI 10.1126/science.1154041; COPELAND LR, 1992, J CHEM PHYS, V96, P5817, DOI 10.1063/1.462681; Crowther AC, 2008, J PHYS CHEM A, V112, P12081, DOI 10.1021/jp8064079; Crowther AC, 2009, J PHYS CHEM A, V113, P3758, DOI 10.1021/jp8084099; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; Greaves SJ, 2010, PHYS CHEM CHEM PHYS, V12, P9129, DOI 10.1039/c001233e; Greetham GM, 2010, APPL SPECTROSC, V64, P1311, DOI 10.1366/000370210793561673; HERZBERG G, 1945, MOL SPECTRA MOL STRU, pR2; Huang C, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968547; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Linstrom P. J., NIST STANDARD REFERE; Mohammed OF, 2005, SCIENCE, V310, P83, DOI 10.1126/science.1117756; MORRIS VR, 1994, CHEM PHYS LETT, V220, P448, DOI 10.1016/0009-2614(94)00212-6; Moskun AC, 2006, SCIENCE, V311, P1907, DOI 10.1126/science.1123738; Moskun AC, 2003, J CHEM PHYS, V119, P4500, DOI 10.1063/1.1591726; OWRUTSKY JC, 1994, ANNU REV PHYS CHEM, V45, P519, DOI 10.1146/annurev.pc.45.100194.002511; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; RAFTERY D, 1993, CHEM PHYS LETT, V201, P513, DOI 10.1016/0009-2614(93)85110-A; Sheps L, 2006, J PHYS CHEM A, V110, P3087, DOI 10.1021/jp0543835; Voth GA, 1996, J PHYS CHEM-US, V100, P13034, DOI 10.1021/jp960317e	27	72	73	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1423	1426		10.1126/science.1197796	http://dx.doi.org/10.1126/science.1197796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21292937	Green Submitted			2022-12-24	WOS:000288504000037
J	Cortazar, D; Kunz, C; Selfridge, J; Lettieri, T; Saito, Y; MacDougall, E; Wirz, A; Schuermann, D; Jacobs, AL; Siegrist, F; Steinacher, R; Jiricny, J; Bird, A; Schar, P				Cortazar, Daniel; Kunz, Christophe; Selfridge, Jim; Lettieri, Teresa; Saito, Yusuke; MacDougall, Eilidh; Wirz, Annika; Schuermann, David; Jacobs, Angelika L.; Siegrist, Fredy; Steinacher, Roland; Jiricny, Josef; Bird, Adrian; Schaer, Primo			Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability	NATURE			English	Article							THYMINE-DNA GLYCOSYLASE; BASE-EXCISION; STEM-CELLS; METHYLATION; PROMOTER; REPAIR; GENE; 5-METHYLCYTOSINE; MLL; DEMETHYLATION	Thymine DNA glycosylase (TDG) is a member of the uracil DNA glycosylase (UDG) superfamily of DNA repair enzymes. Owing to its ability to excise thymine when mispaired with guanine, it was proposed to act against the mutability of 5-methylcytosine (5-mC) deamination in mammalian DNA(1). However, TDG was also found to interact with transcription factors(2,3), histone acetyltransferases(4) and de novo DNA methyltransferases(5,6), and it has been associated with DNA demethylation in gene promoters following activation of transcription(7-9), altogether implicating an engagement in gene regulation rather than DNA repair. Here we use a mouse genetic approach to determine the biological function of this multifaceted DNA repair enzyme. We find that, unlike other DNA glycosylases, TDG is essential for embryonic development, and that this phenotype is associated with epigenetic aberrations affecting the expression of developmental genes. Fibroblasts derived from Tdg null embryos (mouse embryonic fibroblasts, MEFs) show impaired gene regulation, coincident with imbalanced histone modification and CpG methylation at promoters of affected genes. TDG associates with the promoters of such genes both in fibroblasts and in embryonic stem cells (ESCs), but epigenetic aberrations only appear upon cell lineage commitment. We show that TDG contributes to the maintenance of active and bivalent chromatin throughout cell differentiation, facilitating a proper assembly of chromatin-modifying complexes and initiating base excision repair to counter aberrant de novo methylation. We thus conclude that TDG-dependent DNA repair has evolved to provide epigenetic stability in lineage committed cells.	[Cortazar, Daniel; Kunz, Christophe; Saito, Yusuke; Wirz, Annika; Schuermann, David; Jacobs, Angelika L.; Steinacher, Roland; Schaer, Primo] Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4048 Basel, Switzerland; [Selfridge, Jim; MacDougall, Eilidh; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lettieri, Teresa; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Siegrist, Fredy] F Hoffmann La Roche Ltd, Global Preclin Safety, Pharmaceut Res, CH-4058 Basel, Switzerland	University of Basel; University of Edinburgh; University of Zurich; Roche Holding	Schar, P (corresponding author), Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4048 Basel, Switzerland.	primo.schaer@unibas.ch	Schär, Primo/G-5967-2012; Siegrist, Fredy/A-8230-2013; Schuermann, David/AAC-4075-2019	Schär, Primo/0000-0003-1843-6147; Schuermann, David/0000-0003-2904-1378; Kunz, Christophe/0000-0002-0511-3915; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Lettieri, Teresa/0000-0002-3363-9666	Swiss National Science Foundation [3100A0-108436, 3100A0-122574/]; Association For International Cancer Research [01-330]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Association For International Cancer Research	We thank D. Klewe-Nebenius for preparations of mouse primary fibroblast, and F. Mohn and D. Schubeler for discussions and assistance in the setup and evaluation of the ChIP experiments. The work was supported by project grants from the Swiss National Science Foundation (3100A0-108436; 3100A0-122574/) and the Association For International Cancer Research (01-330).	Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gallais R, 2007, MOL ENDOCRINOL, V21, P2085, DOI 10.1210/me.2006-0490; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu B, 2001, P NATL ACAD SCI USA, V98, P5031, DOI 10.1073/pnas.091097298	29	274	283	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					419	U210		10.1038/nature09672	http://dx.doi.org/10.1038/nature09672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21278727				2022-12-24	WOS:000287409100047
J	deMenocal, PB				deMenocal, Peter B.			Climate and Human Evolution	SCIENCE			English	Editorial Material							EAST-AFRICA; PLIOPLEISTOCENE; ECOSYSTEMS; NEOGENE; PERIOD; MA		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	deMenocal, PB (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	peter@ldeo.columbia.edu	demenocal, peter/B-1386-2013	demenocal, peter/0000-0002-7191-717X				Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe Rene, 2009, P173, DOI 10.1007/978-1-4020-9980-9_15; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; DARWIN C, 2003, ORIGIN SPECIES MEANS, pCH3; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kingston JD, 2007, J HUM EVOL, V53, P487, DOI 10.1016/j.jhevol.2006.12.007; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; National Research Council, 2010, UND CLIM INFL HUM EV; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	23	159	163	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					540	542		10.1126/science.1190683	http://dx.doi.org/10.1126/science.1190683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292958				2022-12-24	WOS:000286933600032
J	Marimuthu, MPA; Jolivet, S; Ravi, M; Pereira, L; Davda, JN; Cromer, L; Wang, LL; Nogue, F; Chan, SWL; Siddiqi, I; Mercier, R				Marimuthu, Mohan P. A.; Jolivet, Sylvie; Ravi, Maruthachalam; Pereira, Lucie; Davda, Jayeshkumar N.; Cromer, Laurence; Wang, Lili; Nogue, Fabien; Chan, Simon W. L.; Siddiqi, Imran; Mercier, Raphael			Synthetic Clonal Reproduction Through Seeds	SCIENCE			English	Article									[Ravi, Maruthachalam; Wang, Lili; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Marimuthu, Mohan P. A.; Davda, Jayeshkumar N.; Siddiqi, Imran] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Jolivet, Sylvie; Pereira, Lucie; Cromer, Laurence; Nogue, Fabien; Mercier, Raphael] INRA, UMR1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France	University of California System; University of California Davis; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chan, SWL (corresponding author), Univ Calif Davis, Dept Plant Biol, 1 Shields Ave, Davis, CA 95616 USA.	srchan@ucdavis.edu; imran@ccmb.res.in; raphael.mercier@versailles.inra.fr	mercier, Raphael/L-1497-2016; wang, lili/HDL-7210-2022; cromer, Laurence/I-4814-2014	mercier, Raphael/0000-0001-6508-6608; Maruthachalam, Ravi/0000-0003-0036-3330; Nogue, Fabien/0000-0003-0619-4638	Agence Nationale de la Recherche [ANR-09-EBIO-011]; INRA GAP Department; NSF [IOS-1026094]; March of Dimes; CSIR; Department of Biotechnology	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA GAP Department; NSF(National Science Foundation (NSF)); March of Dimes(March of Dimes); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	We thank D. Singh for fluorescent in situ hybridization analysis; E. Gugan and N. Shukla for technical assistance; and L. Comai, O. Loudet, J. P. Vielle-Calzada, W. Lucas, and V. Sundaresan for comments on the manuscript. This research was funded by Agence Nationale de la Recherche (ANR-09-EBIO-011 to R.M.), INRA GAP Department (R.M.), NSF (IOS-1026094 to S.W. L.C.), the Basil O'Connor Starter Scholar Program from the March of Dimes (S.W.L.C.), a targeted allocation grant from CSIR (I.S.), and a Centre of Excellence grant from Department of Biotechnology (I. S.). Two provisional patent applications based on the work have been filed jointly by INRA and UC Davis (USA 61/418,792) and jointly by CSIR and UC Davis (India 619/DEL/2010).	d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; Pichot C, 2001, NATURE, V412, P39, DOI 10.1038/35083687; Ravi M, 2008, NATURE, V451, P1121, DOI 10.1038/nature06557; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Spillane C, 2004, NAT BIOTECHNOL, V22, P687, DOI 10.1038/nbt976	6	91	103	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					876	876		10.1126/science.1199682	http://dx.doi.org/10.1126/science.1199682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330535				2022-12-24	WOS:000287455100046
J	Powell, T				Powell, Tia			Life Imitates Work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bioethics@montefiore.org							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					542	543		10.1001/jama.2011.98	http://dx.doi.org/10.1001/jama.2011.98			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304072				2022-12-24	WOS:000287080500002
J	Diep, CQ; Ma, DD; Deo, RC; Holm, TM; Naylor, RW; Arora, N; Wingert, RA; Bollig, F; Djordjevic, G; Lichman, B; Zhu, H; Ikenaga, T; Ono, F; Englert, C; Cowan, CA; Hukriede, NA; Handin, RI; Davidson, AJ				Diep, Cuong Q.; Ma, Dongdong; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Arora, Natasha; Wingert, Rebecca A.; Bollig, Frank; Djordjevic, Gordana; Lichman, Benjamin; Zhu, Hao; Ikenaga, Takanori; Ono, Fumihito; Englert, Christoph; Cowan, Chad A.; Hukriede, Neil A.; Handin, Robert I.; Davidson, Alan J.			Identification of adult nephron progenitors capable of kidney regeneration in zebrafish	NATURE			English	Article							TRANSGENIC ZEBRAFISH; GENES; MORPHOGENESIS; PRONEPHROS; REPORTER	Loss of kidney function underlies many renal diseases(1). Mammals can partly repair their nephrons (the functional units of the kidney), but cannot form new ones(2,3). By contrast, fish add nephrons throughout their lifespan and regenerate nephrons de novo after injury(4,5), providing a model for understanding how mammalian renal regeneration may be therapeutically activated. Here we trace the source of new nephrons in the adult zebrafish to small cellular aggregates containing nephron progenitors. Transplantation of single aggregates comprising 10-30 cells is sufficient to engraft adults and generate multiple nephrons. Serial transplantation experiments to test self-renewal revealed that nephron progenitors are long-lived and possess significant replicative potential, consistent with stem-cell activity. Transplantation of mixed nephron progenitors tagged with either green or red fluorescent proteins yielded some mosaic nephrons, indicating that multiple nephron progenitors contribute to a single nephron. Consistent with this, live imaging of nephron formation in transparent larvae showed that nephrogenic aggregates form by the coalescence of multiple cells and then differentiate into nephrons. Taken together, these data demonstrate that the zebrafish kidney probably contains self-renewing nephron stem/progenitor cells. The identification of these cells paves the way to isolating or engineering the equivalent cells in mammals and developing novel renal regenerative therapies.	[Diep, Cuong Q.; Ma, Dongdong; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Wingert, Rebecca A.; Cowan, Chad A.; Handin, Robert I.; Davidson, Alan J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ma, Dongdong; Handin, Robert I.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Wingert, Rebecca A.; Cowan, Chad A.; Handin, Robert I.; Davidson, Alan J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Zhu, Hao] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ikenaga, Takanori; Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Englert, Christoph] Friedrich Schiller Univ, D-07743 Jena, Germany; [Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hukriede, Neil A.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Diep, Cuong Q.; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Arora, Natasha; Wingert, Rebecca A.; Djordjevic, Gordana; Lichman, Benjamin; Cowan, Chad A.; Davidson, Alan J.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Friedrich Schiller University of Jena; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital	Davidson, AJ (corresponding author), Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1142, New Zealand.	a.davidson@auckland.ac.nz	Ma, Diane/AAR-6749-2021; Zhu, Hao/L-5114-2013; Wilson, Matthew H/K-3193-2013; Wingert, Rebecca A/ABE-2786-2020	Zhu, Hao/0000-0002-8417-9698; Wingert, Rebecca A/0000-0003-3133-7549; Ma, Diane/0000-0001-7125-9587; Ikenaga, Takanori/0000-0002-7321-9703; ono, fumihito/0000-0001-7532-5262; Naylor, Richard/0000-0003-2901-7677; Englert, Christoph/0000-0002-5931-3189; Lichman, Benjamin/0000-0002-0033-1120	Harvard Stem Cell Institute; American Society of Nephrology; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P50DK074030]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030, R01DK069403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000437] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; American Society of Nephrology; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank E. C. Liao for help with suturing, and R. Ethier and L. Gyr for zebrafish care. A.J.D. was supported by the Harvard Stem Cell Institute, the American Society of Nephrology and the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (P50DK074030).	Augusto J, 1996, DIS AQUAT ORGAN, V26, P49, DOI 10.3354/dao026049; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reimschuessel R, 2001, ILAR J, V42, P285; Swanhart LM, 2010, INT J DEV BIOL, V54, P731, DOI 10.1387/ijdb.092969ls; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010	23	200	208	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					95	U108		10.1038/nature09669	http://dx.doi.org/10.1038/nature09669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21270795	Green Accepted			2022-12-24	WOS:000286886400041
J	Frio, TR; Bahubeshi, A; Kanellopoulou, C; Hamel, N; Niedziela, M; Sabbaghian, N; Pouchet, C; Gilbert, L; O'Brien, PK; Serfas, K; Broderick, P; Houlston, RS; Lesueur, F; Bonora, E; Muljo, S; Schimke, RN; Bouron-Dal Soglio, D; Arseneau, J; Schultz, KA; Priest, JR; Nguyen, VH; Harach, HR; Livingston, DM; Foulkes, WD; Tischkowitz, M				Frio, Thomas Rio; Bahubeshi, Amin; Kanellopoulou, Chryssa; Hamel, Nancy; Niedziela, Marek; Sabbaghian, Nelly; Pouchet, Carly; Gilbert, Lucy; O'Brien, Paul K.; Serfas, Kim; Broderick, Peter; Houlston, Richard S.; Lesueur, Fabienne; Bonora, Elena; Muljo, Stefan; Schimke, R. Neil; Bouron-Dal Soglio, Dorothee; Arseneau, Jocelyne; Schultz, Kris Ann; Priest, John R.; Nguyen, Van-Hung; Ruben Harach, H.; Livingston, David M.; Foulkes, William D.; Tischkowitz, Marc			DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLEUROPULMONARY BLASTOMA; THYROID-CARCINOMA; DOMINANT FORM; CANCER; GERMLINE; DISEASE; ARRHENOBLASTOMA; DISORDERS; MICRORNAS; FEMALE	Context Nontoxic multinodular goiter (MNG) is frequently observed in the general population, but little is known about the underlying genetic susceptibility to this disease. Familial cases of MNG have been reported, and published reports describe 5 families that also contain at least 1 individual with a Sertoli-Leydig cell tumor of the ovary (SLCT). Germline mutations in DICER1, a gene that codes for an RNase III endoribonuclease, have been identified in families affected by pleuropulmonary blastoma (PPB), some of whom include cases of MNG and gonadal tumors such as SLCTs. Objective To determine whether familial MNG with or without SLCT in the absence of PPB was associated with mutations in DICER1. Design, Setting, and Patients From September 2009 to September 2010, we screened 53 individuals from 2 MNG and 3 MNG/SLCT families at McGill University for mutations in DICER1. We investigated blood lymphocytes and MNG and SLCT tissue from family members for loss of the wild-type DICER1 allele (loss of heterozygosity), DICER1 expression, and microRNA (miRNA) dysregulation. Main Outcome Measure Detection of germline DICER1 gene mutations in familial MNG with and without SLCT. Results We identified and characterized germline DICER1 mutations in 37 individuals from 5 families. Two mutations were predicted to be protein truncating, 2 resulted in inframe deletions, and 1 was a missense mutation. Molecular analysis of the 3 SLCTs showed no loss of heterozygosity of DICER1, and immunohistochemical analysis in 2 samples showed strong expression of DICER1 in Sertoli cells but weak staining of Leydig cells. miRNA profiling of RNA from lymphoblastoid cell lines from both affected and unaffected members of the familial MNG cases revealed miRNA perturbations in DICER1 mutation carriers. Conclusions DICER1 mutations are associated with both familial MNG and MNG with SLCT, independent of PPB. These germline DICER1 mutations are associated with dysregulation of miRNA expression patterns. JAMA. 2011;305(1):68-77 www.jama.com	[Foulkes, William D.] McGill Univ, Ctr Hlth, Gerald Bronfman Ctr Clin Res Oncol, Program Canc Genet,Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Gilbert, Lucy] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H2W 1S6, Canada; [Arseneau, Jocelyne; Nguyen, Van-Hung] McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ H2W 1S6, Canada; [Frio, Thomas Rio; Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ H2W 1S6, Canada; [Frio, Thomas Rio; Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H2W 1S6, Canada; [Bahubeshi, Amin; Sabbaghian, Nelly; Pouchet, Carly; Foulkes, William D.; Tischkowitz, Marc] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H2W 1S6, Canada; [Kanellopoulou, Chryssa; Livingston, David M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Niedziela, Marek] Poznan Univ Med Sci, Dept Pediat Endocrinol & Rheumatol, Poznan, Poland; [O'Brien, Paul K.] Etobicoke Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Serfas, Kim] Hlth Sci Ctr Winnipeg, Hereditary Breast Hlth Clin, Winnipeg, MB, Canada; [Broderick, Peter; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Surrey, England; [Lesueur, Fabienne] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Bonora, Elena] Univ Bologna, S Orsola M Malpighi Hosp, Dept Gynaecol, Med Genet Unit, Bologna, Italy; [Muljo, Stefan] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Schimke, R. Neil] Univ Kansas, Med Ctr, Dept Internal Med, Div Endocrinol Metab & Genet, Kansas City, KS 66103 USA; [Bouron-Dal Soglio, Dorothee] CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Schultz, Kris Ann] Childrens Hosp & Clin Minnesota, St Paul, MN USA; [Priest, John R.] Int Pleuropulm Blastoma Registry, St Paul, MN USA; [Ruben Harach, H.] Hosp Dr A Onativia, Sector Patol, Salta, Argentina; [Frio, Thomas Rio; Bahubeshi, Amin; Hamel, Nancy; Sabbaghian, Nelly; Pouchet, Carly; Foulkes, William D.; Tischkowitz, Marc] McGill Univ, Ctr Hlth, Program Canc Genet, Dept Human Genet, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Harvard University; Dana-Farber Cancer Institute; Poznan University of Medical Sciences; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of London; Institute of Cancer Research - UK; World Health Organization; International Agency for Research on Cancer (IARC); IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kansas; University of Kansas Medical Center; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospitals & Clinics of Minnesota; McGill University	Foulkes, WD (corresponding author), McGill Univ, Ctr Hlth, Gerald Bronfman Ctr Clin Res Oncol, Program Canc Genet,Dept Oncol, 546 Ave Pins, Montreal, PQ H2W 1S6, Canada.	william.foulkes@mcgill.ca	Niedziela, Marek/A-1155-2011; Tischkowitz, Marc/O-4452-2018; Gilbert, Lucy/M-6879-2019; Hamel, Nancy/L-5122-2016; Foulkes, William D./AAR-9586-2021; Lesueur, Fabienne/R-2178-2017; Muljo, Stefan A/F-5671-2015	Niedziela, Marek/0000-0001-8862-6937; Tischkowitz, Marc/0000-0002-7880-0628; Gilbert, Lucy/0000-0001-8605-5472; Hamel, Nancy/0000-0001-8971-0428; Foulkes, William D./0000-0001-7427-4651; Lesueur, Fabienne/0000-0001-7404-4549; Muljo, Stefan A/0000-0003-1013-446X; Broderick, Peter/0000-0002-8348-5829; Nguyen, Van-Hung/0000-0001-5318-2416; Houlston, Richard/0000-0002-5268-0242; Bonora, Elena/0000-0001-6132-7734	Jewish General Hospital; Turner Family Cancer Research Fund; Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research/FRSQ [FRN53888]; Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Pine Tree Apple Tennis Classic; Theodora H. Lang Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131] Funding Source: NIH RePORTER	Jewish General Hospital(General Electric); Turner Family Cancer Research Fund; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research/FRSQ(Fonds de la Recherche en Sante du QuebecCanadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Pine Tree Apple Tennis Classic; Theodora H. Lang Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the Jewish General Hospital Weekend to End Women's Cancers, the Turner Family Cancer Research Fund, and les Fonds de la Recherche en Sante du Quebec (FRSQ). Mr Bahubeshi is funded by the Canadian Institutes of Health Research/FRSQ training grant in cancer research (FRN53888) of the McGill Integrated Cancer Research Training Program. Dr Rio Frio was funded by the Research Institute of the McGill University Health Centre and by the Henry R. Shibata Fellowship of the Cedars Cancer Institute. Dr Priest receives funding support from the Pine Tree Apple Tennis Classic and the Theodora H. Lang Charitable trust. Dr Foulkes holds an FRSQ national scientist award and Dr Tischkowitz holds an FRSQ clinician-scientist award.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bahubeshi A, 2010, J MED GENET, V47, P863, DOI 10.1136/jmg.2010.081216; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Capon F, 2000, AM J HUM GENET, V67, P1004, DOI 10.1086/303095; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; COUCH RM, 1986, AM J HUM GENET, V39, P811; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Druker HA, 1997, AM J MED GENET, V72, P30, DOI 10.1002/(SICI)1096-8628(19971003)72:1<30::AID-AJMG6>3.0.CO;2-Z; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hill DA, 2010, LAB INVEST, V90, P311; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; JENSEN RD, 1974, CANCER, V33, P218, DOI 10.1002/1097-0142(197401)33:1<218::AID-CNCR2820330132>3.0.CO;2-Z; Knobel M, 2003, THYROID, V13, P771, DOI 10.1089/105072503768499671; KOONINGS PP, 1989, OBSTET GYNECOL, V74, P921; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lau PW, 2009, STRUCTURE, V17, P1326, DOI 10.1016/j.str.2009.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Niedziela M, 2008, PEDIATR BLOOD CANCER, V51, P543, DOI 10.1002/pbc.21675; OBRIEN PK, 1981, AM J CLIN PATHOL, V75, P578; Pinchera A., 1996, Annali Italiani di Chirurgia, V67, P317; Priest JR, 2009, PEDIATR PULM, V44, P14, DOI 10.1002/ppul.20917; Priest JR, 1996, J PEDIATR-US, V128, P220, DOI 10.1016/S0022-3476(96)70393-1; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schultz K, 2010, AM SOC PED ONC HEM M; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; WHITCOMB RW, 1986, OBSTET GYNECOL, V67, pS89, DOI 10.1097/00006250-198603001-00026; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; YOUNG RH, 1985, AM J SURG PATHOL, V9, P543, DOI 10.1097/00000478-198508000-00001; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	41	191	194	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					68	77		10.1001/jama.2010.1910	http://dx.doi.org/10.1001/jama.2010.1910			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205968	Green Accepted, Bronze			2022-12-24	WOS:000285924100026
J	Christian, P; Murray-Kolb, LE; Khatry, SK; Katz, J; Schaefer, BA; Cole, PM; LeClerq, SC; Tielsch, JM				Christian, Parul; Murray-Kolb, Laura E.; Khatry, Subarna K.; Katz, Joanne; Schaefer, Barbara A.; Cole, Pamela M.; LeClerq, Steven C.; Tielsch, James M.			Prenatal Micronutrient Supplementation and Intellectual and Motor Function in Early School-aged Children in Nepal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IRON-DEFICIENCY ALTERS; PLACEBO-CONTROLLED TRIAL; ZINC SUPPLEMENTATION; FOLIC-ACID; FOLLOW-UP; PSYCHOMOTOR DEVELOPMENT; MENTAL-DEVELOPMENT; INFANT DEVELOPMENT; RANDOMIZED-TRIAL; PREGNANT-WOMEN	Context Iron and zinc are important for the development of both intellectual and motor skills. Few studies have examined whether iron and zinc supplementation during gestation, a critical period of central nervous system development, affects children's later functioning. Objective To examine intellectual and motor functioning of children whose mothers received micronutrient supplementation during pregnancy. Design, Setting, and Participants Cohort follow-up of 676 children aged 7 to 9 years in June 2007-April 2009 who had been born to women in 4 of 5 groups of a community-based, double-blind, randomized controlled trial of prenatal micronutrient supplementation between 1999 and 2001 in rural Nepal. Study children were also in the placebo group of a subsequent preschool iron and zinc supplementation trial. Interventions Women whose children were followed up had been randomly assigned to receive daily iron/folic acid, iron/folic acid/zinc, or multiple micronutrients containing these plus 11 other micronutrients, all with vitamin A, vs a control group of vitamin A alone from early pregnancy through 3 months postpartum. These children did not receive additional micronutrient supplementation other than biannual vitamin A supplementation. Main Outcome Measures Children's intellectual functioning, assessed using the Universal Nonverbal Intelligence Test (UNIT); tests of executive function, including go/no-go, the Stroop test, and backward digit span; and motor function, assessed using the Movement Assessment Battery for Children (MABC) and finger-tapping test. Results The difference across outcomes was significant (Bonferroni-adjusted P<.001) for iron/folic acid vs control but not for other supplement groups. The mean UNIT T score in the iron/folic acid group was 51.7 (SD, 8.5) and in the control group was 48.2 (SD, 10.2), withanadjustedmeandifference of 2.38 (95% confidence interval [CI], 0.06-4.70; P=.04). Differences were not significant between the control group and either the iron/folic acid/zinc (0.73; 95% CI, -0.95 to 2.42) or multiple micronutrient (1.00; 95% CI, -0.55 to 2.56) groups. In tests of executive function, scores were better in the iron/folic acid group relative to the control group for the Stroop test (adjusted mean difference in proportion who failed, -0.14; 95% CI, -0.23 to -0.04) and backward digit span (adjusted mean difference, 0.36; 95% CI, 0.01-0.71) but not for the go/no-go test. The MABC score was lower (better) in the iron/folic acid group compared with the control group but not after adjustment for confounders (mean difference, -1.47; 95% CI, -3.06 to 0.12; P=.07). Finger-tapping test scores were higher (mean difference, 2.05; 95% CI, 0.87-3.24; P=.001) in the iron/folic acid group. Conclusion Aspects of intellectual functioning including working memory, inhibitory control, and fine motor functioning among offspring were positively associated with prenatal iron/folic acid supplementation in an area where iron deficiency is prevalent.	[Christian, Parul; Murray-Kolb, Laura E.; Katz, Joanne; LeClerq, Steven C.; Tielsch, James M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Murray-Kolb, Laura E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Schaefer, Barbara A.] Penn State Univ, Dept Educ, University Pk, PA 16802 USA; [Schaefer, Barbara A.] Penn State Univ, Sch Psychol & Special Educ, University Pk, PA 16802 USA; [Khatry, Subarna K.; LeClerq, Steven C.] Nepal Eye Hosp Complex, Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Christian, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, 615 N Wolfe St,Room W2041, Baltimore, MD 21205 USA.	pchristi@jhsph.edu	Mireku, Michael/D-5262-2016	Tielsch, James/0000-0002-1151-060X; Katz, Joanne/0000-0002-5997-7823	National Institutes of Health [R01 HD050254-01, HD 38753]; Bill and Melinda Gates Foundation, Seattle, Washington; Johns Hopkins University [HRN-A-00-97-00015-00, GHS-A-00-03-00019-00]; Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development, Washington, DC [HRN-A-00-97-00015-00, GHS-A-00-03-00019-00]; Bill and Melinda Gates Foundation; US Agency for International Development [HRN-A-00-97-00015-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050254, R01HD038753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation, Seattle, Washington(Bill & Melinda Gates Foundation); Johns Hopkins University(Johns Hopkins University); Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development, Washington, DC(United States Agency for International Development (USAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was carried out by the Center for Human Nutrition, Department of International Health of the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, in collaboration with the National Society for the Prevention of Blindness, Kathmandu, Nepal, with funding from National Institutes of Health grant R01 HD050254-01 and the Bill and Melinda Gates Foundation, Seattle, Washington. The antenatal micronutrient supplementation study was conducted under Micronutrients for Health Cooperative Agreement HRN-A-00-97-00015-00 and Global Research Activity Cooperative Agreement GHS-A-00-03-00019-00 between Johns Hopkins University and the Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development, Washington, DC. Bill and Melinda Gates Foundation and Sight and Life Research Institute, Baltimore, Maryland, provided additional support for the study. The preschool child iron and zinc supplementation study was funded by the National Institutes of Health (HD 38753), the Bill and Melinda Gates Foundation, and a cooperative agreement between Johns Hopkins University and the Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development (HRN-A-00-97-00015-00).	Beard JL, 2008, J NUTR, V138, P2534, DOI 10.1093/jn/138.12.2534; Bracken B.A., 1998, UNIVERSAL NONVERBAL; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Caldwell BM, 1984, HOME OBSERVATION MEA; Carlson ES, 2007, HIPPOCAMPUS, V17, P679, DOI 10.1002/hipo.20307; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, J NUTR, V133, p1969S, DOI 10.1093/jn/133.6.1969S; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Clardy SL, 2006, J NEURAL TRANSM-SUPP, P173; Connor J., 1997, METALS OXIDATIVE DAM, P23; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; deUngria M, 2000, PEDIATR RES, V48, P169, DOI 10.1203/00006450-200008000-00009; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Georgieff MK, 2008, BIOCHEM SOC T, V36, P1267, DOI 10.1042/BST0361267; Gillian BJ, 2009, THESIS J HOPKINS U B; Golub MS, 2006, NEUROTOXICOL TERATOL, V28, P3, DOI 10.1016/j.ntt.2005.10.005; Hamadani JD, 2002, LANCET, V360, P290, DOI 10.1016/S0140-6736(02)09551-X; Henderson S., 1992, MOVEMENT ASSESSMENT; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Li Q, 2009, PEDIATRICS, V123, pE685, DOI 10.1542/peds.2008-3007; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Malouf M, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004514; McCallum S, 2001, ESSENTIALS NONVERBAL; McGrath N, 2006, PEDIATRICS, V117, pE216, DOI 10.1542/peds.2004-1668; Merialdi M, 1999, AM J OBSTET GYNECOL, V180, P483, DOI 10.1016/S0002-9378(99)70236-X; Olivares M, 2007, NUTRITION, V23, P292, DOI 10.1016/j.nut.2007.01.006; Ortiz E, 2004, J NEUROSCI RES, V77, P681, DOI 10.1002/jnr.20207; Rao R, 2003, J NUTR, V133, P3215, DOI 10.1093/jn/133.10.3215; Raven JC., 1992, MANUAL RAVENS PROGR; Roza SJ, 2010, BRIT J NUTR, V103, P445, DOI 10.1017/S0007114509991954; Siddappa AM, 2004, PEDIATR RES, V55, P1034, DOI 10.1203/01.pdr.0000127021.38207.62; Snedecor GW, 1980, STAT METHODS; Tamura T, 2003, AM J CLIN NUTR, V77, P1512, DOI 10.1093/ajcn/77.6.1512; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tofail F, 2008, AM J CLIN NUTR, V87, P704, DOI 10.1093/ajcn/87.3.704; Ward KL, 2007, J NUTR, V137, P1043, DOI 10.1093/jn/137.4.1043; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wehby GL, 2008, MATERN CHILD HLTH J, V12, P180, DOI 10.1007/s10995-007-0230-3; Whittaker P, 1998, AM J CLIN NUTR, V68, p442S, DOI 10.1093/ajcn/68.2.442S; Zhou SJ, 2006, AM J CLIN NUTR, V83, P1112, DOI 10.1093/ajcn/83.5.1112	44	169	174	0	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2716	2723		10.1001/jama.2010.1861	http://dx.doi.org/10.1001/jama.2010.1861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177506				2022-12-24	WOS:000285518000016
J	Gentles, AJ; Plevritis, SK; Majeti, R; Alizadeh, AA				Gentles, Andrew J.; Plevritis, Sylvia K.; Majeti, Ravindra; Alizadeh, Ash A.			Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INITIATING CELLS; PROGENITOR CELLS; BREAST-CANCER; MUTATIONS; SURVIVAL; AML; HETEROGENEITY; PROLIFERATION; INDUCTION; FREQUENCY	Context In many cancers, specific subpopulations of cells appear to be uniquely capable of initiating and maintaining tumors. The strongest support for this cancer stem cell model comes from transplantation assays in immunodeficient mice, which indicate that human acute myeloid leukemia (AML) is driven by self-renewing leukemic stem cells (LSCs). This model has significant implications for the development of novel therapies, but its clinical relevance has yet to be determined. Objective To identify an LSC gene expression signature and test its association with clinical outcomes in AML. Design, Setting, and Patients Retrospective study of global gene expression (microarray) profiles of LSC-enriched subpopulations from primary AML and normal patient samples, which were obtained at a US medical center between April 2005 and July 2007, and validation data sets of global transcriptional profiles of AML tumors from 4 independent cohorts (n=1047). Main Outcome Measures Identification of genes discriminating LSC-enriched populations from other subpopulations in AML tumors; and association of LSC-specific genes with overall, event-free, and relapse-free survival and with therapeutic response. Results Expression levels of 52 genes distinguished LSC-enriched populations from other subpopulations in cell-sorted AML samples. An LSC score summarizing expression of these genes in bulk primary AML tumor samples was associated with clinical outcomes in the 4 independent patient cohorts. High LSC scores were associated with worse overall, event-free, and relapse-free survival among patients with either normal karyotypes or chromosomal abnormalities. For the largest cohort of patients with normal karyotypes (n=163), the LSC score was significantly associated with overall survival as a continuous variable (hazard ratio [HR], 1.15; 95% confidence interval [CI], 1.08-1.22; log-likelihood P<.001). The absolute risk of death by 3 years was 57% (95% CI, 43%-67%) for the low LSC score group compared with 78% (95% CI, 66%-86%) for the high LSC score group (HR, 1.9 [95% CI, 1.3-2.7]; log-rank P=.002). In another cohort with available data on event-free survival for 70 patients with normal karyotypes, the risk of an event by 3 years was 48% (95% CI, 27%-63%) in the low LSC score group vs 81% (95% CI, 60%-91%) in the high LSC score group (HR, 2.4 [95% CI, 1.3-4.5]; log-rank P=.006). In multivariate Cox regression including age, mutations in FLT3 and NPM1, and cytogenetic abnormalities, the HRs for LSC score in the 3 cohorts with data on all variables were 1.07 (95% CI, 1.01-1.13; P=.02), 1.10 (95% CI, 1.03-1.17; P=.005), and 1.17 (95% CI, 1.05-1.30; P=.005). Conclusion High expression of an LSC gene signature is independently associated with adverse outcomes in patients with AML. JAMA. 2010;304(24):2706-2715 www.jama.com	[Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA; [Gentles, Andrew J.; Plevritis, Sylvia K.] Stanford Univ, Lucas Ctr MR Spect & Imaging, Dept Radiol, Palo Alto, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Ctr Canc, Dept Internal Med, Div Oncol, Palo Alto, CA 94305 USA; [Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Ctr Canc, Dept Internal Med, Div Hematol, Palo Alto, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Alizadeh, AA (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA.	rmajeti@stanford.edu; arasha@stanford.edu	Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Majeti, Ravindra/0000-0002-5814-0984	National Institutes of Health [1U54CA149145, U56-CA112973]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [U56CA112973, U54CA149145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Integrative Cancer Biology Program through National Institutes of Health awards 1U54CA149145 and U56-CA112973 (Dr Plevritis). Dr Majeti holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Dr Alizadeh holds a Career Development Award from the Leukemia and Lymphoma Society.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cleary ML, 2009, BEST PRACT RES CL HA, V22, P483, DOI 10.1016/j.beha.2009.08.005; Costello RT, 1999, LEUKEMIA, V13, P1513, DOI 10.1038/sj.leu.2401519; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dufour A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gentles AJ, 2009, BLOOD, V114, P3158, DOI 10.1182/blood-2009-02-202465; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade David, 2009, Hematology Am Soc Hematol Educ Program, P385, DOI 10.1182/asheducation-2009.1.385; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Langer C, 2008, BLOOD, V111, P5371, DOI 10.1182/blood-2007-11-124958; LEE EJ, 1987, BLOOD, V70, P1400; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lodygin D, 2002, J CLIN INVEST, V110, P1717, DOI 10.1172/JCI200216588; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; OSHITA AK, 1977, BLOOD, V49, P585; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895	55	255	272	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2706	2715		10.1001/jama.2010.1862	http://dx.doi.org/10.1001/jama.2010.1862			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177505	Bronze, Green Accepted			2022-12-24	WOS:000285518000015
J	Pilling, S; Yesufu-Udechuku, A; Taylor, C; Drummond, C				Pilling, Stephen; Yesufu-Udechuku, Amina; Taylor, Clare; Drummond, Colin		Guideline Dev Grp	Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material												s.pilling@ucl.ac.uk	Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452; Mavranezouli, Ifigeneia/0000-0001-9095-3566	National Institute for Health Research [RP-PG-0609-10162] Funding Source: researchfish; MRC [G0701681, G0701818] Funding Source: UKRI; Medical Research Council [G0701681, G0701818] Funding Source: Medline; Department of Health [RP-PG-0609-10162] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Babor TF., 2001, ALCOHOL USE DISORDER; *DEP HLTH, 2006, MOD CAR ALC MIS; Drummond C, 1990, BR J ADDICT, V85, P357; Drummond DC, 2005, ALCOHOL NEEDS ASSESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuller E., 2008, DRUG USE SMOKING DRI; *N W PUBL HLTH OBS, 2010, N W PUBL HLTH OBS LO; *NAT I HLTH CLIN E, 2009, GUID MAN NAT I HLTH; *NAT I HLTH CLIN E, 2005, CLIN GUID, V31; *NAT I HLTH CLIN E, 2005, CLIN GUID, V26; National Institute for Health and Care Excellence (NICE), 2011, ALCOHOL USE DISORDER; National Institute for Health and Clinical Excellence, 2009, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; National Institute for Health and Clinical Excellence, 2010, CLIN GUID, V94; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Stockwell T, 1979, BR J ADDICT ALCOHOL, V74, P78	17	24	25	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d700	10.1136/bmj.d700	http://dx.doi.org/10.1136/bmj.d700			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345905				2022-12-24	WOS:000287920100006
J	Horsfall, LJ; Rait, G; Walters, K; Swallow, DM; Pereira, SP; Nazareth, I; Petersen, I				Horsfall, Laura J.; Rait, Greta; Walters, Kate; Swallow, Dallas M.; Pereira, Stephen P.; Nazareth, Irwin; Petersen, Irene			Serum Bilirubin and Risk of Respiratory Disease and Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEME OXYGENASE-1; POLYMORPHISMS; ASSOCIATION; POPULATION; PROMOTER; UGT1A1; GENOME; GENES	Context Serum total bilirubin levels in healthy patients reflect genetic and environmental factors that could influence the risk of developing respiratory disease. Objective To examine the relationship between bilirubin levels and respiratory disease. Design, Setting, and Participants Cohort study among 504 206 adults from a UK primary care research database (the Health Improvement Network) with serum bilirubin levels recorded but no evidence of hepatobiliary or hemolytic disease. Data were recorded between January 1988 and December 2008. Main Outcome Measures Incidence of chronic obstructive pulmonary disease (COPD), lung cancer, and all-cause mortality. Results Median bilirubin levels were 0.64 mg/dL (interquartile range, 0.47-0.88 mg/dL) in men and 0.53 mg/dL (interquartile range, 0.41-0.70 mg/dL) in women. There were 1341 cases of lung cancer, 5863 cases of COPD, and 23 103 deaths, with incidence rates of 2.5, 11.9, and 42.5 per 10 000 person-years, respectively. The incidence of lung cancer per 10 000 person-years in men was 5.0 (95% confidence interval [CI], 4.2-6.0) in the first decile category of bilirubin compared with 3.0 (95% CI, 2.3-3.8) in the fifth decile. The corresponding incidences for COPD in men were 19.5 (95% CI, 17.7-21.4) and 14.4 (95% CI, 12.7-16.2). The mortality rates per 10 000 person-years in men were 51.3 (95% CI, 48.5-54.2) in the first decile category compared with 38.1 (95% CI, 35.5-40.8) in the fifth decile. The associations were similar for women. After adjusting for other important health indicators, regression estimates for incidence rate of lung cancer per 0.1-mg/dL increase in bilirubin level were an 8% decrease (95% CI, 5%-11%) for men and an 11% decrease (95% CI, 7%-14%) for women. The regression estimate for COPD in men per 0.1-mg/dL increase in bilirubin level was a 6% decrease (95% CI, 5%-7%) and for mortality in men was a 3% decrease (95% CI, 2%-3%) after accounting for other health indicators. The results for COPD and mortality in women were very similar. Conclusion Among patients with normal-range bilirubin levels in primary care practices, relatively higher levels of bilirubin were associated with a lower risk of respiratory disease and all-cause mortality. JAMA. 2011;305(7):691-697 www.jama.com	[Horsfall, Laura J.; Rait, Greta; Walters, Kate; Nazareth, Irwin; Petersen, Irene] UCL, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Horsfall, Laura J.; Swallow, Dallas M.] UCL, Res Dept Genet Evolut & Environm, London NW3 2PF, England; [Pereira, Stephen P.] UCL, Inst Hepatol, London NW3 2PF, England; [Rait, Greta; Nazareth, Irwin] MRC, Gen Practice Res Framework, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Horsfall, LJ (corresponding author), UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, Rowland Hill St, London NW3 2PF, England.	laura.horsfall@ucl.ac.uk	Pereira, Stephen P/C-5639-2009; Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009	Pereira, Stephen P/0000-0003-0821-1809; Petersen, Irene/0000-0002-0037-7524; Rait, Greta/0000-0002-7216-7294; Nazareth, Irwin/0000-0003-2146-9628; Walters, Kate/0000-0003-2173-2430	National Institute for Health Research School for Primary Care Research; UK Medical Research Council [G0601726, G0900701]; Medical Research Council [G0601726, G0900701, MC_U122797165] Funding Source: researchfish; MRC [G0900701, MC_U122797165, G0601726] Funding Source: UKRI	National Institute for Health Research School for Primary Care Research; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Ms Horsfall completed this work as part of her post at the University College London Department of Primary Care and Population Health with additional funding from the National Institute for Health Research School for Primary Care Research. Dr Petersen received funding through grants G0601726 and G0900701 from the UK Medical Research Council.	Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Booth N, 1994, Health Libr Rev, V11, P177; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bourke Alison, 2004, Inform Prim Care, V12, P171; Campbell MJ, 2009, STAT SQUARE ONE; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Harrell FE, 2001, REGRESSION MODELING; Hong AL, 2007, DRUG METAB DISPOS, V35, P1254, DOI 10.1124/dmd.106.014183; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lin JP, 2010, CLIN CHEM, V56, P1535, DOI 10.1373/clinchem.2010.151043; Lin R, 2009, HUM MUTAT, V30, P609, DOI 10.1002/humu.20895; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Office for National Statistics, 2005, CENS 2001 GEN REP EN; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Thanassoulis G, 2009, JAMA-J AM MED ASSOC, V301, P2386, DOI 10.1001/jama.2009.812; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; WILDING P, 1972, CLIN CHIM ACTA, V41, P375, DOI 10.1016/0009-8981(72)90534-7; Zucker SD, 2004, HEPATOLOGY, V40, P827, DOI 10.1002/hep.20407	31	143	151	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					691	697		10.1001/jama.2011.124	http://dx.doi.org/10.1001/jama.2011.124			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325185	Bronze			2022-12-24	WOS:000287361100020
J	Schreiber, A; Stengel, F; Zhang, ZG; Enchev, RI; Kong, EH; Morris, EP; Robinson, CV; da Fonseca, PCA; Barford, D				Schreiber, Anne; Stengel, Florian; Zhang, Ziguo; Enchev, Radoslav I.; Kong, Eric H.; Morris, Edward P.; Robinson, Carol V.; da Fonseca, Paula C. A.; Barford, David			Structural basis for the subunit assembly of the anaphase-promoting complex	NATURE			English	Article							CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX/CYCLOSOME; EXPRESSION; INSIGHTS; CYCLIN; VISUALIZATION; PURIFICATION	The anaphase-promoting complex or cyclosome (APC/C) is an unusually large E3 ubiquitin ligase responsible for regulating defined cell cycle transitions. Information on how its 13 constituent proteins are assembled, and how they interact with co-activators, substrates and regulatory proteins is limited. Here, we describe a recombinant expression system that allows the reconstitution of holo APC/C and its sub-complexes that, when combined with electron microscopy, mass spectrometry and docking of crystallographic and homology-derived coordinates, provides a precise definition of the organization and structure of all essential APC/C subunits, resulting in a pseudo-atomic model for 70% of the APC/C. A lattice-like appearance of the APC/C is generated by multiple repeat motifs of most APC/C subunits. Three conserved tetratricopeptide repeat (TPR) subunits (Cdc16, Cdc23 and Cdc27) share related superhelical homo-dimeric architectures that assemble to generate a quasi-symmetrical structure. Our structure explains how this TPR sub-complex, together with additional scaffolding subunits (Apc1, Apc4 and Apc5), coordinate the juxtaposition of the catalytic and substrate recognition module (Apc2, Apc11 and Apc10 (also known as Doc1)), and TPR-phosphorylation sites, relative to co-activator, regulatory proteins and substrates.	[Schreiber, Anne; Zhang, Ziguo; Enchev, Radoslav I.; Kong, Eric H.; Morris, Edward P.; da Fonseca, Paula C. A.; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Stengel, Florian; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; Zhang, Ziguo/0000-0002-7268-9631; robinson, carol/0000-0001-7829-5505; Schreiber, Anne/0000-0001-6766-2808; da Fonseca, Paula/0000-0001-8656-5747; Stengel, Florian/0000-0003-1447-4509	Cancer Research UK; EU [HEALTH-F4-2008-201648]	Cancer Research UK(Cancer Research UK); EU(European Commission)	This work was funded by a Cancer Research UK grant to D. B. and EU FP7 PROSPECTS (Proteomics Specification in Space and Time) Grant HEALTH-F4-2008-201648 to C. V. R. We thank F. Beuron for help with electron microscopy and Jing Yang for help with insect cell expression.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfleger CM, 2000, GENE DEV, V14, P655; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045	56	135	142	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					227	+		10.1038/nature09756	http://dx.doi.org/10.1038/nature09756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307936				2022-12-24	WOS:000287144200037
J	Arria, AM; O'Brien, MC				Arria, Amelia M.; O'Brien, Mary Claire			The "High" Risk of Energy Drinks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLEGE-STUDENTS; CAFFEINE INTAKE; ADOLESCENTS; CONSUMPTION		[Arria, Amelia M.] Univ Maryland, Sch Publ Hlth, Dept Family Sci, Ctr Young Adult Hlth & Dev, College Pk, MD 20742 USA; [Arria, Amelia M.] Treatment Res Inst, Philadelphia, PA USA; [O'Brien, Mary Claire] Wake Forest Univ, Sch Med, Dept Emergency Med, Winston Salem, NC 27109 USA	University System of Maryland; University of Maryland College Park; Wake Forest University	Arria, AM (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Family Sci, Ctr Young Adult Hlth & Dev, 1142 Sch Publ Hlth Bldg, College Pk, MD 20742 USA.	aarria@umd.edu		Arria, Amelia/0000-0002-6360-9265	NIAAA NIH HHS [R01 AA014007, R01 AA014007-06A1, R01AA14007] Funding Source: Medline; NIDA NIH HHS [R01 DA014845-08, R01 DA014845, R01 DA014845-07, R01DA14845] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014845] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ARRIA AM, COMMUNICATION; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P1; Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4; Ferreira SE, 2006, ALCOHOL CLIN EXP RES, V30, P598, DOI 10.1111/j.1530-0277.2006.00070.x; Greenwood DC, 2010, EUR J EPIDEMIOL, V25, P275, DOI 10.1007/s10654-010-9443-7; Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Savoca MR, 2005, AM J HYPERTENS, V18, P116, DOI 10.1016/j.amjhyper.2004.08.011	10	122	132	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					600	601		10.1001/jama.2011.109	http://dx.doi.org/10.1001/jama.2011.109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	717XI	21266673	Green Accepted			2022-12-24	WOS:000287080500025
J	Piovia-Scott, J; Spiller, DA; Schoener, TW				Piovia-Scott, Jonah; Spiller, David A.; Schoener, Thomas W.			Effects of Experimental Seaweed Deposition on Lizard and Ant Predation in an Island Food Web	SCIENCE			English	Article							RECENT CLIMATE-CHANGE; SPECIES INTERACTIONS; TROPHIC CASCADES; RESPONSES; SUBSIDIES; PREY; COMMUNITY; EVOLUTION; INVASION; IMPACTS	The effect of environmental change on ecosystems is mediated by species interactions. Environmental change may remove or add species and shift life-history events, altering which species interact at a given time. However, environmental change may also reconfigure multispecies interactions when both species composition and phenology remain intact. In a Caribbean island system, a major manifestation of environmental change is seaweed deposition, which has been linked to eutrophication, overfishing, and hurricanes. Here, we show in a whole-island field experiment that without seaweed two predators-lizards and ants-had a substantially greater-than-additive effect on herbivory. When seaweed was added to mimic deposition by hurricanes, no interactive predator effect occurred. Thus environmental change can substantially restructure food-web interactions, complicating efforts to predict anthropogenic changes in ecosystem processes.	[Piovia-Scott, Jonah] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Piovia-Scott, J (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	jpioviascott@ucdavis.edu	Piovia-Scott, Jonah/W-9308-2019		NSF; University of California Davis Center for Population Biology	NSF(National Science Foundation (NSF)); University of California Davis Center for Population Biology(University of California System)	We thank L. H. Yang, J. J. Stachowicz, M. L. Stanton, and three anonymous reviewers for comments on the manuscript; A. N. Wright and S. S. Porter for help in the field; L. Wong for help in the lab; and the Bahamas Ministry of Agriculture and Marine Resources for permission to conduct this research. This project was supported by grants from NSF and the University of California Davis Center for Population Biology to the authors.	Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blomquist HL, 1943, AM J BOT, V30, P28, DOI 10.2307/2437389; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Nakano S, 1999, ECOLOGY, V80, P2435; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piovia-Scott J, 2011, J ECOL, V99, P327, DOI 10.1111/j.1365-2745.2010.01728.x; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Schoener TW, 1999, AM NAT, V153, P347, DOI 10.1086/303177; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SPILLER DA, 1994, ECOLOGY, V75, P182, DOI 10.2307/1939393; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Takimoto G, 2009, AM NAT, V173, P200, DOI 10.1086/595759; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x	28	35	35	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					461	463		10.1126/science.1200282	http://dx.doi.org/10.1126/science.1200282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273487				2022-12-24	WOS:000286635900053
J	Shirey, PD; Lamberti, GA				Shirey, Patrick D.; Lamberti, Gary A.			Regulate trade in rare plants	NATURE			English	Editorial Material									[Shirey, Patrick D.; Lamberti, Gary A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Shirey, PD (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	pshirey@nd.edu	Shirey, Patrick/A-3017-2010	Shirey, Patrick/0000-0001-5933-5022				BARLOW C, 2009, GAIA TURMOIL CLIMATE, pCH10; Ellstrand NC, 2010, BIOSCIENCE, V60, P384, DOI 10.1525/bio.2010.60.5.8; Goble DD, 1999, ENVIRON SCI POLICY, V2, P43, DOI DOI 10.1016/S1462-9011(98)00041-0; Marris E, 2009, NATURE, V459, P906, DOI 10.1038/459906a; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; READ M, 1989, Oryx, V23, P127; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Shirey PD, 2010, CONSERV LETT, V3, P45, DOI 10.1111/j.1755-263X.2009.00083.x	10	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					465	467		10.1038/469465a	http://dx.doi.org/10.1038/469465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	711MU	21270870				2022-12-24	WOS:000286596500009
J	Aguilera, C; Nakagawa, K; Sancho, R; Chakraborty, A; Hendrich, B; Behrens, A				Aguilera, Cristina; Nakagawa, Kentaro; Sancho, Rocio; Chakraborty, Atanu; Hendrich, Brian; Behrens, Axel			c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex	NATURE			English	Article							BINDING DOMAIN; MAP KINASES; STEM-CELLS; MBD3; NURD; TUMORIGENESIS; ACTIVATION; COMPONENT; MI-2/NURD; COLON	AP-1 (activator protein 1) activity is strongly induced in response to numerous signals, including growth factors, cytokines and extracellular stresses(1). The proto-oncoprotein c-Jun belongs to the AP-1 group of transcription factors and it is a crucial regulator of intestinal progenitor proliferation and tumorigenesis(2-4). An important mechanism of AP-1 stimulation is phosphorylation of c-Jun by the Jun amino-terminal kinases (JNKs)(1). N-terminal phosphorylation of the c-Jun transactivation domain increases target gene transcription(5,6), but a molecular explanation was elusive. Here we show that unphosphorylated, but not N-terminally phosphorylated c-Jun, interacts with Mbd3 and thereby recruits the nucleosome remodelling and histone deacetylation (NuRD) repressor complex. Mbd3 depletion in colon cancer cells increased histone acetylation at AP-1-dependent promoters, which resulted in increased target gene expression. The intestinal stem cell marker lgr5 was identified as a novel target gene controlled by c-Jun/Mbd3. Gut-specific conditional deletion of mbd3 (mbd3(Delta G/Delta G) mice) stimulated c-Jun activity and increased progenitor cell proliferation. In response to inflammation, mdb3 deficiency resulted in colonic hyperproliferation and mbd3(Delta G/Delta G) mice showed markedly increased susceptibility to colitis-induced tumorigenesis. Notably, concomitant inactivation of a single allele of c-jun reverted physiological and pathological hyperproliferation, as well as the increased tumorigenesis in mbd3(Delta G/Delta G) mice. Thus the transactivation domain of c-Jun recruits Mbd3/NuRD to AP-1 target genes to mediate gene repression, and this repression is relieved by JNK-mediated c-Jun N-terminal phosphorylation.	[Aguilera, Cristina; Nakagawa, Kentaro; Sancho, Rocio; Chakraborty, Atanu; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Nakagawa, Kentaro] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Bunkyo Ku, Tokyo 1138519, Japan; [Hendrich, Brian] Univ Cambridge, Dept Biochem, MRC,Wellcome Trust Ctr Stem Cell Res, Ctr Stem Cell Biol & Regenerat Med, Cambridge CB2 1QR, England	Cancer Research UK; Tokyo Medical & Dental University (TMDU); University of Cambridge	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk	Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Sancho, Rocio/0000-0002-4894-5391; Behrens, Axel/0000-0002-1557-1143	Marie Curie Intraeuropean Fellowships [PIEF-GA-2008-220566, MEIF-CT-2006-041119]; Cancer Research UK; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish	Marie Curie Intraeuropean Fellowships(European Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the LRI Animal Unit, Equipment Park, FACS, Peptide synthesis and the Experimental Histopathology unit for technical help and O. S. Gabrielsen for reagents. We thank C. Hill and H. Van Dam for critical reading of the manuscript. C. A. and R. S. were funded by Marie Curie Intraeuropean Fellowships (PIEF-GA-2008-220566 and MEIF-CT-2006-041119). The London Research Institute is funded by Cancer Research UK.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BAICHWAL VR, 1992, GENE DEV, V6, P1493, DOI 10.1101/gad.6.8.1493; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364	28	92	99	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					231	235		10.1038/nature09607	http://dx.doi.org/10.1038/nature09607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21196933				2022-12-24	WOS:000286143400042
J	Poste, G				Poste, George			Bring on the biomarkers	NATURE			English	Editorial Material							MEDICINE		[Poste, George] Complex Adapt Syst Initiat, Scottsdale, AZ 85257 USA; [Poste, George] Arizona State Univ, Scottsdale, AZ 85257 USA	Arizona State University	Poste, G (corresponding author), Complex Adapt Syst Initiat, Scottsdale, AZ 85257 USA.	george.poste@asu.edu						Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Davis JC, 2009, NAT REV DRUG DISCOV, V8, P279, DOI 10.1038/nrd2825; Javitt G, 2010, NATURE, V466, P817, DOI 10.1038/466817a; Meckley LM, 2010, HEALTH POLICY, V94, P91, DOI 10.1016/j.healthpol.2009.09.006; Moore Helen M, 2009, Cancer Res, V69, P6770, DOI 10.1158/0008-5472.CAN-09-1795; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Vaught J., 2009, RES POLICY INITIATIV	9	386	393	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					156	157		10.1038/469156a	http://dx.doi.org/10.1038/469156a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228852				2022-12-24	WOS:000286143400015
J	Prudic, KL; Jeon, C; Cao, H; Monteiro, A				Prudic, Kathleen L.; Jeon, Cheonha; Cao, Hui; Monteiro, Antonia			Developmental Plasticity in Sexual Roles of Butterfly Species Drives Mutual Sexual Ornamentation	SCIENCE			English	Article							BICYCLUS-ANYNANA; ROLE REVERSAL; PHENOTYPIC PLASTICITY; SELECTION; MALES; PATTERN; POLYPHENISM; INVESTMENT; INSECTS; CHOICE	Current explanations for why sexual ornaments are found in both sexes include genetic correlation, same sex competition, and mutual mate choice. In this study, we report developmental plasticity in mating behavior as induced by temperature during development in the butterfly Bicyclus anynana. Males and females reciprocally change their sexual roles depending on their larval rearing temperatures. This switch is correlated with a change in mating benefits to females and costs to males. The discrete seasonal environments, wet season and dry season, are known to produce the two developmental forms and as a consequence impose alternating, symmetrical patterns of sexual selection, one season on male ornaments, the following season on female ornaments. Thus, reciprocal selection through time may result in mutual sexual ornamentation.	[Prudic, Kathleen L.] Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06511 USA; [Monteiro, Antonia] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06511 USA	Yale University; Yale University	Prudic, KL (corresponding author), Yale Univ, Yale Inst Biospher Studies, 165 Prospect St, New Haven, CT 06511 USA.	Kathleen.prudic@yale.edu; antonia.monteiro@yale.edu	Cao, Hui/F-4815-2012; Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Prudic, Kathleen/0000-0001-8242-7769	American Association of University Women; Yale Institute of Biospheric Studies; Yale University; Yale NSF-MRSEC [DMR-0520495]	American Association of University Women; Yale Institute of Biospheric Studies; Yale University; Yale NSF-MRSEC	Visual recordings of O. anynana courtship displays are available online at www.youtube.com/watch?v=_1AjNkJuyX0. We thank A. Alonzo, H. Kindsvater, J. Oliver, D. Papaj, E. Snell-Rood, A. Stoehr, and three anonymous reviewers for comments and R. Rak and C. Bolick for rearing host plants. Funding was provided by the American Association of University Women and Yale Institute of Biospheric Studies to K.L.P., Yale University to A.M., and the Yale NSF-MRSEC (DMR-0520495) to H.C.	Berglund A, 2005, BEHAV ECOL, V16, P649, DOI 10.1093/beheco/ari038; Billing AM, 2007, BEHAV ECOL, V18, P535, DOI 10.1093/beheco/arm007; BOGGS CL, 1990, AM NAT, V136, P598, DOI 10.1086/285118; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Brakefield PM, 2008, PHENOTYPIC PLASTICIT, P121; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Friberg M, 2007, BEHAV ECOL, V18, P758, DOI 10.1093/beheco/arm037; GWYNNE DT, 1984, EVOLUTION, V38, P1011, DOI 10.1111/j.1558-5646.1984.tb00371.x; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; KAITALA A, 1994, BEHAV ECOL SOCIOBIOL, V35, P385, DOI 10.1007/s002650050110; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI [10.2307/2410415, 10.1111/j.1558-5646.1995.tb02328.x]; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lewis Z, 2007, J INSECT BEHAV, V20, P201, DOI 10.1007/s10905-007-9075-2; Molleman F, 2004, BEHAV ECOL SOCIOBIOL, V56, P404, DOI 10.1007/s00265-004-0789-2; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Obara Y, 2008, ZOOL SCI, V25, P1, DOI 10.2108/zsj.25.1; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Ritchie MG, 1998, J INSECT BEHAV, V11, P481, DOI 10.1023/A:1022359228537; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; West-Eberhard Mary Jane, 2003, pi; Wiklund C, 2004, ANIM BEHAV, V68, P621, DOI 10.1016/j.anbehav.2003.12.008	30	101	101	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					73	75		10.1126/science.1197114	http://dx.doi.org/10.1126/science.1197114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212355				2022-12-24	WOS:000285974000038
J	Koksal, M; Jin, YH; Coates, RM; Croteau, R; Christianson, DW				Koeksal, Mustafa; Jin, Yinghua; Coates, Robert M.; Croteau, Rodney; Christianson, David W.			Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis	NATURE			English	Article							ENT-COPALYL DIPHOSPHATE; CRYSTAL-STRUCTURE; TAXOL BIOSYNTHESIS; COMMITTED STEP; GERANYLGERANYL DIPHOSPHATE; DITERPENE CYCLASE; CYCLIZATION; MECHANISM; CATALYZES; TAXA-4(5),11(12)-DIENE	With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization(1) and shows remarkable efficacy in cancer chemotherapy(2). The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)(3) is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5), 11(12) diene(4), which is catalysed by taxadiene synthase(5). The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids(6). We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82 angstrom resolution) and 2-fluorogeranylgeranyl diphosphate (2.25 angstrom resolution). The TXS structure reveals a modular assembly of three alpha-helical domains. The carboxy-terminal catalytic domain is a class I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third 'insertion' domain together adopt the fold of a vestigial class II terpenoid cyclase. A class II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.	[Koeksal, Mustafa; Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Jin, Yinghua; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Jin, Yinghua] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Croteau, Rodney] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Washington State University	Christianson, DW (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, 231 S 34th St, Philadelphia, PA 19104 USA.	chris@sas.upenn.edu	jin, Yinghua/T-7461-2019	JIN, YINGHUA/0000-0002-8446-8350	US National Institutes of Health [GM56838, GM13956, CA55254]; University of Illinois; NATIONAL CANCER INSTITUTE [R37CA055254, R01CA055254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838, R01GM013956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. MacDermaid and J. Saven for advice and assistance with molecular modelling calculations, and E. Oldfield for helpful comments on the manuscript. We thank the National Synchrotron Light Source at Brookhaven National Laboratory for beamline access. The US National Institutes of Health provided grants GM56838 (D.W.C.), GM13956 (R.M.C.) and CA55254 (R.C.) in support of this research. Y.J. thanks the University of Illinois for support through the John C. Bailar and R. C. Fuson Fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARBUCK SG, 1995, TAXOL SCI APPL, P379; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Q, 1996, TETRAHEDRON LETT, V37, P3425, DOI 10.1016/0040-4039(96)00585-0; HEZARI M, 1995, ARCH BIOCHEM BIOPHYS, V322, P437, DOI 10.1006/abbi.1995.1486; Jin QW, 2005, J ORG CHEM, V70, P4667, DOI 10.1021/jo0502091; Jin YH, 2005, J AM CHEM SOC, V127, P7834, DOI 10.1021/ja050592r; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koksal M, 2010, J MOL BIOL, V402, P363, DOI 10.1016/j.jmb.2010.07.009; KOEPP AE, 1995, J BIOL CHEM, V270, P8686, DOI 10.1074/jbc.270.15.8686; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lin XY, 1996, BIOCHEMISTRY-US, V35, P2968, DOI 10.1021/bi9526239; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Trapp SC, 2001, GENETICS, V158, P811; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Williams DC, 2000, CHEM BIOL, V7, P969, DOI 10.1016/S1074-5521(00)00046-6	40	200	214	7	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					116	U138		10.1038/nature09628	http://dx.doi.org/10.1038/nature09628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21160477	Green Accepted			2022-12-24	WOS:000285921600043
J	Bosworth, AM; Steuer, A				Bosworth, Ailsa M.; Steuer, Alan			A Patient's Journey Rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bosworth, Ailsa M.] Natl Rheumatoid Arthrit Soc, Maidenhead SL6 3RT, Berks, England; [Steuer, Alan] Wexham Pk Hosp, Slough SL2 4HL, Berks, England		Bosworth, AM (corresponding author), Natl Rheumatoid Arthrit Soc, Westacott Business Ctr, Maidenhead SL6 3RT, Berks, England.	Ailsa@nras.org.uk							0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 31	2010	341								c7095	10.1136/bmj.c7095	http://dx.doi.org/10.1136/bmj.c7095			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702VB	21196483				2022-12-24	WOS:000285922900008
J	Tan, W; Zhang, WZ; Strasner, A; Grivennikov, S; Cheng, JQ; Hoffman, RM; Karin, M				Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Cheng, Jin Q.; Hoffman, Robert M.; Karin, Michael			Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling	NATURE			English	Article							BREAST-CANCER; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; GLAND DEVELOPMENT; BONE METASTASES; PROSTATE-CANCER; EXPRESSION; ACTIVATION; DENOSUMAB; RECEPTOR	Inflammatory mechanisms influence tumorigenesis and metastatic progression even in cancers whose aetiology does not involve pre-existing inflammation or infection, such as breast and prostate cancers(1). For instance, prostate cancer metastasis is associated with the infiltration of lymphocytes into advanced tumours and the upregulation of two tumour-necrosis-factor family members: receptor activator of nuclear factor-kappa B (RANK) ligand (RANKL) and lymphotoxin(2). But the source of RANKL and its role in metastasis have not been established. RANKL and its receptor RANK control the proliferation of mammary lobuloalveolar cells during pregnancy(3) through inhibitor of nuclear factor-kappa B (I kappa B) kinase-alpha (IKK-alpha)(4), a protein kinase that is needed for the self-renewal of mammary cancer progenitors(5) and for prostate cancer metastasis(2). We therefore examined whether RANKL, RANK and IKK-alpha are also involved in mammary/breast cancer metastasis. Indeed, RANK signalling in mammary carcinoma cells that overexpress the proto-oncogene Erbb2 (also known as Neu)(6), which is frequently amplified in metastatic human breast cancers(7,8), was important for pulmonary metastasis. Metastatic spread of Erbb2-transformed carcinoma cells also required CD4(+)CD25(+) T cells, whose major pro-metastatic function was RANKL production. Most RANKL-producing T cells expressed forkhead box P3 (FOXP3), a transcription factor produced by regulatory T cells, and were located next to smooth muscle actin (SMA)(+) stromal cells in mouse and human breast cancers. The dependence of pulmonary metastasis on T cells was replaceable by exogenous RANKL, which also stimulated pulmonary metastasis of RANK(+) human breast cancer cells. These results are consistent with the adverse impact of tumour-infiltrating CD4(+) or FOXP3(+) T cells on human breast cancer prognosis(9,10) and suggest that the targeting of RANKL-RANK can be used in conjunction with the therapeutic elimination of primary breast tumours to prevent recurrent metastatic disease.	[Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Diego; Anti Cancer Inc	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr,Mail Code 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555	National Institutes of Health (NIH); Susan G. Komen for the Cure; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA132586, T32CA121938, R01CA127923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Coussens for discussions and suggestions, V. Temkin and G. He for advice, and H. Herschman for critical reading. Work was supported by the National Institutes of Health (NIH). W. T. and W.Z. were supported by postdoctoral fellowships from the Susan G. Komen for the Cure. A. S. was supported by NIH Asthma Research and Cancer Therapeutic training grants, and S. G. was supported by a research fellowship from the Crohn's and Colitis Foundation of America. M. K. is an American Cancer Society research professor.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Body JJ, 2010, J BONE MINER RES, V25, P440, DOI 10.1359/jbmr.090810; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Luboshits G, 1999, CANCER RES, V59, P4681; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TIWARI RK, 1992, ANTICANCER RES, V12, P419	27	473	493	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					548	553		10.1038/nature09707	http://dx.doi.org/10.1038/nature09707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326202	Green Accepted			2022-12-24	WOS:000287652900045
J	Mattick, JS				Mattick, John S.			The Genomic Foundation Is Shifting	SCIENCE			English	Editorial Material									Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.		Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527					0	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					874	874		10.1126/science.1203703	http://dx.doi.org/10.1126/science.1203703			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330534				2022-12-24	WOS:000287455100044
J	Orchard, PJ; Wagner, JE				Orchard, Paul J.; Wagner, John E.			Leukodystrophy and Gene Therapy with a Dimmer Switch.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION; CELL		[Orchard, Paul J.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Bone & Marrow Transplant Program, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Orchard, PJ (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.							Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; KRIVIT W, 1995, CELL TRANSPLANT, V4, P385, DOI 10.1016/0963-6897(95)00021-O; Krivit W, 1998, NEW ENGL J MED, V338, P1119, DOI 10.1056/NEJM199804163381605	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					572	573		10.1056/NEJMcibr1013082	http://dx.doi.org/10.1056/NEJMcibr1013082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306246				2022-12-24	WOS:000287139900015
J	Cortada, X				Cortada, Xavier			Painting the Genome for the Public	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203069	http://dx.doi.org/10.1126/science.1203069			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292969				2022-12-24	WOS:000286933600042
J	Bajoghli, B; Guo, P; Aghaallaei, N; Hirano, M; Strohmeier, C; McCurley, N; Bockman, DE; Schorpp, M; Cooper, MD; Boehm, T				Bajoghli, Baubak; Guo, Peng; Aghaallaei, Narges; Hirano, Masayuki; Strohmeier, Christine; McCurley, Nathanael; Bockman, Dale E.; Schorpp, Michael; Cooper, Max D.; Boehm, Thomas			A thymus candidate in lampreys	NATURE			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; EVOLUTION; DIVERSIFICATION; EPITHELIUM; RESPONSES; HAGFISH	Immunologists and evolutionary biologists have been debating the nature of the immune system of jawless vertebrates-lampreys and hagfish-since the nineteenth century. In the past 50 years, these fish were shown to have antibody-like responses and the capacity to reject allografts(1) but were found to lack the immunoglobulin-based adaptive immune system of jawed vertebrates(2). Recent work has shown that lampreys have lymphocytes that instead express somatically diversified antigen receptors that contain leucine-rich-repeats, termed variable lymphocyte receptors (VLRs)(3,4), and that the type of VLR expressed is specific to the lymphocyte lineage: T-like lymphocytes express type A VLR (VLRA) genes, and B-like lymphocytes express VLRB genes(5). These clonally diverse anticipatory antigen receptors are assembled from incomplete genomic fragments by gene conversion(6-9), which is thought to be initiated by either of two genes encoding cytosine deaminase(9), cytosine deaminase 1 (CDA1) in T-like cells and CDA2 in B-like cells(5). It is unknown whether jawless fish, like jawed vertebrates, have dedicated primary lymphoid organs, such as the thymus, where the development and selection of lymphocytes takes place(10,11). Here we identify discrete thymus-like lympho-epithelial structures, termed thymoids, in the tips of the gill filaments and the neighbouring secondary lamellae (both within the gill basket) of lamprey larvae. Only in the thymoids was expression of the orthologue of the gene encoding forkhead box N1 (FOXN1)(10), a marker of the thymopoietic microenvironment in jawed vertebrates(12), accompanied by expression of CDA1 and VLRA. This expression pattern was unaffected by immunization of lampreys or by stimulation with a T-cell mitogen. Non-functional VLRA gene assemblies were found frequently in the thymoids but not elsewhere, further implicating the thymoid as the site of development of T-like cells in lampreys. These findings suggest that the similarities underlying the dual nature of the adaptive immune systems in the two sister groups of vertebrates extend to primary lymphoid organs.	[Bajoghli, Baubak; Aghaallaei, Narges; Strohmeier, Christine; Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany; [Guo, Peng; Hirano, Masayuki; McCurley, Nathanael; Cooper, Max D.] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Guo, Peng; Hirano, Masayuki; McCurley, Nathanael; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Bockman, Dale E.] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	Max Planck Society; Emory University; Emory University; University System of Georgia; Augusta University	Boehm, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de	Bajoghli, Baubak/AAF-8388-2020	Bajoghli, Baubak/0000-0002-7368-7523; Aghaallaei, Narges/0000-0002-9890-3229; Bajoghli, Baubak/0000-0003-1395-6362	Max Planck Society; Deutsche Forschungsgemeinschaft; National Institutes of Health; Georgia Research Alliance	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	We thank C. Happe and M. Held for technical help, C. L. Turnbough Jr for providing B. anthracis spores and exosporia, and the Emory University School of Medicine core facility for flow cytometry for cell-sorting services. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft, the National Institutes of Health and the Georgia Research Alliance.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; BOCKMAN DE, 1973, AM J ANAT, V136, P455, DOI 10.1002/aja.1001360406; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Kishishita N, 2010, EMBO REP, V11, P126, DOI 10.1038/embor.2009.274; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Schaffer J., 1894, SBER K AKAD WISS, V103, P149; Wallin IE, 1917, AM J ANAT, V22, P127, DOI 10.1002/aja.1000220106	19	142	149	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					90	U101		10.1038/nature09655	http://dx.doi.org/10.1038/nature09655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293377				2022-12-24	WOS:000286886400040
J	Chou, R; Qaseem, A; Owens, DK; Shekelle, P				Chou, Roger; Qaseem, Amir; Owens, Douglas K.; Shekelle, Paul		Clinical Guidelines Comm Amer Coll	Diagnostic Imaging for Low Back Pain: Advice for High-Value Health Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; PATIENT EXPECTATIONS; CLINICAL-EVALUATION; PRACTICE PATTERNS; US; PREVALENCE; GUIDELINES; CANCER; COSTS	Diagnostic imaging is indicated for patients with low back pain only if they have severe progressive neurologic deficits or signs or symptoms that suggest a serious or specific underlying condition. In other patients, evidence indicates that routine imaging is not associated with clinically meaningful benefits but can lead to harms. Addressing inefficiencies in diagnostic testing could minimize potential harms to patients and have a large effect on use of resources by reducing both direct and downstream costs. In this area, more testing does not equate to better care. Implementing a selective approach to low back imaging, as suggested by the American College of Physicians and American Pain Society guideline on low back pain, would provide better care to patients, improve outcomes, and reduce costs.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA; Stanford Univ, Palo Alto, CA 94304 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	American College of Physicians; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Chou, Roger/0000-0001-9889-8610	Wellpoint; Palladian Health; Consumers Union; Blue Cross Blue Shield Association; American Pain Society; Agency for Healthcare Research and Quality	Wellpoint; Palladian Health; Consumers Union; Blue Cross Blue Shield Association; American Pain Society; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Chou: Consulting fee or honorarium: Wellpoint, Palladian Health, Consumers Union, Blue Cross Blue Shield Association; Grants/grants pending: American Pain Society; Payment for manuscript preparation: American College of Physicians. Dr. Owens: Support for travel to meetings for the study or other purposes: American College of Physicians; Consultancy: Anthem/Wellpoint. Dr. Shekelle: Grants/grants pending: Agency for Healthcare Research and Quality; Royalties: UptoDate; Other: Unpaid advisor for a Wellpoint project that seeks to identify and certify high-quality back pain centers of excellence. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOflnterestForms.do?msNum=M10-1394. Any conflict of interest of the Clinical Guidelines Committee members was declared, discussed, and resolved.	American College of Physicians Foundation, 2011, HLTH TIPS LOW BACK P; American College of Radiology, 2008, ACR APPR CRIT LOW BA; [Anonymous], 1984, Can Med Assoc J, V130, P1542; [Anonymous], 2011, ANN INTERN MED, V154, P1; [Anonymous], 2009, 2009 MED REIMB FEE S; [Anonymous], 2009, BACKLETTER, V24, P50; Anthem Health Care Advisor, 2008, EST TOT COSTS INS BE; Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Baras JD, 2009, HEALTH AFFAIR, V28, pW1133, DOI 10.1377/hlthaff.28.6.w1133; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Buchbinder R, 2008, SPINE, V33, P74, DOI 10.1097/BRS.0b013e31815e39c8; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Carey TS, 2009, SPINE, V34, P718, DOI 10.1097/BRS.0b013e31819792b0; Carman KL, 2010, HEALTH AFFAIR, V29, P1400, DOI 10.1377/hlthaff.2009.0296; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; CHOU R, 2009, EVALUATION MANAGEMEN; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; DEYO RA, 1987, ARCH INTERN MED, V147, P141, DOI 10.1001/archinte.147.1.141; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2002, ANNU REV PUBL HEALTH, V23, P23, DOI 10.1146/annurev.publhealth.23.092101.134534; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; French SD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006094.pub2; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Gillan MGC, 2001, RADIOLOGY, V220, P393, DOI 10.1148/radiology.220.2.r01au06393; Gray DT, 2003, RADIOLOGY, V227, P669, DOI 10.1148/radiol.2273012213; Grimshaw JM, 2001, MED CARE, V39, pII2; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; HALL FM, 1976, RADIOLOGY, V120, P443, DOI 10.1148/120.2.443; HALPIN SFS, 1991, BRIT MED J, V303, P813, DOI 10.1136/bmj.303.6806.813; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Henschke N, 2007, EUR SPINE J, V16, P1673, DOI 10.1007/s00586-007-0412-0; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McPhillips-Tangum CA, 1998, J GEN INTERN MED, V13, P289, DOI 10.1046/j.1525-1497.1998.00093.x; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; NACHEMSON A L, 1976, Spine, V1, P59, DOI 10.1097/00007632-197603000-00009; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Pham HH, 2009, ARCH INTERN MED, V169, P972, DOI 10.1001/archinternmed.2009.78; Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3; ROCKEY PH, 1978, J FAM PRACTICE, V7, P455; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Schectman JM, 2003, J GEN INTERN MED, V18, P773, DOI 10.1046/j.1525-1497.2003.10205.x; Schers H, 2001, Spine (Phila Pa 1976), V26, pE348, DOI 10.1097/00007632-200108010-00013; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Snowbeck C, 2005, PITTSBURGH POST 0611; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; SuarezAlmazor ME, 1997, JAMA-J AM MED ASSOC, V277, P1782, DOI 10.1001/jama.277.22.1782; SWEDLOW A, 1992, NEW ENGL J MED, V327, P1502, DOI 10.1056/NEJM199211193272107; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; United States Government Accountability Office, 2008, GAO08452; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; Verbeek J, 2004, SPINE, V29, P2309, DOI 10.1097/01.brs.0000142007.38256.7f; Verrilli D, 1996, JAMA-J AM MED ASSOC, V275, P1189, DOI 10.1001/jama.275.15.1189; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53; Webster BS, 2005, J GEN INTERN MED, V20, P1132, DOI 10.1111/j.1525-1497.2005.0230.x; Weiner DK, 2006, PAIN MED, V7, P143, DOI 10.1111/j.1526-4637.2006.00112.x; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Wilson IB, 2001, ARCH INTERN MED, V161, P256, DOI 10.1001/archinte.161.2.256	82	301	307	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					181	+		10.7326/0003-4819-154-3-201102010-00008	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282698				2022-12-24	WOS:000286729200006
J	Song, MS; Carracedo, A; Salmena, L; Song, SJ; Egia, A; Malumbres, M; Pandolfi, PP				Song, Min Sup; Carracedo, Arkaitz; Salmena, Leonardo; Song, Su Jung; Egia, Ainara; Malumbres, Marcos; Pandolfi, Pier Paolo			Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner	CELL			English	Article							SMALL-MOLECULE INHIBITOR; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; GROWTH IN-VIVO; AURORA KINASES; CELLULAR SENESCENCE; MUTATIONAL SPECTRA; CHROMOSOME-10 PTEN; GENOMIC STABILITY; EXPRESSION; GENE	PTEN is a frequently mutated tumor suppressor gene that opposes the PI3K/AKT pathway through dephosphorylation of phosphoinositide-3,4,5-triphosphate. Recently, nuclear compartmentalization of PTEN was found as a key component of its tumor-suppressive activity; however its nuclear function remains poorly defined. Here we show that nuclear PTEN interacts with APC/C, promotes APC/C association with CDH1, and thereby enhances the tumor-suppressive activity of the APC-CDH1 complex. We find that nuclear exclusion but not phosphatase inactivation of PTEN impairs APC-CDH1. This nuclear function of PTEN provides a straightforward mechanistic explanation for the fail-safe cellular senescence response elicited by acute PTEN loss and the tumor-suppressive activity of catalytically inactive PTEN. Importantly, we demonstrate that PTEN mutant and PTEN null states are not synonymous as they are differentially sensitive to pharmacological inhibition of APC-CDH1 targets such as PLK1 and Aurora kinases. This finding identifies a strategy for cancer patient stratification and, thus, optimization of targeted therapies.	[Song, Min Sup; Carracedo, Arkaitz; Salmena, Leonardo; Song, Su Jung; Egia, Ainara; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA; [Malumbres, Marcos] CNIO, Cell Div & Canc Grp, Mol Oncol Programme, Madrid 28029, Spain	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Centro Nacional de Investigaciones Oncologicas (CNIO)	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011; Malumbres, Marcos/E-8834-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Malumbres, Marcos/0000-0002-0829-6315; Salmena, Leonardo/0000-0003-4023-658X; Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH; European Molecular Biology Organization; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to former and present members of the Pandolfi lab for experimental support, advice, or discussion. We are thankful to Drs. Manuel Serrano, Pumin Zhang, Wenyi Wei, and Hongtao Yu for providing reagents. We thank Dr. John Asara for mass-spectrometric analysis. This work was supported by NIH grants to P.P.P. A.C. is supported by a Long-Term Fellowship Award from the European Molecular Biology Organization, and L.S. is supported by a Fellowship from the Canadian Institutes of Health Research.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Cairns P, 1997, CANCER RES, V57, P4997; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Georgescu MM, 2000, CANCER RES, V60, P7033; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Koul D, 2002, ONCOGENE, V21, P2357, DOI 10.1038/sj/onc/1205296; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li DM, 1997, CANCER RES, V57, P2124; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Okumura K, 2005, CELL CYCLE, V4, P540, DOI 10.4161/cc.4.4.1614; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	56	276	301	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					187	199		10.1016/j.cell.2010.12.020	http://dx.doi.org/10.1016/j.cell.2010.12.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241890	Green Accepted, Bronze			2022-12-24	WOS:000286459900005
J	Tseng, HF; Smith, N; Harpaz, R; Bialek, SR; Sy, LS; Jacobsen, SJ				Tseng, Hung Fu; Smith, Ning; Harpaz, Rafael; Bialek, Stephanie R.; Sy, Lina S.; Jacobsen, Steven J.			Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZA VACCINE; VARICELLA; EFFICACY; HOSPITALIZATIONS; EPIDEMIOLOGY; OPHTHALMICUS; MANAGEMENT; ACCURACY; CHILDREN; HISTORY	Context Approximately 1 million episodes of herpes zoster occur annually in the United States. Although prelicensure data provided evidence that herpes zoster vaccine works in a select study population under idealized circumstances, the vaccine needs to be evaluated in field conditions. Objective To evaluate risk of herpes zoster after receipt of herpes zoster vaccine among individuals in general practice settings. Design, Setting, and Participants A retrospective cohort study from January 1, 2007, through December 31, 2009, of individuals enrolled in the Kaiser Permanente Southern California health plan. Participants were immunocompetent community-dwelling adults aged 60 years or older. The 75 761 members in the vaccinated cohort were age matched (1:3) to 227 283 unvaccinated members. Main Outcome Measure Incidence of herpes zoster. Results Herpes zoster vaccine recipients were more likely to be white, women, with more outpatient visits, and fewer chronic diseases. The number of herpes zoster cases among vaccinated individuals was 828 in 130 415 person-years (6.4 per 1000 person-years; 95% confidence interval [CI], 5.9-6.8), and for unvaccinated individuals it was 4606 in 355 659 person-years (13.0 per 1000 person-years; 95% CI, 12.6-13.3). In adjusted analysis, vaccination was associated with a reduced risk of herpes zoster (hazard ratio [HR], 0.45; 95% CI, 0.42-0.48); this reduction occurred in all age strata and among individuals with chronic diseases. Risk of herpes zoster differed by vaccination status to a greater magnitude than the risk of unrelated acute medical conditions, suggesting results for herpes zoster were not due to bias. Ophthalmic herpes zoster (HR, 0.37; 95% CI, 0.23-0.61) and hospitalizations coded as herpes zoster (HR, 0.35; 95% CI, 0.24-0.51) were less likely among vaccine recipients. Conclusions Among immunocompetent community-dwelling adults aged 60 years or older, receipt of the herpes zoster vaccine was associated with a lower incidence of herpes zoster. The risk was reduced among all age strata and among individuals with chronic diseases. JAMA. 2011; 305(2): 160-166	[Tseng, Hung Fu; Smith, Ning; Sy, Lina S.; Jacobsen, Steven J.] So Calif Kaiser Permanente, Dept Res & Evaluat, Pasadena, CA USA; [Harpaz, Rafael; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Kaiser Permanente; Centers for Disease Control & Prevention - USA	Tseng, HF (corresponding author), Kaiser Permanente, So Calif Med Grp, Dept Res & Evaluat, 100 S Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	Hung-Fu.x.Tseng@kp.org	Sy, Lina/AFM-9458-2022	Sy, Lina/0000-0003-2762-9266; Jacobsen, Steven/0000-0002-8174-8533	Merck	Merck(Merck & Company)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Tseng, Smith, and Jacobsen and Ms Sy report having received research funding from Merck for other vaccine studies. Dr Jacobsen reports having served as an unpaid consultant for Merck Research Laboratories. Drs Harpaz and Bialek report no disclosures.	BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hicks LD, 2008, ARCH DERMATOL, V144, P603, DOI 10.1001/archderm.144.5.603; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2008, CLIN INFECT DIS, V47, P754, DOI 10.1086/591132; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Leung J, ANN INTERN IN PRESS; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; Lindley M, 2010, 44 NAT IMM C APR 19; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Merck & Co, MERCK CO ZOSTAVAX ZO; Merck Research Laboratories, 2005, MERCK RES LAB VACC R; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Okamoto S, 2009, J INFECT DIS, V200, P1606, DOI 10.1086/644646; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Schiller JS, 2008, VACCINATION COVERAGE; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Schmader K, 1999, CLIN INFECT DIS, V28, P736, DOI 10.1086/515205; Severson EA, 2003, ARCH OPHTHALMOL-CHIC, V121, P386, DOI 10.1001/archopht.121.3.386; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061; Tate JE, 2009, PEDIATRICS, V123, P744, DOI 10.1542/peds.2008-1200; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tseng HF, 2010, PEDIATR INFECT DIS J, V29, P205, DOI 10.1097/INF.0b013e3181bc379b; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	36	151	157	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					160	166		10.1001/jama.2010.1983	http://dx.doi.org/10.1001/jama.2010.1983			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224457	Bronze			2022-12-24	WOS:000286103400021
J	Deer, B				Deer, Brian			Secrets of the MMR scare How the vaccine crisis was meant to make money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	43	44	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c5258	10.1136/bmj.c5258	http://dx.doi.org/10.1136/bmj.c5258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SO	21224310				2022-12-24	WOS:000286384800029
J	Kelly, B; Whiteley, A; Tallmon, D				Kelly, Brendan; Whiteley, Andrew; Tallmon, David			The Arctic melting pot	NATURE			English	Editorial Material									[Kelly, Brendan] NOAA, Natl Marine Mammal Lab, Juneau, AK 99801 USA; [Whiteley, Andrew] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Tallmon, David] Univ Alaska SE, Fac Biol & Marine Biol, Juneau, AK 99801 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Massachusetts System; University of Massachusetts Amherst; University of Alaska System; University of Alaska Southeastern	Kelly, B (corresponding author), NOAA, Natl Marine Mammal Lab, Juneau, AK 99801 USA.	brendan.kelly@noaa.gov		Whiteley, Andrew/0000-0002-8159-6381					0	74	75	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					891	891		10.1038/468891a	http://dx.doi.org/10.1038/468891a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164461				2022-12-24	WOS:000285344600019
J	Cohen, D; Carter, P				Cohen, Deborah; Carter, Philip			Diabetes How small changes led to big profits for insulin manufacturers	BRITISH MEDICAL JOURNAL			English	Editorial Material							PEOPLE		[Cohen, Deborah] BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						[Anonymous], 2010, CONCLUSIONS AVOCAT G; Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180; Cummins E, 2010, HLTH TECHNOL ASSESS, V14; Currie CJ, 2010, DIABETIC MED, V27, P938, DOI 10.1111/j.1464-5491.2010.03040.x; Diabetes Health Intelligence, 2009, PRESCR DIAB ENGL UPD; Diabetes UK, 2010, DIAB UK 2010 KEY STA; Druglibcom, INS GLARG REC CHEM B; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4; Home PD, 2010, DIABETES OBES METAB, V12, P772, DOI 10.1111/j.1463-1326.2010.01232.x; IMS Health Midas, 2009, TOP 15 GLOB THER CLA; JORGENSEN S, 1989, BRIT MED J, V299, P415, DOI 10.1136/bmj.299.6696.415; Medicines and Healthcare Products Regulatory Agency, 2004, SAN AV ASHF NURS INC; NICE, 2008, TYP 2 DIAB MAN TYP 2; Novo Nordisk, 2010, NOVO NORDISK NOVO NO; Novo Nordisk, 2010, NOV NORD A S Q4 2009; Pharmaceutical Marketing Society, NHS JOINT WORK IN AC; Presciption Medicines Code of Practice Authority, 2004, COD PRACT REV, P122; Presciption Medicines Code of Practice Authority, 2007, COMPL CAS E LILL VER; Rosenstock J, 2009, DIABETOLOGIA, V52, P1778, DOI 10.1007/s00125-009-1415-7; Sanofi-aventis, 2010, DIAB ONC IR THEM SEM; Sanofi-aventis, 2010, DIAB ROUNDT; Watermeadow Medical, 2007, ED PROGR NOM AW	23	12	12	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c7139	10.1136/bmj.c7139	http://dx.doi.org/10.1136/bmj.c7139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159773				2022-12-24	WOS:000285552800006
J	Lal, A; Goldrich, ML; Haines, DA; Azimi, M; Singer, ST; Vichinsky, EP				Lal, Ashutosh; Goldrich, Michael L.; Haines, Drucilla A.; Azimi, Mahin; Singer, Sylvia T.; Vichinsky, Elliott P.			Heterogeneity of Hemoglobin H Disease in Childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHEAST-ASIAN POPULATIONS; ALPHA-THALASSEMIA; CLINICAL-FEATURES; NORTH-AMERICA; SEVERE FORM; GENE; CALIFORNIA; BLACKS	BACKGROUND Early diagnosis during newborn screening or infancy has enabled the observation of the natural history of hemoglobin H disease, a subtype of alpha-thalassemia. METHODS We analyzed longitudinal clinical data for patients with hemoglobin H disease arising from the deletion of three of four a-globin genes (HbH) and from hemoglobin H Constant Spring (HCS), caused by the deletion of two a-globin genes and the Constant Spring mutation. RESULTS We identified 86 patients with hemoglobin H disease (48 through newborn screening). Of these patients, 60 (70%) had HbH, 23 (27%) had HCS, and 3 (3%) had other, nondeletional forms of hemoglobin H disease. The parental ethnic background was Asian in 81% of patients, Hispanic in 5%, and African American in 3%, whereas mixed ancestry was observed in 10% of patients. Among the patients with deletional hemoglobin H disease, 15% had one or both parents with African-American ancestry. Growth was normal in patients with HbH during the first decade, but growth deficits began during infancy in those with HCS. Anemia was more severe in patients with HCS at all ages (P<0.001). Acute worsening of anemia with infections requiring urgent blood transfusion was observed in patients with HCS but not in those with HbH. The probability of receiving at least one transfusion by the age of 20 years was 3% for patients with HbH and 80% for those with HCS (P<0.001). Among patients with HCS, transfusions occurred in 13% of infants and 50% of children under the age of 6 years; splenectomy was associated with a significant improvement in hemoglobin levels (P = 0.01) and a reduction in the number of transfusions. CONCLUSIONS HCS should be recognized as a distinct thalassemia syndrome with a high risk of life-threatening anemia during febrile illnesses. HbH was not associated with an increased rate of severe anemia with infections and was managed without blood transfusions. Many patients with these disorders had mixed ethnic backgrounds, which highlights the need for extended newborn screening in populations that are traditionally considered to be at low risk for hemoglobin H disease.	[Lal, Ashutosh; Azimi, Mahin] Childrens Hosp & Res Ctr Oakland, Hemoglobinopathy Reference Lab, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Lal, A (corresponding author), Childrens Hosp & Res Ctr Oakland, Hemoglobinopathy Reference Lab, 747 52nd St, Oakland, CA 94609 USA.	alal@mail.cho.org	Vichinsky, Elliott P/F-8541-2011	Vichinsky, Elliott P/0000-0002-0500-9579	Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services [57480]	Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Supported in part by Project no. 57480 from the Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services.	Census Bureau, AM COMM SURV 2006 AS; Charoenkwan P, 2005, HEMOGLOBIN, V29, P133, DOI 10.1081/HEM-200058583; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; DOZY AM, 1979, NATURE, V280, P605, DOI 10.1038/280605a0; Fucharoen Suthat, 2009, Hematology Am Soc Hematol Educ Program, P26, DOI 10.1182/asheducation-2009.1.26; GALANELLO R, 1983, ACTA HAEMATOL-BASEL, V69, P56, DOI 10.1159/000206840; Higgs DR, 2009, CELL MOL LIFE SCI, V66, P1154, DOI 10.1007/s00018-008-8529-9; Knapp A, 2010, EVIDENCE REV HEMOGLO; LAIG M, 1990, HUM GENET, V84, P188; Laosombat V, 2009, ANN HEMATOL, V88, P1185, DOI 10.1007/s00277-009-0743-5; Lorey F, 2001, GENET TEST, V5, P93, DOI 10.1089/109065701753145538; Michlitsch J, 2009, PEDIATR BLOOD CANCER, V52, P486, DOI 10.1002/pbc.21883; Origa R, 2007, BRIT J HAEMATOL, V136, P326, DOI 10.1111/j.1365-2141.2006.06423.x; Pakbaz Z, 2007, PEDIATR BLOOD CANCER, V49, P329, DOI 10.1002/pbc.21275; Savongsy O, 2008, ANN HEMATOL, V87, P647, DOI 10.1007/s00277-008-0490-z; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Singer ST, 2009, AM J HEMATOL, V84, P759, DOI 10.1002/ajh.21523; Singsanan S, 2007, ANN HEMATOL, V86, P665, DOI 10.1007/s00277-007-0310-x; Sobota A, 2011, AM J HEMATOL, V86, P92, DOI 10.1002/ajh.21896; STEINBERG MH, 1986, BLOOD, V68, P985; Styles LA, 1997, INT J PEDIAT HEM ONC, V4, P69; Vichinsky EP, 2005, PEDIATRICS, V116, pE818, DOI 10.1542/peds.2005-0843	23	102	114	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					710	718		10.1056/NEJMoa1010174	http://dx.doi.org/10.1056/NEJMoa1010174			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345100	Bronze			2022-12-24	WOS:000287652500005
J	Evans-Brown, M; Bellis, MA; McVeigh, J				Evans-Brown, Michael; Bellis, Mark A.; McVeigh, Jim			Should "legal highs" be regulated as medicinal products?	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK					m.j.evans-brown@ljmu.ac.uk	Bellis, Mark A./HGA-2019-2022; McVeigh, Jim/O-7851-2019	Evans-Brown, Michael/0000-0002-2695-5740; McVeigh, Jim/0000-0001-5319-6885				Ben-Yehudah Nahman., 2009, SOCIAL CONSTRUCTION; BIRCH R, 2010, NEW LAW J, V160; BIRCH R, 2009, NEW LAW J, V159; Brandt SD, 2010, DRUG TEST ANAL, V2, P377, DOI 10.1002/dta.155; Csizmadi I, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P791; *EUR UN, 2004, OFFICIAL J EUROPEAN, V47, P34; European Monitoring Centre for Drugs and Drug Addiction, 2009, UND SPIC PHEN; European Monitoring Centre for Drugs and Drug Addiction, 2010, RISK ASS REP NEW PSY; European Parliament, 2001, OFF J EUR COMMUNITIE, V311, P67; Gunningham N., 2010, OXFORD HDB REGULATIO, P120; *HOUS COMM, 2010, HOUS COMM OFF REP HA, pC149; *HOUS LORD, 1984, HOUS LORDS OFF REP H; House of Commons Science and Technology Committee, 2006, DRUG CLASS MAK HASH; *MED HEALTHC PROD, 2007, 8 MHRA; MONAGHAN M, 2010, EVIDENCE VERSUS POLI; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; STEPHENS M, 2004, STEPHENS DETECTION N, P63; TYLER TOM R., 2006, CONTEMP SOCIOL, DOI [DOI 10.2307/2076193, 10.1515/9781400828609]	18	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d1101	10.1136/bmj.d1101	http://dx.doi.org/10.1136/bmj.d1101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345907				2022-12-24	WOS:000287920100020
J	Kelley, AS; Ettner, SL; Morrison, RS; Du, QL; Wenger, NS; Sarkisian, CA				Kelley, Amy S.; Ettner, Susan L.; Morrison, R. Sean; Du, Qingling; Wenger, Neil S.; Sarkisian, Catherine A.			Determinants of Medical Expenditures in the Last 6 Months of Life	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; REGIONAL-VARIATIONS; PATIENT PREFERENCES; TREATMENT INTENSITY; END; DISABILITY; CANCER; DEATH; AGE; HOSPITALIZATION	Background: End-of-life medical expenditures exceed costs of care during other years, vary across regions, and are likely to be unsustainable. Identifying determinants of expenditure variation may reveal opportunities for reducing costs. Objective: To identify patient-level determinants of Medicare expenditures at the end of life and to determine the contributions of these factors to expenditure variation while accounting for regional characteristics. It was hypothesized that race or ethnicity, social support, and functional status are independently associated with treatment intensity and controlling for regional characteristics, and that individual characteristics account for a substantial proportion of expenditure variation. Design: Using data from the Health and Retirement Study, Medicare claims, and The Dartmouth Atlas of Health Care, relationships were modeled between expenditures and patient and regional characteristics. Setting: United States, 2000 to 2006. Participants: 2394 Health and Retirement Study decedents aged 65.5 years or older. Measurements: Medicare expenditures in the last 6 months of life were estimated in a series of 2-level multivariable regression models that included patient, regional, and patient and regional characteristics. Results: Decline in function (rate ratio [RR], 1.64 [95% CI, 1.46 to 1.83]); Hispanic ethnicity (RR, 1.50 [CI, 1.22 to 1.85]); black race (RR, 1.43 [CI, 1.25 to 1.64]); and certain chronic diseases, including diabetes (RR, 1.16 [CI, 1.06 to 1.27]), were associated with higher expenditures. Nearby family (RR, 0.90 [CI, 0.82 to 0.98]) and dementia (RR, 0.78 CI, 0.71 to 0.87]) were associated with lower expenditures, and advance care planning had no association. Regional characteristics, including end-of-life practice patterns (RR, 1.09 [CI, 1.06 to 1.14]) and hospital beds per capita (RR, 1.01 [CI, 1.00 to 1.02]), were associated with higher expenditures. Patient characteristics explained 10% of overall variance and retained statistically significant relationships with expenditures after regional characteristics were controlled for. Limitation: The study limitations include the decedent sample, proxy informants, and a large proportion of unexplained variation. Conclusion: Patient characteristics, such as functional decline, race or ethnicity, chronic disease, and nearby family, are important determinants of expenditures at the end of life, independent of regional characteristics.	[Kelley, Amy S.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY 10029 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; James J Peters Vet Affairs Med Ctr, Bronx, NY USA; Vet Affairs Greater Los Angeles Healthcare Syst, Geriatr Res Educ Clin Ctr, Los Angeles, CA USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Kelley, AS (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	amy.kelley@mssm.edu			Brookdale Foundation; National Institute on Aging [K24 AG022345]; National Palliative Care Research Center; Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center; NATIONAL INSTITUTE ON AGING [K24AG022345] Funding Source: NIH RePORTER	Brookdale Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Palliative Care Research Center; Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the Brookdale Foundation. Dr. Kelley is a Brookdale Leadership in Aging Fellow. Dr. Morrison is the recipient of a MidCareer Investigator Award in Patient-Oriented Research (K24 AG022345) from the National Institute on Aging and is supported by the National Palliative Care Research Center. Dr. Sarkisian is supported by the Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center.	[Anonymous], HLTH RETIREMENT STUD; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Boyd CM, 2005, AM J MED, V118, P1225, DOI 10.1016/j.amjmed.2005.01.062; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Buccaneer Computer Systems and Services, 2009, CHRON COND DAT WAR U; Cortese D, 2007, HEALTH AFFAIR, V26, pW68, DOI 10.1377/hlthaff.26.1.w68; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Kelley AS, 2010, J PALLIAT MED, V13, P807, DOI 10.1089/jpm.2010.0007; Kelley AS, 2010, J AM GERIATR SOC, V58, P1109, DOI 10.1111/j.1532-5415.2010.02853.x; Levinsky NG, 2001, JAMA-J AM MED ASSOC, V286, P1349, DOI 10.1001/jama.286.11.1349; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Raudenbush SW, 2002, HIERARCHICAL LINEAR; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Shugarman LR, 2007, J WOMENS HEALTH, V16, P214, DOI 10.1089/jwh.2006.0012; Shugarman LR, 2004, J GEN INTERN MED, V19, P127, DOI 10.1111/j.1525-1497.2004.30223.x; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Skinner J, 2009, HEALTH AFFAIR, V28, pW119, DOI 10.1377/hlthaff.28.1.w119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Virnig B A, 1999, J Palliat Med, V2, P23, DOI 10.1089/jpm.1999.2.23; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; Wennberg JE., DARTMOUTH ATLAS HLTH; Wennberg JE, 2009, HEALTH AFFAIR, V28, P103, DOI 10.1377/hlthaff.28.1.103; Werner RM, 2007, J GEN INTERN MED, V22, P1206, DOI 10.1007/s11606-007-0230-4; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	49	124	124	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					235	W78		10.7326/0003-4819-154-4-201102150-00004	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	720VF	21320939	Green Accepted			2022-12-24	WOS:000287310000015
J	Wang, J				Wang, Jun			Personal Genomes: For One and for All	SCIENCE			English	Editorial Material									Beijing Genome Inst, Beijing, Peoples R China	Beijing Genomics Institute (BGI)	Wang, J (corresponding author), Beijing Genome Inst, Beijing, Peoples R China.		Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931					0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	690		10.1126/science.1202811	http://dx.doi.org/10.1126/science.1202811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310998				2022-12-24	WOS:000287205700040
J	Wu, L; Pan, LF; Wei, ZY; Zhang, MJ				Wu, Lin; Pan, Lifeng; Wei, Zhiyi; Zhang, Mingjie			Structure of MyTH4-FERM Domains in Myosin VIIa Tail Bound to Cargo	SCIENCE			English	Article							USHER-SYNDROME; UNCONVENTIONAL MYOSIN; HAIR BUNDLE; MUTATIONS; HARMONIN; DEAFNESS; PROTEIN; CELLS; CADHERIN-23; COHESION	The unconventional myosin VIIa (MYO7A) is one of the five proteins that form a network of complexes involved in formation of stereocilia. Defects in these proteins cause syndromic deaf-blindness in humans [Usher syndrome I (USH1)]. Many disease-causing mutations occur in myosin tail homology 4-protein 4.1, ezrin, radixin, moesin (MyTH4-FERM) domains in the myosin tail that binds to another USH1 protein, Sans. We report the crystal structure of MYO7A MyTH4-FERM domains in complex with the central domain (CEN) of Sans at 2.8 angstrom resolution. The MyTH4 and FERM domains form an integral structural and functional supramodule binding to two highly conserved segments (CEN1 and 2) of Sans. The MyTH4-FERM/CEN complex structure provides mechanistic explanations for known deafness-causing mutations in MYO7A MyTH4-FERM. The structure will also facilitate mechanistic and functional studies of MyTH4-FERM domains in other myosins.	[Wu, Lin; Pan, Lifeng; Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/C-4315-2014; Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/B-5001-2010	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grant Council of Hong Kong [663808, 664009, 663610, CA07/08.SC01, SEG_HKUST06, AoE/B-15/01-II]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	We thank T. Friediman for providing the mouse MYO7A cDNA construct, J. Yu and Y. Shang for the help in crystallography, Y. Zhao for the in-house x-ray diffractor, the BL17U1 of the Shanghai Synchrotron Radiation Facility for the beamline time, and A. Zhang for reading the manuscript. This work was supported by grants from the Research Grant Council of Hong Kong to M.Z. (663808, 664009, 663610, CA07/08.SC01, SEG_HKUST06, and AoE/B-15/01-II). The atomic coordinates and structure factors of the complex structure have been deposited in the Protein Data Bank under the accession code 3PVL. The superimposed final 10 NMR structures of the CEN2 peptide have been deposited in the Protein Data Bank under the accession code 2L7T.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Reiners J, 2006, ADV EXP MED BIOL, V572, P349; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Self T, 1998, DEVELOPMENT, V125, P557; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	19	79	82	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					757	760		10.1126/science.1198848	http://dx.doi.org/10.1126/science.1198848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311020				2022-12-24	WOS:000287205700067
J	Collins, FS				Collins, Francis S.			Faces of the Genome	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	14	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	546		10.1126/science.1202894	http://dx.doi.org/10.1126/science.1202894			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292963	Green Published			2022-12-24	WOS:000286933600037
J	Przeworski, M				Przeworski, Molly			The Golden Age of Human Population Genetics	SCIENCE			English	Editorial Material									[Przeworski, Molly] Univ Chicago, Chicago, IL 60637 USA; [Przeworski, Molly] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Chicago; Howard Hughes Medical Institute	Przeworski, M (corresponding author), Univ Chicago, Chicago, IL 60637 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)			0	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					547	547		10.1126/science.1202571	http://dx.doi.org/10.1126/science.1202571			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292966				2022-12-24	WOS:000286933600039
J	Lipitz-Snyderman, A; Steinwachs, D; Needham, D; Colantuoni, E; Morlock, LL; Pronovos, PJ				Lipitz-Snyderman, Allison; Steinwachs, Donald; Needham, Dale M.; Colantuoni, Elizabeth; Morlock, Laura L; Pronovos, Peter J			Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis	BRITISH MEDICAL JOURNAL			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; ADVERSE EVENTS; PREVENTION; INTERVENTION; COST	Objective To evaluate whether implementation of the Michigan Keystone ICU project, a comprehensive statewide quality improvement initiative focused on reduction of infections, was associated with reductions in hospital mortality and length of stay for adults aged 65 or more admitted to intensive care units. Design Retrospective comparative study, using data from Medicare claims. Setting Michigan and Midwest region, United States. Population The study period (October 2001 to December 2006) spanned two years before the project was initiated to 22 months after its implementation. The study sample included hospital admissions for patients treated in 95 study hospitals in Michigan (238 937 total admissions)compared with 364 hospitals in the surrounding Midwest region (1 091 547 total admissions). Main outcome measures Hospital mortality and length of hospital stay. Results The overall trajectory of mortality outcomes differed significantly between the two groups upon implementation of the project (Wald test chi(2)=8.73,P=0.033). Reductions in mortality were significantly greater for the study group than for the comparison group 1-12 months (odds ratio 0.83, 95% confidence interval 0.79 to 0.87 v 0.88, 0.85 to 0.90, P=0.041) and 13-22 months (0.76, 0.72 to 0.81 v 0.84, 0.81 to 0.86, P=0.007) after implementation of the project. The overall trajectory of length of stay did not differ significantly between the groups upon implementation of the project (Wald test chi 2=2.05, P=0.560). Group differences in adjusted length of stay compared with baseline did not reach significance during implementation of the project(.0.45 days, 95% confidence interval -0.62 to -0.28 v -0.35, -0.52 to -0.19) or during post-implementation months 1-12 (-0.59, -0.80 to -0.37 v -0.42, -0.59 to -0.25) and 13-22 (-0.67, -0.91 to -0.43 v -0.54, -0.72 to -0.37). Conclusions Implementation of the Keystone ICU project was associated with a significant decrease in hospital mortality in Michigan compared with the surroundingarea. The project was not, however, sufficiently powered to show a significant difference in length of stay.	[Lipitz-Snyderman, Allison; Steinwachs, Donald; Morlock, Laura L] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Needham, Dale M.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Outcomes After Crit Illness & Surg Grp, Baltimore, MD USA; [Colantuoni, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Pronovos, Peter J] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Lipitz-Snyderman, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.	alipitz@jhsph.edu						Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; BERENHOLTZ S, 2010, INFECT CONTROL HOSP; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A., 1996, CLIN CLASSIFICATIONS; KHAUS WA, 1993, ANN INTERN MED, V118, P753; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; KOHN LT, 1999, ERR HUMAN BUILDING S; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; POTTER L, 1997, P 5 ANN WESTERN USER; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; PRONOVOST PJ, 2010, BRIT MED J, P340; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shorr AF, 2001, CHEST, V119, P228, DOI 10.1378/chest.119.1.228; Soufir L, 1999, INFECT CONT HOSP EP, V20, P396, DOI 10.1086/501639; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D	24	83	83	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 31	2011	342								d219	10.1136/bmj.d219	http://dx.doi.org/10.1136/bmj.d219			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PN	21282262	Green Published, hybrid			2022-12-24	WOS:000287137500014
J	O'Neill, JS; Reddy, AB				O'Neill, John S.; Reddy, Akhilesh B.			Circadian clocks in human red blood cells	NATURE			English	Article							GENE-EXPRESSION; PEROXIREDOXINS; OSCILLATIONS; FEEDBACK; NADH; MECHANISMS; HEALTH; STATES; RHYTHM; DIMER	Circadian (similar to 24 hour) clocks are fundamentally important for coordinated physiology in organisms as diverse as cyanobacteria and humans. All current models of the molecular circadian clockwork in eukaryotic cells are based on transcription-translation feedback loops. Non-transcriptional mechanisms in the clockwork have been difficult to study in mammalian systems. We circumvented these problems by developing novel assays using human red blood cells, which have no nucleus (or DNA) and therefore cannot perform transcription. Our results show that transcription is not required for circadian oscillations in humans, and that non-transcriptional events seem to be sufficient to sustain cellular circadian rhythms. Using red blood cells, we found that peroxiredoxins, highly conserved antioxidant proteins, undergo similar to 24-hour redox cycles, which persist for many days under constant conditions (that is, in the absence of external cues). Moreover, these rhythms are entrainable (that is, tunable by environmental stimuli) and temperature-compensated, both key features of circadian rhythms. We anticipate that our findings will facilitate more sophisticated cellular clock models, highlighting the interdependency of transcriptional and non-transcriptional oscillations in potentially all eukaryotic cells.	[O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Reddy, AB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net		O'Neill, John Stuart/0000-0003-2204-6096	Wellcome Trust [083643/Z/07/Z]; MRC Centre for Obesity and Related metabolic Disorders (MRC CORD); NIHR Cambridge Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust (083643/Z/07/Z), the MRC Centre for Obesity and Related metabolic Disorders (MRC CORD) and the NIHR Cambridge Biomedical Research Centre. We thank M. Jain and R. Edgar for discussions about the manuscript, A. Coles and J. Jones for providing access to samples, and G. van der Horst and F. Tamanini for providing access to Cry1 Cry2 knockout (and wild-type) mouse embryonic fibroblasts.	Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Griffon N, 1998, PROTEIN SCI, V7, P673, DOI 10.1002/pro.5560070316; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HESS B, 1966, BIOCHEM BIOPH RES CO, V23, P102, DOI 10.1016/0006-291X(66)90276-2; HEWITT JA, 1972, P NATL ACAD SCI USA, V69, P203, DOI 10.1073/pnas.69.1.203; Hu T, 2009, BIOCHEMISTRY-US, V48, P608, DOI 10.1021/bi801880y; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kennett EC, 2005, INT J BIOCHEM CELL B, V37, P1438, DOI 10.1016/j.biocel.2005.02.001; Kippert F, 2002, CURR BIOL, V12, pR47, DOI 10.1016/S0960-9822(01)00670-4; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; LATENKOV V P, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V101, P614; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; OGO S, 1989, J BIOL CHEM, V264, P11302; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; WOOLUM JC, 1991, J BIOL RHYTHM, V6, P129, DOI 10.1177/074873049100600203; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	45	542	560	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					498	U70		10.1038/nature09702	http://dx.doi.org/10.1038/nature09702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270888	Green Accepted			2022-12-24	WOS:000286596500025
J	Zaratiegui, M; Vaughn, MW; Irvine, DV; Goto, D; Watt, S; Bahler, J; Arcangioli, B; Martienssen, RA				Zaratiegui, Mikel; Vaughn, Matthew W.; Irvine, Danielle V.; Goto, Derek; Watt, Stephen; Baehler, Juerg; Arcangioli, Benoit; Martienssen, Robert A.			CENP-B preserves genome integrity at replication forks paused by retrotransposon LTR	NATURE			English	Article							FISSION YEAST HOMOLOGS; SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CHROMOSOME SEGREGATION; FRAGILE SITES; PROTEIN SAP1; RECOMBINATION; CENTROMERE; IDENTIFICATION; PURIFICATION	Centromere-binding protein B (CENP-B) is a widely conserved DNA binding factor associated with heterochromatin and centromeric satellite repeats(1). In fission yeast, CENP-B homologues have been shown to silence long terminal repeat (LTR) retrotransposons by recruiting histone deacetylases(2). However, CENP-B factors also have unexplained roles in DNA replication(3,4). Here we show that a molecular function of CENP-B is to promote replication-fork progression through the LTR. Mutants have increased genomic instability caused by replication-fork blockage that depends on the DNA binding factor switch-activating protein 1 (Sap1), which is directly recruited by the LTR. The loss of Sap1-dependent barrier activity allows the unhindered progression of the replication fork, but results in rearrangements deleterious to the retrotransposon. We conclude that retrotransposons influence replication polarity through recruitment of Sap1 and transposition near replication-fork blocks, whereas CENP-B counteracts this activity and promotes fork stability. Our results may account for the role of LTR in fragile sites, and for the association of CENP-B with pericentromeric heterochromatin and tandem satellite repeats.	[Zaratiegui, Mikel; Vaughn, Matthew W.; Irvine, Danielle V.; Goto, Derek; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Watt, Stephen; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Watt, Stephen; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England; [Arcangioli, Benoit] Inst Pasteur, Dynam GenomeUnit, CNRS URA2171, Dept Genomes & Genet, F-75015 Paris, France; [Arcangioli, Benoit] Inst Pasteur, Dynam GenomeUnit, CNRS URA2171, Dept Dev Biol, F-75015 Paris, France	Cold Spring Harbor Laboratory; University of London; University College London; University of London; University College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Goto, Derek B/B-7053-2009; Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Zaratiegui, Mikel/0000-0002-0342-0268; Vaughn, Matthew/0000-0002-1384-4283	National Institutes of Health [RO1GM076396]; Cancer Research UK [C9546/A6517]; Agence Nationale de la Recherche [ANR-06-BLAN-0271]; National Health and Medical Research Council; Spanish Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Martienssen laboratory, V. Aranda, E. Mejia-Ramirez and F. Antequera for technical advice and discussions, and R. Allshire, E. Noguchi, M. O'Connell, P. Espenshade and the National BioResource Project (T. Nakamura, Japan) for strains. This work was supported by National Institutes of Health grant RO1GM076396 to R.A.M., Cancer Research UK grant C9546/A6517 to J.B., l'Agence Nationale de la Recherche grant ANR-06-BLAN-0271 to B.A., a National Health and Medical Research Council C.J. Martin Fellowship to D.V.I. and a Postdoctoral Fellowship from the Spanish Ministry of Education to M.Z.	Aguilar-Arnal L, 2008, EMBO J, V27, P1029, DOI 10.1038/emboj.2008.53; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; de Lahondes R, 2003, EUKARYOT CELL, V2, P910, DOI 10.1128/EC.2.5.910-921.2003; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; GHAZVINI M, 1995, MOL CELL BIOL, V15, P4939; Gomez EB, 2008, GENETICS, V179, P757, DOI 10.1534/genetics.107.085779; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Irelan JT, 2001, GENETICS, V157, P1191; Irvine DV, 2009, GENOME RES, V19, P1077, DOI 10.1101/gr.089318.108; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; KUPIEC M, 1988, GENETICS, V119, P549; Lee JK, 1997, P NATL ACAD SCI USA, V94, P8427, DOI 10.1073/pnas.94.16.8427; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Locovei AM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-27; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; Murakami Y, 1996, P NATL ACAD SCI USA, V93, P502, DOI 10.1073/pnas.93.1.502; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Sehgal A, 2007, PLOS GENET, V3, P1389, DOI 10.1371/journal.pgen.0030131; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Ton-Hoang B, 2010, CELL, V142, P398, DOI 10.1016/j.cell.2010.06.034; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wong LH, 2004, TRENDS GENET, V20, P611, DOI 10.1016/j.tig.2004.09.011	30	66	67	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					112	115		10.1038/nature09608	http://dx.doi.org/10.1038/nature09608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21151105	Green Submitted, Green Accepted			2022-12-24	WOS:000285921600042
J	Fabbri, M; Bottoni, A; Shimizu, M; Spizzo, R; Nicoloso, MS; Rossi, S; Barbarotto, E; Cimmino, A; Adair, B; Wojcik, SE; Valeri, N; Calore, F; Sampath, D; Fanini, F; Vannini, I; Musuraca, G; Dell'Aquila, M; Alder, H; Davuluri, RV; Rassenti, LZ; Negrini, M; Nakamura, T; Amadori, D; Kay, NE; Rai, KR; Keating, MJ; Kipps, TJ; Calin, GA; Croce, CM				Fabbri, Muller; Bottoni, Arianna; Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Cimmino, Amelia; Adair, Brett; Wojcik, Sylwia E.; Valeri, Nicola; Calore, Federica; Sampath, Deepa; Fanini, Francesca; Vannini, Ivan; Musuraca, Gerardo; Dell'Aquila, Marie; Alder, Hansjuerg; Davuluri, Ramana V.; Rassenti, Laura Z.; Negrini, Massimo; Nakamura, Tatsuya; Amadori, Dino; Kay, Neil E.; Rai, Kanti R.; Keating, Michael J.; Kipps, Thomas J.; Calin, George A.; Croce, Carlo M.			Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRESSION; SURVIVAL; DISEASE; ZAP-70	Context Chromosomal abnormalities (namely 13q, 17p, and 11q deletions) have prognostic implications and are recurrent in chronic lymphocytic leukemia (CLL), suggesting that they are involved in a common pathogenetic pathway; however, the molecular mechanism through which chromosomal abnormalities affect the pathogenesis and outcome of CLL is unknown. Objective To determine whether the microRNA miR-15a/miR-16-1 cluster (located at 13q), tumor protein p53 (TP53, located at 17p), and miR-34b/miR-34c cluster (located at 11q) are linked in a molecular pathway that explains the pathogenetic and prognostic implications (indolent vs aggressive form) of recurrent 13q, 17p, and 11q deletions in CLL. Design, Setting, and Patients CLL Research Consortium institutions provided blood samples from untreated patients (n=206) diagnosed with B-cell CLL between January 2000 and April 2008. All samples were evaluated for the occurrence of cytogenetic abnormalities as well as the expression levels of the miR-15a/miR-16-1 cluster, miR-34b/miR-34c cluster, TP53, and zeta-chain (TCR)-associated protein kinase 70kDa (ZAP70), a surrogate prognostic marker of CLL. The functional relationship between these genes was studied using in vitro gain-and loss-of-function experiments in cell lines and primary samples and was validated in a separate cohort of primary CLL samples. Main Outcome Measures Cytogenetic abnormalities; expression levels of the miR15a/miR-16-1 cluster, miR-34 family, TP53 gene, downstream effectors cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) and B-cell CLL/lymphoma 2 binding component 3 (BBC3), and ZAP70 gene; genetic interactions detected by chromatin immunoprecipitation. Results In CLLs with 13q deletions the miR-15a/miR-16-1 cluster directly targeted TP53 (mean luciferase activity for miR-15a vs scrambled control, 0.68 relative light units (RLU) [95% confidence interval {CI}, 0.63-0.73]; P=.02; mean for miR-16 vs scrambled control, 0.62 RLU [95% CI, 0.59-0.65]; P=.02) and its downstream effectors. In leukemic cell lines and primary CLL cells, TP53 stimulated the transcription of miR-15/miR-16-1 as well as miR-34b/miR-34c clusters, and the miR-34b/miR-34c cluster directly targeted the ZAP70 kinase(mean luciferase activity for miR-34a vs scrambled control, 0.33 RLU [95% CI, 0.30-0.36]; P=.02; mean for miR-34b vs scrambled control, 0.31 RLU [95% CI, 0.30-0.32]; P=.01; and mean for miR-34c vs scrambled control, 0.35 RLU [95% CI, 0.33-0.37]; P=.02). Conclusions A microRNA/TP53 feedback circuitry is associated with CLL pathogenesis and outcome. This mechanism provides a novel pathogenetic model for the association of 13q deletions with the indolent form of CLL that involves microRNAs, TP53, and ZAP70. JAMA. 2011;305(1):59-67 www.jama.com	[Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Sampath, Deepa; Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Sampath, Deepa; Calin, George A.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Fabbri, Muller; Bottoni, Arianna; Adair, Brett; Wojcik, Sylwia E.; Valeri, Nicola; Calore, Federica; Alder, Hansjuerg; Nakamura, Tatsuya; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Barbarotto, Elisa] Univ Ferrara, Dept Morphol & Embryol, Human Anat Sect, I-44100 Ferrara, Italy; [Negrini, Massimo] Univ Ferrara, Dept Expt & Diagnost Med, Interdept Ctr Canc Res, I-44100 Ferrara, Italy; [Cimmino, Amelia] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Fabbri, Muller; Fanini, Francesca; Vannini, Ivan; Musuraca, Gerardo; Amadori, Dino] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy; [Dell'Aquila, Marie; Rassenti, Laura Z.; Kipps, Thomas J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Davuluri, Ramana V.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Kay, Neil E.] Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, Rochester, MN USA; [Rai, Kanti R.] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Meldola (IRST); University of California System; University of California San Diego; The Wistar Institute; Mayo Clinic; Northwell Health	Calin, GA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gcalin@mdanderson.org; carlo.croce@osumc.edu	Sampath, Deepa/J-3298-2016; Musuraca, Gerardo/ADK-9808-2022; Davuluri, Ramana/D-7348-2011; Spizzo, Riccardo/V-1057-2019; Young, Richard A/F-6495-2012; Fanini, Francesca/H-6973-2019; Nicoloso, Milena S/K-6411-2012; Calin, George/E-9390-2011; Negrini, Massimo/J-2377-2016; Sampath, Deepa/T-5069-2019; Vannini, Ivan/T-7226-2019	Musuraca, Gerardo/0000-0003-1947-1032; Spizzo, Riccardo/0000-0001-7772-0960; Young, Richard A/0000-0001-8855-8647; Nicoloso, Milena S/0000-0003-4231-9303; Negrini, Massimo/0000-0002-0007-1920; Vannini, Ivan/0000-0002-9279-1801; valeri, nicola/0000-0002-5426-5683; Calin, George/0000-0001-6704-5615; Cimmino, Amelia/0000-0002-0004-9299; Sampath, Deepa/0000-0002-4366-8436	Kimmel Scholar Award; FIRC (Federazione Italiana Ricerca sul Cancro); University of Texas M. D. Anderson Research Trust; University of Texas; CLL Global Research Foundation; National Institutes of Health; US Department of Defense; Leukemia SPORE Developmental Research Award; National Institutes of Health [R01 CA111953]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA151319, P01CA129242, P30CA010815, R01CA111953] Funding Source: NIH RePORTER	Kimmel Scholar Award; FIRC (Federazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); University of Texas M. D. Anderson Research Trust; University of Texas; CLL Global Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Leukemia SPORE Developmental Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Fabbri is supported by a 2009 Kimmel Scholar Award. Dr Cimmino is supported by a fellowship from FIRC (Federazione Italiana Ricerca sul Cancro). Dr Calin is supported by a fellowship from the University of Texas M. D. Anderson Research Trust, a fellowship from The University of Texas System Regents Research Scholar Program, and a grant from the CLL Global Research Foundation. Dr Calin's laboratory is supported in part by the National Institutes of Health, the US Department of Defense, and a Leukemia SPORE Developmental Research Award. Drs Kay and Croce are supported by National Institutes of Health grant R01 CA111953.	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Auer RL, 2007, BRIT J HAEMATOL, V137, P443, DOI 10.1111/j.1365-2141.2007.06600.x; BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; CALL TG, 1994, MAYO CLIN PROC, V69, P323, DOI 10.1016/S0025-6196(12)62215-0; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Dewald GW, 2003, BRIT J HAEMATOL, V121, P287, DOI 10.1046/j.1365-2141.2003.04265.x; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889	18	216	233	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					59	67		10.1001/jama.2010.1919	http://dx.doi.org/10.1001/jama.2010.1919			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205967	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000285924100025
J	Yadon, AN; Tsukiyama, T				Yadon, Adam N.; Tsukiyama, Toshio			SnapShot: Chromatin Remodeling: ISWI	CELL			English	Editorial Material							TRANSCRIPTION		[Yadon, Adam N.; Tsukiyama, Toshio] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Yadon, AN (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.				NICHD NIH HHS [T32HD007183] Funding Source: Medline; NIGMS NIH HHS [R01 GM058465] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058465] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10	6	46	47	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					454	U154	454.e1	10.1016/j.cell.2011.01.019	http://dx.doi.org/10.1016/j.cell.2011.01.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295704	Bronze			2022-12-24	WOS:000286973100016
J	Pei, HD; Zhang, L; Luo, KT; Qin, YX; Chesi, M; Fei, F; Bergsagel, PL; Wang, LW; You, ZS; Lou, ZK				Pei, Huadong; Zhang, Lindsey; Luo, Kuntian; Qin, Yuxin; Chesi, Marta; Fei, Frances; Bergsagel, P. Leif; Wang, Liewei; You, Zhongsheng; Lou, Zhenkun			MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites	NATURE			English	Article							WOLF-HIRSCHHORN-SYNDROME; DOUBLE-STRAND BREAKS; MULTIPLE-MYELOMA; PROTEIN; METHYLTRANSFERASE; CHECKPOINT; MDC1; RECRUITMENT; REPAIR; DOMAIN	p53-binding protein 1 (53BP1) is known to be an important mediator of the DNA damage response(1), with dimethylation of histone H4 lysine 20 (H4K20me2) critical to the recruitment of 53BP1 to double-strand breaks (DSBs)(2,3). However, it is not clear how 53BP1 is specifically targeted to the sites of DNA damage, as the overall level of H4K20me2 does not seem to increase following DNA damage. It has been proposed that DNA breaks may cause exposure of methylated H4K20 previously buried within the chromosome; however, experimental evidence for such a model is lacking. Here we found that H4K20 methylation actually increases locally upon the induction of DSBs and that methylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or WHSC1) in mammals. Downregulation of MMSET significantly decreases H4K20 methylation at DSBs and the subsequent accumulation of 53BP1. Furthermore, we found that the recruitment of MMSET to DSBs requires the gamma H2AX-MDC1 pathway; specifically, the interaction between the MDC1 BRCT domain and phosphorylated Ser 102 of MMSET. Thus, we propose that a pathway involving gamma H2AX-MDC1-MMSET regulates the induction of H4K20 methylation on histones around DSBs, which, in turn, facilitates 53BP1 recruitment.	[Pei, Huadong; Luo, Kuntian; Lou, Zhenkun] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lindsey; Fei, Frances; You, Zhongsheng] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Qin, Yuxin; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Chesi, Marta; Bergsagel, P. Leif] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA	Mayo Clinic; Washington University (WUSTL); Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Lou, ZK (corresponding author), Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu	Bergsagel, Peter Leif/A-7842-2011; Pei, Huadong/C-9625-2013; You, Zhongsheng/F-5404-2012	Bergsagel, Peter Leif/0000-0003-1523-7388; Fei, Yueyang/0000-0001-9439-9136; You, Zhongsheng/0000-0002-9719-8791	Richard Schulze Family Foundation; NIH [CA130996, CA151329]; American Cancer Society [IRG-58-010-52]; Siteman Career Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE [R01CA133966, R01CA151329, R01CA136671, R01CA130996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020686, R01AG020686] Funding Source: NIH RePORTER	Richard Schulze Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Siteman Career Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Jasin for providing HeLa DR-GFP cells, and S. Baylin for providing MDA-MB-231 cells with inducible I-SceI expression. We thank M. Goldberg, X. Yu and M. Stucki for providing MDC1 and BRCA1 constructs. We thank M. Huen for providing 53BP1 expression constructs. We thank J. D. Licht for providing MMSET antibodies and B. Ho Park for providing MMSET shRNAs. This work was supported by the Richard Schulze Family Foundation and the NIH (CA130996 and CA151329; Z.L.), a grant from the American Cancer Society (IRG-58-010-52; Z.Y.) and a Siteman Career Award in Breast Cancer Research (Z.Y.).	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	30	308	319	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					124	U144		10.1038/nature09658	http://dx.doi.org/10.1038/nature09658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293379	Green Accepted			2022-12-24	WOS:000286886400047
J	Berkman, MB; Plutzer, E				Berkman, Michael B.; Plutzer, Eric			Defeating Creationism in the Courtroom, But Not in the Classroom	SCIENCE			English	Editorial Material							EVOLUTION; STANDARDS		[Berkman, Michael B.; Plutzer, Eric] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Plutzer, E (corresponding author), Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA.	Plutzer@psu.edu		Plutzer, Eric/0000-0002-5456-7227				Berkman M., 2010, EVOLUTION CREATIONIS; Berkman MB, 2009, PERSPECT POLIT, V7, P485, DOI 10.1017/S153759270999082X; Berkman MB, 2008, PLOS BIOL, V6, P920, DOI 10.1371/journal.pbio.0060124; Branch G, 2010, ANNU REV GENOM HUM G, V11, P317, DOI 10.1146/annurev-genom-082509-141815; Donnelly LA, 2007, J RES SCI TEACH, V44, P236, DOI 10.1002/tea.20150; Moore R, 2002, BIOSCIENCE, V52, P378, DOI 10.1641/0006-3568(2002)052[0378:TEDSSM]2.0.CO;2; National Center for Education Statistics, 2005, NAT ASS ED PROGR 200; National Research Council (NRC), 1996, NAT SCI ED STAND; Plutzer E, 2008, PUBLIC OPIN QUART, V72, P540, DOI 10.1093/poq/nfn034; Rutledge ML, 2002, AM BIOL TEACH, V64, P21, DOI 10.1662/0002-7685(2002)064[0021:HSBTKS]2.0.CO;2	10	72	75	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					404	405		10.1126/science.1198902	http://dx.doi.org/10.1126/science.1198902			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BB	21273472				2022-12-24	WOS:000286635900035
J	Blau, HM; Pomerantz, JH				Blau, Helen M.; Pomerantz, Jason H.			Re"evolutionary" Regenerative Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL-CYCLE; INK4A/ARF; RB		[Blau, Helen M.] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Pomerantz, Jason H.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Blau, HM (corresponding author), Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, 269 Campus Dr,CCSR 4215, Stanford, CA 94305 USA.	hblau@stanford.edu; jason.pomerantz@ucsfmedctr.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR059565, F32AR051678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL096113, U01 HL100397-03, R01 HL096113, U01 HL100397, HL100397, R01 HL096113-03] Funding Source: Medline; NIAMS NIH HHS [AR059565, R43 AR059565, F32 AR051678] Funding Source: Medline; NIA NIH HHS [AG009521, R37 AG009521, R01 AG009521, AG020961, R01 AG020961, R01 AG009521-25, R01 AG020961-08] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; del Arroyo AG, 2005, ADV EXP MED BIOL, V570, P227; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	10	17	19	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					87	88		10.1001/jama.2010.1938	http://dx.doi.org/10.1001/jama.2010.1938			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21177496	Green Accepted			2022-12-24	WOS:000285924100028
J	Woodcock, J; Griffin, JP; Behrman, RE				Woodcock, Janet; Griffin, Joseph P.; Behrman, Rachel E.			Development of Novel Combination Therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Griffin, Joseph P.; Behrman, Rachel E.] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							AD L, 2010, SCIENCE, V328, P137; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; *FOOD DRUG ADM, 2010, GUID IND CH IN PRESS; *FOOD DRUG ADM, 2010, GUID IND CO IN PRESS	4	198	202	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					985	987		10.1056/NEJMp1101548	http://dx.doi.org/10.1056/NEJMp1101548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21323535				2022-12-24	WOS:000288439000001
J	Gratton, E				Gratton, Enrico			Deeper Tissue Imaging with Total Detection	SCIENCE			English	Editorial Material							FLUORESCENCE MICROSCOPY		Univ Calif Irvine, Irvine, CA 92679 USA	University of California System; University of California Irvine	Gratton, E (corresponding author), Univ Calif Irvine, Irvine, CA 92679 USA.	egratton22@yahoo.com						Combs CA, 2011, J MICROSC-OXFORD, V241, P153, DOI 10.1111/j.1365-2818.2010.03411.x; Combs CA, 2007, J MICROSC-OXFORD, V228, P330, DOI 10.1111/j.1365-2818.2007.01851.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FISHKIN JB, 1993, J OPT SOC AM A, V10, P127, DOI 10.1364/JOSAA.10.000127; Zimmerley M, 2009, APPL OPTICS, V48, pD79, DOI 10.1364/AO.48.000D79	5	19	22	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1016	1017		10.1126/science.1201542	http://dx.doi.org/10.1126/science.1201542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350154	Green Published			2022-12-24	WOS:000287699000038
J	Cook-Deegan, R				Cook-Deegan, Robert			Gene Patents: The Shadow of Uncertainty	SCIENCE			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.			Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	874		10.1126/science.1203458	http://dx.doi.org/10.1126/science.1203458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330530				2022-12-24	WOS:000287455100043
J	Mathews, DJH; Graff, GD; Saha, K; Winickoff, DE				Mathews, Debra J. H.; Graff, Gregory D.; Saha, Krishanu; Winickoff, David E.			Access to Stem Cells and Data: Persons, Property Rights, and Scientific Progress	SCIENCE			English	Editorial Material								Many fields have struggled to develop strategies, policies, or structures to optimally manage data, materials, and intellectual property rights (IPRs). There is growing recognition that the field of stem cell science, in part because of its complex IPRs landscape and the importance of cell line collections, may require collective action to facilitate basic and translational research. Access to pluripotent stem cell lines and the information associated with them is critical to the progress of stem cell science, but simple notions of access are substantially complicated by shifting boundaries between what is considered information versus material, person versus artifact, and private property versus the public domain.	[Mathews, Debra J. H.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Saha, Krishanu] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Winickoff, David E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Johns Hopkins University; Colorado State University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley	Mathews, DJH (corresponding author), Johns Hopkins Berman Inst Bioeth, Deering Hall 208,1809 Ashland Ave, Baltimore, MD 21205 USA.	dmathews@jhu.edu	Saha, Krishanu/J-3980-2014	Saha, Krishanu/0000-0003-2837-0858; Graff, Gregory/0000-0002-9140-0901; Mathews, Debra/0000-0002-4897-7617				[Anonymous], 2009, NATURE, V461, P145, DOI 10.1038/461145a; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598; Fullerton SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000361; Kohane IS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000809; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Skloot R., 2010, IMMORTAL LIFE HENRIE; Stacey G, 2006, REGEN MED, V1, P139, DOI 10.2217/17460751.1.1.139; The Hinxton Group, 2011, POL PRACT GOV DAT MA; Winickoff, 2009, YALE J HLTH POLICY L, V9, P52	12	21	22	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					725	727		10.1126/science.1201382	http://dx.doi.org/10.1126/science.1201382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311015				2022-12-24	WOS:000287205700058
J	Khunti, K; Walker, N; Satter, N; Davies, M				Khunti, Kamlesh; Walker, Nicola; Satter, Naveed; Davies, Melanie			Unanswered questions over NHS health checks	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Khunti, Kamlesh; Walker, Nicola] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Satter, Naveed] BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Davies, Melanie] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester; University of Glasgow; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099					0	16	16	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6312	10.1136/bmj.c6312	http://dx.doi.org/10.1136/bmj.c6312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270080	Green Accepted			2022-12-24	WOS:000286887800016
J	Cang, H; Labno, A; Lu, CG; Yin, XB; Liu, M; Gladden, C; Liu, YM; Zhang, X				Cang, Hu; Labno, Anna; Lu, Changgui; Yin, Xiaobo; Liu, Ming; Gladden, Christopher; Liu, Yongmin; Zhang, Xiang			Probing the electromagnetic field of a 15-nanometre hotspot by single molecule imaging	NATURE			English	Article							ENHANCED RAMAN-SCATTERING; SURFACE-PLASMONS; SILVER ELECTRODE; DIFFRACTION-LIMIT; ENERGY-TRANSFER; MICROSCOPY; SPECTROSCOPY; PYRIDINE; LOCALIZATION; EXCITATION	When light illuminates a rough metallic surface, hotspots can appear, where the light is concentrated on the nanometre scale, producing an intense electromagnetic field. This phenomenon, called the surface enhancement effect(1,2), has a broad range of potential applications, such as the detection of weak chemical signals. Hotspots are believed to be associated with localized electromagnetic modes(3,4), caused by the randomness of the surface texture. Probing the electromagnetic field of the hotspots would offer much insight towards uncovering the mechanism generating the enhancement; however, it requires a spatial resolution of 1-2 nm, which has been a long-standing challenge in optics. The resolution of an optical microscope is limited to about half the wavelength of the incident light, approximately 200-300 nm. Although current state-of-the-art techniques, including near-field scanning optical microscopy(5), electron energy-loss spectroscopy(6), cathode luminescence imaging(7) and two-photon photoemission imaging(8) have subwavelength resolution, they either introduce a non-negligible amount of perturbation, complicating interpretation of the data, or operate only in a vacuum. As a result, after more than 30 years since the discovery of the surface enhancement effect(9-11), how the local field is distributed remains unknown. Here we present a technique that uses Brownian motion of single molecules to probe the local field. It enables two-dimensional imaging of the fluorescence enhancement profile of single hotspots on the surfaces of aluminium thin films and silver nanoparticle clusters, with accuracy down to 1.2 nm. Strong fluorescence enhancements, up to 54 and 136 times respectively, are observed in those two systems. This strong enhancement indicates that the local field, which decays exponentially from the peak of a hotspot, dominates the fluorescence enhancement profile.	[Cang, Hu; Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Cang, Hu; Labno, Anna; Lu, Changgui; Yin, Xiaobo; Liu, Ming; Gladden, Christopher; Liu, Yongmin; Zhang, Xiang] Univ Calif Berkeley, NSF Nano Scale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Labno, Anna] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Science Foundation (NSF); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011; Yin, Xiaobo/A-4142-2011; Liu, Yongmin/F-5322-2010	Liu, Ming/0000-0001-9849-1845; Liu, Yongmin/0000-0003-1084-6651; Zhang, Xiang/0000-0002-3272-894X	US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	We thank G. Bartal and A. Niv for discussions. This research was supported by the US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231.	ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; CHANCE RR, 1975, J CHEM PHYS, V62, P2245, DOI 10.1063/1.430748; CHANG CC, 1978, J ELECTROCHEM SOC, V125, pC136; CREIGHTON JA, 1979, J CHEM SOC FARAD T 2, V75, P790, DOI 10.1039/f29797500790; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; GERSTEN J, 1980, J CHEM PHYS, V73, P3023, DOI 10.1063/1.440560; Hell S. W., 2009, SINGLE MOL SPECTROSC, P365; Hutchison JA, 2009, NANO LETT, V9, P995, DOI 10.1021/nl8030696; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Kubo A, 2007, J PHYS B-AT MOL OPT, V40, pS259, DOI 10.1088/0953-4075/40/11/S02; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/NMETH.1447, 10.1038/nmeth.1447]; MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Roeffaers MBJ, 2009, ANGEW CHEM INT EDIT, V48, P9285, DOI 10.1002/anie.200904944; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sarychev AK, 1999, PHYS REV B, V60, P16389, DOI 10.1103/PhysRevB.60.16389; Seal K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206103; SHALAEV VM, 1988, Z PHYS D ATOM MOL CL, V10, P71, DOI 10.1007/BF01425582; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Stockman MI, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.167401; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Vesseur EJR, 2007, NANO LETT, V7, P2843, DOI 10.1021/nl071480w; WOKAUN A, 1983, J CHEM PHYS, V79, P509, DOI 10.1063/1.445550; Wu DM, 2008, NANO LETT, V8, P1159, DOI 10.1021/nl0733280	30	209	209	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					385	+		10.1038/nature09698	http://dx.doi.org/10.1038/nature09698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248848				2022-12-24	WOS:000286385600049
J	Nichols, D				Nichols, David			Legal highs: the dark side of medicinal chemistry	NATURE			English	Editorial Material									Purdue Univ, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nichols, D (corresponding author), Purdue Univ, W Lafayette, IN 47907 USA.	drdave@purdue.edu							0	15	15	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					7	7		10.1038/469007a	http://dx.doi.org/10.1038/469007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702UO	21209630	Bronze			2022-12-24	WOS:000285921600002
J	Li, WT; Chetelat, RT				Li, Wentao; Chetelat, Roger T.			A Pollen Factor Linking Inter- and Intraspecific Pollen Rejection in Tomato	SCIENCE			English	Article							SELF-INCOMPATIBILITY; S-RNASE; LYCOPERSICON-ESCULENTUM; UNILATERAL INCOMPATIBILITY; SOLANUM-LYCOPERSICOIDES; IDENTIFICATION; COMPATIBILITY; EXPRESSION; INCONGRUITY; PERUVIANUM	Self-incompatibility (SI)-intraspecific pollen recognition systems that allow plants to avoid inbreeding-in the Solanaceae (the nightshade family) is controlled by a polymorphic S locus where "self" pollen is rejected on pistils with matching S alleles. In contrast, unilateral interspecific incompatibility (UI) prevents hybridization between related species, most commonly when the pollen donor is self-compatible (SC) and the recipient is SI. We observed that in Solanum, a pollen-expressed Cullin1 gene with high similarity to Petunia SI factors interacts genetically with a gene at or near the S locus to control UI. Cultivated tomato and related red-or orange-fruited species (all SC) exhibit the same loss-of-function mutation in this gene, whereas the green-fruited species (mostly SI) contain a functional allele; hence, similar biochemical mechanisms underlie the rejection of both "self" and interspecific pollen.	[Li, Wentao; Chetelat, Roger T.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Chetelat, RT (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	trchetelat@ucdavis.edu			NSF [DBI 0605200]	NSF(National Science Foundation (NSF))	We thank J. DeVerna, P. March, K. Smith, and the C. M. Rick Tomato Genetics Resource Center (TGRC) staff for providing seed or cuttings of key genotypes; P. March for photos of fruit; B. McClure and P. Bedinger for comments on the manuscript; and S. Tanksley for providing seed of S. habrochaites introgression lines. Supported by NSF grant DBI 0605200. Sequence data have been deposited in GenBank under accession numbers HQ610200 and HQ610201. Seed requests submitted to the TGRC are subject to a material transfer agreement (http://tgrc.ucdavis.edu/MTA/TGRC-MTA.pdf).	Bernacchi D, 1997, GENETICS, V147, P861; Canady MA, 2005, GENOME, V48, P685, DOI 10.1139/G05-032; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CHETELAT RT, 1991, THEOR APPL GENET, V82, P704, DOI 10.1007/BF00227314; Covey PA, 2010, PLANT J, V64, P367, DOI 10.1111/j.1365-313X.2010.04340.x; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; HO JY, 1992, PLANT J, V2, P971; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; LEWIS D., 1958, HEREDITY, V12, P233, DOI 10.1038/hdy.1958.26; Li WT, 2010, GENETICS, V185, P1069, DOI 10.1534/genetics.110.116343; Liedl BE, 1996, SEX PLANT REPROD, V9, P299, DOI 10.1007/BF02152705; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2009, J EXP BOT, V60, P1069, DOI 10.1093/jxb/erp024; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Mutschler M. A., 1994, Genetic control of self-incompatibility and reproductive development in flowering plants., P164; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Rick C.M., 1988, PLANT EVOLUTIONARY B, P133, DOI DOI 10.1007/978-94-009-1207-6_6; RICK CM, 1986, P NATL ACAD SCI USA, V83, P3580, DOI 10.1073/pnas.83.11.3580; RICK CM, 1986, SOLANACEAE BIOL SYST, P475; ROYO J, 1994, P NATL ACAD SCI USA, V91, P6511, DOI 10.1073/pnas.91.14.6511; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; TWELL D, 1990, DEVELOPMENT, V109, P705; van Heusden AW, 1999, THEOR APPL GENET, V99, P1068, DOI 10.1007/s001220051416; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	27	81	85	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1827	1830		10.1126/science.1197908	http://dx.doi.org/10.1126/science.1197908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205670				2022-12-24	WOS:000285603700042
J	Van Overwalle, G				Van Overwalle, Geertrui			Turning Patent Swords into Shares	SCIENCE			English	Editorial Material							INTELLECTUAL PROPERTY; LIABILITY RULES; UNCERTAINTY; INNOVATION; GENETICS; SOCIETY; RIGHTS; VIEW		[Van Overwalle, Geertrui] Univ Louvain, Ctr Intellectual Property Rights, B-3000 Louvain, Belgium; [Van Overwalle, Geertrui] Tilburg Univ, Tilburg Inst Law Technol & Soc, NL-5000 LE Tilburg, Netherlands	Tilburg University	Van Overwalle, G (corresponding author), Univ Louvain, Ctr Intellectual Property Rights, B-3000 Louvain, Belgium.	geertrui.vanoverwalle@law.kuleuven.be						AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Burk Daniel L., 2009, PATENT CRISIS COURTS; CALABRESI G, 1972, HARVARD LAW REV, V85, P1089, DOI 10.2307/1340059; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1352, DOI 10.1038/nbt1106-1352; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Drahos Peter, 1996, PHILOS INTELLECTUAL; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HOLMAN CH, 2008, BIOTECH BRIEF, V5, P1; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996; MERGES RP, 2001, EXPANDING BOUNDARIES, P123; RAI K, 2003, LAW CONTEMP PROBL, V66, P289; Reichman JH, 2000, VANDERBILT LAW REV, V53, P1743; *SACGHS, 2010, REV DRAFT REP GE PAT; Shapiro C, 2001, INNOV POLICY EC, V1, P119, DOI DOI 10.1086/ipe.1.25056143; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; VanOverwalle G, 2009, CAM INTELLECT PROP, P1, DOI 10.1017/CBO9780511581182; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; 2010, GENET MED S, V12, pS1	23	27	27	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1630	1631		10.1126/science.1189592	http://dx.doi.org/10.1126/science.1189592			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695RO	21164001				2022-12-24	WOS:000285390500049
J	Osterholm, MT				Osterholm, Michael T.			Foodborne Disease in 2011-The Rest of the Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; ILLNESS; PATHOGENS		Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA.							Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; 2010, MMWR MORB MORTAL WKL, V59, P418	4	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					889	891		10.1056/NEJMp1010907	http://dx.doi.org/10.1056/NEJMp1010907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732FL	21345094				2022-12-24	WOS:000288170300001
J	Jasanoff, S				Jasanoff, Sheila			A Living Constitution	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.								0	2	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					872	872		10.1126/science.1203467	http://dx.doi.org/10.1126/science.1203467			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330528				2022-12-24	WOS:000287455100039
J	Rosebeck, S; Madden, L; Jin, XH; Gu, SF; Apel, IJ; Appert, A; Hamoudi, RA; Noels, H; Sagaert, X; Van Loo, P; Baens, M; Du, MQ; Lucas, PC; McAllister-Lucas, LM				Rosebeck, Shaun; Madden, Lisa; Jin, Xiaohong; Gu, Shufang; Apel, Ingrid J.; Appert, Alex; Hamoudi, Rifat A.; Noels, Heidi; Sagaert, Xavier; Van Loo, Peter; Baens, Mathijs; Du, Ming-Qing; Lucas, Peter C.; McAllister-Lucas, Linda M.			Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-kappa B Activation	SCIENCE			English	Article							T-CELL-ACTIVATION; MALT LYMPHOMA; MARGINAL ZONE; CHROMOSOMAL TRANSLOCATION; UBIQUITIN LIGASE; BINDING-SITE; KINASE; PATHWAYS; TNF; TRAF2	Proper regulation of nuclear factor kappa B (NF-kappa B) transcriptional activity is required for normal lymphocyte function, and deregulated NF-kappa B signaling can facilitate lymphomagenesis. We demonstrate that the API2-MALT1 fusion oncoprotein created by the recurrent t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma induces proteolytic cleavage of NF-kappa B-inducing kinase (NIK) at arginine 325. NIK cleavage requires the concerted actions of both fusion partners and generates a C-terminal NIK fragment that retains kinase activity and is resistant to proteasomal degradation. The resulting deregulated NIK activity is associated with constitutive noncanonical NF-kappa B signaling, enhanced B cell adhesion, and apoptosis resistance. Our study reveals the gain-of-function proteolytic activity of a fusion oncoprotein and highlights the importance of the noncanonical NF-kappa B pathway in B lymphoproliferative disease.	[Jin, Xiaohong; Apel, Ingrid J.; Lucas, Peter C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rosebeck, Shaun; Madden, Lisa; Gu, Shufang; McAllister-Lucas, Linda M.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Appert, Alex; Hamoudi, Rifat A.; Du, Ming-Qing] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, England; [Noels, Heidi; Van Loo, Peter; Baens, Mathijs] Catholic Univ Louvain, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Noels, Heidi; Van Loo, Peter; Baens, Mathijs] Flanders Inst Biotechnol VIB, Dept Mol & Dev Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Sagaert, Xavier] Catholic Univ Louvain, Dept Pathol, Sect Morphol & Mol Pathol, B-3000 Louvain, Belgium	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain	Lucas, PC (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu; lindaluc@umich.edu	Noels, Heidi/AAQ-2622-2020; Van Loo, Peter/A-3287-2012	Du, Ming-Qing/0000-0002-1017-5045; Lucas, Peter/0000-0003-4880-7172; Hamoudi, Rifat/0000-0002-1402-0868; Van Loo, Peter/0000-0003-0292-1949	Nancy Newton Loeb Pediatric Cancer Research; Helen L. Kay Pediatric Cancer Research Award; National Institute of Child Health and Human Development, NIH [T32-HD07513]; National Heart, Lung, and Blood Institute, NIH [T32-HL007622-21A2]; Research Foundation-Flanders (FWO); Belgian Foundation against Cancer; Shirley K. Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center [G007839]; Leukemia and Lymphoma Research UK; National Cancer Institute NIH [R01CA124540]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007513] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA124540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007622, R01HL082914] Funding Source: NIH RePORTER	Nancy Newton Loeb Pediatric Cancer Research; Helen L. Kay Pediatric Cancer Research Award; National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research Foundation-Flanders (FWO)(FWO); Belgian Foundation against Cancer; Shirley K. Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center; Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); National Cancer Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Dyer for the SSK41 cells, R. Renne for the BJAB Tet-On cells, and G. Nunez for several expression plasmids. A Material Transfer Agreement is required for use of the SSK41 cells expressing API2-MALT1. Microarray data from MALT lymphoma tumor collections are Minimum Information About a Microarray Experiment (MIAME) compliant and are available online at the Gene Expression Omnibus (GEO) with accession number GSE25527 for collection no. 1 and accession number GSE25550 for collection no. 2 (www.ncbi.nlm.nih.gov/projects/geo/). L. M. is a recipient of the Nancy Newton Loeb Pediatric Cancer Research and Helen L. Kay Pediatric Cancer Research Awards and received support from National Institute of Child Health and Human Development, NIH, T32-HD07513. L.M. and S.R. were both supported by National Heart, Lung, and Blood Institute, NIH, T32-HL007622-21A2. M.B. is supported by grants from the Research Foundation-Flanders (FWO) and Belgian Foundation against Cancer. H.N. was an aspirant of the FWO-Vlaanderen. X.S. is a Senior Clinical Investigator of FWO-Vlaanderen, and P.V.L. is a postdoctoral researcher of the FWO. This work was supported by the Shirley K. Schlafer Foundation, the Elizabeth Caroline Crosby Fund, and grants from the University of Michigan Comprehensive Cancer Center (G007839), Leukemia and Lymphoma Research UK, and National Cancer Institute NIH (R01CA124540).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McAllister-Lucas LM, 2008, NAT IMMUNOL, V9, P231, DOI 10.1038/ni0308-231; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	32	111	127	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					468	472		10.1126/science.1198946	http://dx.doi.org/10.1126/science.1198946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273489	Green Accepted			2022-12-24	WOS:000286635900055
J	Tarakji, KG; Sabik, JF; Bhudia, SK; Batizy, LH; Blackstone, EH				Tarakji, Khaldoun G.; Sabik, Joseph F., III; Bhudia, Sunil K.; Batizy, Lillian H.; Blackstone, Eugene H.			Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OFF-PUMP; CARDIAC-SURGERY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AXILLARY ARTERY; ON-PUMP; PREDICTORS; MORBIDITY; CANNULATION; SURVIVAL; TERM	Context Stroke is a devastating and potentially preventable complication of coronary artery bypass graft (CABG) surgery. Better understanding of the timing and risk factors for stroke associated with CABG are needed. Objectives To investigate temporal trends in stroke after CABG and to identify stroke risk factors and association with longitudinal outcomes. Design, Setting, and Patients Prospective study conducted from 1982 through 2009 at a single US academic medical center among 45 432 consecutive patients (mean age, 63 [SD, 10] years) undergoing isolated primary or reoperative CABG surgery. Strokes occurring following CABG were recorded prospectively and classified as having occurred intraoperatively or postoperatively. Complications and survival after stroke were assessed in propensity-matched groups. Intervention CABG performed using 4 different operative strategies (off-pump, on-pump with beating heart, on-pump with arrested heart, on-pump with hypothermic circulatory arrest). Main Outcome Measures Hospital complications; late survival. Results Among 45 432 patients undergoing CABG surgery, 705 (1.6% [95% confidence interval {CI}, 1.4%-1.7%]) experienced a stroke. The prevalence of stroke peaked in 1988 at 2.6% (95% CI, 1.9%-3.4%), then declined at 4.69% (95% CI, 4.68%-4.70%) per year (P=.04), despite increasing patient comorbidity. Overall, 279 strokes (40%) occurred intraoperatively and 409 (58%) occurred postoperatively (timing indeterminate in 17 patients). Postoperative stroke peaked at 40 hours, decreasing to 0.055%/d (95% CI, 0.047%-0.065%) by day 6. Risk factors for both intraoperative and postoperative stroke included older age (odds ratio, 8.5 [95% CI, 3.2-22]) and variables representing arteriosclerotic burden. Intraoperative stroke rates were lowest in off-pump CABG (0.14% [95% CI, 0.029%-0.40%]) and on-pump beating-heart CABG (0% [95% CI, 0%-1.6%]), intermediate with on-pump arrested-heart CABG (0.50% [95% CI, 0.41%-0.61%]), and highest with on-pump CABG with hypothermic circulatory arrest (5.3% [95% CI, 2.0%-11%]). Patients with stroke had worse adjusted hospital outcomes, longer intensive care and postoperative stays, and worse downstream survival (mean, 11 [SD, 8.6] years). Conclusion Among patients undergoing CABG surgery at a single center over the past 30 years, the occurrence of stroke declined despite an increasing patient risk profile, and more than half of strokes occurred postoperatively rather than intraoperatively. JAMA. 2011;305(4):381-390 www.jama.com	[Sabik, Joseph F., III; Bhudia, Sunil K.; Blackstone, Eugene H.] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; [Tarakji, Khaldoun G.] Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, Cleveland, OH 44195 USA; [Batizy, Lillian H.; Blackstone, Eugene H.] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sabik, JF (corresponding author), Cleveland Clin, Dept Thorac & Cardiovasc Surg, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA.	sabikj@ccf.org	Bhudia, Sunil/AAF-8325-2020; Bhudia, Sunil K/A-3150-2011	Bhudia, Sunil K/0000-0002-6660-3141	Cleveland Clinic Department of Thoracic and Cardiovascular Surgery	Cleveland Clinic Department of Thoracic and Cardiovascular Surgery	This study was funded in part by the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery and the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research, held by Dr Blackstone.	BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053; Charlson ME, 2007, J CARDIAC SURG, V22, P465, DOI 10.1111/j.1540-8191.2007.00471.x; DavilaRoman VG, 1996, J AM COLL CARDIOL, V28, P942, DOI 10.1016/S0735-1097(96)00263-X; Filsoufi F, 2008, ANN THORAC SURG, V85, P862, DOI 10.1016/j.athoracsur.2007.10.060; Fuchs S, 2002, CIRCULATION, V106, P86, DOI 10.1161/01.CIR.0000020678.16325.E0; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; Hamon M, 2008, CIRCULATION, V118, P678, DOI 10.1161/CIRCULATIONAHA.108.784504; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Koch CG, 2006, ANN THORAC SURG, V82, P1747, DOI 10.1016/j.athoracsur.2006.05.045; Lim E, 2006, J THORAC CARDIOV SUR, V132, P1409, DOI 10.1016/j.jtcvs.2006.08.012; MOODY DM, 1990, ANN NEUROL, V28, P477, DOI 10.1002/ana.410280403; Myers WO, 1999, J AM COLL CARDIOL, V33, P488, DOI 10.1016/S0735-1097(98)00563-4; Newman MF, 1996, CIRCULATION, V94, P74; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishiyama K, 2009, ANN THORAC SURG, V87, P1839, DOI 10.1016/j.athoracsur.2009.02.061; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Peel GK, 2004, J AM COLL CARDIOL, V43, P752, DOI 10.1016/j.jacc.2003.09.047; Puskas JD, 2008, ANN THORAC SURG, V86, P1139, DOI 10.1016/j.athoracsur.2008.05.073; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061; Sabik JF, 2004, ANN THORAC SURG, V77, P1315, DOI 10.1016/j.athoracsur.2003.08.056; Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.121975; SABIK JF, 1995, J THORAC CARDIOV SUR, V109, P885, DOI 10.1016/S0022-5223(95)70312-8; Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0; Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Society of Thoracic Surgeons National Adult Cardiac Database, SOC THOR SURG NAT AD; Stamou SC, 2001, STROKE, V32, P1508, DOI 10.1161/01.STR.32.7.1508; Svensson LG, 2004, ANN THORAC SURG, V78, P1274, DOI 10.1016/j.athoracsur.2004.04.063; Wilson MJ, 2000, ANN THORAC SURG, V70, P25, DOI 10.1016/S0003-4975(00)01256-X	34	215	227	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					381	390		10.1001/jama.2011.37	http://dx.doi.org/10.1001/jama.2011.37			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266685				2022-12-24	WOS:000286595200023
J	Kasten, MM; Clapier, CR; Cairns, BR				Kasten, Margaret M.; Clapier, Cedric R.; Cairns, Bradley R.			SnapShot: Chromatin Remodeling: SWI/SNF	CELL			English	Editorial Material							NUCLEOSOME COMPLEX		[Kasten, Margaret M.; Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, HHMI, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Kasten, MM (corresponding author), Univ Utah, HHMI, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Skiniotis G, 2007, J BIOL CHEM, V282, P20804, DOI 10.1074/jbc.C700081200; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3	10	34	38	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2								10.1016/j.cell.2011.01.007	http://dx.doi.org/10.1016/j.cell.2011.01.007			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241897	Bronze			2022-12-24	WOS:000286459900014
J	Murry, CE; Pu, WT				Murry, Charles E.; Pu, William T.			Reprogramming Fibroblasts into Cardiomyocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murry, Charles E.] Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Pu, William T.] Harvard Stem Cell Inst, Cambridge, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University	Murry, CE (corresponding author), Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.		Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, R01HL084642, RC1HL099618, U01HL100401] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL084642, U01 HL100401, R01 HL094683, RC1 HL099618] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					177	178		10.1056/NEJMcibr1013069	http://dx.doi.org/10.1056/NEJMcibr1013069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226585	Green Accepted			2022-12-24	WOS:000286142900015
J	Wilding, JPH; Hardy, K				Wilding, John P. H.; Hardy, Kevin			Therapeutics Glucagon-like peptide-1 analogues for type 2 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							METFORMIN-TREATED PATIENTS; TWICE-DAILY EXENATIDE; OPEN-LABEL TRIAL; GLYCEMIC CONTROL; RANDOMIZED-TRIAL; INSULIN GLARGINE; PARALLEL-GROUP; LIRAGLUTIDE; SULFONYLUREA; EXENDIN-4					j.p.h.wilding@liv.ac.uk	Wilding, John/ABB-6443-2020; Wilding, John PH/A-7106-2008	Wilding, John/0000-0003-2839-8404; Wilding, John PH/0000-0003-2839-8404				Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; BUSE JB, 2002, TECHN APPR NAT I HLT, V203; Buse JB, 2010, DIABETES CARE, V33, P1300, DOI 10.2337/dc09-2260; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; *MED HEALTHC PROD, 2009, DRUG SAF UPD, V2; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HLTH, V87; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Ratner RE, 2006, DIABETES OBES METAB, V8, P419, DOI 10.1111/j.1463-1326.2006.00589.x; Ray JA, 2007, CURR MED RES OPIN, V23, P609, DOI 10.1185/030079907X178685; Riddle MC, 2006, DIABETES-METAB RES, V22, P483, DOI 10.1002/dmrr.646; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Yoon NM, 2009, CLIN THER, V31, P1511, DOI 10.1016/j.clinthera.2009.07.021; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	23	17	22	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d410	10.1136/bmj.d410	http://dx.doi.org/10.1136/bmj.d410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325387				2022-12-24	WOS:000287656500015
J	Farzadfar, F; Finucane, MM; Danaei, G; Pelizzari, PM; Cowan, MJ; Paciorek, CJ; Singh, GM; Lin, JK; Stevens, GA; Riley, LM; Ezzati, M				Farzadfar, Farshad; Finucane, Mariel M.; Danaei, Goodarz; Pelizzari, Pamela M.; Cowan, Melanie J.; Paciorek, Christopher J.; Singh, Gitanjali M.; Lin, John K.; Stevens, Gretchen A.; Riley, Leanne M.; Ezzati, Majid		Global Burden Metab Risk Factors C	National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants	LANCET			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR RISK; 20-YEAR TRENDS; SECULAR TRENDS; PRIMARY-CARE; HYPERCHOLESTEROLEMIA; PREVALENCE	Background Data for trends in serum cholesterol are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. Previous analyses of trends in serum cholesterol were limited to a few countries, with no consistent and comparable global analysis. We estimated worldwide trends in population mean serum total cholesterol. Methods We estimated trends and their uncertainties in mean serum total cholesterol for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (321 country-years and 3.0 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean total cholesterol by age, country, and year, accounting for whether a study was nationally representative. Findings In 2008, age-standardised mean total cholesterol worldwide was 4.64 mmol/L (95% uncertainty interval 4.51-4.76) for men and 4.76 mmol/L (4.62-4.91) for women. Globally, mean total cholesterol changed little between 1980 and 2008, falling by less than 0.1 mmol/L per decade in men and women. Total cholesterol fell in the high-income region consisting of Australasia, North America, and western Europe, and in central and eastern Europe; the regional declines were about 0.2 mmol/L per decade for both sexes, with posterior probabilities of these being true declines 0.99 or greater. Mean total cholesterol increased in east and southeast Asia and Pacific by 0.08 mmol/L per decade (-0.06 to 0.22, posterior probability=0.86) in men and 0.09 mmol/L per decade (-0.07 to 0.26, posterior probability=0.86) in women. Despite converging trends, serum total cholesterol in 2008 was highest in the high. income region consisting of Australasia, North America, and western Europe; the regional mean was 5.24 mmol/L (5.08-5.39) for men and 5.23 mmol/L (5.03-5.43) for women. It was lowest in sub-Saharan Africa at 4.08 mmol/L (3.82-4.34) for men and 4.27 mmol/L (3.99-4.56) for women. Interpretation Nutritional policies and pharmacological interventions should be used to accelerate improvements in total cholesterol in regions with decline and to curb or prevent the rise in Asian populations and elsewhere. Population-based surveillance of cholesterol needs to be improved in low-income and middle-income countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Farzadfar, Farshad; Singh, Gitanjali M.; Lin, John K.; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Pelizzari, Pamela M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Miranda, J. Jaime/A-8482-2008; Cífková, Renata/O-5731-2017; Danaei, Goodarz/B-6085-2008; Bovet, Pascal/F-4477-2011; Colaus, PsyColaus/K-6607-2013; Rampal, Sanjay/B-9691-2010; Thomas, G. Neil/A-1879-2013; VOLPATO, STEFANO/H-2977-2014; Panza, Francesco/M-6804-2017; Chen, Chien-Jen/N-4723-2019; Castetbon, Katia/F-2686-2017; Bjerregaard, Peter/ABD-8894-2020; You, Qisheng/AAG-7153-2020; Lim, Stephen S/B-4055-2012; Panza, Francesco/Y-2539-2019; Nsour, Mohannad Al/ABE-8741-2020; Marques-Vidal, Pedro/C-9449-2009	Miranda, J. Jaime/0000-0002-4738-5468; Cífková, Renata/0000-0003-2765-3821; Bovet, Pascal/0000-0002-0242-4259; Rampal, Sanjay/0000-0002-0105-6407; Thomas, G. Neil/0000-0002-2777-1847; VOLPATO, STEFANO/0000-0003-4335-6034; Panza, Francesco/0000-0002-7220-0656; Bjerregaard, Peter/0000-0001-7153-8447; You, Qisheng/0000-0003-0743-7320; Panza, Francesco/0000-0002-7220-0656; Nsour, Mohannad Al/0000-0003-1212-1611; Woodward, Mark/0000-0001-9800-5296; Marques-Vidal, Pedro/0000-0002-4548-8500; Lin, John/0000-0003-2490-4453; Eggertsen, Robert/0000-0003-3807-3769; Farzadfar, Farshad/0000-0001-8288-4046; Pelizzari, Pamela/0000-0002-6992-9462; LIN, HSIEN-HO/0000-0002-7481-6016	Harvard University; Bill & Melinda Gates Foundation; WHO; Medical Research Council [G0801056B] Funding Source: researchfish	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; awes CMM, 2003, COMP QUANTIFICATION, P391; Ben Romdhane Habiba, 2005, Tunis Med, V83 Suppl 5, P8; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Bowden RG, 2006, PUBLIC HEALTH, V120, P572, DOI 10.1016/j.puhe.2006.03.005; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; COHN JS, 1988, CLIN CHEM, V34, P2456; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HOFFMEISTER H, 1994, PREV MED, V23, P197, DOI 10.1006/pmed.1994.1027; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; JOOSSENS JV, 1977, LANCET, V1, P1069; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; KEYS A, 1975, ATHEROSCLEROSIS, V22, P149, DOI 10.1016/0021-9150(75)90001-5; Khoo KL, 2003, ATHEROSCLEROSIS, V169, P1, DOI 10.1016/S0021-9150(03)00009-1; KNUIMAN JT, 1982, AM J EPIDEMIOL, V116, P631, DOI 10.1093/oxfordjournals.aje.a113446; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; LABARTHE DR, 1991, ANN NY ACAD SCI, V623, P108, DOI 10.1111/j.1749-6632.1991.tb43722.x; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Law M, 2000, AM J CLIN NUTR, V72, p1291S, DOI 10.1093/ajcn/72.5.1291s; LAW MR, 1994, EUR J CLIN NUTR, V48, P305; Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; OKAYAMA A, 1995, J CLIN EPIDEMIOL, V48, P329, DOI 10.1016/0895-4356(94)00146-H; OKAYAMA A, 1993, INT J EPIDEMIOL, V22, P1038, DOI 10.1093/ije/22.6.1038; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; SJOL A, 1991, INT J EPIDEMIOL, V20, P105, DOI 10.1093/ije/20.1.105; Steinhagen-Thiessen E, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-31; Sun Jia-yi, 2006, Zhonghua Nei Ke Za Zhi, V45, P980; Tolonen H, 2005, INT J EPIDEMIOL, V34, P181, DOI 10.1093/ije/dyi056; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; WILSON PWF, 1989, AM J MED, V87, pS5, DOI 10.1016/S0002-9343(89)80593-5; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	47	418	433	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					578	586		10.1016/S0140-6736(10)62038-7	http://dx.doi.org/10.1016/S0140-6736(10)62038-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724DQ	21295847				2022-12-24	WOS:000287556700028
J	Ives, A; Ronet, C; Prevel, F; Ruzzante, G; Fuertes-Marraco, S; Schutz, F; Zangger, H; Revaz-Breton, M; Lye, LF; Hickerson, SM; Beverley, SM; Acha-Orbea, H; Launois, P; Fasel, N; Masina, S				Ives, Annette; Ronet, Catherine; Prevel, Florence; Ruzzante, Giulia; Fuertes-Marraco, Silvia; Schutz, Frederic; Zangger, Haroun; Revaz-Breton, Melanie; Lye, Lon-Fye; Hickerson, Suzanne M.; Beverley, Stephen M.; Acha-Orbea, Hans; Launois, Pascal; Fasel, Nicolas; Masina, Slavica			Leishmania RNA Virus Controls the Severity of Mucocutaneous Leishmaniasis	SCIENCE			English	Article							MUCOSAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; INNATE IMMUNITY; BRAZILIENSIS; PATHOGENESIS; EXPRESSION; RESISTANCE; EVOLUTION; INFECTION; PARASITES	Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with chronic inflammation. Currently, the mechanisms involved in lesion development are poorly understood. Here we show that metastasizing parasites have a high Leishmania RNA virus-1 (LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune responses rendered mice more susceptible to infection, and the animals developed an increased footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host immune response to Leishmania and promoted parasite persistence.	[Ives, Annette; Ronet, Catherine; Prevel, Florence; Ruzzante, Giulia; Fuertes-Marraco, Silvia; Zangger, Haroun; Revaz-Breton, Melanie; Acha-Orbea, Hans; Fasel, Nicolas; Masina, Slavica] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Schutz, Frederic] Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Dorigny, Switzerland; [Lye, Lon-Fye; Hickerson, Suzanne M.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Launois, Pascal] WHO Immunol Res & Training Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Washington University (WUSTL)	Fasel, N (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	nicolas.fasel@unil.ch	Ronet, Catherine/O-6866-2017; Fasel, Nicolas/O-4253-2016; Marraco, Silvia A Fuertes/I-2481-2014	Ronet, Catherine/0000-0003-1479-2873; Fasel, Nicolas/0000-0003-0136-7245; Ives, Annette/0000-0002-7407-960X; Beverley, Stephen/0000-0001-5319-0811; Fuertes Marraco, Silvia A/0000-0002-3456-3317	FNRS [3100A0-116665/1, 310030-120325]; Foundation Pierre Mercier; NIH [A129646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029646] Funding Source: NIH RePORTER	FNRS(Fonds de la Recherche Scientifique - FNRS); Foundation Pierre Mercier; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to N. Saravia (CIDEIM, Colombia) and Instituto Oswaldo Cruz, for L. guyanensis strains; S. Akira (Frontier Research center, Osaka University), P. Romero (LICR, Lausanne), and B. Ryffel (CNRS, Orleans) for knockout and mutant mice; M. Delorenzi (SIB, Lausanne) for bioinformatics expertise; F. Morgenthaler (Cellular Imaging Facility, Lausanne), S. Cawsey, and M.-A. Hartley for technical assistance; and J. Patterson and Y. T. Ro for the L.g. M4147 strains. This work was funded by FNRS grants 3100A0-116665/1 (N.F.) and 310030-120325 (P.L.), Foundation Pierre Mercier (S.M.), and NIH A129646 (S.M.B.). Microarray data are available within the Gene Expression Omnibus database (GSE21418) and at http://people.unil.ch/nicolasfasel/data-from-fasels-lab/.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; BARRAL A, 1995, AM J TROP MED HYG, V53, P256, DOI 10.4269/ajtmh.1995.53.256; BARRAL A, 1995, AM J PATHOL, V147, P947; Ben-Othman R, 2008, MOL IMMUNOL, V45, P3222, DOI 10.1016/j.molimm.2008.02.019; Blackwell JM, 1999, PARASITOL TODAY, V15, P73, DOI 10.1016/S0169-4758(98)01355-6; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; CADD TL, 1993, J VIROL, V67, P5647, DOI 10.1128/JVI.67.9.5647-5650.1993; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; GUILBRIDE L, 1992, MOL BIOCHEM PARASIT, V54, P101, DOI 10.1016/0166-6851(92)90099-6; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; MARTINEZ JE, 1992, T ROY SOC TROP MED H, V86, P392, DOI 10.1016/0035-9203(92)90233-3; Martinez JE, 2000, J PARASITOL, V86, P792, DOI 10.1645/0022-3395(2000)086[0792:CDITEA]2.0.CO;2; Ogg MM, 2003, AM J TROP MED HYG, V69, P309, DOI 10.4269/ajtmh.2003.69.309; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; REY JA, 1990, AM J TROP MED HYG, V43, P623, DOI 10.4269/ajtmh.1990.43.623; Ro YT, 1997, J VIROL, V71, P8991, DOI 10.1128/JVI.71.12.8991-8998.1997; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; TRAVI B, 1988, J PARASITOL, V74, P1059, DOI 10.2307/3282237; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Vergel C, 2006, J INFECT DIS, V194, P503, DOI 10.1086/505583; Weigle K, 1996, CLIN DERMATOL, V14, P433, DOI 10.1016/0738-081X(96)00036-3; WIDMER G, 1989, P NATL ACAD SCI USA, V86, P5979, DOI 10.1073/pnas.86.15.5979	30	250	258	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					775	778		10.1126/science.1199326	http://dx.doi.org/10.1126/science.1199326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311023	Green Accepted, Green Submitted			2022-12-24	WOS:000287205700072
J	Bjorndal, KA; Bowen, BW; Chaloupka, M; Crowder, LB; Heppell, SS; Jones, CM; Lutcavage, ME; Policansky, D; Solow, AR; Witherington, BE				Bjorndal, Karen A.; Bowen, Brian W.; Chaloupka, Milani; Crowder, Larry B.; Heppell, Selina S.; Jones, Cynthia M.; Lutcavage, Molly E.; Policansky, David; Solow, Andrew R.; Witherington, Blair E.			Better Science Needed for Restoration in the Gulf of Mexico	SCIENCE			English	Editorial Material							LOGGERHEAD SEA-TURTLE; CLIMATE-CHANGE; POPULATION; ECOSYSTEMS; MARINE; ECOLOGISTS		[Bjorndal, Karen A.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA; [Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Chaloupka, Milani] Univ Queensland, Ecol Modelling Serv Pty Ltd, St Lucia, Qld 4067, Australia; [Crowder, Larry B.] Duke Univ, Marine Lab, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Heppell, Selina S.] Oregon State Univ, Dept Wildlife & Fisheries, Corvallis, OR 97331 USA; [Jones, Cynthia M.] Old Dominion Univ, Ctr Quantitat Fisheries Ecol, Norfolk, VA 23529 USA; [Lutcavage, Molly E.] Univ Massachusetts, Dept Environm Conservat, Large Pelag Res Ctr, Gloucester, MA 01930 USA; [Policansky, David] CNR, Washington, DC 20001 USA; [Witherington, Blair E.] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL 32951 USA; [Solow, Andrew R.] Woods Hole Oceanog Inst, Marine Policy Ctr, Woods Hole, MA 02543 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Hawaii System; University of Queensland; Duke University; Oregon State University; Old Dominion University; University of Massachusetts System; Florida Fish & Wildlife Conservation Commission; Woods Hole Oceanographic Institution	Bjorndal, KA (corresponding author), Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA.	bjorndal@ufl.edu		Bjorndal, Karen/0000-0002-6286-1901				Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 2011, FRONT ECOL ENVIRON, V9, P295, DOI 10.1890/090126; BOWEN BW, 1994, SCIENCE, V266, P713, DOI 10.1126/science.7973619; BOWEN BW, 1996, NOAA TECH MEMO NMFS, V396, P1; *BP, FUNDS BP INCLUDE  50; Carr MH, 2003, ECOL APPL, V13, pS90; Chaloupka M, 2003, LOGGERHEAD SEA TURTL, P274; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Ellison AM, 2010, FRONT ECOL ENVIRON, V8, P362, DOI 10.1890/080209; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Graham B., 2011, NATL COMMISSION BP D; Harrison A., 2006, CONNECTIVITY CONSERV, V14, P213; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoekstra JM, 2002, ECOL APPL, V12, P630, DOI 10.2307/3060971; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; LIMPUS CJ, 2010, CHALOUPKA LED DATA C; Lutcavage Molly E., 1997, P387; *NAT RES COUNC, 2010, ASS SEA IURTL STAT T; Nielsen J.L., 2009, TAGGING TRACKING MAR, V9; *OC POL TASK FORC, 2010, FIN REC INT OC POL T; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1	27	56	61	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					537	538		10.1126/science.1199935	http://dx.doi.org/10.1126/science.1199935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292956				2022-12-24	WOS:000286933600030
J	Cole-Turner, R				Cole-Turner, Ronald			What Defines Us?	SCIENCE			English	Editorial Material									Pittsburgh Theol Seminary, Pittsburgh, PA USA		Cole-Turner, R (corresponding author), Pittsburgh Theol Seminary, Pittsburgh, PA USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203070	http://dx.doi.org/10.1126/science.1203070			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292967				2022-12-24	WOS:000286933600041
J	Gibbs, RA				Gibbs, Richard A.			Bringing Genomics and Genetics Back Together	SCIENCE			English	Editorial Material									[Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Gibbs, RA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003273] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203017	http://dx.doi.org/10.1126/science.1203017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292968	Green Accepted			2022-12-24	WOS:000286933600043
J	Zhang, ZH; Pugh, BF				Zhang, Zhenhai; Pugh, B. Franklin			High-Resolution Genome-wide Mapping of the Primary Structure of Chromatin	CELL			English	Review							POSITIONS IN-VIVO; NUCLEOSOME POSITIONS; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; DNA INTERACTIONS; GENE-EXPRESSION; STEM-CELLS; LIFE-SPAN; YEAST; IDENTIFICATION		[Zhang, Zhenhai; Pugh, B. Franklin] Penn State Univ, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG004160, R01 HG004160-04, R01 HG004160, R01 HG004160-05] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Fragoso G, 1997, METHODS, V11, P246, DOI 10.1006/meth.1996.0411; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GEOCKS J, 2010, GENOME BIOL, V11, P86; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guarente L, 2000, GENE DEV, V14, P1021; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Rando OJ, 2010, METHOD ENZYMOL, V470, P105, DOI 10.1016/S0076-6879(10)70005-7; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	51	112	117	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					175	186		10.1016/j.cell.2011.01.003	http://dx.doi.org/10.1016/j.cell.2011.01.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241889	Green Accepted, Bronze			2022-12-24	WOS:000286459900004
J	Notta, F; Mullighan, CG; Wang, JCY; Poeppl, A; Doulatov, S; Phillips, LA; Ma, J; Minden, MD; Downing, JR; Dick, JE				Notta, Faiyaz; Mullighan, Charles G.; Wang, Jean C. Y.; Poeppl, Armando; Doulatov, Sergei; Phillips, Letha A.; Ma, Jing; Minden, Mark D.; Downing, James R.; Dick, John E.			Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; INTRAFEMORAL TRANSPLANTATION; PANCREATIC-CANCER; CLONAL EVOLUTION; NUMBER; GENOME; HETEROGENEITY; DELETION; ENGRAFTMENT; METASTASIS	Many tumours are composed of genetically diverse cells; however, little is known about how diversity evolves or the impact that diversity has on functional properties. Here, using xenografting and DNA copy number alteration (CNA) profiling of human BCR-ABL1 lymphoblastic leukaemia, we demonstrate that genetic diversity occurs in functionally defined leukaemia-initiating cells and that many diagnostic patient samples contain multiple genetically distinct leukaemia-initiating cell subclones. Reconstructing the subclonal genetic ancestry of several samples by CNA profiling demonstrated a branching multi-clonal evolution model of leukaemogenesis, rather than linear succession. For some patient samples, the predominant diagnostic clone repopulated xenografts, whereas in others it was outcompeted by minor subclones. Reconstitution with the predominant diagnosis clone was associated with more aggressive growth properties in xenografts, deletion of CDKN2A and CDKN2B, and a trend towards poorer patient outcome. Our findings link clonal diversity with leukaemia-initiating-cell function and underscore the importance of developing therapies that eradicate all intratumoral subclones.	[Notta, Faiyaz; Wang, Jean C. Y.; Poeppl, Armando; Doulatov, Sergei; Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Notta, Faiyaz; Doulatov, Sergei; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Mullighan, Charles G.; Phillips, Letha A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Wang, Jean C. Y.; Minden, Mark D.] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada; [Wang, Jean C. Y.; Minden, Mark D.] Univ Toronto, Dept Med, Toronto, ON M5G 2M9, Canada; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; St Jude Children's Research Hospital	Dick, JE (corresponding author), Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Mullighan, Charles/H-3253-2011; Downing, James R./N-8102-2018	Mullighan, Charles/0000-0002-1871-1850; Wang, Jean/0000-0001-7543-3917; Dick, John/0000-0002-9527-8317	Canadian Institutes for Health Research (CIHR); Pew Charitable Trusts; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society; Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society; Canadian Institutes for Health Research; Canada Research Chair; American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pew Charitable Trusts; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We would like to thank S. Minkin for statistical analysis of patient outcome, the Dick Laboratory and B. Neel for critical review of this manuscript, M. Cooper for editorial assistance, and P. A. Penttila, L. Jamieson, J. Yuan and S. Zhao for preparative flow cytometry. This work was supported by funds from Canadian Institutes for Health Research (CIHR) studentships (F.N., S.D.), the Pew Charitable Trusts (C.G.M.), The Stem Cell Network of Canadian National Centres of Excellence, the Canadian Cancer Society and the Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, the Leukemia and Lymphoma Society, the Canadian Institutes for Health Research, a Canada Research Chair, and the American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li AH, 2003, BLOOD, V102, P4520, DOI 10.1182/blood-2003-05-1455; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	34	360	374	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					362	+		10.1038/nature09733	http://dx.doi.org/10.1038/nature09733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248843				2022-12-24	WOS:000286385600044
J	Coureuil, M; Lecuyer, H; Scott, MGH; Boularan, C; Enslen, H; Soyer, M; Mikaty, G; Bourdoulous, S; Nassif, X; Marullo, S				Coureuil, Mathieu; Lecuyer, Herve; Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Soyer, Magali; Mikaty, Guillain; Bourdoulous, Sandrine; Nassif, Xavier; Marullo, Stefano			Meningococcus Hijacks a beta 2-Adrenoceptor/beta-Arrestin Pathway to Cross Brain Microvasculature Endothelium	CELL			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; NEISSERIA-MENINGITIDIS; TYROSINE-KINASE; BETA-ARRESTINS; IV PILI; ACTIVATION; BARRIER; ADHESION; INVASION; CELLS	Following pilus-mediated adhesion to human brain endothelial cells, meningococcus (N. meningitidis), the bacterium causing cerebrospinal meningitis, initiates signaling cascades, which eventually result in the opening of intercellular junctions, allowing meningeal colonization. The signaling receptor activated by the pathogen remained unknown. We report that N. meningitidis specifically stimulates a biased beta 2-adrenoceptor/beta-arrestin signaling pathway in endothelial cells, which ultimately traps beta-arrestin-interacting partners, such as the Src tyrosine kinase and junctional proteins, under bacterial colonies. Cytoskeletal reorganization mediated by beta-arrestinactivated Src stabilizes bacterial adhesion to endothelial cells, whereas beta-arrestin-dependent delocalization of junctional proteins results in anatomical gaps used by bacteria to penetrate into tissues. Activation of beta-adrenoceptor endocytosis with specific agonists prevents signaling events downstream of N. meningitidis adhesion and inhibits bacterial crossing of the endothelial barrier. The identification of the mechanism used for hijacking host cell signaling machineries opens perspectives for treatment and prevention of meningococcal infection.	[Coureuil, Mathieu; Lecuyer, Herve; Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Soyer, Magali; Mikaty, Guillain; Bourdoulous, Sandrine; Nassif, Xavier; Marullo, Stefano] Univ Paris 05, Fac Med, F-75006 Paris, France; [Coureuil, Mathieu; Lecuyer, Herve; Mikaty, Guillain; Nassif, Xavier] INSERM, U1002, Paris, France; [Lecuyer, Herve; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Bourdoulous, Sandrine; Marullo, Stefano] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Bourdoulous, Sandrine; Marullo, Stefano] INSERM, U1016, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marullo, S (corresponding author), Univ Paris 05, Fac Med, F-75006 Paris, France.	stefano.marullo@inserm.fr	Marullo, Stefano/C-6142-2008; Enslen, Hervé/M-3400-2017; Coureuil, Mathieu/D-4793-2017; Enslen, Hervé/AAH-4492-2021; Scott, Mark/R-3521-2019	Marullo, Stefano/0000-0001-9604-9973; Enslen, Hervé/0000-0001-9741-5293; Coureuil, Mathieu/0000-0001-7655-9685; Enslen, Hervé/0000-0001-9741-5293; Nassif, Xavier/0000-0003-2855-3240; Scott, Mark G.H./0000-0002-1557-1856	Fondation pour la Recherche Medicale; AXA; Association pour la Recherche contre le Cancer [ARC-4954];  [ANR-09-BLAN-0137-03];  [ANR-07-BLAN-0072-01]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); AXA; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ; 	We thank Drs P.O. Couraud, R. Jockers, A. Benmerah, G. Bismuth, and G. Dumenil (Institut Cochin and Cardiovascular Research Center [G. D.], Paris) for reviewing the manuscript; M. Garfa-Traore, N. Goudin, and O. Duc of the Necker Institute imaging facility for their technical support; and G. Guilbaud for advice and technical assistance. M. C. was supported by fellowships of the Fondation pour la Recherche Medicale and of the AXA Research Fund. This work was supported by a collaboration study grant (ANR-09-BLAN-0137-03) to S. B., X. N., and S. M., the ANR-07-BLAN-0072-01 grant to S. M., and a grant from the Association pour la Recherche contre le Cancer (ARC-4954) to M.G.H.S.	Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Benmerah A, 1999, J CELL SCI, V112, P1303; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eugene E, 2002, J CELL SCI, V115, P1231; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Martin MC, 2008, EMERG INFECT DIS, V14, P1672, DOI 10.3201/eid1410.080118; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje	36	138	145	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1149	1160		10.1016/j.cell.2010.11.035	http://dx.doi.org/10.1016/j.cell.2010.11.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183077	Green Submitted, Bronze			2022-12-24	WOS:000285625400012
J	Gallio, M; Ofstad, TA; Macpherson, LJ; Wang, JW; Zuker, CS				Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.			The Coding of Temperature in the Drosophila Brain	CELL			English	Article							MICE LACKING; TRP CHANNEL; CAPSAICIN-RECEPTOR; ION-CHANNEL; EXPRESSION; HEAT; MECHANISMS; NEURONS; THERMOSENSATION; HYGROSENSATION	Thermosensation is an indispensable sensory modality. Here, we study temperature coding in Drosophila, and show that temperature is represented by a spatial map of activity in the brain. First, we identify TRP channels that function in the fly antenna to mediate the detection of cold stimuli. Next, we identify the hot-sensing neurons and show that hot and cold antennal receptors project onto distinct, but adjacent glomeruli in the Proximal-Antennal-Protocerebrum (PAP) forming a thermotopic map in the brain. We use two-photon imaging to reveal the functional segregation of hot and cold responses in the PAP, and show that silencing the hot-or cold-sensing neurons produces animals with distinct and discrete deficits in their behavioral responses to thermal stimuli. Together, these results demonstrate that dedicated populations of cells orchestrate behavioral responses to different temperature stimuli, and reveal a labeled-line logic for the coding of temperature information in the brain.	[Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, Columbia Coll Phys & Surg, New York, NY 10032 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Zuker, Charles S.] Columbia Univ, Dept Neurosci, Howard Hughes Med Inst, Columbia Coll Phys & Surg, New York, NY 10032 USA; [Ofstad, Tyler A.; Zuker, Charles S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA.	cz2195@columbia.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Gallio, Marco/0000-0003-2132-0639; Macpherson, Lindsey/0000-0002-1089-3733	Wenner-Grens Stiftelse; Human Frontiers Science Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597] Funding Source: NIH RePORTER	Wenner-Grens Stiftelse; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Cahir O'Kane for UAS-TeNT flies; Paul Garrity for dTRPA1<SUP>KO</SUP> flies; and especially Michael Reiser for invaluable help with designing and implementing the behavioral arenas and assays. We also thank David Julius and Avi Priel for their help and kindness hosting us (M. G.) in our efforts to express Brv channels in Xenopus oocytes. Wilson Kwan, George Gallardo, and Lisa Ha provided expert help with fly husbandry. We are grateful to Hojoon Lee, Dimitri Trankner, and Robert Barretto for help with experiments and data analysis; and Nick Ryba, Michael Reiser, and members of the Zuker lab for critical comments on the manuscript. We also thank Kevin Moses, Gerry Rubin, and the Janelia Farm Visitor Program. M. G. was supported by a Wenner-Grens Stiftelse and a Human Frontiers Science Program long term fellowship. L.J.M. is a fellow of the Jane Coffin Childs Foundation. C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farm Research Campus. Author contributions: M. G. and C.S.Z. conceived all the experiments and wrote the paper. M. G. performed all the experiments presented in this paper, except the in situ hybridizations (T.A.O.). T.A.O. also helped with the set up for 2-choice behavioral assays, and J.W.W. helped design and setup the custom imaging system. L.J.M., M. G., and T.A.O. carried out extensive efforts to heterologously express Brv channels (data not shown).	ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Darian-Smith I.D.R.W., 1971, PERIPHERAL NEURAL ME; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Guler AD, 2002, J NEUROSCI, V22, P6408; Ha TS, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.010.2009; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hensel H, 1981, THERMORECEPTION TEMP; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; McKemy D.D., 2007, TEMPERATURE SENSING; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Plant T. D., 2007, V179, P189; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Till BJ, 2003, METH MOL B, V236, P205; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	58	162	164	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					614	624		10.1016/j.cell.2011.01.028	http://dx.doi.org/10.1016/j.cell.2011.01.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335241	Bronze, Green Accepted			2022-12-24	WOS:000287473100015
J	Xian, Y; Holloway, RG; Chan, PS; Noyes, K; Shah, MN; Ting, HH; Chappel, AR; Peterson, ED; Friedman, B				Xian, Ying; Holloway, Robert G.; Chan, Paul S.; Noyes, Katia; Shah, Manish N.; Ting, Henry H.; Chappel, Andre R.; Peterson, Eric D.; Friedman, Bruce			Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; REDUCE MORTALITY; TRAUMA CENTERS; CARE; OUTCOMES; QUALITY; COMPARE; DISEASE; BIAS	Context Although stroke centers are widely accepted and supported, little is known about their effect on patient outcomes. Objective To examine the association between admission to stroke centers for acute ischemic stroke and mortality. Design, Setting, and Participants Observational study using data from the New York Statewide Planning and Research Cooperative System. We compared mortality for patients admitted with acute ischemic stroke (n = 30 947) between 2005 and 2006 at designated stroke centers and nondesignated hospitals using differential distance to hospitals as an instrumental variable to adjust for potential prehospital selection bias. Patients were followed up for mortality for 1 year after the index hospitalization through 2007. To assess whether our findings were specific to stroke, we also compared mortality for patients admitted with gastrointestinal hemorrhage (n = 39 409) or acute myocardial infarction (n = 40 024) at designated stroke centers and nondesignated hospitals. Main Outcome Measure Thirty-day all-cause mortality. Results Among 30 947 patients with acute ischemic stroke, 15 297 (49.4%) were admitted to designated stroke centers. Using the instrumental variable analysis, admission to designated stroke centers was associated with lower 30-day all-cause mortality (10.1% vs 12.5%; adjusted mortality difference, -2.5%; 95% confidence interval [CI], -3.6% to -1.4%; P<.001) and greater use of thrombolytic therapy (4.8% vs 1.7%; adjusted difference, 2.2%; 95% CI, 1.6% to 2.8%; P<.001). Differences in mortality also were observed at 1-day, 7-day, and 1-year follow-up. The outcome differences were specific for stroke, as stroke centers and nondesignated hospitals had similar 30-day all-cause mortality rates among those with gastrointestinal hemorrhage (5.0% vs 5.8%; adjusted mortality difference, +0.3%; 95% CI, -0.5% to 1.0%; P=.50) or acute myocardial infarction (10.5% vs 12.7%; adjusted mortality difference, +0.1%; 95% CI, -0.9% to 1.1%; P=.83). Conclusion Among patients with acute ischemic stroke, admission to a designated stroke center was associated with modestly lower mortality and more frequent use of thrombolytic therapy. JAMA. 2011;305(4):373-380 www.jama.com	[Xian, Ying; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27705 USA; [Holloway, Robert G.; Noyes, Katia; Shah, Manish N.; Chappel, Andre R.; Friedman, Bruce] Univ Rochester, Rochester, NY USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Ting, Henry H.] Mayo Clin, Rochester, MN USA	Duke University; University of Rochester; Saint Luke's Mid America Heart Institute; Mayo Clinic	Xian, Y (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	ying.xian@duke.edu	Peterson, Eric David/ABF-5033-2021; Xian, Ying/O-1956-2019	Xian, Ying/0000-0002-1237-1162; Shah, Manish/0000-0001-6331-1074	Schering Plough; Bristol-Myers Squibb; Merck/Schering Plough; Sanofi Aventis; Saint Judes; American Heart Association (AHA) [0815772D]; Agency for Healthcare Research and Quality (AHRQ) [U18HS016964]; National Heart, Lung, and Blood Institute [K23HL102224]; National Institute on Aging [1K23AG028942]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028942] Funding Source: NIH RePORTER	Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck/Schering Plough(Merck & CompanySchering Plough Corporation); Sanofi Aventis(Sanofi-Aventis); Saint Judes; American Heart Association (AHA)(American Heart Association); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Holloway reported being a consultant for Milliman Guidelines, reviewing neurology guidelines. Dr Peterson reported receiving research grants from Schering Plough, Bristol-Myers Squibb, Merck/Schering Plough, Sanofi Aventis, and Saint Judes and being a consultant/advisory board member to Pfizer and Bayer Corp. No other disclosures were reported.; This study was funded in part by a predoctoral fellowship 0815772D from the American Heart Association (AHA) Founders Affiliate (Dr Xian). This study received infrastructure support from the Agency for Healthcare Research and Quality (AHRQ) (U18HS016964). Dr Chan is supported by a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute. Dr Shah is supported by the Paul B. Beeson Career Development Award (National Institute on Aging 1K23AG028942).	Agency for Healthcare Research and Quality, 2006, INP QUAL IND OV; Alberts MJ, 2010, STROKE, V41, P1100, DOI 10.1161/STROKEAHA.110.582148; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; [Anonymous], NEW YORK STATE EMT A; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Beck CA, 2003, HEALTH SERV RES, V38, P1423, DOI 10.1111/j.1475-6773.2003.00186.x; Bhattacharya J, 2006, STAT MED, V25, P389, DOI 10.1002/sim.2226; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; Douglas VC, 2005, NEUROLOGY, V64, P422, DOI 10.1212/01.WNL.0000150903.38639.E1; Fonarow GC, 2010, CIRCULATION, V122, P2459, DOI 10.1161/CIR.0b013e3182011a81; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Goldstein LB, 2003, NEUROLOGY, V61, P792, DOI 10.1212/01.WNL.0000082724.77447.3A; Greene W., 2003, ECONOMETRIC ANAL; Gropen TI, 2006, NEUROLOGY, V67, P88, DOI 10.1212/01.wnl.0000223622.13641.6d; Holloway RG, 2007, JAMA-J AM MED ASSOC, V298, P802, DOI 10.1001/jama.298.7.802; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lattimore SU, 2003, STROKE, V34, pE55, DOI 10.1161/01.STR.0000073789.12120.F3; Lichtman JH, 2009, STROKE, V40, pE127; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Meretoja A, 2010, STROKE, V41, pE361; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pracht EE, 2007, MED CARE RES REV, V64, P83, DOI 10.1177/1077558706296241; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Stradling D, 2007, NEUROLOGY, V68, P469, DOI 10.1212/01.wnl.0000252930.82140.65; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; U.S. Department of Agriculture, MEAS RUR RUR URB COM; *US DEP HHS, HOSP COMP	31	234	235	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					373	380		10.1001/jama.2011.22	http://dx.doi.org/10.1001/jama.2011.22			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711MH	21266684	Green Accepted, Bronze			2022-12-24	WOS:000286595200022
J	Kessler, JD; Valentine, DL; Redmond, MC; Du, MR; Chan, EW; Mendes, SD; Quiroz, EW; Villanueva, CJ; Shusta, SS; Werra, LM; Yvon-Lewis, SA; Weber, TC				Kessler, John D.; Valentine, David L.; Redmond, Molly C.; Du, Mengran; Chan, Eric W.; Mendes, Stephanie D.; Quiroz, Erik W.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.; Yvon-Lewis, Shari A.; Weber, Thomas C.			A Persistent Oxygen Anomaly Reveals the Fate of Spilled Methane in the Deep Gulf of Mexico	SCIENCE			English	Article							OXIDATION; HYDRATE; CARBON; DISSOCIATION; INPUT	Methane was the most abundant hydrocarbon released during the 2010 Deepwater Horizon oil spill in the Gulf of Mexico. Beyond relevancy to this anthropogenic event, this methane release simulates a rapid and relatively short-term natural release from hydrates into deep water. Based on methane and oxygen distributions measured at 207 stations throughout the affected region, we find that within similar to 120 days from the onset of release similar to 3.0 x 10(10) to 3.9 x 10(10) moles of oxygen were respired, primarily by methanotrophs, and left behind a residual microbial community containing methanotrophic bacteria. We suggest that a vigorous deepwater bacterial bloom respired nearly all the released methane within this time, and that by analogy, large-scale releases of methane from hydrate in the deep ocean are likely to be met by a similarly rapid methanotrophic response.	[Kessler, John D.; Du, Mengran; Chan, Eric W.; Yvon-Lewis, Shari A.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Quiroz, Erik W.] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX 77843 USA; [Weber, Thomas C.] Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Texas A&M University System; Texas A&M University College Station; University System Of New Hampshire; University of New Hampshire	Kessler, JD (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	jkessler@ocean.tamu.edu; valentine@geol.ucsb.edu	Valentine, David/E-5594-2012; Weber, Thomas C/H-2428-2012; Kessler, John/U-6398-2017; du, mengran/AAO-7295-2021; Yvon-Lewis, Shari/E-4108-2012	Weber, Thomas C/0000-0001-8320-361X; Kessler, John/0000-0003-1097-6800; Yvon-Lewis, Shari/0000-0003-1378-8434; Valentine, David/0000-0001-5914-9107; du, meng ran/0000-0001-8862-5256; Redmond, Molly/0000-0003-4227-394X	NSF [OCE 1042650, OCE 0849246, OCE 1042097, OCE 0961725]; U.S. Department of Energy [DE-NT0005667]; NOAA; Consolidated Safety Services, Incorporated; Direct For Education and Human Resources [0806926] Funding Source: National Science Foundation; Division Of Human Resource Development [0929836] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Consolidated Safety Services, Incorporated; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division Of Human Resource Development(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	J.D.K. and D.L.V. contributed equally to this work. This research was supported by the NSF through grants OCE 1042650 and OCE 0849246 to J.D.K. and OCE 1042097 and OCE 0961725 to D.L.V. and by the U.S. Department of Energy (DE-NT0005667) to D.L.V. The August, September, and October expeditions were funded by NOAA through a contract with Consolidated Safety Services, Incorporated. We thank the officers and crew of the NOAA ship Pisces, as well as S. Joye, M. Heintz, C. Farwell, F. Kinnaman, K. Mouyard, T. Bryant, B. Pierce, A. Lee, R. Hansman, S. Socolofsky, L. Hu, F. Garcia Tigreros, T. Bianchi, X. Li, S. DiMarco, S. Bagby, G. Paradis, and the staff at Picarro Incorporated and Los Gatos Research Incorporated for valuable technical assistance and discussions. Sequences are available on GenBank, accession numbers HQ738556 to HQ733567, HQ433363 to HQ433432, and HQ652514 to HQ652537.	Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Brooks J. M., 1975, THESIS TEXAS A M U C; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; DEANGELIS MA, 1993, DEEP-SEA RES PT I, V40, P1169, DOI 10.1016/0967-0637(93)90132-M; Dickens, 2001, GEOPHYS MONOGR SER, V124, P19, DOI DOI 10.1029/GM124P0019; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Judd AG, 2002, GEOFLUIDS, V2, P109, DOI 10.1046/j.1468-8123.2002.00027.x; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Kessler JD, 2006, EARTH PLANET SC LETT, V243, P366, DOI 10.1016/j.epsl.2006.01.006; McGinnis DF, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003183; REEBURGH WS, 1991, DEEP-SEA RES, V38, pS1189; REEBURGH WS, 2003, TREATISE GEOCHEMISTR, V4, P65, DOI DOI 10.1016/B0-08-043751-6/04036-6; Rehder G, 2009, MAR CHEM, V114, P19, DOI 10.1016/j.marchem.2009.03.004; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Socolofsky SA, 2005, J HYDRAUL ENG, V131, P273, DOI 10.1061/(ASCE)0733-9429(2005)131:4(273); Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; U. S. Department of Energy, DEEPW HOR RESP; U. S. Geological Survey, 2010, DEEPW HOR MC252 GULF; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Valentine DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2633, DOI 10.1016/S0016-7037(01)00625-1; WARD BB, 1987, NATURE, V327, P226, DOI 10.1038/327226a0; Yvon-Lewis SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045928	24	343	351	7	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					312	315		10.1126/science.1199697	http://dx.doi.org/10.1126/science.1199697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21212320				2022-12-24	WOS:000286636300031
J	Deer, B				Deer, Brian			Secrets of the MMR scare The Lancet's two days to bury bad news	BRITISH MEDICAL JOURNAL			English	Editorial Material							STATEMENT											BARR R, 1996, PROPOSED PROTO UNPUB; CORRIGAN S, 2006, MAIL SUNDAY     0716; DEER B, IS WAKEFIELD CLUSTER; Deer B., 2006, SUNDAY TIMES 1231; DEER B, ROYAL FREE D HULL IN; DEER B, WALKERSMITH EXPLAINS; DEER B, 2004, SUNDAY TIMES    0222; Deer B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c5258; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c5347; FILIPEK PA, 1999, PEDIAT NEUROLOGY PRI; *GMC, A WAK DET SER PROF M; *GMC, J WALK DET SER PROF; *GMC, 2010, FITN PRACT PAN FIND; Hodgson H, 2004, LANCET, V363, P824, DOI 10.1016/S0140-6736(04)15711-5; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; HORTON R, 2010, PRESS GAZETTE    MAR, P19; Horton Richard C., 2003, 2 OPINION DOCTORS DI; LAURANCE J, 2004, INDEPENDENT     0229; *LEG AID BOARD, 1996, AUTH DO CONTR WORK; MEIKLE J, 2004, GUARDIAN        0224; Murch S, 2004, LANCET, V363, P821, DOI 10.1016/S0140-6736(04)15708-5; *U COLL LOND, 2010, FREED INF REQ 10045; Wakefield A, 2004, LANCET, V363, P823, DOI 10.1016/S0140-6736(04)15710-3; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Walker-Smith J, 2004, LANCET, V363, P822, DOI 10.1016/S0140-6736(04)15709-7; [No title captured]	26	32	34	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2011	342								c7001	10.1136/bmj.c7001	http://dx.doi.org/10.1136/bmj.c7001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OH	21245118				2022-12-24	WOS:000286600800018
J	Eikelboom, JW; Weitz, JI				Eikelboom, John W.; Weitz, Jeffrey I.			Therapeutics New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; DOUBLE-BLIND; ENOXAPARIN; RIVAROXABAN; PREVENTION; REPLACEMENT; THROMBIN					eikelbj@mcmaster.ca	Eikelboom, John/AAG-6117-2019; Weitz, Jeffrey/AAD-1929-2019	Eikelboom, John/0000-0003-4126-1285; Weitz, Jeffrey/0000-0002-1092-7550				[Anonymous], 2010, PROD MON PRAD; [Anonymous], 2008, PROD MON XAR; Apostolakis S, 2009, PHARMACOECONOMICS, V27, P793, DOI 10.2165/11313780-000000000-00000; Eikelboom JW, 2010, CIRCULATION, V121, P1523, DOI 10.1161/CIRCULATIONAHA.109.853119; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; McCullagh L, 2009, PHARMACOECONOMICS, V27, P829, DOI 10.2165/11313800-000000000-00000; National Institute for Health and Clinical Excellence, 2010, 92 NAT I HLTH CLIN E; Trkulja V, 2010, CROAT MED J, V51, P113, DOI 10.3325/cmj.2010.51.113; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758	17	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2011	342								c7270	10.1136/bmj.c7270	http://dx.doi.org/10.1136/bmj.c7270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OH	21245113				2022-12-24	WOS:000286600800014
J	Bai, G; Chivatakarn, O; Bonanomi, D; Lettieri, K; Franco, L; Xia, CH; Stein, E; Ma, L; Lewcock, JW; Pfaff, SL				Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Xia, Caihong; Stein, Elke; Ma, Le; Lewcock, Joseph W.; Pfaff, Samuel L.			Presenilin-Dependent Receptor Processing Is Required for Axon Guidance	CELL			English	Article							SONIC HEDGEHOG; SLIT PROTEINS; MICE LACKING; NETRIN-1; CHEMOATTRACTANT; CHEMOREPELLENTS; ATTRACTION; MECHANISMS; OUTGROWTH; BIOLOGY	The Alzheimer's disease-linked gene presenilin is required for intramembrane proteolysis of amyloid-beta precursor protein, contributing to the pathogenesis of neurodegeneration that is characterized by loss of neuronal connections, but the role of Presenilin in establishing neuronal connections is less clear. Through a forward genetic screen in mice for recessive genes affecting motor neurons, we identified the Columbus allele, which disrupts motor axon projections from the spinal cord. We mapped this mutation to the Presenilin-1 gene. Motor neurons and commissural interneurons in Columbus mutants lacking Presenilin-1 acquire an inappropriate attraction to Netrin produced by the floor plate because of an accumulation of DCC receptor fragments within the membrane that are insensitive to Slit/Robo silencing. Our findings reveal that Presenilin-dependent DCC receptor processing coordinates the interplay between Netrin/DCC and Slit/Robo signaling. Thus, Presenilin is a key neural circuit builder that gates the spatiotemporal pattern of guidance signaling, thereby ensuring neural projections occur with high fidelity.	[Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Lewcock, Joseph W.; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Lewcock, Joseph W.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Xia, Caihong; Ma, Le] Univ So Calif, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90089 USA; [Stein, Elke] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Southern California; Yale University	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu	Ma, Le/A-3733-2013; Bai, Ge/K-2608-2014; Stein, Elke/E-8107-2013; Bonanomi, Dario/K-3450-2016	Stein, Elke/0000-0001-8965-5692; Bonanomi, Dario/0000-0003-4517-1244; Ma, Le/0000-0003-2769-9416	National Institutes of Health through National Institute of Neurological Disorders and Stroke [R37NS037116]; Howard Hughes Medical Institute; NINDS [R37NS037116, P01NS031249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031249, R01NS054172, R01NS062047, R37NS037116] Funding Source: NIH RePORTER	National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Edward Koo for critical reading of the manuscript, Shane Andrews for assistance with imaging, and members of the Pfaff lab for advice and discussions on the experiments and manuscript. We are also grateful to Marc Tessier-Lavigne and Jie Shen for providing Netrin-1, DCC and PS1<SUP>fl/fl</SUP> mutant mice. We thank Roman Giger and Geetha Suresh for plasmids and Developmental Studies Hybridoma Bank for antibodies. These experiments were supported by National Institutes of Health Grant R37NS037116 through National Institute of Neurological Disorders and Stroke and the Howard Hughes Medical Institute. G.B., D.B., and K.L. are supported by the Howard Hughes Medical Institute. O.C. is supported by NINDS Grant R37NS037116. L.F. is supported by NINDS Grant P01NS031249. S.L.P. is a Howard Hughes Medical Institute Investigator.	Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Kandel E., 2000, PRINCIPLES NEURAL SC; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kim SK, 2005, FASEB J, V19, P157, DOI 10.1096/fj.05-4055fje; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Patel K, 2001, DEVELOPMENT, V128, P5031; Puschel AW, 1999, MECH DEVELOP, V83, P65, DOI 10.1016/S0925-4773(99)00035-0; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	38	89	90	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					106	118		10.1016/j.cell.2010.11.053	http://dx.doi.org/10.1016/j.cell.2010.11.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215373	Green Accepted, Bronze			2022-12-24	WOS:000285993600011
J	Tonelli, M; Muntner, P; Lloyd, A; Manns, BJ; James, MT; Klarenbach, S; Quinn, RR; Wiebe, N; Hemmelgarn, BR				Tonelli, Marcello; Muntner, Paul; Lloyd, Anita; Manns, Braden J.; James, Matthew T.; Klarenbach, Scott; Quinn, Robert R.; Wiebe, Natasha; Hemmelgarn, Brenda R.		Alberta Kidney Dis Network	Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; SERUM CREATININE; ADMINISTRATIVE DATA; GENERAL-POPULATION; PREVALENCE; MORTALITY; ALBERTA; INSUFFICIENCY; HYPERTENSION; PREDICTION	Background: The staging system for chronic kidney disease relies almost exclusively on estimated glomerular filtration rate (eGFR), although proteinuria is also associated with adverse outcomes. Objective: To validate a 5-category system for risk stratification based on the combination of eGFR and proteinuria. Design: Retrospective cohort study. Setting: A provincial laboratory registry in Alberta, Canada, and a representative sample of noninstitutionalized U.S. adults. Patients: A derivation data set of 474 521 adult outpatients, 2 independent internal validation cohorts with 51 356 and 460 623 patients, and an external validation cohort of 14 358 patients. Measurements: Glomerular filtration rate, estimated by using the Modification of Diet in Renal Disease Study equation, and proteinuria, measured by using urine albumin-to-creatinine ratio or dipstick urinalysis. Outcomes included all-cause mortality and a composite renal outcome of kidney failure or doubling of serum creatinine level. Results: Over a median follow-up of 38 months in the internal validation cohorts, higher risk categories (indicating lower eGFR or more proteinuria) were associated with a graded increase in the risk for the composite renal outcome. The projected number of U. S. adults assigned to risk categories 3 and 4 in the alternate system was 3.9 million, compared with 16.3 million assigned to stage 3 and 4 in the current staging system. The alternate system was more likely to correctly reclassify persons who did not develop the renal outcome than those who did, although some persons developed the renal outcome despite reclassification to a lower category. However, all analyses of patients reclassified to a lower category showed that substantially fewer such patients developed the renal outcome than did not. Correct reclassification by the alternate system was more likely when proteinuria was measured by using albumin-to-creatinine ratio than with dipstick testing, and also more likely for the composite renal outcome than for mortality. Limitation: The study had a short follow-up time. Conclusion: Using proteinuria in combination with eGFR may reduce unnecessary referrals for care at the cost of not referring or delaying referral for some patients who go on to develop kidney failure.	Univ Alberta, Edmonton, AB, Canada; Univ Alabama Birmingham, Birmingham, AL USA; Univ Calgary, Calgary, AB, Canada	University of Alberta; University of Alabama System; University of Alabama Birmingham; University of Calgary	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.		Manns, Braden J/I-8942-2012; Hemmelgarn, Brenda R./I-6894-2012; Wiebe, Natasha/V-7803-2019; Quinn, Robert R/E-7017-2011; Tonelli, Marcello/B-3028-2009; Klarenbach, Scott/E-7731-2013	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187; Klarenbach, Scott/0000-0002-8611-1056	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research; Shire Biochem-KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shire Biochem-KRESCENT	Primary Funding Source: Alberta Heritage Foundation for Medical Research interdisciplinary research team grant.; Grant Support: By an interdisciplinary research team grant from the Alberta Heritage Foundation for Medical Research (AHFMR), career salary awards from the AHFMR (Drs. Hemmelgarn, Tonelli, and Klarenbach), New Investigator Awards from the Canadian Institutes of Health Research (Drs. Hemmelgarn, Tonelli, and Manns), a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary (Drs. Hemmelgarn, Klarenbach, Manns, and Tonelli), and a Shire Biochem-KRESCENT Joint Fellowship and an AHFMR research Award (Dr. James).	[Anonymous], 1994, VITAL HLTH STAT, P1; Chen MLW, 2003, AM J KIDNEY DIS, V42, P623, DOI 10.1016/S0272-6386(03)00870-9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Gao S, 2007, J AM SOC NEPHROL, V18, P2953, DOI 10.1681/ASN.2007030360; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49; 2002, AM J KIDNEY DIS S1, V39, pS76	30	131	134	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					12	U146		10.7326/0003-4819-154-1-201101040-00003	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00003			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200034				2022-12-24	WOS:000285830900002
J	Kapoor, A; Goldberg, MS; Cumberland, LK; Ratnakumar, K; Segura, MF; Emanuel, PO; Menendez, S; Vardabasso, C; LeRoy, G; Vidal, CI; Polsky, D; Osman, I; Garcia, BA; Hernando, E; Bernstein, E				Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Segura, Miguel F.; Emanuel, Patrick O.; Menendez, Silvia; Vardabasso, Chiara; LeRoy, Gary; Vidal, Claudia I.; Polsky, David; Osman, Iman; Garcia, Benjamin A.; Hernando, Eva; Bernstein, Emily			The histone variant macroH2A suppresses melanoma progression through regulation of CDK8	NATURE			English	Article							INACTIVE X-CHROMOSOME; CORE HISTONE; CANCER; METASTASIS; EXPRESSION; GENE; TRANSCRIPTION; STAGE; LINES	Cancer is a disease consisting of both genetic and epigenetic changes. Although increasing evidence demonstrates that tumour progression entails chromatin-mediated changes such as DNA methylation, the role of histone variants in cancer initiation and progression currently remains unclear. Histone variants replace conventional histones within the nucleosome and confer unique biological functions to chromatin(1-3). Here we report that the histone variant macroH2A (mH2A) suppresses tumour progression of malignant melanoma. Loss of mH2A isoforms, histone variants generally associated with condensed chromatin and fine-tuning of developmental gene expression programs(1,4-6), is positively correlated with increasing malignant phenotype of melanoma cells in culture and human tissue samples. Knockdown of mH2A isoforms in melanoma cells of low malignancy results in significantly increased proliferation and migration in vitro and growth and metastasis in vivo. Restored expression of mH2A isoforms rescues these malignant phenotypes in vitro and in vivo. We demonstrate that the tumour-promoting function of mH2A loss is mediated, at least in part, through direct transcriptional upregulation of CDK8. Suppression of CDK8, a colorectal cancer oncogene(7,8), inhibits proliferation of melanoma cells, and knockdown of CDK8 in cells depleted of mH2A suppresses the proliferative advantage induced by mH2A loss. Moreover, a significant inverse correlation between mH2A and CDK8 expression levels exists in melanoma patient samples. Taken together, our results demonstrate that mH2A is a critical component of chromatin that suppresses the development of malignant melanoma, a highly intractable cutaneous neoplasm.	[Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Vardabasso, Chiara; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Emanuel, Patrick O.; Vardabasso, Chiara; Vidal, Claudia I.; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Emanuel, Patrick O.; Vidal, Claudia I.] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Segura, Miguel F.; Menendez, Silvia; Polsky, David; Hernando, Eva] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Polsky, David; Osman, Iman] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Segura, Miguel F.; Menendez, Silvia; Polsky, David; Osman, Iman; Hernando, Eva] NYU, Interdisciplinary Melanoma Cooperat Grp, Langone Med Ctr, New York, NY 10016 USA; [LeRoy, Gary; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Princeton University	Bernstein, E (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.	emily.bernstein@mssm.edu	Polsky, David/AAO-6254-2020; Segura, Miguel F/J-4749-2013; Grieshaber-Bouyer, Ricardo/R-7512-2016	Polsky, David/0000-0001-9554-5289; Segura, Miguel F/0000-0003-0916-3618; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Hernando, Eva/0000-0003-1023-0312	American Skin Association; American Society for Mass Spectrometry; New Jersey Commission on Cancer Research; National Science Foundation [CBET-0941143]; National Institutes of Health [CA109388]; Sergei S. Zlinkoff Fund for Medical Education; New York University Cancer Institute Cancer Center [5P30CA016087-27]; Marc Jacobs Campaign; NYSTEM IDEA [C024291]; Harry L. Lloyd Charitable Trust; Ellison Medical Foundation; Tisch Cancer Institute; NCI [R21CA150117]; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA109388, R21CA150117] Funding Source: NIH RePORTER	American Skin Association; American Society for Mass Spectrometry; New Jersey Commission on Cancer Research; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sergei S. Zlinkoff Fund for Medical Education; New York University Cancer Institute Cancer Center; Marc Jacobs Campaign; NYSTEM IDEA; Harry L. Lloyd Charitable Trust; Ellison Medical Foundation(Lawrence Ellison Foundation); Tisch Cancer Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Hannon, S. Hake and M. Wirtz for reading this manuscript; J. Doucette for statistical support; the laboratories of S. Aaronson, J. Aguirre-Ghiso, D. Burstein and M. O'Connell for discussions and advice; M. Lebwohl, S. Mercer, J. Emer and G. Singer for dermatology and pathology support. We also thank N. Mall, L. Murray, S. Malu and S. Mungamuri for technical assistance; J. Pehrson, M. Narita, A. Aplin, H. Wei, A. Ting, S. Young Kim, M. Herlyn and J. Espinosa for reagents; T. Chu (Mount Sinai School of Medicine Microarray SRF) for data analysis; Q. Yu, the New York University Interdisciplinary Melanoma Cooperative Group and Mount Sinai Biorepository Cooperative for melanoma specimens. This work was supported by an American Skin Association Medical Student Grant to M. S. G., American Society for Mass Spectrometry Award, New Jersey Commission on Cancer Research Seed Grant, and National Science Foundation CBET-0941143 to B. A. G., National Institutes of Health CA109388 and the Sergei S. Zlinkoff Fund for Medical Education to D. P., New York University Cancer Institute Cancer Center Support Grant (5P30CA016087-27) and Marc Jacobs Campaign to I.O., NYSTEM IDEA C024291 and Harry L. Lloyd Charitable Trust to E. H., and an American Skin Association Research Scholar Award, Ellison Medical Foundation New Scholar Award, Tisch Cancer Institute Developmental Funds and NCI R21CA150117 to E.B.	Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; QIAN F, 1994, CELL, V77, P335, DOI 10.1016/0092-8674(94)90149-X; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	30	284	299	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1105	U509		10.1038/nature09590	http://dx.doi.org/10.1038/nature09590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179167	Green Accepted			2022-12-24	WOS:000285553800059
J	Mozaffarian, D; Cao, HM; King, IB; Lemaitre, RN; Song, XL; Siscovick, DS; Hotamisligil, GS				Mozaffarian, Dariush; Cao, Haiming; King, Irena B.; Lemaitre, Rozenn N.; Song, Xiaoling; Siscovick, David S.; Hotamisligil, Goekhan S.			Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CONJUGATED LINOLEIC-ACID; DE-NOVO LIPOGENESIS; NONFATAL MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE SYNDROME; SERUM-CHOLESTEROL ESTERS; ISCHEMIC-HEART-DISEASE; C-REACTIVE PROTEIN; DAIRY FAT INTAKE; ADIPOSE-TISSUE; HIGH-CARBOHYDRATE	Background: Palmitoleic acid (cis-16:1n-7), which is produced by endogenous fat synthesis, has been linked to both beneficial and deleterious metabolic effects, potentially confounded by diverse determinants and tissue sources of endogenous production. Trans-palmitoleate (trans-16:1n-7) represents a distinctly exogenous source of 16:1n-7, unconfounded by endogenous synthesis or its determinants, that may be uniquely informative. Objective: To investigate whether circulating trans-palmitoleate is independently related to lower metabolic risk and incident type 2 diabetes. Design: Prospective cohort study from 1992 to 2006. Setting: Four U.S. communities. Patients: 3736 adults in the Cardiovascular Health Study. Measurements: Anthropometric characteristics and levels of plasma phospholipid fatty acids, blood lipids, inflammatory markers, and glucose-insulin measured at baseline in 1992 and dietary habits measured 3 years earlier. Multivariate-adjusted models were used to investigate how demographic, clinical, and lifestyle factors independently related to plasma phospholipid trans-palmitoleate; how trans-palmitoleate related to major metabolic risk factors; and how trans-palmitoleate related to new-onset diabetes (304 incident cases). Findings were validated for metabolic risk factors in an independent cohort of 327 women. Results: In multivariate analyses, whole-fat dairy consumption was most strongly associated with higher trans-palmitoleate levels. Higher trans-palmitoleate levels were associated with slightly lower adiposity and, independently, with higher high-density lipoprotein cholesterol levels (1.9% across quintiles; P = 0.040), lower triglyceride levels (-19.0%; P < 0.001), a lower total cholesterol-HDL cholesterol ratio (-4.7%; P < 0.001), lower C-reactive protein levels (-13.8%; P = 0.05), and lower insulin resistance (-16.7%, P < 0.001). Trans-palmitoleate was also associated with a substantially lower incidence of diabetes, with multivariate hazard ratios of 0.41 (95% CI, 0.27 to 0.64) and 0.38 (CI, 0.24 to 0.62) in quintiles 4 and 5 versus quintile 1 (P for trend < 0.001). Findings were independent of estimated dairy consumption or other fatty acid dairy biomarkers. Protective associations with metabolic risk factors were confirmed in the validation cohort. Limitation: Results could be affected by measurement error or residual confounding. Conclusion: Circulating trans-palmitoleate is associated with lower insulin resistance, presence of atherogenic dyslipidemia, and incident diabetes. Our findings may explain previously observed metabolic benefits of dairy consumption and support the need for detailed further experimental and clinical investigation.	[Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; NIH, Bethesda, MD 20892 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; University of New Mexico; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Cao, Haiming/P-4634-2016; Mozaffarian, Dariush/B-2276-2008		National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01-HL085710, DK064360, DK71507-04, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, -85086, N01-HC-15103, N01-HC-55222, U01-HL080295]; Searle Scholar Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC075150, N01HC045133, N01HC085084, N01HC085079, N01HC085085, N01HC035129, N01HC055222, N01HC085083, N01HC015103, N01HC085080, N01HC085082, N01HC085086, N01HC085081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R01DK064360, R90DK071507] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Searle Scholar Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.; By the National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (grants R01-HL085710, DK064360, and DK71507-04 and grants N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through -85086, N01-HC-15103, N01-HC-55222, and U01-HL080295 for the CHS), with additional contributions from the National Institutes of Health Office of Dietary Supplements and National Institute of Neurological Disorders and Stroke. A subset of additional fatty acid measurements was supported by a Searle Scholar Award.	Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523; Barazzoni R, 2003, DIABETES, V52, P1851, DOI 10.2337/diabetes.52.7.1851; Baumgard LH, 2002, J DAIRY SCI, V85, P2155, DOI 10.3168/jds.S0022-0302(02)74294-X; Beydoun MA, 2008, AM J CLIN NUTR, V87, P1914, DOI 10.1093/ajcn/87.6.1914; Brevik A, 2005, EUR J CLIN NUTR, V59, P1417, DOI 10.1038/sj.ejcn.1602256; CAMBIEN F, 1988, AM J EPIDEMIOL, V127, P75, DOI 10.1093/oxfordjournals.aje.a114793; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Devaraj S, 2009, CURR OPIN LIPIDOL, V20, P182, DOI 10.1097/MOL.0b013e32832ac03e; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Elwood PC, 2008, J AM COLL NUTR, V27, p723S, DOI 10.1080/07315724.2008.10719750; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gertow K, 2006, EUR J CLIN NUTR, V60, P1406, DOI 10.1038/sj.ejcn.1602471; Harvatine KJ, 2009, J NUTR, V139, P849, DOI 10.3945/jn.108.099994; Harvey-Berino J, 2005, OBES RES, V13, P1720, DOI 10.1038/oby.2005.210; Hodgson JM, 1996, ATHEROSCLEROSIS, V120, P147, DOI 10.1016/0021-9150(95)05696-3; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Hudgins LC, 2008, J NUTR BIOCHEM, V19, P237, DOI 10.1016/j.jnutbio.2007.02.013; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; King IB, 2006, AM J CLIN NUTR, V83, P227; Kumanyika SK, 1997, AM J CLIN NUTR, V65, P1123; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; LEPAGE G, 1986, J LIPID RES, V27, P114; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lindgarde F, 2006, AM J CLIN NUTR, V84, P1009, DOI 10.1093/ajcn/84.5.1009; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maguire LS, 2004, INT J FOOD SCI NUTR, V55, P171, DOI 10.1080/09637480410001725175; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Motard-Belanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, AM J CLIN NUTR  1013; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Riserus U, 2004, AM J CLIN NUTR, V79, p1146S; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; ROSSNER S, 1989, INT J OBESITY, V13, P603; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; SALOMAA V, 1990, METABOLISM, V39, P1285, DOI 10.1016/0026-0495(90)90185-F; Sarabi M, 2001, ATHEROSCLEROSIS, V156, P349, DOI 10.1016/S0021-9150(00)00658-4; Sauma L, 2006, NUTRITION, V22, P60, DOI 10.1016/j.nut.2005.04.011; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Simon JA, 1996, HYPERTENSION, V27, P303, DOI 10.1161/01.HYP.27.2.303; SOMMERFELD M, 1983, PROG LIPID RES, V22, P221, DOI 10.1016/0163-7827(83)90010-3; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tremblay A, 2009, J AM COLL NUTR, V28, p91S, DOI 10.1080/07315724.2009.10719809; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Willett W, 2008, AM J CLIN NUTR, V87, P515, DOI 10.1093/ajcn/87.3.515; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	69	265	285	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					790	+		10.7326/0003-4819-153-12-201012210-00005	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173413	Green Accepted			2022-12-24	WOS:000285453700002
J	Cao, Y; Jin, XS; Huang, H; Derebe, MG; Levin, EJ; Kabaleeswaran, V; Pan, YP; Punta, M; Love, J; Weng, J; Quick, M; Ye, S; Kloss, B; Bruni, R; Martinez-Hackert, E; Hendrickson, WA; Rost, B; Javitch, JA; Rajashankar, KR; Jiang, YX; Zhou, M				Cao, Yu; Jin, Xiangshu; Huang, Hua; Derebe, Mehabaw Getahun; Levin, Elena J.; Kabaleeswaran, Venkataraman; Pan, Yaping; Punta, Marco; Love, James; Weng, Jun; Quick, Matthias; Ye, Sheng; Kloss, Brian; Bruni, Renato; Martinez-Hackert, Erik; Hendrickson, Wayne A.; Rost, Burkhard; Javitch, Jonathan A.; Rajashankar, Kanagalaghatta R.; Jiang, Youxing; Zhou, Ming			Crystal structure of a potassium ion transporter, TrkH	NATURE			English	Article							K+-UPTAKE SYSTEM; ESCHERICHIA-COLI; CATION-TRANSPORT; GLYCINE RESIDUES; LIGHT-SCATTERING; HIGH-AFFINITY; KTRAB SYSTEM; PROTEIN TRKA; CHANNEL; SELECTIVITY	The TrkH/TrkG/KtrB proteins mediate K+ uptake in bacteria and probably evolved from simple K+ channels by multiple gene duplications or fusions. Here we present the crystal structure of a TrkH from Vibrio parahaemolyticus. TrkH is a homodimer, and each protomer contains an ion permeation pathway. A selectivity filter, similar in architecture to those of K+ channels but significantly shorter, is lined by backbone and side-chain oxygen atoms. Functional studies showed that TrkH is selective for permeation of K+ and Rb+ over smaller ions such as Na+ or Li+. Immediately intracellular to the selectivity filter are an intramembrane loop and an arginine residue, both highly conserved, which constrict the permeation pathway. Substituting the arginine with an alanine significantly increases the rate of K+ flux. These results reveal the molecular basis of K+ selectivity and suggest a novel gating mechanism for this large and important family of membrane transport proteins.	[Cao, Yu; Huang, Hua; Levin, Elena J.; Kabaleeswaran, Venkataraman; Pan, Yaping; Weng, Jun; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Derebe, Mehabaw Getahun; Ye, Sheng; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Derebe, Mehabaw Getahun; Ye, Sheng; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Punta, Marco; Love, James; Kloss, Brian; Bruni, Renato; Rost, Burkhard] New York Struct Biol Ctr, NewYork Consortium Membrane Prot Struct, New York, NY 10027 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, NE CAT, Adv Photon Source, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Punta, Marco/ABH-4698-2020; Rost, Burkhard/A-1908-2016; Cao, Yu/GNP-6653-2022	Punta, Marco/0000-0002-0050-0676; Rost, Burkhard/0000-0003-0179-8424; Cao, Yu/0000-0003-1409-2068; Bruni, Renato/0000-0002-2312-0254; Javitch, Jonathan/0000-0001-7395-2967; Martinez-Hackert, Erik/0000-0002-6182-7023; Kloss, Brian/0000-0003-0130-8739; Jin, Xiangshu/0000-0002-6551-8850	U.S. National Institutes of Health [HL086392, DK088057, GM05026-sub0007]; American Heart Association [0630148N]; National Institute of General Medical Sciences [GM05026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source and the NE-CAT 24ID-C and E at the Advanced Photon Source. This work was supported by the U.S. National Institutes of Health (grants HL086392, DK088057 and GM05026-sub0007 to M. Z.) and the American Heart Association (0630148N to M. Z.). M. Z is a Pew Scholar in Biomedical Sciences. The New York Consortium on Membrane Protein Structure central facility is supported by grant GM05026 to W. A. H. aspart of the Protein Structure Initiative (PSI-2) established by the National Institute of General Medical Sciences. We thank B. Honig for support, K. Jung for providing E. coli LB650, and J. Morais-Cabral, S.-Y. Lee, H. R. Guy, C. L. Slayman and E. P. Bakker for discussions and comments on the manuscript. M. Z. is grateful to R. MacKinnon for advice and support throughout the project.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hille B., 2001, ION CHANNELS EXCITAB; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kato N, 2007, CHANNELS, V1, P161, DOI 10.4161/chan.4374; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; KROLL RG, 1981, BIOCHEM J, V198, P691, DOI 10.1042/bj1980691; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLACK RH, 1980, J BIOL CHEM, V255, P3824; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; SCHULTZ SG, 1963, J GEN PHYSIOL, V47, P329, DOI 10.1085/jgp.47.2.329; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Zeng GF, 2004, J BIOL CHEM, V279, P3003, DOI 10.1074/jbc.M309760200; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	100	105	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					336	+		10.1038/nature09731	http://dx.doi.org/10.1038/nature09731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21317882	Green Accepted			2022-12-24	WOS:000288444000036
J	Bloss, CS; Schork, NJ; Topol, EJ				Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.			Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPHYLACTIC SURGERY; ALZHEIMERS-DISEASE; IMPACT	Background: The use of direct-to-consumer genomewide profiling to assess disease risk is controversial, and little is known about the effect of this technology on consumers. We examined the psychological, behavioral, and clinical effects of risk scanning with the Navigenics Health Compass, a commercially available test of uncertain clinical validity and utility. Methods: We recruited subjects from health and technology companies who elected to purchase the Health Compass at a discounted rate. Subjects reported any changes in symptoms of anxiety, intake of dietary fat, and exercise behavior at a mean (+/-SD) of 5.6+/-2.4 months after testing, as compared with baseline, along with any test-related distress and the use of health-screening tests. Results: From a cohort of 3639 enrolled subjects, 2037 completed follow-up. Primary analyses showed no significant differences between baseline and follow-up in anxiety symptoms (P=0.80), dietary fat intake (P=0.89), or exercise behavior (P=0.61). Secondary analyses revealed that test-related distress was positively correlated with the average estimated lifetime risk among all the assessed conditions ((beta)=0.117, P<0.001). However, 90.3% of subjects who completed follow-up had scores indicating no test-related distress. There was no significant increase in the rate of use of screening tests associated with genomewide profiling, most of which are not considered appropriate for screening asymptomatic persons in any case. Conclusions: In a selected sample of subjects who completed follow-up after undergoing consumer genomewide testing, such testing did not result in any measurable short-term changes in psychological health, diet or exercise behavior, or use of screening tests. Potential effects of this type of genetic testing on the population at large are not known. (Funded by the National Institutes of Health and Scripps Health.) N Engl J Med 2011;364:524-34.	[Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Hlth, La Jolla, CA USA; [Schork, Nicholas J.; Topol, Eric J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Clin, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct,Suite 300, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729; Schork, Nicholas/0000-0003-0920-5013	National Center for Research Resources of the National Institutes of Health (NIH) [1UL1RR025774-01]; NIH's National Human Genome Research Institute [1R21HG005747-01]; Scripps Genomic Medicine Division of Scripps Health; National Institutes of Health and Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005747] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH's National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Scripps Genomic Medicine Division of Scripps Health; National Institutes of Health and Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported in part by grants from the National Center for Research Resources of the National Institutes of Health (NIH) (1UL1RR025774-01, to Dr. Topol) and the NIH's National Human Genome Research Institute (1R21HG005747-01, to Dr. Bloss) and by the Scripps Genomic Medicine Division of Scripps Health.; Funded by the National Institutes of Health and Scripps Health.	Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7; Bloss CS, 2010, GENET MED, V12, P556, DOI 10.1097/GIM.0b013e3181eb51c6; Botkin JR, 2003, AM J MED GENET A, V118A, P201, DOI 10.1002/ajmg.a.10102; Collins VR, 2007, GENET MED, V9, P290, DOI 10.1097/GIM.0b013e31804b45db; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Healy M, 2009, LOS ANGELES TIM 1024, P4; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Pollack A, 2010, NY TIMES        0611, pB2; Roberts JS, 2005, J GERIATR PSYCH NEUR, V18, P250, DOI 10.1177/0891988705281883; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Weiss Daniel S., 1997, P399	18	382	382	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					524	534		10.1056/NEJMoa1011893	http://dx.doi.org/10.1056/NEJMoa1011893			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21226570	Green Accepted			2022-12-24	WOS:000287139900006
J	Ogawa, T; Akahane, M; Koike, S; Tanabe, S; Mizoguchi, T; Imamura, T				Ogawa, Toshio; Akahane, Manabu; Koike, Soichi; Tanabe, Seizan; Mizoguchi, Tatsuhiro; Imamura, Tomoaki			Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; SUDDEN CARDIAC-ARREST; BASIC LIFE-SUPPORT; HEALTH-PROFESSIONALS; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; GUIDELINES; ATTITUDES	ABSTRACT Objective To compare the effectiveness of cardiopulmonary resuscitation (CPR) with chest compression only and conventional CPR on outcomes after cardiopulmonary arrest out of hospital. Design Nationwide population based observational study. Setting A nationwide emergency medical service system in Japan. Population All consecutive patients with out of hospital cardiopulmonary arrest, January 2005 to December 2007 in Japan, witnessed at the moment of collapse. Lay people attempted chest compression only CPR (n=20 707) or conventional CPR (mouth to mouth ventilation and chest compression) (n=19 328), and patients were transferred to hospital by ambulance. Main outcome measures Factors associated with better outcomes (assessed with chi superset of 2 superset of, multiple logistic regression analysis, odds ratios and their 95% confidence intervals): one month survival and neurologically favourable one month survival rates defined as category one (good cerebral performance) or two (moderate cerebral disability) of the cerebral performance categories. Results Conventional CPR was associated with better outcomes than chest compression only CPR, for both one month survival (adjusted odds ratio 1.17, 95% confidence interval 1.06 to 1.29) and neurologically favourable one month survival (1.17, 1.01 to 1.35). Neurologically favourable one month survival decreased with increasing age and with delays of up to 10 minutes in starting CPR for both conventional and chest compression only CPR. The benefit of conventional CPR over chest compression only CPR was significantly greater in younger people in non-cardiac cases (P=0.025) and with a delay in start of CPR after the event was witnessed in non-cardiac cases (P=0.015) and all cases combined (P=0.037). Conclusions Conventional CPR is associated with better outcomes than chest compression only CPR for selected patients with out of hospital cardiopulmonary arrest, such as those with arrests of non-cardiac origin and younger people, and people in whom there was delay in the start of CPR.	[Ogawa, Toshio; Akahane, Manabu; Imamura, Tomoaki] Nara Med Univ, Sch Med, Dept Publ Hlth Hlth Management & Policy, Kashihara 6348521, Nara, Japan; [Koike, Soichi] Univ Tokyo Hosp, Dept Planning Information & Management, Bunkyo Ku, Tokyo 1920364, Japan; [Tanabe, Seizan; Mizoguchi, Tatsuhiro] Emergency Life Saving Technique Acad Of Tokyo, Fdn Ambulance Serv Dev, Tokyo 1920364, Japan; Fire & Disaster Management Agcy, Ambulance Serv Planning Off, Chiyoda Ku, Tokyo 1008927, Japan	Nara Medical University; University of Tokyo	Ogawa, T (corresponding author), Nara Med Univ, Sch Med, Dept Publ Hlth Hlth Management & Policy, 840 Shijo Cho, Kashihara 6348521, Nara, Japan.	ogawat@naramed-u.ac.jp	Akahane, Manabu/GYD-5539-2022					[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arrich J, 2009, RESUSCITATION, V80, P876, DOI 10.1016/j.resuscitation.2009.04.045; Bohm K, 2007, CIRCULATION, V116, P2908, DOI 10.1161/CIRCULATIONAHA.107.710194; Caves ND, 2006, RESUSCITATION, V68, P93, DOI 10.1016/j.resuscitation.2005.05.014; Chamberlain D, 2005, RESUSCITATION, V67, P157, DOI 10.1016/j.resuscitation.2005.05.011; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Holmberg M, 1999, AM J CARDIOL, V83, p88D; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; LOCKE CJ, 1995, ARCH INTERN MED, V155, P938, DOI 10.1001/archinte.155.9.938; *MIN ED CULT SPORT, 2006, SPORTS SCI TECHNOL J; Nagao K, 2007, LANCET, V369, P920; Olasveengen TM, 2008, ACTA ANAESTH SCAND, V52, P914, DOI 10.1111/j.1399-6576.2008.01723.x; Ong MEH, 2008, RESUSCITATION, V78, P119, DOI 10.1016/j.resuscitation.2008.03.012; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Sayre MR, 2009, PREHOSP EMERG CARE, V13, P469, DOI 10.1080/10903120903144965; Steen PA, 2007, CIRCULATION, V116, P2514, DOI 10.1161/CIRCULATIONAHA.107.739086; Taniguchi T, 2007, RESUSCITATION, V75, P82, DOI 10.1016/j.resuscitation.2007.02.019; Vukmir RB, 2004, EMERG MED J, V21, P370, DOI 10.1136/emj.2003.008383	23	85	93	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2011	342								c7106	10.1136/bmj.c7106	http://dx.doi.org/10.1136/bmj.c7106			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715MM	21273279	Green Submitted, hybrid			2022-12-24	WOS:000286888600014
J	Gostin, LO; Kim, SC				Gostin, Lawrence O.; Kim, Susan C.			Ethical Allocation of Preexposure HIV Prophylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Kim, Susan C.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Dabis F, 2005, AIDS, V19, P309; Gostin LO, 2010, JAMA-J AM MED ASSOC, V304, P789, DOI 10.1001/jama.2010.1164; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; MCNEILL DG, 2010, NY TIMES        0510, pA10; Obengo T.J., 2020, UTILITARIAN ASSESSME; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; *UNAIDS, REP G UNAIDS REP GLO; *US CDCP, PREL RES 1 SAF STUD; *US PRES EM PLAN A, EX SUMM PEPFARS STRA	10	18	18	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					191	192		10.1001/jama.2010.1975	http://dx.doi.org/10.1001/jama.2010.1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224461	Green Published			2022-12-24	WOS:000286103400025
J	Black, B; Cleveland, DW				Black, Ben E.; Cleveland, Don W.			Epigenetic Centromere Propagation and the Nature of CENP-A Nucleosomes	CELL			English	Article							E3 UBIQUITIN LIGASE; FISSION YEAST SCM3; HISTONE H3 VARIANT; CHROMATIN REQUIRES; MAINTENANCE; DOMAIN; CSE4; ORGANIZATION; REPLICATION; RECOGNITION	Centromeres direct chromosome inheritance, but in multicellular organisms their positions on chromosomes are primarily specified epigenetically rather than by a DNA sequence. The major candidate for the epigenetic mark is chromatin assembled with the histone H3 variant CENP-A. Recent studies offer conflicting evidence for the structure of CENP-A-containing chromatin, including the histone composition and handedness of the DNA wrapped around the histones. We present a model for the assembly and deposition of centromeric nucleosomes that couples these processes to the cell cycle. This model reconciles divergent data for CENP-A-containing nucleosomes and provides a basis for how centromere identity is stably inherited.	[Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of Pennsylvania; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Black, B (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	National Institutes of Health [GM82989, GM74150]; Burroughs Wellcome Fund; Rita Allen Foundation; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, R01GM074150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of their laboratories for many discussions of centromere inheritance and anonymous reviewers for helpful comments. This work was supported by grants from the National Institutes of Health to B. E. B. (GM82989) and D. W. C. (GM74150). B. E. B. is also supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and a Rita Allen Foundation Scholar Award. D. W. C. receives salary support from the Ludwig Institute for Cancer Research.	Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dimitriadis EK, 2010, P NATL ACAD SCI USA, V107, P20317, DOI 10.1073/pnas.1009563107; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kingston IJ, 2011, J BIOL CHEM, V286, P4021, DOI 10.1074/jbc.M110.189340; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lavelle C, 2009, CELL, V139, P1216, DOI 10.1016/j.cell.2009.12.014; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Maggert KA, 2001, GENETICS, V158, P1615; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106	53	237	239	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					471	479		10.1016/j.cell.2011.02.002	http://dx.doi.org/10.1016/j.cell.2011.02.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335232	Green Accepted, Bronze			2022-12-24	WOS:000287473100004
J	Fujiwara, H; Ferreira, M; Donati, G; Marciano, DK; Linton, JM; Sato, Y; Hartner, A; Sekiguchi, K; Reichardt, LF; Watt, FM				Fujiwara, Hironobu; Ferreira, Manuela; Donati, Giacomo; Marciano, Denise K.; Linton, James M.; Sato, Yuya; Hartner, Andrea; Sekiguchi, Kiyotoshi; Reichardt, Louis F.; Watt, Fiona M.			The Basement Membrane of Hair Follicle Stem Cells Is a Muscle Cell Niche	CELL			English	Article							ARRECTOR PILI MUSCLE; BETA-CATENIN; INTEGRIN ALPHA-8-BETA-1; MOUSE EPIDERMIS; DIFFERENTIATED PHENOTYPE; KIDNEY MORPHOGENESIS; PROTEIN NEPHRONECTIN; MAMMALIAN EPIDERMIS; ADULT EPIDERMIS; SKIN	The hair follicle bulge in the epidermis associates with the arrector pili muscle (APM) that is responsible for piloerection ("goosebumps''). We show that stem cells in the bulge deposit nephronectin into the underlying basement membrane, thus regulating the adhesion of mesenchymal cells expressing the nephronectin receptor, alpha 8 beta 1 integrin, to the bulge. Nephronectin induces alpha 8 integrin-positive mesenchymal cells to upregulate smooth muscle markers. In nephronectin knockout mice, fewer arrector pili muscles form in the skin, and they attach to the follicle above the bulge, where there is compensatory upregulation of the nephronectin family member EGFL6. Deletion of alpha 8 integrin also abolishes selective APM anchorage to the bulge. Nephronectin is a Wnt target; epidermal beta-catenin activation upregulates epidermal nephronectin and dermal alpha 8 integrin expression. Thus, bulge stem cells, via nephronectin expression, create a smooth muscle cell niche and act as tendon cells for the APM. Our results reveal a functional role for basement membrane heterogeneity in tissue patterning.	[Fujiwara, Hironobu; Ferreira, Manuela; Donati, Giacomo; Watt, Fiona M.] Li Ka Shing Ctr, Cancer Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Marciano, Denise K.] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94158 USA; [Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Linton, James M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Sato, Yuya; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Hartner, Andrea] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany	Cancer Research UK; CRUK Cambridge Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Osaka University; University of Erlangen Nuremberg	Watt, FM (corresponding author), Li Ka Shing Ctr, Cancer Res UK Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	fiona.watt@cancer.org.uk	Fujiwara, Hironobu/A-5971-2016; Ferreira, Manuela/AAF-5299-2020; Watt, Fiona/AHB-0226-2022; Ferreira, Manuela/I-7904-2018	Fujiwara, Hironobu/0000-0003-0883-3384; Ferreira, Manuela/0000-0001-9498-8061; Watt, Fiona/0000-0001-9151-5154; Ferreira, Manuela/0000-0001-9498-8061; DONATI, Giacomo/0000-0002-0370-8288; Marciano, Denise/0000-0003-0612-4664; Ferreira, Manuela/0000-0002-0075-2400	Cancer Research UK; University of Cambridge and Hutchison Whampoa Ltd.; NIH [NS19090]; Uehara Memorial Foundation; EU; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); University of Cambridge and Hutchison Whampoa Ltd.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); EU(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Vladimir Botchkarev for K14-Noggin skin and Takako Sasaki for Fibulin-1 antibody. We gratefully acknowledge the technical assistance of the core resources of the CRUK Cambridge Research Institute. We thank the entire Watt lab for valuable reagents, suggestions, and advice. This work was funded by Cancer Research UK and supported by the University of Cambridge and Hutchison Whampoa Ltd. We also gratefully acknowledge financial support from the NIH (NS19090 to L. F. R.), from the Uehara Memorial Foundation (H. F.), and from EU FP7 (Optistem).	AKIYAMA M, 1995, J INVEST DERMATOL, V105, P844, DOI 10.1111/1523-1747.ep12326649; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Baker CM, 2010, DEV BIOL, V343, P40, DOI 10.1016/j.ydbio.2010.04.005; Barcaui CB, 2002, BRIT J DERMATOL, V146, P657, DOI 10.1046/j.1365-2133.2002.04541.x; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Christiano AM, 2004, CELL, V118, P530, DOI 10.1016/j.cell.2004.08.024; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; HALL PA, 1989, DEVELOPMENT, V106, P619; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kuroda K, 2004, J CUTAN PATHOL, V31, P241, DOI 10.1111/j.0303-6987.2003.00166.x; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Niemann C, 2002, DEVELOPMENT, V129, P95; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Poblet E, 2004, J AM ACAD DERMATOL, V51, P217, DOI 10.1016/j.jaad.2004.01.054; RODRIGO FG, 1975, BRIT J DERMATOL, V93, P631, DOI 10.1111/j.1365-2133.1975.tb05112.x; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Sharov AA, 2009, AM J PATHOL, V175, P1303, DOI 10.2353/ajpath.2009.090163; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2008, COLD SH Q B, V73, P503, DOI 10.1101/sqb.2008.73.011; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Zargham R, 2007, ATHEROSCLEROSIS, V195, P303, DOI 10.1016/j.atherosclerosis.2007.01.005; Zargham R, 2006, CARDIOVASC RES, V71, P170, DOI 10.1016/j.cardiores.2006.03.003	54	215	224	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					577	589		10.1016/j.cell.2011.01.014	http://dx.doi.org/10.1016/j.cell.2011.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335239	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000287473100012
J	Rada-Iglesias, A; Bajpai, R; Swigut, T; Brugmann, SA; Flynn, RA; Wysocka, J				Rada-Iglesias, Alvaro; Bajpai, Ruchi; Swigut, Tomek; Brugmann, Samantha A.; Flynn, Ryan A.; Wysocka, Joanna			A unique chromatin signature uncovers early developmental enhancers in humans	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION ANALYSIS; GENE-EXPRESSION; TRANSCRIPTION; IDENTIFICATION; ZEBRAFISH; PROMOTERS; GENOME; EOMESODERMIN; DATABASE	Cell-fate transitions involve the integration of genomic information encoded by regulatory elements, such as enhancers, with the cellular environment(1,2). However, identification of genomic sequences that control human embryonic development represents a formidable challenge(3). Here we show that in human embryonic stem cells (hESCs), unique chromatin signatures identify two distinct classes of genomic elements, both of which are marked by the presence of chromatin regulators p300 and BRG1, monomethylation of histone H3 at lysine 4 (H3K4me1), and low nucleosomal density. In addition, elements of the first class are distinguished by the acetylation of histone H3 at lysine 27 (H3K27ac), overlap with previously characterized hESC enhancers, and are located proximally to genes expressed in hESCs and the epiblast. In contrast, elements of the second class, which we term 'poised enhancers', are distinguished by the absence of H3K27ac, enrichment of histone H3 lysine 27 trimethylation (H3K27me3), and are linked to genes inactive in hESCs and instead are involved in orchestrating early steps in embryogenesis, such as gastrulation, mesoderm formation and neurulation. Consistent with the poised identity, during differentiation of hESCs to neuroepithelium, a neuroectoderm-specific subset of poised enhancers acquires a chromatin signature associated with active enhancers. When assayed in zebrafish embryos, poised enhancers are able to direct cell-type and stage-specific expression characteristic of their proximal developmental gene, even in the absence of sequence conservation in the fish genome. Our data demonstrate that early developmental enhancers are epigenetically pre-marked in hESCs and indicate an unappreciated role of H3K27me3 at distal regulatory elements. Moreover, the wealth of new regulatory sequences identified here provides an invaluable resource for studies and isolation of transient, rare cell populations representing early stages of human embryogenesis.	[Rada-Iglesias, Alvaro; Bajpai, Ruchi; Swigut, Tomek; Brugmann, Samantha A.; Flynn, Ryan A.; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Rada-Iglesias, Alvaro/0000-0001-7137-1341; Swigut, Tomek/0000-0002-7649-6781; Bajpai, Ruchi/0000-0001-7737-3567	WM Keck Foundation; CIRM [RN1 00579-1]; EMBO; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE019853] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); CIRM(California Institute for Regenerative Medicine); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Wysocka laboratory members for ideas and manuscript comments; I. A. Shestopalov and J. K. Chen for sharing zebrafish resources, equipment and knowledge; T. Howes and D. M. Kingsley for the pT2HE vector; Z. Weng and A. Sidow for Illumina sequencing; and A. Valouev for discussion on ChIP-seq data analysis. This work was supported by WM Keck Foundation Distinguished Young Scholar in Biomedical Research Award and CIRM RN1 00579-1 grant to J.W.A.R.-I. was supported by an EMBO long-term fellowship.	Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Itani HA, 2007, ENDOCRINOLOGY, V148, P1424, DOI 10.1210/en.2006-1381; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Marin O, 2002, DEVELOPMENT, V129, P761; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nakabayashi H, 2004, BIOCHEM BIOPH RES CO, V318, P773, DOI 10.1016/j.bbrc.2004.04.096; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yeom YI, 1996, DEVELOPMENT, V122, P881	39	1469	1501	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					279	+		10.1038/nature09692	http://dx.doi.org/10.1038/nature09692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21160473	Green Accepted			2022-12-24	WOS:000287144200048
J	Kaeser, PS; Deng, LB; Wang, Y; Dulubova, I; Liu, XR; Rizo, J; Sudhof, TC				Kaeser, Pascal S.; Deng, Lunbin; Wang, Yun; Dulubova, Irina; Liu, Xinran; Rizo, Josep; Suedhof, Thomas C.			RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction	CELL			English	Article							CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; RAB3 EFFECTOR; RIM1-ALPHA; COMPLEX; BINDING; CALYX; DELETION; FAMILY	At a synapse, fast synchronous neurotransmitter release requires localization of Ca2+ channels to presynaptic active zones. How Ca2+ channels are recruited to active zones, however, remains unknown. Using unbiased yeast two-hybrid screens, we here identify a direct interaction of the central PDZ domain of the active-zone protein RIM with the C termini of presynaptic N- and P/Q-type Ca2+ channels but not L-type Ca2+ channels. To test the physiological significance of this interaction, we generated conditional knockout mice lacking all multidomain RIM isoforms. Deletion of RIM proteins ablated most neurotransmitter release by simultaneously impairing the priming of synaptic vesicles and by decreasing the presynaptic localization of Ca2+ channels. Strikingly, rescue of the decreased Ca2+-channel localization required the RIM PDZ domain, whereas rescue of vesicle priming required the RIM N terminus. We propose that RIMs tether N- and P/Q-type Ca2+ channels to presynaptic active zones via a direct PDZ-domain-mediated interaction, thereby enabling fast, synchronous triggering of neurotransmitter release at a synapse.	[Kaeser, Pascal S.; Deng, Lunbin; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kaeser, Pascal S.; Deng, Lunbin; Wang, Yun; Liu, Xinran; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Dulubova, Irina; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Lorry Lokey Bldg,265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu			NIH [NINDS 33564, NS37200, DA029044]; Swiss National Science Foundation; NARSAD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NARSAD(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Borowicz, I. Kornblum, L. Fan, J. Mitchell, H. Ly, and I. Huryeva for technical assistance, Dr. R.E. Hammer for blastocyst injections, Dr. N. Brose for Munc 13-1 antibodies, Dr. C. Acuna-Goycolea for advice on Ca<SUP>2+</SUP>-imaging experiments, Dr. Z. Ma for assistance with yeast two-hybrid screening, Drs. Z. Pang, T. Bacaj, and C. Foldy for help with data analysis, and Dr. R. Schneggenburger for comments. This work was supported by grants from the NIH (NINDS 33564 to T.C.S., NS37200 to J.R., DA029044 to P.S.K.), a Swiss National Science Foundation Postdoctoral Fellowship (to P.S.K.), and a NARSAD Young Investigator Award (to P.S.K.).	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; DENG L, 2011, NEURON IN PRESS, V69, DOI DOI 10.1016/J.NEURON.2011.01.005; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; HAN Y, 2011, NEURON IN PRESS, V69, DOI DOI 10.1016/J.NEURON.2010.12.014; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; Katz B., 1969, RELEASE NEURAL TRANS; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lu J, 2005, J MOL BIOL, V352, P455, DOI 10.1016/j.jmb.2005.07.047; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mittelstaedt T, 2010, BIOL CHEM, V391, P599, DOI 10.1515/BC.2010.064; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Wu LG, 1999, J NEUROSCI, V19, P726	42	374	383	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					282	295		10.1016/j.cell.2010.12.029	http://dx.doi.org/10.1016/j.cell.2010.12.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241895	Bronze, Green Accepted			2022-12-24	WOS:000286459900012
J	Huang, PY; Ruiz-Vargas, CS; van der Zande, AM; Whitney, WS; Levendorf, MP; Kevek, JW; Garg, S; Alden, JS; Hustedt, CJ; Zhu, Y; Park, J; McEuen, PL; Muller, DA				Huang, Pinshane Y.; Ruiz-Vargas, Carlos S.; van der Zande, Arend M.; Whitney, William S.; Levendorf, Mark P.; Kevek, Joshua W.; Garg, Shivank; Alden, Jonathan S.; Hustedt, Caleb J.; Zhu, Ye; Park, Jiwoong; McEuen, Paul L.; Muller, David A.			Grains and grain boundaries in single-layer graphene atomic patchwork quilts	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; ELECTRONIC TRANSPORT; CARBON NANOTUBES; LARGE-AREA; DEFECTS; FILMS; MICROSCOPY; STRENGTH; GROWTH; FOILS	The properties of polycrystalline materials are often dominated by the size of their grains and by the atomic structure of their grain boundaries. These effects should be especially pronounced in two-dimensional materials, where even a line defect can divide and disrupt a crystal. These issues take on practical significance in graphene, which is a hexagonal, two-dimensional crystal of carbon atoms. Single-atom-thick graphene sheets can now be produced by chemical vapour deposition(1-3) on scales of up to metres(4), making their polycrystallinity almost unavoidable. Theoretically, graphene grain boundaries are predicted to have distinct electronic(5-8), magnetic(9), chemical(10) and mechanical(11-13) properties that strongly depend on their atomic arrangement. Yet because of the five-order-of-magnitude size difference between grains and the atoms at grain boundaries, few experiments have fully explored the graphene grain structure. Here we use a combination of old and new transmission electron microscopy techniques to bridge these length scales. Using atomic-resolution imaging, we determine the location and identity of every atom at a grain boundary and find that different grains stitch together predominantly through pentagon-heptagon pairs. Rather than individually imaging the several billion atoms in each grain, we use diffraction-filtered imaging(14) to rapidly map the location, orientation and shape of several hundred grains and boundaries, where only a handful have been previously reported(15-19). The resulting images reveal an unexpectedly small and intricate patchwork of grains connected by tilt boundaries. By correlating grain imaging with scanning probe and transport measurements, we show that these grain boundaries severely weaken the mechanical strength of graphene membranes but do not as drastically alter their electrical properties. These techniques open a new window for studies on the structure, properties and control of grains and grain boundaries in graphene and other two-dimensional materials.	[Huang, Pinshane Y.; Ruiz-Vargas, Carlos S.; Alden, Jonathan S.; Zhu, Ye; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [van der Zande, Arend M.; Whitney, William S.; McEuen, Paul L.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Levendorf, Mark P.; Garg, Shivank; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Kevek, Joshua W.] Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA; [Hustedt, Caleb J.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA; [Park, Jiwoong; McEuen, Paul L.; Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Oregon State University; Brigham Young University	Muller, DA (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	david.a.muller@cornell.edu	Muller, David/A-7745-2010; Zhu, Ye/A-1844-2011; van der Zande, Arend M/C-1989-2016; Park, Jiwoong/C-2327-2013; Zhu, Ye/U-3836-2019	Muller, David/0000-0003-4129-0473; Zhu, Ye/0000-0002-5217-493X; van der Zande, Arend M/0000-0001-5104-9646; Zhu, Ye/0000-0002-5217-493X; Huang, Pinshane/0000-0002-1095-1833	National Science Foundation through the Cornell Center for Materials Research; Nanoscale Science and Engineering Initiative of the National Science Foundation [EEC-0117770, 064654]; NSF	National Science Foundation through the Cornell Center for Materials Research; Nanoscale Science and Engineering Initiative of the National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	The authors acknowledge discussions with M. Blees, J. Cha, S. Gerbode, J. Grazul, E. Kirkland, L. Fitting-Kourkoutis, O. Krivanek, S. Shi, S. Wang and H. Zhuang. This work was supported in part by the National Science Foundation through the Cornell Center for Materials Research and the Nanoscale Science and Engineering Initiative of the National Science Foundation under NSF Award EEC-0117770, 064654. Additional support was provided by the Army Research Office, CONACYT-Mexico, the Air Force Office of Scientific Research, DARPA-MTO and the MARCO Focused Research Center on Materials, Structures, and Devices. Sample fabrication was performed at the Cornell node of the National Nanofabrication Infrastructure Network, funded by the NSF. Additional facilities support was provided by the Cornell Center for Materials Research (NSF DMR-0520404 and IMR-0417392) and NYSTAR.	Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Cervenka J, 2009, NAT PHYS, V5, P840, DOI 10.1038/NPHYS1399; Cervenka J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195429; Cockayne E., 2010, ROTATIONAL GRAIN BOU; de Villeneuve VWA, 2005, J PHYS-CONDENS MAT, V17, pS3371, DOI 10.1088/0953-8984/17/45/024; Gao L, 2010, NANO LETT, V10, P3512, DOI 10.1021/nl1016706; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Grantab R, 2010, SCIENCE, V330, P946, DOI 10.1126/science.1196893; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Hirsch P., 1965, ELECT MICROSCOPY THI; Jiao LY, 2008, J AM CHEM SOC, V130, P12612, DOI 10.1021/ja805070b; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu YY, 2010, NANO LETT, V10, P2178, DOI 10.1021/nl100988r; Malola S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165447; Mesaros A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205119; Meyer J. C., 2009, MC2009, V3, P347; Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m; Park HJ, 2010, CARBON, V48, P1088, DOI 10.1016/j.carbon.2009.11.030; Park S, 2010, CARBON, V48, P797, DOI 10.1016/j.carbon.2009.10.030; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Regan W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3337091; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Suenaga K, 2007, NAT NANOTECHNOL, V2, P358, DOI 10.1038/nnano.2007.141; Thiel S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046809; van der Zande AM, 2010, NANO LETT, V10, P4869, DOI 10.1021/nl102713c; Wofford JM, 2010, NANO LETT, V10, P4890, DOI 10.1021/nl102788f; Yazyev OV, 2010, NAT MATER, V9, P806, DOI [10.1038/NMAT2830, 10.1038/nmat2830]; Yazyev OV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195420; Zhao L., 2010, ATOMIC SCALE GROWTH	33	1589	1624	27	1245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					389	+		10.1038/nature09718	http://dx.doi.org/10.1038/nature09718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21209615	Green Submitted			2022-12-24	WOS:000286385600050
J	Rasmussen, SGF; Choi, HJ; Fung, JJ; Pardon, E; Casarosa, P; Chae, PS; DeVree, BT; Rosenbaum, DM; Thian, FS; Kobilka, TS; Schnapp, A; Konetzki, I; Sunahara, RK; Gellman, SH; Pautsch, A; Steyaert, J; Weis, WI; Kobilka, BK				Rasmussen, Soren G. F.; Choi, Hee-Jung; Fung, Juan Jose; Pardon, Els; Casarosa, Paola; Chae, Pil Seok; DeVree, Brian T.; Rosenbaum, Daniel M.; Thian, Foon Sun; Kobilka, Tong Sun; Schnapp, Andreas; Konetzki, Ingo; Sunahara, Roger K.; Gellman, Samuel H.; Pautsch, Alexander; Steyaert, Jan; Weis, William I.; Kobilka, Brian K.			Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor	NATURE			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; PROTEIN; RHODOPSIN; CONFORMATIONS; ACTIVATION	G protein coupled receptors (GPCRs) exhibit a spectrum of functional behaviours in response to natural and synthetic ligands. Recent crystal structures provide insights into inactive states of several GPCRs. Efforts to obtain an agonist-bound active-state GPCR structure have proven difficult due to the inherent instability of this state in the absence of a G protein. We generated a camelid antibody fragment (nanobody) to the human beta(2) adrenergic receptor (beta(2)AR) that exhibits G protein-like behaviour, and obtained an agonist-bound, active-state crystal structure of the receptor-nanobody complex. Comparison with the inactive beta(2)AR structure reveals subtle changes in the binding pocket; however, these small changes are associated with an 11 angstrom outward movement of the cytoplasmic end of transmembrane segment 6, and rearrangements of transmembrane segments 5 and 7 that are remarkably similar to those observed in opsin, an active form of rhodopsin. This structure provides insights into the process of agonist binding and activation.	[Rasmussen, Soren G. F.; Choi, Hee-Jung; Fung, Juan Jose; Rosenbaum, Daniel M.; Thian, Foon Sun; Kobilka, Tong Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Casarosa, Paola; Schnapp, Andreas; Konetzki, Ingo; Pautsch, Alexander] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [DeVree, Brian T.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; University of Copenhagen; Stanford University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Boehringer Ingelheim; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	bill.weis@stanford.edu; kobilka@stanford.edu	DeVree, Brian T/F-6205-2011; Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022; Weis, William I/G-1437-2011; Sunahara, Roger/AAJ-8667-2020	Steyaert, Jan/0000-0002-3825-874X; Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526; DeVree, Brian/0000-0003-0582-8125; Rasmussen, Soren/0000-0002-1853-1841; Kobilka, Brian/0000-0001-5958-3990; Pardon, Els/0000-0002-2466-0172	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, P60DK-20572]; Mathers Foundation; Lundbeck Foundation; University of Michigan; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, P01GM075913, R01GM068603, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); University of Michigan(University of Michigan System); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), and P60DK-20572 (R. K. S.), the Mathers Foundation (B. K. K. and W. I. W.), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), the University of Michigan Biomedical Sciences Scholars Program (R. K. S.), the Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E.P. and J.S.).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	31	1247	1287	10	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					175	180		10.1038/nature09648	http://dx.doi.org/10.1038/nature09648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228869	Green Published, Green Accepted			2022-12-24	WOS:000286143400030
J	Kruta, I; Landman, N; Rouget, I; Cecca, F; Tafforeau, P				Kruta, Isabelle; Landman, Neil; Rouget, Isabelle; Cecca, Fabrizio; Tafforeau, Paul			The Role of Ammonites in the Mesozoic Marine Food Web Revealed by Jaw Preservation	SCIENCE			English	Article							ZOOPLANKTON; CEPHALOPODA; BEHAVIOR	Ammonites are prominent in macroevolutionary studies because of their abundance and diversity in the fossil record, but their paleobiology and position in the marine food web are not well understood due to the lack of preserved soft tissue. We present three-dimensional reconstructions of the buccal apparatus in the Mesozoic ammonite Baculites with the use of synchrotron x-ray microtomography. Buccal mass morphology, combined with the coexistence of food remains found in the buccal mass, suggests that these ammonites fed on plankton. This diet may have extended to all aptychophoran ammonites, which share the same buccal mass morphology. Understanding the role of these ammonites in the Mesozoic food web provides insights into their radiation in the Early Jurassic, as well as their extinction at the end of the Cretaceous/early Paleogene.	[Kruta, Isabelle] Museum Natl Hist Nat, Dept Hist Terre, CNRS, UMR 7207, F-75231 Paris 05, France; [Landman, Neil] Amer Museum Nat Hist, Dept Paleontol Invertebrates, New York, NY 10024 USA; [Rouget, Isabelle; Cecca, Fabrizio] Univ Paris 06, CNRS, UMR 7207, F-75252 Paris 05, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; European Synchrotron Radiation Facility (ESRF)	Kruta, I (corresponding author), Museum Natl Hist Nat, Dept Hist Terre, CNRS, UMR 7207, 47 Rue Cuvier, F-75231 Paris 05, France.	kruta@mnhn.fr		Tafforeau, Paul/0000-0002-5962-1683	ESRF; UMR CNRS [7207]; Annette Kade Fellowship (AMNH)	ESRF; UMR CNRS(Centre National de la Recherche Scientifique (CNRS)); Annette Kade Fellowship (AMNH)	This work was supported by ESRF, UMR CNRS 7207, its 3D platform, and the Annette Kade Fellowship (AMNH). P. Janvier and C. Klug reviewed an earlier draft of the manuscript; A. Lethiers helped produce the figures and movie; N. Larson and K. Cochran helped in field work; and D. Defaye, N. Bruce, R. Feldmann, and K. Bandel helped in the identification of non-ammonite material. Data are available at the ESRF database http://paleo.esrf.eu.	ALLDREDGE AL, 1985, MAR BIOL, V84, P253, DOI 10.1007/BF00392494; Arkell W. J., 1957, MOLLUSCA, pL80; CASTRO JJ, 1995, SCI MAR, V59, P347; Cecca F, 1997, CR ACAD SCI II A, V325, P629, DOI 10.1016/S1251-8050(97)89465-7; Doguzhaeva Larisa A., 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V223, P167; Engeser T, 2002, LETHAIA, V35, P79, DOI 10.1080/002411602317345894; Huber BT, 2002, GEOL SOC AM SPEC PAP, V356, P277; Jacobs D. K., 1996, AMMONOID PALEOBIOLOG, P169; JACOBS DK, 1993, LETHAIA, V26, P101, DOI 10.1111/j.1502-3931.1993.tb01799.x; Jager M, 1997, PALAEONTOLOGY, V40, P557; Kennedy William J., 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P113; Korn D, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P57, DOI 10.1007/978-1-4020-6806-5_3; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Landman NH, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P257, DOI 10.1007/978-1-4020-6806-5_13; Lehmann U., 1981, AMMONITES THEIR LIFE; Machalski M, 2005, B GEOL SOC DENMARK, V52, P97; MILLER AK, 1949, EVOLUTION, V3, P231, DOI 10.2307/2405560; NIXON M, 1995, J ZOOL, V236, P73, DOI 10.1111/j.1469-7998.1995.tb01785.x; Nixon M., 2003, BRAINS LIVES CEPHALO; Owen G., 1966, PHYSL MOLLUSCA, V2, P1; Rigby S, 2000, ANNU REV ECOL SYST, V31, P293, DOI 10.1146/annurev.ecolsys.31.1.293; Runham N. W., 1997, Scientia Marina, V61, P67; Tanabe Kazushige, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P157; Tanabe Kazushige, 1999, P245; Thore S., 1949, Dana Reports, VNo. 33, P1; Ward P. D., 1987, NATURAL HIST NAUTILU; Westermann GEG, 1996, AMMONOID PALEOBIOLOG, P607; Wright C. W., 1996, TREATISE INVERTEBR L, P1	28	117	123	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					70	72		10.1126/science.1198793	http://dx.doi.org/10.1126/science.1198793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212354				2022-12-24	WOS:000285974000037
J	Bhutta, ZA; Soofi, S; Cousens, S; Mohammad, S; Memon, ZA; Ali, I; Feroze, A; Raza, F; Khan, A; Wall, S; Martines, J				Bhutta, Zulfiqar A.; Soofi, Sajid; Cousens, Simon; Mohammad, Shah; Memon, Zahid A.; Ali, Imran; Feroze, Asher; Raza, Farrukh; Khan, Amanullah; Wall, Steve; Martines, Jose			Improvement of perinatal and newborn care in rural Pakistan through community-based strategies: a cluster-randomised effectiveness trial	LANCET			English	Article							NEONATAL DEATHS; DEVELOPING-COUNTRIES; MORTALITY; INDIA; INTERVENTIONS; STILLBIRTHS; MANAGEMENT; PROGRAM; IMPACT	Background Newborn deaths account for 57% of deaths in children younger than 5 years in Pakistan. Although a large programme of trained lady health workers (LHWs) exists, the effectiveness of this training on newborn outcomes has not been studied. We aimed to evaluate the effectiveness of a community-based intervention package, principally delivered through LHWs working with traditional birth attendants and community health committees, for reduction of perinatal and neonatal mortality in a rural district of Pakistan. Methods We undertook a cluster randomised trial between February, 2006, and March, 2008, in Hala and Matiari subdistricts, Pakistan. Catchment areas of primary care facilities and all affiliated LHWs were used to define clusters, which were allocated to intervention and control groups by restricted, stratified randomisation. The intervention package delivered by LHWs through group sessions consisted of promotion of antenatal care and maternal health education, use of clean delivery kits, facility births, immediate newborn care, identification of danger signs, and promotion of careseeking; control clusters received routine care. Independent data collectors undertook quarterly household surveillance to capture data for births, deaths, and household practices related to maternal and newborn care. Data collectors were masked to cluster allocation; those analysing data were not. The primary outcome was perinatal and all-cause neonatal mortality. Analysis was by intention to treat. This trial is registered, ISRCTN16247511. Findings 16 clusters were assigned to intervention (23 353 households, 12 391 total births) and control groups (23 768 households, 11 443 total births). LHWs in the intervention clusters were able to undertake 4428 (63%) of 7084 planned group sessions, but were only able to visit 2943 neonates (24%) of a total 12 028 livebirths in their catchment villages. Stillbirths were reduced in intervention clusters (39.1 stillbirths per 1000 total births) compared with control (48.7 per 1000; risk ratio [RR] 0.79, 95% CI 0.68-0.92; p=0.006). The neonatal mortality rate was 43.0 deaths per 1000 livebirths in intervention clusters compared with 49.1 per 1000 in control groups (RR 0.85, 0.76-0.96; p=0.02). Interpretation Our results support the scale-up of preventive and promotive maternal and newborn interventions through community health workers and emphasise the need for attention to issues of programme management and coverage for such initiatives to achieve maximum potential.	[Bhutta, Zulfiqar A.; Soofi, Sajid; Mohammad, Shah; Memon, Zahid A.; Ali, Imran; Feroze, Asher; Raza, Farrukh] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Khan, Amanullah; Wall, Steve] Save Children USA, Saving Newborn Lives, Washington, DC USA; [Martines, Jose] WHO, Dept Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; Save the Children; World Health Organization	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Memon, Zahid Ali/GRE-8118-2022	Memon, Zahid Ali/0000-0002-5321-8885	WHO; Bill & Melinda Gates Foundation	WHO(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Hala trial was funded by grants from WHO and the Saving Newborn Lives programme funded by the Bill & Melinda Gates Foundation. We thank Department of Health, Sindh Government, and the National Program for Family Planning and Primary Health Care for their encouragement and support towards undertaking this trial, all staff of the Hala project office for their hard work and support, and notably, the excellent support provided by Usman Chachar, the district coordinating officer, and Hasan Murad Shah, the executive district officer for health for Matiari district.	[Anonymous], NAT PROGR FAM PLANN; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Baqui AH, 2008, HEALTH POLICY PLANN, V23, P234, DOI 10.1093/heapol/czn012; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2004, MATERNAL CHILD HLTH, V1st; Bhutta ZA, 2008, PAKISTAN DEMOGRAPHIC; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Douthwaite M, 2005, HEALTH POLICY PLANN, V20, P117, DOI 10.1093/heapol/czi014; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Haq Zaeem, 2008, Int J Ment Health Syst, V2, P15, DOI 10.1186/1752-4458-2-15; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Jafarey S N, 1981, J Pak Med Assoc, V31, P288; Kalter HD, 2008, PAEDIATR PERINAT EP, V22, P321, DOI 10.1111/j.1365-3016.2008.00943.x; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lassi ZS, 2010, COMMUNITY BASED INTE; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mavalankar D, 2009, INT J GYNECOL OBSTET, V107, P271, DOI 10.1016/j.ijgo.2009.09.008; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa; Oxford Policy Management, 2003, EV PRIM MIN LAD HLTH; Oxford Policy Management, 2009, EXT EV LAD HLTH WORK; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Tugwell P, 2006, BMJ-BRIT MED J, V332, P358, DOI 10.1136/bmj.332.7537.358; World Health Organization, 2003, STAND NEON VERB AUT	39	184	187	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					403	412		10.1016/S0140-6736(10)62274-X	http://dx.doi.org/10.1016/S0140-6736(10)62274-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721ES	21239052	Green Accepted			2022-12-24	WOS:000287337000030
J	Petherick, A				Petherick, Anna			Mother's milk: A rich opportunity	NATURE			English	Editorial Material							LARGE RANDOMIZED-TRIAL											Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; KRAMER MS, 2007, BRIT MED J; LEFEVRE CM, 2010, GENOMICS HUMAN GENET, V11, P219; Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sullivan EC, 2011, DEV PSYCHOBIOL, V53, P96, DOI 10.1002/dev.20483; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05	11	63	70	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S5	S7		10.1038/468S5a	http://dx.doi.org/10.1038/468S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179083	Bronze			2022-12-24	WOS:000285553800002
J	Taelman, VF; Dobrowolski, R; Plouhinec, JL; Fuentealba, LC; Vorwald, PP; Gumper, I; Sabatini, DD; De Robertis, EM				Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; Gumper, Iwona; Sabatini, David D.; De Robertis, Edward M.			Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes	CELL			English	Article							ENDOCYTIC TRAFFICKING; DESTRUCTION COMPLEX; BODY BIOGENESIS; RECEPTOR; LRP6; WINGLESS; INTERNALIZATION; MECHANISM; PATHWAY; TARGETS	Canonical Wnt signaling requires inhibition of Glycogen Synthase Kinase 3 (GSK3) activity, but the molecular mechanism by which this is achieved remains unclear. Here, we report that Wnt signaling triggers the sequestration of GSK3 from the cytosol into multivesicular bodies (MVBs), so that this enzyme becomes separated from its many cytosolic substrates. Endocytosed Wnt colocalized with GSK3 in acidic vesicles positive for endosomal markers. After Wnt addition, endogenous GSK3 activity decreased in the cytosol, and GSK3 became protected from protease treatment inside membrane-bounded organelles. Cryoimmunoelectron microscopy showed that these corresponded to MVBs. Two proteins essential for MVB formation, HRS/Vps27 and Vps4, were required for Wnt signaling. The sequestration of GSK3 extended the half-life of many other proteins in addition to beta-Catenin, including an artificial Wnt-regulated reporter protein containing GSK3 phosphorylation sites. We conclude that multivesicular endosomes are essential components of the Wnt signal-transduction pathway.	[Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; De Robertis, Edward M.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gumper, Iwona; Sabatini, David D.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		Dobrowolski, Radek/0000-0002-1805-5806; De Robertis, Edward/0000-0002-7843-1869	Deutsche Forschungsgemeinschaft [DO1429/1-1]; NIH [HD21502-24]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021502, R37HD021502] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Drs. R. Moon for beta-Catenin-GFP and SuperTopFlash reporter, X. He for CA-LRP6, B. van Deurs for dog Rab7-GFP, S. Sokol for Myc-xDvl, M. Bienz for DIX > Ctail-GFP, M. Taira for xWnt8-Venus, P. Woodman for Vps4-EQ-GFP, R. Pagano for Rab5-DsRed-WT, P. De Camilli for DN-Dynamin-GFP, H. Stenmark for FYVE-GFP, H. Clevers for DN-xTcf3, O. Wessely for beta-Catenin-DN-xTcf3, P. Lemaire for Siamois, and R. Nusse for Wnt3a-producing L cells. We thank three anonymous referees and members of our laboratories for improving the manuscript, H. Snitkin for her help in processing cultured cells for electron microscopy, U. Lendahl for suggesting the HRS depletion experiments, the Deutsche Forschungsgemeinschaft for supporting R. D. (DO1429/1-1), and the NIH (HD21502-24) for funding. E. M. D. R. is an Investigator of the Howard Hughes Medical Institute.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DUNN LA, 1983, J BIOL CHEM, V258, P4989; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; Metcalfe C, 2010, J CELL SCI, V123, P1588, DOI 10.1242/jcs.067546; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	42	497	504	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1136	1148		10.1016/j.cell.2010.11.034	http://dx.doi.org/10.1016/j.cell.2010.11.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183076	Green Accepted, Bronze			2022-12-24	WOS:000285625400011
J	Gharbi-Ayachi, A; Labbe, JC; Burgess, A; Vigneron, S; Strub, JM; Brioudes, E; Van-Dorsselaer, A; Castro, A; Lorca, T				Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Strub, Jean-Marc; Brioudes, Estelle; Van-Dorsselaer, Alain; Castro, Anna; Lorca, Thierry			The Substrate of Greatwall Kinase, Arpp19, Controls Mitosis by Inhibiting Protein Phosphatase 2A	SCIENCE			English	Article							ALPHA-ENDOSULFINE; ARREST; ENTRY; EXIT	Initiation and maintenance of mitosis require the activation of protein kinase cyclin B-Cdc2 and the inhibition of protein phosphatase 2A (PP2A), which, respectively, phosphorylate and dephosphorylate mitotic substrates. The protein kinase Greatwall (Gwl) is required to maintain mitosis through PP2A inhibition. We describe how Gwl activation results in PP2A inhibition. We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and alpha-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry. Conversely, in the absence of Gwl activity, Arpp19 and alpha-Endosulfine are dephosphorylated and lose their capacity to bind and inhibit PP2A. Although both proteins can inhibit PP2A, endogenous Arpp19, but not alpha-Endosulfine, is responsible for PP2A inhibition at mitotic entry in Xenopus egg extracts.	[Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Brioudes, Estelle; Castro, Anna; Lorca, Thierry] Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, F-34293 Montpellier 5, France; [Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Brioudes, Estelle; Castro, Anna; Lorca, Thierry] Univ Montpellier 1, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, F-34293 Montpellier 5, France; [Strub, Jean-Marc; Van-Dorsselaer, Alain] Inst Pluridisciplinaire Hubert Curien, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Castro, A (corresponding author), Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, 1919 Route Mende, F-34293 Montpellier 5, France.	anna.castro@crbm.cnrs.fr; thierry.lorca@crbm.cnrs.fr	Gharbi, Aicha/C-5521-2011; CASTRO, ANNA/F-4350-2010; labbe, jean-claude/B-2277-2009; Burgess, Andrew/C-7952-2009; Burgess, Andrew/H-3339-2019	CASTRO, ANNA/0000-0002-3655-1352; Burgess, Andrew/0000-0003-4536-9226; Burgess, Andrew/0000-0003-4536-9226; Lorca, Thierry/0000-0003-2007-8924; Strub, Jean-Marc/0000-0001-6224-3428	Ligue Regionale Contre le Cancer (Comite du Gard); Association pour la Recherche sur le Cancer	Ligue Regionale Contre le Cancer (Comite du Gard); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank L. Gros and A. Virsolvy for providing the pBKS-Arpp19, pBKS-alpha-Endosulfine constructs, and antibodies to human alpha-Endosulfine and T. Hunt and S. Mochida for the antibody to phosphoS67/62 Endo-Arp. This work was supported by the Ligue Regionale Contre le Cancer (Comite du Gard) and the "Association pour la Recherche sur le Cancer". A. B. and E. B. are "Fondation pour la Recherche Medicale" and "Ligue Nationale Contre le Cancer" fellows, respectively. There is a patent pending that pertains to results presented in this paper.	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Bataille D, 1999, CELL MOL LIFE SCI, V56, P78, DOI 10.1007/s000180050008; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Lorca T, 2010, J CELL SCI, V123, P2281, DOI 10.1242/jcs.064527; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Von Stetina JR, 2008, DEVELOPMENT, V135, P3697, DOI 10.1242/dev.025114; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	11	299	308	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1673	1677		10.1126/science.1197048	http://dx.doi.org/10.1126/science.1197048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164014	Green Published			2022-12-24	WOS:000285390500066
J	Harismendy, O; Notani, D; Song, XY; Rahim, NG; Tanasa, B; Heintzman, N; Ren, B; Fu, XD; Topol, EJ; Rosenfeld, MG; Frazer, KA				Harismendy, Olivier; Notani, Dimple; Song, Xiaoyuan; Rahim, Nazli G.; Tanasa, Bogdan; Heintzman, Nathaniel; Ren, Bing; Fu, Xiang-Dong; Topol, Eric J.; Rosenfeld, Michael G.; Frazer, Kelly A.			9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response	NATURE			English	Article							GENOME-WIDE ASSOCIATION; NEGATIVE REGULATOR; RAPID EVOLUTION; NONCODING RNA; PROTEIN CTCF; LOCUS; SUSCEPTIBILITY; SEQUENCE; PROJECT; ANRIL	Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in the 9p21 gene desert associated with coronary artery disease (CAD)(1-4) and type 2 diabetes(5-7). Despite evidence for a role of the associated interval in neighbouring gene regulation(8-10), the biological underpinnings of these genetic associations with CAD or type 2 diabetes have not yet been explained. Here we identify 33 enhancers in 9p21; the interval is the second densest gene desert for predicted enhancers and six times denser than the whole genome (P < 6.55 x 10(-33)). The CAD risk alleles of SNPs rs10811656 and rs10757278 are located in one of these enhancers and disrupt a binding site for STAT1. Lymphoblastoid cell lines homozygous for the CAD risk haplotype show no binding of STAT1, and in lymphoblastoid cell lines homozygous for the CAD non-risk haplotype, binding of STAT1 inhibits CDKN2BAS (also known as CDKN2B-AS1) expression, which is reversed by short interfering RNA knockdown of STAT1. Using a new, open-ended approach to detect long-distance interactions, we find that in human vascular endothelial cells the enhancer interval containing the CAD locus physically interacts with the CDKN2A/B locus, the MTAP gene and an interval downstream of IFNA21. In human vascular endothelial cells, interferon-c activation strongly affects the structure of the chromatin and the transcriptional regulation in the 9p21 locus, including STAT1-binding, long-range enhancer interactions and altered expression of neighbouring genes. Our findings establish a link between CAD genetic susceptibility and the response to inflammatory signalling in a vascular cell type and thus demonstrate the utility of genome-wide association study findings in directing studies to novel genomic loci and biological processes important for disease aetiology.	[Rahim, Nazli G.; Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Radys Childrens Hosp, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Notani, Dimple; Song, Xiaoyuan; Tanasa, Bogdan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Heintzman, Nathaniel; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Topol, EJ (corresponding author), Scripps Res Inst, Scripps Translat Sci Inst, 3344 N Torrey Pines Court, La Jolla, CA 92037 USA.	etopol@scripps.edu; mrosenfeld@ucsd.edu; kafrazer@ucsd.edu	Harismendy, Olivier/AAM-2072-2021; , songxy/P-1094-2014; Stefanadis, Christodoulos/ABH-2232-2020	Harismendy, Olivier/0000-0002-8098-9888; , songxy/0000-0002-9011-5033; Topol, Eric/0000-0002-1478-4729; Frazer, Kelly/0000-0002-6060-8902; Stefanadis, Christodoulos/0000-0001-5974-6454; Notani, Dimple/0000-0002-9460-8070	National Center for Research Resources [1U54RR025204, 1UL1RR025774, 1UL1RR031980-01]; National Institutes of Health [HL065445, DK39949, DK018477, DK074868, L65445, CA97134, DK74686, NS34934, 1R21CA152613-01]; Department of Defence [BC075019]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R21CA152613, R01CA097134] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980, UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, U01HL107442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK018477, R37DK039949, R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025204] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank X. Wang, K. Trevarthen and M. Nakano for experimental assistance. We thank the Scripps Genomic Medicine Clinical team for sample collection. This work was partially supported by National Center for Research Resources grants 1U54RR025204, 1UL1RR025774 and 1UL1RR031980-01 and National Institutes of Health grants HL065445, DK39949, DK018477, DK074868, L65445, CA97134, DK74686, NS34934 and 1R21CA152613-01, the Department of Defence grant BC075019 and the Prostate Cancer Foundation. M. G. R. is an Investigator with the Howard Hughes Medical Institute.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hindorff LA, CATALOG PUBLISHED GE; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tousoulis D, 2008, TRENDS MOL MED, V14, P441, DOI 10.1016/j.molmed.2008.08.004; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x	45	454	476	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					264	+		10.1038/nature09753	http://dx.doi.org/10.1038/nature09753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307941	Green Accepted			2022-12-24	WOS:000287144200045
J	O'Neill, JS; van Ooijen, G; Dixon, LE; Troein, C; Corellou, F; Bouget, FY; Reddy, AB; Millar, AJ				O'Neill, John S.; van Ooijen, Gerben; Dixon, Laura E.; Troein, Carl; Corellou, Florence; Bouget, Francois-Yves; Reddy, Akhilesh B.; Millar, Andrew J.			Circadian rhythms persist without transcription in a eukaryote	NATURE			English	Article							CLOCK; PHOSPHORYLATION; OSTREOCOCCUS; SYSTEM; PLANTS	Circadian rhythms are ubiquitous in eukaryotes, and coordinate numerous aspects of behaviour, physiology and metabolism, from sleep/wake cycles in mammals to growth and photosynthesis in plants(1,2). This daily timekeeping is thought to be driven by transcriptional-translational feedback loops, whereby rhythmic expression of 'clock' gene products regulates the expression of associated genes in approximately 24-hour cycles. The specific transcriptional components differ between phylogenetic kingdoms(3). The unicellular pico-eukaryotic alga Ostreococcus tauri possesses a naturally minimized clock, which includes many features that are shared with plants, such as a central negative feedback loop that involves the morning-expressed CCA1 and evening-expressed TOC1 genes(4). Given that recent observations in animals and plants have revealed prominent post-translational contributions to time-keeping(5), a reappraisal of the transcriptional contribution to oscillator function is overdue. Here we show that non-transcriptional mechanisms are sufficient to sustain circadian timekeeping in the eukaryotic lineage, although they normally function in conjunction with transcriptional components. We identify oxidation of peroxiredoxin proteins as a transcription-independent rhythmic biomarker, which is also rhythmic in mammals(6). Moreover we show that pharmacological modulators of the mammalian clock mechanism have the same effects on rhythms in Ostreococcus. Post-translational mechanisms, and at least one rhythmic marker, seem to be better conserved than transcriptional clock regulators. It is plausible that the oldest oscillator components are non-transcriptional in nature, as in cyanobacteria(7), and are conserved across kingdoms.	[O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Inst Metab Sci,Dept Clin Neurosci, Cambridge CB2 0QQ, England; [O'Neill, John S.; van Ooijen, Gerben; Dixon, Laura E.; Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JD, Midlothian, Scotland; [Troein, Carl; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Corellou, Florence; Bouget, Francois-Yves] Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, F-66651 Banyuls Sur Mer, France; [Corellou, Florence; Bouget, Francois-Yves] CNRS, UMR7621, Lab Observ Oceanog Microbienne, Observ Oceanol, F-66651 Banyuls Sur Mer, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Reddy, AB (corresponding author), Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Inst Metab Sci,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net; Andrew.Millar@ed.ac.uk	Millar, Andrew J/G-2423-2012; Corellou, Florence/E-1378-2011; van Ooijen, Gerben/E-9371-2013	Millar, Andrew J/0000-0003-1756-3654; van Ooijen, Gerben/0000-0001-7967-0637; Corellou, Florence/0000-0001-8026-2120; O'Neill, John Stuart/0000-0003-2204-6096	BBSRC; EPSRC [D019621]; BBSRC/ANR [F005466]; HFSP; Wellcome Trust [083643/Z/07/Z]; MRC Centre for Obesity and Related metabolic Disorders (MRC CORD); Biotechnology and Biological Sciences Research Council [BB/F005466/1, BB/D019621/1] Funding Source: researchfish; BBSRC [BB/F005466/1, BB/D019621/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC/ANR(French National Research Agency (ANR)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CSBE is a Centre for Integrative Systems Biology funded by BBSRC and EPSRC award D019621. C.T. is supported by a BBSRC/ANR joint project F005466 awarded to F.-Y.B. and A.J.M. and by the HFSP. A.B.R. is supported by the Wellcome Trust (083643/Z/07/Z) and the MRC Centre for Obesity and Related metabolic Disorders (MRC CORD).	Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Khalsa SBS, 1996, AM J PHYSIOL-CELL PH, V271, pC1646, DOI 10.1152/ajpcell.1996.271.5.C1646; KONOPKA RJ, 1979, FED PROC, V38, P2602; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Merrow M, 2006, GENE DEV, V20, P2629, DOI 10.1101/gad.1479706; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; WOOLUM JC, 1991, J BIOL RHYTHM, V6, P129, DOI 10.1177/074873049100600203	29	361	370	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					554	558		10.1038/nature09654	http://dx.doi.org/10.1038/nature09654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270895	Green Accepted			2022-12-24	WOS:000286596500037
J	Kuhns, DB; Alvord, WG; Heller, T; Feld, JJ; Pike, KM; Marciano, BE; Uzel, G; DeRavin, SS; Priel, DAL; Soule, BP; Zarember, KA; Malech, HL; Holland, SM; Gallin, JI				Kuhns, Douglas B.; Alvord, W. Gregory; Heller, Theo; Feld, Jordan J.; Pike, Kristen M.; Marciano, Beatriz E.; Uzel, Gulbu; DeRavin, Suk See; Priel, Debra A. Long; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Holland, Steven M.; Gallin, John I.			Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOLOGICALLY IMPORTANT MUTATIONS; MARROW-TRANSPLANTATION; RESPIRATORY-BURST; INVOLVEMENT; DEFICIENCY; GP91-PHOX; DOMAIN; RISK	Background: Failure to generate phagocyte-derived superoxide and related reactive oxygen intermediates (ROIs) is the major defect in chronic granulomatous disease, causing recurrent infections and granulomatous complications. Chronic granulomatous disease is caused by missense, nonsense, frameshift, splice, or deletion mutations in the genes for p22(sup phox), p40(sup phox), p47(sup phox), p67(sup phox) (autosomal chronic granulomatous disease), or gp91(sup phox) (X-linked chronic granulomatous disease), which result in variable production of neutrophil-derived ROIs. We hypothesized that residual ROI production might be linked to survival in patients with chronic granulomatous disease. Methods: We assessed the risks of illness and death among 287 patients with chronic granulomatous disease from 244 kindreds. Residual ROI production was measured with the use of superoxide-dependent ferricytochrome c reduction and flow cytometry with dihydrorhodamine oxidation assays. Expression of NADPH oxidase component protein was detected by means of immunoblotting, and the affected genes were sequenced to identify causal mutations. Results: Survival of patients with chronic granulomatous disease was strongly associated with residual ROI production as a continuous variable, independently of the specific gene affected. Patients with mutations in p47(sup phox) and most missense mutations in gp91(sup phox) (with the exception of missense mutations in the nucleotide-binding and heme-binding domains) had more residual ROI production than patients with nonsense, frameshift, splice, or deletion mutations in gp91(sup phox). After adolescence, mortality curves diverged according to the extent of residual ROI production. Conclusions: Patients with chronic granulomatous disease and modest residual production of ROI have significantly less severe illness and a greater likelihood of long-term survival than patients with little residual ROI production. The production of residual ROI is predicted by the specific NADPH oxidase mutation, regardless of the specific gene affected, and it is a predictor of survival in patients with chronic granulomatous disease. (Funded by the National Institutes of Health.) N Engl J Med 2010;363:2600-10.	[DeRavin, Suk See; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Kuhns, Douglas B.; Priel, Debra A. Long] SAIC Frederick, Clin Serv Program, Frederick, MD USA; [Pike, Kristen M.] SAIC Frederick, Lab Mol Technol, Frederick, MD USA; [Alvord, W. Gregory] NCI Frederick, Biostat Consulting Div, Data Management Serv, Frederick, MD USA; [Heller, Theo] NIDDKD, Liver Dis Branch, Bethesda, MD USA; [Marciano, Beatriz E.; Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [DeRavin, Suk See; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Feld, Jordan J.] Univ Toronto, Toronto Western Hosp, McLaughlin Rotman Ctr Global Hlth, Ctr Liver, Toronto, ON M5T 2S8, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gallin, JI (corresponding author), NIAID, Host Def Lab, NIH, Bldg 10,Rm 6-2551, Bethesda, MD 20892 USA.	jgallin@cc.nih.gov	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; Heller, Theo/0000-0002-2643-6289; Malech, Harry/0000-0001-5874-5775; De Ravin, Suk See/0000-0002-9800-774X; Zarember, Kol/0000-0002-9624-7096	National Institute of Allergy and Infectious Diseases [Z01-AI-000155, Z01-AI-000645, Z01-AI-00646-06]; National Institute of Diabetes and Digestive and Kidney Diseases [ZIA DK075008-04 LDB]; National Cancer Institute [HH-SN261200800001E]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, Z01AI000646, ZIAAI000645, ZIAAI000155, Z01AI000155, Z01AI000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by intramural grants from the National Institute of Allergy and Infectious Diseases (Z01-AI-000155, Z01-AI-000645, and Z01-AI-00646-06), a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075008-04 LDB), and a contract from the National Cancer Institute (HH-SN261200800001E).; Funded by the National Institutes of Health	Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; BERENDES H, 1957, Minn Med, V40, P309; Cale CM, 2000, CLIN EXP IMMUNOL, V120, P351, DOI 10.1046/j.1365-2249.2000.01234.x; Carnide EG, 2005, PEDIATR ALLERGY IMMU, V16, P5, DOI 10.1111/j.1399-3038.2005.00225.x; Collett D, 1994, MODELLING SURVIVAL D; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COOPER MR, 1972, J CLIN INVEST, V51, P769, DOI 10.1172/JCI106871; Cross AR, 1996, BLOOD CELL MOL DIS, V22, P268, DOI 10.1006/bcmd.1996.0109; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Feld JJ, 2008, GASTROENTEROLOGY, V134, P1917, DOI 10.1053/j.gastro.2008.02.081; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; FREY D, 1988, BLOOD, V71, P252; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Guide SV, 2003, J INFECT DIS, V187, P845, DOI 10.1086/368388; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; Jirapongsananuruk O, 2003, J ALLERGY CLIN IMMUN, V111, P374, DOI 10.1067/mai.2003.58; Kang EM, 2009, IMMUNOL RES, V43, P77, DOI 10.1007/s12026-008-8051-z; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; LUCARELLI G, 1993, NEW ENGL J MED, V329, P840, DOI 10.1056/NEJM199309163291204; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; Sodani P, 2004, BLOOD, V104, P1201, DOI 10.1182/blood-2003-08-2800; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; VOLPP BD, 1993, J CLIN INVEST, V91, P201, DOI 10.1172/JCI116171; Weening RS, 2000, CLIN EXP IMMUNOL, V122, P410, DOI 10.1046/j.1365-2249.2000.01405.x; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yoshida LS, 1998, J BIOL CHEM, V273, P27879, DOI 10.1074/jbc.273.43.27879	40	358	371	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2600	2610		10.1056/NEJMoa1007097	http://dx.doi.org/10.1056/NEJMoa1007097			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190454	Green Accepted			2022-12-24	WOS:000285763700005
J	Fiumara, F; Fioriti, L; Kandel, ER; Hendrickson, WA				Fiumara, Ferdinando; Fioriti, Luana; Kandel, Eric R.; Hendrickson, Wayne A.			Essential Role of Coiled Coils for Aggregation and Activity of Q/N-Rich Prions and PolyQ Proteins	CELL			English	Article							CRYSTAL-STRUCTURE; SECONDARY STRUCTURE; TERMINAL DOMAIN; GLUTAMINE-RICH; APLYSIA CPEB; YEAST; SEQUENCE; PEPTIDES; ANGSTROM; FIBRILS	The functional switch of glutamine/asparagine (Q/N)-rich prions and the neurotoxicity of polyQ-expanded proteins involve complex aggregation-prone structural transitions, commonly presumed to be forming beta sheets. By analyzing sequences of interaction partners of these proteins, we discovered a recurrent presence of coiled-coil domains both in the partners and in segments that flank or overlap Q/N-rich and polyQ domains. Since coiled coils can mediate protein interactions and multimerization, we studied their possible involvement in Q/N-rich and polyQ aggregations. Using circular dichroism and chemical crosslinking, we found that Q/N-rich and polyQ peptides form alpha-helical coiled coils in vitro and assemble into multimers. Using structure-guided mutagenesis, we found that coiled-coil domains modulate in vivo properties of two Q/N-rich prions and polyQ-expanded huntingtin. Mutations that disrupt coiled coils impair aggregation and activity, whereas mutations that enhance coiled-coil propensity promote aggregation. These findings support a coiled-coil model for the functional switch of Q/N-rich prions and for the pathogenesis of polyQ-expansion diseases.	[Fiumara, Ferdinando; Fioriti, Luana; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Fioriti, Luana; Kandel, Eric R.; Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Fiumara, Ferdinando] Univ Turin, Dept Neurosci, I-10124 Turin, Italy	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of Turin	Kandel, ER (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	erk5@columbia.edu; wayne@convex.hhmi.columbia.edu	Fiumara, Ferdinando/AAE-3074-2022; Fioriti, Luana/AAN-7207-2021	fioriti, luana/0000-0003-2429-8967; FIUMARA, Ferdinando/0000-0003-0715-7863	HHMI; Mathers Foundation; Broitman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Mathers Foundation; Broitman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Emi Ling for technical support; Francisco Monje, Burkhard Rost, and Ann McDermott for helpful discussions and suggestions; and Craig Bailey, Christoph Kellendonk, and Radegonda Mazzitelli for critical reading of the manuscript. This work was supported by grants from HHMI, Mathers Foundation, and Broitman Foundation.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chang DK, 1999, J STRUCT BIOL, V128, P270, DOI 10.1006/jsbi.1999.4182; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Frost DWH, 2005, BIOPOLYMERS, V80, P26, DOI 10.1002/bip.20188; Gazi AD, 2008, J BIOL CHEM, V283, P34062, DOI 10.1074/jbc.M803408200; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1002, DOI 10.1038/nsb1296-1002; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Harada N, 2010, J STEROID BIOCHEM, V118, P77, DOI 10.1016/j.jsbmb.2009.10.003; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Lathrop R H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P105; Leitgeb B, 2007, J MOL MODEL, V13, P1141, DOI 10.1007/s00894-007-0241-4; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Narayanan S, 2006, CHEMBIOCHEM, V7, P757, DOI 10.1002/cbic.200500382; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Niu Q, 2008, J MOL BIOL, V375, P1197, DOI 10.1016/j.jmb.2007.11.036; Odgren PR, 1996, PROTEINS, V24, P467, DOI 10.1002/(SICI)1097-0134(199604)24:4<467::AID-PROT6>3.0.CO;2-B; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Ono BI, 2008, PRION, V2, P37, DOI 10.4161/pri.2.1.6436; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4; PRUSINER SB, 1987, ANNU REV MED, V38, P381, DOI 10.1146/annurev.me.38.020187.002121; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Schwalbe M, 2010, PROTEINS, V78, P2433, DOI 10.1002/prot.22752; Shin DH, 2006, PROTEIN SCI, V15, P921, DOI 10.1110/ps.051993506; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116	53	171	171	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1121	1135		10.1016/j.cell.2010.11.042	http://dx.doi.org/10.1016/j.cell.2010.11.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183075	Green Accepted, Bronze			2022-12-24	WOS:000285625400010
J	Vacic, V; McCarthy, S; Malhotra, D; Murray, F; Chou, HH; Peoples, A; Makarov, V; Yoon, S; Bhandari, A; Corominas, R; Iakoucheva, LM; Krastoshevsky, O; Krause, V; Larach-Walters, V; Welsh, DK; Craig, D; Kelsoe, JR; Gershon, ES; Leal, SM; Aquila, MD; Morris, DW; Gill, M; Corvin, A; Insel, PA; McClellan, J; King, MC; Karayiorgou, M; Levy, DL; DeLisi, LE; Sebat, J				Vacic, Vladimir; McCarthy, Shane; Malhotra, Dheeraj; Murray, Fiona; Chou, Hsun-Hua; Peoples, Aine; Makarov, Vladimir; Yoon, Seungtai; Bhandari, Abhishek; Corominas, Roser; Iakoucheva, Lilia M.; Krastoshevsky, Olga; Krause, Verena; Larach-Walters, Veronica; Welsh, David K.; Craig, David; Kelsoe, John R.; Gershon, Elliot S.; Leal, Suzanne M.; Aquila, Marie Dell; Morris, Derek W.; Gill, Michael; Corvin, Aiden; Insel, Paul A.; McClellan, Jon; King, Mary-Claire; Karayiorgou, Maria; Levy, Deborah L.; DeLisi, Lynn E.; Sebat, Jonathan			Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia	NATURE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MICRODELETIONS; 7Q	Rare copy number variants (CNVs) have a prominent role in the aetiology of schizophrenia and other neuropsychiatric disorders(1). Substantial risk for schizophrenia is conferred by large (>500-kilobase) CNVs at several loci, including microdeletions at 1q21.1 (ref. 2), 3q29 (ref. 3), 15q13.3 (ref. 2) and 22q11.2 (ref. 4) and microduplication at 16p11.2 (ref. 5). However, these CNVs collectively account for a small fraction (2-4%) of cases, and the relevant genes and neurobiological mechanisms are not well understood. Here we performed a large two-stage genome-wide scan of rare CNVs and report the significant association of copy number gains at chromosome 7q36.3 with schizophrenia. Microduplications with variable breakpoints occurred within a 362-kilobase region and were detected in 29 of 8,290 (0.35%) patients versus 2 of 7,431 (0.03%) controls in the combined sample. All duplications overlapped or were located within 89 kilobases upstream of the vasoactive intestinal peptide receptor gene VIPR2. VIPR2 transcription and cyclic-AMP signalling were significantly increased in cultured lymphocytes from patients with microduplications of 7q36.3. These findings implicate altered vasoactive intestinal peptide signalling in the pathogenesis of schizophrenia and indicate the VPAC2 receptor as a potential target for the development of new antipsychotic drugs.	[Vacic, Vladimir; McCarthy, Shane; Malhotra, Dheeraj; Bhandari, Abhishek; Sebat, Jonathan] Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Cold Spring Harbor, NY 12824 USA; [Vacic, Vladimir] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Malhotra, Dheeraj; Chou, Hsun-Hua; Bhandari, Abhishek; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA USA; [Malhotra, Dheeraj; Chou, Hsun-Hua; Bhandari, Abhishek; Corominas, Roser; Iakoucheva, Lilia M.; Welsh, David K.; Kelsoe, John R.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA; [Murray, Fiona; Aquila, Marie Dell; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Murray, Fiona; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA USA; [Peoples, Aine; Morris, Derek W.; Gill, Michael; Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Peoples, Aine; Morris, Derek W.; Gill, Michael; Corvin, Aiden] Trinity Coll Dublin, Dept Psychiat, Dublin 2, Ireland; [Makarov, Vladimir; Yoon, Seungtai] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY 10029 USA; [Makarov, Vladimir; Yoon, Seungtai] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Krastoshevsky, Olga; Krause, Verena; Levy, Deborah L.] McLean Hosp, Belmont, MA 02478 USA; [Larach-Walters, Veronica] Univ Andres Bello, Fac Med, Santiago, Chile; [Welsh, David K.; Kelsoe, John R.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Welsh, David K.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA USA; [Craig, David] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Kelsoe, John R.; Sebat, Jonathan] Univ Calif San Diego, Inst Genom Med, La Jolla, CA USA; [Gershon, Elliot S.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77025 USA; [Aquila, Marie Dell] Univ Calif San Diego, Div Med Genet, La Jolla, CA USA; [McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [DeLisi, Lynn E.] Boston VA Healthcare Syst, Dept Psychiat, Brockton, MA 02301 USA; [DeLisi, Lynn E.] Harvard Univ, Sch Med, Brockton, MA 02301 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA	Cold Spring Harbor Laboratory; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Trinity College Dublin; Trinity College Dublin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; McLean Hospital; Universidad Andres Bello; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Translational Genomics Research Institute; University of California System; University of California San Diego; University of Chicago; Baylor College of Medicine; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; Harvard University; University of California System; University of California San Diego	Sebat, J (corresponding author), Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Cold Spring Harbor, NY 12824 USA.	jsebat@ucsd.edu	Morris, Derek/AAW-8343-2021; Welsh, David K/G-2277-2011; Corominas, Roser/H-4163-2016; Craig, David Wesley/K-6961-2019	Morris, Derek/0000-0002-3413-570X; Corominas, Roser/0000-0001-8888-5402; Craig, David Wesley/0000-0003-2040-1955; King, Mary-Claire/0000-0001-9426-1743; Corvin, Aiden/0000-0001-6717-4089; Iakoucheva, Lilia/0000-0002-4542-5219; Sebat, Jonathan/0000-0002-9087-526X; Walters, James/0000-0002-6980-4053; Murray, Fiona/0000-0002-5572-4810; Gill, Michael/0000-0003-0206-5337; Vacic, Vladimir/0000-0001-6571-2293	Beyster family foundation; NIH [MH076431, HG04222, MH071523, MH083989, GM66232, HL091061, MH082945, MH061399, MH044245]; NARSAD; Wellcome Trust [072894/Z/03/Z]; Science Foundation Ireland [08INIB1916]; Sidney R. Baer, Jr Foundation; Essel Foundation; Veterans Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071523, R01MH082945, R01MH044245, R01MH083989, R01MH091350, R01MH076431, R01MH061399] Funding Source: NIH RePORTER	Beyster family foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Sidney R. Baer, Jr Foundation; Essel Foundation; Veterans Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a gift from Ted and Vada Stanley to the Cold Spring Harbor Laboratory, a gift to J.S. from the Beyster family foundation, NIH grants to J.S. (MH076431, HG04222), D.L.L. (MH071523), M.-C.K. (MH083989), P.A.I. (GM66232), F.M. (HL091061), D.K.W. (MH082945), M.K. (MH061399), L.E.D. (MH044245), grants to J.S., D.K.W., D.L.L. and M.-C.K from NARSAD, grants to A.C., M.G., D.M. from the Wellcome Trust (072894/Z/03/Z) and Science Foundation Ireland (08INIB1916), a career development award to D.K.W. by the Veterans Administration, and grants to D.L.L. from the Sidney R. Baer, Jr Foundation and Essel Foundation. We wish to thank the Genetic Association Information Network (GAIN), Molecular Genetics of Schizophrenia (MGS) and the Bipolar Genome Study (BiGS) for providing data for this study (investigators listed in the Supplementary Note). We wish to thank B. Trask, R. Malinow and J. Gleeson for discussions.	Bartsch O, 2007, CYTOGENET GENOME RES, V119, P158, DOI 10.1159/000109634; Braun MM, 2010, NAT REV DRUG DISCOV, V9, P519, DOI 10.1038/nrd3160; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Chu A, 2010, MOL PHARMACOL, V77, P95, DOI 10.1124/mol.109.060137; FAHRENKRUG J, 1993, PHARMACOL TOXICOL, V72, P354, DOI 10.1111/j.1600-0773.1993.tb01344.x; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Morava E, 2003, CLIN DYSMORPHOL, V12, P123, DOI 10.1097/01.mcd.0000059768.40218.9b; Moreno D, 2000, PEPTIDES, V21, P1543, DOI 10.1016/S0196-9781(00)00309-0; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; SHEWARD WJ, 1995, NEUROSCIENCE, V67, P409, DOI 10.1016/0306-4522(95)00048-N; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Turetsky BI, 2009, AM J PSYCHIAT, V166, P226, DOI 10.1176/appi.ajp.2008.07071210; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WASCHEK JA, 1995, DEV NEUROSCI-BASEL, V17, P1, DOI 10.1159/000111268; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72; Yang K, 2009, HIPPOCAMPUS, V19, P779, DOI 10.1002/hipo.20559; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	30	239	251	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					499	503		10.1038/nature09884	http://dx.doi.org/10.1038/nature09884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21346763	Green Accepted, Green Submitted			2022-12-24	WOS:000288702200059
J	Perrings, C; Duraiappah, A; Larigauderie, A; Mooney, H				Perrings, Charles; Duraiappah, Anantha; Larigauderie, Anne; Mooney, Harold			The Biodiversity and Ecosystem Services Science-Policy Interface	SCIENCE			English	Editorial Material							GLOBAL BIODIVERSITY		[Perrings, Charles] Arizona State Univ, Sch Life Sci, IPBES Proc, ICSU, Tempe, AZ 85287 USA; [Duraiappah, Anantha] United Nations Univ, IHDP, D-53113 Bonn, Germany; [Larigauderie, Anne] Museum Natl Hist Nat, DIVERSITAS, F-75231 Paris, France; [Mooney, Harold] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Arizona State University; Arizona State University-Tempe; Museum National d'Histoire Naturelle (MNHN); Stanford University	Perrings, C (corresponding author), Arizona State Univ, Sch Life Sci, IPBES Proc, ICSU, Tempe, AZ 85287 USA.	charles.perrings@asu.edu			Division Of Behavioral and Cognitive Sci [1134890] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Andrefouet S, 2008, GEO BIODIVERSITY OBS; [Anonymous], 1995, GLOBAL BIODIVERSITY; Bolin B, 2007, HISTORY OF THE SCIENCE AND POLITICS OF CLIMATE CHANGE: THE ROLE OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P1, DOI 10.1017/CBO9780511721731; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; *CBD, 2010, C PART 10 CBD DOC, P10; Convention on Biological Diversity, 2010, GLOB BIOD OUTL; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Kumar P., 2010, EC ECOSYSTEMS BIODIV; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; *MILL EC ASS, 2005, EC HUM WELL BEING GE; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Reid WV, 2010, SCIENCE, V330, P916, DOI 10.1126/science.1196263; Reid WV, 2009, SCIENCE, V325, P245, DOI 10.1126/science.1178591; Shapiro H. T., 2010, CLIMATE CHANGE ASSES; *UN GEN ASS, GEN ASS UN RES 64 SE; UNEP, 2010, GREEN EC DRIV GREEN; Van Kersberen K, 2004, COMP EUROPEAN POLITI, V2, P142, DOI DOI 10.1057/PALGRAVE.CEP.6110033; BUSAN OUTCOME; STRATEGIC PLAN INCLU	23	212	230	2	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1139	1140		10.1126/science.1202400	http://dx.doi.org/10.1126/science.1202400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729SN	21330488				2022-12-24	WOS:000287971200024
J	Regot, S; Macia, J; Conde, N; Furukawa, K; Kjellen, J; Peeters, T; Hohmann, S; de Nadal, E; Posas, F; Sole, R				Regot, Sergi; Macia, Javier; Conde, Nuria; Furukawa, Kentaro; Kjellen, Jimmy; Peeters, Tom; Hohmann, Stefan; de Nadal, Eulalia; Posas, Francesc; Sole, Ricard			Distributed biological computation with multicellular engineered networks	NATURE			English	Article							SYNTHETIC BIOLOGY; COMMUNICATION; PARTS	Ongoing efforts within synthetic and systems biology have been directed towards the building of artificial computational devices(1) using engineered biological units as basic building blocks(2,3). Such efforts, inspired in the standard design of electronic circuits(4-7), are limited by the difficulties arising from wiring the basic computational units (logic gates) through the appropriate connections, each one to be implemented by a different molecule. Here, we show that there is a logically different form of implementing complex Boolean logic computations that reduces wiring constraints thanks to a redundant distribution of the desired output among engineered cells. A practical implementation is presented using a library of engineered yeast cells, which can be combined in multiple ways. Each construct defines a logic function and combining cells and their connections allow building more complex synthetic devices. As a proof of principle, we have implemented many logic functions by using just a few engineered cells. Of note, small modifications and combination of those cells allowed for implementing more complex circuits such as a multiplexer or a 1-bit adder with carry, showing the great potential for re-utilization of small parts of the circuit. Our results support the approach of using cellular consortia as an efficient way of engineering complex tasks not easily solvable using single-cell implementations.	[Macia, Javier; Conde, Nuria; Sole, Ricard] UPF, ICREA Complex Syst Lab, E-08003 Barcelona, Spain; [Regot, Sergi; Conde, Nuria; Peeters, Tom; de Nadal, Eulalia; Posas, Francesc] UPF, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; [Furukawa, Kentaro; Kjellen, Jimmy; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden; [Sole, Ricard] Santa Fe Inst, Santa Fe, NM 87501 USA; [Sole, Ricard] UPF, CSIC, Inst Biol Evolut, E-08003 Barcelona, Spain	ICREA; Pompeu Fabra University; Pompeu Fabra University; University of Gothenburg; The Santa Fe Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Sole, R (corresponding author), UPF, ICREA Complex Syst Lab, E-08003 Barcelona, Spain.	francesc.posas@upf.edu; ricard.sole@upf.edu	Posas, Francesc/K-1364-2013; Conde, Núria/ABC-5973-2021; Hohmann, Stefan/K-9895-2013; de Nadal, Eulalia/J-8178-2014	Posas, Francesc/0000-0002-4164-7076; Conde, Nuria/0000-0001-5766-309X; Hohmann, Stefan/0000-0002-0809-1985; de Nadal, Eulalia/0000-0003-0039-5607; Sole, Ricard/0000-0001-6974-1008; Peeters, Tom/0000-0003-3929-9559; Furukawa, Kentaro/0000-0002-1551-1538; Regot, Sergi/0000-0001-9786-3897	FPU (Spanish Government); James McDonnell Foundation; MICINN [BIO2009-07762, FIS2009-12365]; Consolider Ingenio 2010 programme [CSD2007-0015]; ESF [ERAS-CT-2003-980409]; CELLCOMPUT (FP6) project; FP7 UNICELLSYS [201142]; Santa Fe Institute; Fundacion Marcelino Botin (FMB); ICREA Academia (Generalitat de Catalunya); ICREA Funding Source: Custom	FPU (Spanish Government)(Spanish Government); James McDonnell Foundation; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Consolider Ingenio 2010 programme(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ESF(European Commission); CELLCOMPUT (FP6) project(European Commission); FP7 UNICELLSYS; Santa Fe Institute; Fundacion Marcelino Botin (FMB); ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); ICREA(ICREA)	We thank L. Subirana and S. Ovejas for technical support and S. Pellet and M. Peter for their help in setting up the microfluidics platform, and K. Kuchler for the FUS1-mCherry construct. S. R. is recipient of a FPU fellowship (Spanish Government). This work was supported by grants from the James McDonnell Foundation to R. S., the MICINN (BIO2009-07762 and FIS2009-12365); Consolider Ingenio 2010 programme (grant CSD2007-0015), from the ESF (ERAS-CT-2003-980409) FP6 as part of a EURYI scheme award (www.esf.org/euryi) to F. P. and the CELLCOMPUT (FP6) project to F. P., R. S. and S. H., and FP7 UNICELLSYS grant (#201142) to F. P. and S. H., and The Santa Fe Institute to R. S.; F. P. and R. S. laboratories are also supported by the Fundacion Marcelino Botin (FMB). F. P. is recipient of an ICREA Academia (Generalitat de Catalunya).	Amos M, 2004, SER SYST BIOL, P3; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; ARKIN A, 1994, BIOPHYS J, V67, P560, DOI 10.1016/S0006-3495(94)80516-8; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chin JW, 2006, CURR OPIN STRUC BIOL, V16, P551, DOI 10.1016/j.sbi.2006.06.011; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Greber D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq671; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	27	211	219	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					207	211		10.1038/nature09679	http://dx.doi.org/10.1038/nature09679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21150900				2022-12-24	WOS:000286143400037
J	Berkes, P; Orban, G; Lengyel, M; Fiser, J				Berkes, Pietro; Orban, Gergo; Lengyel, Mate; Fiser, Jozsef			Spontaneous Cortical Activity Reveals Hallmarks of an Optimal Internal Model of the Environment	SCIENCE			English	Article							BAYESIAN-INFERENCE; NATURAL SCENES; VISUAL-CORTEX; POPULATION; PERCEPTION; EMERGENCE	The brain maintains internal models of its environment to interpret sensory inputs and to prepare actions. Although behavioral studies have demonstrated that these internal models are optimally adapted to the statistics of the environment, the neural underpinning of this adaptation is unknown. Using a Bayesian model of sensory cortical processing, we related stimulus-evoked and spontaneous neural activities to inferences and prior expectations in an internal model and predicted that they should match if the model is statistically optimal. To test this prediction, we analyzed visual cortical activity of awake ferrets during development. Similarity between spontaneous and evoked activities increased with age and was specific to responses evoked by natural scenes. This demonstrates the progressive adaptation of internal models to the statistics of natural stimuli at the neural level.	[Berkes, Pietro; Orban, Gergo; Fiser, Jozsef] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA; [Orban, Gergo] Hungarian Acad Sci, Res Inst Particle & Nucl Phys, Dept Biophys, H-1121 Budapest, Hungary; [Orban, Gergo; Lengyel, Mate] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Fiser, Jozsef] Brandeis Univ, Dept Psychol, Waltham, MA 02454 USA; [Fiser, Jozsef] Brandeis Univ, Neurosci Program, Waltham, MA 02454 USA; [Fiser, Jozsef] Coll Budapest Inst Adv Study, H-1014 Budapest, Hungary	Brandeis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; University of Cambridge; Brandeis University; Brandeis University	Berkes, P (corresponding author), Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA.	berkes@brandeis.edu	Lengyel, Mate/A-6665-2013	Lengyel, Mate/0000-0001-7266-0049; Orban, Gergo/0000-0002-2406-5912; Fiser, Jozsef/0000-0002-7064-0690; Berkes, Pietro/0000-0002-2827-3911	Swartz Foundation; Swiss National Science Foundation; EU; Wellcome Trust; NIH; NATIONAL EYE INSTITUTE [R01EY018196] Funding Source: NIH RePORTER	Swartz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Wolpert and D. Katz for suggestions on the manuscript, C. Chiu and M. Weliky for help with the data collection, and D. Lisitsyn for technical help. This work was supported by the Swartz Foundation (J.F., G.O., and P.B.), the Swiss National Science Foundation (P.B.), an EU-FP7 Marie Curie Intra-European Fellowship (G.O.), the Wellcome Trust (M.L.), and NIH (J.F.).	Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Dayan P., 1999, THEORETICAL NEUROSCI; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; Hoyer P., 2003, ADV NEURAL INFORM PR, V16, P293; Jaynes E.T., 2003, PROBABILITY THEORY L; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Teh YW, 2004, J MACH LEARN RES, V4, P1235; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	22	399	400	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					83	87		10.1126/science.1195870	http://dx.doi.org/10.1126/science.1195870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212356	Green Accepted			2022-12-24	WOS:000285974000041
J	Yazawa, M; Hsueh, B; Jia, XL; Pasca, AM; Bernstein, JA; Hallmayer, J; Dolmetsch, RE				Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Bernstein, Jonathan A.; Hallmayer, Joachim; Dolmetsch, Ricardo E.			Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome	NATURE			English	Article							GATING MECHANISMS; SYNDROME MUTATION; SUDDEN-DEATH; CHANNELS; CARDIOMYOCYTES; ROSCOVITINE; ARRHYTHMIA; INHIBITOR; MYOCYTES	Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia(1,2). LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors(1,3). A missense mutation in the L-type calcium channel Ca(V)1.2 leads to LQTS in patients with Timothy syndrome(4,5). To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca2+) imaging studies of these cells revealed irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca(V)1.2 (refs 6-8), restored the electrical and Ca2+ signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.	[Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu		Jia, Xiaolin/0000-0002-2172-4716	Japan Society for the Promotion for Science; American Heart Association Western States; National Institutes of Health; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099904, R21MH087898] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	Japan Society for the Promotion for Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association Western States(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the Timothy syndrome patients who participated in this study; U. Francke for discussion and for providing karyotyping expertise; A. Cherry and D. Bangs for fibroblast isolation; K. C. Chan for iPSC cultures; O. Shcheglovitov for help with electrophysiological recordings; and A. Olson for help with the confocal microscope. Funding was provided by grants from the Japan Society for the Promotion for Science and the American Heart Association Western States to M.Y., and a National Institutes of Health Director's Pioneer Award, a grant from the Simons Foundation to R.E.D and gifts from L. Miller, B. and F. Horowitz and M. McCaffery.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Keating MT, 1996, MEDICINE, V75, P1, DOI 10.1097/00005792-199601000-00001; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Paakkari I, 2002, TOXICOL LETT, V127, P279, DOI 10.1016/S0378-4274(01)00510-0; REUTER H, 1984, ANNU REV PHYSIOL, V46, P473; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Yarotskyy V, 2007, BRIT J PHARMACOL, V152, P386, DOI 10.1038/sj.bjp.0707414; Yarotskyy V, 2010, J BIOL CHEM, V285, P43, DOI 10.1074/jbc.M109.076448; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	27	474	489	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					230	U120		10.1038/nature09855	http://dx.doi.org/10.1038/nature09855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21307850	Green Accepted			2022-12-24	WOS:000288170200040
J	Gohler, B; Hamelbeck, V; Markus, TZ; Kettner, M; Hanne, GF; Vager, Z; Naaman, R; Zacharias, H				Goehler, B.; Hamelbeck, V.; Markus, T. Z.; Kettner, M.; Hanne, G. F.; Vager, Z.; Naaman, R.; Zacharias, H.			Spin Selectivity in Electron Transmission Through Self-Assembled Monolayers of Double-Stranded DNA	SCIENCE			English	Article							LOW-ENERGY ELECTRONS; SCATTERING; POLARIZATION; FILMS; GOLD; SPINTRONICS; METALS	In electron-transfer processes, spin effects normally are seen either in magnetic materials or in systems containing heavy atoms that facilitate spin-orbit coupling. We report spin-selective transmission of electrons through self-assembled monolayers of double-stranded DNA on gold. By directly measuring the spin of the transmitted electrons with a Mott polarimeter, we found spin polarizations exceeding 60% at room temperature. The spin-polarized photoelectrons were observed even when the photoelectrons were generated with unpolarized light. The observed spin selectivity at room temperature was extremely high as compared with other known spin filters. The spin filtration efficiency depended on the length of the DNA in the monolayer and its organization.	[Markus, T. Z.; Naaman, R.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Goehler, B.; Hamelbeck, V.; Kettner, M.; Hanne, G. F.; Zacharias, H.] Univ Munster, Inst Phys, D-48149 Munster, Germany; [Vager, Z.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel	Weizmann Institute of Science; University of Munster; Weizmann Institute of Science	Naaman, R (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	ron.naaman@weizmann.ac.il	Markus, Tal Z/C-8905-2011	Zacharias, Helmut/0000-0001-9807-1103	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	T.Z.M. and R.N. acknowledge the partial support from the Israel Science Foundation.	Aqua T, 2003, LANGMUIR, V19, P10573, DOI 10.1021/la035116y; Awschalom DD, 2007, NAT PHYS, V3, P153, DOI 10.1038/nphys551; Brede J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047204; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Cacho C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066601; Drouhin HJ, 1997, PHYS REV B, V56, P14886, DOI 10.1103/PhysRevB.56.14886; GELLRICH A, 1991, PHYS REV A, V43, P204, DOI 10.1103/PhysRevA.43.204; GETZLAFF M, 1993, SOLID STATE COMMUN, V87, P467, DOI 10.1016/0038-1098(93)90799-S; Grobli C., 1995, PHYS REV B, V51, P2945; LASSAILLY Y, 1994, PHYS REV B, V50, P13054, DOI 10.1103/PhysRevB.50.13054; Levy N, 2010, SCIENCE, V329, P544, DOI 10.1126/science.1191700; Markus TZ, 2009, J AM CHEM SOC, V131, P89, DOI 10.1021/ja804177j; MARUYAMA T, 1991, PHYS REV LETT, V66, P2376, DOI 10.1103/PhysRevLett.66.2376; MAYER S, 1995, PHYS REV LETT, V74, P4803, DOI 10.1103/PhysRevLett.74.4803; Mott NF, 1932, P R SOC LOND A-CONTA, V135, P429, DOI 10.1098/rspa.1932.0044; Mott NF, 1929, P R SOC LOND A-CONTA, V124, P425, DOI 10.1098/rspa.1929.0127; Naaman R, 2010, MRS BULL, V35, P429, DOI 10.1557/mrs2010.580; Oberli D, 1998, PHYS REV LETT, V81, P4228, DOI 10.1103/PhysRevLett.81.4228; PAPPAS DP, 1991, PHYS REV LETT, V66, P504, DOI 10.1103/PhysRevLett.66.504; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Ray K, 1999, SCIENCE, V283, P814, DOI 10.1126/science.283.5403.814; Ray SG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036101; Ron H, 1998, LANGMUIR, V14, P1116, DOI 10.1021/la970785v; SCHONHENSE G, 1993, ANN PHYS-LEIPZIG, V2, P465, DOI 10.1002/andp.19935050504; Skourtis SS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238103; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yeganeh S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167404	29	451	457	24	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					894	897		10.1126/science.1199339	http://dx.doi.org/10.1126/science.1199339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330541				2022-12-24	WOS:000287455100052
J	Li, QX; Kannan, A; DeMayo, FJ; Lydon, JP; Cooke, PS; Yamagishi, H; Srivastava, D; Bagchi, MK; Bagchi, IC				Li, Quanxi; Kannan, Athilakshmi; DeMayo, Francesco J.; Lydon, John P.; Cooke, Paul S.; Yamagishi, Hiroyuki; Srivastava, Deepak; Bagchi, Milan K.; Bagchi, Indrani C.			The Antiproliferative Action of Progesterone in Uterine Epithelium Is Mediated by Hand2	SCIENCE			English	Article							GROWTH-FACTOR; MOUSE UTERUS; IMPLANTATION; INHIBITION; RECEPTOR; PROLIFERATION; CANCER	During pregnancy, progesterone inhibits the growth-promoting actions of estrogen in the uterus. However, the mechanism for this is not clear. The attenuation of estrogen-mediated proliferation of the uterine epithelium by progesterone is a prerequisite for successful implantation. Our study reveals that progesterone-induced expression of the basic helix-loop-helix transcription factor Hand2 in the uterine stroma suppresses the production of several fibroblast growth factors (FGFs) that act as paracrine mediators of mitogenic effects of estrogen on the epithelium. In mouse uteri lacking Hand2, continued induction of these FGFs in the stroma maintains epithelial proliferation and stimulates estrogen-induced pathways, resulting in impaired implantation. Thus, Hand2 is a critical regulator of the uterine stromal-epithelial communication that directs proper steroid regulation conducive for the establishment of pregnancy.	[Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61820 USA; [DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yamagishi, Hiroyuki] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Li, Quanxi; Kannan, Athilakshmi; Cooke, Paul S.; Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Keio University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Illinois System; University of Illinois Urbana-Champaign	Bagchi, MK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61820 USA.	mbagchi@life.illinois.edu; ibagchi@illinois.edu	Yamagishi, Hiroyuki/A-6345-2017; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Cooke, Paul/0000-0002-9370-4896	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [U54HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Laws for genotyping and Y. Li for immunohistochemistry. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, through U54HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. The Gene Expression Omnibus (GEO) microarray accession number is GSE25881.	Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; Bagchi IC, 2003, FRONT BIOSCI-LANDMRK, V8, pS852, DOI 10.2741/1148; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINN CA, 1974, J REPROD FERTIL, V39, P195, DOI 10.1530/jrf.0.0390195; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Pan HY, 2006, P NATL ACAD SCI USA, V103, P14021, DOI 10.1073/pnas.0601271103; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639	18	243	257	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					912	916		10.1126/science.1197454	http://dx.doi.org/10.1126/science.1197454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330545	Green Accepted			2022-12-24	WOS:000287455100058
J	Janes, H; Pepe, MS; Bossuyt, PM; Barlow, WE				Janes, Holly; Pepe, Margaret S.; Bossuyt, Patrick M.; Barlow, William E.			Measuring the Performance of Markers for Guiding Treatment Decisions	ANNALS OF INTERNAL MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; VALIDATION; CANCER; PREDICTIVENESS; CHEMOTHERAPY	Treatment selection markers, sometimes called predictive markers, are factors that help clinicians select therapies that maximize good outcomes and minimize adverse outcomes for patients. Existing statistical methods for evaluating a treatment selection marker include assessing its prognostic value, evaluating treatment effects in patients with a restricted range of marker values, and testing for a statistical interaction between marker value and treatment. These methods are inadequate, because they give misleading measures of performance that do not answer key clinical questions about how the marker might help patients choose treatment, how treatment decisions should be made on the basis of a continuous marker measurement, what effect using the marker to select treatment would have on the population, or what proportion of patients would have treatment changes on the basis of marker measurement. Marker-by-treatment predictiveness curves are proposed as a more useful aid to answering these clinically relevant questions, because they illustrate treatment effects as a function of marker value, outcomes when using or not using the marker to select treatment, and the proportion of patients for whom treatment recommendations change after marker measurement. Randomized therapeutic clinical trials, in which entry criteria and treatment regimens are not restricted by the marker, are also proposed as the basis for constructing the curves and evaluating and comparing markers.	[Janes, Holly] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Fred Hutchinson Cancer Center; University of Amsterdam; Academic Medical Center Amsterdam	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M2 C200, Seattle, WA 98109 USA.	hjanes@fhcrc.org	Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128	National Institutes of Health [R01CA152089]; NATIONAL CANCER INSTITUTE [R01CA152089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Institutes of Health (grant R01CA152089).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Buyse M, 2007, EJC SUPPL, V5, P89, DOI 10.1016/S1359-6349(07)70028-9; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Freidlin B, 2005, CLIN CANCER RES, V11, P7872, DOI 10.1158/1078-0432.CCR-05-0605; Huang Y, 2007, BIOMETRICS, V63, P1181, DOI 10.1111/j.1541-0420.2007.00814.x; Lazar AA, 2010, J CLIN ONCOL, V28, P4539, DOI 10.1200/JCO.2009.27.9182; NCCN, 2010, NCCN CLIN PRACT GUID; Oratz R, 2007, J ONCOL PRACT, V3, P182, DOI 10.1200/JOP.0742001; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Simon R, 2008, J STAT PLAN INFER, V138, P308, DOI 10.1016/j.jspi.2007.06.010; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Song XY, 2004, ACTA CRYSTALLOGR E, V60, pO1919, DOI 10.1107/S1600536804024250; Stern RH, 2008, J CLIN HYPERTENS, V10, P485, DOI 10.1111/j.1751-7176.2008.07814.x; Vickers AJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-14; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	25	100	100	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					253	W80		10.7326/0003-4819-154-4-201102150-00006	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320940	Green Accepted			2022-12-24	WOS:000287310000017
J	Lin, JZ; Lai, SM; Jia, R; Xu, AB; Zhang, LM; Lu, J; Ye, KQ				Lin, Jinzhong; Lai, Shaomei; Jia, Ru; Xu, Anbi; Zhang, Liman; Lu, Jing; Ye, Keqiong			Structural basis for site-specific ribose methylation by box C/D RNA protein complexes	NATURE			English	Article							CRYSTAL-STRUCTURE; SOLUBLE-RNA; CORE; 2'-O-METHYLATION; REQUIREMENT; RNPS	Box C/D RNA protein complexes (RNPs) direct site-specific 2'-O-methylation of RNA and ribosome assembly(1-4). The guide RNA in C/D RNP forms base pairs with complementary substrates and selects the modification site using a molecular ruler(5-7). Despite many studies of C/D RNP structure(8-25), the fundamental questions of how C/D RNAs assemble into RNPs and how they guide modification remain unresolved. Here we report the crystal structure of an entire catalytically active archaeal C/D RNP consisting of a bipartite C/D RNA associated with two substrates and two copies each of Nop5, L7Ae and fibrillarin at 3.15-angstrom resolution. The substrate pairs with the second through the eleventh nucleotide of the 12-nucleotide guide, and the resultant duplex is bracketed in a channel with flexible ends. The methyltransferase fibrillarin binds to an undistorted A-form structure of the guide-substrate duplex and specifically loads the target ribose into the active site. Because interaction with the RNA duplex alone does not determine the site specificity, fibrillarin is further positioned by non-specific and specific protein interactions. Compared with the structure of the inactive C/D RNP, extensive domain movements are induced by substrate loading. Our results reveal the organization of a monomeric C/D RNP and the mechanism underlying its site-specific methylation activity.	[Lin, Jinzhong; Lai, Shaomei; Jia, Ru; Xu, Anbi; Zhang, Liman; Lu, Jing; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Liman; Lu, Jing] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Zhang, Liman; Lu, Jing] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ye, KQ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526	Chinese Ministry of Science and Technology [2008AA022310]; Beijing Municipal Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government	We are grateful to the staff at the Shanghai Synchrotron Radiation Facility beamline BL17U for assistance in data collection and to B. Zhu for help with the methylation assay. This research was supported by the Chinese Ministry of Science and Technology (863 grant 2008AA022310) and the Beijing Municipal Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Appel CD, 2007, RNA, V13, P899, DOI 10.1261/rna.517307; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chen CL, 2007, J MOL BIOL, V369, P771, DOI 10.1016/j.jmb.2007.03.052; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hardin JW, 2006, NUCLEIC ACIDS RES, V34, P5039, DOI 10.1093/nar/gkl644; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Omer AD, 2006, RNA, V12, P1708, DOI 10.1261/rna.31506; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	37	91	95	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					559	U140		10.1038/nature09688	http://dx.doi.org/10.1038/nature09688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270896				2022-12-24	WOS:000286596500038
J	Bodemann, BO; Orvedahl, A; Cheng, TL; Ram, RR; Ou, YH; Formstecher, E; Maiti, M; Hazelett, CC; Wauson, EM; Balakireva, M; Camonis, JH; Yeaman, C; Levine, B; White, MA				Bodemann, Brian O.; Orvedahl, Anthony; Cheng, Tzuling; Ram, Rosalyn R.; Ou, Yi-Hung; Formstecher, Etienne; Maiti, Mekhala; Hazelett, C. Clayton; Wauson, Eric M.; Balakireva, Maria; Camonis, Jacques H.; Yeaman, Charles; Levine, Beth; White, Michael A.			RalB and the Exocyst Mediate the Cellular Starvation Response by Direct Activation of Autophagosome Assembly	CELL			English	Article							PROTEIN CONJUGATION SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASE; EFFECTOR COMPLEX; DISTINCT ROLES; BECLIN 1; MEMBRANE; KINASE; YEAST; GTPASES; MACROAUTOPHAGY	The study of macroautophagy in mammalian cells has described induction, vesicle nucleation, and membrane elongation complexes as key signaling intermediates driving autophagosome biogenesis. How these components are recruited to nascent autophagosomes is poorly understood, and although much is known about signaling mechanisms that restrain autophagy, the nature of positive inductive signals that can promote autophagy remain cryptic. We find that the Ras-like small G protein, RalB, is localized to nascent autophagosomes and is activated on nutrient deprivation. RalB and its effector Exo84 are required for nutrient starvation-induced autophagocytosis, and RalB activation is sufficient to promote autophagosome formation. Through direct binding to Exo84, RalB induces the assembly of catalytically active ULK1 and Beclin1-VPS34 complexes on the exocyst, which are required for isolation membrane formation and maturation. Thus, RalB signaling is a primary adaptive response to nutrient limitation that directly engages autophagocytosis through mobilization of the core vesicle nucleation machinery.	[Bodemann, Brian O.; Cheng, Tzuling; Ram, Rosalyn R.; Ou, Yi-Hung; Maiti, Mekhala; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Microbiol, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Wauson, Eric M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Formstecher, Etienne] Hybrigenics Inc, F-75014 Paris, France; [Hazelett, C. Clayton; Yeaman, Charles] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Balakireva, Maria; Camonis, Jacques H.] INSERM, Inst Curie, U548, F-75248 Paris, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Yeaman, Charles A/A-1624-2009	Yeaman, Charles/0000-0001-6149-628X; Ou, Yi-Hung/0000-0002-9909-7791; FORMSTECHER, Etienne/0000-0002-6410-4365	National Institutes of Health [CA71443, CA129451, CA84254, CA109618]; GenHomme Network [02490-6088]; Welch Foundation [I-1414]; DOD [W81XWH-06-1-0749]; CPRIT [RP101496];  [ARC4845];  [T32GM008203]; NATIONAL CANCER INSTITUTE [R01CA071443, R01CA084254, R56CA109618, R01CA129451, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002, T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GenHomme Network; Welch Foundation(The Welch Foundation); DOD(United States Department of Defense); CPRIT; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Noboru Mishuzima for GFP-Atg5 and GFP-LC3, Zhenyu Yue for Flag-ATG14L and Flag-RUBICON, and Noriko Okazaki for HA-ULK1 and HA-ULK1(K46N). We thank members of the White and Levine labs for productive discussions. We thank Melanie Cobb for helpful discussion and assistance with kinase assays. This work was supported by grants from the National Institutes of Health (CA71443 and CA129451 to M.W. and CA84254 and CA109618 to B.L.), ARC4845 and GenHomme Network Grant 02490-6088 to J.C., and the Welch Foundation (I-1414 to M.W.). B.B. was supported by DOD Award Number W81XWH-06-1-0749. R.R. was supported by T32GM008203. Y.O. was supported by CPRIT RP101496.	Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Bhuvanakantham R, 2010, CELL MICROBIOL, V12, P453, DOI 10.1111/j.1462-5822.2009.01407.x; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jung C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/3/035607; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	61	232	242	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					253	267		10.1016/j.cell.2010.12.018	http://dx.doi.org/10.1016/j.cell.2010.12.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241894	Bronze, Green Accepted			2022-12-24	WOS:000286459900010
J	Rust, MJ; Golden, SS; O'Shea, EK				Rust, Michael J.; Golden, Susan S.; O'Shea, Erin K.			Light-Driven Changes in Energy Metabolism Directly Entrain the Cyanobacterial Circadian Oscillator	SCIENCE			English	Article							SYNECHOCOCCUS-ELONGATUS; KAIC PHOSPHORYLATION; CLOCK PROTEIN; ATP LEVEL; RHYTHMS; INHIBITORS; FIXATION; LDPA; PH	Circadian clocks are self-sustained biological oscillators that can be entrained by environmental cues. Although this phenomenon has been studied in many organisms, the molecular mechanisms of entrainment remain unclear. Three cyanobacterial proteins and adenosine triphosphate (ATP) are sufficient to generate oscillations in phosphorylation in vitro. We show that changes in illumination that induce a phase shift in cultured cyanobacteria also cause changes in the ratio of ATP to adenosine diphosphate (ADP). When these nucleotide changes are simulated in the in vitro oscillator, they cause phase shifts similar to those observed in vivo. Physiological concentrations of ADP inhibit kinase activity in the oscillator, and a mathematical model constrained by data shows that this effect is sufficient to quantitatively explain entrainment of the cyanobacterial circadian clock.	[Rust, Michael J.; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rust, Michael J.; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, Ctr Chronobiol, La Jolla, CA 92093 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Diego	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.	eoshea@mcb.harvard.edu			NIH [GM62419]; Helen Hay Whitney Foundation; Burroughs-Wellcome Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Burroughs-Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Dong for advice on culture conditions, and K. Cook, V. Denic, Q. Justman, J. Markson, A. Rizvi, and V. Vijayan for valuable discussions and comments on the manuscript. E.K.O. is an investigator of the Howard Hughes Medical Institute. Supported by NIH grant GM62419 (S. S. G.), a Helen Hay Whitney Foundation postdoctoral fellowship (M. J. R.), and a Burroughs-Wellcome Foundation Career Award at the Scientific Interface (M.J.R.).	Andersson CR, 2000, METHOD ENZYMOL, V305, P527; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BORNEFELD T, 1974, PLANTA, V115, P309, DOI 10.1007/BF00388613; IHLENFELDT MJA, 1975, ARCH MICROBIOL, V102, P13, DOI 10.1007/BF00428339; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Katayama M, 2003, J BACTERIOL, V185, P1415, DOI 10.1128/JB.185.4.1415-1422.2003; Kiyohara YB, 2005, J BACTERIOL, V187, P2559, DOI 10.1128/JB.187.8.2559-2564.2005; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LUBBERDING HJ, 1984, FEMS MICROBIOL LETT, V22, P93; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; SCHERER S, 1988, PHOTOSYNTH RES, V15, P95, DOI 10.1007/BF00035255; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Wood TL, 2010, P NATL ACAD SCI USA, V107, P5804, DOI 10.1073/pnas.0910141107; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101	27	140	140	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					220	223		10.1126/science.1197243	http://dx.doi.org/10.1126/science.1197243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233390	Green Accepted			2022-12-24	WOS:000286433100044
J	Deutsch, GB; Zielonka, EM; Coutandin, D; Weber, TA; Schafer, B; Hannewald, J; Luh, LM; Durst, FG; Ibrahim, M; Hoffmann, J; Niesen, FH; Senturk, A; Kunkel, H; Brutschy, B; Schleiff, E; Knapp, S; Acker-Palmer, A; Grez, M; McKeon, F; Dotsch, V				Deutsch, Gregor B.; Zielonka, Elisabeth M.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Hannewald, Jens; Luh, Laura M.; Durst, Florian G.; Ibrahim, Mohamed; Hoffmann, Jan; Niesen, Frank H.; Sentuerk, Aycan; Kunkel, Hana; Brutschy, Bernd; Schleiff, Enrico; Knapp, Stefan; Acker-Palmer, Amparo; Grez, Manuel; McKeon, Frank; Doetsch, Volker			DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63 alpha from Dimer to Tetramer	CELL			English	Article							P53 TUMOR-SUPPRESSOR; STRUCTURAL EVOLUTION; MASS-SPECTROMETRY; MUTANT P53; GERM-LINE; P63; PROTEIN; DOMAIN; HOMOLOG; P73	TAp63 alpha, a homolog of the p53 tumor suppressor, is a quality control factor in the female germline. Remarkably, already undamaged oocytes express high levels of the protein, suggesting that TAp63 alpha's activity is under tight control of an inhibitory mechanism. Biochemical studies have proposed that inhibition requires the C-terminal transactivation inhibitory domain. However, the structural mechanism of TAp63 alpha inhibition remains unknown. Here, we show that TAp63 alpha is kept in an inactive dimeric state. We reveal that relief of inhibition leads to tetramer formation with similar to 20-fold higher DNA affinity. In vivo, phosphorylation-triggered tetramerization of TAp63 alpha is not reversible by dephosphorylation. Furthermore, we show that a helix in the oligomerization domain of p63 is crucial for tetramer stabilization and competes with the transactivation domain for the same binding site. Our results demonstrate how TAp63 alpha is inhibited by complex domain-domain interactions that provide the basis for regulating quality control in oocytes.	[Deutsch, Gregor B.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Luh, Laura M.; Durst, Florian G.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Deutsch, Gregor B.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Luh, Laura M.; Durst, Florian G.; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Zielonka, Elisabeth M.; McKeon, Frank] Univ Strasbourg, ISIS, F-67000 Strasbourg, France; [Zielonka, Elisabeth M.; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Hannewald, Jens] Merck KGaA, MS DTB C Prot Purificat, D-64293 Darmstadt, Germany; [Ibrahim, Mohamed; Schleiff, Enrico] Goethe Univ Frankfurt, Inst Mol & Cell Biol Plants, D-60438 Frankfurt, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Niesen, Frank H.; Knapp, Stefan] Univ Oxford, Nuffield Dept Med, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Struct Genom Consortium, Oxford OX3 7DQ, England; [McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Goethe University Frankfurt; Goethe University Frankfurt; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Merck KGaA; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Oxford; University of Oxford; Harvard University; Harvard Medical School	Dotsch, V (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Doetsch, Volker/D-5697-2011; Ibrahim, Mohamed/AAH-8007-2019; Schleiff, Enrico/C-5105-2017; Coutandin, Daniel/O-8449-2016; Knapp, Stefan/AAG-2347-2019	Schleiff, Enrico/0000-0002-0518-3489; Coutandin, Daniel/0000-0003-4537-1393; Knapp, Stefan/0000-0001-5995-6494; Dotsch, Volker/0000-0001-5720-212X	DFG [DO 545/2-1]; EU [LSHB-CT-019067]; Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); ANR; ERC; Boehringer Ingelheim Fonds PhD Fellowship; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	DFG(German Research Foundation (DFG)); EU(European Commission); Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	The research was funded by the DFG (DO 545/2-1), EU-Grant EPISTEM (LSHB-CT-019067), the Centre for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt (Macromolecular Complexes). F. M. acknowledges support by ANR and ERC. D. C. was supported by a Boehringer Ingelheim Fonds PhD Fellowship. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. J. Hannewald is an employee of Merck KGaA, Darmstadt.	Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Burge S, 2009, P NATL ACAD SCI USA, V106, P3142, DOI 10.1073/pnas.0900383106; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; Coutandin D, 2010, P NATL ACAD SCI USA, V107, P15318, DOI 10.1073/pnas.1001069107; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hoffmann J, 2009, RAPID COMMUN MASS SP, V23, P2176, DOI 10.1002/rcm.4129; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Straub WE, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.1; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005	44	97	101	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					566	576		10.1016/j.cell.2011.01.013	http://dx.doi.org/10.1016/j.cell.2011.01.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335238	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000287473100011
J	Douglas, NR; Reissmann, S; Zhang, JJ; Chen, B; Jakana, J; Kumar, R; Chiu, W; Frydman, J				Douglas, Nicholai R.; Reissmann, Stefanie; Zhang, Junjie; Chen, Bo; Jakana, Joanita; Kumar, Ramya; Chiu, Wah; Frydman, Judith			Dual Action of ATP Hydrolysis Couples Lid Closure to Substrate Release into the Group II Chaperonin Chamber	CELL			English	Article							EUKARYOTIC CHAPERONIN; IN-VIVO; CONFORMATIONAL-CHANGE; FOLDING CHAMBER; CRYO-EM; PROTEIN; MECHANISM; TRIC/CCT; GROEL; THERMOSOME	Group II chaperonins are ATP-dependent ring-shaped complexes that bind nonnative polypeptides and facilitate protein folding in archaea and eukaryotes. A built-in lid encapsulates substrate proteins within the central chaperonin chamber. Here, we describe the fate of the substrate during the nucleotide cycle of group II chaperonins. The chaperonin substrate-binding sites are exposed, and the lid is open in both the ATP-free and ATP-bound prehydrolysis states. ATP hydrolysis has a dual function in the folding cycle, triggering both lid closure and substrate release into the central chamber. Notably, substrate release can occur in the absence of a lid, and lid closure can occur without substrate release. However, productive folding requires both events, so that the polypeptide is released into the confined space of the closed chamber where it folds. Our results show that ATP hydrolysis coordinates the structural and functional determinants that trigger productive folding.	[Douglas, Nicholai R.; Reissmann, Stefanie; Kumar, Ramya; Frydman, Judith] Stanford Univ, Dept Biol & BioX Program, Stanford, CA 94305 USA; [Chen, Bo; Chiu, Wah] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Zhang, Junjie; Jakana, Joanita; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA	Stanford University; Baylor College of Medicine; Baylor College of Medicine	Frydman, J (corresponding author), Stanford Univ, Dept Biol & BioX Program, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Zhang, Junjie/V-3855-2019	Zhang, Junjie/0000-0002-7912-0819; , judith/0000-0003-2302-6943	NIH [GM74074, 5PN2EY016525, P41RR002250, T32-007276, R90 DK071054, T90 DA022885]; ARCS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. W.E. Moerner for providing Nile Red maleimide and advice on fluorescence microscopy. We also thank members of the J.F. laboratory and Raul Andino for critical reading of the manuscript; Frank DiMaio and David Baker for advice on modeling; Erik Miller for useful discussions; and Jeremy England and Erik Miller for providing PepB. This work was supported by NIH Grants GM74074 (to J.F.), 5PN2EY016525 (to J.F. and W.C.), and P41RR002250 (to W.C.). N.R.D. was a recipient of predoctoral ARCS fellowships and was supported by an NIH training grant (T32-007276). J.Z. was a recipient of NIH training grants on nanobiology (R90 DK071054 and T90 DA022885).	Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; Bigotti MG, 2006, J MOL BIOL, V362, P835, DOI 10.1016/j.jmb.2006.07.064; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gomez-Puertas P, 2004, J MOL RECOGNIT, V17, P85, DOI 10.1002/jmr.654; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hayer-Hartl M, 2000, METH MOL B, V140, P127; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; Kim SY, 2005, J PHYS CHEM B, V109, P24517, DOI 10.1021/jp0534232; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Stuart SF, 2011, J BIOL CHEM, V286, P178, DOI 10.1074/jbc.M110.166256; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Villebeck L, 2007, BIOCHEMISTRY-US, V46, P5083, DOI 10.1021/bi062093o; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	32	68	70	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					240	252		10.1016/j.cell.2010.12.017	http://dx.doi.org/10.1016/j.cell.2010.12.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241893	Bronze, Green Accepted			2022-12-24	WOS:000286459900009
J	Nury, H; Van Renterghem, C; Weng, Y; Tran, A; Baaden, M; Dufresne, V; Changeux, JP; Sonner, JM; Delarue, M; Corringer, PJ				Nury, Hugues; Van Renterghem, Catherine; Weng, Yun; Tran, Alphonso; Baaden, Marc; Dufresne, Virginie; Changeux, Jean-Pierre; Sonner, James M.; Delarue, Marc; Corringer, Pierre-Jean			X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-DYNAMICS; BINDING-SITE; ALLOSTERIC TRANSITIONS; CRYSTAL-STRUCTURES; GLYCINE RECEPTORS; GABA(A) RECEPTORS; HIGH-RESOLUTION; IDENTIFICATION; MODULATION	General anaesthetics have enjoyed long and widespread use but their molecular mechanism of action remains poorly understood. There is good evidence that their principal targets are pentameric ligand-gated ion channels(1,2) (pLGICs) such as inhibitory GABA(A) (gamma-aminobutyric acid) receptors and excitatory nicotinic acetylcholine receptors, which are respectively potentiated and inhibited by general anaesthetics. The bacterial homologue from Gloeobacter violaceus(3) (GLIC), whose X-ray structure was recently solved(4,5), is also sensitive to clinical concentrations of general anaesthetics(6). Here we describe the crystal structures of the complexes propofol/GLIC and desflurane/GLIC. These reveal a common general-anaesthetic binding site, which pre-exists in the apo-structure in the upper part of the transmembrane domain of each protomer. Both molecules establish van der Waals interactions with the protein; propofol binds at the entrance of the cavity whereas the smaller, more flexible, desflurane binds deeper inside. Mutations of some amino acids lining the binding site profoundly alter the ionic response of GLIC to protons, and affect its general-anaesthetic pharmacology. Molecular dynamics simulations, performed on the wild type (WT) and two GLIC mutants, highlight differences in mobility of propofol in its binding site and help to explain these effects. These data provide a novel structural framework for the design of general anaesthetics and of allosteric modulators of brain pLGICs.	[Nury, Hugues; Van Renterghem, Catherine; Dufresne, Virginie; Corringer, Pierre-Jean] Inst Pasteur, Grp Recepteurs Canaux, F-75015 Paris, France; [Nury, Hugues; Van Renterghem, Catherine; Dufresne, Virginie; Changeux, Jean-Pierre; Corringer, Pierre-Jean] CNRS, URA2182, F-75015 Paris, France; [Nury, Hugues; Delarue, Marc] Inst Pasteur, Unite Dynam Struct Macromol, F-75015 Paris, France; [Nury, Hugues; Delarue, Marc] CNRS, URA2185, F-75015 Paris, France; [Weng, Yun; Tran, Alphonso; Sonner, James M.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Baaden, Marc] CNRS, UPR 9080, Inst Biol Physicochim, F-75005 Paris, France; [Changeux, Jean-Pierre] Coll France, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Corringer, PJ (corresponding author), Inst Pasteur, Grp Recepteurs Canaux, F-75015 Paris, France.	delarue@pasteur.fr; pjcorrin@pasteur.fr	Baaden, Marc/C-6623-2008	Baaden, Marc/0000-0001-6472-0486; Nury, Hugues/0000-0002-3433-256X	Commission of the European Communities; Louis D. Foundation of the Institut de France; Network of European Neuroscience Institutes (ENI-NET); National Institutes of Health [NIGMS R01 GM069379]; Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS) [2009-072292]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069379] Funding Source: NIH RePORTER	Commission of the European Communities(European Commission); Louis D. Foundation of the Institut de France; Network of European Neuroscience Institutes (ENI-NET); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commission of the European Communities (Neurocypres project; to H.N.), the Louis D. Foundation of the Institut de France, the Network of European Neuroscience Institutes (ENI-NET) and a National Institutes of Health grant NIGMS R01 GM069379 (to J.M.S.). We thank J. Brallet for the gift of desflurane, the European Synchrotron Radiation Facility and Soleil staff for assistance during data collection, and G. Brannigan for providing propofol simulation parameters. Simulations were performed using high-performance computing resources from the Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS, grant 2009-072292).	Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; BARTH LG, 1959, J EMBRYOL EXP MORPH, V7, P210; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bricogne G, 2009, BUSTER VERSION 2 8 0; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis I. W., 2007, NUCLEIC ACIDS RES, V35, pW375; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; HUMPHREY W, 1996, J MOL GRAPH MODEL, V14, P33, DOI DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nievas GAF, 2008, J BIOL CHEM, V283, P21478, DOI 10.1074/jbc.M800345200; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Schrodinger L., 2020, PYMOL; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	47	346	348	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					428	+		10.1038/nature09647	http://dx.doi.org/10.1038/nature09647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248852				2022-12-24	WOS:000286385600059
J	Graveley, BR; Brooks, AN; Carlson, J; Duff, MO; Landolin, JM; Yang, L; Artieri, CG; van Baren, MJ; Boley, N; Booth, BW; Brown, JB; Cherbas, L; Davis, CA; Dobin, A; Li, RH; Lin, W; Malone, JH; Mattiuzzo, NR; Miller, D; Sturgill, D; Tuch, BB; Zaleski, C; Zhang, DY; Blanchette, M; Dudoit, S; Eads, B; Green, RE; Hammonds, A; Jiang, LC; Kapranov, P; Langton, L; Perrimon, N; Sandler, JE; Wan, KH; Willingham, A; Zhang, Y; Zou, Y; Andrews, J; Bickel, PJ; Brenner, SE; Brent, MR; Cherbas, P; Gingeras, TR; Hoskins, RA; Kaufman, TC; Oliver, B; Celniker, SE				Graveley, Brenton R.; Brooks, Angela N.; Carlson, JosephW.; Duff, Michael O.; Landolin, Jane M.; Yang, Li; Artieri, Carlo G.; van Baren, Marijke J.; Boley, Nathan; Booth, Benjamin W.; Brown, James B.; Cherbas, Lucy; Davis, Carrie A.; Dobin, Alex; Li, Renhua; Lin, Wei; Malone, John H.; Mattiuzzo, Nicolas R.; Miller, David; Sturgill, David; Tuch, Brian B.; Zaleski, Chris; Zhang, Dayu; Blanchette, Marco; Dudoit, Sandrine; Eads, Brian; Green, Richard E.; Hammonds, Ann; Jiang, Lichun; Kapranov, Phil; Langton, Laura; Perrimon, Norbert; Sandler, Jeremy E.; Wan, Kenneth H.; Willingham, Aarron; Zhang, Yu; Zou, Yi; Andrews, Justen; Bickel, Peter J.; Brenner, Steven E.; Brent, Michael R.; Cherbas, Peter; Gingeras, Thomas R.; Hoskins, Roger A.; Kaufman, Thomas C.; Oliver, Brian; Celniker, Susan E.			The developmental transcriptome of Drosophila melanogaster	NATURE			English	Article							GENE-EXPRESSION; FUNCTIONAL ELEMENTS; BITHORAX COMPLEX; ABDOMINAL-B; IDENTIFICATION; GENOMES; TARGETS	Drosophila melanogaster is one of the most well studied genetic model organisms; nonetheless, its genome still contains unannotated coding and non-coding genes, transcripts, exons and RNA editing sites. Full discovery and annotation are pre-requisites for understanding how the regulation of transcription, splicing and RNA editing directs the development of this complex organism. Here we used RNA-Seq, tiling microarrays and cDNA sequencing to explore the transcriptome in 30 distinct developmental stages. We identified 111,195 new elements, including thousands of genes, coding and non-coding transcripts, exons, splicing and editing events, and inferred protein isoforms that previously eluded discovery using established experimental, prediction and conservation-based approaches. These data substantially expand the number of known transcribed elements in the Drosophila genome and provide a high-resolution view of transcriptome dynamics throughout development.	[Graveley, Brenton R.; Duff, Michael O.; Yang, Li] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA; [Brooks, Angela N.; Brenner, Steven E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Carlson, JosephW.; Landolin, Jane M.; Booth, Benjamin W.; Hammonds, Ann; Sandler, Jeremy E.; Wan, Kenneth H.; Hoskins, Roger A.; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Artieri, Carlo G.; Li, Renhua; Malone, John H.; Mattiuzzo, Nicolas R.; Sturgill, David; Jiang, Lichun; Zhang, Yu; Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [van Baren, Marijke J.; Langton, Laura; Brent, Michael R.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [van Baren, Marijke J.; Langton, Laura; Brent, Michael R.] Washington Univ, Dept Comp Sci, St Louis, MO 63108 USA; [Boley, Nathan; Brown, James B.; Bickel, Peter J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cherbas, Lucy; Zhang, Dayu; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Davis, Carrie A.; Dobin, Alex; Lin, Wei; Zaleski, Chris; Kapranov, Phil; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Miller, David; Eads, Brian; Andrews, Justen; Cherbas, Peter; Kaufman, Thomas C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Tuch, Brian B.] Life Technol, Res & Dev, Genet Syst Div, Foster City, CA 94404 USA; [Tuch, Brian B.] Amgen Inc, Genome Anal Unit, San Francisco, CA 94080 USA; [Blanchette, Marco] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Blanchette, Marco] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Dudoit, Sandrine] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Willingham, Aarron; Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA	University of Connecticut; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; Cold Spring Harbor Laboratory; Indiana University System; Indiana University Bloomington; Thermo Fisher Scientific; Amgen; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Affymetrix	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	graveley@neuron.uchc.edu; celniker@fruitfly.org	Brown, James/H-2971-2015; jiang, lichun/F-3776-2012; Lin, Wei/AAH-9924-2019; Brent, Michael/AAK-3702-2020	jiang, lichun/0000-0003-2462-7636; Lin, Wei/0000-0002-7506-3466; Brent, Michael/0000-0002-8689-0299; Gingeras, Thomas/0000-0001-9106-3573; Graveley, Brenton/0000-0001-5777-5892; Sturgill, David/0000-0002-7902-3605; Perrimon, Norbert/0000-0001-7542-472X; Green, Richard/0000-0003-0516-5827; yang, li/0000-0001-8833-7473; Dobin, Alexander/0000-0002-4115-9128	National Human Genome Research INstitute [U01 HB004271]; Department of Energy [DE-AC02-05CH11231]; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER	National Human Genome Research INstitute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Trapnell and L. Pachter for discussions and assistance with Cufflinks, and E. Clough for comments and feedback. A.N.B. was partially supported by an NSF graduate fellowship. This work was funded by an award from the National Human Genome Research INstitute modENCODE Project (U01 HB004271) to S.E.C. (Principal Investigator) and M.R.B., P.C., T.R.G., B.R.G. and N.P. (co-Principal Investigators) under Department of Energy contract no. DE-AC02-05CH11231, and by the National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (B.O.).	ANDRES AJ, 1992, DEVELOPMENT, V116, P865; ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bass BL, 2001, RNA EDITING; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Costantino BFB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000102; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hild M, 2004, GENOME BIOL, V5; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jepson JEC, 2007, METHOD ENZYMOL, V424, P265, DOI 10.1016/S0076-6879(07)24012-1; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; LOCKETT TJ, 1989, DEV BIOL, V134, P430, DOI 10.1016/0012-1606(89)90115-2; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Padgett RA, 2002, RNA, V8, P125, DOI 10.1017/S1355838202017156; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Philipps DL, 2004, RNA, V10, P1838, DOI 10.1261/rna.7136104; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Spradling AC, 2006, GENETICS, V174, P1; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang JW, 2010, J NEUROGENET, V24, P67, DOI 10.3109/01677061003746341; Warren JT, 2006, DEV DYNAM, V235, P315, DOI 10.1002/dvdy.20626; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1035	1061	8	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					473	479		10.1038/nature09715	http://dx.doi.org/10.1038/nature09715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21179090	Green Accepted, Green Submitted			2022-12-24	WOS:000288702200054
J	Lara-Tejero, M; Kato, J; Wagner, S; Liu, XY; Galan, JE				Lara-Tejero, Maria; Kato, Junya; Wagner, Samuel; Liu, Xiaoyun; Galan, Jorge E.			A Sorting Platform Determines the Order of Protein Secretion in Bacterial Type III Systems	SCIENCE			English	Article							CULTURED EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; NEEDLE LENGTH; YERSINIA-ENTEROCOLITICA; HOST-CELLS; INVASION; APPARATUS; ATPASE; TRANSLOCATION	Bacterial type III protein secretion systems deliver effector proteins into eukaryotic cells in order to modulate cellular processes. Central to the function of these protein-delivery machines is their ability to recognize and secrete substrates in a defined order. Here, we describe a mechanism by which a type III secretion system from the bacterial enteropathogen Salmonella enterica serovar Typhimurium can sort its substrates before secretion. This mechanism involves a cytoplasmic sorting platform that is sequentially loaded with the appropriate secreted proteins. The sequential loading of this platform, facilitated by customized chaperones, ensures the hierarchy in type III protein secretion. Given the presence of these machines in many important pathogens, these findings can serve as the bases for the development of novel antimicrobial strategies.	[Lara-Tejero, Maria; Kato, Junya; Wagner, Samuel; Liu, Xiaoyun; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Kato, Junya/0000-0001-5432-157X	NIH [U54 AI0157158, AI30492]; International Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030492, R37AI030492, R01AI030492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Galan laboratory for critical reading of this manuscript. This work was supported by NIH grant U54 AI0157158 (M.L.-T.), a long-term fellowship of the International Human Frontiers Science Program (S.W.), and NIH grant AI30492 (J.E.G.).	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; HKANSSON S, 1996, EMBO J, V15, P5812; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; ZIERLER MK, 1995, INFECT IMMUN, V63, P4024, DOI 10.1128/IAI.63.10.4024-4028.1995	33	187	191	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1188	1191		10.1126/science.1201476	http://dx.doi.org/10.1126/science.1201476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21292939	Green Accepted			2022-12-24	WOS:000287971200041
J	Evans, JP; Meslin, EM; Marteau, TM; Caulfield, T				Evans, James P.; Meslin, Eric M.; Marteau, Theresa M.; Caulfield, Timothy			Deflating the Genomic Bubble	SCIENCE			English	Editorial Material							RISK; ASSOCIATION; PERFORMANCE; VARIANTS		[Evans, James P.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Evans, James P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Meslin, Eric M.] Indiana Univ, Ctr Bioeth, Indianapolis, IN 46202 USA; [Marteau, Theresa M.] Kings Coll London, Hlth Psychol Sect, London SE1 9RT, England; [Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Sch Publ Hlth, Edmonton, AB T6G 2H5, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; King's College London; University of Alberta; University of Alberta	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu		Marteau, Theresa/0000-0003-3025-1129	Medical Research Council [G0500274] Funding Source: Medline; MRC [G0500274] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, NATURE, V464, P649, DOI 10.1038/464649a; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Carlsson B, 2009, IND CORP CHANGE, V18, P1193, DOI 10.1093/icc/dtp043; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Garrison LP, 2008, DRUG METAB REV, V40, P377, DOI 10.1080/03602530801952500 ; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; GOODMAN KW, 2003, ETHICS EVIDENCE BASE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Keeney RL, 2008, OPER RES, V56, P1335, DOI 10.1287/opre.1080.0588; Kimmelman J., 2009, GENE TRANSFER ETHICS; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Navigenics Inc, GEN HLTH; Pedersen NL, 2010, JAMA-J AM MED ASSOC, V303, P1864, DOI 10.1001/jama.2010.609; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petersen A, 2009, MONASH BIOETH REV, V28, P22, DOI 10.2104/mber0905; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pohlhaus JR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-472; Pollack Andrew, 2010, NY TIMES, pB5; Silver H. J., 2008, 33 AAAS; Tucker G, 2004, BMJ-BRIT MED J, V329, P4, DOI 10.1136/bmj.329.7456.4; Varmus H., 2009, ART POLITICS SCI; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; WHO Regional Committee for Europe, 2008, RES BEH CHANG STRAT; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	34	137	143	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					861	862		10.1126/science.1198039	http://dx.doi.org/10.1126/science.1198039			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330519				2022-12-24	WOS:000287455100031
J	Culyba, EK; Price, JL; Hanson, SR; Dhar, A; Wong, CH; Gruebele, M; Powers, ET; Kelly, JW				Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Dhar, Apratim; Wong, Chi-Huey; Gruebele, Martin; Powers, Evan T.; Kelly, Jeffery W.			Protein Native-State Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse Turns	SCIENCE			English	Article							ASPARAGINE-LINKED GLYCOSYLATION; STABILITY; CARBOHYDRATE; CONFORMATION; ACYLPHOSPHATASE; GLYCANS; CONTEXT; CD2	N-glycosylation of eukaryotic proteins helps them fold and traverse the cellular secretory pathway and can increase their stability, although the molecular basis for stabilization is poorly understood. Glycosylation of proteins at naive sites (ones that normally are not glycosylated) could be useful for therapeutic and research applications but currently results in unpredictable changes to protein stability. We show that placing a phenylalanine residue two or three positions before a glycosylated asparagine in distinct reverse turns facilitates stabilizing interactions between the aromatic side chain and the first N-acetylglucosamine of the glycan. Glycosylating this portable structural module, an enhanced aromatic sequon, in three different proteins stabilizes their native states by -0.7 to -2.0 kilocalories per mole and increases cellular glycosylation efficiency.	[Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Wong, Chi-Huey; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Wong, Chi-Huey; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dhar, Apratim; Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Powers, ET (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	epowers@scripps.edu; jkelly@scripps.edu		Price, Joshua/0000-0002-0116-0968; Powers, Evan/0000-0001-8185-8487	Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NIH [GM051105, F32 GM086039, AI072155]; NSF [MCB 1019958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051105, F32GM086039] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1019958] Funding Source: National Science Foundation	Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. A. Dwek, I. A. Wilson, J. C. Paulson, S. Deechongkit, and D. L. Powers for presubmission reviews and for helpful prepublication discussions. This work was supported in part by the Skaggs Institute for Chemical Biology, the Lita Annenberg Hazen Foundation, and by NIH grant GM051105 to J. W. K. and E. T. P. J. L. P. was supported in part by NIH postdoctoral fellowship F32 GM086039. A. D. and M. G. were supported by NSF grant MCB 1019958. S. R. H. and C.-H. W. were supported by NIH grant AI072155. The Scripps Research Institute has filed a provisional patent application covering the results described in this paper.	ANDREOTTI AH, 1993, J AM CHEM SOC, V115, P3352, DOI 10.1021/ja00061a053; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen MM, 2010, P NATL ACAD SCI USA, V107, P22528, DOI 10.1073/pnas.1015356107; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Geierhaas CD, 2004, J MOL BIOL, V343, P1111, DOI 10.1016/j.jmb.2004.08.100; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KERN G, 1992, PROTEIN SCI, V1, P120; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Price JL, 2010, J AM CHEM SOC, V132, P15359, DOI 10.1021/ja106896t; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yamaguchi H, 1996, J BIOCHEM-TOKYO, V120, P474; Yeung RCY, 2006, ACTA CRYSTALLOGR F, V62, P80, DOI 10.1107/S174430910504145X; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	28	140	146	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					571	575		10.1126/science.1198461	http://dx.doi.org/10.1126/science.1198461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292975	Green Accepted			2022-12-24	WOS:000286933600050
J	Pornillos, O; Ganser-Pornillos, BK; Yeager, M				Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark			Atomic-level modelling of the HIV capsid	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TERMINAL DOMAIN; ROUS-SARCOMA-VIRUS; DIMERIZATION DOMAIN; IN-VITRO; STRUCTURE VALIDATION; ASSEMBLY PROPERTIES; PROTEIN; TYPE-1; CORE	The mature capsids of human immunodeficiency virus type 1 (HIV-1) and other retroviruses are fullerene shells, composed of the viral CA protein, that enclose the viral genome and facilitate its delivery into new host cells(1). Retroviral CA proteins contain independently folded amino (N)- and carboxy (C)-terminal domains (NTD and CTD) that are connected by a flexible linker(2-4). The NTD forms either hexameric or pentameric rings, whereas the CTD forms symmetric homodimers that connect the rings into a hexagonal lattice(3,5-13). We previously used a disulphide crosslinking strategy to enable isolation and crystallization of soluble HIV-1 CA hexamers(11,14). Here we use the same approach to solve the X-ray structure of the HIV-1 CA pentamer at 2.5 angstrom resolution. Two mutant CA proteins with engineered disulphides at different positions (P17C/T19C and N21C/A22C) converged onto the same quaternary structure, indicating that the disulphide-crosslinked proteins recapitulate the structure of the native pentamer. Assembly of the quasi-equivalent hexamers and pentamers requires remarkably subtle rearrangements in subunit interactions, and appears to be controlled by an electrostatic switch that favours hexamers over pentamers. This study completes the gallery of substructures describing the components of the HIV-1 capsid and enables atomic-level modelling of the complete capsid. Rigid-body rotations around two assembly interfaces appear sufficient to generate the full range of continuously varying lattice curvature in the fullerene cone.	[Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yeager, Mark] Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA	University of Virginia; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	yeager@virginia.edu			US National Institutes of Health [R01-GM066087, P50-GM082545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, R01GM066087] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the US National Institutes of Health to M.Y. (R01-GM066087 and P50-GM082545). X-ray diffraction data were collected at beamlines 22-BM and 22-ID at the Advanced Photon Source, Argonne National Laboratory. Initial crystal screening was performed with the assistance of S. Banumathi through the Collaborative Crystallography Program, Lawrence Berkeley National Laboratory at the Advanced Light Source. We thank J.E. Johnson and D. Borek for crystallographic advice; Y. Hua for assistance with molecular biology experiments; and I. A. Wilson, C. P. Hill and W. I. Sundquist for critical reading of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Hyun JK, 2010, J BIOL CHEM, V285, P15056, DOI 10.1074/jbc.M110.108209; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1997, PROTEINS, V29, P1	37	274	278	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					424	+		10.1038/nature09640	http://dx.doi.org/10.1038/nature09640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248851	Green Accepted			2022-12-24	WOS:000286385600058
J	Yonehara, K; Balint, K; Noda, M; Nagel, G; Bamberg, E; Roska, B				Yonehara, Keisuke; Balint, Kamill; Noda, Masaharu; Nagel, Georg; Bamberg, Ernst; Roska, Botond			Spatially asymmetric reorganization of inhibition establishes a motion-sensitive circuit	NATURE			English	Article							SELECTIVE GANGLION-CELLS; STARBURST AMACRINE CELLS; DIRECTION SELECTIVITY; RABBIT RETINA; VISUAL EXPERIENCE; MAMMALIAN RETINA; MOUSE RETINA; CHANNELRHODOPSIN-2; ARCHITECTURE; MECHANISMS	Spatial asymmetries in neural connectivity have an important role in creating basic building blocks of neuronal processing(1,2). A key circuit module of directionally selective (DS) retinal ganglion cells is a spatially asymmetric inhibitory input from starburst amacrine cells(3-5). It is not known how and when this circuit asymmetry is established during development. Here we photostimulate mouse starburst cells targeted with channelrhodopsin-2 (refs 6-8) while recording from a single genetically labelled type of DS cell(9,10). We follow the spatial distribution of synaptic strengths between starburst and DS cells during early postnatal development before these neurons can respond to a physiological light stimulus, and confirm connectivity by monosynaptically restricted trans-synaptic rabies viral tracing. We show that asymmetry develops rapidly over a 2-day period through an intermediate state in which random or symmetric synaptic connections have been established. The development of asymmetry involves the spatially selective reorganization of inhibitory synaptic inputs. Intriguingly, the spatial distribution of excitatory synaptic inputs from starburst cells is significantly more symmetric than that of the inhibitory inputs at the end of this developmental period. Our work demonstrates a rapid developmental switch from a symmetric to asymmetric input distribution for inhibition in the neural circuit of a principal cell.	[Yonehara, Keisuke; Balint, Kamill; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; [Nagel, Georg] Univ Wurzburg, D-97082 Wurzburg, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany	Friedrich Miescher Institute for Biomedical Research; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Wurzburg; Max Planck Society; Goethe University Frankfurt	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Noda, Masaharu/D-7146-2016; Roska, Botond/AAD-7268-2021	Noda, Masaharu/0000-0002-3796-524X; Yonehara, Keisuke/0000-0001-9541-6671; Nagel, Georg/0000-0001-8174-8712	Friedrich Miescher Institute for Biomedical Research; US Office of Naval Research; Marie Curie Excellence grant; National Centre of Competence in Research; European Research Council; European Union; EMBO	Friedrich Miescher Institute for Biomedical Research; US Office of Naval Research(Office of Naval Research); Marie Curie Excellence grant(European Commission); National Centre of Competence in Research; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank B. G. Scherf, S. Djaffer and J. Juttner for technical assistance, T. Szikra for helping with light intensity calibration, V. Busskamp for suggesting the use of the 2A element and the cloning strategy for the 2A-based expression system, and V. Busskamp, K. Farrow, S. Oakeley and P. King for their comments on the manuscript. We thank E. Callaway for providing the rabies viruses and K. Conzelmann and S. Arber for discussion about rabies viruses. The study was supported by the Friedrich Miescher Institute for Biomedical Research, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant, a Marie Curie Excellence grant, a National Centre of Competence in Research Frontiers in Genetics grant, an European Research Council as well as RETICIRC, TREATRUSH and OPTONEURO grants from the European Union to B. R. and an EMBO Long-Term Fellowship to K.Y.	ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	34	117	120	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					407	+		10.1038/nature09711	http://dx.doi.org/10.1038/nature09711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21170022				2022-12-24	WOS:000286385600054
J	Coleman, MP; Forman, D; Bryant, H; Butler, J; Rachet, B; Maringe, C; Nur, U; Tracey, E; Coory, M; Hatcher, J; McGahan, CE; Turner, D; Marrett, L; Gjerstorff, ML; Johannesen, TB; Adolfsson, J; Lambe, M; Lawrence, G; Meechan, D; Morris, EJ; Middleton, R; Steward, J; Richards, MA				Coleman, M. P.; Forman, D.; Bryant, H.; Butler, J.; Rachet, B.; Maringe, C.; Nur, U.; Tracey, E.; Coory, M.; Hatcher, J.; McGahan, C. E.; Turner, D.; Marrett, L.; Gjerstorff, M. L.; Johannesen, T. B.; Adolfsson, J.; Lambe, M.; Lawrence, G.; Meechan, D.; Morris, E. J.; Middleton, R.; Steward, J.; Richards, M. A.		ICBP Module 1 Working Grp	Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data	LANCET			English	Article							BREAST-CANCER; DEATHS; STAGE; AGE; DIAGNOSIS; ENGLAND; EUROPE; TRENDS; CARE	Background Cancer survival is a key measure of the effectiveness of health-care systems. Persistent regional and international differences in survival represent many avoidable deaths. Differences in survival have prompted or guided cancer control strategies. This is the first study in a programme to investigate international survival disparities, with the aim of informing health policy to raise standards and reduce inequalities in survival. Methods Data from population-based cancer registries in 12 jurisdictions in six countries were provided for 2.4 million adults diagnosed with primary colorectal, lung, breast (women), or ovarian cancer during 1995-2007, with follow-up to Dec 31, 2007. Data quality control and analyses were done centrally with a common protocol, overseen by external experts. We estimated 1-year and 5-year relative survival, constructing 252 complete life tables to control for background mortality by age, sex, and calendar year. We report age-specific and age-standardised relative survival at 1 and 5 years, and 5-year survival conditional on survival to the first anniversary of diagnosis. We also examined incidence and mortality trends during 1985-2005. Findings Relative survival improved during 1995-2007 for all four cancers in all jurisdictions. Survival was persistently higher in Australia, Canada, and Sweden, intermediate in Norway, and lower in Denmark, England, Northern Ireland, and Wales, particularly in the first year after diagnosis and for patients aged 65 years and older. International differences narrowed at all ages for breast cancer, from about 9% to 5% at 1 year and from about 14% to 8% at 5 years, but less or not at all for the other cancers. For colorectal cancer, the international range narrowed only for patients aged 65 years and older, by 2-6% at 1 year and by 2-3% at 5 years. Interpretation Up-to-date survival trends show increases but persistent differences between countries. Trends in cancer incidence and modality are broadly consistent with these trends in survival. Data quality and changes in classification are not likely explanations. The patterns are consistent with later diagnosis or differences in treatment, particularly in Denmark and the UK, and in patients aged 65 years and older.	[Coleman, M. P.] Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Forman, D.] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France; [Bryant, H.] Canadian Partnership Against Canc, Toronto, ON, Canada; [Tracey, E.] Canc Inst New S Wales, Sydney, NSW, Australia; [Coory, M.] Canc Council Victoria, Melbourne, Vic, Australia; [Hatcher, J.] Alberta Hlth Serv, Edmonton, AB, Canada; [McGahan, C. E.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Turner, D.] CancerCare Manitoba, Winnipeg, MB, Canada; [Marrett, L.] Canc Care Ontario, Toronto, ON, Canada; [Gjerstorff, M. L.] Natl Board Hlth, Danish Canc Registry, Copenhagen, Denmark; [Johannesen, T. B.] Norwegian Canc Registry, Oslo, Norway; [Adolfsson, J.] Karolinska Univ Hosp, Ctr Oncol, Stockholm, Sweden; [Adolfsson, J.] Karolinska Inst, CLINTEC Dept, Stockholm, Sweden; [Lambe, M.] Univ Uppsala Hosp, Reg Oncol Ctr, Uppsala, Sweden; [Lawrence, G.] W Midlands Canc Intelligence Unit, Birmingham, W Midlands, England; [Meechan, D.] Trent Canc Registry, Sheffield, S Yorkshire, England; [Morris, E. J.] No & Yorkshire Canc Registrat & Informat Serv, Leeds, W Yorkshire, England; [Middleton, R.] No Ireland Canc Registry, Belfast, Antrim, North Ireland; [Steward, J.] Welsh Canc Intelligence & Surveillance Unit, Cardiff, S Glam, Wales; [Richards, M. A.] Dept Hlth, Natl Canc Act Team, London SE1 6TE, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Council Victoria; Alberta Health Services (AHS); British Columbia Cancer Agency; CancerCare Manitoba Foundation; Cancer Care Ontario; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Coleman, MP (corresponding author), Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	michel.coleman@lshtm.ac.uk	Menon, Usha/C-4716-2008; Coleman, Michel/AAA-9543-2020	Menon, Usha/0000-0003-3708-1732; Coleman, Michel/0000-0001-8940-3807; Currow, David/0000-0003-1988-1250; Boyages, John/0000-0003-3208-3966; Lambe, Mats/0000-0002-4624-3767; Quaresma, Manuela/0000-0002-5290-279X; Bergh, Jonas/0000-0001-5526-1847; Adolfsson, Jan/0000-0003-2992-1869; Rachet, Bernard/0000-0001-5837-7773; Walters, Sarah/0000-0001-9929-1917	Department of Health; Department of Health, England (London, UK); Cancer Research UK (London, UK); Cancer Research UK [9805, 11700] Funding Source: researchfish	Department of Health; Department of Health, England (London, UK); Cancer Research UK (London, UK)(Cancer Research UK); Cancer Research UK(Cancer Research UK)	MAR is the National Cancer Director (England, funded by the Department of Health); and J Bu is Clinical Advisor to the Medical Director of the NHS (England, funded by the Department of Health). Other authors declare that they have no conflicts of interest.; This study was funded by the Department of Health, England (London, UK), and Cancer Research UK (London, UK). We thank the cancer registry staff in all jurisdictions, whose sustained efforts in data collection and quality control over many years have enabled trends in cancer patient survival to be analysed and compared in this study. We are grateful for the expert contributions from our Epidemiology Reference Group, who advised on protocol, study design, and analytical methods: Bruce Armstrong (Department of Public Health, University of Sydney, Sydney, NSW, Australia); Paul Dickman (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden); Paul Lambert (Biostatistics Group, Department of Health Sciences, University of Leicester, Leicester, UK); Dianne O'Connell (Cancer Council New South Wales, Sydney, NSW, Australia); Milena Sant (Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy); and Hannah Weir (Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA). We also thank Jacques Ferlay (IARC, Lyon, France) for providing the incidence and mortality data for figure 3, and Max van Eijk (McKinsey) for sustained logistical support. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of any government agency.	Abdel-Rahman M, 2009, BRIT J CANCER, V101, pS115, DOI 10.1038/sj.bjc.6605401; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; [Anonymous], 2021, CANC INCIDENCE 5 CON; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 1995, IARC SCI PUBLICATION, V132; Berrino F, 1999, IARC SCI PUBLICATION, V151; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; *CANC RES UK CANC, 2010, STREL COMP PROGR VER; Cavalli F, 2008, LANCET ONCOL, V9, P810, DOI 10.1016/S1470-2045(08)70213-4; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coleman MP, 2000, LANCET, V356, P590, DOI 10.1016/S0140-6736(00)02593-9; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; *DEP HUM SERV, 2008, VICT CANC ACT PLAN 2; Dickman PW, 1997, J EPIDEMIOL BIOSTAT, V2, P87; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; FERLAY J, 2010, IARC CANC BASE, V9; Fritz A, 2000, INT CLASSIFICATION D; Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Lavelle K, 2007, BRIT J CANCER, V96, P1197, DOI 10.1038/sj.bjc.6603709; Percy C., 1990, INT CLASSIFICATION D; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Pokhrel A, 2010, BRIT J CANCER, V103, P1109, DOI 10.1038/sj.bjc.6605861; Quaglia A, 2009, EUR J CANCER, V45, P1006, DOI 10.1016/j.ejca.2008.11.028; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895; Sanjoaquin MA, 2007, EUR J CANCER PREV, V16, P10, DOI 10.1097/01.cej.0000228398.30235.f5; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M, 2001, INT J CANCER, V93, P894, DOI 10.1002/ijc.1408; Skirnisdottir I, 2008, INT J CANCER, V123, P1897, DOI 10.1002/ijc.23724; Storm HH, 2010, ACTA ONCOL, V49, P532, DOI 10.3109/02841861003801148; Storm Hans Henrik, 2008, Ugeskr Laeger, V170, P3065; Storm HH, 1999, EUR RESPIR J, V13, P430, DOI 10.1183/09031936.99.13243099; Williams MV, 2009, CLIN ONCOL-UK, V21, P431, DOI 10.1016/j.clon.2009.05.006; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 1994, INT STAT CLASS DIS R	41	865	892	0	99	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					127	138		10.1016/S0140-6736(10)62231-3	http://dx.doi.org/10.1016/S0140-6736(10)62231-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21183212	Green Published, Green Accepted			2022-12-24	WOS:000286292800025
J	Typas, A; Banzhaf, M; van Saparoea, BV; Verheul, J; Biboy, J; Nichols, RJ; Zietek, M; Beilharz, K; Kannenberg, K; von Rechenberg, M; Breukink, E; den Blaauwen, T; Gross, CA; Vollmer, W				Typas, Athanasios; Banzhaf, Manuel; van Saparoea, Bart van den Berg; Verheul, Jolanda; Biboy, Jacob; Nichols, Robert J.; Zietek, Matylda; Beilharz, Katrin; Kannenberg, Kai; von Rechenberg, Moritz; Breukink, Eefjan; den Blaauwen, Tanneke; Gross, Carol A.; Vollmer, Waldemar			Regulation of Peptidoglycan Synthesis by Outer-Membrane Proteins	CELL			English	Article							CELL-DIVISION MACHINERY; TOL-PAL COMPLEX; ESCHERICHIA-COLI; MUREIN SACCULUS; BACILLUS-SUBTILIS; SYNTHASE PBP1B; ELONGATION; BACTERIA; GROWTH; LYSIS	Growth of the mesh-like peptidoglycan (PG) sacculus located between the bacterial inner and outer membranes (OM) is tightly regulated to ensure cellular integrity, maintain cell shape, and orchestrate division. Cytoskeletal elements direct placement and activity of PG synthases from inside the cell, but precise spatiotemporal control over this process is poorly understood. We demonstrate that PG synthases are also controlled from outside of the sacculus. Two OM lipoproteins, LpoA and LpoB, are essential for the function, respectively, of PBP1A and PBP1B, the major E. coli bifunctional PG synthases. Each Lpo protein binds specifically to its cognate PBP and stimulates its transpeptidase activity, thereby facilitating attachment of new PG to the sacculus. LpoB shows partial septal localization, and our data suggest that the LpoB-PBP1B complex contributes to OM constriction during cell division. LpoA/ LpoB and their PBP-docking regions are restricted to gamma-proteobacteria, providing models for niche-specific regulation of sacculus growth.	[Typas, Athanasios; Nichols, Robert J.; Zietek, Matylda; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA; [Banzhaf, Manuel; Biboy, Jacob; Beilharz, Katrin; Vollmer, Waldemar] Univ Newcastle, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [van Saparoea, Bart van den Berg; Verheul, Jolanda; den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands; [Nichols, Robert J.] Univ Calif San Francisco, Oral & Craniofacial Sci Grad Program, San Francisco, CA 94143 USA; [Kannenberg, Kai] Univ Tubingen, D-72076 Tubingen, Germany; [von Rechenberg, Moritz] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA; [Breukink, Eefjan] Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Dept Biochem Membranes, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Newcastle University - UK; University of Amsterdam; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Utrecht University	Typas, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	athanasios.typas@ucsf.edu; w.vollmer@ncl.ac.uk	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; Typas, Athanasios/0000-0002-0797-9018; den Blaauwen, Tanneke/0000-0002-5403-5597; Banzhaf, Manuel/0000-0002-4682-1037; van den Berg van Saparoea, Bart/0000-0003-3337-5506	BBSRC [BB/F001231/1]; European Commission [LSHM-CT-2004-512138, HEALTH-F3-2009-223431]; NIH [R01 GM085697, ARRA GM085697-01S1, R01 GM036278, K99GM092984, F31 DE020206-01, T32 DE007306]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085697, K99GM092984, R01GM036278] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F001231/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Jeff Errington, Dyche Mullins, and Monica Guo for critically reading this manuscript; H. Mori and his lab for sharing mutants of the second E. coli single-gene deletion (ASKA collection) prior to publishing; P. Born for PBP1A; N.K. Bui for PG sacculi; and Sarah Wittmer for help with the model illustration. We would like to thank T. Berhardt, D. Kahne, and their labs for communicating unpublished results. This work was supported by BBSRC BB/F001231/1 to W. V.; European Commission grants EUR-INTAFAR LSHM-CT-2004-512138 to W. V., T.d.B., and E. B. and DIVINOCELL HEALTH-F3-2009-223431 to W. V. and T.d.B.; NIH R01 GM085697, ARRA GM085697-01S1, and R01 GM036278 to C. A. G.; NIH K99GM092984 to A. T.; and NIH F31 DE020206-01 and NIH T32 DE007306 to R.J.N.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; BURMAN LG, 1984, P NATL ACAD SCI-BIOL, V81, P1844, DOI 10.1073/pnas.81.6.1844; CARBALLIDOLO PEZR, 2006, LYTE DEV CELL, V11, P399; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DEJONGE BLM, 1989, J BACTERIOL, V171, P5783, DOI 10.1128/jb.171.11.5783-5794.1989; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GLAUNER B, 1990, J BIOL CHEM, V265, P18988; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KOCH AL, 1992, J BACTERIOL, V174, P4811, DOI 10.1128/JB.174.14.4811-4819.1992; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Meisel U, 2003, J BACTERIOL, V185, P5342, DOI 10.1128/JB.185.18.5342-5348.2003; Morlot C, 2010, GENE DEV, V24, P411, DOI 10.1101/gad.1878110; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	44	255	260	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1097	1109		10.1016/j.cell.2010.11.038	http://dx.doi.org/10.1016/j.cell.2010.11.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183073	hybrid, Green Accepted, Green Submitted			2022-12-24	WOS:000285625400008
J	Witten, IB; Lin, SC; Brodsky, M; Prakash, R; Diester, I; Anikeeva, P; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Witten, Ilana B.; Lin, Shih-Chun; Brodsky, Matthew; Prakash, Rohit; Diester, Ilka; Anikeeva, Polina; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Cholinergic Interneurons Control Local Circuit Activity and Cocaine Conditioning	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; ACETYLCHOLINE-RECEPTORS; RAT NEOSTRIATUM; FIRING PATTERNS; NEURONS; ADDICTION; STRIATUM; NICOTINE; SYSTEMS; REINFORCEMENT	Cholinergic neurons are widespread, and pharmacological modulation of acetylcholine receptors affects numerous brain processes, but such modulation entails side effects due to limitations in specificity for receptor type and target cell. As a result, causal roles of cholinergic neurons in circuits have been unclear. We integrated optogenetics, freely moving mammalian behavior, in vivo electrophysiology, and slice physiology to probe the cholinergic interneurons of the nucleus accumbens by direct excitation or inhibition. Despite representing less than 1% of local neurons, these cholinergic cells have dominant control roles, exerting powerful modulation of circuit activity. Furthermore, these neurons could be activated by cocaine, and silencing this drug-induced activity during cocaine exposure (despite the fact that the manipulation of the cholinergic interneurons was not aversive by itself) blocked cocaine conditioning in freely moving mammals.	[Witten, Ilana B.; Lin, Shih-Chun; Brodsky, Matthew; Prakash, Rohit; Diester, Ilka; Anikeeva, Polina; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lin, Shih-Chun] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Diester, Ilka/D-4473-2011		Deisseroth lab; Helen Hay Whitney Foundation; National Institute of Neurological Disorders and Stroke; DAAD; Human Frontier Science Program; Stanford Dean's fellowship; Bio-X SIGF; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R01MH086373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Deisseroth lab; Helen Hay Whitney Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Human Frontier Science Program(Human Frontier Science Program); Stanford Dean's fellowship; Bio-X SIGF; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM(California Institute for Regenerative Medicine); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the entire Deisseroth lab for their support. I. B. W. is supported by the Helen Hay Whitney Foundation; S.-C. L. is supported by the National Institute of Neurological Disorders and Stroke; I. D. is supported by DAAD and the Human Frontier Science Program; P. A. is supported by the Stanford Dean's fellowship; V. G. is supported by Bio-X SIGF; K. D. is supported by the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as by CIRM, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARELLI RM, 1994, J NEUROSCI, V14, P7735; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Crespo JA, 2006, J NEUROSCI, V26, P6004, DOI 10.1523/JNEUROSCI.4494-05.2006; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; Hrabovska A, 2010, CHEM-BIOL INTERACT, V183, P194, DOI 10.1016/j.cbi.2009.09.025; Ikemoto S, 1998, PHYSIOL BEHAV, V63, P811, DOI 10.1016/S0031-9384(98)00007-9; Inokawa H, 2010, NEUROSCIENCE, V168, P395, DOI 10.1016/j.neuroscience.2010.03.062; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Maskos U, 2008, BRIT J PHARMACOL, V153, pS438, DOI 10.1038/bjp.2008.5; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nisell M, 1997, J NEURAL TRANSM, V104, P1, DOI 10.1007/BF01271290; Peoples LL, 1996, J NEUROSCI, V16, P3459; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wise R A, 1984, NIDA Res Monogr, V50, P15; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	39	329	372	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1677	1681		10.1126/science.1193771	http://dx.doi.org/10.1126/science.1193771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164015	Green Accepted			2022-12-24	WOS:000285390500067
J	Wirgin, I; Roy, NK; Loftus, M; Chambers, RC; Franks, DG; Hahn, ME				Wirgin, Isaac; Roy, Nirmal K.; Loftus, Matthew; Chambers, R. Christopher; Franks, Diana G.; Hahn, Mark E.			Mechanistic Basis of Resistance to PCBs in Atlantic Tomcod from the Hudson River	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; FISH FUNDULUS-HETEROCLITUS; DIOXIN SENSITIVITY; MICROGADUS-TOMCOD; INDUCTION; CYTOCHROME-P4501A; POPULATIONS; KILLIFISH; AHR2	The mechanistic basis of resistance of vertebrate populations to contaminants, including Atlantic tomcod from the Hudson River (HR) to polychlorinated biphenyls (PCBs), is unknown. HR tomcod exhibited variants in the aryl hydrocarbon receptor 2 (AHR2) that were nearly absent elsewhere. In ligand-binding assays, AHR2-1 protein (common in the HR) was impaired as compared to widespread AHR2-2 in binding TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) and in driving expression in reporter gene assays in AHR-deficient cells treated with TCDD or PCB126. We identified a six-base deletion in AHR2 as the basis of resistance and suggest that the HR population has undergone rapid evolution, probably due to contaminant exposure. This mechanistic basis of resistance in a vertebrate population provides evidence of evolutionary change due to selective pressure at a single locus.	[Wirgin, Isaac; Roy, Nirmal K.; Loftus, Matthew] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Franks, Diana G.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Chambers, R. Christopher] NOAA, Howard Marine Sci Lab, NE Fisheries Sci Ctr, Fisheries Serv, Highlands, NJ 07732 USA	New York University; Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA	Wirgin, I (corresponding author), NYU, Dept Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	Isaac.wirgin@nyumc.org	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082	Hudson River Foundation; Northeast Fisheries Science Center;  [R01ES015447];  [P42ES007381];  [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, P30ES000260, R01ES015447, P42ES010344] Funding Source: NIH RePORTER	Hudson River Foundation; Northeast Fisheries Science Center; ; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge support of R01ES015447, P42ES007381, ES00260, the Hudson River Foundation, and the Northeast Fisheries Science Center. We thank M. Mattson, K. Sullivan, D. Danila, S. Courtenay, C. Burnett, L. Upchurch, P. Roy, S. Karchner, and A. Nadas for assistance. Accession nos. FJ215751 to FJ215756.	Able K. W., 1998, 1 YEAR LIFE ESTUARIN; Fernandez MP, 2004, ENVIRON SCI TECHNOL, V38, P976, DOI 10.1021/es034177f; Hahn ME, 2004, PHARMACOGENETICS, V14, P131, DOI 10.1097/00008571-200402000-00007; Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743; Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Nacci D, 2005, MECH PCB DIOXIN RESI; Nacci DE, 2010, ESTUAR COAST, V33, P853, DOI 10.1007/s12237-009-9257-6; POLAND A, 1994, MOL PHARMACOL, V46, P915; Powell WH, 2000, TOXICOL SCI, V57, P229, DOI 10.1093/toxsci/57.2.229; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; van Straalen N. M., 2000, DEMOGRAPHY ECOTOXICO, P147; Van Veld Peter A., 2008, P597, DOI 10.1201/9780203647295.ch13; WIRGIN I, 2004, MUTAT RES, V55, P1897; WIRGIN II, 1992, MAR ENVIRON RES, V34, P103, DOI 10.1016/0141-1136(92)90091-Y; Wirgin I, 2006, AM FISH S S, V51, P331; Yuan ZP, 2006, AQUAT TOXICOL, V76, P306, DOI 10.1016/j.aquatox.2005.10.006; Yuan ZP, 2006, ENVIRON HEALTH PERSP, V114, P77, DOI 10.1289/ehp.8255	21	146	152	4	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1322	1325		10.1126/science.1197296	http://dx.doi.org/10.1126/science.1197296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21330491	Green Accepted			2022-12-24	WOS:000288215200046
J	Pape, KA; Taylor, JJ; Maul, RW; Gearhart, PJ; Jenkins, MK				Pape, Kathryn A.; Taylor, Justin J.; Maul, Robert W.; Gearhart, Patricia J.; Jenkins, Marc K.			Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response	SCIENCE			English	Article							INDUCED CYTIDINE DEAMINASE; SUBSETS; RECOMBINATION; HYPERMUTATION; EXPRESSION; ANTIGENS; AID	Memory B cells formed in response to microbial antigens provide immunity to later infections; however, the inability to detect rare endogenous antigen-specific cells limits current understanding of this process. Using an antigen-based technique to enrich these cells, we found that immunization with a model protein generated B memory cells that expressed isotype-switched immunoglobulins (swIg) or retained IgM. The more numerous IgM(+) cells were longer lived than the swIg(+) cells. However, swIg(+) memory cells dominated the secondary response because of the capacity to become activated in the presence of neutralizing serum immunoglobulin. Thus, we propose that memory relies on swIg(+) cells until they disappear and serum immunoglobulin falls to a low level, in which case memory resides with durable IgM(+) reserves.	[Pape, Kathryn A.; Taylor, Justin J.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Maul, Robert W./Y-6818-2019; Jenkins, Marc K/G-1063-2012; Gearhart, Patricia/Y-7227-2019	Jenkins, Marc K/0000-0001-8009-7655; Maul, Robert/0000-0002-6958-8514	NIH [R01 AI036914, R37 AI027998, F32 AI091033, T32 CA009138]; NIH, National Institute on Aging; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027998, F32AI091033, R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Walter and R. Speier for expert technical assistance and all members of the Jenkins lab for helpful discussions. This work was supported by grants from the NIH (R01 AI036914 and R37 AI027998 to M.K.J., F32 AI091033 and T32 CA009138 to J.T.), and the Intramural Research Program of the NIH, National Institute on Aging (R.W.M. and P.J.G.).	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Freund J, 1937, P SOC EXP BIOL MED, V37, P509; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; Ravetch JV, 1997, CURR OPIN IMMUNOL, V9, P121, DOI 10.1016/S0952-7915(97)80168-9; Ridderstad A, 1998, J IMMUNOL, V160, P4688; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	26	372	379	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1203	1207		10.1126/science.1201730	http://dx.doi.org/10.1126/science.1201730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21310965	Green Accepted			2022-12-24	WOS:000287971200045
J	van Breugel, M; Hirono, M; Andreeva, A; Yanagisawa, H; Yamaguchi, S; Nakazawa, Y; Morgner, N; Petrovich, M; Ebong, IO; Robinson, CV; Johnson, CM; Veprintsev, D; Zuber, B				van Breugel, Mark; Hirono, Masafumi; Andreeva, Antonina; Yanagisawa, Haru-aki; Yamaguchi, Shoko; Nakazawa, Yuki; Morgner, Nina; Petrovich, Miriana; Ebong, Ima-Obong; Robinson, Carol V.; Johnson, Christopher M.; Veprintsev, Dmitry; Zuber, Benoit			Structures of SAS-6 Suggest Its Organization in Centrioles	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BASAL BODY; CENTROSOME DUPLICATION; 9-FOLD SYMMETRY; PROTEIN; PROCENTRIOLE; CARTWHEEL; CHLAMYDOMONAS; BIOGENESIS; MECHANISMS	Centrioles are cylindrical, ninefold symmetrical structures with peripheral triplet microtubules strictly required to template cilia and flagella. The highly conserved protein SAS-6 constitutes the center of the cartwheel assembly that scaffolds centrioles early in their biogenesis. We determined the x-ray structure of the amino-terminal domain of SAS-6 from zebrafish, and we show that recombinant SAS-6 self-associates in vitro into assemblies that resemble cartwheel centers. Point mutations are consistent with the notion that centriole formation in vivo depends on the interactions that define the self-assemblies observed here. Thus, these interactions are probably essential to the structural organization of cartwheel centers.	[van Breugel, Mark; Andreeva, Antonina; Petrovich, Miriana; Johnson, Christopher M.; Veprintsev, Dmitry; Zuber, Benoit] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Hirono, Masafumi; Yanagisawa, Haru-aki; Yamaguchi, Shoko; Nakazawa, Yuki] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Morgner, Nina; Ebong, Ima-Obong; Robinson, Carol V.] Univ Oxford, Chem Res Lab, Oxford, England	MRC Laboratory Molecular Biology; University of Tokyo; University of Oxford	van Breugel, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	vanbreug@mrc-lmb.cam.ac.uk	HIRONO, MASAFUMI/G-4948-2014; Hirono, Masafumi/G-5140-2013; Zuber, Benoît/U-1952-2019; Veprintsev, Dmitry B/H-2228-2012; Morgner, Nina/I-7975-2012; Morgner, Nina/O-7021-2018	HIRONO, MASAFUMI/0000-0002-2497-4227; Hirono, Masafumi/0000-0002-2497-4227; Zuber, Benoît/0000-0001-7725-5579; Veprintsev, Dmitry B/0000-0002-3583-5409; Morgner, Nina/0000-0002-1872-490X; Andreeva, Antonina/0000-0002-0450-0091; Yanagisawa, Haruaki/0000-0003-0313-2343; robinson, carol/0000-0001-7829-5505	MRC; Ministry of Education, Culture, Science and Technology of Japan [21370088]; European Molecular Biology Organization; MRC [MC_U105184294, MC_U105192716] Funding Source: UKRI; Grants-in-Aid for Scientific Research [23657046] Funding Source: KAKEN; Medical Research Council [MC_U105192716, MC_U105184294] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The structure factors and coordinates of D. rerio N-SAS-6<SUP>1-156</SUP> and D. rerio N-SAS-6<SUP>1-179</SUP> F131D have been deposited at the Protein Data Bank Europe under wwPDB ID codes 2y3v and 2y3w. We gratefully acknowledge P. Evans (MRC-LMB, Cambridge, UK) for his modeling of SAS-6 ring assemblies and our beamline support team, M. Nanao at ID29 and H. Belrhali at BM14UK at the European Synchrotron Radiation Facility (Grenoble, France). We thank L. Rey (MRC-LMB) for the kind gift of U2OS cells and S. Munro (MRC-LMB) for the kind gift of a construct expressing the red fluorescent protein (RFP)-tagged C-terminal PACT domain of pericentrin. This work was supported by a MRC Career Development Fellowship (to M.v.B.); Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Science and Technology of Japan (21370088) (to M.H.); and a European Molecular Biology Organization long-term fellowship (to B.Z.). Material will be provided to academic and not-for-profit research organizations under the MRC's standard academic Material Transfer Agreement. The UltraSpin software will be provided by MRC under an academic license.	ALLEN RD, 1969, J CELL BIOL, V40, P716, DOI 10.1083/jcb.40.3.716; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Gillingham AK, 2000, EMBO REP, V1, P524; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Jerka-Dziadosz M, 2010, CYTOSKELETON, V67, P161, DOI 10.1002/cm.20433; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Yabe T, 2007, DEV BIOL, V312, P44, DOI 10.1016/j.ydbio.2007.08.054	34	219	223	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1196	1199		10.1126/science.1199325	http://dx.doi.org/10.1126/science.1199325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21273447				2022-12-24	WOS:000287971200043
J	Williams, SE; Beronja, S; Pasolli, HA; Fuchs, E				Williams, Scott E.; Beronja, Slobodan; Pasolli, H. Amalia; Fuchs, Elaine			Asymmetric cell divisions promote Notch-dependent epidermal differentiation	NATURE			English	Article							REGULATES SPINDLE ORIENTATION; STEM-CELLS; PLANAR DIVISIONS; DROSOPHILA; PROTEIN; NUMA; LGN; POLARITY; FATE; PINS	Stem and progenitor cells use asymmetric cell divisions to balance proliferation and differentiation. Evidence from invertebrates shows that this process is regulated by proteins asymmetrically distributed at the cell cortex during mitosis: Par3-Par6-aPKC, which confer polarity, and G alpha(i)-LGN/AGS3-NuMA-dynein/dynactin, which govern spindle positioning. Here we focus on developing mouse skin, where progenitor cells execute a switch from symmetric to predominantly asymmetric divisions concomitant with stratification. Using in vivo skin-specific lentiviral RNA interference, we investigate spindle orientation regulation and provide direct evidence that LGN (also called Gpsm2), NuMA and dynactin (Dctn1) are involved. In compromising asymmetric cell divisions, we uncover profound defects in stratification, differentiation and barrier formation, and implicate Notch signalling as an important effector. Our study demonstrates the efficacy of applying RNA interference in vivo to mammalian systems, and the ease of uncovering complex genetic interactions, here to gain insights into how changes in spindle orientation are coupled to establishing proper tissue architecture during skin development.	[Williams, Scott E.; Beronja, Slobodan; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Beronja, Slobodan/0000-0002-6769-9261; Pasolli, Hilda Amalia/0000-0003-3899-3530; Williams, Scott/0000-0001-9975-7334	National Institutes of Health [R01AR27883]; American Cancer Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR027883, R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank N. Stokes, L. Polak and D. Oristian for their assistance in the mouse facility; S. Lanier and T. Gettys for providing AGS3 and G alpha<INF>i</INF> antibodies; N. Gaiano and C. Cepko for constructs; D. Melton and T. Honjo for mice; S. Chai for Numb constructs; E. Ezhkova for sharing microarray data; and J. Knoblich for sharing unpublished results and reagents. We are grateful to M. Schober, D. Devenport, E. Ezratty, C. Luxenburg and members of the Fuchs laboratory for discussions and critical reading of the manuscript. We thank S. Mazel and the RU Flow Cytometry Resource Center for assistance with cell sorting, A. North and the RU Bioimaging Resource Center for assistance with image acquisition and the Comparative Biology Center (AAALAC accredited) for veterinary care of our mice. S.E.W. was supported by an American Cancer Society postdoctoral fellowship and S.B. was a Human Frontier Science Program postdoctoral fellow. E.F. is an investigator in the Howard Hughes Medical Institute. Work in the Fuchs laboratory was supported by a grant from the National Institutes of Health (E.F. R01AR27883).	Adams RJ, 1996, J NEUROSCI, V16, P7610; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	49	310	316	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					353	358		10.1038/nature09793	http://dx.doi.org/10.1038/nature09793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331036	Green Accepted			2022-12-24	WOS:000287409100033
J	Shapiro, ND; Rauniyar, V; Hamilton, GL; Wu, J; Toste, FD				Shapiro, Nathan D.; Rauniyar, Vivek; Hamilton, Gregory L.; Wu, Jeffrey; Toste, F. Dean			Asymmetric additions to dienes catalysed by a dithiophosphoric acid	NATURE			English	Article							O,O-DIETHYLDITHIOPHOSPHORIC ACID; PHOSPHORIC-ACID; HYDROAMINATION; ALKENES	Chiral Bronsted acids (proton donors) have been shown to facilitate a broad range of asymmetric chemical transformations under catalytic conditions without requiring additional toxic or expensive metals(1-8). Although the catalysts developed thus far are remarkably effective at activating polarized functional groups, it is not clear whether organic Bronsted acids can be used to catalyse highly enantioselective transformations of unactivated carbon-carbon multiple bonds. This deficiency persists despite the fact that racemic acid-catalysed 'Markovnikov' additions to alkenes are well known chemical transformations. Here we show that chiral dithiophosphoric acids can catalyse the intramolecular hydroamination and hydroarylation of dienes and allenes to generate heterocyclic products in exceptional yield and enantiomeric excess. We present a mechanistic hypothesis that involves the addition of the acid catalyst to the diene, followed by nucleophilic displacement of the resulting dithiophosphate intermediate; we also report mass spectroscopic and deuterium labelling studies in support of the proposed mechanism. The catalysts and concepts revealed in this study should prove applicable to other asymmetric functionalizations of unsaturated systems.	[Shapiro, Nathan D.; Rauniyar, Vivek; Hamilton, Gregory L.; Wu, Jeffrey; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NIHGMS [R01 GM074774]; Natural Sciences and Engineering Research Council of Canada (NSERC); Bristol-Myers/Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074774] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bristol-Myers/Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Benitez and E. Tkatchouk (Goddard Group, California Institute of Technology) for performing DFT calculations, to U. Anderson and T. Iavarone of the QB3/Chemistry Mass Spectrometry Facility, and to A. DiPasquale of the X-ray Crystallography Facility. We acknowledge funding from the Director, Office of Science of the US Department of Energy (contract no. DE-AC02-05CH11231) and from NIHGMS (R01 GM074774). V. R. is grateful for a Natural Sciences and Engineering Research Council of Canada (NSERC) postdoctoral fellowship. G. L. H. is grateful for a Bristol-Myers/Squibb graduate fellowship.	Ackermann L, 2008, SYNLETT, P995, DOI 10.1055/s-2008-1072505; Aillaud I, 2007, DALTON T, P5105, DOI 10.1039/b711126f; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Borrmann T, 1996, LIEBIGS ANN, P1593; Cheng XC, 2008, BIOORGAN MED CHEM, V16, P7932, DOI 10.1016/j.bmc.2008.07.073; Cheon CH, 2008, J AM CHEM SOC, V130, P9246, DOI 10.1021/ja8041542; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; HOUK KN, 1983, J MOL STRUC-THEOCHEM, V12, P197, DOI 10.1016/0166-1280(83)85020-9; Hultzsch KC, 2005, ORG BIOMOL CHEM, V3, P1819, DOI 10.1039/b418521h; Hultzsch KC, 2005, ADV SYNTH CATAL, V347, P367, DOI 10.1002/adsc.200404261; KABACHNIK MI, 1960, TETRAHEDRON, V9, P10, DOI 10.1016/0040-4020(60)80048-8; Leavitt CM, 2008, INORG CHEM, V47, P3056, DOI 10.1021/ic7020897; Li ZG, 2006, ORG LETT, V8, P4175, DOI 10.1021/ol0610035; Liu C, 2007, ORG LETT, V9, P1935, DOI 10.1021/ol070483c; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; MASTRYUKOVA TA, 1971, ZH OBSHCH KHIM+, V41, P1938; MEBAH JMN, 1992, PHOSPHORUS SULFUR, V73, P49, DOI 10.1080/10426509208034430; MUELLER WH, 1966, J ORG CHEM, V31, P1894, DOI 10.1021/jo01344a051; Mutel V., 2005, European patent, Patent No. [1,299 383, 1299383]; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; NORMAN GR, 1952, J AM CHEM SOC, V74, P161, DOI 10.1021/ja01121a040; OBUSHAK ND, 1987, ZH OBSHCH KHIM+, V57, P1078; Pousse G, 2009, TETRAHEDRON, V65, P10617, DOI 10.1016/j.tet.2009.10.068; Roesky PW, 2003, ANGEW CHEM INT EDIT, V42, P2708, DOI 10.1002/anie.200301637; Rosenfeld DC, 2006, ORG LETT, V8, P4179, DOI 10.1021/ol061174+; Schlummer B, 2002, ORG LETT, V4, P1471, DOI 10.1021/ol025659j; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533	30	150	150	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					245	+		10.1038/nature09723	http://dx.doi.org/10.1038/nature09723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	718RQ	21307938	Green Accepted, Green Submitted			2022-12-24	WOS:000287144200041
J	Maillet, F; Poinsot, V; Andre, O; Puech-Pages, V; Haouy, A; Gueunier, M; Cromer, L; Giraudet, D; Formey, D; Niebel, A; Martinez, EA; Driguez, H; Becard, G; Denarie, J				Maillet, Fabienne; Poinsot, Verena; Andre, Olivier; Puech-Pages, Virginie; Haouy, Alexandra; Gueunier, Monique; Cromer, Laurence; Giraudet, Delphine; Formey, Damien; Niebel, Andreas; Martinez, Eduardo Andres; Driguez, Hugues; Becard, Guillaume; Denarie, Jean			Fungal lipochitooligosaccharide symbiotic signals in arbuscular mycorrhiza	NATURE			English	Article							CHITOOLIGOSACCHARIDE NODULATION FACTORS; MEDICAGO-TRUNCATULA; NODULE DEVELOPMENT; DIFFUSIBLE FACTOR; ESCHERICHIA-COLI; RHIZOBIUM; GENES; LEGUMES; BACTERIAL; PROTEIN	Arbuscular mycorrhiza (AM) is a root endosymbiosis between plants and glomeromycete fungi. It is the most widespread terrestrial plant symbiosis, improving plant uptake of water and mineral nutrients. Yet, despite its crucial role in land ecosystems, molecular mechanisms leading to its formation are just beginning to be unravelled. Recent evidence suggests that AM fungi produce diffusible symbiotic signals. Here we show that Glomus intraradices secretes symbiotic signals that are a mixture of sulphated and non-sulphated simple lipochitooligosaccharides (LCOs), which stimulate formation of AM in plant species of diverse families (Fabaceae, Asteraceae and Umbelliferae). In the legume Medicago truncatula these signals stimulate root growth and branching by the symbiotic DMI signalling pathway. These findings provide a better understanding of the evolution of signalling mechanisms involved in plant root endosymbioses and will greatly facilitate their molecular dissection. They also open the way to using these natural and very active molecules in agriculture.	[Maillet, Fabienne; Andre, Olivier; Haouy, Alexandra; Gueunier, Monique; Cromer, Laurence; Giraudet, Delphine; Niebel, Andreas; Denarie, Jean] INRA, CNRS 2594, UMR 441, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; [Poinsot, Verena] Univ Toulouse 3, CNRS, UMR 5623, Lab IMRCP, F-31062 Toulouse, France; [Puech-Pages, Virginie; Gueunier, Monique; Formey, Damien; Becard, Guillaume] Univ Toulouse, UPS, UMR 5546, F-31326 Castanet Tolosan, France; [Puech-Pages, Virginie; Gueunier, Monique; Formey, Damien; Becard, Guillaume] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Martinez, Eduardo Andres; Driguez, Hugues] Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Denarie, J (corresponding author), INRA, CNRS 2594, UMR 441, Lab Interact Plantes Microorganismes, BP 52627, F-31326 Castanet Tolosan, France.	jean.denarie@toulouse.inra.fr	Poinsot, Verena/AAU-2614-2021; cromer, Laurence/I-4814-2014; Formey, Damien/X-5542-2019; poinssot, benoit/B-2569-2009; NIEBEL, Andreas/AAL-7687-2020	Formey, Damien/0000-0003-2852-4706; poinssot, benoit/0000-0001-5890-4318; Niebel, Andreas/0000-0002-3402-8381; Poinsot, Verena/0000-0002-9746-6768	EMD Crop BioScience; Charles-Leopold Mayer Prize; French Academy of Sciences; Institut National de la Recherche Agronomique	EMD Crop BioScience; Charles-Leopold Mayer Prize; French Academy of Sciences; Institut National de la Recherche Agronomique	This work was supported in part by a grant from EMD Crop BioScience and by the Charles-Leopold Mayer Prize (2005) attributed to J.D. by the French Academy of Sciences. M. G. was supported by an Institut National de la Recherche Agronomique fellowship. We are grateful to C. Gough and G. Oldroyd for providing seeds of M. truncatula mutants, and to S. Roy and J. Loubradou for providing sterile mycorrhized roots and spores of G. intraradices. The UPLC/QToF mass spectrometer was made available to us by the Institut des Technologies Avancees du Vivant and the QTRAP mass spectrometer by the Metabolomics and fluxomics platform (MetaToul). We thank S. Danoun for her help with UPLC/QToF mass spectrometry, F. Letisse for his advice and help in setting up experiments on the QTrap mass spectrometer, P. Lavedan for NMR measurements, C. Herve for her advice and help for quantitative PCR with reverse transcription experiments and C. Briere for his advice for statistical analysis. We thank C. Gough, J. Cullimore and G. Oldroyd for their comments on this manuscript.	Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Chen CY, 2008, NEW PHYTOL, V180, P311, DOI 10.1111/j.1469-8137.2008.02612.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; DEMONT N, 1993, J BIOL CHEM, V268, P20134; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gutjahr C, 2009, NEW PHYTOL, V183, P53, DOI 10.1111/j.1469-8137.2009.02871.x; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kuhn H, 2010, NEW PHYTOL, V185, P716, DOI 10.1111/j.1469-8137.2009.03116.x; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2006, CURR OPIN PLANT BIOL, V9, P351, DOI 10.1016/j.pbi.2006.05.003; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Olsthoorn MMA, 1998, BIOCHEMISTRY-US, V37, P9024, DOI 10.1021/bi972937r; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Poinsot V, 2001, J BACTERIOL, V183, P3721, DOI 10.1128/JB.183.12.3721-3728.2001; PRICE NPJ, 1992, MOL MICROBIOL, V6, P3575, DOI 10.1111/j.1365-2958.1992.tb01793.x; R Development Core Team, 2009, R FDN STAT COMP; Rasmussen MO, 2004, ORG BIOMOL CHEM, V2, P1908, DOI 10.1039/b403575e; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Riely BK, 2004, CURR OPIN PLANT BIOL, V7, P408, DOI 10.1016/j.pbi.2004.04.005; ROCHE P, 1991, J BIOL CHEM, V266, P10933; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P145, DOI 10.1016/B978-012370526-6.50007-6; SPAINK HP, 1995, J BACTERIOL, V177, P6276, DOI 10.1128/jb.177.21.6276-6281.1995; SPAINK HP, 1994, MOL MICROBIOL, V13, P821, DOI 10.1111/j.1365-2958.1994.tb00474.x; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Wang B, 2010, NEW PHYTOL, V186, P514, DOI 10.1111/j.1469-8137.2009.03137.x; Weidmann S, 2004, MOL PLANT MICROBE IN, V17, P1385, DOI 10.1094/MPMI.2004.17.12.1385	55	614	669	9	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					58	U1501		10.1038/nature09622	http://dx.doi.org/10.1038/nature09622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	702UO	21209659				2022-12-24	WOS:000285921600030
J	Carone, BR; Fauquier, L; Habib, N; Shea, JM; Hart, CE; Li, RW; Bock, C; Li, CJ; Gu, HC; Zamore, PD; Meissner, A; Weng, ZP; Hofmann, HA; Friedman, N; Rando, OJ				Carone, Benjamin R.; Fauquier, Lucas; Habib, Naomi; Shea, Jeremy M.; Hart, Caroline E.; Li, Ruowang; Bock, Christoph; Li, Chengjian; Gu, Hongcang; Zamore, Phillip D.; Meissner, Alexander; Weng, Zhiping; Hofmann, Hans A.; Friedman, Nir; Rando, Oliver J.			Paternally Induced Transgenerational Environmental Reprogramming of Metabolic Gene Expression in Mammals	CELL			English	Article							DNA METHYLATION; EPIGENETIC INHERITANCE; HUMAN GENOME; MOUSE; MICE; DROSOPHILA; CHROMATIN; PROMOTER; ALLELE; CELLS	Epigenetic information can be inherited through the mammalian germline and represents a plausible transgenerational carrier of environmental information. To test whether transgenerational inheritance of environmental information occurs in mammals, we carried out an expression profiling screen for genes in mice that responded to paternal diet. Offspring of males fed a low-protein diet exhibited elevated hepatic expression of many genes involved in lipid and cholesterol biosynthesis and decreased levels of cholesterol esters, relative to the offspring of males fed a control diet. Epigenomic profiling of offspring livers revealed numerous modest (similar to 20%) changes in cytosine methylation depending on paternal diet, including reproducible changes in methylation over a likely enhancer for the key lipid regulator Ppara. These results, in conjunction with recent human epidemiological data, indicate that parental diet can affect cholesterol and lipid metabolism in offspring and define a model system to study environmental reprogramming of the heritable epigenome.	[Carone, Benjamin R.; Fauquier, Lucas; Shea, Jeremy M.; Hart, Caroline E.; Li, Chengjian; Zamore, Phillip D.; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Li, Ruowang; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Habib, Naomi] Hebrew Univ Jerusalem, Dept Mol Genet & Biotechnol, Fac Med, IL-91120 Jerusalem, Israel; [Bock, Christoph; Gu, Hongcang; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Texas System; University of Texas Austin; Hebrew University of Jerusalem	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu	Hofmann, Hans A/E-4538-2016; Zamore, Phillip D/A-8941-2013; Habib, Naomi/AAA-8937-2020; Friedman, Nir/H-9692-2012; Bock, Christoph/AAE-7618-2019	Hofmann, Hans A/0000-0002-3335-330X; Friedman, Nir/0000-0002-9678-3550; Bock, Christoph/0000-0001-6091-3088; Rando, Oliver/0000-0003-1516-9397; Gu, Hongcang/0000-0002-1439-7606; Zamore, Phillip/0000-0002-4505-9618; Carone, Benjamin/0000-0002-9822-4218	Burroughs Wellcome Fund; NIGMS [GM088618, GM62862, GM65236]; NIH; US-Israel Binational Science Foundation (BSF); NSF; Alfred P. Sloan Foundation; Meidan fellowship; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862, R01GM065236, R01GM088618] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Meidan fellowship; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Haig for initial discussions motivating this experiment and K. Ahmad, P. Kaufman, C. Meiklejohn, Y. Nahmias, and members of the Rando lab for critical reading of the manuscript. O.J.R. is supported in part by a Career Award in Biomedical Sciences from the Burroughs Wellcome Fund, by grant GM088618 from NIGMS, and by the Mathers Foundation and is a member of the UMass Diabetes Endocrinology Research Center (DK32520). N.F. is supported by grants from the NIH and the US-Israel Binational Science Foundation (BSF). H. A. H. is supported by NSF, an Alfred P. Sloan Foundation Fellowship and a Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology. P.D.Z. is supported by grants GM62862 and GM65236 from the NIGMS. N.H. is supported by the Meidan fellowship. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; Avital Eytan, 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Champagne F, 2001, Prog Brain Res, V133, P287; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Horton TH, 2005, AM J HUM BIOL, V17, P34, DOI 10.1002/ajhb.20092; Jablonka E., 1995, EPIGENETIC INHERITAN; Jablonka E, 2005, EVOLUTION 4 DIMENSIO; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Torrisani J, 2007, CURR GENOMICS, V8, P229; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Yamaguchi R, 2010, HORM METAB RES, V42, P821, DOI 10.1055/s-0030-1261954; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	56	770	811	5	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1084	1096		10.1016/j.cell.2010.12.008	http://dx.doi.org/10.1016/j.cell.2010.12.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183072	Green Accepted, Bronze			2022-12-24	WOS:000285625400007
J	Reich, D; Green, RE; Kircher, M; Krause, J; Patterson, N; Durand, EY; Viola, B; Briggs, AW; Stenzel, U; Johnson, PLF; Maricic, T; Good, JM; Marques-Bonet, T; Alkan, C; Fu, QM; Mallick, S; Li, H; Meyer, M; Eichler, EE; Stoneking, M; Richards, M; Talamo, S; Shunkov, MV; Derevianko, AP; Hublin, JJ; Kelso, J; Slatkin, M; Paabo, S				Reich, David; Green, Richard E.; Kircher, Martin; Krause, Johannes; Patterson, Nick; Durand, Eric Y.; Viola, Bence; Briggs, Adrian W.; Stenzel, Udo; Johnson, Philip L. F.; Maricic, Tomislav; Good, Jeffrey M.; Marques-Bonet, Tomas; Alkan, Can; Fu, Qiaomei; Mallick, Swapan; Li, Heng; Meyer, Matthias; Eichler, Evan E.; Stoneking, Mark; Richards, Michael; Talamo, Sahra; Shunkov, Michael V.; Derevianko, Anatoli P.; Hublin, Jean-Jacques; Kelso, Janet; Slatkin, Montgomery; Paeaebo, Svante			Genetic history of an archaic hominin group from Denisova Cave in Siberia	NATURE			English	Article							MITOCHONDRIAL-DNA; GENOME SEQUENCE; NEANDERTHAL; PATTERNS; FLORES; SIMA	Using DNA extracted from a finger bone found in Denisova Cave in southern Siberia, we have sequenced the genome of an archaic hominin to about 1.9-fold coverage. This individual is from a group that shares a common origin with Neanderthals. This population was not involved in the putative gene flow from Neanderthals into Eurasians; however, the data suggest that it contributed 4-6% of its genetic material to the genomes of present-day Melanesians. We designate this hominin population 'Denisovans' and suggest that it may have been widespread in Asia during the Late Pleistocene epoch. A tooth found in Denisova Cave carries a mitochondrial genome highly similar to that of the finger bone. This tooth shares no derived morphological features with Neanderthals or modern humans, further indicating that Denisovans have an evolutionary history distinct from Neanderthals and modern humans.	[Reich, David; Briggs, Adrian W.; Mallick, Swapan] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick; Mallick, Swapan; Li, Heng] MIT, Broad Inst, Cambridge, MA 02142 USA; [Reich, David; Patterson, Nick; Mallick, Swapan; Li, Heng] Harvard Univ, Cambridge, MA 02142 USA; [Green, Richard E.; Kircher, Martin; Krause, Johannes; Viola, Bence; Briggs, Adrian W.; Stenzel, Udo; Maricic, Tomislav; Fu, Qiaomei; Meyer, Matthias; Stoneking, Mark; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Krause, Johannes] Univ Tubingen, Inst Nat Wissensch Archaol, D-72070 Tubingen, Germany; [Durand, Eric Y.; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Viola, Bence; Richards, Michael; Talamo, Sahra; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Marques-Bonet, Tomas; Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas] Inst Evolutionary Biol UPF CSIC, Barcelona 08003, Spain; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, CAS MPS Joint Lab Human Evolut & Archeometry, Beijing 100044, Peoples R China; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Inst Archaeol Ethnog, Siberian Branch, Palaeolith Dept, Novosibirsk 630090, Russia	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; University of California System; University of California Santa Cruz; Eberhard Karls University of Tubingen; University of California System; University of California Berkeley; Max Planck Society; Emory University; University of Montana System; University of Montana; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of British Columbia; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; bence.viola@eva.mpg.de; paabo@eva.mpg.de	Marques-Bonet, Tomas/ABF-3734-2020; Kelso, Janet/N-1812-2019; Talamo, Sahra/AAD-1774-2022; Marques-Bonet, Tomas/I-4618-2014; Shunkov, Mikhail V./Q-6576-2016; Krause, Johannes/E-6640-2015; Richards, Michael/A-9374-2008; Richards, Michael/O-3717-2016; Kircher, Martin/HDL-9392-2022; Alkan, Can/D-2982-2009; Li, Heng/D-9344-2011; Ganesh, Dunna Sai/AGX-5170-2022; Krause, Johannes/AFP-2642-2022; Viola, Bence/B-7390-2011; Kircher, Martin/H-6909-2019; Derevianko, Anatoly P./Q-5975-2016; Hug, Balthasar L./G-1568-2010	Marques-Bonet, Tomas/0000-0002-5597-3075; Kelso, Janet/0000-0002-3618-322X; Talamo, Sahra/0000-0002-2406-3132; Marques-Bonet, Tomas/0000-0002-5597-3075; Shunkov, Mikhail V./0000-0003-1388-2308; Krause, Johannes/0000-0001-5475-4690; Richards, Michael/0000-0001-5274-8887; Richards, Michael/0000-0001-5274-8887; Alkan, Can/0000-0002-5443-0706; Li, Heng/0000-0003-4874-2874; Krause, Johannes/0000-0001-9144-3920; Kircher, Martin/0000-0001-9278-5471; Derevianko, Anatoly P./0000-0003-1156-8331; Viola, Bence/0000-0001-8052-707X; Green, Richard/0000-0003-0516-5827	Max Planck Society; Krekeler Foundation; US National Institutes of Health [R01-GM40282]; National Science Foundation [OISE-0754461, 1032255]; Direct For Biological Sciences [0906041] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); Krekeler Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Bustamante, A. I. Krivoshapkin, M. Lachmann, R. Nielsen, K. Pruefer, A. Tsybankov, L. Vigilant and W. Zhai for comments; K. Finstermeier for graphics work; the MPI-EVA sequencing group, R. Schultz and S. Weihnachtsmann for technical support; and P. Fujita, A. Hinrichs and K. Learned for designing the UCSC genome browser portal to the Denisova data. The Presidential Innovation Fund of the Max Planck Society and the Krekeler Foundation provided financial support. M.S. was supported by a US National Institutes of Health grant (R01-GM40282). The National Science Foundation provided an International Postdoctoral Fellowship (OISE-0754461) to J.M.G., a Fellowship in Biological Informatics to P.L.F.J. and a HOMINID grant (1032255) to D.R.	Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Derevianko AP, 2008, ARCHAEOL ETHNOL ANTH, V34, P13, DOI 10.1016/j.aeae.2008.07.002; Derevianko A.P., 1998, PALAEOLITHIC SIBERIA; Derevianko A.P., 2003, PALEOENVIRONMENT PAL; DEREVIANKO AP, 1998, ARCHAEOLOGY GEOLOGY; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morwood MJ, 2009, J HUM EVOL, V57, P437, DOI 10.1016/j.jhevol.2009.07.003; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; POPE GG, 1992, AM J PHYS ANTHR S15, V15, P243; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; WU X, 1995, HUMAN EVOLUTION ASI	40	1027	1073	25	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1053	1060		10.1038/nature09710	http://dx.doi.org/10.1038/nature09710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179161	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000285553800049
J	Hankinson, AL; Daviglus, ML; Bouchard, C; Carnethon, M; Lewis, CE; Schreiner, PJ; Liu, KA; Sidney, S				Hankinson, Arlene L.; Daviglus, Martha L.; Bouchard, Claude; Carnethon, Mercedes; Lewis, Cora E.; Schreiner, Pamela J.; Liu, Kiang; Sidney, Stephen			Maintaining a High Physical Activity Level Over 20 Years and Weight Gain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ENERGY-BALANCE; PUBLIC-HEALTH; UNITED-STATES; FOLLOW-UP; EXERCISE; MEN; OBESITY; ADULTS; ASSOCIATIONS	Context Data supporting physical activity guidelines to prevent long-term weight gain are sparse, particularly during the period when the highest risk of weight gain occurs. Objective To evaluate the relationship between habitual activity levels and changes in body mass index (BMI) and waist circumference over 20 years. Design, Setting, and Participants The Coronary Artery Risk Development in Young Adults (CARDIA) study is a prospective longitudinal study with 20 years of follow-up, 1985-1986 to 2005-2006. Habitual activity was defined as maintaining high, moderate, and low activity levels based on sex-specific tertiles of activity scores at baseline. Participants comprised a population-based multicenter cohort (Chicago, Illinois; Birmingham, Alabama; Minneapolis, Minnesota; and Oakland, California) of 3554 men and women aged 18 to 30 years at baseline. Main Outcome Measures Average annual changes in BMI and waist circumference. Results Over 20 years, maintaining high levels of activity was associated with smaller gains in BMI and waist circumference compared with low activity levels after adjustment for race, baseline BMI, age, education, cigarette smoking status, alcohol use, and energy intake. Men maintaining high activity gained 2.6 fewer kilograms per year (+0.15 BMI units; 95% confidence interval [CI], 0.11-0.18 vs +0.20 in the lower activity group; 95% CI, 0.17-0.23), and women maintaining higher activity gained 6.1 fewer kilograms per year (+0.17 BMI units; 95% CI, 0.12-0.21 vs +0.30 in the lower activity group; 95% CI, 0.25-0.34). Men maintaining high activity gained 3.1 fewer centimeters in waist circumference per year (+0.52 cm; 95% CI, 0.43-0.61 cm vs 0.67 cm in the lower activity group; 95% CI, 0.60-0.75 cm) and women maintaining higher activity gained 3.8 fewer centimeters per year (+0.49 cm; 95% CI, 0.39-0.58 cm vs 0.67 cm in the lower activity group; 95% CI, 0.60-0.75 cm). Conclusion Maintaining high activity levels through young adulthood may lessen weight gain as young adults transition to middle age, particularly in women. JAMA. 2010;304(23):2603-2610 www.jama.com	[Hankinson, Arlene L.; Daviglus, Martha L.; Carnethon, Mercedes; Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Sidney, Stephen] Kaiser Permanente, Div Res, Oakland, CA USA	Northwestern University; Feinberg School of Medicine; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Kaiser Permanente	Hankinson, AL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	alhankinson@northwestern.edu	s, s/GYR-2278-2022; Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019; s, s/HHD-0404-2022; s, s/HIK-1178-2022	Bouchard, Claude/0000-0002-0048-491X; Schreiner, Pamela/0000-0002-9920-6257; Carnethon, Mercedes/0000-0001-7035-0848	National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, R01 HL078972]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC048050, N01HC048047, N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R29HL048048, R01HL078972, R01HL048048, R01HL048049] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the following contracts and grants from the National Heart, Lung, and Blood Institute: N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, and R01 HL078972.	Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; Di Pietro L, 2004, INT J OBESITY, V28, P1541, DOI 10.1038/sj.ijo.0802821; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gordon-Larsen P, 2009, AM J CLIN NUTR, V89, P19, DOI 10.3945/ajcn.2008.26147; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Littman AJ, 2005, INT J OBESITY, V29, P524, DOI 10.1038/sj.ijo.0802886; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Parker ED, 2007, AM J PUBLIC HEALTH, V97, P703, DOI 10.2105/AJPH.2004.055889; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Pratt M, 1999, MED SCI SPORT EXER, V31, pS526, DOI 10.1097/00005768-199911001-00007; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Schmitz KH, 2000, INT J OBESITY, V24, P1475, DOI 10.1038/sj.ijo.0801415; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Sternfeld B, 2004, AM J EPIDEMIOL, V160, P912, DOI 10.1093/aje/kwh299; VAUGHAN L, 1991, AM J CLIN NUTR, V53, P821, DOI 10.1093/ajcn/53.4.821; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wenche Droyvold B, 2004, J Womens Health (Larchmt), V13, P55; Westerterp KR, 1997, INT J OBESITY, V21, P184, DOI 10.1038/sj.ijo.0800385; Westerterp KR, 1998, AM J CLIN NUTR, V68, p970S, DOI 10.1093/ajcn/68.4.970S; Williams PT, 2006, INT J OBESITY, V30, P543, DOI 10.1038/sj.ijo.0803172; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279; World Health Organization, 1999, OB PREV MAN GLOB EP; 2002, CARBOHYDRATE FIBER F	39	186	192	3	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2603	2610		10.1001/jama.2010.1843	http://dx.doi.org/10.1001/jama.2010.1843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156948	Green Accepted			2022-12-24	WOS:000285303400023
J	Grover, A; Citro, B				Grover, Anand; Citro, Brian			India: access to affordable drugs and the right to health	LANCET			English	Editorial Material									[Grover, Anand; Citro, Brian] Lawyers Collect HIV AIDS Unit, Bombay 400001, Maharashtra, India		Grover, A (corresponding author), Lawyers Collect HIV AIDS Unit, Bombay 400001, Maharashtra, India.	anandgrover@gmail.com						[Anonymous], 2004, WHO MED STRAT COUNTR; [Anonymous], 2004, WORLD MED SIT; European Commission, 2009, ANT TRAD AGR ACTA FA; *IND DEP IND POL P, 2010, DISC PAP SUBJ COMP L; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Office of the United Nations High Commissioner for Human Rights, INT COV EC SOC CULT; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; VIVASEUGUI D, 2003, REGIONAL BILATERAL A; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; *WHO, 2004, EQ ACC ESS MED FRAM, V8	10	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					976	977		10.1016/S0140-6736(10)62042-9	http://dx.doi.org/10.1016/S0140-6736(10)62042-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	740FA	21227487				2022-12-24	WOS:000288775800008
J	Hernandez, RD; Kelley, JL; Elyashiv, E; Melton, SC; Auton, A; McVean, G; Sella, G; Przeworski, M				Hernandez, Ryan D.; Kelley, Joanna L.; Elyashiv, Eyal; Melton, S. Cord; Auton, Adam; McVean, Gilean; Sella, Guy; Przeworski, Molly		1000 Genomes Project	Classic Selective Sweeps Were Rare in Recent Human Evolution	SCIENCE			English	Article							POSITIVE SELECTION; NATURAL-SELECTION; DELETERIOUS MUTATIONS; SOFT SWEEPS; ADAPTATION; POLYMORPHISM; DIVERSITY; SIGNATURE; GENETICS; SIZE	Efforts to identify the genetic basis of human adaptations from polymorphism data have sought footprints of "classic selective sweeps" (in which a beneficial mutation arises and rapidly fixes in the population). Yet it remains unknown whether this form of natural selection was common in our evolution. We examined the evidence for classic sweeps in resequencing data from 179 human genomes. As expected under a recurrent-sweep model, we found that diversity levels decrease near exons and conserved noncoding regions. In contrast to expectation, however, the trough in diversity around human-specific amino acid substitutions is no more pronounced than around synonymous substitutions. Moreover, relative to the genome background, amino acid and putative regulatory sites are not significantly enriched in alleles that are highly differentiated between populations. These findings indicate that classic sweeps were not a dominant mode of human adaptation over the past similar to 250,000 years.	[Hernandez, Ryan D.; Kelley, Joanna L.; Melton, S. Cord; Przeworski, Molly] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Elyashiv, Eyal; Sella, Guy] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel; [Auton, Adam; McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McVean, Gilean] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Przeworski, Molly] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Przeworski, Molly] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; Hebrew University of Jerusalem; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Przeworski, M (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	mfp@uchicago.edu	Wang, Jun/A-7261-2013; Kelley, Joanna L/H-1693-2012	Kelley, Joanna L/0000-0002-7731-605X	NSF; National Research Service [GM087069]; Wellcome Trust [WT086084MA]; Israeli Science Foundation [1492/10]; NIH [GM083228, GM20373, GM72861]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007644, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083228, F32GM087069, R01GM072861] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Research Service; Wellcome Trust(Wellcome TrustEuropean Commission); Israeli Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Coop, T. Long, G. McVicker, J. Pickrell, J. Pritchard, and K. Thornton for helpful discussions, and G. Coop, A. Di Rienzo, and J. Pritchard for comments. Supported by an NSF minority postdoctoral fellowship (R.D.H.), National Research Service Award postdoctoral fellowship GM087069 (J.L.K.), Wellcome Trust grant WT086084MA (G.M.), Israeli Science Foundation grant 1492/10 and NIH grant GM083228 (G.S.), and NIH grants GM20373 and GM72861 (M.P.). M.P. is a Howard Hughes Medical Institute Early Career Scientist.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Cai JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000336; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Orr HA, 1998, GENETICS, V149, P2099; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Przeworski M, 2002, GENETICS, V160, P1179; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Santiago E, 2005, GENETICS, V169, P475, DOI 10.1534/genetics.104.032813; SANTIAGO E, 1995, GENETICS, V139, P1013; Sattath S., 2010, PLOS GENET, P1001302; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	33	294	300	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					920	924		10.1126/science.1198878	http://dx.doi.org/10.1126/science.1198878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330547	Green Accepted			2022-12-24	WOS:000287455100060
J	Popow, J; Englert, M; Weitzer, S; Schleiffer, A; Mierzwa, B; Mechtler, K; Trowitzsch, S; Will, CL; Luhrmann, R; Soll, D; Martinez, J				Popow, Johannes; Englert, Markus; Weitzer, Stefan; Schleiffer, Alexander; Mierzwa, Beata; Mechtler, Karl; Trowitzsch, Simon; Will, Cindy L.; Luehrmann, Reinhard; Soell, Dieter; Martinez, Javier			HSPC117 Is the Essential Subunit of a Human tRNA Splicing Ligase Complex	SCIENCE			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; HELA-CELL EXTRACT; JUNCTION PHOSPHATE; FUNCTIONAL DOMAINS; LIGATION; PROTEIN; REVEALS; IDENTIFICATION; ENDONUCLEASE; PURIFICATION	Splicing of mammalian precursor transfer RNA (tRNA) molecules involves two enzymatic steps. First, intron removal by the tRNA splicing endonuclease generates separate 5' and 3' exons. In animals, the second step predominantly entails direct exon ligation by an elusive RNA ligase. Using activity-guided purification of tRNA ligase from HeLa cell extracts, we identified HSPC117, a member of the UPF0027 (RtcB) family, as the essential subunit of a tRNA ligase complex. RNA interference-mediated depletion of HSPC117 inhibited maturation of intron-containing pre-tRNA both in vitro and in living cells. The high sequence conservation of HSPC117/RtcB proteins is suggestive of RNA ligase roles of this protein family in various organisms.	[Englert, Markus; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Popow, Johannes; Weitzer, Stefan; Mierzwa, Beata; Martinez, Javier] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Schleiffer, Alexander] Res Inst Mol Pathol IMP IMBA, Bioinformat Dept, A-1030 Vienna, Austria; [Mechtler, Karl] Res Inst Mol Pathol IMP IMBA, Dept Prot Chem, A-1030 Vienna, Austria; [Trowitzsch, Simon; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; javier.martinez@imba.oeaw.ac.at	Mechtler, Karl/AAF-2717-2019; Trowitzsch, Simon/O-4957-2016; Mierzwa, Beata/A-6382-2016	Mechtler, Karl/0000-0002-3392-9946; Trowitzsch, Simon/0000-0001-9143-766X; Mierzwa, Beata/0000-0002-2146-4352; Schleiffer, Alexander/0000-0001-6251-2747; Martinez, Javier/0000-0001-9152-7323	European Commission [EURASNET-518238]; Fonds zur Forderung der wissenschaftlichen Forschung [W1207 RNA Biologie]; National Institute of General Medical Sciences; S.D. Prinz Max von und zu Liechtenstein	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); S.D. Prinz Max von und zu Liechtenstein	We thank H. Beier, T. Biederer, T. Clausen, A. Meinhart, A. F. Nielsen, R. Schroeder, K. Sheppard, T. Tuschl, and S. Westermann for reagents and helpful discussions; and G. Heyne, O. Kuzyk, G. Schmauss, and G. Stengl for technical assistance; and H. Urlaub for MS analysis of HSPC117 complexes. M.E. was a Feodor-Lynen Postdoctoral Fellow of the Alexander von Humboldt Stiftung (Bonn, Germany). Supported by grants from the European Commission (EURASNET-518238) (R.L.), the Fonds zur Forderung der wissenschaftlichen Forschung (W1207 RNA Biologie) (J.P.), and the National Institute of General Medical Sciences (D.S.). J.M. would like to especially acknowledge the generous financial contribution and support by S.D. Prinz Max von und zu Liechtenstein.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; APOSTOL BL, 1991, J BIOL CHEM, V266, P7445; Cao D, 2009, RNA, V15, P1971, DOI 10.1261/rna.1782209; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, pD3, DOI 10.1093/nar/gkh143; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Goyal K, 2008, PROTEINS, V70, P1206, DOI 10.1002/prot.21601; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Reid CE, 2000, P NATL ACAD SCI USA, V97, P424, DOI 10.1073/pnas.97.1.424; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; VICENTE O, 1988, EUR J BIOCHEM, V176, P431, DOI 10.1111/j.1432-1033.1988.tb14300.x; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	28	153	164	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					760	764		10.1126/science.1197847	http://dx.doi.org/10.1126/science.1197847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311021	Green Submitted			2022-12-24	WOS:000287205700068
J	Minc, N; Burgess, D; Chang, F				Minc, Nicolas; Burgess, David; Chang, Fred			Influence of Cell Geometry on Division-Plane Positioning	CELL			English	Article							CAENORHABDITIS-ELEGANS EMBRYO; MITOTIC SPINDLE ORIENTATION; FISSION YEAST; DYNAMIC MICROTUBULES; PRONUCLEAR MIGRATION; SHAPE; MECHANISM; CLEAVAGE; FORCES; LENGTH	The spatial organization of cells depends on their ability to sense their own shape and size. Here, we investigate how cell shape affects the positioning of the nucleus, spindle and subsequent cell division plane. To manipulate geometrical parameters in a systematic manner, we place individual sea urchin eggs into microfabricated chambers of defined geometry (e. g., triangles, rectangles, and ellipses). In each shape, the nucleus is positioned at the center of mass and is stretched by microtubules along an axis maintained through mitosis and predictive of the future division plane. We develop a simple computational model that posits that microtubules sense cell geometry by probing cellular space and orient the nucleus by exerting pulling forces that scale to microtubule length. This model quantitatively predicts division-axis orientation probability for a wide variety of cell shapes, even in multicellular contexts, and estimates scaling exponents for length-dependent microtubule forces.	[Burgess, David] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Minc, Nicolas; Burgess, David; Chang, Fred] Marine Biol Lab, Woods Hole, MA 02543 USA; [Minc, Nicolas; Chang, Fred] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Boston College; Marine Biological Laboratory - Woods Hole; Columbia University	Minc, N (corresponding author), Inst Curie, UMR 144 CNRS IC, 26 Rue Ulm, F-75248 Paris 05, France.	nicolas.minc@curie.fr		Minc, Nicolas/0000-0002-5543-7950	National Institutes of Health (NIH) [GM069670, GM056836]; Ellison Senior Scholar award; CNRS; ANR [ANR-10PDOC-003-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056836, R01GM069670] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Senior Scholar award(Lawrence Ellison Foundation); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge all members of the Chang and Burgess laboratories for discussions and technical assistance. We thank A. Boudaoud for careful reading of the manuscript and J. Brill for discussions. Microfabrication was made in the Columbia CEPSR clean room. Part of the microscopy was performed in the Microbiology Department confocal microscopy facility. This work, which was initiated at the Marine Biological Laboratory, was supported by National Institutes of Health (NIH) RO1 grants GM069670 and GM056836 and an Ellison Senior Scholar award to F. C. N.M. acknowledges support from the CNRS and an ANR "retour post-doctorants'' grant ANR-10PDOC-003-01. The authors dedicate this manuscript to the memory of Ray Rappaport.	Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; BJERKNES M, 1986, SCIENCE, V234, P1413, DOI 10.1126/science.3787253; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Concha ML, 1998, DEVELOPMENT, V125, P983; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; GOLDSTEIN B, 1995, J CELL BIOL, V129, P1071, DOI 10.1083/jcb.129.4.1071; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Guyer M.F., 1900, THESIS U CHICAGO CHI; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; HAYS TS, 1982, J CELL BIOL, V93, P374, DOI 10.1083/jcb.93.2.374; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; Holy J, 1997, CELL TISSUE RES, V289, P285, DOI 10.1007/s004410050875; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jenkinson J.W., 1909, EXPT EMBRYOLOGY; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Minc N, 2010, CURR BIOL, V20, P710, DOI 10.1016/j.cub.2010.02.047; Minc N, 2009, CURR BIOL, V19, P1096, DOI 10.1016/j.cub.2009.05.031; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Reinsch S, 1998, J CELL SCI, V111, P2283; SCHATTEN G, 1986, EXP CELL RES, V166, P191, DOI 10.1016/0014-4827(86)90519-7; Schierenberg Einhard, 2006, WormBook, P1; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Seetapun D, 2010, CURR BIOL, V20, P979, DOI 10.1016/j.cub.2010.04.040; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Strickland L, 2004, METHOD CELL BIOL, V74, P371; Strickland LI, 2005, CURR BIOL, V15, P2249, DOI 10.1016/j.cub.2005.10.073; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Vaziri A, 2007, J BIOMECH, V40, P2053, DOI 10.1016/j.jbiomech.2006.09.023; Velve-Casquillas G, 2010, NANO TODAY, V5, P28, DOI 10.1016/j.nantod.2009.12.001; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; von Dassow G, 2009, J CELL BIOL, V187, P831, DOI 10.1083/jcb.200907090; Wang SW, 1997, DEVELOPMENT, V124, P773; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Wuhr M, 2009, CELL CYCLE, V8, P1115; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	56	249	249	0	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					414	426		10.1016/j.cell.2011.01.016	http://dx.doi.org/10.1016/j.cell.2011.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295701	Green Accepted, Bronze			2022-12-24	WOS:000286973100013
J	Riehle, MM; Guelbeogo, WM; Gneme, A; Eiglmeier, K; Holm, I; Bischoff, E; Garnier, T; Snyder, GM; Li, XZ; Markianos, K; Sagnon, N; Vernick, KD				Riehle, Michelle M.; Guelbeogo, Wamdaogo M.; Gneme, Awa; Eiglmeier, Karin; Holm, Inge; Bischoff, Emmanuel; Garnier, Thierry; Snyder, Gregory M.; Li, Xuanzhong; Markianos, Kyriacos; Sagnon, N'Fale; Vernick, Kenneth D.			A Cryptic Subgroup of Anopheles gambiae Is Highly Susceptible to Human Malaria Parasites	SCIENCE			English	Article							MULTILOCUS GENOTYPE DATA; DISEASE TRANSMISSION; MOLECULAR-FORMS; HOST SELECTION; MOSQUITOS; COMPLEX; INFERENCE; AFRICA; SPECIATION; CULICIDAE	Population subgroups of the African malaria vector Anopheles gambiae have not been comprehensively characterized owing to the lack of unbiased sampling methods. In the arid savanna zone of West Africa, where potential oviposition sites are scarce, widespread collection from larval pools in the peridomestic human habitat yielded a comprehensive genetic survey of local A. gambiae population subgroups, independent of adult resting behavior and ecological preference. A previously unknown subgroup of exophilic A. gambiae is sympatric with the known endophilic A. gambiae in this region. The exophilic subgroup is abundant, lacks differentiation into M and S molecular forms, and is highly susceptible to infection with wild Plasmodium falciparum. These findings might have implications for the epidemiology of malaria transmission and control.	[Riehle, Michelle M.; Eiglmeier, Karin; Holm, Inge; Bischoff, Emmanuel; Garnier, Thierry; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol,Dept Environm & Sustainabl, Unit Hosts Vectors & Pathogens URA 3012,CNRS, F-75015 Paris, France; [Riehle, Michelle M.; Snyder, Gregory M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Guelbeogo, Wamdaogo M.; Gneme, Awa; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Li, Xuanzhong; Markianos, Kyriacos] Harvard Univ, Childrens Hosp Boston, Sch Med, Program Genom, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Harvard Medical School	Vernick, KD (corresponding author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol,Dept Environm & Sustainabl, Unit Hosts Vectors & Pathogens URA 3012,CNRS, 28 Rue Docteur Roux, F-75015 Paris, France.	kenneth.vernick@pasteur.fr	Bischoff, Emmanuel/F-1197-2011; GNEME, Awa/M-3299-2015	Bischoff, Emmanuel/0000-0003-4655-4247; Markianos, Kyriacos/0000-0003-0214-6014; GNEME, Awa/0000-0003-2514-5313	National Institute of Allergy and Infectious Diseases, NIH [AI073685, AI042361]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073685, R01AI042361] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge support from National Institute of Allergy and Infectious Diseases, NIH, to K.D.V., AI073685 and AI042361.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; BOCKARIE MJ, 1994, ANN TROP MED PARASIT, V88, P251, DOI 10.1080/00034983.1994.11812865; BRUCECHWATT LJ, 1966, B WORLD HEALTH ORGAN, V35, P405; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; COLUZZI M, 1977, NATURE, V266, P832, DOI 10.1038/266832a0; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1967, Parassitologia, V9, P73; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265; Odiere M, 2007, J MED ENTOMOL, V44, P14, DOI 10.1603/0022-2585(2007)44[14:SORAGA]2.0.CO;2; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pritchard JK, 2000, GENETICS, V155, P945; REISEN WK, 1979, AM J TROP MED HYG, V28, P408, DOI 10.4269/ajtmh.1979.28.408; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Smits A, 1996, J MED ENTOMOL, V33, P545, DOI 10.1093/jmedent/33.4.545; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2	27	102	104	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					596	598		10.1126/science.1196759	http://dx.doi.org/10.1126/science.1196759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292978	Green Accepted			2022-12-24	WOS:000286933600057
J	Yanagitani, K; Kimata, Y; Kadokura, H; Kohno, K				Yanagitani, Kota; Kimata, Yukio; Kadokura, Hiroshi; Kohno, Kenji			Translational Pausing Ensures Membrane Targeting and Cytoplasmic Splicing of XBP1u mRNA	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; TRANSLOCATION; TUNNEL; IRE1	Upon endoplasmic reticulum (ER) stress, an endoribonuclease, inositol-requiring enzyme-1 alpha, splices the precursor unspliced form of X-box-binding protein 1 messenger RNA (XBP1u mRNA) on the ER membrane to yield an active transcription factor (XBP1s), leading to the alleviation of the stress. The nascent peptide encoded by XBP1u mRNA drags the mRNA-ribosome-nascent chain (R-RNC) complex to the membrane for efficient cytoplasmic splicing. We found that translation of the XBP1u mRNA was briefly paused to stabilize the R-RNC complex. Mutational analysis of XBP1u revealed an evolutionarily conserved peptide module at the carboxyl terminus that was responsible for the translational pausing and was required for the efficient targeting and splicing of the XBP1u mRNA. Thus, translational pausing may be used for unexpectedly diverse cellular processes in mammalian cells.	[Yanagitani, Kota; Kimata, Yukio; Kadokura, Hiroshi; Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, Nara 6300192, Japan	Nara Institute of Science & Technology	Kohno, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, 8916-5 Takayama, Nara 6300192, Japan.	kkouno@bs.naist.jp	Yanagitani, Kota/N-4106-2018; Kadokura, Hiroshi/AAE-1645-2019; Kohno, Kenji/AAZ-6573-2020	Yanagitani, Kota/0000-0002-5905-9950; Kohno, Kenji/0000-0002-3503-6551; Kadokura, Hiroshi/0000-0001-7308-7141	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank J. Iida-Hashimoto and N. Fujimoto for technical assistance and K. Ito, S. Chiba, and H. Yoshida for discussions. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (K.K., Y.K.) and Scientific Research B (K.K.) of KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan. K.Y. is a special postdoctoral fellow supported by Global Center of Excellence program from the Japan Society for the Promotion of Science.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	7	140	141	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					586	589		10.1126/science.1197142	http://dx.doi.org/10.1126/science.1197142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233347				2022-12-24	WOS:000286933600054
J	Caronia, LM; Martin, C; Welt, CK; Sykiotis, GP; Quinton, R; Thambundit, A; Avbelj, M; Dhruvakumar, S; Plummer, L; Hughes, VA; Seminara, SB; Boepple, PA; Sidis, Y; Crowley, WF; Martin, KA; Hall, JE; Pitteloud, N				Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Quinton, Richard; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly			A Genetic Basis for Functional Hypothalamic Amenorrhea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; KALLMANN-SYNDROME; LUTEINIZING-HORMONE; EATING-DISORDERS; WOMEN; MUTATIONS; RECEPTOR; DEFICIENCY; WEIGHT	Background: Functional hypothalamic amenorrhea is a reversible form of gonadotropin-releasing hormone (GnRH) deficiency commonly triggered by stressors such as excessive exercise, nutritional deficits, or psychological distress. Women vary in their susceptibility to inhibition of the reproductive axis by such stressors, but it is unknown whether this variability reflects a genetic predisposition to hypothalamic amenorrhea. We hypothesized that mutations in genes involved in idiopathic hypogonadotropic hypogonadism, a congenital form of GnRH deficiency, are associated with hypothalamic amenorrhea. Methods: We analyzed the coding sequence of genes associated with idiopathic hypogonadotropic hypogonadism in 55 women with hypothalamic amenorrhea and performed in vitro studies of the identified mutations. Results: Six heterozygous mutations were identified in 7 of the 55 patients with hypothalamic amenorrhea: two variants in the fibroblast growth factor receptor 1 gene FGFR1 (G260E and R756H), two in the prokineticin receptor 2 gene PROKR2 (R85H and L173R), one in the GnRH receptor gene GNRHR (R262Q), and one in the Kallmann syndrome 1 sequence gene KAL1 (V371I). No mutations were found in a cohort of 422 controls with normal menstrual cycles. In vitro studies showed that FGFR1 G260E, FGFR1 R756H, and PROKR2 R85H are loss-of-function mutations, as has been previously shown for PROKR2 L173R and GNRHR R262Q. Conclusions: Rare variants in genes associated with idiopathic hypogonadotropic hypogonadism are found in women with hypothalamic amenorrhea, suggesting that these mutations may contribute to the variable susceptibility of women to the functional changes in GnRH secretion that characterize hypothalamic amenorrhea. Our observations provide evidence for the role of rare variants in common multifactorial disease. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT00494169.) N Engl J Med 2011;364:215-25.	[Sidis, Yisrael; Pitteloud, Nelly] Univ Lausanne, CHU Vaudois, Div Endocrine, CH-1011 Lausanne, Switzerland; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Harvard Ctr Reprod Endocrine Sci, Boston, MA 02114 USA; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Quinton, Richard] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Quinton, Richard] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Newcastle University - UK; Newcastle University - UK	Pitteloud, N (corresponding author), Univ Lausanne, CHU Vaudois, Div Endocrine, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	nelly.pitteloud@chuv.ch	Hall, Janet E/F-3516-2019; Sykiotis, Gerasimos P/E-7407-2017; PITTELOUD, Nelly/K-2709-2014	Hall, Janet E/0000-0003-4644-3061; Avbelj Stefanija, Magdalena/0000-0002-0836-5114; Sykiotis, Gerasimos/0000-0002-9565-4941; Welt, Corrine/0000-0002-8219-5504	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) [5U54HD028138, 1R01HD056264, 5R01HD015788, 5R01HD42708]; National Center for Research Resources [1 UL1 RR025758-01, M01-RR-01066]; Newcastle University Teaching Hospitals Special Trustees; Pew Latin American Fellows Program in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056264, U54HD028138, R01HD043341, R01HD015788] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013241] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Newcastle University Teaching Hospitals Special Trustees; Pew Latin American Fellows Program in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) (through cooperative agreement 5U54HD028138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and NICHD-NIH grants 1R01HD056264, 5R01HD015788, and 5R01HD42708), by the National Center for Research Resources (grants 1 UL1 RR025758-01 and M01-RR-01066 to the Harvard Clinical and Translational Science Center), the Newcastle University Teaching Hospitals Special Trustees, and the Pew Latin American Fellows Program in the Biomedical Sciences (grant to Dr. Martin).	Beranova M, 2001, J CLIN ENDOCR METAB, V86, P1580, DOI 10.1210/jc.86.4.1580; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; BOYAR RM, 1974, NEW ENGL J MED, V291, P861, DOI 10.1056/NEJM197410242911701; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; Canto P, 2009, J ANDROL, V30, P41, DOI 10.2164/jandrol.108.005314; Centeno ML, 2007, J NEUROENDOCRINOL, V19, P594, DOI 10.1111/j.1365-2826.2007.01566.x; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Gardiner JV, 2010, DIABETES, V59, P397, DOI 10.2337/db09-1198; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GILES DE, 1993, FERTIL STERIL, V60, P486; Hayes FJ, 1999, J CLIN ENDOCR METAB, V84, P1028, DOI 10.1210/jc.84.3.1028; Kim SH, 2008, J NEUROENDOCRINOL, V20, P141, DOI 10.1111/j.1365-2826.2007.01627.x; LOUCKS AB, 1989, J CLIN ENDOCR METAB, V68, P402, DOI 10.1210/jcem-68-2-402; Loucks AB, 2003, J CLIN ENDOCR METAB, V88, P297, DOI 10.1210/jc.2002-020369; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Mercader JM, 2008, HUM MOL GENET, V17, P1234, DOI 10.1093/hmg/ddn013; Miller KK, 1998, J CLIN ENDOCR METAB, V83, P2309, DOI 10.1210/jc.83.7.2309; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Perkins RB, 2001, HUM REPROD, V16, P2198, DOI 10.1093/humrep/16.10.2198; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P1317, DOI 10.1210/jc.2004-1361; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179; REINDOLLAR RH, 1986, AM J OBSTET GYNECOL, V155, P531, DOI 10.1016/0002-9378(86)90274-7; SANTORO N, 1986, ENDOCR REV, V7, P11, DOI 10.1210/edrv-7-1-11; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Thome Jennifer L, 2007, Eat Behav, V8, P334, DOI 10.1016/j.eatbeh.2006.11.009; WARREN MP, 1980, J CLIN ENDOCR METAB, V51, P1150, DOI 10.1210/jcem-51-5-1150; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wilfley DE, 2007, INT J EAT DISORDER, V40, pS123, DOI 10.1002/eat.20436	45	132	139	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					215	225		10.1056/NEJMoa0911064	http://dx.doi.org/10.1056/NEJMoa0911064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247312	Green Accepted, Bronze			2022-12-24	WOS:000286383900006
J	Dragoi, G; Tonegawa, S				Dragoi, George; Tonegawa, Susumu			Preplay of future place cell sequences by hippocampal cellular assemblies	NATURE			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL CELLS; MEMORY; REPLAY; EXPERIENCE; REACTIVATION; SLEEP; CONSOLIDATION; DYNAMICS; STATE	During spatial exploration, hippocampal neurons show a sequential firing pattern in which individual neurons fire specifically at particular locations along the animal's trajectory (place cells(1,2)). According to the dominant model of hippocampal cell assembly activity, place cell firing order is established for the first time during exploration, to encode the spatial experience, and is subsequently replayed during rest(3-6) or slow-wave sleep(7-10) for consolidation of the encoded experience(11,12). Here we report that temporal sequences of firing of place cells expressed during a novel spatial experience occurred on a significant number of occasions during the resting or sleeping period preceding the experience. This phenomenon, which is called preplay, occurred in disjunction with sequences of replay of a familiar experience. These results suggest that internal neuronal dynamics during resting or sleep organize hippocampal cellular assemblies(13-15) into temporal sequences that contribute to the encoding of a related novel experience occurring in the future.	[Dragoi, George; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Dragoi, George; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Dragoi, G (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gdragoi@mit.edu; tonegawa@mit.edu			NIH [R01-MH078821, P50-MH58880]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH078821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. A. Wilson for assistance with data acquisition, discussions and comments on an earlier version of the manuscript; J. O'Keefe, A. Siapas, F. Kloosterman, D. L. Buhl for comments on earlier versions of the manuscript; and F. Kloosterman for providing assistance with the line detection for the Bayesian decoding. This work was supported by NIH grants R01-MH078821 and P50-MH58880 to S. T., who was an HHMI Investigator in an earlier part of this study.	BLACK JE, 1986, ADV DEV PSYCHOL; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	28	342	346	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					397	+		10.1038/nature09633	http://dx.doi.org/10.1038/nature09633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21179088	Green Accepted, Green Submitted			2022-12-24	WOS:000286385600052
J	Flagel, SB; Clark, JJ; Robinson, TE; Mayo, L; Czuj, A; Willuhn, I; Akers, CA; Clinton, SM; Phillips, PEM; Akil, H				Flagel, Shelly B.; Clark, Jeremy J.; Robinson, Terry E.; Mayo, Leah; Czuj, Alayna; Willuhn, Ingo; Akers, Christina A.; Clinton, Sarah M.; Phillips, Paul E. M.; Akil, Huda			A selective role for dopamine in stimulus-reward learning	NATURE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; NUCLEUS-ACCUMBENS CORE; INCENTIVE SALIENCE; NOVELTY-SEEKING; ACQUISITION; SENSITIZATION; PERFORMANCE; RECEPTORS; SYSTEMS; NMDA	Individuals make choices and prioritize goals using complex processes that assign value to rewards and associated stimuli. During Pavlovian learning, previously neutral stimuli that predict rewards can acquire motivational properties, becoming attractive and desirable incentive stimuli. However, whether a cue acts solely as a predictor of reward, or also serves as an incentive stimulus, differs between individuals. Thus, individuals vary in the degree to which cues bias choice and potentially promote maladaptive behaviour. Here we use rats that differ in the incentive motivational properties they attribute to food cues to probe the role of the neurotransmitter dopamine in stimulus-reward learning. We show that intact dopamine transmission is not required for all forms of learning in which reward cues become effective predictors. Rather, dopamine acts selectively in a form of stimulus-reward learning in which incentive salience is assigned to reward cues. In individuals with a propensity for this form of learning, reward cues come to powerfully motivate and control behaviour. This work provides insight into the neurobiology of a form of stimulus-reward learning that confers increased susceptibility to disorders of impulse control.	[Clark, Jeremy J.; Willuhn, Ingo; Akers, Christina A.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Clark, Jeremy J.; Willuhn, Ingo; Akers, Christina A.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Flagel, Shelly B.; Mayo, Leah; Clinton, Sarah M.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Robinson, Terry E.; Czuj, Alayna] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu; akil@umich.edu	Flagel, Shelly B/G-5561-2012; Clark, Jeremy/J-9552-2015; Phillips, Paul/E-7813-2013; Clinton, Sarah M/N-3953-2017; Willuhn, Ingo/AAP-4276-2021; Mayo, Leah/AAX-5320-2020; Phillips, Paul E. M./A-4463-2008	Flagel, Shelly B/0000-0002-7309-9908; Phillips, Paul/0000-0002-8749-7026; Clinton, Sarah M/0000-0001-7158-411X; Willuhn, Ingo/0000-0001-6540-6894; Mayo, Leah/0000-0002-0645-4869; Phillips, Paul E. M./0000-0002-8749-7026	National Institutes of Health [R01-MH079292, R01-DA027858, T32-DA07278, F32-DA24540, R37-DA04294, 5P01-DA021633-02]; Office of Naval Research [N00014-02-1-0879]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH085859, R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633, T32DA007278, R37DA004294, F32DA024540, R01DA027858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R01-MH079292 (to P.E.M.P.), R01-DA027858 (to P.E.M.P.), T32-DA07278 (to J.J.C.), F32-DA24540 (to J.J.C.), R37-DA04294 (to T.E.R.), and 5P01-DA021633-02 (to T.E.R. and H.A.). The selective breeding colony was supported by a grant from the Office of Naval Research to H.A. (N00014-02-1-0879). We thank K. Berridge and J. Morrow for comments on earlier versions of the manuscript, and S. Ng-Evans for technical support.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Clinton SM, 2007, HORM BEHAV, V51, P655, DOI 10.1016/j.yhbeh.2007.03.009; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Hearst E, 1974, HEARSTSIGN TRACKING; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; Kuo WJ, 2009, SCIENCE, V324, P519, DOI 10.1126/science.1165598; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Stead JDH, 2006, BEHAV GENET, V36, P697, DOI 10.1007/s10519-006-9058-7; Tindell AJ, 2009, J NEUROSCI, V29, P12220, DOI 10.1523/JNEUROSCI.2499-09.2009; Tomie A, 1998, PSYCHOPHARMACOLOGY, V139, P376, DOI 10.1007/s002130050728; Verbeke G, 2000, LINEAR MIXED MODELS; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zhang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000437	35	633	637	3	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					53	U63		10.1038/nature09588	http://dx.doi.org/10.1038/nature09588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21150898	Green Accepted			2022-12-24	WOS:000285921600029
J	Roostalu, J; Hentrich, C; Bieling, P; Telley, IA; Schiebel, E; Surrey, T				Roostalu, Johanna; Hentrich, Christian; Bieling, Peter; Telley, Ivo A.; Schiebel, Elmar; Surrey, Thomas			Directional Switching of the Kinesin Cin8 Through Motor Coupling	SCIENCE			English	Article							MITOTIC SPINDLE; BUDDING YEAST; EG5; PROTEINS; MOTILITY; MICROTUBULES; CONFORMATION; ORGANIZATION; SUPERFAMILY; ANAPHASE	Kinesin motor proteins are thought to move exclusively in either one or the other direction along microtubules. Proteins of the kinesin-5 family are tetrameric microtubule cross-linking motors important for cell division and differentiation in various organisms. Kinesin-5 motors are considered to be plus-end-directed. However, here we found that purified kinesin-5 Cin8 from budding yeast could behave as a bidirectional kinesin. On individual microtubules, single Cin8 motors were minus-end-directed motors, whereas they switched to plus-end-directed motility when working in a team of motors sliding antiparallel microtubules apart. This kinesin can thus change directionality of movement depending on whether it acts alone or in an ensemble.	[Roostalu, Johanna; Schiebel, Elmar] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany; [Hentrich, Christian; Bieling, Peter; Telley, Ivo A.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Schiebel, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de; thomas.surrey@cancer.org.uk	Telley, Ivo Andreas/D-2063-2011; Surrey, Thomas/AAC-4608-2021	Telley, Ivo Andreas/0000-0003-4444-1046; Roostalu, Johanna/0000-0002-6757-0468; Bieling, Peter/0000-0002-7458-4358; Hentrich, Christian/0000-0001-6697-5001; Surrey, Thomas/0000-0001-9082-1870	Deutsche Forschungsgemeinschaft; European Commission; Swiss National Science Foundation; Cancer Research UK [14256] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research UK(Cancer Research UK)	We thank D. Pellman and M. Knop for plasmids; I. Hagan, J. Ellenberg, and M. Kaksonen for critically reading the manuscript; and the Deutsche Forschungsgemeinschaft, the European Commission (Marie Curie Research Training Network "Spindle Dynamics"), and the Swiss National Science Foundation for financial support.	Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Cheerambathur DK, 2008, J CELL BIOL, V182, P429, DOI 10.1083/jcb.200804100; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Guerin T, 2010, CURR OPIN CELL BIOL, V22, P14, DOI 10.1016/j.ceb.2009.12.012; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032	30	114	116	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					94	99		10.1126/science.1199945	http://dx.doi.org/10.1126/science.1199945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21350123				2022-12-24	WOS:000289000000045
J	Kaneko, H; Dridi, S; Tarallo, V; Gelfand, BD; Fowler, BJ; Cho, WG; Kleinman, ME; Ponicsan, SL; Hauswirth, WW; Chiodo, VA; Kariko, K; Yoo, JW; Lee, DK; Hadziahmetovic, M; Song, Y; Misra, S; Chaudhuri, G; Buaas, FW; Braun, RE; Hinton, DR; Zhang, Q; Grossniklaus, HE; Provis, JM; Madigan, MC; Milam, AH; Justice, NL; Albuquerque, RJC; Blandford, AD; Bogdanovich, S; Hirano, Y; Witta, J; Fuchs, E; Littman, DR; Ambati, BK; Rudin, CM; Chong, MMW; Provost, P; Kugel, JF; Goodrich, JA; Dunaief, JL; Baffi, JZ; Ambati, J				Kaneko, Hiroki; Dridi, Sami; Tarallo, Valeria; Gelfand, Bradley D.; Fowler, Benjamin J.; Cho, Won Gil; Kleinman, Mark E.; Ponicsan, Steven L.; Hauswirth, William W.; Chiodo, Vince A.; Kariko, Katalin; Yoo, Jae Wook; Lee, Dong-ki; Hadziahmetovic, Majda; Song, Ying; Misra, Smita; Chaudhuri, Gautam; Buaas, Frank W.; Braun, Robert E.; Hinton, David R.; Zhang, Qing; Grossniklaus, Hans E.; Provis, Jan M.; Madigan, Michele C.; Milam, Ann H.; Justice, Nikki L.; Albuquerque, Romulo J. C.; Blandford, Alexander D.; Bogdanovich, Sasha; Hirano, Yoshio; Witta, Jassir; Fuchs, Elaine; Littman, Dan R.; Ambati, Balamurali K.; Rudin, Charles M.; Chong, Mark M. W.; Provost, Patrick; Kugel, Jennifer F.; Goodrich, James A.; Dunaief, Joshua L.; Baffi, Judit Z.; Ambati, Jayakrishna			DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration	NATURE			English	Article							EMBRYONIC STEM-CELLS; MICRORNA BIOGENESIS; MOUSE OOCYTES; LDL RECEPTOR; RECOMBINATION; ARGONAUTE2; EXPRESSION; CANCER; SIRNAS; DIFFERENTIATION	Geographic atrophy (GA), an untreatable advanced form of age-related macular degeneration, results from retinal pigmented epithelium (RPE) cell degeneration. Here we show that the microRNA (miRNA)-processing enzyme DICER1 is reduced in the RPE of humans with GA, and that conditional ablation of Dicer1, but not seven other miRNA-processing enzymes, induces RPE degeneration in mice. DICER1 knockdown induces accumulation of Alu RNA in human RPE cells and Alu-like B1 and B2 RNAs in mouse RPE. Alu RNA is increased in the RPE of humans with GA, and this pathogenic RNA induces human RPE cytotoxicity and RPE degeneration in mice. Antisense oligonucleotides targeting Alu/B1/B2 RNAs prevent DICER1 depletion-induced RPE degeneration despite global miRNA downregulation. DICER1 degrades Alu RNA, and this digested Alu RNA cannot induce RPE degeneration in mice. These findings reveal a miRNA-independent cell survival function for DICER1 involving retrotransposon transcript degradation, show that Alu RNA can directly cause human pathology, and identify new targets for a major cause of blindness.	[Kaneko, Hiroki; Dridi, Sami; Tarallo, Valeria; Gelfand, Bradley D.; Fowler, Benjamin J.; Cho, Won Gil; Kleinman, Mark E.; Justice, Nikki L.; Albuquerque, Romulo J. C.; Blandford, Alexander D.; Bogdanovich, Sasha; Hirano, Yoshio; Baffi, Judit Z.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Cho, Won Gil] Yonsei Univ, Wonju Coll Med, Dept Anat, Wonju 220701, South Korea; [Ponicsan, Steven L.; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Hauswirth, William W.; Chiodo, Vince A.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Kariko, Katalin] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Sch Chem Mat Sci BK21, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Suwon 440746, South Korea; [Hadziahmetovic, Majda; Song, Ying; Milam, Ann H.; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Buaas, Frank W.; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Hinton, David R.] Univ So Calif, Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Zhang, Qing; Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Zhang, Qing; Grossniklaus, Hans E.] Emory Univ, Atlanta, GA 30322 USA; [Provis, Jan M.] Australian Natl Univ, ANU Med Sch, ARC Ctr Excellence Vis Sci, Canberra, ACT 0200, Australia; [Provis, Jan M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Madigan, Michele C.] Univ Sydney, Save Sight Inst, Sydney, NSW 2001, Australia; [Witta, Jassir] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Littman, Dan R.; Chong, Mark M. W.] NYU, Sch Med, Howard Hughes Med Inst, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Rudin, Charles M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21231 USA; [Chong, Mark M. W.] Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3052, Australia; [Provost, Patrick] Univ Laval, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada; [Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Global Res Lab RNAi Med, Suwon 440746, South Korea	University of Kentucky; Yonsei University; University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Florida; University of Pennsylvania; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); University of Pennsylvania; Pennsylvania Medicine; Meharry Medical College; Jackson Laboratory; Doheny Eye Institute; University of Southern California; Emory University; Emory University; Australian National University; Australian National University; University of New South Wales Sydney; University of Sydney; University of Kentucky; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; New York University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Johns Hopkins University; Johns Hopkins Medicine; Walter & Eliza Hall Institute; Laval University; Laval University; University of Kentucky; Sungkyunkwan University (SKKU)	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Kaneko, Hiroki/AHA-2461-2022; Kaneko, Hiroki/O-7695-2015; Dridi, Sami/Q-8207-2019; Provost, Patrick/G-2786-2010; Gelfand, Brad/L-3926-2019; Fuchs, Elaine/G-1565-2016; Chong, Mark/H-6684-2016; Fowler, Benjamin/F-4987-2012; Provis, Jan/C-9529-2009; Rudin, Charles/R-2530-2019	Kaneko, Hiroki/0000-0003-0731-6465; Kaneko, Hiroki/0000-0003-0731-6465; Provost, Patrick/0000-0002-6099-6562; Chong, Mark/0000-0002-3701-7397; Provis, Jan/0000-0002-6405-2868; Rudin, Charles/0000-0001-5204-3465; hauswirth, william/0000-0002-3244-4947; Kleinman, Mark/0000-0001-8557-7949; Hirano, Yoshio/0000-0002-9173-0839; Tarallo, Valeria/0000-0002-6920-4402	National Eye Institute (NEI)/National Institutes of Health (NIH) [R01EY015422, R01EY018350, R01EY018836, R01EY020672, R21EY019778, RC1EY020442, R01EY017182, R01EY017950, R01HD027215, R21AI076757, P30EY06360, U10EY013729, R01EY011123, P30EY008571, R01GM068414, R01EY015240, P30EY003040, R01EY001545, T32HL091812]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness Senior Scientist Investigator Awards; University of Kentucky Physician Scientist Award; International Retinal Research Foundation; American Health Assistance Foundation; VA Merit Award; Department of Defense; MEST, Korea; Arnold and Mabel Beckman Foundation; Macular Vision Research Foundation and Foundation Fighting Blindness; ARC Centres of Excellence [CE0561903]; Sydney Foundation for Medical Research; National Health and Medical Research Council, Australia [637228]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [RC1EY020442, R01EY011123, U10EY013729, P30EY003040, R01EY001545, P30EY006360, R01EY017182, P30EY014800, R01EY018350, R01EY015422, P30EY008571, R01EY020672, R21EY019778, R01EY015240, R01EY017950, P30EY021721, R01EY018836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068414] Funding Source: NIH RePORTER	National Eye Institute (NEI)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness Senior Scientist Investigator Awards(Research to Prevent Blindness (RPB)); University of Kentucky Physician Scientist Award; International Retinal Research Foundation; American Health Assistance Foundation; VA Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); MEST, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Arnold and Mabel Beckman Foundation; Macular Vision Research Foundation and Foundation Fighting Blindness; ARC Centres of Excellence(Australian Research Council); Sydney Foundation for Medical Research; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Chrenek, J. Garcia-Perez, T. Heidmann, C. Kanellopoulou, D. M. Livingston, J. V. Moran, R. F. Mullins, J. M. Nickerson, E. A. Pearce, A. Tarakhovsky, B. Vogelstein, V. E. Velculescu and D. J. Zack for providing mice, reagents or tissues; R. King, L. Xu, M. McConnell, C. Payne, G. R. Pattison, G. J. Jaffe, S. Medearis and C. Spee for technical assistance; and A. Sinai, R. Mohan, T. S. Khurana, R. A. Brekken, P. L. Deininger, S. Bondada, P. A. Pearson, A. M. Rao, G. S. Rao and K. Ambati for discussions. J. A. was supported by National Eye Institute (NEI)/National Institutes of Health (NIH) grants R01EY015422, R01EY018350, R01EY018836, R01EY020672, R21EY019778, RC1EY020442, the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, and the Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair. Research to Prevent Blindness Senior Scientist Investigator Awards or departmental unrestricted grants supported J. A., H. E. G. and W. W. H.; J. Z. B. was supported by University of Kentucky Physician Scientist Award, International Retinal Research Foundation, and American Health Assistance Foundation; B. K. A. by VA Merit Award and Department of Defense; D.-k. L. by Global Research Laboratory program by MEST, Korea; D. R. H. by Arnold and Mabel Beckman Foundation; W. W. H. by Macular Vision Research Foundation and Foundation Fighting Blindness; J. M. P. by ARC Centres of Excellence Grant CE0561903; M. C. M. by Sydney Foundation for Medical Research. B. K. A was supported by NIH R01EY017182 and R01EY017950; R. E. B. by NIH R01HD027215; G. C. by NIH R21AI076757; H. E. G. by NIH P30EY06360; W. W. H. by NIH U10EY013729, R01EY011123, and P30EY008571; J. F. K. and J. A. G. by NIH R01GM068414; J. L. D. by NIH R01EY015240; D. R. H. by NIH P30EY003040 and R01EY001545; M. E. K. and S. B. by NIH T32HL091812. P. P. is a Senior Scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). M. M. W. C. is a QEII Fellow of the Australian Research Council and is supported by National Health and Medical Research Council, Australia Project Grant 637228. E. F. and D. R. L. are investigators of the Howard Hughes Medical Institute.	Alexander JJ, 2008, ADV EXP MED BIOL, V613, P121, DOI 10.1007/978-0-387-74904-4_13; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Prades C, 1996, J MOL EVOL, V42, P37, DOI 10.1007/BF00163209; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105	52	438	467	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					325	+		10.1038/nature09830	http://dx.doi.org/10.1038/nature09830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21297615	Green Accepted			2022-12-24	WOS:000288444000034
J	Dubey, GP; Ben-Yehuda, S				Dubey, Gyanendra P.; Ben-Yehuda, Sigal			Intercellular Nanotubes Mediate Bacterial Communication	CELL			English	Article							BACILLUS-SUBTILIS; MECHANISMS; PROTEIN; CYANOBACTERIA; PEPTIDES; PLASMID; SYSTEM; CELLS	Bacteria are known to communicate primarily via secreted extracellular factors. Here we identify a previously uncharacterized type of bacterial communication mediated by nanotubes that bridge neighboring cells. Using Bacillus subtilis as a model organism, we visualized transfer of cytoplasmic fluorescent molecules between adjacent cells. Additionally, by coculturing strains harboring different antibiotic resistance genes, we demonstrated that molecular exchange enables cells to transiently acquire nonhereditary resistance. Furthermore, non-conjugative plasmids could be transferred from one cell to another, thereby conferring hereditary features to recipient cells. Electron microscopy revealed the existence of variously sized tubular extensions bridging neighboring cells, serving as a route for exchange of intracellular molecules. These nanotubes also formed in an interspecies manner, between B. subtilis and Staphylococcus aureus, and even between B. subtilis and the evolutionary distant bacterium Escherichia coli. We propose that nanotubes represent a major form of bacterial communication in nature, providing a network for exchange of cellular molecules within and between species.	[Dubey, Gyanendra P.; Ben-Yehuda, Sigal] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada IMRIC, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada IMRIC, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	sigalb@ekmd.huji.ac.il			European Research Council [209130]; Israel Science Foundation [696/07]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	We thank I. Popov, E. Blayvas, N. Feinstein, and E. Rahamim (Hebrew University, IL) for technical support during EM studies. We are grateful to A. Rouvinski (Hebrew University, IL) for experimental advice and insightful discussions. We thank R. Losick (Harvard University, USA), M. Kassel (National Institutes of Health, USA), G. Bachrach (Hebrew University, IL), D. Kearns (Indiana University, USA), A. Taraboulos (Hebrew University, IL), and members of the Ben-Yehuda laboratory for valuable discussions and comments. We thank the National BioResource Project National Institute of Genetics, Japan (NIG, Japan) for providing B. subtilis mutant strains. This work was supported by the European Research Council Starting Grant (209130), and by the Israel Science Foundation (696/07) awarded to S. B-Y.	Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GIDDINGS TH, 1981, ARCH MICROBIOL, V129, P295, DOI 10.1007/BF00414700; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Harwood C.R., 1990, MOL BIOL METHODS BAC; Haugland R.P., 2005, HDB A GUIDEBOOK FLUO; Heinlein M, 2004, INT REV CYTOL, V235, P93, DOI 10.1016/S0074-7696(04)35003-5; Hershey A.D., 1983, LAMBDA 2; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615; Kearns DB, 2001, TRENDS MICROBIOL, V9, P126, DOI 10.1016/S0966-842X(01)01948-5; KOEHLER TM, 1987, J BACTERIOL, V169, P5271, DOI 10.1128/jb.169.11.5271-5278.1987; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kuchma SL, 2000, CURR OPIN BIOTECH, V11, P429, DOI 10.1016/S0958-1669(00)00123-3; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Madigan M.T., 2006, BROCK BIOL MICROORGA; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Schara K, 2009, CELL MOL BIOL LETT, V14, P636, DOI 10.2478/s11658-009-0018-0; SCHLEPER C, 1995, J BACTERIOL, V177, P4417, DOI 10.1128/jb.177.15.4417-4426.1995; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Silverman PM, 1997, MOL MICROBIOL, V23, P423, DOI 10.1046/j.1365-2958.1997.2411604.x; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; TANAKA T, 1977, J BACTERIOL, V131, P699, DOI 10.1128/JB.131.2.699-701.1977; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	44	355	380	12	186	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					590	600		10.1016/j.cell.2011.01.015	http://dx.doi.org/10.1016/j.cell.2011.01.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335240	Bronze			2022-12-24	WOS:000287473100013
J	Papamichos-Chronakis, M; Watanabe, S; Rando, OJ; Peterson, CL				Papamichos-Chronakis, Manolis; Watanabe, Shinya; Rando, Oliver J.; Peterson, Craig L.			Global Regulation of H2A.Z Localization by the INO80 Chromatin-Remodeling Enzyme Is Essential for Genome Integrity	CELL			English	Article							HISTONE VARIANT H2A.Z; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; RECOMBINANT HISTONES; CELL-CYCLE; COMPLEX; ACETYLATION; REPAIR; YEAST; TRANSCRIPTION	INO80 is an evolutionarily conserved, ATP-dependent chromatin-remodeling enzyme that plays roles in transcription, DNA repair, and replication. Here, we show that yeast INO80 facilitates these diverse processes at least in part by controlling genome-wide distribution of the histone variant H2A.Z. In the absence of INO80, H2A.Z nucleosomes are mislocalized, and H2A.Z levels at promoters show reduced responsiveness to transcriptional changes, suggesting that INO80 controls H2A.Z dynamics. Additionally, we demonstrate that INO80 has a histone-exchange activity in which the enzyme can replace nucleosomal H2A.Z/H2B with free H2A/H2B dimers. Genetic interactions between ino80 and htz1 support a model in which INO80 catalyzes the removal of unacetylated H2A.Z from chromatin as a mechanism to promote genome stability.	[Papamichos-Chronakis, Manolis; Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.	craig.peterson@umassmed.edu		Rando, Oliver/0000-0003-1516-9397; Papamichos-Chronakis, Emmanouil/0000-0002-4144-2070	National Institutes of Health [GM54096]; Burroughs Wellcome Fund; National Institute of General Medical Sciences; Human Frontier Science Program; Inserm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054096, R01GM079205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program(Human Frontier Science Program); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to C.L.P. (GM54096). O.J.R. is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and grants from the National Institute of General Medical Sciences and Human Frontier Science Program. M.P.-C. is supported by the Avenir Program from Inserm. We thank John Holik [University of Massachusetts Medical School (UMMS)] for assistance with the tiling array studies, Jerry Workman (Stowers Institute) for yeast histone expression vectors, John Lescyz (UMMS) for mass spectrometry analysis, Nicholas Adkins (UMMS) for the western blot with Millipore alpha-Htz1 sera (Figure S7), Erica Hong (Harvard Medical School) for help with Figure 7, members of the Peterson lab for helpful discussions throughout the course of this work, and Genevieve Almouzni (Curie Institute), Angela Taddei (Curie Institute), and Valerie Borde (Curie Institute) for critical reading of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Begley TJ, 2002, MOL CANCER RES, V1, P103; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kurihara LJ, 1996, MOL CELL BIOL, V16, P3990; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Logie C, 1999, METHOD ENZYMOL, V304, P726; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Svotelis A, 2010, CELL CYCLE, V9, P364, DOI 10.4161/cc.9.2.10465; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	51	287	295	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					200	213		10.1016/j.cell.2010.12.021	http://dx.doi.org/10.1016/j.cell.2010.12.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241891	Green Accepted, Bronze			2022-12-24	WOS:000286459900006
J	Fowler, CD; Lu, Q; Johnson, PM; Marks, MJ; Kenny, PJ				Fowler, Christie D.; Lu, Qun; Johnson, Paul M.; Marks, Michael J.; Kenny, Paul J.			Habenular alpha 5 nicotinic receptor subunit signalling controls nicotine intake	NATURE			English	Article							INTRACRANIAL SELF-STIMULATION; BRAIN REWARD SYSTEMS; LUNG-CANCER; INTERPEDUNCULAR NUCLEUS; ACETYLCHOLINE-RECEPTORS; SUSCEPTIBILITY LOCUS; RISK; ASSOCIATION; RATS; ACTIVATION	Genetic variation in CHRN alpha 5, the gene encoding the alpha 5 nicotinic acetylcholine receptor subunit, increases vulnerability to tobacco addiction and lung cancer, but the underlying mechanisms are unknown. Here we report markedly increased nicotine intake in mice with a null mutation in Chrn alpha 5. This effect was 'rescued' in knockout mice by re-expressing alpha 5 subunits in the medial habenula (MHb), and recapitulated in rats through alpha 5 subunit knockdown in MHb. Remarkably, alpha 5 subunit knockdown in MHb did not alter the rewarding effects of nicotine but abolished the inhibitory effects of higher nicotine doses on brain reward systems. The MHb extends projections almost exclusively to the interpeduncular nucleus (IPN). We found diminished IPN activation in response to nicotine in alpha 5 knockout mice. Further, disruption of IPN signalling increased nicotine intake in rats. Our findings indicate that nicotine activates the habenulo-interpeduncular pathway through alpha 5-containing nAChRs, triggering an inhibitory motivational signal that acts to limit nicotine intake.	[Fowler, Christie D.; Lu, Qun; Johnson, Paul M.; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA; [Marks, Michael J.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu	Fowler, Christie D/A-1754-2015	Fowler, Christie/0000-0003-2864-2163	National Institute on Drug Abuse [DA020686, DA026693, P30DA015663]; Florida Department of Health [07KN-06]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020686, F32DA026693, P30DA015663] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Florida Department of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse (DA020686 to P.J.K.; DA026693 to C.D.F.; P30DA015663 to M.J.M.) and The James and Esther King Biomedical Research Program, Florida Department of Health (07KN-06 to P.J.K.).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; DONOVICK PJ, 1970, J COMP PHYSIOL PSYCH, V71, P376, DOI 10.1037/h0029114; Gavrilov Yu V, 2008, Neurosci Behav Physiol, V38, P189, DOI 10.1007/s11055-008-0028-9; Girod R, 2000, NEUROPHARMACOLOGY, V39, P2715, DOI 10.1016/S0028-3908(00)00145-3; Glick SD, 2006, EUR J PHARMACOL, V537, P94, DOI 10.1016/j.ejphar.2006.03.045; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P989, DOI 10.1016/0091-3057(83)90405-7; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hussain RJ, 2008, NEUROSCI LETT, V440, P270, DOI 10.1016/j.neulet.2008.06.001; HUSTONLYONS D, 1992, PHARMACOL BIOCHEM BE, V41, P755, DOI 10.1016/0091-3057(92)90223-3; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Kenny PJ, 2009, NEUROPSYCHOPHARMACOL, V34, P266, DOI 10.1038/npp.2008.58; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; KORNETSKY C, 1979, ARCH GEN PSYCHIAT, V36, P289; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Laviolette SR, 2002, J NEUROSCI, V22, P8653; Le Foll B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000230; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; LONDON ED, 1988, J NEUROSCI, V8, P3920; Lynch WJ, 1999, EXP CLIN PSYCHOPHARM, V7, P198, DOI 10.1037/1064-1297.7.3.198; Lynch WJ, 2001, EXP CLIN PSYCHOPHARM, V9, P131, DOI 10.1037//1064-1297.9.2.131; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Rauhut AS, 2008, PHARMACOL BIOCHEM BE, V90, P598, DOI 10.1016/j.pbb.2008.05.002; RISNER ME, 1983, J PHARMACOL EXP THER, V224, P319; RUSSELL MAH, 1975, BRIT MED J, V2, P414, DOI 10.1136/bmj.2.5968.414; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; SCHAEFER GJ, 1986, NEUROPHARMACOLOGY, V25, P125, DOI 10.1016/0028-3908(86)90033-X; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Shoaib M, 2002, NEUROPHARMACOLOGY, V42, P530, DOI 10.1016/S0028-3908(01)00194-0; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287	56	442	446	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					597	601		10.1038/nature09797	http://dx.doi.org/10.1038/nature09797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21278726	Green Accepted, Green Submitted			2022-12-24	WOS:000288951200034
J	Takemoto, T; Uchikawa, M; Yoshida, M; Bell, DM; Lovell-Badge, R; Papaioannou, VE; Kondoh, H				Takemoto, Tatsuya; Uchikawa, Masanori; Yoshida, Megumi; Bell, Donald M.; Lovell-Badge, Robin; Papaioannou, Virginia E.; Kondoh, Hisato			Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells	NATURE			English	Article							MOUSE EMBRYO; PARAXIAL MESODERM; PRESOMITIC MESODERM; NERVOUS-SYSTEM; EXPRESSION; GENE; WNT; TBX6; GASTRULATION; ELEMENTS	The classical view of neural plate development held that it arises from the ectoderm, after its separation from the mesodermal and endodermal lineages. However, recent cell-lineage-tracing experiments indicate that the caudal neural plate and paraxial mesoderm are generated from common bipotential axial stem cells originating from the caudal lateral epiblast(1,2). Tbx6 null mutant mouse embryos which produce ectopic neural tubes at the expense of paraxial mesoderm(3) must provide a clue to the regulatory mechanism underlying this neural versus mesodermal fate choice. Here we demonstrate that Tbx6-dependent regulation of Sox2 determines the fate of axial stem cells. In wild-type embryos, enhancer N1 of the neural primordial gene Sox2 is activated in the caudal lateral epiblast, and the cells staying in the superficial layer sustain N1 activity and activate Sox2 expression in the neural plate(4-6). In contrast, the cells destined to become mesoderm activate Tbx6 and turn off enhancer N1 before migrating into the paraxial mesoderm compartment. In Tbx6 mutant embryos, however, enhancer N1 activity persists in the paraxial mesoderm compartment, eliciting ectopic Sox2 activation and transforming the paraxial mesoderm into neural tubes. An enhancer-N1-specific deletion mutation introduced into Tbx6 mutant embryos prevented this Sox2 activation in the mesodermal compartment and subsequent development of ectopic neural tubes, indicating that Tbx6 regulates Sox2 via enhancer N1. Tbx6-dependent repression of Wnt3a in the paraxial mesodermal compartment is implicated in this regulatory process. Paraxial mesoderm-specific misexpression of a Sox2 transgene in wild-type embryos resulted in ectopic neural tube development. Thus, Tbx6 represses Sox2 by inactivating enhancer N1 to inhibit neural development, and this is an essential step for the specification of paraxial mesoderm from the axial stem cells.	[Takemoto, Tatsuya; Uchikawa, Masanori; Yoshida, Megumi; Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Bell, Donald M.; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Papaioannou, Virginia E.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Osaka University; MRC National Institute for Medical Research; Columbia University	Kondoh, H (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	kondohh@fbs.osaka-u.ac.jp		Bell, Donald/0000-0002-3788-1580; Lovell-Badge, Robin/0000-0001-9364-4179; Papaioannou, Virginia/0000-0001-7558-8601	MEXT Japan; NIH; MRC; MRC [MC_U117562207] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056248] Funding Source: NIH RePORTER; Medical Research Council [MC_U117562207] Funding Source: researchfish	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the members of Kondoh laboratory for discussions. This study was supported by Grants-in-Aid for Scientific Research from MEXT Japan to T.T. and H.K., an NIH grant to V.E.P., and MRC funding to R.L.-B.	Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Conlon FL, 2001, DEVELOPMENT, V128, P3749; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Delfino-Machin M, 2005, DEVELOPMENT, V132, P4273, DOI 10.1242/dev.02009; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dosch R, 1997, DEVELOPMENT, V124, P2325; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; Kamachi Y, 2009, P JPN ACAD B-PHYS, V85, P55, DOI 10.2183/pjab.85.55; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Nagy A., 2003, MANIPULATING MOUSE E; NISWANDER L, 1992, DEVELOPMENT, V114, P755; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SASAKI H, 1993, DEVELOPMENT, V118, P47; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Tonegawa A, 1998, DEV BIOL, V202, P172, DOI 10.1006/dbio.1998.8895; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Xu PX, 1999, DEVELOPMENT, V126, P383; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamaguchi Terry P., 2008, V468, P287, DOI 10.1007/978-1-59745-249-6_23; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144	43	174	175	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					394	398		10.1038/nature09729	http://dx.doi.org/10.1038/nature09729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331042	Green Accepted			2022-12-24	WOS:000287409100042
J	Lin, DY; Boyle, MP; Dollar, P; Lee, H; Lein, ES; Perona, P; Anderson, DJ				Lin, Dayu; Boyle, Maureen P.; Dollar, Piotr; Lee, Hyosang; Lein, E. S.; Perona, Pietro; Anderson, David J.			Functional identification of an aggression locus in the mouse hypothalamus	NATURE			English	Article							BRAIN-STIMULATION; FEMALE RATS; ANTERIOR HYPOTHALAMUS; VENTROMEDIAL NUCLEUS; VIOLENT AGGRESSION; AGONISTIC BEHAVIOR; RECEPTOR BLOCKADE; LORDOSIS REFLEX; NEURAL ACTIVITY; C-FOS	Electrical stimulation of certain hypothalamic regions in cats and rodents can elicit attack behaviour, but the exact location of relevant cells within these regions, their requirement for naturally occurring aggression and their relationship to mating circuits have not been clear. Genetic methods for neural circuit manipulation in mice provide a potentially powerful approach to this problem, but brain-stimulation-evoked aggression has never been demonstrated in this species. Here we show that optogenetic, but not electrical, stimulation of neurons in the ventromedial hypothalamus, ventrolateral subdivision (VMHvl) causes male mice to attack both females and inanimate objects, as well as males. Pharmacogenetic silencing of VMHvl reversibly inhibits inter-male aggression. Immediate early gene analysis and single unit recordings from VMHvl during social interactions reveal overlapping but distinct neuronal subpopulations involved in fighting and mating. Neurons activated during attack are inhibited during mating, suggesting a potential neural substrate for competition between these opponent social behaviours.	[Lin, Dayu; Lee, Hyosang; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Lin, Dayu; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Boyle, Maureen P.; Lein, E. S.] Allen Inst Brain Sci, Seattle, WA 98103 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Allen Institute for Brain Science	Lin, DY (corresponding author), CALTECH, Div Biol 216 76, 1201 E Calif Blvd, Pasadena, CA 91125 USA.	dayu.lin@nyumc.org; wuwei@caltech.edu		Lin, Dayu/0000-0003-2006-0791; , Hyosang/0000-0002-3200-8678	Weston-Havens Foundation; Jane Coffin Childs Foundation	Weston-Havens Foundation; Jane Coffin Childs Foundation	We thank S. Ciocchi, S. Lin, Y. Ben-Shaul and A. Wang for advice on electrode and microdrive design; M. Gerfen and M. Vondrus for microdrive fabrication; M. P. Walsh, T. D. Heitzman and V. Rush for electronics support; A. Steele, R. Robbins, S. Ossorio, K. Gunapala, A. Paul, D. Oh, C. Kim and J. Nishiguchi for behaviour annotation and video scoring; H. Kim for technical assistance; W. E. Haubensak for teaching fibre-optic implant methods; J. T. Henderson for advice on stereotactic surgery; M. Kruk for advice on electrical stimulation experiments; K. Deisseroth for the Cre-dependent ChR2-EYFP AAV construct. M. Kruk, R. Mooney and R. Simerly for comments on the manuscripts; G. Mosconi for lab management and G. Mancuso for administrative support. This work was supported in part by the Weston-Havens Foundation and Jane Coffin Childs Foundation. D. J. A. is an Investigator of the Howard Hughes Medical Institute.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bragin A, 2000, J NEUROSCI METH, V98, P77, DOI 10.1016/S0165-0270(00)00193-X; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Halasz J, 2008, BIOL PSYCHIAT, V63, P271, DOI 10.1016/j.biopsych.2007.04.022; Halasz J, 2009, EUR J PHARMACOL, V611, P35, DOI 10.1016/j.ejphar.2009.03.050; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hess W. R., 1943, HELVETICA PHYSIOL ET PHARMACOL ACTA, V1, P33; Hess W. R., 1928, PHYSIOLOGIE, V42, P554; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KRUK MR, 1991, NEUROSCI BIOBEHAV R, V15, P527, DOI 10.1016/S0149-7634(05)80144-7; KRUK MR, 1984, PROG BRAIN RES, V61, P303; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P311, DOI 10.1016/0006-8993(88)91046-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Mongeau R, 2003, J NEUROSCI, V23, P3855; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; OLIVIER B, 1974, BRAIN RES, V65, P521, DOI 10.1016/0006-8993(74)90241-8; OLIVIER B, 1977, AGGRESSIVE BEHAV, V3, P47, DOI 10.1002/1098-2337(1977)3:1<47::AID-AB2480030105>3.0.CO;2-H; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; ROELING TAP, 1994, NEUROSCIENCE, V59, P1001, DOI 10.1016/0306-4522(94)90302-6; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Slimko EM, 2002, J NEUROSCI, V22, P7373; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Tinbergen, 1951, STUDY INSTINCT; VANDERPOEL AM, 1983, PHYSIOL BEHAV, V31, P259, DOI 10.1016/0031-9384(83)90130-0; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041	47	533	542	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					221	+		10.1038/nature09736	http://dx.doi.org/10.1038/nature09736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307935	Green Accepted			2022-12-24	WOS:000287144200036
J	Kitagawa, D; Vakonakis, I; Olieric, N; Hilbert, M; Keller, D; Olieric, V; Bortfeld, M; Erat, MC; Fluckiger, I; Gonczy, P; Steinmetz, MO				Kitagawa, Daiju; Vakonakis, Ioannis; Olieric, Natacha; Hilbert, Manuel; Keller, Debora; Olieric, Vincent; Bortfeld, Miriam; Erat, Michele C.; Flueckiger, Isabelle; Goenczy, Pierre; Steinmetz, Michel O.			Structural Basis of the 9-Fold Symmetry of Centrioles	CELL			English	Article							CENTROSOME DUPLICATION; BASAL BODY; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN SPD-2; HUMAN-CELLS; SAS-6; PROCENTRIOLE; CYCLE; MECHANISMS	The centriole, and the related basal body, is an ancient organelle characterized by a universal 9-fold radial symmetry and is critical for generating cilia, flagella, and centrosomes. The mechanisms directing centriole formation are incompletely understood and represent a fundamental open question in biology. Here, we demonstrate that the centriolar protein SAS-6 forms rod-shaped homodimers that interact through their N-terminal domains to form oligomers. We establish that such oligomerization is essential for centriole formation in C. elegans and human cells. We further generate a structural model of the related protein Bld12p from C. reinhardtii, in which nine homodimers assemble into a ring from which nine coiled-coil rods radiate outward. Moreover, we demonstrate that recombinant Bld12p self-assembles into structures akin to the central hub of the cartwheel, which serves as a scaffold for centriole formation. Overall, our findings establish a structural basis for the universal 9-fold symmetry of centrioles.	[Kitagawa, Daiju; Keller, Debora; Flueckiger, Isabelle; Goenczy, Pierre] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland; [Vakonakis, Ioannis; Hilbert, Manuel; Olieric, Vincent] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Olieric, Natacha; Hilbert, Manuel; Bortfeld, Miriam; Steinmetz, Michel O.] Paul Scherrer Inst, Biomol Res, CH-5232 Villigen, Switzerland; [Vakonakis, Ioannis; Erat, Michele C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Oxford	Gonczy, P (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland.	pierre.gonczy@epfl.ch	Olieric, Vincent/D-1078-2011; Steinmetz, Michel O/AAA-3349-2022	Olieric, Vincent/0000-0002-0533-7222; Steinmetz, Michel O/0000-0001-6157-3687; Keller, Debora/0000-0002-5284-3195; Gonczy, Pierre/0000-0002-6305-6883; Olieric, Natacha/0000-0002-6273-390X	JSPS; EMBO [ALTF-667-2007]; Wellcome Trust; FP7 Marie Curie Fellowship; Oncosuisse [OCS KLS 02024-02-2007]; ERC [AdG 233335]; Swiss National Foundation [CRSII3_125463]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); FP7 Marie Curie Fellowship; Oncosuisse; ERC(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF))	We are grateful to Fritz Winkler (PSI) for help with the modeling and critical reading of the manuscript; to Vesna Oliveri, Ursula Sauder, and Gianni Morson (ZMB, University of Basel) for excellent support and access to the electron microscope; to Meitian Wang, Andrea Prota, and Daniel Frey (PSI) for help with crystallization and X-ray data collection; to Davide Demuras and Graham Knott (BioEM core facility, EPFL), as well as Petr Leiman (EPFL), for help with EM analysis; to Christine Wandrey (EPFL) for AUC analysis; to Coralie Busso (EPFL) for help in generating the C. elegans transgenic lines; to Diego Chiappe and Marc Moniatte (Proteomic core facility, EPFL) for mass spectrometry; and to Katayoun Afshar, Virginie Hachet, and Joachim Lingner for helpful comments on the manuscript. D. K. held postdoctoral fellowships from the JSPS and EMBO (ALTF-667-2007). I. V. was partly supported by the Wellcome Trust Career Development Fellowship program. M. C. E. was supported by a FP7 Marie Curie Fellowship. This work was supported also by grants to P. G. from Oncosuisse (OCS KLS 02024-02-2007) and from the ERC (AdG 233335) as well as by grants from the Swiss National Foundation to P. G. and M. S. (Sinergia CRSII3_125463). We are also indebted to Clemens Schulze-Briese (PSI) for generous support.	Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9; GAVIN RH, 1984, J CELL SCI, V66, P147; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marshall WF, 2000, CURR TOP DEV BIOL, V49, P187; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Yabe T, 2007, DEV BIOL, V312, P44, DOI 10.1016/j.ydbio.2007.08.054	38	247	252	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					364	375		10.1016/j.cell.2011.01.008	http://dx.doi.org/10.1016/j.cell.2011.01.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21277013	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000286973100009
J	Sousa-Nunes, R; Yee, LL; Gould, AP				Sousa-Nunes, Rita; Yee, Lih Ling; Gould, Alex P.			Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila	NATURE			English	Article							NEURAL STEM-CELLS; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; TEMPORAL IDENTITY; NERVOUS-SYSTEM; GROWTH; PROLIFERATION; RECEPTOR; SIZE	Many stem, progenitor and cancer cells undergo periods of mitotic quiescence from which they can be reactivated(1-5). The signals triggering entry into and exit from this reversible dormant state are not well understood. In the developing Drosophila central nervous system, multipotent self-renewing progenitors called neuroblasts(6-9) undergo quiescence in a stereotypical spatiotemporal pattern(10). Entry into quiescence is regulated by Hox proteins and an internal neuroblast timer(11-13). Exit from quiescence (reactivation) is subject to a nutritional checkpoint requiring dietary amino acids(14). Organ co-cultures also implicate an unidentified signal from an adipose/hepatic-like tissue called the fat body(14). Here we provide in vivo evidence that Slimfast amino-acid sensing and Target of rapamycin (TOR) signalling(15) activate a fat-body-derived signal (FDS) required for neuroblast reactivation. Downstream of this signal, Insulin-like receptor signalling and the Phosphatidylinositol 3-kinase (PI3K)/TOR network are required in neuroblasts for exit from quiescence. We demonstrate that nutritionally regulated glial cells provide the source of Insulin-like peptides (ILPs) relevant for timely neuroblast reactivation but not for overall larval growth. Conversely, ILPs secreted into the haemolymph by median neurosecretory cells systemically control organismal size(16-18) but do not reactivate neuroblasts. Drosophila thus contains two segregated ILP pools, one regulating proliferation within the central nervous system and the other controlling tissue growth systemically. Our findings support a model in which amino acids trigger the cell cycle re-entry of neural progenitors via a fat-body-glia-neuroblasts relay. This mechanism indicates that dietary nutrients and remote organs, as well as local niches, are key regulators of transitions in stem-cell behaviour.	[Sousa-Nunes, Rita; Yee, Lih Ling; Gould, Alex P.] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/A-7479-2010; Gould, Alex/M-5353-2019; Sousa-Nunes, Rita/AAE-4628-2020	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Sousa-Nunes, Rita/0000-0002-7401-8081	Medical Research Council [U117584237]; MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A. Brand, S. Cohen, B. Edgar, U. Gaul, E. Hafen, C. Klambt, T. Lee, S. Leevers, P. Leopold, F. Matsuzaki, I. Miguel-Aliaga, T. Neufeld, R. Palmer, L. Partridge, L. Pick, E. Sanchez-Herrero, H. Stocker, N. Tapon and T. Xu, and also to the Bloomington stock centre and Kyoto National Institute of Genetics (NIG) for Drosophila stocks, antibodies and plasmids. We also acknowledge I. Salecker, J.-P. Vincent, A. Bailey, E. Cinnamon, L. Cheng, R. Makki, A. Matheu, P. Pachnis, P. Serpente and I. Stefana for providing advice, reagents and critical reading of the manuscript. The authors were supported by the Medical Research Council (U117584237).	Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Chen E, 2009, CELL STEM CELL, V5, P451, DOI 10.1016/j.stem.2009.10.011; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; Moline MM, 1999, DEVELOPMENT, V126, P4375; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sanchez-Garcia I, 2007, BIOESSAYS, V29, P1269, DOI 10.1002/bies.20679; Scholz H, 1997, MECH DEVELOP, V64, P137; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	54	264	267	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					508	+		10.1038/nature09867	http://dx.doi.org/10.1038/nature09867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21346761	Green Accepted			2022-12-24	WOS:000288702200061
J	Berger, MF; Lawrence, MS; Demichelis, F; Drier, Y; Cibulskis, K; Sivachenko, AY; Sboner, A; Esgueva, R; Pflueger, D; Sougnez, C; Onofrio, R; Carter, SL; Park, K; Habegger, L; Ambrogio, L; Fennell, T; Parkin, M; Saksena, G; Voet, D; Ramos, AH; Pugh, TJ; Wilkinson, J; Fisher, S; Winckler, W; Mahan, S; Ardlie, K; Baldwin, J; Simons, JW; Kitabayashi, N; MacDonald, TY; Kantoff, PW; Chin, L; Gabriel, SB; Gerstein, MB; Golub, TR; Meyerson, M; Tewari, A; Lander, ES; Getz, G; Rubin, MA; Garraway, LA				Berger, Michael F.; Lawrence, Michael S.; Demichelis, Francesca; Drier, Yotam; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sboner, Andrea; Esgueva, Raquel; Pflueger, Dorothee; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Park, Kyung; Habegger, Lukas; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Simons, Jonathan W.; Kitabayashi, Naoki; MacDonald, Theresa Y.; Kantoff, Philip W.; Chin, Lynda; Gabriel, Stacey B.; Gerstein, Mark B.; Golub, Todd R.; Meyerson, Matthew; Tewari, Ashutosh; Lander, Eric S.; Getz, Gad; Rubin, Mark A.; Garraway, Levi A.			The genomic complexity of primary human prostate cancer	NATURE			English	Article							GENE FUSIONS; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; HUMAN BREAST; PTEN; MUTATION; PATHWAY; REARRANGEMENTS; IMMUNOTHERAPY; TMPRSS2-ERG	Prostate cancer is the second most common cause of male cancer deaths in the United States. However, the full range of prostate cancer genomic alterations is incompletely characterized. Here we present the complete sequence of seven primary human prostate cancers and their paired normal counterparts. Several tumours contained complex chains of balanced (that is, 'copy-neutral') rearrangements that occurred within or adjacent to known cancer genes. Rearrangement breakpoints were enriched near open chromatin, androgen receptor and ERG DNA binding sites in the setting of the ETS gene fusion TMPRSS2-ERG, but inversely correlated with these regions in tumours lacking ETS fusions. This observation suggests a link between chromatin or transcriptional regulation and the genesis of genomic aberrations. Three tumours contained rearrangements that disrupted CADM2, and four harboured events disrupting either PTEN (unbalanced events), a prostate tumour suppressor, or MAGI2 (balanced events), a PTEN interacting protein not previously implicated in prostate tumorigenesis. Thus, genomic rearrangements may arise from transcriptional or chromatin aberrancies and engage prostate tumorigenic mechanisms.	[Demichelis, Francesca; Esgueva, Raquel; Pflueger, Dorothee; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Berger, Michael F.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Chin, Lynda; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Berger, Michael F.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Chin, Lynda; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] MIT, Cambridge, MA 02142 USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Sboner, Andrea; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sboner, Andrea; Habegger, Lukas; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Ramos, Alex H.; Pugh, Trevor J.; Kantoff, Philip W.; Chin, Lynda; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pugh, Trevor J.; Kantoff, Philip W.; Chin, Lynda; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Simons, Jonathan W.] Prostate Canc Fdn, Santa Monica, CA 90401 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Golub, Todd R.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Inst Prostate Canc, Dept Urol, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Lefrak Ctr Robot Surg, New York, NY 10065 USA; [Tewari, Ashutosh] New York Presbyterian Hosp, New York, NY 10065 USA; [Lander, Eric S.] 9 Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Cornell University; Weizmann Institute of Science; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Yale University; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Rubin, MA (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.	rubinma@med.cornell.edu; levi_garraway@dfci.harvard.edu	Lawrence, Michael/AAC-8202-2020; Sboner, Andrea/C-6487-2008; Cibulskis, Kristian/AAC-7380-2019; Demichelis, Francesca/J-9829-2016; Meyerson, Matthew L/E-7123-2012; Drier, Yotam/K-5208-2012; Pugh, Trevor/Y-2535-2019	Sboner, Andrea/0000-0001-6915-3070; Demichelis, Francesca/0000-0002-8266-8631; Drier, Yotam/0000-0003-1725-2995; Pugh, Trevor/0000-0002-8073-5888; Cibulskis, Kristian/0000-0003-1343-1582; Rubin, Mark/0000-0002-8321-9950; Simons, Jonathan/0000-0001-7660-0748; Meyerson, Matthew/0000-0002-9133-8108; Kantoff, Philip/0000-0001-7275-0597	Prostate Cancer Foundation/Movember; Howard Hughes Medical Institute; National Human Genome Research Institute; Kohlberg Foundation; National Cancer Institute (NCI); NCI Early Detection Research Network; National Institutes of Health; Department of Defense; Dana-Farber/Harvard Cancer Center [2 P50 CA090381-11]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [P50CA090381, R33CA126674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	Prostate Cancer Foundation/Movember; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Kohlberg Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Dana-Farber/Harvard Cancer Center; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Leung and all members of the Broad Institute Sequencing Platform. This work was supported by the Prostate Cancer Foundation/Movember (T. R. G., M. A. R., L. A. G.), the Howard Hughes Medical Institute (T. R. G.), the National Human Genome Research Institute (S. B. G., E. S. L.), the Kohlberg Foundation (P. W. K., L. A. G.), the National Cancer Institute (NCI; F. D., M. A. R., M. M.), the NCI Early Detection Research Network (M. A. R.), the National Institutes of Health (L. A. G.), the Department of Defense (F. D.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE grant 2 P50 CA090381-11 (P. W. K.), and the Starr Cancer Consortium (M. F. B., F. D., M. A. R., L.A.G.).	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	50	921	954	3	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					214	220		10.1038/nature09744	http://dx.doi.org/10.1038/nature09744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307934	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-24	WOS:000287144200035
J	Spence, JR; Mayhew, CN; Rankin, SA; Kuhar, MF; Vallance, JE; Tolle, K; Hoskins, EE; Kalinichenko, VV; Wells, SI; Zorn, AM; Shroyer, NF; Wells, JM				Spence, Jason R.; Mayhew, Christopher N.; Rankin, Scott A.; Kuhar, Matthew F.; Vallance, Jefferson E.; Tolle, Kathryn; Hoskins, Elizabeth E.; Kalinichenko, Vladimir V.; Wells, Susanne I.; Zorn, Aaron M.; Shroyer, Noah F.; Wells, James M.			Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro	NATURE			English	Article							EFFICIENT DIFFERENTIATION; ENDOCRINE-CELLS; ENDODERM; NEUROGENIN-3; SPECIFICATION; GENERATION; CULTURE; LIVER; FATE	Studies in embryonic development have guided successful efforts to direct the differentiation of human embryonic and induced pluripotent stem cells (PSCs) into specific organ cell types in vitro(1,2). For example, human PSCs have been differentiated into monolayer cultures of liver hepatocytes and pancreatic endocrine cells(3-6) that have therapeutic efficacy in animal models of liver disease(7,8) and diabetes(9), respectively. However, the generation of complex three-dimensional organ tissues in vitro remains a major challenge for translational studies. Here we establish a robust and efficient process to direct the differentiation of human PSCs into intestinal tissue in vitro using a temporal series of growth factor manipulations to mimic embryonic intestinal development(10). This involved activin-induced definitive endoderm formation(11), FGF/Wnt-induced posterior endoderm pattering, hindgut specification and morphogenesis(12-14), and a pro-intestinal culture system(15,16) to promote intestinal growth, morphogenesis and cytodifferentiation. The resulting three-dimensional intestinal 'organoids' consisted of a polarized, columnar epithelium that was patterned into villus-like structures and crypt-like proliferative zones that expressed intestinal stem cell markers(17). The epithelium contained functional enterocytes, as well as goblet, Paneth and enteroendocrine cells. Using this culture system as a model to study human intestinal development, we identified that the combined activity of WNT3A and FGF4 is required for hindgut specification whereas FGF4 alone is sufficient to promote hindgut morphogenesis. Our data indicate that human intestinal stem cells form de novo during development. We also determined that NEUROG3, a pro-endocrine transcription factor that is mutated in enteric anendocrinosis(18), is both necessary and sufficient for human enteroendocrine cell development in vitro. PSC-derived human intestinal tissue should allow for unprecedented studies of human intestinal development and disease.	[Spence, Jason R.; Mayhew, Christopher N.; Rankin, Scott A.; Kuhar, Matthew F.; Tolle, Kathryn; Kalinichenko, Vladimir V.; Zorn, Aaron M.; Shroyer, Noah F.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Vallance, Jefferson E.; Shroyer, Noah F.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Hoskins, Elizabeth E.; Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Div Hematol & Oncol, Cincinnati, OH 45229 USA; [Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	james.wells@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	Vallance, Jefferson/0000-0001-6473-3623; Mayhew, Chris/0000-0002-7408-1726; Shroyer, Noah/0000-0002-5934-2852	Juvenile Diabetes Research Foundation [JDRF-2-2003-530]; NIH [R01GM072915, R01DK080823A1 and S1, R03 DK084167, R01 CA142826, F32 DK83202-01, T32 HD07463];  [P30 DK078392];  [U54 RR025216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007463] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092456, P30DK078392, K01DK091415, R03DK084167, R01DK080823, F32DK083202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072915] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the laboratory, D. Wiginton and C. Wylie for input. We also thank M. Kofron, T. Stefader and R. Lang for assistance with imaging. Vectors and antibodies were from D. Melton (Addgene no. 19410, 19413), S. Yamanaka (17217-17220), C. Baum (OCT4, KLF4, SOX4, MYC lenti), and I. Manabe (KLF5 antibody). This work was supported by the Juvenile Diabetes Research Foundation JDRF-2-2003-530 (J.M.W.) and NIH, R01GM072915 (J.M.W.); R01DK080823A1 and S1 (A.M.Z. and J.M.W.); R03 DK084167 and R01 CA142826 (N.F.S.), F32 DK83202-01 and T32 HD07463 (J.R.S.). We also acknowledge core support for viral vectors, microarrays (supported by P30 DK078392), karyotyping and the Pluripotent Stem Cell Facility (supported by U54 RR025216).	Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697, DOI 10.1152/ajpgi.2001.281.3.G697; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lambert PF, 2005, METH MOLEC MED, V119, P141; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lopez-Diaz L, 2007, DEV BIOL, V309, P298, DOI 10.1016/j.ydbio.2007.07.015; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mayhew CN, 2010, CURR OPIN ORGAN TRAN, V15, P54, DOI 10.1097/MOT.0b013e3283337e1c; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torihashi S, 2006, STEM CELLS, V24, P2618, DOI 10.1634/stemcells.2006-0148; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	38	1152	1222	14	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					105	U120		10.1038/nature09691	http://dx.doi.org/10.1038/nature09691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21151107	Green Accepted			2022-12-24	WOS:000286886400043
J	Atarashi, K; Tanoue, T; Shima, T; Imaoka, A; Kuwahara, T; Momose, Y; Cheng, GH; Yamasaki, S; Saito, T; Ohba, Y; Taniguchi, T; Takeda, K; Hori, S; Ivanov, II; Umesaki, Y; Itoh, K; Honda, K				Atarashi, Koji; Tanoue, Takeshi; Shima, Tatsuichiro; Imaoka, Akemi; Kuwahara, Tomomi; Momose, Yoshika; Cheng, Genhong; Yamasaki, Sho; Saito, Takashi; Ohba, Yusuke; Taniguchi, Tadatsugu; Takeda, Kiyoshi; Hori, Shohei; Ivanov, Ivaylo I.; Umesaki, Yoshinori; Itoh, Kikuji; Honda, Kenya			Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species	SCIENCE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL IMMUNE-RESPONSES; MICROBIOTA; INTERLEUKIN-10; HOMEOSTASIS; COLITIS; INFLAMMATION; SYSTEM; BETA	CD4(+) T regulatory cells (T-regs), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T-regs were most abundant in the colonic mucosa. The spore-forming component of indigenous intestinal microbiota, particularly clusters IV and XIVa of the genus Clostridium, promoted T-reg cell accumulation. Colonization of mice by a defined mix of Clostridium strains provided an environment rich in transforming growth factor-beta and affected Foxp3(+) T-reg number and function in the colon. Oral inoculation of Clostridium during the early life of conventionally reared mice resulted in resistance to colitis and systemic immunoglobulin E responses in adult mice, suggesting a new therapeutic approach to autoimmunity and allergy.	[Atarashi, Koji; Tanoue, Takeshi; Taniguchi, Tadatsugu; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Shima, Tatsuichiro; Imaoka, Akemi; Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Kuwahara, Tomomi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Bacteriol, Tokushima 7708503, Japan; [Momose, Yoshika; Itoh, Kikuji] Univ Tokyo, Dept Vet Publ Hlth, Tokyo 1138657, Japan; [Cheng, Genhong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yamasaki, Sho; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido 0608638, Japan; [Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Hori, Shohei] RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Kanagawa 2300045, Japan; [Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Honda, Kenya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Yakult Honsha Company, Limited; Tokushima University; University of Tokyo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN; Hokkaido University; Osaka University; RIKEN; Columbia University; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan.	kenya@m.u-tokyo.ac.jp	Saito, Takashi/C-9684-2009; Hori, Shohei/O-6163-2019; Honda, Kenya/N-5297-2015; Ohba, Yusuke/E-7944-2011; Atarashi, Koji/I-5363-2014	Saito, Takashi/0000-0001-9495-3547; Hori, Shohei/0000-0001-8770-4593; Atarashi, Koji/0000-0001-5422-0736; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Inoue Foundation for Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052359, R01AI056154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085329] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Inoue Foundation for Science(Inoue Foundation for Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Ueda, J. Nishimura, and H. Saiga for technical assistance, R. Eisenman for critically reading the manuscript, and A. Miyawaki for Venus. We thank the staff at the Sankyo Laboratories for gnotobiotic handling of the mice. The work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Kato Memorial Bioscience Foundation, the Mishima Kaiun Memorial Foundation, Kanae Foundation for the Promotion of Medical Science, and Inoue Foundation for Science. The authors have applied for a patent for use of bacteria belonging to the genus Clostridium or a physiologically active substance derived from these bacteria to induce proliferation or accumulation of regulatory T cells and suppress immune functions (patent application no. JP 2010-129134). Material transfer agreements are required for the use of the IL-10 Venus mice, SFB, Clostridium spp. 46 strains, Bacteroides spp. 16 strains, and Lactobacillus spp. 3 strains.	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Momose Y, 2009, J APPL MICROBIOL, V107, P2088, DOI 10.1111/j.1365-2672.2009.04431.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	25	2398	2584	16	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					337	341		10.1126/science.1198469	http://dx.doi.org/10.1126/science.1198469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21205640	Green Accepted			2022-12-24	WOS:000286636300039
J	Tamsir, A; Tabor, JJ; Voigt, CA				Tamsir, Alvin; Tabor, Jeffrey J.; Voigt, Christopher A.			Robust multicellular computing using genetically encoded NOR gates and chemical 'wires'	NATURE			English	Article							SYNTHETIC GENE NETWORKS; CIRCUIT; QUORUM; LOGIC; MORPHOGENESIS; SYSTEM; CELLS; MODEL	Computation underlies the organization of cells into higher-order structures, for example during development or the spatial association of bacteria in a biofilm(1-3). Each cell performs a simple computational operation, but when combined with cell-cell communication, intricate patterns emerge. Here we study this process by combining a simple genetic circuit with quorum sensing to produce more complex computations in space. We construct a simple NOR logic gate in Escherichia coli by arranging two tandem promoters that function as inputs to drive the transcription of a repressor. The repressor inactivates a promoter that serves as the output. Individual colonies of E. coli carry the same NOR gate, but the inputs and outputs are wired to different orthogonal quorum-sensing 'sender' and 'receiver' devices(4,5). The quorum molecules form the wires between gates. By arranging the colonies in different spatial configurations, all possible two-input gates are produced, including the difficult XOR and EQUALS functions. The response is strong and robust, with 5- to >300-fold changes between the 'on' and 'off' states. This work helps elucidate the design rules by which simple logic can be harnessed to produce diverse and complex calculations by rewiring communication between cells.	[Tabor, Jeffrey J.; Voigt, Christopher A.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Tamsir, Alvin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Voigt, CA (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008	Tabor, Jeffrey/0000-0001-7316-0361	National Science Foundation (NSF) [0943385, CCF-0943385]; Office of Naval Research; Division of Computing and Communication Foundations [0943385] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM095765] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Mulyasasmita and K. Temme for critical discussions. This work was supported by the National Science Foundation (SynBERC, NSF#0943385 and NSF Sandpit CCF-0943385) and the Office of Naval Research.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Ilachinski A., 2001, CELLULAR AUTOMATA DI, V1st, P1; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Katz R. H., 1994, CONT LOGIC DESIGN, P141; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Neumann J. V., 1951, GEN LOGICAL THEORY A; Niklas KJ, 2003, AM J BOT, V90, P515, DOI 10.3732/ajb.90.4.515; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; RAJU BS, 1971, INT J CONTROL, V14, P1041, DOI 10.1080/00207177108932113; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Scharle TW., 1965, NOTRE DAME J FORM L, V6, P209, DOI [10.1305/ndjfl/1093958259, DOI 10.1305/NDJFL/1093958259]; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Turing A. M., 1990, B MATH BIOL, V52, P119; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Wolfram S., 2002, NEW KIND SCI, P23; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	31	517	544	5	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					212	215		10.1038/nature09565	http://dx.doi.org/10.1038/nature09565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21150903	Green Accepted			2022-12-24	WOS:000286143400038
J	Ataide, SF; Schmitz, N; Shen, KA; Ke, AL; Shan, SO; Doudna, JA; Ban, NN				Ataide, Sandro F.; Schmitz, Nikolaus; Shen, Kuang; Ke, Ailong; Shan, Shu-ou; Doudna, Jennifer A.; Ban, Nenad			The Crystal Structure of the Signal Recognition Particle in Complex with Its Receptor	SCIENCE			English	Article							SRP GTPASES FFH; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; TRANSLATING RIBOSOME; NUCLEOTIDE SPECIFICITY; 4.5S RNA; FTSY; BINDING; DOMAIN; CORE	Cotranslational targeting of membrane and secretory proteins is mediated by the universally conserved signal recognition particle (SRP). Together with its receptor (SR), SRP mediates the guanine triphosphate (GTP)-dependent delivery of translating ribosomes bearing signal sequences to translocons on the target membrane. Here, we present the crystal structure of the SRP: SR complex at 3.9 angstrom resolution and biochemical data revealing that the activated SRP: SR guanine triphosphatase (GTPase) complex binds the distal end of the SRP hairpin RNA where GTP hydrolysis is stimulated. Combined with previous findings, these results suggest that the SRP: SR GTPase complex initially assembles at the tetraloop end of the SRP RNA and then relocalizes to the opposite end of the RNA. This rearrangement provides a mechanism for coupling GTP hydrolysis to the handover of cargo to the translocon.	[Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ataide, Sandro F.; Schmitz, Nikolaus; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Shen, Kuang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; Cornell University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu; ban@mol.biol.ethz.ch	Shen, Kuang/H-9441-2016	Dietz, Nikolaus/0000-0001-7300-4342; F Ataide, Sandro/0000-0003-1807-5708	Howard Hughes Medical Institute; ETH; Boehringer Ingelheim Fonds; NIH [GM078024]; Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) of the SNSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024, R01GM086766] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); ETH(ETH Zurich); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) of the SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Zhou for excellent technical assistance and help with crystal preparation during the early stages of the project. Initial crystallographic analysis was performed at beamline 8.2.2 at the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory; we acknowledge C. Ralston for outstanding technical assistance at the ALS. Crystallographic data were collected at the beamline X06SA at the Swiss Light Source (SLS). We thank A. Brunger for the prerelease version of CNS and for helpful comments on the refinement, C. Schulze-Briese and T. Tomizaki for their outstanding support at the SLS, T. Maier and S. Klinge for critical discussion and reading of the manuscript, and T. Maier and M. Leibundgut for help and assistance with data collection and solving the structure. S.F.A. was funded initially by the Howard Hughes Medical Institute and currently by an ETH postdoctoral fellowship, N.S. is funded by Boehringer Ingelheim Fonds, and K.S. is funded by NIH grant GM078024 to S.S. This work was supported in part by the Howard Hughes Medical Institute (J.A.D.) and by the Swiss National Science Foundation (SNSF) and the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF. Atomic coordinates and structure factors for the SRP:SR crystal structure have been deposited with the Protein Data Bank under accession code 2xxa.	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batey RT, 2002, BIOCHEMISTRY-US, V41, P11703, DOI 10.1021/bi026163c; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gawronski-Salerno J, 2007, J STRUCT BIOL, V158, P122, DOI 10.1016/j.jsb.2006.10.025; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Reyes CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000607; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Schmitz U, 1996, RNA, V2, P1213; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Weiche B, 2008, J MOL BIOL, V377, P761, DOI 10.1016/j.jmb.2008.01.040; WOOD H, 1992, NUCLEIC ACIDS RES, V20, P5919, DOI 10.1093/nar/20.22.5919; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; ZWIEB C, 1992, NUCLEIC ACIDS RES, V20, P2207, DOI 10.1093/nar/20.suppl.2207	39	108	111	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					881	886		10.1126/science.1196473	http://dx.doi.org/10.1126/science.1196473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330537	Green Accepted			2022-12-24	WOS:000287455100048
J	Sinha, B; Koster, D; Ruez, R; Gonnord, P; Bastiani, M; Abankwa, D; Stan, RV; Butler-Browne, G; Vedie, B; Johannes, L; Morone, N; Parton, RG; Raposo, G; Sens, P; Lamaze, C; Nassoy, P				Sinha, Bidisha; Koester, Darius; Ruez, Richard; Gonnord, Pauline; Bastiani, Michele; Abankwa, Daniel; Stan, Radu V.; Butler-Browne, Gillian; Vedie, Benoit; Johannes, Ludger; Morone, Nobuhiro; Parton, Robert G.; Raposo, Graca; Sens, Pierre; Lamaze, Christophe; Nassoy, Pierre			Cells Respond to Mechanical Stress by Rapid Disassembly of Caveolae	CELL			English	Article							SIGNAL-REGULATED KINASE; MEMBRANE TENSION; DEPENDENT ACTIVATION; ENDOTHELIAL-CELLS; IN-VITRO; PROTEIN; ENDOCYTOSIS; MUTATIONS; MUSCLE; GENE	The functions of caveolae, the characteristic plasma membrane invaginations, remain debated. Their abundance in cells experiencing mechanical stress led us to investigate their role in membrane-mediated mechanical response. Acute mechanical stress induced by osmotic swelling or by uniaxial stretching results in a rapid disappearance of caveolae, in a reduced caveolin/Cavin1 interaction, and in an increase of free caveolins at the plasma membrane. Tether-pulling force measurements in cells and in plasma membrane spheres demonstrate that caveola flattening and disassembly is the primary actin-and ATP-independent cell response that buffers membrane tension surges during mechanical stress. Conversely, stress release leads to complete caveola reassembly in an actin-and ATP-dependent process. The absence of a functional caveola reservoir in myotubes from muscular dystrophic patients enhanced membrane fragility under mechanical stress. Our findings support a new role for caveolae as a physiological membrane reservoir that quickly accommodates sudden and acute mechanical stresses.	[Ruez, Richard; Gonnord, Pauline; Johannes, Ludger; Raposo, Graca; Lamaze, Christophe] CNRS UMR144, F-75248 Paris 05, France; [Sinha, Bidisha; Koester, Darius; Nassoy, Pierre] Univ Paris 06, CNRS UMR168, F-75248 Paris 05, France; [Sinha, Bidisha; Koester, Darius; Nassoy, Pierre] Inst Curie, Ctr Rech, Chim Phys Lab, F-75248 Paris 05, France; [Ruez, Richard; Gonnord, Pauline; Johannes, Ludger; Lamaze, Christophe] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Raposo, Graca] PICT IBiSA Inst Curie, F-75248 Paris 05, France; [Raposo, Graca] Inst Curie, Ctr Rech, Lab Struct & Compartiments Membranaires, F-75248 Paris 05, France; [Sens, Pierre] ESPCI, CNRS UMR 7083, F-75231 Paris 05, France; [Bastiani, Michele; Abankwa, Daniel; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Bastiani, Michele; Abankwa, Daniel; Parton, Robert G.] Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Stan, Radu V.] Dartmouth Med Sch, Lebanon, NH 03756 USA; [Butler-Browne, Gillian] UM76 UPMC, Hop La Pitie Salpetriere, Inst Myol, CNRS AIM,Inserm U974,UMR7215, F-75651 Paris 13, France; [Vedie, Benoit] Hop Europeen Georges Pompidou, Biochim Lab, F-75015 Paris, France; [Morone, Nobuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of Queensland; University of Queensland; Dartmouth College; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; National Center for Neurology & Psychiatry - Japan	Lamaze, C (corresponding author), CNRS UMR144, F-75248 Paris 05, France.	christophe.lamaze@curie.fr; pierre.nassoy@curie.fr	Johannes, Ludger/W-8593-2019; Lamaze, Christophe/M-4912-2017; Köster, Darius Vasco/Y-1387-2019; Mouly, Gillian/G-6595-2017; sens, pierre/C-3537-2011; Bastiani, Michele/J-1823-2014; Ruez, Richard/A-3479-2013; Stan, Radu/AAE-7574-2021; Nassoy, Pierre/AAC-2606-2019; Parton, Robert G/C-5673-2009; Johannes, Ludger/M-9778-2017	Johannes, Ludger/0000-0002-2168-0004; Köster, Darius Vasco/0000-0001-8530-5476; sens, pierre/0000-0003-4523-3791; Bastiani, Michele/0000-0001-6752-4157; Ruez, Richard/0000-0001-5187-2210; Stan, Radu/0000-0003-2969-1725; Parton, Robert G/0000-0002-7494-5248; Johannes, Ludger/0000-0002-2168-0004; Abankwa, Daniel/0000-0003-2769-0745; LAMAZE, Christophe/0000-0001-5430-2707; butler-browne, gillian/0000-0002-3431-242X; Raposo, graca/0000-0001-9590-1298; Morone, Nobuhiro/0000-0002-7672-158X; Nassoy, Pierre/0000-0003-4615-9431	Institut Curie (PIC Division Cellulaire, Polarite et Cancer); Agence Nationale pour la Recherche; Fondation de France; Association Francaise contre les Myopathies; National Health and Medical Research Council of Australia; Australian Research Council; NIH [HL83249, HL92085]; Institut Curie; Association pour la Recherche sur le Cancer; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092085, R01HL083249] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23310087] Funding Source: KAKEN	Institut Curie (PIC Division Cellulaire, Polarite et Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Curie; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Institut Curie (PIC Division Cellulaire, Polarite et Cancer), Agence Nationale pour la Recherche, Fondation de France (programme tumeurs), Association Francaise contre les Myopathies, the National Health and Medical Research Council of Australia and the Australian Research Council (R. G. P. and D. A.), and NIH grants HL83249 and HL92085 (R. V. S.). Microscopy (M. B.) was performed at the ACRF/IMB Dynamic Imaging Centre for Cancer Biology. D. K. was funded by a doctorate fellowship from the Institut Curie, and B. S. was funded by postdoctoral fellowships from the Institut Curie and the Association pour la Recherche sur le Cancer. D. A. is a fellow of the Swiss National Science Foundation (PA00A-111446) and is indebted to K. Alexandrov for support. The authors gratefully acknowledge the Nikon Imaging Centre at Institut Curie and the CNRS consortium CellTis. We thank F. Perez for the pDendra2-C plasmid, A. Helenius for the Cav1-EGFP plasmid and MEF cells, and F. Pinaud for Cav1-EGFP HeLa. We are also grateful to M. Piel and N. Carpi for help in micropatterning and P. Bassereau for access to the confocal microscope coupled to optical tweezers. We thank C. Viaris and C. Blouin for carefully reading the manuscript, and we are indebted to A. Bigot for providing human muscle cells. We would like to thank Eurobiobank and Pr. C. Minette for giving access to primary cells to isolate the immortalized Cav3 cell line. C. L. wishes to dedicate this work to the memory of his father, Robert Lamaze, and to all patients suffering from pancreatic cancer.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai JW, 1998, J NEUROSCI, V18, P6681; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kozera L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008312; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Merlini L, 2002, J NEUROL NEUROSUR PS, V73, P65, DOI 10.1136/jnnp.73.1.65; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Park H, 2000, AM J PHYSIOL-HEART C, V278, pH1285, DOI 10.1152/ajpheart.2000.278.4.H1285; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; PRESCOTT L, 1976, TISSUE CELL, V8, P241, DOI 10.1016/0040-8166(76)90050-1; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	51	567	568	5	96	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					402	413		10.1016/j.cell.2010.12.031	http://dx.doi.org/10.1016/j.cell.2010.12.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295700	Green Accepted, Bronze			2022-12-24	WOS:000286973100012
J	Ngo, VN; Young, RM; Schmitz, R; Jhavar, S; Xiao, WM; Lim, KH; Kohlhammer, H; Xu, WH; Yang, YD; Zhao, H; Shaffer, AL; Romesser, P; Wright, G; Powell, J; Rosenwald, A; Muller-Hermelink, HK; Ott, G; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Staudt, LM				Ngo, Vu N.; Young, Ryan M.; Schmitz, Roland; Jhavar, Sameer; Xiao, Wenming; Lim, Kian-Huat; Kohlhammer, Holger; Xu, Weihong; Yang, Yandan; Zhao, Hong; Shaffer, Arthur L.; Romesser, Paul; Wright, George; Powell, John; Rosenwald, Andreas; Muller-Hermelink, Hans Konrad; Ott, German; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Denny D.; Chan, Wing C.; Staudt, Louis M.			Oncogenically active MYD88 mutations in human lymphoma	NATURE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; TNFAIP3 A20; GENE; INHIBITORS; SIGNATURES; PATHWAYS; SURVIVAL; SUBTYPES; KINASE	The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) remains the least curable form of this malignancy despite recent advances in therapy(1). Constitutive nuclear factor (NF)-kappa B and JAK kinase signalling promotes malignant cell survival in these lymphomas, but the genetic basis for this signalling is incompletely understood. Here we describe the dependence of ABC DLBCLs on MYD88, an adaptor protein that mediates toll and interleukin (IL)-1 receptor signalling(2,3), and the discovery of highly recurrent oncogenic mutations affecting MYD88 in ABC DLBCL tumours. RNA interference screening revealed that MYD88 and the associated kinases IRAK1 and IRAK4 are essential for ABC DLBCL survival. High-throughput RNA resequencing uncovered MYD88 mutations in ABC DLBCL lines. Notably, 29% of ABC DLBCL tumours harboured the same amino acid substitution, L265P, in the MYD88 Toll/IL-1 receptor (TIR) domain at an evolutionarily invariant residue in its hydrophobic core. This mutation was rare or absent in other DLBCL subtypes and Burkitt's lymphoma, but was observed in 9% of mucosa-associated lymphoid tissue lymphomas. At a lower frequency, additional mutations were observed in the MYD88 TIR domain, occurring in both the ABC and germinal centre B-cell-like (GCB) DLBCL subtypes. Survival of ABC DLBCL cells bearing the L265P mutation was sustained by the mutant but not the wild-type MYD88 isoform, demonstrating that L265P is a gain-of-function driver mutation. The L265P mutant promoted cell survival by spontaneously assembling a protein complex containing IRAK1 and IRAK4, leading to IRAK4 kinase activity, IRAK1 phosphorylation, NF-kappa B signalling, JAK kinase activation of STAT3, and secretion of IL-6, IL-10 and interferon-beta. Hence, the MYD88 signalling pathway is integral to the pathogenesis of ABC DLBCL, supporting the development of inhibitors of IRAK4 kinase and other components of this pathway for the treatment of tumours bearing oncogenic MYD88 mutations.	[Ngo, Vu N.; Young, Ryan M.; Schmitz, Roland; Jhavar, Sameer; Lim, Kian-Huat; Kohlhammer, Holger; Xu, Weihong; Yang, Yandan; Zhao, Hong; Shaffer, Arthur L.; Romesser, Paul; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Romesser, Paul] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Rimsza, Lisa M.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, J. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Denny D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Denny D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; Southwest Oncology Group; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Connors, Joseph/AAF-5284-2019; Wright, George W/M-1660-2017; Smeland, Erlend/AAO-3214-2020; Campo, Elias/AAC-5593-2019; Jaffe, Elaine/G-8981-2014	Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Ngo, Vu/0000-0002-9501-6990; Romesser, Paul/0000-0001-8268-2903; Delabie, Jan/0000-0001-5023-0689; Jaffe, Elaine/0000-0003-4632-0301; Lim, Kian-Huat/0000-0002-2766-200X	NIH, National Cancer Institute, Center for Cancer Research; NCI SPECS [UO1-CA 114778]; Foundation for NIH; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, ZIABC011007, U01CA114778] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI SPECS; Foundation for NIH; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant (UO1-CA 114778), and by the Foundation for NIH, through a gift from the Richard A. Lauderbaugh Memorial Fund. This study was conducted under the auspices of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP). R.S. is supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). P.R. was an HHMI-NIH Research Scholar. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov). We thank D. Staudt for discussions, K. Meyer for help with the GEO submission, and X. Li for IRAK1 plasmids. We are grateful to B. Tran and the Center for Cancer Research Sequencing Facility for implementation of next generation RNA sequencing.	Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dierlamm J, 1997, LEUKEMIA, V11, P747, DOI 10.1038/sj.leu.2400635; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Schmidlin H, 2009, TRENDS IMMUNOL, V30, P277, DOI 10.1016/j.it.2009.03.008; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	27	1015	1112	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					115	U133		10.1038/nature09671	http://dx.doi.org/10.1038/nature09671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21179087	Green Accepted			2022-12-24	WOS:000286886400045
J	Schroeder, BO; Wu, ZH; Nuding, S; Groscurth, S; Marcinowski, M; Beisner, J; Buchner, J; Schaller, M; Stange, EF; Wehkamp, J				Schroeder, Bjoern O.; Wu, Zhihong; Nuding, Sabine; Groscurth, Sandra; Marcinowski, Moritz; Beisner, Julia; Buchner, Johannes; Schaller, Martin; Stange, Eduard F.; Wehkamp, Jan			Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; IMMUNE-RESPONSES; PEPTIDES; THIOREDOXIN; ASSOCIATION; BETA-DEFENSIN-1; DISEASE; ASSAYS; COLON	Human epithelia are permanently challenged by bacteria and fungi, including commensal and pathogenic microbiota(1,2). In the gut, the fraction of strict anaerobes increases from proximal to distal, reaching 99% of bacterial species in the colon(3). At colonic mucosa, oxygen partial pressure is below 25% of airborne oxygen content, moreover microbial metabolism causes reduction to a low redox potential of -200 mV to -300 mV in the colon(4). Defensins, characterized by three intramolecular disulphide-bridges, are key effector molecules of innate immunity that protect the host from infectious microbes and shape the composition of microbiota at mucosal surfaces(5-8). Human beta-defensin 1 (hBD-1) is one of the most prominent peptides of its class but despite ubiquitous expression by all human epithelia, comparison with other defensins suggested only minor antibiotic killing activity(9,10). Whereas much is known about the activity of antimicrobial peptides in aerobic environments, data about reducing environments are limited. Herein we show that after reduction of disulphide-bridges hBD-1 becomes a potent antimicrobial peptide against the opportunistic pathogenic fungus Candida albicans and against anaerobic, Gram-positive commensals of Bifidobacterium and Lactobacillus species. Reduced hBD-1 differs structurally from oxidized hBD-1 and free cysteines in the carboxy terminus seem important for the bactericidal effect. In vitro, the thioredoxin (TRX) system(11) is able to reduce hBD-1 and TRX co-localizes with reduced hBD-1 in human epithelia. Hence our study indicates that reduced hBD-1 shields the healthy epithelium against colonisation by commensal bacteria and opportunistic fungi. Accordingly, an intimate interplay between redox-regulation and innate immune defence seems crucial for an effective barrier protecting human epithelia.	[Schroeder, Bjoern O.; Nuding, Sabine; Beisner, Julia; Wehkamp, Jan] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Schroeder, Bjoern O.; Nuding, Sabine; Beisner, Julia; Wehkamp, Jan] Univ Tubingen, D-72076 Tubingen, Germany; [Wu, Zhihong] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Groscurth, Sandra] Max Planck Inst Dev Biol, Dept Prot Evolut 1, D-72076 Tubingen, Germany; [Marcinowski, Moritz; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Schaller, Martin] Univ Tubingen Hosp, Dept Dermatol, D-72076 Tubingen, Germany; [Stange, Eduard F.; Wehkamp, Jan] Robert Bosch Krankenhaus, Dept Internal Med 1, D-70376 Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus	Wehkamp, J (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.	jan.wehkamp@ikp-stuttgart.de	hongbo, yi/G-9615-2011; Wu, Zhihong/AAK-3433-2020; Schroeder, Bjoern O/F-3353-2011; Wu, Zhihong/G-3569-2011; Wehkamp, Jan/B-7319-2011; Buchner, Johannes/A-2651-2010	Schroeder, Bjoern O/0000-0002-6716-8284; Buchner, Johannes/0000-0003-1282-7737; Wehkamp, Jan/0000-0001-6788-841X	Deutsche Forschungsgemeinschaft [WE 436/1-1, SCH 897/1-3, SFB685]; Robert-Bosch Foundation (Stuttgart, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert-Bosch Foundation (Stuttgart, Germany)	We thank M. Katajew, H. Loffler, C. Martensen-Kerl, C. Mehrens, J. Quitzau and A. Rose for technical assistance, B. Fehrenbacher for performing electron microscopy and H.-P. Kreichgauer, C. Schafer, O. Muller, K. R. Herrlinger and M. Escher for collecting biopsies. Furthermore we thank M. Schwab for discussions and support, C. L. Bevins and J.-M. Schroder for discussions and reading of the manuscript and Ardeypharm GmbH for providing anaerobic bacterial strains and L. Zabel for providing C. albicans strains. This work was supported by Deutsche Forschungsgemeinschaft (WE 436/1-1, SCH 897/1-3 and SFB685) and the Robert-Bosch Foundation (Stuttgart, Germany). J. W. is an Emmy Noether Scholar of Deutsche Forschungsgemeinschaft.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Bevins C L, 2003, Contrib Microbiol, V10, P106; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Nagy E, 2010, DRUGS, V70, P841, DOI 10.2165/11534490-000000000-00000; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Nuding S, 2009, MICROBES INFECT, V11, P384, DOI 10.1016/j.micinf.2009.01.001; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schaefer AS, 2010, GENES IMMUN, V11, P45, DOI 10.1038/gene.2009.75; Schroeder B. O., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2010.204, DOI 10.1038/PROTEX.2010.204]; Schroder JM, 2010, METHODS MOL BIOL, V618, P15, DOI 10.1007/978-1-60761-594-1_2; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Sido B, 2005, EUR J IMMUNOL, V35, P408, DOI 10.1002/eji.200424500; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; WILSON M, 2005, MICROBIAL INHABITANT, P251; Wu Z., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2010.205, DOI 10.1038/PROTEX.2010.205]; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	342	359	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					419	+		10.1038/nature09674	http://dx.doi.org/10.1038/nature09674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248850				2022-12-24	WOS:000286385600057
J	Yaffe, K; Weston, A; Graff-Radford, NR; Satterfield, S; Simonsick, EM; Younkin, SG; Younkin, LH; Kuller, L; Ayonayon, HN; Ding, JZ; Harris, TB				Yaffe, Kristine; Weston, Andrea; Graff-Radford, Neill R.; Satterfield, Suzanne; Simonsick, Eleanor M.; Younkin, Steven G.; Younkin, Linda H.; Kuller, Lewis; Ayonayon, Hilsa N.; Ding, Jingzhong; Harris, Tamara B.			Association of Plasma beta-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; CARDIOVASCULAR HEALTH; OLDER PERSONS; RISK; IMPAIRMENT; DEMENTIA; PROTEIN; EDUCATION; LITERACY; MEMORY	Context Lower plasma beta-amyloid 42 and 42/40 levels have been associated with incident dementia, but results are conflicting and few have investigated cognitive decline among elders without dementia. Objective To determine if plasma beta-amyloid is associated with cognitive decline and if this association is modified by measures of cognitive reserve. Design, Setting, and Participants We studied 997 black and white community-dwelling older adults from Memphis, Tennessee, and Pittsburgh, Pennsylvania, who were enrolled in the Health ABC Study, a prospective observational study begun in 1997-1998 with 10-year follow-up in 2006-2007. Participant mean age was 74.0 (SD, 3.0) years; 55.2% (n=550) were female; and 54.0% (n=538) were black. Main Outcome Measures Association of near-baseline plasma beta-amyloid levels (42 and 42/40 measured in 2010) and repeatedly measured Modified Mini-Mental State Examination (3MS) results. Results Low beta-amyloid 42/40 level was associated with greater 9-year 3MS cognitive decline (lowest beta-amyloid tertile: mean change in 3MS score, -6.59 [95% confidence interval [CI], -5.21 to -7.67] points; middle tertile: -6.16 [95% CI, -4.92 to -7.32] points; and highest tertile: -3.60 [95% CI, -2.27 to -4.73] points; P<.001). Results were similar after multivariate adjustment for age, race, education, diabetes, smoking, and apolipoprotein E [APOE] e4 status and after excluding the 72 participants with incident dementia. Measures of cognitive reserve modified this association whereby among those with high reserve (at least a high school diploma, higher than sixth-grade literacy, or no APOE e4 allele), beta-amyloid 42/40 was less associated with multivariate adjusted 9-year decline. For example, among participants with less than a high school diploma, the 3MS score decline was -8.94 (95% CI, -6.94 to -10.94) for the lowest tertile compared with -4.45 (95% CI, -2.31 to -6.59) for the highest tertile, but for those with at least a high school diploma, 3MS score decline was -4.60 (95% CI, -3.07 to -6.13) for the lowest tertile and -2.88 (95% CI, -1.41 to -4.35) for the highest tertile (P=.004 for interaction). Interactions were also observed for literacy (P=.005) and for APOE e4 allele (P=.02). Conclusion Lower plasma beta-amyloid 42/40 is associated with greater cognitive decline among elderly persons without dementia over 9 years, and this association is stronger among those with low measures of cognitive reserve. JAMA. 2011; 305(3): 261-266	[Yaffe, Kristine; Weston, Andrea] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yaffe, Kristine; Ayonayon, Hilsa N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Younkin, Steven G.; Younkin, Linda H.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Satterfield, Suzanne] Univ Tennessee, Dept Prevent Med, Memphis, TN USA; [Simonsick, Eleanor M.] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Baltimore, MD 21224 USA; [Kuller, Lewis] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ding, Jingzhong] Wake Forest Univ, Med Ctr, Dept Gerontol & Geriatr Med, Winston Salem, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 181,4150 Clement St, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu	Simonsick, Eleanor/W-6864-2019		National Institute on Aging [N01-AG62101, N01-AG62103, N01-AG62106, K24AG031155]; NATIONAL INSTITUTE ON AGING [ZIAAG000971, ZIAAG007390, K24AG031155, N01AG062103, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institute on Aging contracts N01-AG62101, N01-AG62103, and N01-AG62106. This research was supported in part by the Intramural Research Program of the National Institute on Aging. Dr Yaffe is supported in part by National Institute on Aging grant K24AG031155 and by an anonymous foundation.	Arvanitakis Z, 2002, ALZ DIS ASSOC DIS, V16, P187, DOI 10.1097/00002093-200207000-00009; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cosentino SA, 2010, ARCH NEUROL-CHICAGO, V67, P1485, DOI 10.1001/archneurol.2010.189; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 1998, HEALTH EDUC BEHAV, V25, P613, DOI 10.1177/109019819802500508; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Innogenetics, NEW PROSP RES ALZH D; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lewczuk P, 2010, EXP NEUROL, V223, P366, DOI 10.1016/j.expneurol.2009.07.024; Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Pesaresi M, 2006, NEUROBIOL AGING, V27, P904, DOI 10.1016/j.neurobiolaging.2006.03.004; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Prince M, 2009, WORLD ALZHEIMER REPO; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Rothman R, 2004, DIABETES EDUCATOR, V30, P263, DOI 10.1177/014572170403000219; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Yaffe K, 2007, NEUROBIOL AGING, V28, P171, DOI 10.1016/j.neurobiolaging.2006.10.004; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	33	171	180	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					261	266		10.1001/jama.2010.1995	http://dx.doi.org/10.1001/jama.2010.1995			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245181	Green Accepted, Bronze			2022-12-24	WOS:000286328700021
J	Hsu, YC; Pasolli, HA; Fuchs, E				Hsu, Ya-Chieh; Pasolli, H. Amalia; Fuchs, Elaine			Dynamics between Stem Cells, Niche, and Progeny in the Hair Follicle	CELL			English	Article							LABEL-RETAINING CELLS; SELF-RENEWAL; SKIN; REGENERATION; PROLIFERATION; MORPHOGENESIS; HOMEOSTASIS; ACTIVATION; EPIDERMIS; DISTINCT	Here, we exploit the hair follicle to define the point at which stem cells (SCs) become irreversibly committed along a differentiation lineage. Employing histone and nucleotide double-pulse-chase and lineage tracing, we show that the early SC descendents en route to becoming transit-amplifying cells retain stemness and slow-cycling properties and home back to the bulge niche when hair growth stops. These become the primary SCs for the next hair cycle, whereas initial bulge SCs become reserves for injury. Proliferating descendents further en route irreversibly lose their stemness, although they retain many SC markers and survive, unlike their transit-amplifying progeny. Remarkably, these progeny also home back to the bulge. Combining purification and gene expression analysis with differential ablation and functional experiments, we define critical functions for these non-SC niche residents and unveil the intriguing concept that an irreversibly committed cell in an SC lineage can become an essential contributor to the niche microenvironment.	[Hsu, Ya-Chieh; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH [R01AR050452]; Starr Foundation; NYSTEM [N09G074]; Empire State Stem Cell fund through NYSDOH [C023046]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NYSTEM; Empire State Stem Cell fund through NYSDOH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to colleagues who generously donated mice, especially B. de Crombrugghe (UTMD Anderson) and H. Akiyama (Kyoto University) for sharing Sox9-CreER mice prior to publication; S. Mazel, C. Bare, and RU's FCRC for FACS sorting; A. North (Bioimaging Resource Center) for advice in image acquisition; Comparative Biology Center (AAALAC-accredited) for health care to our mice; and members of the Fuchs' lab, in particular: T. Chen, D. Devenport, E. Ezhkova, and B. Keyes for comments on the manuscript; M. Schober for advice on image analyses and quantifications; N. Stokes and D. Oristian for assistance in mouse research. Y.-C.H. is a Starr Stem Cell Scholars Postdoctoral Fellow. This work was supported by grants from NIH (R01AR050452), Starr Foundation, and NYSTEM (N09G074) to E.F., who is an HHMI Investigator. RU FCRC is supported by the Empire State Stem Cell fund through NYSDOH Contract #C023046.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; UNNA PG, 1876, ARCH MIKROSK ANAT, V12, P665; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	39	419	428	4	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					92	105		10.1016/j.cell.2010.11.049	http://dx.doi.org/10.1016/j.cell.2010.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215372	Green Accepted, Bronze			2022-12-24	WOS:000285993600010
J	Kalinka, AT; Varga, KM; Gerrard, DT; Preibisch, S; Corcoran, DL; Jarrells, J; Ohler, U; Bergman, CM; Tomancak, P				Kalinka, Alex T.; Varga, Karolina M.; Gerrard, Dave T.; Preibisch, Stephan; Corcoran, David L.; Jarrells, Julia; Ohler, Uwe; Bergman, Casey M.; Tomancak, Pavel			Gene expression divergence recapitulates the developmental hourglass model	NATURE			English	Article							CONSERVED EMBRYONIC STAGE; PHYLOTYPIC STAGE; EVOLUTION; PATTERNS; VARIABILITY; SEQUENCE; LEVEL	The observation that animal morphology tends to be conserved during the embryonic phylotypic period (a period of maximal similarity between the species within each animal phylum) led to the proposition that embryogenesis diverges more extensively early and late than in the middle, known as the hourglass model(1,2). This pattern of conservation is thought to reflect a major constraint on the evolution of animal body plans(3). Despite a wealth of morphological data confirming that there is often remarkable divergence in the early and late embryos of species from the same phylum(4-7), it is not yet known to what extent gene expression evolution, which has a central role in the elaboration of different animal forms(8,9), underpins the morphological hourglass pattern. Here we address this question using species-specific microarrays designed from six sequenced Drosophila species separated by up to 40 million years. We quantify divergence at different times during embryogenesis, and show that expression is maximally conserved during the arthropod phylotypic period. By fitting different evolutionary models to each gene, we show that at each time point more than 80% of genes fit best to models incorporating stabilizing selection, and that for genes whose evolutionarily optimal expression level is the same across all species, selective constraint is maximized during the phylotypic period. The genes that conform most to the hourglass pattern are involved in key developmental processes. These results indicate that natural selection acts to conserve patterns of gene expression during mid-embryogenesis, and provide a genome-wide insight into the molecular basis of the hourglass pattern of developmental evolution.	[Kalinka, Alex T.; Varga, Karolina M.; Preibisch, Stephan; Jarrells, Julia; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Gerrard, Dave T.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Corcoran, David L.; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Max Planck Society; University of Manchester; Duke University	Tomancak, P (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	tomancak@mpi-cbg.de	Tomancak, Pavel/C-2109-2009; Gerrard, Dave/C-6366-2008; Bergman, Casey/F-7854-2010	Tomancak, Pavel/0000-0002-2222-9370; Bergman, Casey/0000-0002-5462-9854; Gerrard, Dave/0000-0001-6890-7213; Corcoran, David/0000-0001-7460-9247; Preibisch, Stephan/0000-0002-0276-494X	Human Frontier Science Program (HFSP) [RGY0084]	Human Frontier Science Program (HFSP)(Human Frontier Science Program)	We thank A. Alexa for providing modified code for his topGO R package, A. Larracuente and T. Sackton for sharing data with us, M. Weber for generating the embryo images for Fig. 2, and Carl Zeiss MicroImaging for providing the SPIM microscope. We also thank N. Barton, T. Bedford, D. Hartl, J. Howard, A. Oates and D. Robertson for providing useful comments and discussion on the manuscript. This work was funded by The Human Frontier Science Program (HFSP) Young Investigator's Grant RGY0084.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Artieri CG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-26; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Darwin C., 1959, WHATS NEW, V67, P2; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; DUBOULE D, 1994, DEVELOPMENT, P135; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galis F, 2001, J EXP ZOOL, V291, P195, DOI 10.1002/jez.1069; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Ge Y, 2003, RESAMPLING BASED MUL; Goldstein B, 1998, CURR BIOL, V8, P157, DOI 10.1016/S0960-9822(98)70062-4; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hazkani-Covo E, 2005, J EXP ZOOL PART B, V304B, P150, DOI 10.1002/jez.b.21033; Heger A, 2007, GENOME RES, V17, P1837, DOI 10.1101/gr.6249707; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Lemos B, 2005, EVOLUTION, V59, P126; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poe S, 2004, AM NAT, V164, P415, DOI 10.1086/422658; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Sander K., 1983, DEV EVOLUTION, P137; Schmidt K, 2004, J EXP ZOOL PART B, V302B, P446, DOI 10.1002/jez.b.21010; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; VONBAER KE, 1928, ENTWICKELUNGSGESCHIC; WRAY GA, 1991, EVOLUTION, V45, P1741, DOI 10.1111/j.1558-5646.1991.tb02684.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	50	264	268	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					811	U102		10.1038/nature09634	http://dx.doi.org/10.1038/nature09634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150996				2022-12-24	WOS:000285093700043
J	Liang, XF; Li, L; Liu, DW; Li, KL; Wu, WD; Zhu, BP; Wang, HQ; Luo, HM; Cao, LS; Zheng, JS; Yin, DP; Cao, L; Wu, BB; Bao, HH; Xu, DS; Yang, WZ; Wang, Y				Liang, Xiao-Feng; Li, Li; Liu, Da-Wei; Li, Ke-Li; Wu, Wen-Di; Zhu, Bao-Ping; Wang, Hua-Qing; Luo, Hui-Ming; Cao, Ling-Sheng; Zheng, Jing-Shan; Yin, Da-Peng; Cao, Lei; Wu, Bing-Bing; Bao, Hong-Hong; Xu, Di-Sha; Yang, Wei-Zhong; Wang, Yu			Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUILLAIN-BARRE-SYNDROME; UNITED-STATES	Background: On September 21, 2009, China began administering vaccines, obtained from 10 different manufacturers, against 2009 pandemic influenza A (H1N1) virus infection in priority populations. We aimed to assess the safety of this vaccination program. Methods: We designed a plan for passive surveillance for adverse events after immunization with the influenza A (H1N1) vaccine. Physicians or vaccination providers were required to report the numbers of vaccinees and all adverse events to their local Center for Disease Control and Prevention (CDC), which then reported the data to the Chinese CDC through the online National Immunization Information System's National Adverse Event Following Immunization Surveillance System. Data were collected through March 21, 2010, and were verified and analyzed by the Chinese CDC. Results: A total of 89.6 million doses of vaccine were administered from September 21, 2009, through March 21, 2010, and 8067 vaccinees reported having an adverse event, for a rate of 90.0 per 1 million doses. The age-specific rates of adverse events ranged from 31.4 per 1 million doses among persons 60 years of age or older to 130.6 per 1 million doses among persons 9 years of age or younger, and the manufacturer-specific rates ranged from 4.6 to 185.4 per 1 million doses. A total of 6552 of the 8067 adverse events (81.2%; rate, 73.1 per 1 million doses) were verified as vaccine reactions; 1083 of the 8067 (13.4%; rate, 12.1 per 1 million doses) were rare and more serious (vs. common, minor events), most of which (1050) were allergic reactions. Eleven cases of the Guillain-Barre syndrome were reported, for a rate of 0.1 per 1 million doses, which is lower than the background rate in China. Conclusions: No pattern of adverse events that would be of concern was observed after the administration of influenza A (H1N1) vaccine, nor was there evidence of an increased risk of the Guillain-Barre syndrome. N Engl J Med 2011;364:638-47.	[Liang, Xiao-Feng; Li, Li; Liu, Da-Wei; Li, Ke-Li; Wu, Wen-Di; Wang, Hua-Qing; Luo, Hui-Ming; Cao, Ling-Sheng; Zheng, Jing-Shan; Yin, Da-Peng; Cao, Lei; Wu, Bing-Bing; Bao, Hong-Hong; Xu, Di-Sha; Yang, Wei-Zhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China; [Zhu, Bao-Ping] Chinese Field Epidemiol Training Program, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China.	wangyu@chinacdc.cn		Zhu, Baoping/0000-0003-0065-0153				[Anonymous], PRELIMINARY REPORT A; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *EUR MED AG, EUR MED AG REAFF EFF; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Liu D., 2007, CHIN J VACCINES IMMU, V13, P505; *MIN HLTH PEOPL RE, 2009, GUID VACC PAND H1N1; Ministry of Health of the People's Republic of China, 2008, GUID ID ADV REACT IM; Ministry of Health of the People's Republic of China, 2005, CHIN STAND PROC VACC; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; *STAT FOOD DRUG AD, 2009, LIC PAND H1N1 VACC P; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; *WHO, 1999, WPROEPI9901; *WHO, 2000, SUPPL INF VACC SAF 2; WHO, 2009, 16 WHO; WU WD, 2009, CHIN J VACC IMNMUNIZ, V15, P481; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	22	92	99	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					638	647		10.1056/NEJMoa1008553	http://dx.doi.org/10.1056/NEJMoa1008553			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21288090	Bronze			2022-12-24	WOS:000287406000009
J	Danaei, G; Finucane, MM; Lin, JK; Singh, GM; Paciorek, CJ; Cowan, MJ; Farzadfar, F; Stevens, GA; Lim, SS; Riley, LM; Ezzati, M; Abdeen, Z; Agyemang, C; Al Nsour, M; Ali, MM; Ambady, R; Babu, BV; Barbagallo, CM; Barcelo, A; Barreto, SM; Barros, H; Bautista, LE; Bjerregaard, P; Bjorkelund, C; Bo, S; Bobak, M; Bonora, E; Botana, MA; Bovet, P; Breckenkamp, J; Breteler, MM; Broda, G; Brown, IJ; Bursztyn, M; de Leon, AC; Casiglia, E; Castetbon, K; Chatterji, S; Chen, ZM; Chen, CJ; Chua, L; Cifkova, R; Cobiac, LJ; Cooper, RS; Dankner, RS; Dong, GH; Elliott, P; Erem, C; Esteghamati, A; Fan, JG; Ferreccio, C; Firmo, JO; Fornes, NS; Fuchs, FD; Getz, L; Giampaoli, S; Gomez, LF; Graff-Iversen, S; Carvajal, RG; Gulliford, MC; Gupta, PC; Gureje, O; Hansen, TW; He, J; Heinrich, J; Hennis, A; Herrera, VM; Ho, SC; Ibrahim, MM; Ikeda, N; Jafar, TH; Joffres, MR; Jonas, JB; Kamadjeu, RM; Karalis, I; Kastarinen, MJ; Katz, J; Kelly, P; Khalilzadeh, O; Khang, YH; Kiechl, S; Kim, KW; Kobayashi, J; Kubinova, R; Kusuma, YS; Lam, TH; Lawes, CMM; Le, C; Lee, J; Lin, X; Lin, HH; Lin, CC; Liu, XQ; Lorbeer, R; Ma, S; Ma, GS; Magliano, DJ; Makdisse, M; Mancia, G; Mbanya, JCN; Miettola, J; Minh, HV; Miranda, JJ; Mohamed, MK; Mohan, V; Mokdad, AH; Morales, DD; Morgan, K; Muiesan, LM; Muntoni, S; Nabipour, I; Nangia, V; Neuhauser, H; Ninomiya, T; Olivieri, O; Onal, AE; Onat, A; Orostegui, M; Panagiotakos, DB; Panza, F; Pednekar, MS; Perez, C; Perez-Fernandez, R; Pichardo, R; Phua, HP; Plans, P; Poulter, N; Raitakari, OT; Rampal, S; Rampal, L; Redon, J; Revilla, L; Roaeid, RB; Rojas-Martinez, R; Sanisoglu, SY; Sans, S; Schelleman, H; Schneider, IJC; Silva, DAS; Silva, E; Simons, LA; Smith, M; Soebardi, S; Solfrizzi, V; Stein, AD; Stergiou, GS; Stessman, J; Suka, M; Tambs, K; Tesfaye, F; Thorogood, M; Tilvis, RS; Trenkwalder, P; Tuomilehto, JO; Tzourio, C; Vander Hoorn, S; Vanderpump, MP; Verschuren, M; Vioque, J; Waspadji, S; Wilhelmsen, L; Willeit, J; Woodward, M; Xavier, AJ; Xu, L; Yang, GH; Yeh, LC; Yoon, JS; You, QS; Zhou, M				Danaei, Goodarz; Finucane, Mariel M.; Lin, John K.; Singh, Gitanjali M.; Paciorek, Christopher J.; Cowan, Melanie J.; Farzadfar, Farshad; Stevens, Gretchen A.; Lim, Stephen S.; Riley, Leanne M.; Ezzati, Majid; Abdeen, Ziad; Agyemang, Charles; Al Nsour, Mohannad; Ali, Mohamed M.; Ambady, Ramachandran; Babu, Bontha V.; Barbagallo, Carlo M.; Barcelo, Alberto; Barreto, Sandhi M.; Barros, Henrique; Bautista, Leonelo E.; Bjerregaard, Peter; Bjoerkelund, Cecilia; Bo, Simona; Bobak, Martin; Bonora, Enzo; Botana, Manuel A.; Bovet, Pascal; Breckenkamp, Juergen; Breteler, Monique M.; Broda, Grazyna; Brown, Ian J.; Bursztyn, Michael; de Leon, Antonio Cabrera; Casiglia, Edoardo; Castetbon, Katia; Chatterji, Somnath; Chen, Zhengming; Chen, Chien-Jen; Chua, Lily; Cifkova, Renata; Cobiac, Linda J.; Cooper, Richard S.; Dankner, Rachel S.; Dong, Guang-Hui; Elliott, Paul; Erem, Cihangir; Esteghamati, Alireza; Fan, Jian-Gao; Ferreccio, Catterina; Firmo, Joselia O.; Fornes, Nelida S.; Fuchs, Flavio D.; Getz, Linn; Giampaoli, Simona; Gomez, Luis F.; Graff-Iversen, Sidsel; Carvajal, Ramiro Guerrero; Gulliford, Martin C.; Gupta, Prakash C.; Gureje, Oye; Hansen, Tine W.; He, Jiang; Heinrich, Joachim; Hennis, Anselm; Herrera, Victor M.; Ho, Suzanne C.; Ibrahim, M. Mohsen; Ikeda, Nayu; Jafar, Tazeen H.; Joffres, Michel R.; Jonas, Jost B.; Kamadjeu, Raoul M.; Karalis, Ioannis; Kastarinen, Mika J.; Katz, Joanne; Kelly, Paul; Khalilzadeh, Omid; Khang, Young-Ho; Kiechl, Stefan; Kim, Ki Woong; Kobayashi, Junji; Kubinova, Ruzena; Kusuma, Yadlapalli S.; Lam, Tai H.; Lawes, Carlene M. M.; Le, Cai; Lee, Jeannette; Lin, Xu; Lin, Hsien-Ho; Lin, Cheng-Chieh; Liu, Xiaoqing; Lorbeer, Roberto; Ma, Stefan; Ma, Guansheng; Magliano, Dianna J.; Makdisse, Marcia; Mancia, Giuseppe; Mbanya, Jean Claude N.; Miettola, Juhani; Minh, Hoang V.; Miranda, J. Jaime; Mohamed, Mostafa K.; Mohan, V.; Mokdad, Ali H.; Morales, Dante D.; Morgan, Karen; Muiesan, Lorenza M.; Muntoni, Sergio; Nabipour, Iraj; Nangia, Vinay; Neuhauser, Hannelore; Ninomiya, Toshiharu; Olivieri, Oliviero; Oenal, Ayse Emel; Onat, Altan; Orostegui, Myriam; Panagiotakos, Demosthenes B.; Panza, Francesco; Pednekar, Mangesh S.; Perez, Cynthia; Perez-Fernandez, Roman; Pichardo, Rafael; Phua, Hwee Pin; Plans, Pedro; Poulter, Neil; Raitakari, Olli T.; Rampal, Sanjay; Rampal, Lekhraj; Redon, Josep; Revilla, Luis; Roaeid, Ragab B.; Rojas-Martinez, Rosalba; Sanisoglu, Selim Y.; Sans, Susana; Schelleman, Hedi; Schneider, Ione J. C.; Silva, Diego Augusto Santos; Silva, Egle; Simons, Leon A.; Smith, Margaret; Soebardi, Suharko; Solfrizzi, Vincenzo; Stein, Aryeh D.; Stergiou, George S.; Stessman, Jochanan; Suka, Machi; Tambs, Kristian; Tesfaye, Fikru; Thorogood, Margaret; Tilvis, Reijo S.; Trenkwalder, Peter; Tuomilehto, Jaakko O.; Tzourio, Christophe; Vander Hoorn, Stephen; Vanderpump, Mark P.; Verschuren, Monique; Vioque, Jesus; Waspadji, Sarwono; Wilhelmsen, Lars; Willeit, Johann; Woodward, Mark; Xavier, Andre J.; Xu, Liang; Yang, Gonghuan; Yeh, Li-Chia; Yoon, Jin-Sang; You, Qisheng; Zhou, Maigeng		Global Burden Metab Risk Factors C	National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; HYPERTENSION CONTROL; EUROPEAN COUNTRIES; UNITED-STATES; PREVALENCE; AWARENESS; DISEASE; POPULATION; MONICA; GUIDELINES	Background Data for trends in blood pressure are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. However, few worldwide analyses of trends in blood pressure have been done. We estimated worldwide trends in population mean systolic blood pressure (SBP). Methods We estimated trends and their uncertainties in mean SBP for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (786 country-years and 5.4 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean SBP by age, country, and year, accounting for whether a study was nationally representative. Findings In 2008, age-standardised mean SBP worldwide was 128.1 mm Hg (95% uncertainty interval 126.7-129.4) in men and 124.4 mm Hg (123.0-125.9) in women. Globally, between 1980 and 2008, S BP decreased by 0.8 mm Hg per decade (-0.4 to 2.2, posterior probability of being a true decline=0.90) in men and 1.0 mm Hg per decade (-0.3 to 2.3, posterior probability=0.93) in women. Female SBP decreased by 3.5 mm Hg or more per decade in western Europe and Australasia (posterior probabilities >= 0.999). Male SBP fell most in high-income North America, by 2.8 mm Hg per decade (1.3-4.5, posterior probability >0.999), followed by Australasia and western Europe where it decreased by more than 2.0 mm Hg per decade (posterior probabilities >0.98). SBP rose in Oceania, east Africa, and south and southeast Asia for both sexes, and in west Africa for women, with the increases ranging 0.8-1.6 mm Hg per decade in men (posterior probabilities 0.72-0.91) and 1.0-2.7 mm Hg per decade for women (posterior probabilities 0.75-0.98). Female SBP was highest in some east and west African countries, with means of 135 mm Hg or greater. Male SBP was highest in Baltic and east and west African countries, where mean SBP reached 138 mm Hg or more. Men and women in western Europe had the highest SBP in high-income regions. Interpretation On average, global population SBP decreased slightly since 1980, but trends varied significantly across regions and countries. SBP is currently highest in low-income and middle-income countries. Effective population-based and personal interventions should be targeted towards low-income and middle-income countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lin, John K.; Singh, Gitanjali M.; Farzadfar, Farshad; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Lim, Stephen S.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; World Health Organization; World Health Organization; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Gulliford, Martin C/I-8606-2018; Kim, Ki Woong/D-5801-2012; REDON, JOSEP/E-1719-2019; CHATTERJI, Somnath/ABE-6832-2020; Mokdad, Ali H./AAD-1232-2022; Tzourio, christophe/L-6344-2019; Bonora, Enzo/AAA-5300-2022; Stergiou, George/J-3083-2019; Xavier, André J/D-3287-2015; Bjerregaard, Peter/ABD-8894-2020; Woodward, Mark/L-6817-2017; Rampal, Sanjay/B-9691-2010; Barros, Henrique/A-5488-2008; Rampal, Lekhraj/G-6117-2010; Danaei, Goodarz/B-6085-2008; You, Qisheng/AAG-7153-2020; Lim, Stephen S/B-4055-2012; Heinrich, Joachim/N-1720-2013; Sans, Susana/ABD-5378-2021; Panagiotakos, Demosthenes/C-9776-2013; Bovet, Pascal/F-4477-2011; Perez-Fernandez, Roman/L-6342-2014; Tzourio, christophe/B-4015-2009; Önal, Ayşe Emel/AAC-8984-2020; Iats, Inct/K-2300-2013; Ma, Guansheng/AAD-6767-2020; Dong, Guanghui/AAN-4630-2020; vioque, jesus/A-1066-2008; He, Jiang/AAF-5303-2020; Castetbon, Katia/F-2686-2017; morgan, karen/C-3846-2012; Abdeen, Ziad/AAC-7889-2019; Chen, Chien-Jen/N-4723-2019; solfrizzi, vincenzo/AAL-3222-2020; Panagiotakos, Demosthenes/M-9167-2019; You, Qisheng/A-3619-2014; mohamed, mostafa/AFE-7371-2022; Miranda, J. Jaime/A-8482-2008; Firmo, Josélia Oliveira Araújo/AAD-6553-2022; Van Hoang, Minh/AET-0962-2022; Fuchs, Flávio D/L-5078-2016; Bo, Simona/AAC-1110-2019; Adewuya, Abiodun/N-4997-2017; Cífková, Renata/O-5731-2017; Breteler, Monique M.B./J-5058-2014; BABU, BONTHA VEERRAJU/X-2096-2019; Barreto, Sandhi M/D-2855-2014; Panza, Francesco/Y-2539-2019; Panagiotakos, Demosthenes/K-8294-2019; Makdisse, Marcia/AAY-9814-2020; Nsour, Mohannad Al/ABE-8741-2020; Schneider, Ione J.C./J-8762-2013; Redon, Josep/L-5997-2019; Raitakari, Olli/AAQ-7389-2021; Ikeda, Nayu/J-9890-2019; Herrera, Víctor/ABB-4480-2020; Silva, Diego Augusto Santos/AAB-9249-2020; Gureje, Oye/J-1183-2014; Silva, Diego/GRF-5446-2022; Barros, Henrique/Q-8609-2019; Panza, Francesco/M-6804-2017; Dankner, Rachel/Q-5245-2019; Mbanya, Jean Claude N/T-5147-2018	Gulliford, Martin C/0000-0003-1898-9075; Kim, Ki Woong/0000-0002-1103-3858; Mokdad, Ali H./0000-0002-4994-3339; Tzourio, christophe/0000-0002-6517-2984; Stergiou, George/0000-0002-6132-0038; Xavier, André J/0000-0002-8282-0939; Bjerregaard, Peter/0000-0001-7153-8447; Rampal, Sanjay/0000-0002-0105-6407; You, Qisheng/0000-0003-0743-7320; Heinrich, Joachim/0000-0002-9620-1629; Sans, Susana/0000-0002-0400-5197; Panagiotakos, Demosthenes/0000-0001-8583-153X; Bovet, Pascal/0000-0002-0242-4259; Perez-Fernandez, Roman/0000-0002-5894-0615; Tzourio, christophe/0000-0002-6517-2984; vioque, jesus/0000-0002-2284-148X; He, Jiang/0000-0002-8286-9652; morgan, karen/0000-0001-6193-1747; solfrizzi, vincenzo/0000-0002-8524-0315; Panagiotakos, Demosthenes/0000-0001-8583-153X; You, Qisheng/0000-0003-0743-7320; mohamed, mostafa/0000-0002-1421-2667; Miranda, J. Jaime/0000-0002-4738-5468; Firmo, Josélia Oliveira Araújo/0000-0001-5330-476X; Adewuya, Abiodun/0000-0002-7611-6953; Cífková, Renata/0000-0003-2765-3821; Breteler, Monique M.B./0000-0002-0626-9305; BABU, BONTHA VEERRAJU/0000-0001-5096-2222; Barreto, Sandhi M/0000-0001-7383-7811; Panza, Francesco/0000-0002-7220-0656; Nsour, Mohannad Al/0000-0003-1212-1611; Schneider, Ione J.C./0000-0001-6339-7832; Redon, Josep/0000-0001-8777-6773; Ikeda, Nayu/0000-0002-3424-1991; Herrera, Víctor/0000-0002-6295-1640; Silva, Diego Augusto Santos/0000-0002-0489-7906; Gureje, Oye/0000-0003-0094-5947; Barros, Henrique/0000-0003-4699-6571; Panza, Francesco/0000-0002-7220-0656; Dankner, Rachel/0000-0001-6454-6000; Elliott, Paul/0000-0002-7511-5684; Lin, John/0000-0003-2490-4453; Farzadfar, Farshad/0000-0001-8288-4046; Mbanya, Jean Claude N/0000-0001-9651-8653; Dong, Guang-Hui/0000-0002-2578-3369; Hoang Van, Minh/0000-0002-4749-5536; CASTETBON, Katia/0000-0002-1207-6729; Woodward, Mark/0000-0001-9800-5296; Pednekar, Mangesh/0000-0001-6266-5356; LIN, HSIEN-HO/0000-0002-7481-6016	Harvard University; Bill & Melinda Gates Foundation; WHO; Medical Research Council [G0801056B, G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Andersen UO, 2010, J HYPERTENS, V28, P1091, DOI 10.1097/HJH.0b013e328335fa81; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Antikainen RL, 2010, J HUM HYPERTENS, V24, P439, DOI 10.1038/jhh.2009.85; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Fasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HOFFMEISTER H, 1994, PREV MED, V23, P197, DOI 10.1006/pmed.1994.1027; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; Kastarinen M, 2009, J HYPERTENS, V27, P1552, DOI 10.1097/HJH.0b013e32832c41cd; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lanti M, 2005, AGING CLIN EXP RES, V17, P306; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CM, 2004, COMP QUANTIFICATION, P497; Lee K, 2010, ASIA PAC J CLIN NUTR, V19, P261; Lenfant C, 2002, ARCH INTERN MED, V162, P131, DOI 10.1001/archinte.162.2.131; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Opie LH, 2009, CARDIOVASC J AFR, V20, P52; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Sheffer R, 2008, EUR J PUBLIC HEALTH, V18, P121, DOI 10.1093/eurpub/ckm083; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Venketasubramanian N, 1998, INT J EPIDEMIOL, V27, P15, DOI 10.1093/ije/27.1.15; Vlasoff T, 2008, EUR J PUBLIC HEALTH, V18, P666, DOI 10.1093/eurpub/ckn063; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	44	698	722	2	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					568	577		10.1016/S0140-6736(10)62036-3	http://dx.doi.org/10.1016/S0140-6736(10)62036-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21295844				2022-12-24	WOS:000287556700027
J	Akil, H; Martone, ME; Van Essen, DC				Akil, Huda; Martone, Maryann E.; Van Essen, David C.			Challenges and Opportunities in Mining Neuroscience Data	SCIENCE			English	Editorial Material							MICROSCOPY; BRAIN	Understanding the brain requires a broad range of approaches and methods from the domains of biology, psychology, chemistry, physics, and mathematics. The fundamental challenge is to decipher the "neural choreography" associated with complex behaviors and functions, including thoughts, memories, actions, and emotions. This demands the acquisition and integration of vast amounts of data of many types, at multiple scales in time and in space. Here we discuss the need for neuroinformatics approaches to accelerate progress, using several illustrative examples. The nascent field of "connectomics" aims to comprehensively describe neuronal connectivity at either a macroscopic level (in long-distance pathways for the entire brain) or a microscopic level (among axons, dendrites, and synapses in a small brain region). The Neuroscience Information Framework (NIF) encompasses all of neuroscience and facilitates the integration of existing knowledge and databases of many types. These examples illustrate the opportunities and challenges of data mining across multiple tiers of neuroscience information and underscore the need for cultural and infrastructure changes if neuroinformatics is to fulfill its potential to advance our understanding of the brain.	[Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Martone, Maryann E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Van Essen, David C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; Washington University (WUSTL)	Akil, H (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	akil@umich.edu	Van Essen, David/ABA-8888-2020	Martone, Maryann/0000-0002-8406-3871	NIDA NIH HHS [P01 DA021633, 5P01-DA021633-02, P01 DA021633-01A2] Funding Source: Medline; NIMH NIH HHS [U54 MH091657, 1U54MH091657-01, R01 MH060974] Funding Source: Medline; NINDS NIH HHS [HHSN271200800035C] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060974, U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bernard R, 2010, MOL PSYCHIAT    0413; Bjorklund A., 1983, HDB CHEM NEUROANATOM, VI; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Bug WJ, 2008, NEUROINFORMATICS, V6, P175, DOI 10.1007/s12021-008-9032-z; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Gardner D, 2008, NEUROINFORMATICS, V6, P149, DOI 10.1007/s12021-008-9024-z; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; Gupta A, 2008, NEUROINFORMATICS, V6, P205, DOI 10.1007/s12021-008-9033-y; Hey T., 2009, 4 PARADIGM DATA INTE; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229; Nicolson N., 1982, LETT V WOOLF; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Watson BO, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00029; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	27	116	118	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					708	712		10.1126/science.1199305	http://dx.doi.org/10.1126/science.1199305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311009	Green Accepted			2022-12-24	WOS:000287205700052
J	Gong, CG; Maquat, LE				Gong, Chenguang; Maquat, Lynne E.			lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3 ' UTRs via Alu elements	NATURE			English	Article							THERMODYNAMIC PARAMETERS; NONCODING RNAS; EXPRESSION; PREDICTION; DATABASE; REPEATS; BINDING; PROTEIN; IMPACT	Staufen 1 (STAU1)-mediated messenger RNA decay (SMD) involves the degradation of translationally active mRNAs whose 3'-untranslated regions (39 UTRs) bind to STAU1, a protein that binds to double-stranded RNA(1,2). Earlier studies defined the STAU1-binding site within ADP-ribosylation factor 1 (ARF1) mRNA as a 19-base-pair stem with a 100-nucleotide apex(2). However, we were unable to identify comparable structures in the 3' UTRs of other targets of SMD. Here we show that STAU1-binding sites can be formed by imperfect base-pairing between an Alu element in the 3' UTR of an SMD target and another Alu element in a cytoplasmic, polyadenylated long non-coding RNA (lncRNA). An individual lncRNA can downregulate a subset of SMD targets, and distinct lncRNAs can downregulate the same SMD target. These are previously unappreciated functions of non-coding RNAs and Alu elements(3-5). Not all mRNAs that contain an Alu element in the 3' UTR are targeted for SMD even in the presence of a complementary lncRNA that targets other mRNAs for SMD. Most known trans-acting RNA effectors consist of fewer than 200 nucleotides, and these include small nucleolar RNAs and microRNAs. Our finding that the binding of STAU1 to mRNAs can be transactivated by lncRNAs uncovers an unexpected strategy that cells use to recruit proteins to mRNAs and mediate the decay of these mRNAs. We name these lncRNAs half-STAU1-binding site RNAs (1/2-sbsRNAs).	[Gong, Chenguang; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA; [Gong, Chenguang; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Ctr RNA Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu	Gong, Chenguang/F-5791-2014	Maquat, Lynne/0000-0002-2789-2075	National Institutes of Health [GM074593]; Elon Huntington Hooker Graduate Student Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM074593, R01GM074593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elon Huntington Hooker Graduate Student Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mathews and A. Grossfield for the use of computer clusters, D. Matthews for access to the program Structure 5.0, K. Nerhrke for fluorescence microscope time, S. de Lucas and J. Ortiz for anti-STAU1 antibodies, M. Gorospe for pcDNA3-MS2bsX12, S. Higgins and P. Higgins for HaCaT cells and advice on the scrape-injury repair assay, J. Wang for the initial BAG5 mRNA assays, and O. Isken, M. Gleghorn and D. Matthews for comments on the manuscript. This work was supported by the National Institutes of Health (GM074593 to L. E. M.) and an Elon Huntington Hooker Graduate Student Fellowship (C.G.).	ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	897	966	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					284	+		10.1038/nature09701	http://dx.doi.org/10.1038/nature09701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307942	Green Accepted			2022-12-24	WOS:000287144200049
J	Chapman, HN; Fromme, P; Barty, A; White, TA; Kirian, RA; Aquila, A; Hunter, MS; Schulz, J; DePonte, DP; Weierstall, U; Doak, RB; Maia, FRNC; Martin, AV; Schlichting, I; Lomb, L; Coppola, N; Shoeman, RL; Epp, SW; Hartmann, R; Rolles, D; Rudenko, A; Foucar, L; Kimmel, N; Weidenspointner, G; Holl, P; Liang, MN; Barthelmess, M; Caleman, C; Boutet, S; Bogan, MJ; Krzywinski, J; Bostedt, C; Bajt, S; Gumprecht, L; Rudek, B; Erk, B; Schmidt, C; Homke, A; Reich, C; Pietschner, D; Struder, L; Hauser, G; Gorke, H; Ullrich, J; Herrmann, S; Schaller, G; Schopper, F; Soltau, H; Kuhnel, KU; Messerschmidt, M; Bozek, JD; Hau-Riege, SP; Frank, M; Hampton, CY; Sierra, RG; Starodub, D; Williams, GJ; Hajdu, J; Timneanu, N; Seibert, MM; Andreasson, J; Rocker, A; Jonsson, O; Svenda, M; Stern, S; Nass, K; Andritschke, R; Schroter, CD; Krasniqi, F; Bott, M; Schmidt, KE; Wang, XY; Grotjohann, I; Holton, JM; Barends, TRM; Neutze, R; Marchesini, S; Fromme, R; Schorb, S; Rupp, D; Adolph, M; Gorkhover, T; Andersson, I; Hirsemann, H; Potdevin, G; Graafsma, H; Nilsson, B; Spence, JCH				Chapman, Henry N.; Fromme, Petra; Barty, Anton; White, Thomas A.; Kirian, Richard A.; Aquila, Andrew; Hunter, Mark S.; Schulz, Joachim; DePonte, Daniel P.; Weierstall, Uwe; Doak, R. Bruce; Maia, Filipe R. N. C.; Martin, Andrew V.; Schlichting, Ilme; Lomb, Lukas; Coppola, Nicola; Shoeman, Robert L.; Epp, Sascha W.; Hartmann, Robert; Rolles, Daniel; Rudenko, Artem; Foucar, Lutz; Kimmel, Nils; Weidenspointner, Georg; Holl, Peter; Liang, Mengning; Barthelmess, Miriam; Caleman, Carl; Boutet, Sebastien; Bogan, Michael J.; Krzywinski, Jacek; Bostedt, Christoph; Bajt, Sasa; Gumprecht, Lars; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Reich, Christian; Pietschner, Daniel; Strueder, Lothar; Hauser, Guenter; Gorke, Hubert; Ullrich, Joachim; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Soltau, Heike; Kuehnel, Kai-Uwe; Messerschmidt, Marc; Bozek, John D.; Hau-Riege, Stefan P.; Frank, Matthias; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri; Williams, Garth J.; Hajdu, Janos; Timneanu, Nicusor; Seibert, M. Marvin; Andreasson, Jakob; Rocker, Andrea; Joensson, Olof; Svenda, Martin; Stern, Stephan; Nass, Karol; Andritschke, Robert; Schroeter, Claus-Dieter; Krasniqi, Faton; Bott, Mario; Schmidt, Kevin E.; Wang, Xiaoyu; Grotjohann, Ingo; Holton, James M.; Barends, Thomas R. M.; Neutze, Richard; Marchesini, Stefano; Fromme, Raimund; Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais; Andersson, Inger; Hirsemann, Helmut; Potdevin, Guillaume; Graafsma, Heinz; Nilsson, Bjoern; Spence, John C. H.			Femtosecond X-ray protein nanocrystallography	NATURE			English	Article							REFINEMENT	X-ray crystallography provides the vast majority of macromolecular structures, but the success of the method relies on growing crystals of sufficient size. In conventional measurements, the necessary increase in X-ray dose to record data from crystals that are too small leads to extensive damage before a diffraction signal can be recorded(1-3). It is particularly challenging to obtain large, well-diffracting crystals of membrane proteins, for which fewer than 300 unique structures have been determined despite their importance in all living cells. Here we present a method for structure determination where single-crystal X-ray diffraction 'snapshots' are collected from a fully hydrated stream of nanocrystals using femtosecond pulses from a hard-X-ray free-electron laser, the Linac Coherent Light Source(4). We prove this concept with nanocrystals of photosystem I, one of the largest membrane protein complexes(5). More than 3,000,000 diffraction patterns were collected in this study, and a three-dimensional data set was assembled from individual photosystem I nanocrystals (similar to 200 nm to 2 mm in size). We mitigate the problem of radiation damage in crystallography by using pulses briefer than the timescale of most damage processes(6). This offers a new approach to structure determination of macromolecules that do not yield crystals of sufficient size for studies using conventional radiation sources or are particularly sensitive to radiation damage.	[Chapman, Henry N.; Barty, Anton; White, Thomas A.; Aquila, Andrew; Schulz, Joachim; DePonte, Daniel P.; Martin, Andrew V.; Coppola, Nicola; Liang, Mengning; Caleman, Carl; Gumprecht, Lars; Stern, Stephan] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Chapman, Henry N.; Nass, Karol] Univ Hamburg, D-22761 Hamburg, Germany; [Fromme, Petra; Hunter, Mark S.; Grotjohann, Ingo; Fromme, Raimund] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kirian, Richard A.; Weierstall, Uwe; Doak, R. Bruce; Schmidt, Kevin E.; Wang, Xiaoyu; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Maia, Filipe R. N. C.; Hajdu, Janos; Timneanu, Nicusor; Seibert, M. Marvin; Andreasson, Jakob; Rocker, Andrea; Joensson, Olof; Svenda, Martin] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Schlichting, Ilme; Epp, Sascha W.; Rolles, Daniel; Rudenko, Artem; Foucar, Lutz; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Strueder, Lothar; Ullrich, Joachim; Krasniqi, Faton] Max Planck Adv Study Grp, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Schlichting, Ilme; Lomb, Lukas; Shoeman, Robert L.; Rolles, Daniel; Foucar, Lutz; Krasniqi, Faton; Bott, Mario; Barends, Thomas R. M.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Epp, Sascha W.; Rudenko, Artem; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Ullrich, Joachim; Kuehnel, Kai-Uwe; Schroeter, Claus-Dieter] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, Robert; Holl, Peter; Reich, Christian; Soltau, Heike] PNSensor GmbH, D-81739 Munich, Germany; [Kimmel, Nils; Weidenspointner, Georg; Pietschner, Daniel; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Weidenspointner, Georg] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Boutet, Sebastien; Krzywinski, Jacek; Bostedt, Christoph; Messerschmidt, Marc; Bozek, John D.; Williams, Garth J.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Gorke, Hubert] Forschungszentrum Julich, Inst ZEL, D-52425 Julich, Germany; [Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Holton, James M.; Marchesini, Stefano] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Neutze, Richard] Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden; [Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany; [Andersson, Inger] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Uppsala University; Max Planck Society; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Research Center Julich; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Gothenburg; Technical University of Berlin; Swedish University of Agricultural Sciences	Chapman, HN (corresponding author), DESY, Ctr Free Electron Laser Sci, Notkestr 85, D-22607 Hamburg, Germany.	henry.chapman@desy.de	Bajt, Sasa/O-4695-2019; Rudek, Benedikt/AAX-1278-2021; FRS, Henry N Chapman/G-2153-2010; Marchesini, Stefano/GYR-1409-2022; Bajt, Sasa/G-2228-2010; Rupp, Daniela/P-7590-2016; Jönsson, H Olof/O-8664-2017; Kirian, Richard/M-3750-2013; Nass, Karol/K-1970-2012; Williams, Garth/H-1606-2012; Bogan, Mike/I-6962-2012; Barty, Anton/K-5137-2014; Fromme, Raimund/AAG-6578-2019; Rupp, Daniela/AAD-7978-2021; Frank, Matthias/O-9055-2014; Neutze, Richard/A-7573-2010; Rudenko, Artem/C-7412-2009; Maia, Filipe R.N.C./C-3146-2014; Fromme, Raimund/C-8885-2012; Timneanu, Nicusor/C-7691-2012; Messerschmidt, Marc/Y-8929-2019; Weierstall, Uwe/B-3568-2011; Rudek, Benedikt/A-5100-2017; Bozek, John D/E-9260-2010; Messerschmidt, Marc/F-3796-2010; Schlichting, Ilme/I-1339-2013; Gorkhover, Tais/K-8468-2012; Fromme, Raimund/W-5838-2019; Marchesini, Stefano/A-6795-2009	Bajt, Sasa/0000-0002-7163-7602; Rudek, Benedikt/0000-0002-6404-4294; FRS, Henry N Chapman/0000-0002-4655-1743; Jönsson, H Olof/0000-0002-2076-0918; Nass, Karol/0000-0001-8843-1566; Bogan, Mike/0000-0001-9318-3333; Barty, Anton/0000-0003-4751-2727; Rupp, Daniela/0000-0002-6504-7956; Neutze, Richard/0000-0003-0986-6153; Rudenko, Artem/0000-0002-9154-8463; Maia, Filipe R.N.C./0000-0002-2141-438X; Fromme, Raimund/0000-0003-4835-1080; Timneanu, Nicusor/0000-0001-7328-0400; Messerschmidt, Marc/0000-0002-8641-3302; Bozek, John D/0000-0001-7486-7238; Messerschmidt, Marc/0000-0002-8641-3302; Fromme, Raimund/0000-0003-4835-1080; Marchesini, Stefano/0000-0002-6798-2913; Andreasson, Jakob/0000-0002-3202-2330; Kirian, Richard/0000-0001-7197-3086; Fromme, Petra/0000-0003-0953-4909; Schulz, Joachim/0000-0002-9310-8832; Schmidt, Kevin/0000-0002-1597-9835; Seibert, Mark Marvin/0000-0003-0251-0744; Aquila, Andrew/0000-0003-0358-2774; Erk, Benjamin/0000-0001-8413-3588; Epp, Sascha/0000-0001-6366-9113; graafsma, heinz/0000-0003-2304-667X; Stern, Stephan/0000-0001-9786-7513; MARTIN, ANDREW/0000-0003-3704-1829; RUDENKO, Artem/0000-0001-6771-2510; Frank, Matthias/0000-0002-5244-0791	DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Center for Bio-Inspired Solar Fuel Production; DOE, Office of Basic Energy Sciences [DE-SC0001016]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung; Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics; Max Planck Society; US National Science Foundation [0417142, MCB-1021557]; US National Institutes of Health [1R01GM095583-01, 1U54GM094625-01]; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; CBST at the University of California [PHY 0120999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599, R01GM095583, U54GM094625] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1021557] Funding Source: National Science Foundation	DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Center for Bio-Inspired Solar Fuel Production; DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Hamburg Ministry of Science and Research; Joachim Herz Stiftung; Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics; Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG)); CBST at the University of California; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Experiments were carried out at the Linac Coherent Light Source and the Advanced Light Source, both National User Facilities operated respectively by Stanford University and the University of California on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. We acknowledge support from the DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; the Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344; the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the DOE, Office of Basic Energy Sciences (award DE-SC0001016); the Hamburg Ministry of Science and Research and the Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics; the Max Planck Society, for funding the development and operation of the CAMP instrument within the ASG at CFEL; the US National Science Foundation (awards 0417142 and MCB-1021557); the US National Institutes of Health (awards 1R01GM095583-01 (ROADMAP) and 1U54GM094625-01 (PSI: Biology)); the Swedish Research Council; the Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; and the CBST at the University of California under cooperative agreement no. PHY 0120999. We acknowledge discussions with M. Rossmann, E. Snell, R. Stroud and A. Brunger, thank B. Hedman, E. Gullikson, F. Filsinger, A. Berg, H. Mahn and C. Kaiser for technical help and thank the staff of the LCLS for their support in carrying out these experiments.	Bergh M, 2008, Q REV BIOPHYS, V41, P181, DOI 10.1017/S003358350800471X; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Chapman HN, 2007, NATURE, V448, P676, DOI 10.1038/nature06049; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; DePonte DP, 2009, MICRON, V40, P507, DOI 10.1016/j.micron.2008.12.009; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Emma P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074801; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Fromme P., 2009, CURR TOP MEMBR, V63, P192; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Hunter M. S., BIOPHYS J IN PRESS; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; Robinson I, 2009, NAT MATER, V8, P291, DOI [10.1038/NMAT2400, 10.1038/nmat2400]; ROSSMANN MG, 1979, J APPL CRYSTALLOGR, V12, P570, DOI 10.1107/S0021889879013273; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Spence JCH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198102; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; WANG DN, 1991, J MOL BIOL, V217, P691, DOI 10.1016/0022-2836(91)90526-C; Willis B., 1975, THERMAL VIBRATIONS C, V92; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177; Zaefferer S, 2000, J APPL CRYSTALLOGR, V33, P10, DOI 10.1107/S0021889899010894	35	1482	1519	10	588	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					73	U81		10.1038/nature09750	http://dx.doi.org/10.1038/nature09750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293373	Green Published, Green Accepted			2022-12-24	WOS:000286886400036
J	Brock, DA; Douglas, TE; Queller, DC; Strassmann, JE				Brock, Debra A.; Douglas, Tracy E.; Queller, David C.; Strassmann, Joan E.			Primitive agriculture in a social amoeba	NATURE			English	Article							EVOLUTION; BACTERIA; COOPERATION; MUTUALISM	Agriculture has been a large part of the ecological success of humans(1). A handful of animals, notably the fungus-growing ants, termites and ambrosia beetles(2-4), have advanced agriculture that involves dispersal and seeding of food propagules, cultivation of the crop and sustainable harvesting(5). More primitive examples, which could be called husbandry because they involve fewer adaptations, include marine snails farming intertidal fungi(6) and damsel-fish farming algae(7). Recent work has shown that microorganisms are surprisingly like animals in having sophisticated behaviours such as cooperation, communication(8,9) and recognition(10,11), as well as many kinds of symbiosis(12-15). Here we show that the social amoeba Dictyostelium discoideum has a primitive farming symbiosis that includes dispersal and prudent harvesting of the crop. About one-third of wild-collected clones engage in husbandry of bacteria. Instead of consuming all bacteria in their patch, they stop feeding early and incorporate bacteria into their fruiting bodies. They then carry bacteria during spore dispersal and can seed a new food crop, which is a major advantage if edible bacteria are lacking at the new site. However, if they arrive at sites already containing appropriate bacteria, the costs of early feeding cessation are not compensated for, which may account for the dichotomous nature of this farming symbiosis. The striking convergent evolution between bacterial husbandry in social amoebas and fungus farming in social insects makes sense because multigenerational benefits of farming go to already established kin groups.	[Brock, Debra A.; Douglas, Tracy E.; Queller, David C.; Strassmann, Joan E.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA	Rice University	Brock, DA (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, 6100 Main St, Houston, TX 77005 USA.	dbrock@rice.edu		Strassmann, Joan/0000-0003-0638-8440	US National Science Foundation; Division Of Environmental Biology [0816690, 1204352] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Rudgers, G. Saxer Quance, L. Campbell, E. Ostrowski, O. Gilbert, A. Savage, J. Ahern, K. Crawford, S. Chamberlain, S. Read, D. Nguyen, K. Foster, H. Kaplan, D. Hatton and K. Boomsma for discussions and advice. This material is based on work supported by the US National Science Foundation.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; CLARK F. E., 1967, Soil Biology., P15; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; HEIJNEN CE, 1993, APPL ENVIRON MICROB, V59, P743, DOI 10.1128/AEM.59.3.743-747.1993; HORN EG, 1971, ECOLOGY, V52, P475, DOI 10.2307/1937630; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Nadson G. A., 1899, SCRIPTA BOT HORTI U, V15, P188; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Raper K. B., 1984, DICTYOSTELIDS, P87; Raper KB, 1937, J AGRIC RES, V55, P0289; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Skupienski F. X., 1920, THESIS U PARIS; Smith B.D., 1995, EMERGENCE AGR; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	32	149	152	10	183	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					393	+		10.1038/nature09668	http://dx.doi.org/10.1038/nature09668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248849				2022-12-24	WOS:000286385600051
J	Olzscha, H; Schermann, SM; Woerner, AC; Pinkert, S; Hecht, MH; Tartaglia, GG; Vendruscolo, M; Hayer-Hartl, M; Hartl, FU; Vabulas, RM				Olzscha, Heidi; Schermann, Sonya M.; Woerner, Andreas C.; Pinkert, Stefan; Hecht, Michael H.; Tartaglia, Gian G.; Vendruscolo, Michele; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Vabulas, R. Martin			Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions	CELL			English	Article							MOLECULAR CHAPERONES; IN-VIVO; PREDICTION; DISEASE; OLIGOMERS; TOXICITY; REGIONS; STRESS	Protein aggregation is linked with neurodegeneration and numerous other diseases by mechanisms that are not well understood. Here, we have analyzed the gain-of-function toxicity of artificial beta sheet proteins that were designed to form amyloid-like fibrils. Using quantitative proteomics, we found that the toxicity of these proteins in human cells correlates with the capacity of their aggregates to promote aberrant protein interactions and to deregulate the cytosolic stress response. The endogenous proteins that are sequestered by the aggregates share distinct physicochemical properties: They are relatively large in size and significantly enriched in predicted unstructured regions, features that are strongly linked with multifunctionality. Many of the interacting proteins occupy essential hub positions in cellular protein networks, with key roles in chromatin organization, transcription, translation, maintenance of cell architecture and protein quality control. We suggest that amyloidogenic aggregation targets a metastable subproteome, thereby causing multifactorial toxicity and, eventually, the collapse of essential cellular functions.	[Olzscha, Heidi; Schermann, Sonya M.; Woerner, Andreas C.; Pinkert, Stefan; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Vabulas, R. Martin] Max Planck Inst Biochem, Dept Cellular Biochem, D-82159 Martinsried, Germany; [Hecht, Michael H.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Tartaglia, Gian G.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Max Planck Society; Princeton University; University of Cambridge	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82159 Martinsried, Germany.	mhartl@biochem.mpg.de; uhartl@biochem.mpg.de; vabulas@biochem.mpg.de	Vendruscolo, Michele/F-5901-2012; Olzscha, Heidi/AAU-1296-2020; Hartl, F. Ulrich/Y-8206-2019; Pinkert, Stefan/A-5534-2009; Hayer-Hartl, Manajit/V-8078-2017; Vabulas, R. Martin/D-3506-2011; Tartaglia, Gian Gaetano/K-1229-2014	Vendruscolo, Michele/0000-0002-3616-1610; Olzscha, Heidi/0000-0002-1929-1384; Hayer-Hartl, Manajit/0000-0001-8213-6742; Tartaglia, Gian Gaetano/0000-0001-7524-6310; Hecht, Michael/0000-0002-5538-9813	EU; Deutsche Forschungsgemeinschaft [SFB 596]; Ernst-Jung Foundation; Korber Foundation; Fonds der Chemischen Industrie; Elite Graduate Network of Bavaria	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Jung Foundation; Korber Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Elite Graduate Network of Bavaria	We thank C.G. Glabe for providing the A11 antibody and H. Wagner for plasmids HSP70-Luc and NF-kappa B-Luc. We acknowledge the help of H. Engelhardt with FTIR measurements, technical assistance by O. Mihalache and V. Marcus with electron microscopy, and R. Zenke (MPIB core facility) for confocal microscopy. Financial support from EU Framework 7 Integrated Project PROSPECTS, the Deutsche Forschungsgemeinschaft (SFB 596), the Ernst-Jung Foundation, and the Korber Foundation is acknowledged. H.O. and A.W. have a fellowship from the Fonds der Chemischen Industrie, and H.O. is supported by the Elite Graduate Network of Bavaria.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Erkina TY, 2010, NUCLEIC ACIDS RES, V38, P1441, DOI 10.1093/nar/gkp1130; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lee EK, 2006, BIOCHEM BIOPH RES CO, V344, P471, DOI 10.1016/j.bbrc.2006.03.166; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Shearman MS, 1999, METHOD ENZYMOL, V309, P716; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; Wei YN, 2003, PROTEIN SCI, V12, P92, DOI 10.1110/ps.0228003; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; WILLIAMS GT, 1989, MOL CELL BIOL, V9, P2574, DOI 10.1128/MCB.9.6.2574; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	43	488	494	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					67	78		10.1016/j.cell.2010.11.050	http://dx.doi.org/10.1016/j.cell.2010.11.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215370	Green Submitted, Bronze			2022-12-24	WOS:000285993600008
J	Stephens, PJ; Greenman, CD; Fu, BY; Yang, FT; Bignell, GR; Mudie, LJ; Pleasance, ED; Lau, KW; Beare, D; Stebbings, LA; McLaren, S; Lin, ML; McBride, DJ; Varela, I; Nik-Zainal, S; Leroy, C; Jia, MM; Menzies, A; Butler, AP; Teague, JW; Quail, MA; Burton, J; Swerdlow, H; Carter, NP; Morsberger, LA; Iacobuzio-Donahue, C; Follows, GA; Green, AR; Flanagan, AM; Stratton, MR; Futreal, PA; Campbell, PJ				Stephens, Philip J.; Greenman, Chris D.; Fu, Beiyuan; Yang, Fengtang; Bignell, Graham R.; Mudie, Laura J.; Pleasance, Erin D.; Lau, King Wai; Beare, David; Stebbings, Lucy A.; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Quail, Michael A.; Burton, John; Swerdlow, Harold; Carter, Nigel P.; Morsberger, Laura A.; Iacobuzio-Donahue, Christine; Follows, George A.; Green, Anthony R.; Flanagan, Adrienne M.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.			Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development	CELL			English	Article							CELL LUNG-CANCER; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; MUTATIONS; EVOLUTION; INSTABILITY; SIGNATURES; RESOLUTION; SEQUENCE	Cancer is driven by somatically acquired point mutations and chromosomal rearrangements, conventionally thought to accumulate gradually over time. Using next-generation sequencing, we characterize a phenomenon, which we term chromothripsis, whereby tens to hundreds of genomic rearrangements occur in a one-off cellular crisis. Rearrangements involving one or a few chromosomes crisscross back and forth across involved regions, generating frequent oscillations between two copy number states. These genomic hallmarks are highly improbable if rearrangements accumulate over time and instead imply that nearly all occur during a single cellular catastrophe. The stamp of chromothripsis can be seen in at least 2%-3% of all cancers, across many subtypes, and is present in similar to 25% of bone cancers. We find that one, or indeed more than one, cancer-causing lesion can emerge out of the genomic crisis. This phenomenon has important implications for the origins of genomic remodeling and temporal emergence of cancer.	[Stephens, Philip J.; Greenman, Chris D.; Fu, Beiyuan; Yang, Fengtang; Bignell, Graham R.; Mudie, Laura J.; Pleasance, Erin D.; Lau, King Wai; Beare, David; Stebbings, Lucy A.; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Quail, Michael A.; Burton, John; Swerdlow, Harold; Carter, Nigel P.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Morsberger, Laura A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Morsberger, Laura A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; [Follows, George A.; Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Green, Anthony R.; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Flanagan, Adrienne M.] UCL, Inst Canc, London WC1E 6BT, England; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	University of Cambridge; Wellcome Trust Sanger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; Institute of Cancer Research - UK	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	pc8@sanger.ac.uk	Nik-Zainal, Serena/ABD-4437-2020; Varela, Ignacio/AAA-7680-2021; Pillay, Nischalan/F-9536-2012; Yang, Fan/GYU-4249-2022; Quail, michael/ABE-6131-2020; Varela, Ignacio/G-1699-2016; Califano, Andrea/F-7239-2012; Iacobuzio-Donahue, Christine/ABF-1295-2020	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Nik-Zainal, Serena/0000-0001-5054-1727; Swerdlow, Harold/0000-0002-9510-160X; Green, Anthony/0000-0002-9795-0218; Flanagan, Adrienne/0000-0002-2832-1303; Yang, Fengtang/0000-0002-3573-2354	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Chordoma Foundation; International Human Frontier Science Program Organization	Wellcome Trust(Wellcome TrustEuropean Commission); Chordoma Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z) and the Chordoma Foundation. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. We also acknowledge support for sample banking and processing from the Cambridge and UCL/UCLH NIHR Biomedical Research Centres and Skeletal Action Cancer Trust (SCAT), especially Dr. Anthony Bench, Dr. Wendy Erber, and Miss Dina Halai. We would like to thank George Vassiliou for the neologism "chromothripsis.''	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JM, 2009, HUM MUTAT, V30, P1435, DOI 10.1002/humu.21088; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Geigl JB, 2006, NAT PROTOC, V1, P1172, DOI 10.1038/nprot.2006.160; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McClintock B, 1941, GENETICS, V26, P234; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104	36	1513	1550	5	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					27	40		10.1016/j.cell.2010.11.055	http://dx.doi.org/10.1016/j.cell.2010.11.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215367	hybrid, Green Published			2022-12-24	WOS:000285993600005
J	Mochida, S; Maslen, SL; Skehel, M; Hunt, T				Mochida, Satoru; Maslen, Sarah L.; Skehel, Mark; Hunt, Tim			Greatwall Phosphorylates an Inhibitor of Protein Phosphatase 2A That Is Essential for Mitosis	SCIENCE			English	Article							CELL-CYCLE; ALPHA-ENDOSULFINE; XENOPUS; PHOSPHOPROTEINS; EXPRESSION; EXTRACTS; ENTRY; LOOP; EXIT	Entry into mitosis in eukaryotes requires the activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 is opposed by protein phosphatases in two ways: They inhibit activation of Cdk1 by dephosphorylating the protein kinases Wee1 and Myt1 and the protein phosphatase Cdc25 (key regulators of Cdk1), and they also antagonize Cdk1's own phosphorylation of downstream targets. A particular form of protein phosphatase 2A (PP2A) containing a B55 delta subunit (PP2A-B55 delta) is the major protein phosphatase that acts on model CDK substrates in Xenopus egg extracts and has antimitotic activity. The activity of PP2A-B55 delta is high in interphase and low in mitosis, exactly opposite that of Cdk1. We report that inhibition of PP2A-B55 delta results from a small protein, known as alpha-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55 delta. This pathway represents a previously unknown element in the control of mitosis.	[Mochida, Satoru; Maslen, Sarah L.; Skehel, Mark; Hunt, Tim] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Mochida, Satoru] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8600811, Japan	Cancer Research UK; Kumamoto University	Hunt, T (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	tim.hunt@cancer.org.uk	Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Mahbubani, J. Kirk, and L. Egbuniwe for care of frogs and other members of the laboratory for advice and reagents, especially J. Gannon for the antibody to doubly phosphorylated Thr<SUP>14</SUP>-Tyr<SUP>15</SUP> of Cdk1 (CP 3.2). S. M. was supported by a fellowship from the Japan Society for the Promotion of Science.	Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; Dulubova I, 2001, J NEUROCHEM, V77, P229, DOI 10.1046/j.1471-4159.2001.00191.x; GIRAULT JA, 1990, J NEUROSCI, V10, P1124; Goldberg M., COMMUNICATION; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Morgan D.O., 2007, CELL CYCLE PRINCIPLE, P297; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Ohsumi Keita, 2006, V322, P445; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; VIRSOLVYVERGINE A, 1992, P NATL ACAD SCI USA, V89, P6629, DOI 10.1073/pnas.89.14.6629; Von Stetina JR, 2008, DEVELOPMENT, V135, P3697, DOI 10.1242/dev.025114; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	28	305	316	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1670	1673		10.1126/science.1195689	http://dx.doi.org/10.1126/science.1195689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164013				2022-12-24	WOS:000285390500065
J	Toien, O; Blake, J; Edgar, DM; Grahn, DA; Heller, HC; Barnes, BM				Toien, Oivind; Blake, John; Edgar, Dale M.; Grahn, Dennis A.; Heller, H. Craig; Barnes, Brian M.			Hibernation in Black Bears: Independence of Metabolic Suppression from Body Temperature	SCIENCE			English	Article							DAILY TORPOR; ARCTIC HIBERNATOR; GROUND-SQUIRRELS; URSUS-AMERICANUS; CNS REGULATION; MARMOTA; MAMMALS; MUSCLE; PHYSIOLOGY; REDUCTION	Black bears hibernate for 5 to 7 months a year and, during this time, do not eat, drink, urinate, or defecate. We measured metabolic rate and body temperature in hibernating black bears and found that they suppress metabolism to 25% of basal rates while regulating body temperature from 30 degrees to 36 degrees C, in multiday cycles. Heart rates were reduced from 55 to as few as 9 beats per minute, with profound sinus arrhythmia. After returning to normal body temperature and emerging from dens, bears maintained a reduced metabolic rate for up to 3 weeks. The pronounced reduction and delayed recovery of metabolic rate in hibernating bears suggest that the majority of metabolic suppression during hibernation is independent of lowered body temperature.	[Toien, Oivind; Blake, John; Barnes, Brian M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Edgar, Dale M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Grahn, Dennis A.; Heller, H. Craig] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Alaska System; University of Alaska Fairbanks; Stanford University; Stanford University	Toien, O (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	otoien@alaska.edu; bmbarnes@alaska.edu	Heller, H. Craig/C-9785-2011	Heller, H Craig/0000-0003-4479-5880; Toien, Oivind/0000-0001-5967-2483	U.S. Army Medical Research and Materiel Command [05178001]; NSF [9819540, 0076039, 0732755]; NIH [HD-00973]; American Heart Association [0020626Z]; Fulbright Program	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fulbright Program	This work was supported by U.S. Army Medical Research and Materiel Command grant 05178001; NSF grants 9819540, 0076039, and 0732755; NIH HD-00973; and gift funds to Stanford University, American Heart Association #0020626Z, and the Fulbright Program. We thank the Alaska Department of Fish and Game for providing bears, D. Ritter for technical assistance, and J. Kenagy and J. Duman for comments.	AZIZI F, 1979, AM J PHYSIOL, V237, pE224, DOI 10.1152/ajpendo.1979.237.3.E224; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Donahue SW, 2003, J EXP BIOL, V206, P4233, DOI 10.1242/jeb.00671; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; FLORANT GL, 1977, AM J PHYSIOL, V232, pR203, DOI 10.1152/ajpregu.1977.232.5.R203; Folk Jr G. E., 1980, BEARS THEIR BIOL MAN, P43; Folk Jr G. E., 1967, MAMMAL HIBERNAT, VIII, P75; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GEISER F, 1988, J COMP PHYSIOL B, V158, P25, DOI 10.1007/BF00692726; Harlow HJ, 2004, J MAMMAL, V85, P414, DOI 10.1644/1545-1542(2004)085<0414:BSTOHB>2.0.CO;2; Harlow HJ, 2001, NATURE, V409, P997, DOI 10.1038/35059165; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; HELLER HC, 1974, AM J PHYSIOL, V227, P583, DOI 10.1152/ajplegacy.1974.227.3.583; Hissa R, 1997, ANN ZOOL FENN, V34, P267; Hock R. J., 1951, AAAS, V2, P310; Hume ID, 2002, J COMP PHYSIOL B, V172, P197, DOI 10.1007/s00360-001-0240-1; Lee TN, 2009, ETHOL ECOL EVOL, V21, P403, DOI 10.1080/08927014.2009.9522495; Lyman C.P., 1982, HIBERNATION TORPOR M; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Nelson OL, 2010, J COMP PHYSIOL B, V180, P465, DOI 10.1007/s00360-009-0421-x; Rausch RL., 1961, Z SAUGETIERKD, V26, P1; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; SNAPP BD, 1981, PHYSIOL ZOOL, V54, P297, DOI 10.1086/physzool.54.3.30159944; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; WATTS P, 1988, ACTA PHYSIOL SCAND, V134, P149, DOI 10.1111/j.1748-1716.1988.tb08471.x	29	242	248	3	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					906	909		10.1126/science.1199435	http://dx.doi.org/10.1126/science.1199435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330544				2022-12-24	WOS:000287455100056
J	Schooler, SS; Salau, B; Julien, MH; Ives, AR				Schooler, Shon S.; Salau, Buck; Julien, Mic H.; Ives, Anthony R.			Alternative stable states explain unpredictable biological control of Salvinia molesta in Kakadu	NATURE			English	Article							REGIME SHIFTS; ECOSYSTEMS; RESTORATION; ECOLOGY; COMMUNITIES; THRESHOLDS; TRANSIENTS; NITROGEN; GROWTH; FIELD	Suppression of the invasive plant Salvinia molesta by the salvinia weevil is an iconic example of successful biological control. However, in the billabongs (oxbow lakes) of Kakadu National Park, Australia, control is fitful and incomplete. By fitting a process-based nonlinear model to thirteen-year data sets from four billabongs, here we show that incomplete control can be explained by alternative stable states(1-4)-one state in which salvinia is suppressed and the other in which salvinia escapes weevil control. The shifts between states are associated with annual flooding events. In some years, high water flow reduces weevil populations, allowing the shift from a controlled to an uncontrolled state; in other years, benign conditions for weevils promote the return shift to the controlled state. In most described ecological examples, transitions between alternative stable states are relatively rare, facilitated by slow-moving environmental changes, such as accumulated nutrient loading or climate change(5,6). The billabongs of Kakadu give a different manifestation of alternative stable states that generate complex and seemingly unpredictable dynamics. Because shifts between alternative stable states are stochastic, they present a potential management strategy to maximize effective biological control: when the domain of attraction to the state of salvinia control is approached, augmentation of the weevil population or reduction of the salvinia biomass may allow the lower state to trap the system.	[Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Schooler, Shon S.; Julien, Mic H.] CSIRO Ecosyst Sci, Long Pocket Labs, Indooroopilly, Qld 4068, Australia; [Salau, Buck] Dept Environm Water Heritage & Arts, Jabiru, NT 0886, Australia	University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Julien, Mic/B-6619-2009; Schooler, Shon/C-1860-2008; Ives, Anthony/A-5698-2008; Schooler, Shon/AAE-9369-2019	Ives, Anthony/0000-0001-9375-9523; 	Australian Department of Agriculture, Fisheries and Forestry; CSIRO; United States National Science Foundation through the North Temperate Lakes Long Term Ecological Research Network	Australian Department of Agriculture, Fisheries and Forestry(Australian GovernmentDepartment of Agriculture and Water Resources); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); United States National Science Foundation through the North Temperate Lakes Long Term Ecological Research Network	We thank S. Winderlich (Kakadu National Park) for facilitating data processing, and S. Cruickshank and G. Willis of the Northern Territory Department of Natural Resources, Environment, the Arts and Sport for providing gauging station data. M. Storrs, C. Murakami, F. Hunter, M. Hattand F. Baird provided field assistance. A. Bourne assisted with data interpretation, and P. Milewski provided value insight into the mathematical analyses. S.S.S. received funding from the Australian Department of Agriculture, Fisheries and Forestry and A.R.I. received funding from a CSIRO McMaster's Fellowship and United States National Science Foundation funds through the North Temperate Lakes Long Term Ecological Research Network and individual grants. S. R. Carpenter, Y. Buckley, and R. van Klinken provided comments on earlier versions of this manuscript.	Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; FINLAYSON CM, 1984, AQUAT BOT, V18, P257, DOI 10.1016/0304-3770(84)90067-6; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Julien MH, 2009, BIOLOGICAL CONTROL OF TROPICAL WEEDS USING ARTHROPODS, P378, DOI 10.1017/CBO9780511576348.019; KNOWLTON N, 1992, AM ZOOL, V32, P674; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; ROOM PM, 1986, J APPL ECOL, V23, P1013, DOI 10.2307/2403952; ROOM PM, 1986, AQUAT BOT, V24, P213, DOI 10.1016/0304-3770(86)90058-6; ROOM PM, 1990, TRENDS ECOL EVOL, V5, P74, DOI 10.1016/0169-5347(90)90234-5; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schmitz OJ, 2006, ECOSYSTEMS, V9, P659, DOI 10.1007/s10021-006-0006-4; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Storrs MJ, 1996, NO LANDSCAPES OCCASI, V1; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0	28	62	64	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					86	89		10.1038/nature09735	http://dx.doi.org/10.1038/nature09735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293376				2022-12-24	WOS:000286886400039
J	Zaidi, MR; Davis, S; Noonan, FP; Graff-Cherry, C; Hawley, TS; Walker, RL; Feigenbaum, L; Fuchs, E; Lyakh, L; Young, HA; Hornyak, TJ; Arnheiter, H; Trinchieri, G; Meltzer, PS; De Fabo, EC; Merlino, G				Zaidi, M. Raza; Davis, Sean; Noonan, Frances P.; Graff-Cherry, Cari; Hawley, Teresa S.; Walker, Robert L.; Feigenbaum, Lionel; Fuchs, Elaine; Lyakh, Lyudmila; Young, Howard A.; Hornyak, Thomas J.; Arnheiter, Heinz; Trinchieri, Giorgio; Meltzer, Paul S.; De Fabo, Edward C.; Merlino, Glenn			Interferon-gamma links ultraviolet radiation to melanomagenesis in mice	NATURE			English	Article							HLA-G; MOUSE; MELANOCYTES; EXPRESSION; CELLS; SEQUENCE; EXPOSURE; LEVEL; NICHE	Cutaneous malignant melanoma is a highly aggressive and frequently chemoresistant cancer, the incidence of which continues to rise. Epidemiological studies show that the major aetiological melanoma risk factor is ultraviolet (UV) solar radiation, with the highest risk associated with intermittent burning doses, especially during childhood(1,2). We have experimentally validated these epidemiological findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops lesions in stages highly reminiscent of human melanoma with respect to biological, genetic and aetiological criteria, but only when irradiated as neonatal pups with UVB, not UVA(3,4). However, the mechanisms underlying UVB-initiated, neonatal-specific melanomagenesis remain largely unknown. Here we introduce a mouse model permitting fluorescence-aided melanocyte imaging and isolation following in vivo UV irradiation. We use expression profiling to show that activated neonatal skin melanocytes isolated following a melanomagenic UVB dose bear a distinct, persistent interferon response signature, including genes associated with immunoevasion. UVB-induced melanocyte activation, characterized by aberrant growth and migration, was abolished by antibody-mediated systemic blockade of interferon-gamma (IFN-gamma), but not type-I interferons. IFN-gamma was produced by macrophages recruited to neonatal skin by UVB-induced ligands to the chemokine receptor Ccr2. Admixed recruited skin macrophages enhanced transplanted melanoma growth by inhibiting apoptosis; notably, IFN-gamma blockade abolished macrophage-enhanced melanoma growth and survival. IFN-gamma-producing macrophages were also identified in 70% of human melanomas examined. Our data reveal an unanticipated role for IFN-gamma in promoting melanocytic cell survival/immunoevasion, identifying a novel candidate therapeutic target for a subset of melanoma patients.	[Zaidi, M. Raza; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Davis, Sean; Walker, Robert L.; Meltzer, Paul S.] NCI, Genet Branch, Bethesda, MD 20892 USA; [Noonan, Frances P.; De Fabo, Edward C.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; [Graff-Cherry, Cari; Feigenbaum, Lionel] NCI, Lab Anim Sci Program, Frederick, MD 21702 USA; [Fuchs, Elaine] Rockefeller Univ, New York, NY 10021 USA; [Lyakh, Lyudmila; Young, Howard A.; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Hornyak, Thomas J.] NCI, Dermatol Branch, Bethesda, MD 20892 USA; [Arnheiter, Heinz] NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	drmecd@gwumc.edu; gmerlino@helix.nih.gov	Fuchs, Elaine/G-1565-2016; Trinchieri, Giorgio/F-9369-2015; Young, Howard/R-5140-2019; Davis, Sean/AAD-1801-2021; Zaidi, M. Raza/H-1386-2016; Young, Howard/A-6350-2008	Trinchieri, Giorgio/0000-0001-5892-7464; Davis, Sean/0000-0002-8991-6458; Zaidi, M. Raza/0000-0003-0480-3188; Young, Howard/0000-0002-3118-5111; Walker, Robert/0000-0001-8235-4686; Noonan, Frances/0000-0002-3302-7280; Arnheiter, Heinz/0000-0003-2537-1134	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute; National Institutes of Health [CA53765, CA92258]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010479, ZIABC010720, ZIABC010565, R01CA092258, R01CA053765, ZIABC010733, ZIABC010734, ZIABC011091, ZIABC008756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003021] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the following individuals for their support: S. Yuspa for primary keratinocytes; C. Toniatti and H. Bujard for the rtTA2sM2 construct; V. Hearing for melan-c cell line; S. Hewitt for the human melanoma tissue microarray; M. Anver for immunohistochemical staining and production/analysis of mouse melanoma tissue microarray; K. Blas and E. Vega-Valle for technical help; N. Restifo and A. Hurwitz for suggestions and discussions. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. M.R.Z. was supported by a National Cancer Institute Director's Innovation Career Development Award. E.C.D. and F.P.N. were supported by grants from the National Institutes of Health (awards CA53765 and CA92258), and the Melanoma Research Foundation.	Serrano MA, 2010, PHOTOCHEM PHOTOBIOL, V86, P716, DOI 10.1111/j.1751-1097.2009.00693.x; Aoki H, 2005, J INVEST DERMATOL, V124, P1053, DOI 10.1111/j.0022-202X.2005.23721.x; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; DEFABO EC, 1990, PHOTOCHEM PHOTOBIOL, V52, P811; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Garibyan L, 2010, CURR ONCOL REP, V12, P319, DOI 10.1007/s11912-010-0119-y; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldszmid RS, 2007, J EXP MED, V204, P2591, DOI 10.1084/jem.20070634; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; He YF, 2005, CANCER IMMUNOL IMMUN, V54, P891, DOI 10.1007/s00262-004-0654-1; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; MEYSKENS FL, 1995, J NATL CANCER I, V87, P1710, DOI 10.1093/jnci/87.22.1710; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Porter GA, 2001, ANN SURG ONCOL, V8, P116, DOI 10.1245/aso.2001.8.2.116; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; R Core Team, 2021, R LANG ENV STAT COMP; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P422, DOI 10.1016/j.semcancer.2007.06.010; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah KV, 2008, J INVEST DERMATOL, V128, P2870, DOI 10.1038/jid.2008.170; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Walker GJ, 2009, J INVEST DERMATOL, V129, P184, DOI 10.1038/jid.2008.210; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Wischhusell J, 2007, SEMIN CANCER BIOL, V17, P459, DOI 10.1016/j.semcancer.2007.07.005; Wolnicka-Glubisz A, 2006, PHOTOCH PHOTOBIO SCI, V5, P254, DOI 10.1039/b506974b; Wolnicka-Glubisz A, 2005, J INVEST DERMATOL, V125, P383, DOI 10.1111/j.0022-202X.2005.23781.x; Wolnicka-Glubisz A, 2007, J LEUKOCYTE BIOL, V81, P1352, DOI 10.1189/jlb.1206729	43	200	210	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					548	U129		10.1038/nature09666	http://dx.doi.org/10.1038/nature09666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21248750	Green Accepted			2022-12-24	WOS:000286596500036
J	Elyada, E; Pribluda, A; Goldstein, RE; Morgenstern, Y; Brachya, G; Cojocaru, G; Snir-Alkalay, I; Burstain, I; Haffner-Krausz, R; Jung, S; Wiener, Z; Alitalo, K; Oren, M; Pikarsky, E; Ben-Neriah, Y				Elyada, Ela; Pribluda, Ariel; Goldstein, Robert E.; Morgenstern, Yael; Brachya, Guy; Cojocaru, Gady; Snir-Alkalay, Irit; Burstain, Ido; Haffner-Krausz, Rebecca; Jung, Steffen; Wiener, Zoltan; Alitalo, Kari; Oren, Moshe; Pikarsky, Eli; Ben-Neriah, Yinon			CKI alpha ablation highlights a critical role for p53 in invasiveness control	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; INTESTINAL EPITHELIUM; MOUSE MODEL; EXPRESSION; INVASION; TUMORIGENESIS; TRANSGENE; MUTATIONS; APOPTOSIS; BIOLOGY	The mature gut renews continuously and rapidly throughout adult life, often in a damage-inflicting micro-environment. The major driving force for self-renewal of the intestinal epithelium is the Wnt-mediated signalling pathway, and Wnt signalling is frequently hyperactivated in colorectal cancer(1). Here we show that casein kinase I alpha (CKI alpha), a component of the beta-catenin-destruction complex(1), is a critical regulator of the Wnt signalling pathway. Inducing the ablation of Csnk1a1 (the gene encoding CKI alpha) in the gut triggers massive Wnt activation, surprisingly without causing tumorigenesis. CKI alpha-deficient epithelium shows many of the features of human colorectal tumours in addition to Wnt activation, in particular the induction of the DNA damage response and cellular senescence, both of which are thought to provide a barrier against malignant transformation(2). The epithelial DNA damage response in mice is accompanied by substantial activation of p53, suggesting that the p53 pathway may counteract the pro-tumorigenic effects of Wnt hyperactivation. Notably, the transition from benign adenomas to invasive colorectal cancer in humans is typically linked to p53 inactivation, underscoring the importance of p53 as a safeguard against malignant progression(3); however, the mechanism of p53-mediated tumour suppression is unknown. We show that the maintenance of intestinal homeostasis inCKI alpha-deficient gut requires p53-mediated growth control, because the combined ablation of Csnk1a1 and either p53 or its target gene p21 (also known as Waf1, Cip1, Sdi1 and Cdkn1a) triggered high-grade dysplasia with extensive proliferation. Unexpectedly, these ablations also induced non-proliferating cells to invade the villous lamina propria rapidly, producing invasive carcinomas throughout the small bowel. Furthermore, in p53-deficient gut, loss of heterozygosity of the gene encoding CKI alpha caused a highly invasive carcinoma, indicating that CKI alpha functions as a tumour suppressor when p53 is inactivated. We identified a set of genes (the p53-suppressed invasiveness signature, PSIS) that is activated by the loss of both p53 and CKI alpha and which probably accounts for the brisk induction of invasiveness. PSIS transcription and tumour invasion were suppressed by p21, independently of cell cycle control. Restraining tissue invasion through suppressing PSIS expression is thus a novel tumour-suppressor function of wild-type p53.	[Elyada, Ela; Pribluda, Ariel; Goldstein, Robert E.; Morgenstern, Yael; Brachya, Guy; Cojocaru, Gady; Snir-Alkalay, Irit; Burstain, Ido; Pikarsky, Eli; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel; [Haffner-Krausz, Rebecca] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Wiener, Zoltan; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Program, FIN-00014 Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science; University of Helsinki; University of Helsinki; Weizmann Institute of Science; Hebrew University of Jerusalem	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel.	peli@hadassah.org.il; yinon@cc.huji.ac.il	Ben-Neriah, Yinon/L-6285-2019; pikarsky, eli/GXV-7099-2022; Jung, Steffen/K-1409-2012; Alitalo, Kari K/J-5013-2014	Jung, Steffen/0000-0003-4290-5716; Alitalo, Kari K/0000-0002-7331-0902; Oren, Moshe/0000-0003-4311-7172; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation; RUBICON EC Network of Excellence; Israel Cancer Research Fund; Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST); Marie-Curie Intra-European Fellowship	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation(Israel Science Foundation); RUBICON EC Network of Excellence; Israel Cancer Research Fund; Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST); Marie-Curie Intra-European Fellowship(European Commission)	We thank S. Robine for the Vil1-Cre-ER<SUP>T2</SUP> mice, O. Sansom and B. Romagnolo for intestinal sections of Apc<SUP>Delta gut</SUP> mice, K. Rajewsky for the pGEM-loxP-Neo-loxP and pCA-NLS-Cre vectors; and E. Horwitz, M. Farago, D. Naor, N. Asherie and D. Knigin for providing expertise and reagents. We are grateful to A. Yaron for critical reading of the manuscript. This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), the Israel Science Foundation, the RUBICON EC Network of Excellence, the Israel Cancer Research Fund and Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST). Z.W. is supported by a Marie-Curie Intra-European Fellowship.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; DAVALLI AM, 1995, TRANSPLANTATION, V59, P817, DOI 10.1097/00007890-199503270-00003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fazeli A, 1997, P NATL ACAD SCI USA, V94, P10199, DOI 10.1073/pnas.94.19.10199; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Ko CH, 2005, MOL CANCER THER, V4, P281; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Valentin-Vega YA, 2009, DIFFERENTIATION, V77, P442, DOI 10.1016/j.diff.2009.03.001; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; YIN J, 1993, GASTROENTEROLOGY, V104, pA464	42	143	160	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					409	U208		10.1038/nature09673	http://dx.doi.org/10.1038/nature09673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331045				2022-12-24	WOS:000287409100045
J	Colbourne, JK; Pfrender, ME; Gilbert, D; Thomas, WK; Tucker, A; Oakley, TH; Tokishita, S; Aerts, A; Arnold, GJ; Basu, MK; Bauer, DJ; Caceres, CE; Carmel, L; Casola, C; Choi, JH; Detter, JC; Dong, QF; Dusheyko, S; Eads, BD; Frohlich, T; Geiler-Samerotte, KA; Gerlach, D; Hatcher, P; Jogdeo, S; Krijgsveld, J; Kriventseva, EV; Kultz, D; Laforsch, C; Lindquist, E; Lopez, J; Manak, JR; Muller, J; Pangilinan, J; Patwardhan, RP; Pitluck, S; Pritham, EJ; Rechtsteiner, A; Rho, M; Rogozin, IB; Sakarya, O; Salamov, A; Schaack, S; Shapiro, H; Shiga, Y; Skalitzky, C; Smith, Z; Souvorov, A; Sung, W; Tang, ZJ; Tsuchiya, D; Tu, H; Vos, H; Wang, M; Wolf, YI; Yamagata, H; Yamada, T; Ye, YZ; Shaw, JR; Andrews, J; Crease, TJ; Tang, HX; Lucas, SM; Robertson, HM; Bork, P; Koonin, EV; Zdobnov, EM; Grigoriev, IV; Lynch, M; Boore, JL				Colbourne, John K.; Pfrender, Michael E.; Gilbert, Donald; Thomas, W. Kelley; Tucker, Abraham; Oakley, Todd H.; Tokishita, Shinichi; Aerts, Andrea; Arnold, Georg J.; Basu, Malay Kumar; Bauer, Darren J.; Caceres, Carla E.; Carmel, Liran; Casola, Claudio; Choi, Jeong-Hyeon; Detter, John C.; Dong, Qunfeng; Dusheyko, Serge; Eads, Brian D.; Froehlich, Thomas; Geiler-Samerotte, Kerry A.; Gerlach, Daniel; Hatcher, Phil; Jogdeo, Sanjuro; Krijgsveld, Jeroen; Kriventseva, Evgenia V.; Kueltz, Dietmar; Laforsch, Christian; Lindquist, Erika; Lopez, Jacqueline; Manak, J. Robert; Muller, Jean; Pangilinan, Jasmyn; Patwardhan, Rupali P.; Pitluck, Samuel; Pritham, Ellen J.; Rechtsteiner, Andreas; Rho, Mina; Rogozin, Igor B.; Sakarya, Onur; Salamov, Asaf; Schaack, Sarah; Shapiro, Harris; Shiga, Yasuhiro; Skalitzky, Courtney; Smith, Zachary; Souvorov, Alexander; Sung, Way; Tang, Zuojian; Tsuchiya, Dai; Tu, Hank; Vos, Harmjan; Wang, Mei; Wolf, Yuri I.; Yamagata, Hideo; Yamada, Takuji; Ye, Yuzhen; Shaw, Joseph R.; Andrews, Justen; Crease, Teresa J.; Tang, Haixu; Lucas, Susan M.; Robertson, Hugh M.; Bork, Peer; Koonin, Eugene V.; Zdobnov, Evgeny M.; Grigoriev, Igor V.; Lynch, Michael; Boore, Jeffrey L.			The Ecoresponsive Genome of Daphnia pulex	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENES; EXPRESSION; DUPLICATIONS; EVOLUTION; MAGNA	We describe the draft genome of the microcrustacean Daphnia pulex, which is only 200 megabases and contains at least 30,907 genes. The high gene count is a consequence of an elevated rate of gene duplication resulting in tandem gene clusters. More than a third of Daphnia's genes have no detectable homologs in any other available proteome, and the most amplified gene families are specific to the Daphnia lineage. The coexpansion of gene families interacting within metabolic pathways suggests that the maintenance of duplicated genes is not random, and the analysis of gene expression under different environmental conditions reveals that numerous paralogs acquire divergent expression patterns soon after duplication. Daphnia-specific genes, including many additional loci within sequenced regions that are otherwise devoid of annotations, are the most responsive genes to ecological challenges.	[Colbourne, John K.; Gilbert, Donald; Choi, Jeong-Hyeon; Dong, Qunfeng; Eads, Brian D.; Lopez, Jacqueline; Patwardhan, Rupali P.; Rechtsteiner, Andreas; Smith, Zachary; Tang, Zuojian; Tsuchiya, Dai; Shaw, Joseph R.; Andrews, Justen; Tang, Haixu] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Pfrender, Michael E.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Gilbert, Donald; Tucker, Abraham; Casola, Claudio; Eads, Brian D.; Schaack, Sarah; Andrews, Justen; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Thomas, W. Kelley; Tucker, Abraham; Bauer, Darren J.; Hatcher, Phil; Jogdeo, Sanjuro; Sung, Way] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Oakley, Todd H.; Geiler-Samerotte, Kerry A.; Sakarya, Onur] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Tokishita, Shinichi; Shiga, Yasuhiro; Yamagata, Hideo] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Div Environm Sci, Lab Environm & Mol Biol, Tokyo 1920392, Japan; [Aerts, Andrea; Detter, John C.; Dusheyko, Serge; Lindquist, Erika; Pangilinan, Jasmyn; Pitluck, Samuel; Salamov, Asaf; Shapiro, Harris; Tu, Hank; Wang, Mei; Lucas, Susan M.; Grigoriev, Igor V.; Boore, Jeffrey L.] JGI, Dept Energy, Walnut Creek, CA 94598 USA; [Arnold, Georg J.; Froehlich, Thomas] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, D-82152 Planegg Martinsried, Germany; [Basu, Malay Kumar; Carmel, Liran; Rogozin, Igor B.; Souvorov, Alexander; Wolf, Yuri I.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Caceres, Carla E.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Gerlach, Daniel; Kriventseva, Evgenia V.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gerlach, Daniel; Kriventseva, Evgenia V.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CA Utrecht, Netherlands; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Netherlands Prote Ctr, NL-3584 CA Utrecht, Netherlands; [Kueltz, Dietmar] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Laforsch, Christian] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Laforsch, Christian] Univ Munich, GeoBio Ctr Munich, D-82152 Planegg Martinsried, Germany; [Manak, J. Robert; Skalitzky, Courtney] Roche NimbleGen Inc, Gene Express, Madison, WI 53719 USA; [Muller, Jean; Yamada, Takuji; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Pritham, Ellen J.; Schaack, Sarah] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Rho, Mina; Ye, Yuzhen; Tang, Haixu] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Boore, Jeffrey L.] Genome Project Solut, Hercules, CA 94547 USA; [Boore, Jeffrey L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University; Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire; University of California System; University of California Santa Barbara; Tokyo University of Pharmacy & Life Sciences; United States Department of Energy (DOE); Joint Genome Institute - JGI; University of Munich; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Illinois System; University of Illinois Urbana-Champaign; University of Geneva; Swiss Institute of Bioinformatics; Utrecht University; Utrecht University; Utrecht University; University of California System; University of California Davis; University of Munich; University of Munich; Roche Holding; European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Arlington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Guelph; University of Illinois System; University of Illinois Urbana-Champaign; Imperial College London; University of California System; University of California Berkeley	Colbourne, JK (corresponding author), Indiana Univ, Ctr Genom & Bioinformat, 915 E 3rd St, Bloomington, IN 47405 USA.	jcolbour@indiana.edu	Krijgsveld, Jeroen/F-5974-2011; Fröhlich, Thomas/C-6735-2011; Pfrender, Micheal E./C-5065-2019; , DK/AAU-3163-2021; Colbourne, John K/L-7748-2014; Bork, Peer/F-1813-2013; Zdobnov, Evgeny/AAB-2745-2022; Muller, Jean/L-7412-2018; Choi, Justin/F-8792-2014; Zdobnov, Evgeny M/K-1133-2012; Crease, Teresa/E-2932-2015; Choi, Jeong-Hyeon/E-3084-2010	Fröhlich, Thomas/0000-0002-4709-3211; Colbourne, John K/0000-0002-6966-2972; Bork, Peer/0000-0002-2627-833X; Zdobnov, Evgeny/0000-0002-5178-1498; Muller, Jean/0000-0002-7682-559X; Crease, Teresa/0000-0001-8074-8024; Gerlach, Daniel/0000-0001-9338-3765; Oakley, Todd/0000-0002-4478-915X; Wolf, Yuri/0000-0002-0247-8708; Rechtsteiner, Andreas/0000-0001-6031-1087; Vos, Harmjan/0000-0002-4696-6068; Krijgsveld, Jeroen/0000-0001-7549-9326; Rogozin, Igor/0000-0003-0802-4851; Grigoriev, Igor/0000-0002-3136-8903; Manak, John/0000-0002-6562-7694; Casola, Claudio/0000-0003-4853-1866	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Daphnia Genomics Consortium (DGC); NSF [0221837, 0328516]; NIH [R24GM07827401]; METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019324, P42ES004699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078274] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000073] Funding Source: NIH RePORTER	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Daphnia Genomics Consortium (DGC); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Frazer (JGI), P. Cherbas (CGB), R. Green, and T. Takova (Roche NimbleGen, Inc.). The work conducted by the U.S. Department of Energy Joint Genome Institute (JGI) was supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231 and in collaboration with the Daphnia Genomics Consortium (DGC). This project was also supported by NSF grants 0221837 and 0328516 and NIH grant R24GM07827401. Coordination infrastructure for the DGC is provided by the Center for Genomics and Bioinformatics (CGB) at Indiana University, which is supported in part by the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. Additional contributions and acknowledgments are provided in the SOM. Our work benefits from and contributes to the Daphnia Genomics Consortium. Daphnia pulex genome assembly version 1.1 and annotations are deposited at DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank databases under accession ACJG00000000. ESTs (FE274839 to FE425949) are in GenBank. Microarray platforms GPL11200 to GPL11201 and data GSE25823 are deposited at National Center for Biotechnology Information Gene Expression Omnibus database.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Colbourne John K., 1997, P163; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Hebert P.D.N., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P439; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P591, DOI 10.1093/molbev/msn004; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Kimura S, 1999, J BIOL CHEM, V274, P10649, DOI 10.1074/jbc.274.15.10649; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lynch Michael, 1994, P109; Martins J, 2007, ENVIRON INT, V33, P414, DOI 10.1016/j.envint.2006.12.006; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Shaw JR, 2008, ADV EXP BIOL, V2, P165, DOI 10.1016/S1872-2423(08)00005-7; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Taylor DJ, 1999, P ROY SOC B-BIOL SCI, V266, P791, DOI 10.1098/rspb.1999.0707; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P177; Wang FY, 2009, VISION RES, V49, P1860, DOI 10.1016/j.visres.2009.04.023; Zeis B, 2008, COMP BIOCHEM PHYS A, V151, pS38, DOI 10.1016/j.cbpa.2008.05.141; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	24	901	953	12	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					555	561		10.1126/science.1197761	http://dx.doi.org/10.1126/science.1197761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292972	Green Submitted, Green Accepted			2022-12-24	WOS:000286933600046
J	Schmidt, O; Harbauer, AB; Rao, S; Eyrich, B; Zahedi, RP; Stojanovski, D; Schonfisch, B; Guiard, B; Sickmann, A; Pfanner, N; Meisinger, C				Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana; Eyrich, Beate; Zahedi, Rene P.; Stojanovski, Diana; Schoenfisch, Birgit; Guiard, Bernard; Sickmann, Albert; Pfanner, Nikolaus; Meisinger, Chris			Regulation of Mitochondrial Protein Import by Cytosolic Kinases	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; RECEPTOR TOM70; COMPLEX-I; PREPROTEINS; BINDING; CK2; IDENTIFICATION; TRANSLOCATION; EVOLUTION	Mitochondria import a large number of nuclear-encoded proteins via membrane-bound transport machineries; however, little is known about regulation of the preprotein translocases. We report that the main protein entry gate of mitochondria, the translocase of the outer membrane (TOM complex), is phosphorylated by cytosolic kinases-in particular, casein kinase 2 (CK2) and protein kinase A (PKA). CK2 promotes biogenesis of the TOM complex by phosphorylation of two key components, the receptor Tom22 and the import protein Mim1, which in turn are required for import of further Tom proteins. Inactivation of CK2 decreases the levels of the TOM complex and thus mitochondrial protein import. PKA phosphorylates Tom70 under nonrespiring conditions, thereby inhibiting its receptor activity and the import of mitochondrial metabolite carriers. We conclude that cytosolic kinases exert stimulatory and inhibitory effects on biogenesis and function of the TOM complex and thus regulate protein import into mitochondria.	[Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana; Stojanovski, Diana; Schoenfisch, Birgit; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Schmidt, Oliver; Harbauer, Angelika B.; Schoenfisch, Birgit; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Rao, Sanjana] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Eyrich, Beate; Zahedi, Rene P.; Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS eV, D-44139 Dortmund, Germany; [Stojanovski, Diana] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteom Ctr, D-44801 Bochum, Germany; [Meisinger, Chris] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); La Trobe University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ruhr University Bochum; University of Bern	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; chris.meisinger@biochemie.uni-freiburg.de	Meisinger, Chris/J-1110-2014; Sickmann, Albert/A-1010-2011; Zahedi, René/A-9148-2012; Zahedi, Rene/HGU-5710-2022; Pfanner, Nikolaus/AAV-7878-2021	Meisinger, Chris/0000-0002-8326-3548; Sickmann, Albert/0000-0002-2388-5265; Zahedi, René/0000-0002-4960-5460; Schmidt, Oliver/0000-0002-7921-4663; Stojanovski, Diana/0000-0002-0199-3222; Harbauer, Angelika/0000-0002-4568-9003	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments; Bundesministerium fur Bildung und Forschung (Dynamo); Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich [746]; Gottfried Wilhelm Leibniz Program; Landesforschungspreis Baden-Wurttemberg	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Dynamo)(Federal Ministry of Education & Research (BMBF)); Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; Landesforschungspreis Baden-Wurttemberg	We thank Drs. C.V. Glover, A.P. Bidwai, K.M. Dombek, and C. Mann for strains and antisera; Drs. N. Wiedemann, K. Wagner, T. Becker, N. Gebert, M. Bohnert, M. Gebert, and D. Stroud for discussion; and C. Prinz for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School), Bundesministerium fur Bildung und Forschung (Dynamo), Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich 746, Gottfried Wilhelm Leibniz Program, and Landesforschungspreis Baden-Wurttemberg. This paper is dedicated to Klaus Paal (1955-2009), who is deeply missed.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Onorato TM, 2005, J BIOL CHEM, V280, P19527, DOI 10.1074/jbc.M410422200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tripodi F, 2010, BIOCHEM BIOPH RES CO, V398, P44, DOI 10.1016/j.bbrc.2010.06.028; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	30	177	177	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					227	239		10.1016/j.cell.2010.12.015	http://dx.doi.org/10.1016/j.cell.2010.12.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21215441	Bronze			2022-12-24	WOS:000286459900008
J	Haldane, AG; May, RM				Haldane, Andrew G.; May, Robert M.			Systemic risk in banking ecosystems	NATURE			English	Article							NETWORK STRUCTURE; COMPLEX-SYSTEMS; ECOLOGY; MODEL	In the run-up to the recent financial crisis, an increasingly elaborate set of financial instruments emerged, intended to optimize returns to individual institutions with seemingly minimal risk. Essentially no attention was given to their possible effects on the stability of the system as a whole. Drawing analogies with the dynamics of ecological food webs and with networks within which infectious diseases spread, we explore the interplay between complexity and stability in deliberately simplified models of financial networks. We suggest some policy lessons that can be drawn from such models, with the explicit aim of minimizing systemic risk.	[May, Robert M.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England; [Haldane, Andrew G.] Bank England, London EC2R 8AH, England	University of Oxford; Bank of England	May, RM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	robert.may@zoo.ox.ac.uk						Alessandri P., 2009, BANKING ON THE STATE; ANDERSON R M, 1991; Arrow KJ, 1954, ECONOMETRICA, V22, P265, DOI 10.2307/1907353; Avellaneda M, 2003, QUANT FINANC, V3, P417, DOI 10.1088/1469-7688/3/6/301; Bank of England, 2009, ROL MACR POL DISC PA; Barabesi A.-L., 2002, LINKED NEW SCI NETWO; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Battiston A., 2009, LIAISONS DANGEREUSES; Brock W. A., 2008, J EC DYNAM CONT, V33, P1912; Buffet W. E., 2002, 15 BERKSH HATH INC, P15; Caccioli F, 2009, EUR PHYS J B, V71, P467, DOI 10.1140/epjb/e2009-00316-y; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Elton C. S., 1958, ECOLOGY INVASIONS AN; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Haldane A. G., 2009, FIN STUD ASS AMST; Haldane A. G., 2010, 100 BILLION QUESTION; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jones C, 2010, CENT BANKING, V21, P69; Kyriakopoulos F, 2009, EUR PHYS J B, V71, P523, DOI 10.1140/epjb/e2009-00255-7; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R. M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Osler CL, 2006, INT J FINANC ECON, V11, P55, DOI 10.1002/ijfe.288; Pascuale M., 2006, ECOLOGICAL NETWORKS; Pliska S.R., 1997, INTRO MATH FINANCE D; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sircar R., 1998, APPL MATH FINANC, V5, P45, DOI [10.1080/135048698334727, DOI 10.1080/135048698334727]; Stiglitz J., J GLOBAL DE IN PRESS; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Sugihara G, 2009, NATURE, V458, P979, DOI 10.1038/458979a; Turner P., 2009, DEBATE FINANCIAL SYS	40	699	717	22	388	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330								10.1038/nature09659	http://dx.doi.org/10.1038/nature09659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248842	Green Submitted			2022-12-24	WOS:000286385600042
J	Alexandrou, MA; Oliveira, C; Maillard, M; McGill, RAR; Newton, J; Creer, S; Taylor, MI				Alexandrou, Markos A.; Oliveira, Claudio; Maillard, Marjorie; McGill, Rona A. R.; Newton, Jason; Creer, Simon; Taylor, Martin I.			Competition and phylogeny determine community structure in Mullerian co-mimics	NATURE			English	Article							POSITIVE INTERACTIONS; STABLE-ISOTOPES; DNA CONTENT; FISH; CONSPICUOUSNESS; FACILITATION; EVOLUTION	Until recently, the study of negative and antagonistic interactions (for example, competition and predation) has dominated our understanding of community structure, maintenance and assembly(1). Nevertheless, a recent theoretical model suggests that positive interactions (for example, mutualisms) may counterbalance competition, facilitating long-term coexistence even among ecologically undifferentiated species(2). Mullerian mimics are mutualists that share the costs of predator education(3) and are therefore ideally suited for the investigation of positive and negative interactions in community dynamics. The sole empirical test of this model in a Mullerian mimetic community supports the prediction that positive interactions outweigh the negative effects of spatial overlap(4) (without quantifying resource acquisition). Understanding the role of trophic niche partitioning in facilitating the evolution and stability of Mullerian mimetic communities is now of critical importance, but has yet to be formally investigated. Here we show that resource partitioning and phylogeny determine community structure and outweigh the positive effects of Mullerian mimicry in a species-rich group of neotropical catfishes. From multiple, independent reproductively isolated allopatric communities displaying convergently evolved colour patterns, 92% consist of species that do not compete for resources. Significant differences in phylogenetically conserved traits (snout morphology and body size) were consistently linked to trait-specific resource acquisition. Thus, we report the first evidence, to our knowledge, that competition for trophic resources and phylogeny are pivotal factors in the stable evolution of Mullerian mimicry rings. More generally, our work demonstrates that competition for resources is likely to have a dominant role in the structuring of communities that are simultaneously subject to the effects of both positive and negative interactions.	[Alexandrou, Markos A.; Maillard, Marjorie; Creer, Simon; Taylor, Martin I.] Bangor Univ, Coll Nat Sci, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab,Environm Ctr Wales, Bangor LL57 2UW, Gwynedd, Wales; [Oliveira, Claudio] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil; [McGill, Rona A. R.; Newton, Jason] Scottish Univ Environm Res Ctr, NERC Life Sci Mass Spectrometry Facil, E Kilbride G75 0QF, Lanark, Scotland	Bangor University; Universidade Estadual Paulista; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Taylor, MI (corresponding author), Bangor Univ, Coll Nat Sci, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab,Environm Ctr Wales, Bangor LL57 2UW, Gwynedd, Wales.	m.taylor@bangor.ac.uk	McGill, Rona/F-1793-2010; Oliveira, Claudio/D-7713-2012; Taylor, Martin I/B-4298-2013; Alexandrou, Markos/E-1509-2012; Newton, Jason/A-9536-2009	McGill, Rona/0000-0003-0400-7288; Oliveira, Claudio/0000-0002-7010-8880; Newton, Jason/0000-0001-7594-3693	NERC [NE/C001168/1, NE/F007205/1]; UNESP, Brazil; Natural Environment Research Council [NE/C001168/2] Funding Source: researchfish; NERC [lsmsf010002] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UNESP, Brazil; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC small grant (NE/C001168/1), NERC Mass Spectrometry access grant (NE/F007205/1) awarded to M.I.T., and a NERC PhD studentship (NE/F007205/1) awarded to M.A.A. Research was also supported by UNESP, Brazil. We would like to thank the staff and students of UNESP, Botucatu, Brazil for facilities and research support during fieldwork including P. Venere for helping to collect samples in the Rio Araguaia, and M. Britto for identifying samples. We would also like to thank B. Emerson and G. Ruxton for their suggestions and critical evaluation of the manuscript. We thank J. Montoya-Burgos, M. Sabaj Perez, I. Fuller, H.-G. Evers, M. Walters and K. Mathiesen for providing tissue samples and photographs, and A. Orchard for photographing preserved specimens.	Axenrot T. E., 2003, ICHTHYOL EXPLOR FRES, V14, P249; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; DRUMMOND AJ, 2009, GENEIOUS V4 7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elias M, 2008, PLOS BIOL, V6, P2642, DOI 10.1371/journal.pbio.0060300; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Fuller IA, 2005, IDENTIFYING CORYDORA; Genner MJ, 1999, ECOL LETT, V2, P185; Greven H., 2006, VERHANDLUNGEN GESELL, V5, P65; Gross K, 2008, ECOL LETT, V11, P929, DOI 10.1111/j.1461-0248.2008.01204.x; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kiehl Ernst, 2006, Verhandlungen der Gesellschaft fuer Ichthyologie (GfI) e V, V5, P111; Kovach W. L, 1999, MVSP MULTIVARIATE ST; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; MAY RM, 1981, AM ZOOL, V21, P903; Merilaita S, 2007, J THEOR BIOL, V245, P268, DOI 10.1016/j.jtbi.2006.10.022; Muller F., 1878, ZOOL ANZ, V1, P54; Nelson JS, 1984, FISHES WORLD; NIJSSEN H, 1970, Beaufortia, V18, P1; OLIVEIRA C, 1992, J FISH BIOL, V40, P419, DOI 10.1111/j.1095-8649.1992.tb02587.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWER ME, 1984, ECOLOGY, V65, P523, DOI 10.2307/1941414; RAMBAUT A, 2004, TRACER V1 4; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Ruxton G. D., 2004, AVOIDING ATTACK; Sands D. D., 1994, BEHAV EVOLUTIONARY E; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wright JJ, 2011, EVOLUTION, V65, P395, DOI 10.1111/j.1558-5646.2010.01149.x; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894	42	94	101	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					84	U97		10.1038/nature09660	http://dx.doi.org/10.1038/nature09660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209663				2022-12-24	WOS:000285921600036
J	Jarosz, DF; Lindquist, S				Jarosz, Daniel F.; Lindquist, Susan			Hsp90 and Environmental Stress Transform the Adaptive Value of Natural Genetic Variation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MORPHOLOGICAL EVOLUTION; PHENOTYPIC VARIATION; DRUG-RESISTANCE; CHAPERONE; PROTEIN; CAPACITOR; YEAST; ACTS	How can species remain unaltered for long periods yet also undergo rapid diversification? By linking genetic variation to phenotypic variation via environmental stress, the Hsp90 protein-folding reservoir might promote both stasis and change. However, the nature and adaptive value of Hsp90-contingent traits remain uncertain. In ecologically and genetically diverse yeasts, we find such traits to be both common and frequently adaptive. Most are based on preexisting variation, with causative polymorphisms occurring in coding and regulatory sequences alike. A common temperature stress alters phenotypes similarly. Both selective inhibition of Hsp90 and temperature stress increase correlations between genotype and phenotype. This system broadly determines the adaptive value of standing genetic variation and, in so doing, has influenced the evolution of current genomes.	[Jarosz, Daniel F.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Jarosz, Daniel/0000-0003-3497-5888	Broad Institute; Harold and Leila Y. Mathers Foundation; HHMI	Broad Institute; Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute)	We are grateful to L. Kruglyak, E. Perlstein, L. Cowen, S. Schreiber, A. Regev, I. Barassa, E. Louis, S. Dietzmann, and F. Dietrich for materials, discussion, and help. S.L. is a Howard Hughes Medical Institute (HHMI) investigator, and D.F.J. is an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08). This work was supported by grants from the Broad Institute, the G. Harold and Leila Y. Mathers Foundation, and HHMI.	BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hikkel I, 2003, J BIOL CHEM, V278, P11427, DOI 10.1074/jbc.M208549200; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ramanathan Arvind, 2007, J Biol, V6, P3, DOI 10.1186/jbiol56; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; VITOLS E, 1970, BIOCHEM BIOPH RES CO, V41, P71, DOI 10.1016/0006-291X(70)90470-5; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324	27	236	241	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1820	1824		10.1126/science.1195487	http://dx.doi.org/10.1126/science.1195487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205668	Green Submitted, Green Accepted			2022-12-24	WOS:000285603700040
J	Carter, AP; Cho, C; Jin, L; Vale, RD				Carter, Andrew P.; Cho, Carol; Jin, Lan; Vale, Ronald D.			Crystal Structure of the Dynein Motor Domain	SCIENCE			English	Article							MICROTUBULE-BINDING DOMAIN; ENERGY TRANSDUCTION; COILED-COIL; MECHANISMS; ATPASE; PROCESSIVITY; HYDROLYSIS; RESOLUTION; REVEALS; MOTIONS	Dyneins are microtubule-based motor proteins that power ciliary beating, transport intracellular cargos, and help to construct the mitotic spindle. Evolved from ring-shaped hexameric AAA-family adenosine triphosphatases (ATPases), dynein's large size and complexity have posed challenges for understanding its structure and mechanism. Here, we present a 6 angstrom crystal structure of a functional dimer of two similar to 300-kilodalton motor domains of yeast cytoplasmic dynein. The structure reveals an unusual asymmetric arrangement of ATPase domains in the ring-shaped motor domain, the manner in which the mechanical element interacts with the ATPase ring, and an unexpected interaction between two coiled coils that create a base for the microtubule binding domain. The arrangement of these elements provides clues as to how adenosine triphosphate-driven conformational changes might be transmitted across the motor domain.	[Carter, Andrew P.; Cho, Carol; Jin, Lan; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Carter, Andrew P.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Howard Hughes Medical Institute; University of California System; University of California San Francisco; MRC Laboratory Molecular Biology	Carter, AP (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	cartera@mrc-lmb.cam.ac.uk; vale@cmp.ucsf.edu		Carter, Andrew/0000-0001-7292-5430; Cho, Carol/0000-0003-4070-6561	NIH; Jane Coffin Child Foundation; Lymphoma and Leukemia Foundation; American Heart Association; Genentech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097312] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A025_1011] Funding Source: researchfish; MRC [MC_UP_A025_1011] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Child Foundation; Lymphoma and Leukemia Foundation; American Heart Association(American Heart Association); Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Zhang (UCSF), J. Holton (Advanced Light Source), H. Schmidt (MRC), E. Gleave (MRC), and M. Sirajuddin (UCSF) for their assistance and helpful discussions. This work was supported by the NIH (R.D.V.), Jane Coffin Child Foundation (A.P.C.), Lymphoma and Leukemia Foundation (A.P.C.), American Heart Association (C.C.), and Genentech Graduate Student Fellowship (C.C.). The PDB accession number for this dynein dimer structure is 3QMZ.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Bushnell DA, 2001, STRUCTURE, V9, pR11, DOI 10.1016/S0969-2126(00)00554-2; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Neuwald AF, 1999, GENOME RES, V9, P27; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Serohijos AWR, 2006, P NATL ACAD SCI USA, V103, P18540, DOI 10.1073/pnas.0602867103; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	37	173	175	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1159	1165		10.1126/science.1202393	http://dx.doi.org/10.1126/science.1202393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21330489	Green Accepted			2022-12-24	WOS:000287971200033
J	Gardy, JL; Johnston, JC; Sui, SJH; Cook, VJ; Shah, LN; Brodkin, E; Rempel, S; Moore, R; Zhao, YJ; Holt, R; Varhol, R; Birol, I; Lem, M; Sharma, MK; Elwood, K; Jones, SJM; Brinkman, FSL; Brunham, RC; Tang, P				Gardy, Jennifer L.; Johnston, James C.; Sui, Shannan J. Ho; Cook, Victoria J.; Shah, Lena; Brodkin, Elizabeth; Rempel, Shirley; Moore, Richard; Zhao, Yongjun; Holt, Robert; Varhol, Richard; Birol, Inanc; Lem, Marcus; Sharma, Meenu K.; Elwood, Kevin; Jones, Steven J. M.; Brinkman, Fiona S. L.; Brunham, Robert C.; Tang, Patrick			Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR EPIDEMIOLOGY; CONTACT INVESTIGATIONS; CRACK COCAINE; RISK-FACTORS; DRUG-USERS; TRANSMISSION	BACKGROUND An outbreak of tuberculosis occurred over a 3-year period in a medium-size community in British Columbia, Canada. The results of mycobacterial interspersed repetitive unit-variable-number tandem-repeat (MIRU-VNTR) genotyping suggested the outbreak was clonal. Traditional contact tracing did not identify a source. We used whole-genome sequencing and social-network analysis in an effort to describe the outbreak dynamics at a higher resolution. METHODS We sequenced the complete genomes of 32 Mycobacterium tuberculosis outbreak isolates and 4 historical isolates (from the same region but sampled before the outbreak) with matching genotypes, using short-read sequencing. Epidemiologic and genomic data were overlaid on a social network constructed by means of interviews with patients to determine the origins and transmission dynamics of the outbreak. RESULTS Whole-genome data revealed two genetically distinct lineages of M. tuberculosis with identical MIRU-VNTR genotypes, suggesting two concomitant outbreaks. Integration of social-network and phylogenetic analyses revealed several transmission events, including those involving "superspreaders." Both lineages descended from a common ancestor and had been detected in the community before the outbreak, suggesting a social, rather than genetic, trigger. Further epidemiologic investigation revealed that the onset of the outbreak coincided with a recorded increase in crack cocaine use in the community. CONCLUSIONS Through integration of large-scale bacterial whole-genome sequencing and social-network analysis, we show that a socioenvironmental factor - most likely increased crack cocaine use - triggered the simultaneous expansion of two extant lineages of M. tuberculosis that was sustained by key members of a high-risk social network. Genotyping and contact tracing alone did not capture the true dynamics of the outbreak. (Funded by Genome British Columbia and others.)	[Gardy, Jennifer L.; Johnston, James C.; Cook, Victoria J.; Shah, Lena; Rempel, Shirley; Elwood, Kevin; Brunham, Robert C.; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; [Gardy, Jennifer L.; Cook, Victoria J.; Elwood, Kevin; Brunham, Robert C.; Tang, Patrick] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Moore, Richard; Zhao, Yongjun; Holt, Robert; Varhol, Richard; Birol, Inanc; Jones, Steven J. M.] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Shah, Lena] Publ Hlth Agcy Canada, Canadian Field Epidemiol Program, Vancouver, BC, Canada; [Lem, Marcus] Hlth Canada, Vancouver, BC, Canada; [Sui, Shannan J. Ho; Jones, Steven J. M.; Brinkman, Fiona S. L.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Brodkin, Elizabeth] Fraser Hlth Author, Surrey, BC, Canada; [Sharma, Meenu K.] Natl Microbiol Lab, Winnipeg, MB, Canada	University of British Columbia; Public Health Agency of Canada; Health Canada; Simon Fraser University	Tang, P (corresponding author), British Columbia Ctr Dis Control, 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.	patrick.tang@bccdc.ca	Sharma, Meenu/GWM-5030-2022; Birol, Inanc/G-5440-2011; Brinkman, Fiona/N-3195-2013; Sharma, Meenu/AAE-2536-2022; Holt, Robert A/C-3303-2009; Jones, Steven J/C-3621-2009	Birol, Inanc/0000-0003-0950-7839; Brinkman, Fiona/0000-0002-0584-4099; Sharma, Meenu/0000-0002-6020-9995; Holt, Robert A/0000-0002-7259-1247; Jones, Steven J/0000-0003-3394-2208; Tang, Patrick/0000-0003-1583-5484; /0000-0002-6191-4709	Genome British Columbia, Health Canada; Simon Fraser University Community Trust; British Columbia Lung Association; Canadian Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research	Genome British Columbia, Health Canada; Simon Fraser University Community Trust; British Columbia Lung Association; Canadian Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by grants from Genome British Columbia, Health Canada, and the Simon Fraser University Community Trust, as well as from the British Columbia Lung Association (to Dr. Johnston), the Canadian Cystic Fibrosis Foundation (to Dr. Ho Sui), and the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research (to Dr. Brinkman).	[Anonymous], 2007, CAN TUB STAND; [Anonymous], 2009, TUB CAN 2007; Asghar RJ, 2009, J URBAN HEALTH, V86, P776, DOI 10.1007/s11524-009-9378-z; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P485; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Cook VJ, 2007, J INFECT DIS, V196, P1517, DOI 10.1086/523109; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Fenner L, 2009, INT J EPIDEMIOL, V38, P1425, DOI 10.1093/ije/dyp367; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Grimes CZ, 2007, INT J TUBERC LUNG D, V11, P1183; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Howard AA, 2002, CLIN INFECT DIS, V35, P1183, DOI 10.1086/343827; Malakmadze N, 2005, CLIN INFECT DIS, V40, P366, DOI 10.1086/427112; McElroy RD, 2003, INT J TUBERC LUNG D, V7, pS486; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Story A, 2008, EMERG INFECT DIS, V14, P1466, DOI 10.3201/eid1409.070654; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization (WHO), 2009, WHOHTMTB2009420	20	520	532	4	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					730	739		10.1056/NEJMoa1003176	http://dx.doi.org/10.1056/NEJMoa1003176			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345102	Green Published			2022-12-24	WOS:000287652500007
J	Lister, R; Pelizzola, M; Kida, YS; Hawkins, RD; Nery, JR; Hon, G; Antosiewicz-Bourget, J; O'Malley, R; Castanon, R; Klugman, S; Downes, M; Yu, R; Stewart, R; Ren, B; Thomson, JA; Evans, RM; Ecker, JR				Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R.			Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells	NATURE			English	Article							DNA METHYLATION; DIFFERENTIATION; GENES; MICE	Induced pluripotent stem cells (iPSCs) offer immense potential for regenerative medicine and studies of disease and development. Somatic cell reprogramming involves epigenomic reconfiguration, conferring iPSCs with characteristics similar to embryonic stem (ES) cells. However, it remains unknown how complete the reestablishment of ES-cell-like DNA methylation patterns is throughout the genome. Here we report the first whole-genome profiles of DNA methylation at single-base resolution in five human iPSC lines, along with methylomes of ES cells, somatic cells, and differentiated iPSCs and ES cells. iPSCs show significant reprogramming variability, including somatic memory and aberrant reprogramming of DNA methylation. iPSCs share megabase-scale differentially methylated regions proximal to centromeres and telomeres that display incomplete reprogramming of non-CG methylation, and differences in CG methylation and histone modifications. Lastly, differentiation of iPSCs into trophoblast cells revealed that errors in reprogramming CG methylation are transmitted at a high frequency, providing an iPSC reprogramming signature that is maintained after differentiation.	[Lister, Ryan; Pelizzola, Mattia; Nery, Joseph R.; O'Malley, Ronan; Castanon, Rosa; Ecker, Joseph R.] Salk Inst Biol Studies, Genome Anal Lab, La Jolla, CA 92037 USA; [Kida, Yasuyuki S.; Downes, Michael; Yu, Ruth; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hawkins, R. David; Hon, Gary; Klugman, Sarit; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Ludwig Institute for Cancer Research; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genome Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; kida, yasuyuki S/J-1718-2018; Lister, Ryan/B-5168-2012; Nery, Joseph/AAE-8422-2019; Evans, Ronald/AAF-4001-2019	Ecker, Joseph R/0000-0001-5799-5895; kida, yasuyuki S/0000-0002-9972-293X; Lister, Ryan/0000-0001-6637-7239; Nery, Joseph/0000-0003-0153-5659; Evans, Ronald/0000-0002-9986-5965; Pelizzola, Mattia/0000-0001-6672-9636	California Institute; Catharina Foundation; American Cancer Society; Japan Society for the Promotion of Science; Mary K. Chapman Foundation; National Science Foundation (NSF) [NSF 0726408]; National Institutes of Health (NIH) [U01 ES017166, U01 1U01ES017166-01, DK062434]; California Institute for Regenerative Medicine [RB2-01530]; Morgridge Institute for Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	California Institute; Catharina Foundation; American Cancer Society(American Cancer Society); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mary K. Chapman Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Morgridge Institute for Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Zhang and G. Schroth for assistance with MethylC-Seq library sequencing. R.L. is supported by a California Institute for Regenerative Medicine Training Grant. M.P. is supported by a Catharina Foundation postdoctoral fellowship. R.D.H. is supported by an American Cancer Society Postdoctoral Fellowship. Y.K. is supported by the Japan Society for the Promotion of Science. This work was supported by grants from the following: Mary K. Chapman Foundation, the National Science Foundation (NSF) (NSF 0726408), the National Institutes of Health (NIH) (U01 ES017166, U01 1U01ES017166-01, DK062434), the California Institute for Regenerative Medicine (RB2-01530), the Morgridge Institute for Research and the Howard Hughes Medical Institute. We thank the NIH Roadmap Reference Epigenome Consortium (http://www.roadmapepigenomics.org/). This study was carried out as part of the NIH Roadmap Epigenomics Program.	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yilmaz Gokhan, 2010, Exp Transl Stroke Med, V2, P11, DOI 10.1186/2040-7378-2-11; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	37	1110	1168	2	319	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					68	U84		10.1038/nature09798	http://dx.doi.org/10.1038/nature09798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21289626	Green Accepted, Green Published			2022-12-24	WOS:000287924100035
J	Parsons, DW; Li, M; Zhang, XS; Jones, S; Leary, RJ; Lin, JCH; Boca, SM; Carter, H; Samayoa, J; Bettegowda, C; Gallia, GL; Jallo, GI; Binder, ZA; Nikolsky, Y; Hartigan, J; Smith, DR; Gerhard, DS; Fults, DW; VandenBerg, S; Berger, MS; Marie, SKN; Shinjo, SMO; Clara, C; Phillips, PC; Minturn, JE; Biegel, JA; Judkins, AR; Resnick, AC; Storm, PB; Curran, T; He, YP; Rasheed, BA; Friedman, HS; Keir, ST; McLendon, R; Northcott, PA; Taylor, MD; Burger, PC; Riggins, GJ; Karchin, R; Parmigiani, G; Bigner, DD; Yan, H; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE				Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Boca, Simina M.; Carter, Hannah; Samayoa, Josue; Bettegowda, Chetan; Gallia, Gary L.; Jallo, George I.; Binder, Zev A.; Nikolsky, Yuri; Hartigan, James; Smith, Doug R.; Gerhard, Daniela S.; Fults, Daniel W.; VandenBerg, Scott; Berger, Mitchel S.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Clara, Carlos; Phillips, Peter C.; Minturn, Jane E.; Biegel, Jaclyn A.; Judkins, Alexander R.; Resnick, Adam C.; Storm, Phillip B.; Curran, Tom; He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Northcott, Paul A.; Taylor, Michael D.; Burger, Peter C.; Riggins, Gregory J.; Karchin, Rachel; Parmigiani, Giovanni; Bigner, Darell D.; Yan, Hai; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.			The Genetic Landscape of the Childhood Cancer Medulloblastoma	SCIENCE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; GENOME; AMPLIFICATION; METHYLATION; PROGRESSION; SEQUENCES; COMPLEX; ARID1A; OTX2	Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high-density microarrays and sequenced all known protein-coding genes and microRNA genes using Sanger sequencing in a set of 22 MBs. We found that, on average, each tumor had 11 gene alterations, fewer by a factor of 5 to 10 than in the adult solid tumors that have been sequenced to date. In addition to alterations in the Hedgehog and Wnt pathways, our analysis led to the discovery of genes not previously known to be altered in MBs. Most notably, inactivating mutations of the histone-lysine N-methyltransferase genes MLL2 or MLL3 were identified in 16% of MB patients. These results demonstrate key differences between the genetic landscapes of adult and childhood cancers, highlight dysregulation of developmental pathways as an important mechanism underlying MBs, and identify a role for a specific type of histone methylation in human tumorigenesis.	[Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Bettegowda, Chetan; Riggins, Gregory J.; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Bettegowda, Chetan; Riggins, Gregory J.; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Parsons, D. Williams] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Boca, Simina M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Carter, Hannah; Samayoa, Josue; Karchin, Rachel] Johns Hopkins Med Inst, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Bettegowda, Chetan; Gallia, Gary L.; Jallo, George I.; Binder, Zev A.; Riggins, Gregory J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA; [Nikolsky, Yuri] GeneGo Inc, St Joseph, MI 49085 USA; [Hartigan, James; Smith, Doug R.] Beckman Coulter Genom Inc, Danvers, MA 01923 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Fults, Daniel W.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84132 USA; [VandenBerg, Scott] Univ Calif San Diego, Dept Pathol, Div Neuropathol, San Diego, CA 92103 USA; [Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Clara, Carlos] Barretos Canc Hosp, Pio XII Fdn, Sao Paulo, Brazil; [Phillips, Peter C.; Minturn, Jane E.; Biegel, Jaclyn A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Resnick, Adam C.; Storm, Phillip B.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Judkins, Alexander R.; Curran, Tom] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr,Dept Pathol, Durham, NC 27710 USA; [He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Burger, Peter C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Parmigiani, Giovanni] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Beckman Coulter Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of California System; University of California San Francisco; Universidade de Sao Paulo; Hospital de Cancer de Barretos; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; Duke University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Vogelstein, B (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@gmail.com; kinzlke@jhmi.edu; velculescu@jhmi.edu	Marie, Suely Kazue Nagahashi/D-1870-2012; Velculescu, Victor/ABF-4846-2020; Northcott, Paul A/N-4022-2018; Karchin, Rachel/A-3385-2010; Boca, Simina/ABE-3747-2020; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Papadopoulos, Nickolas/K-7272-2012; Jones, Sian/A-5050-2012; Oba-Shinjo, Sueli M./C-4017-2012; Curran, Tom/C-1164-2008; Curran, Thomas/AAE-7631-2019; Carter, Hannah/R-8425-2017	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Velculescu, Victor/0000-0003-1195-438X; Northcott, Paul A/0000-0002-1220-5252; Boca, Simina/0000-0002-1400-3398; Curran, Tom/0000-0003-1444-7551; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Parsons, Donald/0000-0002-8775-3501; Carter, Hannah/0000-0002-1729-2463; Taylor, Michael/0000-0001-7009-3466; Karchin, Rachel/0000-0002-5069-1239	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Virginia and D. K. Ludwig Fund for Cancer Research; Alex's Lemonade Stand Foundation; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Hoglund Foundation; Ready or Not Foundation; Children's Brain Tumor Foundation; Pediatric Brain Tumor Foundation Institute; David and Barbara B. Hirschhorn Foundation; American Association for Cancer Research; Johns Hopkins Sommer Scholar Program; NIH [CA121113, CA096832, CA057345, CA118822, CA135877, GM074906-01A1/B7BSCW]; NSF [DBI 0845275]; DOD NDSEG [32 CFR 168a]; NATIONAL CANCER INSTITUTE [R01CA121113, R37CA057345, R01CA057345, R01CA118822, R21CA135877, R01CA108622, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074906] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Virginia and D. K. Ludwig Fund for Cancer Research; Alex's Lemonade Stand Foundation; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Hoglund Foundation; Ready or Not Foundation; Children's Brain Tumor Foundation; Pediatric Brain Tumor Foundation Institute; David and Barbara B. Hirschhorn Foundation; American Association for Cancer Research; Johns Hopkins Sommer Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOD NDSEG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Ptak, N. Silliman, L. Dobbyn, and M. Whalen for technical assistance with sequencing analyses, and M. Ehinger, D. Satterfield, E. Lipp, D. Lister, and M. J. Dougherty for help with sample preparation and data collection. This project has been funded in part by the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, Alex's Lemonade Stand Foundation, the American Brain Tumor Association, the Brain Tumor Research Fund at Johns Hopkins, the Hoglund Foundation, the Ready or Not Foundation, the Children's Brain Tumor Foundation, the Pediatric Brain Tumor Foundation Institute, the David and Barbara B. Hirschhorn Foundation, American Association for Cancer Research Stand Up To Cancer Dream Team Translational Cancer Research Grant, Johns Hopkins Sommer Scholar Program, NIH grants CA121113, CA096832, CA057345, CA118822, CA135877, and GM074906-01A1/B7BSCW, NSF grant DBI 0845275, and DOD NDSEG Fellowship 32 CFR 168a. D. W. P. is a Graham Cancer Research Scholar at Texas Children's Cancer Center. Under licensing agreements between the Johns Hopkins University and Beckman Coulter, B.V., K.W.K., and V.E.V. are entitled to a share of royalties received by the university on sales of products related to research described in this paper. N.P., B.V., K.W.K., and V.E.V are cofounders of Inostics and Personal Genome Diagnostics and are members of their Scientific Advisory Boards. N.P., B.V., K.W.K., and V.E.V. own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict-of-interest policies.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; BIGNER SH, 1990, CANCER RES, V50, P2347; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Boon K, 2005, CANCER RES, V65, P703; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Di CH, 2005, CANCER RES, V65, P919; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Giangaspero F., 2007, WHO CLASSIFICATION C; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09218; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; SAYLORS RL, 1991, CANCER RES, V51, P4721; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soussi T, 2003, HUM MUTAT, V21, P192, DOI 10.1002/humu.10189; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	43	552	561	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					435	439		10.1126/science.1198056	http://dx.doi.org/10.1126/science.1198056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21163964	Green Accepted			2022-12-24	WOS:000286635900045
J	Nichols, RJ; Sen, S; Choo, YJ; Beltrao, P; Zietek, M; Chaba, R; Lee, S; Kazmierczak, KM; Lee, KJ; Wong, A; Shales, M; Lovett, S; Winkler, ME; Krogan, NJ; Typas, A; Gross, CA				Nichols, Robert J.; Sen, Saunak; Choo, Yoe Jin; Beltrao, Pedro; Zietek, Matylda; Chaba, Rachna; Lee, Sueyoung; Kazmierczak, Krystyna M.; Lee, Karis J.; Wong, Angela; Shales, Michael; Lovett, Susan; Winkler, Malcolm E.; Krogan, Nevan J.; Typas, Athanasios; Gross, Carol A.			Phenotypic Landscape of a Bacterial Cell	CELL			English	Article							SYSTEMATIC GENETIC-ANALYSIS; TRANSPOSON MUTANT LIBRARY; ANTIBIOTIC-RESISTANCE MAR; ESCHERICHIA-COLI; MARA/SOXS/ROB REGULON; MEMBRANE-PROTEINS; DRUG-INTERACTIONS; FISSION YEAST; E. COLI; GENOME	The explosion of sequence information in bacteria makes developing high-throughput, cost-effective approaches to matching genes with phenotypes imperative. Using E. coli as proof of principle, we show that combining large-scale chemical genomics with quantitative fitness measurements provides a high-quality data set rich in discovery. Probing growth profiles of a mutant library in hundreds of conditions in parallel yielded > 10,000 phenotypes that allowed us to study gene essentiality, discover leads for gene function and drug action, and understand higher-order organization of the bacterial chromosome. We highlight new information derived from the study, including insights into a gene involved in multiple antibiotic resistance and the synergy between a broadly used combinatory antibiotic therapy, trimethoprim and sulfonamides. This data set, publicly available at http://ecoliwiki.net/tools/chemgen/, is a valuable resource for both the microbiological and bioinformatic communities, as it provides high-confidence associations between hundreds of annotated and uncharacterized genes as well as inferences about the mode of action of several poorly understood drugs.	[Nichols, Robert J.; Choo, Yoe Jin; Zietek, Matylda; Chaba, Rachna; Lee, Sueyoung; Lee, Karis J.; Wong, Angela; Typas, Athanasios; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Nichols, Robert J.] Univ Calif San Francisco, Oral & Craniofacial Sci Grad Program, San Francisco, CA 94143 USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Beltrao, Pedro; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Beltrao, Pedro; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Kazmierczak, Krystyna M.; Winkler, Malcolm E.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Lovett, Susan] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Lovett, Susan] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; Brandeis University; Brandeis University; University of California System; University of California San Francisco	Typas, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St, San Francisco, CA 94158 USA.	athanasios.typas@ucsf.edu; cgrossucsf@gmail.com	Beltrao, Pedro/B-3342-2010; Lovett, Susan/AAC-1810-2021	Beltrao, Pedro/0000-0002-2724-7703; Lovett, Susan/0000-0003-2792-1857; Typas, Athanasios/0000-0002-0797-9018	NIH [R01 GM085697, R01 GM036278, K99GM092984, AI060744, GM078338, F31 DE020206-01, T32 DE007306]; ARRA [GM085697-01S1]; European Molecular Biology Organization; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085697, R01GM078338, K99GM092984, R01GM036278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kishony, J. Weissman, A. Hochschild, and R.G. Martin for critically reading this manuscript; J. Hu and P. Thomas for hosting these data on E. coli Wiki; C. Raetz for CHIR-090 and M. Gottesman for Bicyclomycin; H. Mori for the Keio Collection; G. Storz for sharing the sRNA deletion library prior to publication; J. Greenblatt and A. Emili for SPA-tagged alleles; W. Margolin, R. Misra, T. Silhavy, and B. Palsson for mutants; and T. Baker and R. Sauer for controllable degradation plasmids. This work was supported by NIH R01 GM085697 and ARRA GM085697-01S1 to C.A.G. and N.J.K.; NIH R01 GM036278 to C.A.G.; NIH K99GM092984 to A.T.; NIH AI060744 to M.E.W.; NIH GM078338 to S.S.; NIH F31 DE020206-01 and NIH T32 DE007306 (R.J.N. support); European Molecular Biology Organization long-term fellowship (to A.T.); and Human Frontier Science Program Long-Term Postdoctoral Fellowship (to P.B.). In loving memory of S.R. Bartlett and J.T. Blair.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker CA, 2010, CHEM BIOL, V17, P624, DOI 10.1016/j.chembiol.2010.05.010; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GILONI L, 1981, J BIOL CHEM, V256, P8608; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jeanguenin L, 2010, J BIOL CHEM, V285, P41557, DOI 10.1074/jbc.M110.190504; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; Martin RG, 2008, J MOL BIOL, V380, P278, DOI 10.1016/j.jmb.2008.05.015; MCOSKER CC, 1994, J ANTIMICROB CHEMOTH, V33, P23, DOI 10.1093/jac/33.suppl_A.23; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nicoloff H, 2007, ANTIMICROB AGENTS CH, V51, P1293, DOI 10.1128/AAC.01128-06; Nicoloff H, 2006, J BACTERIOL, V188, P4413, DOI 10.1128/JB.01502-05; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TU Y, 1975, BIOCHIM BIOPHYS ACTA, V402, P142, DOI 10.1016/0005-2787(75)90032-5; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Warner DM, 2010, MICROBIOL-SGM, V156, P570, DOI 10.1099/mic.0.033415-0; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	70	458	466	1	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					143	156		10.1016/j.cell.2010.11.052	http://dx.doi.org/10.1016/j.cell.2010.11.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21185072	Green Accepted, Bronze			2022-12-24	WOS:000285993600014
J	Studenski, S; Perera, S; Patel, K; Rosano, C; Faulkner, K; Inzitari, M; Brach, J; Chandler, J; Cawthon, P; Connor, EB; Nevitt, M; Visser, M; Kritchevsky, S; Badinelli, S; Harris, T; Newman, AB; Cauley, J; Ferrucci, L; Guralnik, J				Studenski, Stephanie; Perera, Subashan; Patel, Kushang; Rosano, Caterina; Faulkner, Kimberly; Inzitari, Marco; Brach, Jennifer; Chandler, Julie; Cawthon, Peggy; Connor, Elizabeth Barrett; Nevitt, Michael; Visser, Marjolein; Kritchevsky, Stephen; Badinelli, Stefania; Harris, Tamara; Newman, Anne B.; Cauley, Jane; Ferrucci, Luigi; Guralnik, Jack			Gait Speed and Survival in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL PERFORMANCE-MEASURES; LOWER-EXTREMITY FUNCTION; LOWER-BODY FUNCTION; WALKING SPEED; MUSCLE STRENGTH; MOBILITY LIMITATIONS; 5-YEAR MORTALITY; LIFE EXPECTANCY; ELDERLY PERSONS; HEALTH	Context Survival estimates help individualize goals of care for geriatric patients, but life tables fail to account for the great variability in survival. Physical performance measures, such as gait speed, might help account for variability, allowing clinicians to make more individualized estimates. Objective To evaluate the relationship between gait speed and survival. Design, Setting, and Participants Pooled analysis of 9 cohort studies (collected between 1986 and 2000), using individual data from 34 485 community-dwelling older adults aged 65 years or older with baseline gait speed data, followed up for 6 to 21 years. Participants were a mean (SD) age of 73.5 (5.9) years; 59.6%, women; and 79.8%, white; and had a mean (SD) gait speed of 0.92 (0.27) m/s. Main Outcome Measures Survival rates and life expectancy. Results There were 17 528 deaths; the overall 5-year survival rate was 84.8% (confidence interval [CI], 79.6%-88.8%) and 10-year survival rate was 59.7% (95% CI, 46.5%-70.6%). Gait speed was associated with survival in all studies (pooled hazard ratio per 0.1 m/s, 0.88; 95% CI, 0.87-0.90; P<.001). Survival increased across the full range of gait speeds, with significant increments per 0.1 m/s. At age 75, predicted 10-year survival across the range of gait speeds ranged from 19% to 87% in men and from 35% to 91% in women. Predicted survival based on age, sex, and gait speed was as accurate as predicted based on age, sex, use of mobility aids, and self-reported function or as age, sex, chronic conditions, smoking history, blood pressure, body mass index, and hospitalization. Conclusion In this pooled analysis of individual data from 9 selected cohorts, gait speed was associated with survival in older adults. JAMA. 2011;305(1):50-58 www.jama.com	[Studenski, Stephanie; Perera, Subashan] Univ Pittsburgh, Sch Med, Dept Med, Div Geriatr Med, Pittsburgh, PA 15260 USA; [Rosano, Caterina; Newman, Anne B.; Cauley, Jane] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Brach, Jennifer] Univ Pittsburgh, Sch Hlth & Rehabil, Dept Phys Therapy, Pittsburgh, PA 15260 USA; [Faulkner, Kimberly] Natl Personal Protect Technol Lab, Pittsburgh, PA USA; [Patel, Kushang; Harris, Tamara; Guralnik, Jack] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Inzitari, Marco] Autonomous Univ Barcelona, Pere Virgili Hosp, Barcelona, Spain; [Inzitari, Marco] Autonomous Univ Barcelona, Inst Aging, Barcelona, Spain; [Chandler, Julie] Merck Res Labs, N Wales, PA USA; [Nevitt, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Connor, Elizabeth Barrett] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kritchevsky, Stephen] Wake Forest Univ, Winston Salem, NC 27109 USA; [Badinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Autonomous University of Barcelona; Autonomous University of Barcelona; Merck & Company; University of California System; University of California San Francisco; University of California System; University of California San Diego; Wake Forest University; Azienda Sanitaria di Firenze	Studenski, S (corresponding author), Kaufmann Bldg,Ste 500,3471 5th Ave, Pittsburgh, PA 15143 USA.	sas33@pitt.edu	Perera, Subashan/D-7603-2014; Visser, Marjolein/AAP-3224-2020; Newman, Anne B./C-6408-2013; Inzitari, Marco/ABC-1529-2021; Brach, Jennifer/A-6912-2009	Newman, Anne B./0000-0002-0106-1150; Visser, Marjolein/0000-0002-5136-298X; Rosano, Caterina/0000-0002-4271-6010; Rosano, Caterina/0000-0002-0909-1506; Cauley, Jane A/0000-0003-0752-4408; Inzitari, Marco/0000-0002-3796-0625; Brach, Jennifer/0000-0002-7793-2004; Kritchevsky, Stephen/0000-0003-3336-6781	Merck; Novartis; GTX; Merck Research Lab; Amgen; National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services [11200800292P];  [AG023641];  [AG024827]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG023641, P30AG021332, P30AG024827] Funding Source: NIH RePORTER	Merck(Merck & Company); Novartis(Novartis); GTX; Merck Research Lab; Amgen(Amgen); National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Studenski reported receiving institutional grant support, travel expenses, and consultancy fees from Merck; consultlancy fees from Novartis and GTX; and royalties from Hazzart Text McGraw Hill. Dr Perera reported receiving institutional grant support from Merck Research Lab. Dr Inzitari reported receiving insitutional grant support from Merck. Dr Brach reported receiving institutional grant support from Merck. Dr Cawthon reported receiving consultancy fees from Amgen and Merck. Dr Cauley reported receiving consultancy fees and institutional grant support from Novartis. Drs Patel, Faulkner, Barett-Connor, Nevitt, Visser, Bandellini, Harris, Newman, Ferrucci, and Gurlanik reported no disclosures.; Additional support for the pooled analyses was provided by grants AG023641, AG024827 and the Intramural Research Program, National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services number 11200800292P. Dr Studenski received grant support from Merck to perform this work.	[Anonymous], 2006, SURVIVAL ANAL TECHNI; Apfel CC, 2001, BRIT J ANAESTH, V86, P822, DOI 10.1093/bja/86.6.822; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Buchman Aron S, 2009, Proc Am Thorac Soc, V6, P581, DOI 10.1513/pats.200905-030RM; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Cham R, 2008, EXP BRAIN RES, V185, P391, DOI 10.1007/s00221-007-1161-3; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; Cuoco A, 2004, J GERONTOL A-BIOL, V59, P1200, DOI 10.1093/gerona/59.11.1200; DEAR KBG, 1994, BIOMETRICS, V50, P989, DOI 10.2307/2533438; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fitzpatrick AL, 2007, J GERONTOL A-BIOL, V62, P1244, DOI 10.1093/gerona/62.11.1244; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gill TM, 2010, J AM GERIATR SOC, V58, pS308, DOI 10.1111/j.1532-5415.2010.02914.x; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hall WJ, 2006, ANN INTERN MED, V145, P538, DOI 10.7326/0003-4819-145-7-200610030-00012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Jones LM, 2009, J PHYS ACT HEALTH, V6, P327, DOI 10.1123/jpah.6.3.327; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Katsahian S, 2008, CONTEMP CLIN TRIALS, V29, P220, DOI 10.1016/j.cct.2007.08.002; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Kerrigan DC, 2001, ARCH PHYS MED REHAB, V82, P26, DOI 10.1053/apmr.2001.18584; Kuo Chen-Ko, 2009, BMC Geriatr, V9, P49, DOI 10.1186/1471-2318-9-49; LAVSKYSHULAN M, 1985, J AM GERIATR SOC, V33, P23, DOI 10.1111/j.1532-5415.1985.tb02855.x; Lawless J. F., 2002, STAT MODELS METHODS, V2nd, DOI DOI 10.1002/9781118033005; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Markides KS, 1999, SERVING MINORITY ELDERS IN THE 21ST CENTURY, P72; Markides KS, 2001, J GERONTOL A-BIOL, V56, pM243, DOI 10.1093/gerona/56.4.M243; Martin FC, 2005, AGE AGEING, V34, P281, DOI 10.1093/ageing/afi074; Mazzaglia G, 2007, J AM GERIATR SOC, V55, P1955, DOI 10.1111/j.1532-5415.2007.01446.x; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Nebes RD, 2007, J GERONTOL A-BIOL, V62, P83, DOI 10.1093/gerona/62.1.83; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Ostbye T, 1999, J AM GERIATR SOC, V47, P1249, DOI 10.1111/j.1532-5415.1999.tb05207.x; Ostir GV, 2007, AM J EPIDEMIOL, V166, P599, DOI 10.1093/aje/kwm121; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Rolland Y, 2006, EUR J EPIDEMIOL, V21, P113, DOI 10.1007/s10654-005-5458-x; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Simonsick EM, 2008, J GERONTOL A-BIOL, V63, P841, DOI 10.1093/gerona/63.8.841; Solway S, 2001, CHEST, V119, P256, DOI 10.1378/chest.119.1.256; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Thernau TM, 2000, MODELING SURVIVAL DA; *US DEP HHS, 2004, 941308 PHS US DEP HL; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2000, J AM GERIATR SOC, V48, P381, DOI 10.1111/j.1532-5415.2000.tb04694.x; Volpato S, 2002, DIABETES CARE, V25, P678, DOI 10.2337/diacare.25.4.678; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Woo J, 1999, J AM GERIATR SOC, V47, P1257, DOI 10.1111/j.1532-5415.1999.tb05209.x; 2010, US LIFE TABLES	67	2557	2604	9	235	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					50	58		10.1001/jama.2010.1923	http://dx.doi.org/10.1001/jama.2010.1923			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702VN	21205966	Green Accepted, Bronze			2022-12-24	WOS:000285924100024
J	Phelps, J; Webb, EL; Bickford, D; Nijman, V; Sodhi, NS				Phelps, Jacob; Webb, Edward L.; Bickford, David; Nijman, Vincent; Sodhi, Navjot S.			Boosting CITES	SCIENCE			English	Editorial Material							INTERNATIONAL WILDLIFE TRADE; CONSERVATION; DYNAMICS		[Phelps, Jacob; Webb, Edward L.; Bickford, David; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England	National University of Singapore; Oxford Brookes University	Phelps, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	jacob.phelps@gmail.com; dbsbdp@nus.edu.sg	Nijman, Vincent/AHD-8685-2022; Bickford, David P/A-5306-2011; Webb, Edward L/E-8343-2011	Bickford, David P/0000-0003-1478-3387; Webb, Edward L/0000-0001-5554-9955; Nijman, Vincent/0000-0002-5600-4276; Phelps, Jacob/0000-0001-6489-1103				Amir O. G., 2006, WILDLIFE TRADE SOMAL; [Anonymous], WILDLIFE TRADE POLIC; [Anonymous], RESOLUTION FINANCING; [Anonymous], GATHERING ANAL DATA; Blundell AG, 2004, ORYX, V38, P84, DOI 10.1017/S0030605304000134; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Carpenter AI, 2004, BIOL CONSERV, V120, P291, DOI 10.1016/j.biocon.2004.03.002; CITES, NOND FIND; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davenport TRB, 2003, ORYX, V37, P55, DOI 10.1017/S0030605303000127; Dickson B, 2008, ORYX, V42, P548, DOI 10.1017/S0030605307000786; Gehring T, 2008, GLOBAL ENVIRON POLIT, V8, P123, DOI 10.1162/glep.2008.8.2.123; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Giles BG, 2006, BIODIVERS CONSERV, V15, P2497, DOI 10.1007/s10531-005-2432-6; Green EP, 1999, CORAL REEFS, V18, P403, DOI 10.1007/s003380050218; IUCN Species Survival Commission, 2009, ORCH SPEC GROUP GEN; Li YM, 1998, BIODIVERS CONSERV, V7, P895, DOI 10.1023/A:1008873119651; Milius S., 2010, SCI NEWS        0326; Mohneke M., 2010, Traffic Bulletin, V22, P117; Moyle B, 2009, GLOB CRIME, V10, P124, DOI 10.1080/17440570902783921; Nguyen Van Song, 2008, Journal of Environment & Development, V17, P145, DOI 10.1177/1070496508316220; Nijman V., 2010, WILDLIFE TRADE ASEAN; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Olsen CS, 2005, MT RES DEV, V25, P37, DOI 10.1659/0276-4741(2005)025[0037:ATOEAI]2.0.CO;2; Parsons ECM, 2010, MAR POLICY, V34, P384, DOI 10.1016/j.marpol.2009.08.008; Pistoni Juliana, 2010, South American Journal of Herpetology, V5, P51, DOI 10.2994/057.005.0106; Reeve R, 2006, INT AFF, V82, P881, DOI 10.1111/j.1468-2346.2006.00576.x; RENCTAS (Rede Nacional de Combate ao Trafico de Animais, 2001, 1 REL NAC TRAF FAUN; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Sand P H, 1997, EUR J INT LAW, V8, P29, DOI [10.1093/oxfordjournals.ejil.a015561, DOI 10.1093/OXFORDJOURNALS.EJIL.A015561]; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; *SING MIN ED HS TR, R154000400133 SING M; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Sodhi NS., 2007, TROPICAL CONSERVATIO; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; United Nations Environment Programme-World Conservation Monitoring Centre (UNEP-WCMC), 2010, THREAT SPEC DAT; Veith M, 2000, BIODIVERS CONSERV, V9, P333, DOI 10.1023/A:1008906918236; Vitousek PM, 1996, AM SCI, V84, P468; Warkentin IG, 2009, CONSERV BIOL, V23, P1056, DOI 10.1111/j.1523-1739.2008.01165.x; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P221, DOI 10.1007/s12024-010-9167-8	41	79	82	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1752	1753		10.1126/science.1195558	http://dx.doi.org/10.1126/science.1195558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21205655				2022-12-24	WOS:000285603700020
J	Liu, GH; Barkho, BZ; Ruiz, S; Diep, D; Qu, J; Yang, SL; Panopoulos, AD; Suzuki, K; Kurian, L; Walsh, C; Thompson, J; Boue, S; Fung, HL; Sancho-Martinez, I; Zhang, K; Yates, J; Belmonte, JCI				Liu, Guang-Hui; Barkho, Basam Z.; Ruiz, Sergio; Diep, Dinh; Qu, Jing; Yang, Sheng-Lian; Panopoulos, Athanasia D.; Suzuki, Keiichiro; Kurian, Leo; Walsh, Christopher; Thompson, James; Boue, Stephanie; Fung, Ho Lim; Sancho-Martinez, Ignacio; Zhang, Kun; Yates, John, III; Izpisua Belmonte, Juan Carlos			Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome	NATURE			English	Article							MUSCLE-CELL SENESCENCE; HUMAN SOMATIC-CELLS; TUMOR-SUPPRESSOR; YEAST PROTEOME; LAMIN; PRELAMIN; DEFECTS; ATHEROSCLEROSIS; DIFFERENTIATION; PHENOTYPE	Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature ageing disease(1-5), characterized by premature arteriosclerosis and degeneration of vascular smooth muscle cells (SMCs)(6-8). HGPS is caused by a single point mutation in the lamin A (LMNA) gene, resulting in the generation of progerin, a truncated splicing mutant of lamin A. Accumulation of progerin leads to various ageing-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin(9-12). Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature ageing. Upon differentiation of HGPS-iPSCs, progerin and its ageing-associated phenotypic consequences are restored. Specifically, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescence phenotypes associated with vascular ageing. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs, also known as PRKDC) as a downstream target of progerin. The absence of nuclear DNAPK holoenzyme correlates with premature as well as physiological ageing. Because progerin also accumulates during physiological ageing(6,12,13), our results provide an in vitro iPSC-based model to study the pathogenesis of human premature and physiological vascular ageing.	[Liu, Guang-Hui; Barkho, Basam Z.; Ruiz, Sergio; Qu, Jing; Yang, Sheng-Lian; Panopoulos, Athanasia D.; Suzuki, Keiichiro; Kurian, Leo; Walsh, Christopher; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Diep, Dinh; Fung, Ho Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Thompson, James; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Boue, Stephanie; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Qu, Jing/ABB-9088-2020; Kurian, Leo/M-1598-2014; Ruiz, Sergio/G-1561-2016; Zhang, Kun/ABE-6349-2020	Kurian, Leo/0000-0001-7466-5169; Ruiz, Sergio/0000-0002-0177-6965; Zhang, Kun/0000-0002-7596-5224; qu, jing/0000-0002-3988-5067; Suzuki, Keiichiro/0000-0001-5603-9105; Boue, Stephanie/0000-0003-0680-4168; Liu, Guang-Hui/0000-0001-9289-8177; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Panopoulos, Athanasia/0000-0002-9610-2604	CIRM [TG2-01158]; AFAR/Ellison Medical Foundation; NIH [T32 CA009370, R01-DA025779, P41 RR011823]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ellison Medical Foundation; MICINN; Fundacion Cellex (JCIB); NATIONAL CANCER INSTITUTE [T32CA009370] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ellison Medical Foundation(Lawrence Ellison Foundation); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex (JCIB); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Comai for providing experimental material, M. Hetzer, J. Karlseder, J.-F. Deleuze, M. J. Barrero, C. Rodriguez Esteban and L. Gerace for helpful discussions, M. Marti for teratoma analysis, M. C. Llach for karyotyping, T. Berggren, M. Lutz, I. Dubova, S. Stewart, R. Dev, M. Li, L. Laricchia-Robbio, A. M. Goebl and J. Kim for technical help, and M. Schwarz for administrative help. G.-H.L. and L.K. were partially supported by a CIRM grant (TG2-01158), J.Q. was partially supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship; A.D.P. was partially supported by a NIH training grant T32 CA009370. This study was supported by grants from NIH R01-DA025779 (K.Z.), and NIH P41 RR011823 (J.Y.); the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Ellison Medical Foundation, MICINN and Fundacion Cellex (JCIB).	Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Candelario J, 2011, EXP CELL RES, V317, P319, DOI 10.1016/j.yexcr.2010.10.014; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SR, 2005, HUM GENET, V118, P444, DOI 10.1007/s00439-005-0051-7; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Liu GH, 2009, MOL CELL BIOL, V29, P5800, DOI 10.1128/MCB.00684-09; Lu SJ, 2009, REGEN MED, V4, P37, DOI 10.2217/17460751.4.1.37; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	41	403	420	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					221	225		10.1038/nature09879	http://dx.doi.org/10.1038/nature09879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21346760	Green Accepted			2022-12-24	WOS:000289469100043
J	Brodribb, TJ; McAdam, SAM				Brodribb, Tim J.; McAdam, Scott A. M.			Passive Origins of Stomatal Control in Vascular Plants	SCIENCE			English	Article							RESPONSES; EVOLUTION; LAND; CO2; TRANSPIRATION; DIVERSITY; CLOSURE; ABA	Carbon and water flow between plants and the atmosphere is regulated by the opening and closing of minute stomatal pores in surfaces of leaves. By changing the aperture of stomata, plants regulate water loss and photosynthetic carbon gain in response to many environmental stimuli, but stomatal movements cannot yet be reliably predicted. We found that the complexity that characterizes stomatal control in seed plants is absent in early-diverging vascular plant lineages. Lycophyte and fern stomata are shown to lack key responses to abscisic acid and epidermal cell turgor, making their behavior highly predictable. These results indicate that a fundamental transition from passive to active metabolic control of plant water balance occurred after the divergence of ferns about 360 million years ago.	[Brodribb, Tim J.; McAdam, Scott A. M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia	University of Tasmania	Brodribb, TJ (corresponding author), Univ Tasmania, Sch Plant Sci, Private Bag 55, Hobart, Tas 7001, Australia.	timothyb@utas.edu.au	McAdam, Scott/J-7197-2014; Brodribb, Timothy John/C-6797-2013	McAdam, Scott/0000-0002-9625-6750; Brodribb, Timothy John/0000-0002-4964-6107	Australian Research Council [DP0878177, DP0559266]; APA	Australian Research Council(Australian Research Council); APA	We thank K. Mott and G. Jordan for discussion and comments on the manuscript, and J. Ross and N. Davies for assistance with ABA quantification techniques. Supported by Australian Research Council grants DP0878177 and DP0559266 (T.J.B.) and an APA award (S.A.M.M.).	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Buckley TN, 2003, PLANT CELL ENVIRON, V26, P1767, DOI 10.1046/j.1365-3040.2003.01094.x; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; Darwin, 1898, P R SOC LOND, V190, P531, DOI [10.1098/RSTB.1898.0009, DOI 10.1098/RSPL.1898.0053]; Dewar RC, 2002, PLANT CELL ENVIRON, V25, P1383, DOI 10.1046/j.1365-3040.2002.00909.x; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Duan BL, 2007, J EXP BOT, V58, P3025, DOI 10.1093/jxb/erm160; Duckett JG, 2009, NEW PHYTOL, V183, P1053, DOI 10.1111/j.1469-8137.2009.02905.x; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; Edwards D, 2003, PLANT CELL ENVIRON, V26, P57, DOI 10.1046/j.1365-3040.2003.00878.x; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Hartung W, 2010, FUNCT PLANT BIOL, V37, P806, DOI 10.1071/FP10058; HICKOK LG, 1983, CAN J BOT, V61, P888, DOI 10.1139/b83-098; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lin BL, 2005, J EXP BOT, V56, P2935, DOI 10.1093/jxb/eri290; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; MEIDNER H, 1965, BIOL REV, V40, P483, DOI 10.1111/j.1469-185X.1965.tb00813.x; MITTELHEUSER CJ, 1969, NATURE, V221, P281, DOI 10.1038/221281a0; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pieruschka R, 2010, P NATL ACAD SCI USA, V107, P13372, DOI 10.1073/pnas.0913177107; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; REYNOLDS TL, 1993, J EXP BOT, V44, P1771, DOI 10.1093/jxb/44.12.1771; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sharpe P. J. H., 1987, STOMATAL FUNCTION, P92; Shope JC, 2008, PLANT CELL ENVIRON, V31, P1290, DOI 10.1111/j.1365-3040.2008.01844.x; TARDIEU F, 1993, PLANT CELL ENVIRON, V16, P341, DOI 10.1111/j.1365-3040.1993.tb00880.x	32	287	298	9	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					582	585		10.1126/science.1197985	http://dx.doi.org/10.1126/science.1197985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21163966				2022-12-24	WOS:000286933600053
J	Lewis, SL; Brando, PM; Phillips, OL; van der Heijden, GMF; Nepstad, D				Lewis, Simon L.; Brando, Paulo M.; Phillips, Oliver L.; van der Heijden, Geertje M. F.; Nepstad, Daniel			The 2010 Amazon Drought	SCIENCE			English	Article							DEFORESTATION		[Lewis, Simon L.; Phillips, Oliver L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Brando, Paulo M.; Nepstad, Daniel] Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; [Brando, Paulo M.] Woods Hole Res Ctr, Falmouth, MA 02450 USA; [van der Heijden, Geertje M. F.] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; Woods Hole Research Center; University of Sheffield	Lewis, SL (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk	Brando, Paulo/AAC-9396-2019; Phillips, Oliver/A-1523-2011; Brando, Paulo M/C-4302-2012; van der Heijden, Geertje/AAB-4102-2019	Brando, Paulo/0000-0001-8952-7025; Phillips, Oliver/0000-0002-8993-6168; Brando, Paulo M/0000-0001-8952-7025; van der Heijden, Geertje/0000-0002-2110-5173; Lewis, Simon/0000-0002-8066-6851	NERC [NE/D01025X/1, NE/I02982X/1, NE/D010306/1] Funding Source: UKRI; Natural Environment Research Council [NE/B504630/1, NE/D010306/1, NE/D01025X/1, NE/I02982X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Nogueira EM, 2008, FOREST ECOL MANAG, V255, P2963, DOI 10.1016/j.foreco.2008.02.002; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rammig A, 2010, NEW PHYTOL, V187, P694, DOI 10.1111/j.1469-8137.2010.03318.x	7	776	805	8	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					554	554		10.1126/science.1200807	http://dx.doi.org/10.1126/science.1200807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292971				2022-12-24	WOS:000286933600045
J	Egan, DF; Shackelford, DB; Mihaylova, MM; Gelino, S; Kohnz, RA; Mair, W; Vasquez, DS; Joshi, A; Gwinn, DM; Taylor, R; Asara, JM; Fitzpatrick, J; Dillin, A; Viollet, B; Kundu, M; Hansen, M; Shaw, RJ				Egan, Daniel F.; Shackelford, David B.; Mihaylova, Maria M.; Gelino, Sara; Kohnz, Rebecca A.; Mair, William; Vasquez, Debbie S.; Joshi, Aashish; Gwinn, Dana M.; Taylor, Rebecca; Asara, John M.; Fitzpatrick, James; Dillin, Andrew; Viollet, Benoit; Kundu, Mondira; Hansen, Malene; Shaw, Reuben J.			Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy	SCIENCE			English	Article							CATALYTIC SUBUNIT; AUTOPHAGY; COMPLEX; ROLES; METABOLISM; DOMAINS; TARGET; LIVER	Adenosine monophosphate-activated protein kinase (AMPK) is a conserved sensor of intracellular energy activated in response to low nutrient availability and environmental stress. In a screen for conserved substrates of AMPK, we identified ULK1 and ULK2, mammalian orthologs of the yeast protein kinase Atg1, which is required for autophagy. Genetic analysis of AMPK or ULK1 in mammalian liver and Caenorhabditis elegans revealed a requirement for these kinases in autophagy. In mammals, loss of AMPK or ULK1 resulted in aberrant accumulation of the autophagy adaptor p62 and defective mitophagy. Reconstitution of ULK1-deficient cells with a mutant ULK1 that cannot be phosphorylated by AMPK revealed that such phosphorylation is required for mitochondrial homeostasis and cell survival during starvation. These findings uncover a conserved biochemical mechanism coupling nutrient status with autophagy and cell survival.	[Egan, Daniel F.; Shackelford, David B.; Mihaylova, Maria M.; Kohnz, Rebecca A.; Mair, William; Vasquez, Debbie S.; Gwinn, Dana M.; Taylor, Rebecca; Dillin, Andrew; Shaw, Reuben J.] Salk Inst Biol Studies, Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Dillin, Andrew; Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Fitzpatrick, James] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Gelino, Sara; Hansen, Malene] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Joshi, Aashish; Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Viollet, Benoit] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016,UMR 8104, Paris, France	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Fitzpatrick, James/C-2268-2009; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Mihaylova, Maria M./ACZ-4949-2022; Kundu, Mondira/N-8139-2018	Fitzpatrick, James/0000-0002-7907-3602; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Mihaylova, Maria M./0000-0002-2725-767X; Kundu, Mondira/0000-0001-9946-2472; Taylor, Rebecca/0000-0003-3429-3123; Mair, William/0000-0002-0661-1342	CMG; NIH [R01 DK080425, 1P01CA120964]; National Cancer Institute [P30CA014195]; American Cancer Society; American Diabetes Association [1-08-JF-47]; Howard Hughes Medical Institute; NHBLI [K08]; Burroughs Welcome Fund; American Lebanese Syrian Association; Agence Nationale de la Recherche (ANR); Ellison Medical Foundation; Helmsley Charitable Trust;  [T32 CA009370];  [5P30CA006516-43];  [1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195, T32CA009370, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	CMG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHBLI; Burroughs Welcome Fund(Burroughs Wellcome Fund); American Lebanese Syrian Association; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Gerken for mouse colony assistance, F. Esterman for confocal assistance, C. Chu for assistance in scoring LGG-1 assays, M. Wood at The Scripps Research Institute EM facility, X. Yang in the Beth Israel Deaconess Medical Center mass spectometry facility, R. Chitta from St. Jude's proteomic core, and K. Lamia for comments on the manuscript. D.F.E., D.M.G., and M.M.M. were supported through the T32 CMG training grant to the UCSD-Salk Biological Sciences Graduate Program. D.B.S. was funded by T32 CA009370 to the Salk Institute Center for Cancer Research. R.J.S. is funded by the NIH grants R01 DK080425 and 1P01CA120964, National Cancer Institute grant P30CA014195, an American Cancer Society Research Scholar Award, the American Diabetes Association Junior Faculty Award 1-08-JF-47, and a Howard Hughes Medical Institute Early Career Scientist Award. J.M.A. is supported by grants 5P30CA006516-43 and 1P01CA120964-01A. M.K. is funded by grant NHBLI K08, Burroughs Welcome Fund, and the American Lebanese Syrian Association. B.V. is supported by Agence Nationale de la Recherche (ANR). M.H. is an Ellison Medical Foundation New Scholar in Aging. We also thank the Leona M. and Harry B. Helmsley Charitable Trust for their generous support. Several of the authors (D.F.E., D.B.S., M.M.M, and R.J.S.) have filed a patent related to this work (U.S. patent application 61/325361).	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781	32	1756	1841	14	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					456	461		10.1126/science.1196371	http://dx.doi.org/10.1126/science.1196371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21205641	Green Accepted			2022-12-24	WOS:000286635900052
J	Horie, T; Shinki, R; Ogura, Y; Kusakabe, TG; Satoh, N; Sasakura, Y				Horie, Takeo; Shinki, Ryoko; Ogura, Yosuke; Kusakabe, Takehiro G.; Satoh, Nori; Sasakura, Yasunori			Ependymal cells of chordate larvae are stem-like cells that form the adult nervous system	NATURE			English	Article							ASCIDIAN CIONA-INTESTINALIS; ORIGIN; EXPRESSION; PLACODES; GENES; BRAIN; IDENTIFICATION; TRANSGENESIS; NETWORKS; INSIGHTS	In ascidian tunicates, the metamorphic transition from larva to adult is accompanied by dynamic changes in the body plan. For instance, the central nervous system (CNS) is subjected to extensive rearrangement because its regulating larval organs are lost and new adult organs are created(1). To understand how the adult CNS is reconstructed, we traced the fate of larval CNS cells during ascidian metamorphosis by using transgenic animals and imaging technologies with photoconvertible fluorescent proteins(2). Here we show that most parts of the ascidian larval CNS, except for the tail nerve cord, are maintained during metamorphosis and recruited to form the adult CNS. We also show that most of the larval neurons disappear and only a subset of cholinergic motor neurons and glutamatergic neurons are retained. Finally, we demonstrate that ependymal cells of the larval CNS contribute to the construction of the adult CNS and that some differentiate into neurons in the adult CNS. An unexpected role of ependymal cells highlighted by this study is that they serve as neural stem-like cells to reconstruct the adult nervous network during chordate metamorphosis. Consequently, the plasticity of non-neuronal ependymal cells and neuronal cells in chordates should be re-examined by future studies(3,4).	[Horie, Takeo; Shinki, Ryoko; Ogura, Yosuke; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Kusakabe, Takehiro G.] Konan Univ, Dept Biol, Kobe, Hyogo 6588501, Japan; [Satoh, Nori] Sci & Technol Promot Corp, Okinawa Inst, Marine Genom Unit, Okinawa 9040412, Japan	University of Tsukuba; Konan University	Horie, T (corresponding author), Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan.	horie@kurofune.shimoda.tsukuba.ac.jp	Satoh, Nori/C-4123-2009; Horie, Takeo/AAN-6967-2020; Kusakabe, Takehiro/H-7178-2012	Satoh, Nori/0000-0002-4480-3572; Horie, Takeo/0000-0002-4843-3775; Kusakabe, Takehiro/0000-0002-8325-3665; Ogura, Yosuke/0000-0002-5251-9176	Japan Society for the Promotion of Science; MEXT; National Institute of Genetics; Grants-in-Aid for Scientific Research [22310120] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Genetics; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge the members of the Shimoda Marine Research Center at the University of Tsukuba for their cooperation with our study. We also thank National Bio-resource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), S. Fujiwara and all members of the Maizuru Fishery Research Station of Kyoto University and the Education and Research Center of Marine Bioresources of Tohoku University for providing us with Ciona adults, and C. Savakis for providing Minos. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and MEXT to T.H., T.G.K., N.S. and Y.S. Y.S. was supported by the National Institute of Genetics Cooperative Research Program.	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Cole AG, 2004, DEV BIOL, V271, P239, DOI 10.1016/j.ydbio.2004.04.001; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Gilbert SF, 2006, DEV BIOL; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; Horie T, 2009, DEV GROWTH DIFFER, V51, P207, DOI 10.1111/j.1440-169X.2009.01105.x; Hozumi A, 2010, DEV DYNAM, V239, P1076, DOI 10.1002/dvdy.22254; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai KS, 2009, DEVELOPMENT, V136, P285, DOI 10.1242/dev.026419; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; KATZ MJ, 1983, BIOL BULL-US, V164, P1, DOI 10.2307/1541186; Konno A, 2010, DEV BIOL, V337, P42, DOI 10.1016/j.ydbio.2009.10.012; Kusakabe T, 2004, DEV BIOL, V276, P563, DOI 10.1016/j.ydbio.2004.09.037; Manni L, 2005, J EXP ZOOL PART B, V304B, P324, DOI 10.1002/jez.b.21039; Manni L, 2004, J EXP ZOOL PART B, V302B, P483, DOI 10.1002/jez.b.21013; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; Moret F, 2005, DEV BIOL, V277, P567, DOI 10.1016/j.ydbio.2004.11.004; NICOL D, 1991, J COMP NEUROL, V309, P415, DOI 10.1002/cne.903090402; Nielsen C, 2005, EVOL DEV, V7, P483, DOI 10.1111/j.1525-142X.2005.05051.x; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Takamura K, 2002, DEV GENES EVOL, V212, P50, DOI 10.1007/s00427-001-0205-0; Tarallo R, 2004, DEV DYNAM, V230, P251, DOI 10.1002/dvdy.20055; Tsuda M, 2003, VISION RES, V43, P3045, DOI 10.1016/j.visres.2003.09.012; Wada H, 1998, DEVELOPMENT, V125, P1113; Yoshida R, 2004, GENESIS, V39, P130, DOI 10.1002/gene.20032	33	62	63	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					525	U256		10.1038/nature09631	http://dx.doi.org/10.1038/nature09631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21196932				2022-12-24	WOS:000286596500031
J	Sengupta, S; Peterson, TR; Laplante, M; Oh, S; Sabatini, DM				Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.			mTORC1 controls fasting-induced ketogenesis and its modulation by ageing	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; RAT-LIVER; MICE; IDENTIFICATION; GENES	The multi-component mechanistic target of rapamycin complex 1 (mTORC1) kinase is the central node of a mammalian pathway that coordinates cell growth with the availability of nutrients, energy and growth factors(1). Progress has been made in the identification of mTORC1 pathway components and in understanding their functions in cells, but there is relatively little known about the role of the pathway in vivo. Specifically, we have little knowledge regarding the role mTOCR1 has in liver physiology. In fasted animals, the liver performs numerous functions that maintain whole-body homeostasis, including the production of ketone bodies for peripheral tissues to use as energy sources. Here we show that mTORC1 controls ketogenesis in mice in response to fasting. We find that liver-specific loss of TSC1 (tuberous sclerosis 1), an mTORC1 inhibitor(1), leads to a fasting-resistant increase in liver size, and to a pronounced defect in ketone body production and ketogenic gene expression on fasting. The loss of raptor (regulatory associated protein of mTOR, complex 1) an essential mTORC1 component(1), has the opposite effects. In addition, we find that the inhibition of mTORC1 is required for the fasting-induced activation of PPAR alpha (peroxisome proliferator activated receptor alpha), the master transcriptional activator of ketogenic genes(2), and that suppression of NCoR1 (nuclear receptor co-repressor 1), a co-repressor of PPAR alpha(3), reactivates ketogenesis in cells and livers with hyperactive mTORC1 signalling. Like livers with activated mTORC1, livers from aged mice have a defect in ketogenesis(4,5), which correlates with an increase in mTORC1 signalling. Moreover, we show that the suppressive effects of mTORC1 activation and ageing on PPAR alpha activity and ketone production are not additive, and that mTORC1 inhibition is sufficient to prevent the ageing-induced defect in ketogenesis. Thus, our findings reveal that mTORC1 is a key regulator of PPAR alpha function and hepatic ketogenesis and suggest a role for mTORC1 activity in promoting the ageing of the liver.	[Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Oh, Stephanie/0000-0002-6287-9116	American Diabetes Association; Ludwig Cancer Fund; Canadian Institutes of Health Research; NIH [CA103866, CA129105]; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Ludwig Cancer Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Biddinger and C. R. Kahn for providing the Ir<SUP>loxP/loxP</SUP> and Li-Ir<SUP>KO</SUP> mice; D. Kwiatkowski for the Tsc1<SUP>loxP/loxP</SUP> mice; R. Zoncu for assistance with imaging experiments and image analysis; F. Reinhardt for assistance in animal virus injections; and T. Jacks, L. Guarente, V. Mootha and members of the Sabatini laboratory for support and discussions. This research was supported by fellowships from the American Diabetes Association and Ludwig Cancer Fund to T. R. P.; a fellowship from the Canadian Institutes of Health Research to M. L.; and NIH grants CA103866 and CA129105 to D. M. S. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Faraj M, 2004, AM J PHYSIOL-ENDOC M, V287, pE150, DOI 10.1152/ajpendo.00398.2003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Glass CK, 2000, GENE DEV, V14, P121; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; MCGARRY JD, 1973, J BIOL CHEM, V248, P270; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Osoegawa K, 2000, GENOME RES, V10, P116; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283	30	439	447	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1100	U502		10.1038/nature09584	http://dx.doi.org/10.1038/nature09584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179166				2022-12-24	WOS:000285553800058
J	Hellal, F; Hurtado, A; Ruschel, J; Flynn, KC; Laskowski, CJ; Umlauf, M; Kapitein, LC; Strikis, D; Lemmon, V; Bixby, J; Hoogenraad, CC; Bradke, F				Hellal, Farida; Hurtado, Andres; Ruschel, Joerg; Flynn, Kevin C.; Laskowski, Claudia J.; Umlauf, Martina; Kapitein, Lukas C.; Strikis, Dinara; Lemmon, Vance; Bixby, John; Hoogenraad, Casper C.; Bradke, Frank			Microtubule Stabilization Reduces Scarring and Causes Axon Regeneration After Spinal Cord Injury	SCIENCE			English	Article							TGF-BETA; FUNCTIONAL RECOVERY; GROWTH; PROLIFERATION; INHIBITION; ELEVATION; CAMP; CNS	Hypertrophic scarring and poor intrinsic axon growth capacity constitute major obstacles for spinal cord repair. These processes are tightly regulated by microtubule dynamics. Here, moderate microtubule stabilization decreased scar formation after spinal cord injury in rodents through various cellular mechanisms, including dampening of transforming growth factor-beta signaling. It prevented accumulation of chondroitin sulfate proteoglycans and rendered the lesion site permissive for axon regeneration of growth-competent sensory neurons. Microtubule stabilization also promoted growth of central nervous system axons of the Raphe-spinal tract and led to functional improvement. Thus, microtubule stabilization reduces fibrotic scarring and enhances the capacity of axons to grow.	[Hellal, Farida; Ruschel, Joerg; Flynn, Kevin C.; Laskowski, Claudia J.; Umlauf, Martina; Bradke, Frank] Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, D-82152 Martinsried, Germany; [Hurtado, Andres] Johns Hopkins Univ, Hugo W Moser Res Inst Kennedy Krieger, Int Ctr Spinal Cord Injury, Dept Neurol, Baltimore, MD 21205 USA; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Strikis, Dinara; Lemmon, Vance; Bixby, John] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	Max Planck Society; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; University of Miami	Bradke, F (corresponding author), Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, Klopferspitz 18, D-82152 Martinsried, Germany.	fbradke@neuro.mpg.de	Hellal, Farida/E-8533-2013; Hellal, Farida/AHC-2588-2022; Lemmon, Vance/A-7410-2010; Hoogenraad, Casper/B-8866-2011; Hellal, Farida/D-1834-2015; Kapitein, Lukas C/J-4776-2016	Hellal, Farida/0000-0002-9344-1846; Lemmon, Vance/0000-0003-3550-7576; Hoogenraad, Casper/0000-0002-2666-0758; Hellal, Farida/0000-0002-9344-1846; Kapitein, Lukas C/0000-0001-9418-6739; Bixby, John/0000-0003-1633-5318; Bradke, Frank/0000-0002-0345-3772; Ruschel, Joerg/0000-0002-4782-9786	Max-Planck-Society; Deutsche Forschungsgemeinschaft; International Foundation for Paraplegia; Human Frontier Science Program; NIH; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMW)-TOP; European Science Foundation; NWO-VICI; Marie Curie Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Foundation for Paraplegia; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMW)-TOP(Netherlands Organization for Health Research and Development); European Science Foundation(European Science Foundation (ESF)European Commission); NWO-VICI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Fellowship(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Hill for the SMAD2-PAGFP plasmid; A. Ullrich for the HaCaT cells; Ariad Pharmaceuticals for FKBP/FRB plasmids and Rapalog; G. Morfini for technical advice; K. Dornmair, M. Hubener, R. Klein, D. Neukirchen, M. Stiess, S. Tahirovic, and H. Wekerle for critically reading the manuscript; and V. Ha, T. Irl, D. F. Wendell, and R. Zenke for technical assistance. This work was supported by the Max-Planck-Society, Deutsche Forschungsgemeinschaft, International Foundation for Paraplegia, and Human Frontier Science Program (F.B.); NIH (J.B.); Netherlands Organization for Scientific Research (NWO)-Veni (L.C.K.); Netherlands Organization for Health Research and Development (ZonMW)-TOP, European Science Foundation Young Investigator Award, and NWO-VICI (C.C.H.); and a Marie Curie Fellowship (K.C.F.). The Max-Planck-Society has filed a patent on the use of Taxol after spinal cord injury.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Dergham P, 2002, J NEUROSCI, V22, P6570; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017	28	416	430	7	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					928	931		10.1126/science.1201148	http://dx.doi.org/10.1126/science.1201148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21273450	Green Accepted, Green Published			2022-12-24	WOS:000287455100062
J	Lim, C; Lee, J; Choi, C; Kilman, VL; Kim, J; Park, SM; Jang, SK; Allada, R; Choe, J				Lim, Chunghun; Lee, Jongbin; Choi, Changtaek; Kilman, Valerie L.; Kim, Juwon; Park, Sung Mi; Jang, Sung Key; Allada, Ravi; Choe, Joonho			The novel gene twenty-four defines a critical translational step in the Drosophila clock	NATURE			English	Article							MESSENGER-RNA TRANSLATION; CIRCADIAN-RHYTHMS; BINDING-PROTEIN; PERIOD PROTEIN; MOLECULAR OSCILLATIONS; EXPRESSION; NEURONS; SYSTEM; ABLATION; ORANGE	Daily oscillations of gene expression underlie circadian behaviours in multicellular organisms(1). While attention has been focused on transcriptional and post-translational mechanisms(1-3), other post-transcriptional modes have been less clearly delineated. Here we report mutants of a novel Drosophila gene twenty-four (tyf) that show weak behavioural rhythms. Weak rhythms are accompanied by marked reductions in the levels of the clock protein Period (PER) as well as more modest effects on Timeless (TIM). Nonetheless, PER induction in pacemaker neurons can rescue tyf mutant rhythms. TYF associates with a 5'-cap-binding complex, poly(A)-binding protein (PABP), as well as per and tim transcripts. Furthermore, TYF activates reporter expression when tethered to reporter messenger RNA even in vitro. Taken together, these data indicate that TYF potently activates PER translation in pacemaker neurons to sustain robust rhythms, revealing a new and important role for translational control in the Drosophila circadian clock.	[Lim, Chunghun; Kilman, Valerie L.; Allada, Ravi] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lee, Jongbin; Choi, Changtaek; Kim, Juwon; Choe, Joonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Sung Mi; Jang, Sung Key] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Northwestern University; Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH)	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu; jchoe@kaist.ac.kr	Lim, Chunghun/AAB-1253-2020; Jang, Sung K/P-1230-2017; Choe, Joonho/F-3066-2011	Lim, Chunghun/0000-0001-8473-9272; Lee, Jongbin/0000-0002-5868-7437	Ministry of Education, Science and Technology, the Republic of Korea; National Institutes of Health [R01NS059042, R01NS052903, R01MH067870]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059042, R01NS052903] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Edery, J. Hall, H. Keshishian, M. Rosbash, F. Rouyer, A. Sehgal, the Bloomington Drosophila stock center, Harvard Exelixis Drosophila stock collection, KAIST GenExel Drosophila library and the National Institute of Genetics for Drosophila strains; P. Hardin, E. Izaurralde, A. Nakamura, M. Rosbash and N. Sonenberg for antibodies; J. Lykke-Andersen for plasmids; K. E. Duncan for suggestions on in vitro translation assays. This work was supported by grants from the Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, the Republic of Korea (J.C.) and from the National Institutes of Health (R01NS059042, R01NS052903, R01MH067870; R.A.)	Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Castagnetti S, 2000, DEVELOPMENT, V127, P1063; Cheng YZ, 1998, MOL CELL BIOL, V18, P6505, DOI 10.1128/MCB.18.11.6505; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Keryer-Bibens C, 2008, BIOL CELL, V100, P125, DOI 10.1042/BC20070067; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suri V, 2000, J NEUROSCI, V20, P7547; Thoma Christian, 2004, Methods Mol Biol, V257, P171, DOI 10.1385/1-59259-750-5:171; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	51	63	64	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					399	U152		10.1038/nature09728	http://dx.doi.org/10.1038/nature09728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331043	Green Accepted			2022-12-24	WOS:000287409100043
J	Bock, C; Kiskinis, E; Verstappen, G; Gu, HC; Boulting, G; Smith, ZD; Ziller, M; Croft, GF; Amoroso, MW; Oakley, DH; Gnirke, A; Eggan, K; Meissner, A				Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Gu, Hongcang; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Gnirke, Andreas; Eggan, Kevin; Meissner, Alexander			Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines	CELL			English	Article							EMBRYONIC STEM-CELLS; METHYLATION; DIFFERENTIATION; DERIVATION; MOUSE; BIOINFORMATICS; GENERATION; BIOLOGY	The developmental potential of human pluripotent stem cells suggests that they can produce disease-relevant cell types for biomedical research. However, substantial variation has been reported among pluripotent cell lines, which could affect their utility and clinical safety. Such cell-line-specific differences must be better understood before one can confidently use embryonic stem (ES) or induced pluripotent stem (iPS) cells in translational research. Toward this goal we have established genome-wide reference maps of DNA methylation and gene expression for 20 previously derived human ES lines and 12 human iPS cell lines, and we have measured the in vitro differentiation propensity of these cell lines. This resource enabled us to assess the epigenetic and transcriptional similarity of ES and iPS cells and to predict the differentiation efficiency of individual cell lines. The combination of assays yields a scorecard for quick and comprehensive characterization of pluripotent cell lines.	[Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Eggan, Kevin; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Verstappen, Griet; Gu, Hongcang; Smith, Zachary D.; Ziller, Michael; Gnirke, Andreas; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Eggan, Kevin; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Kiskinis, Evangelos; Boulting, Gabriella; Eggan, Kevin] Howard Hughes Med Inst, Chevy Chase, MD USA; [Boulting, Gabriella] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Pathol, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Neurol, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Neurosci, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, CSCI, New York, NY 10032 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; Howard Hughes Medical Institute; Harvard University; Columbia University; Columbia University; Columbia University; Columbia University	Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu; alexander_meissner@harvard.edu	Bock, Christoph/AAE-7618-2019; Oakley, Derek/ABA-4689-2020; Eggan, Kevin/P-7119-2018	Bock, Christoph/0000-0001-6091-3088; Oakley, Derek/0000-0002-6998-9510; Gu, Hongcang/0000-0002-1439-7606; Croft, Gist/0000-0002-9721-0148; Boulting, Gabriella/0000-0003-2012-1259; Mathis, Mackenzie/0000-0001-7368-4456	Alexander von Humboldt Foundation; NIH Roadmap Initiative on Epigenomics [U01ES017155]; Massachusetts Life Science Center (MLSC); Pew Charitable Trusts; Harvard Research Computing team; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042191] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NIH Roadmap Initiative on Epigenomics; Massachusetts Life Science Center (MLSC); Pew Charitable Trusts; Harvard Research Computing team; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Christopher Henderson and Hynek Wichterle (Columbia University Motor Neuron Center, Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research) for sharing fibroblast and iPS cell lines prior to publication and for many helpful discussions. We would also like to thank Tarjei Mikkelsen, Eleni Tomazou, Chad Cowan, Leon Plastek, and Tim Ahfeldt for their involvement in early pilot experiments; Patrick Boyle for technical assistance; the Harvard Research Computing team for support and computation time on the Odyssey cluster; and the members of the Eggan and Meissner labs for their comments on the manuscript. Furthermore, we acknowledge the members of the Broad Institute's Genome Sequencing Platform, Genetic Analysis Platform, and Epigenomics Initiative, including Ido Amit, Fontina Kelley, Kathleen Tibbetts, Tim Fennell, Supriya Gupta, Andrew Crenshaw, Charles Epstein, and Brad Bernstein. C. B. is supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation. E. K. is a fellow of the European Molecular Biology Organization. K. E. is an assistant investigator of the Stowers Medical Institute, a Howard Hughes Medical Institute early career scientist, and fellow of the MacArthur Foundation. The described work was funded by the NIH Roadmap Initiative on Epigenomics (U01ES017155), the Massachusetts Life Science Center (MLSC), and the Pew Charitable Trusts. A patent has been filed for the scorecard described in the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nistri A, 2006, J PHYSIOL-LONDON, V572, P323, DOI 10.1113/jphysiol.2005.100610; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tukey JW, 1977, EXPLORATORY DATA ANA; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	46	690	731	3	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					439	452		10.1016/j.cell.2010.12.032	http://dx.doi.org/10.1016/j.cell.2010.12.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295703	Green Accepted, Bronze			2022-12-24	WOS:000286973100015
J	Coudreuse, D; Nurse, P				Coudreuse, Damien; Nurse, Paul			Driving the cell cycle with a minimal CDK control network	NATURE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; B-TYPE CYCLIN; FISSION YEAST; S-PHASE; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; DEPENDENT KINASES; GENETIC-ANALYSIS; DNA-REPLICATION; MITOTIC CONTROL	Control of eukaryotic cell proliferation involves an extended regulatory network, the complexity of which has made it difficult to understand the basic principles of the cell cycle. To investigate the core engine of the mitotic cycle we have generated a minimal control network in fission yeast that efficiently sustains cellular reproduction. Here we demonstrate that orderly progression through the major events of the cell cycle can be driven by oscillation of an engineered monomolecular cyclin-dependent protein kinase (CDK) module lacking much of the canonical regulation. We show further that the CDK oscillator acts as the primary organizer of the cell cycle, imposing timing and directionality to a system of two CDK activity thresholds that define independent cell cycle phases. We propose that this simple core architecture forms the basic control of the eukaryotic cell cycle.	[Coudreuse, Damien; Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA	Rockefeller University	Coudreuse, D (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	dcoudreuse@rockefeller.edu		Coudreuse, Damien/0000-0003-2534-1621	EMBO [ALTF 899-2007]; Human Frontier Science Program [LT00623/2008]; Breast Cancer Research Foundation; Rockefeller University; Anderson Cancer Center Research at Rockefeller University	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Breast Cancer Research Foundation; Rockefeller University; Anderson Cancer Center Research at Rockefeller University	We thank J. Hayles, P.-Y. Wu and F. Navarro for critically reading the manuscript, and N. Rhind for the anti-Cds1 antibody. D. C. was supported by post-doctoral fellowships from EMBO (ALTF 899-2007) and the Human Frontier Science Program (LT00623/2008) and P. N. by the Breast Cancer Research Foundation, The Rockefeller University and the Anderson Cancer Center Research at Rockefeller University.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BOOHER RN, 1989, CELL, V58, P485, DOI 10.1016/0092-8674(89)90429-7; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; Buck V, 1995, EMBO J, V14, P6173, DOI 10.1002/j.1460-2075.1995.tb00308.x; BUENO A, 1991, CELL, V66, P149, DOI 10.1016/0092-8674(91)90147-Q; CorreaBordes J, 1997, EMBO J, V16, P4657, DOI 10.1093/emboj/16.15.4657; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Decottignies A, 2001, J CELL SCI, V114, P2627; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; DENHAESE GJ, 1995, MOL BIOL CELL, V6, P371, DOI 10.1091/mbc.6.4.371; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; FORSBURG SL, 1991, NATURE, V351, P245, DOI 10.1038/351245a0; FORSBURG SL, 1994, J CELL SCI, V107, P601; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Martin-Castellanos C, 1996, EMBO J, V15, P839, DOI 10.1002/j.1460-2075.1996.tb00419.x; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OBARAISHIHARA T, 1994, EMBO J, V13, P1863, DOI 10.1002/j.1460-2075.1994.tb06455.x; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rhind N, 1998, MOL CELL BIOL, V18, P3782, DOI 10.1128/MCB.18.7.3782; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SAZER S, 1990, J CELL SCI, V97, P509; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Snaith HA, 1999, GENETICS, V152, P839; Stern B, 1996, TRENDS GENET, V12, P345; Tanaka K, 2000, MOL BIOL CELL, V11, P2845, DOI 10.1091/mbc.11.9.2845; THURIAUX P, 1980, J GEN MICROBIOL, V116, P525; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; WOODS A, 1989, J CELL SCI, V93, P491; Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Zarzov P, 2002, EMBO J, V21, P3370, DOI 10.1093/emboj/cdf346	67	264	269	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1074	U474		10.1038/nature09543	http://dx.doi.org/10.1038/nature09543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179163				2022-12-24	WOS:000285553800052
J	Chen, SD; Zhang, YE; Long, MY				Chen, Sidi; Zhang, Yong E.; Long, Manyuan			New Genes in Drosophila Quickly Become Essential	SCIENCE			English	Article							EVOLUTION; MELANOGASTER; GENOME; MOUSE; DIVERGENCE; PHYLOGENY; DUPLICATE; INSIGHTS; ORIGIN	To investigate the origin and evolution of essential genes, we identified and phenotyped 195 young protein-coding genes, which originated 3 to 35 million years ago in Drosophila. Knocking down expression with RNA interference showed that 30% of newly arisen genes are essential for viability. The proportion of genes that are essential is similar in every evolutionary age group that we examined. Under constitutive silencing of these young essential genes, lethality was high in the pupal stage and also found in the larval stages. Lethality was attributed to diverse cellular and developmental defects, such as organ formation and patterning defects. These data suggest that new genes frequently and rapidly evolve essential functions and participate in development.	[Chen, Sidi; Zhang, Yong E.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	mlong@uchicago.edu	Zhang, Yong E./AAC-8610-2019; Zhang, Yong/A-7855-2011; CHEN, SIDI/D-8284-2016	Zhang, Yong E./0000-0003-3770-2383; CHEN, SIDI/0000-0002-3819-5005	University of Chicago Biological Sciences Division; National Institutes of Health [R01GM065429-01A1, R01GM078070-01A1]; National Science Foundation [MCB 0238168]; Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065429, R01GM078070] Funding Source: NIH RePORTER	University of Chicago Biological Sciences Division(University of Chicago); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. H. Langley and D. Begun for providing polymorphism data; W. Du, J. Gavin-Smyth, Q. Guo, and M. Guffey for technical assistance and discussion; J. Coyne, M. Kreitman, and X. Ni for critically reading and/or revising the manuscript; and the members of the Manyuan Long laboratory, C. Ferguson, R. Hudson, C. I. Wu, and T. Nagylaki, for valuable discussion. S. C. was supported by University of Chicago Biological Sciences Division Fellowships. This research was supported by National Institutes of Health (R01GM065429-01A1 and R01GM078070-01A1) and National Science Foundation (CAREER Award MCB 0238168) to M. L. Y.E.Z. was also supported by the Searle Funds from Chicago Biomedical Consortium (2009, Spark).	Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gauhar Z., 2008, COMMUNICATION; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Ida H, 2009, NUCLEIC ACIDS RES, V37, P1423, DOI 10.1093/nar/gkn1068; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; Joppich C, 2009, CHROMOSOME RES, V17, P19, DOI 10.1007/s10577-008-9002-1; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keleman K, 2009, COMMUNICATION; Kilpatrick S. T., 2009, LEWINS ESSENTIAL GEN; Kreitman M, 1999, CURR OPIN GENET DEV, V9, P637, DOI 10.1016/S0959-437X(99)00034-9; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lynch M, 2001, GENETICS, V159, P1789; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Perrimon N, 1996, GENETICS, V144, P1681; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Su ZX, 2008, J MOL EVOL, V67, P705, DOI 10.1007/s00239-008-9170-9; WALSH JB, 1995, GENETICS, V139, P421; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041	28	204	214	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1682	1685		10.1126/science.1196380	http://dx.doi.org/10.1126/science.1196380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164016	Green Accepted			2022-12-24	WOS:000285390500068
J	Kharchenko, PV; Alekseyenko, AA; Schwartz, YB; Minoda, A; Riddle, NC; Ernst, J; Sabo, PJ; Larschan, E; Gorchakov, AA; Gu, TT; Linder-Basso, D; Plachetka, A; Shanower, G; Tolstorukov, MY; Luquette, LJ; Xi, RB; Jung, YL; Park, RW; Bishop, EP; Canfield, TK; Sandstrom, R; Thurman, RE; MacAlpine, DM; Stamatoyannopoulos, JA; Kellis, M; Elgin, SCR; Kuroda, MI; Pirrotta, V; Karpen, GH; Park, PJ				Kharchenko, Peter V.; Alekseyenko, Artyom A.; Schwartz, Yuri B.; Minoda, Aki; Riddle, Nicole C.; Ernst, Jason; Sabo, Peter J.; Larschan, Erica; Gorchakov, Andrey A.; Gu, Tingting; Linder-Basso, Daniela; Plachetka, Annette; Shanower, Gregory; Tolstorukov, Michael Y.; Luquette, Lovelace J.; Xi, Ruibin; Jung, Youngsook L.; Park, Richard W.; Bishop, Eric P.; Canfield, Theresa K.; Sandstrom, Richard; Thurman, Robert E.; MacAlpine, David M.; Stamatoyannopoulos, John A.; Kellis, Manolis; Elgin, Sarah C. R.; Kuroda, Mitzi I.; Pirrotta, Vincenzo; Karpen, Gary H.; Park, Peter J.			Comprehensive analysis of the chromatin landscape in Drosophila melanogaster	NATURE			English	Article							HISTONE MODIFICATIONS; GENE-EXPRESSION; HUMAN GENOME; SHORT RNAS; DNASE-I; TRANSCRIPTION; POLYCOMB; SEQUENCE; ENHANCERS; COHESIN	Chromatin is composed of DNA and a variety of modified histones and non-histone proteins, which have an impact on cell differentiation, gene regulation and other key cellular processes. Here we present a genome-wide chromatin landscape for Drosophila melanogaster based on eighteen histone modifications, summarized by nine prevalent combinatorial patterns. Integrative analysis with other data (non-histone chromatin proteins, DNase I hypersensitivity, GRO-Seq reads produced by engaged polymerase, short/long RNA products) reveals discrete characteristics of chromosomes, genes, regulatory elements and other functional domains. We find that active genes display distinct chromatin signatures that are correlated with disparate gene lengths, exon patterns, regulatory functions and genomic contexts. We also demonstrate a diversity of signatures among Polycomb targets that include a subset with paused polymerase. This systematic profiling and integrative analysis of chromatin signatures provides insights into how genomic elements are regulated, and will serve as a resource for future experimental investigations of genome structure and function.	[Kharchenko, Peter V.; Tolstorukov, Michael Y.; Luquette, Lovelace J.; Xi, Ruibin; Jung, Youngsook L.; Park, Richard W.; Bishop, Eric P.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Plachetka, Annette; Jung, Youngsook L.; Kuroda, Mitzi I.; Park, Peter J.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Plachetka, Annette; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schwartz, Yuri B.; Linder-Basso, Daniela; Shanower, Gregory; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Minoda, Aki; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Minoda, Aki; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Riddle, Nicole C.; Gu, Tingting; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Ernst, Jason; Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ernst, Jason; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sabo, Peter J.; Canfield, Theresa K.; Sandstrom, Richard; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02906 USA; [Park, Richard W.; Bishop, Eric P.] Boston Univ, Grad Program Bioinformat, Boston, MA 02115 USA; [MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; Brown University; Boston University; Duke University; University of Washington; University of Washington Seattle	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	karpen@fruitfly.org; peter_park@harvard.edu	Kellis, Manolis/ABE-7385-2020; Minoda, Aki/D-5335-2017; Gorchakov, Andrey A/N-5840-2015; Minoda, Aki/Q-4454-2019	Kellis, Manolis/0000-0001-7113-9630; Minoda, Aki/0000-0002-2927-5791; Gorchakov, Andrey A/0000-0003-2830-4236; Minoda, Aki/0000-0002-2927-5791; Xi, Ruibin/0000-0001-7545-7361; Elgin, Sarah C. R./0000-0002-5176-2510; Riddle, Nicole/0000-0003-1827-9145; Sandstrom, Richard/0000-0002-3356-1547; Park, Peter/0000-0001-9378-960X	modENCODE [U01HG004258]; Department of Energy [DE-AC02-05CH11231];  [RC2 HG005639];  [U01 HG004279];  [R01 GM082798];  [R37 GM45744];  [RC1 HG005334];  [R01 GM071923];  [U54 HG004592];  [NSF 0905968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004258, RC1HG005334, U54HG004592, R01HG004037, U01HG004279, RC2HG005639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, R01GM071923, R01GM082798] Funding Source: NIH RePORTER	modENCODE; Department of Energy(United States Department of Energy (DOE)); ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our technicians D. Acevedo, S. Gadel, C. Kennedy, O.-K. Lee, S. Marchetti, S. Vong and M. Weaver, and Rutgers BRTC. We also thank our colleagues who donated antibodies: J. Kadonaga (H1), A. L. Greenleaf (RNA pol II), G. Reuter (SU(VAR)3-9), G. Cavalli (GAF) and I. F. Zhimulev/H. Saumweber (Chromator). The major support for this work came from the modENCODE grant U01HG004258 to G.H.K. (Principal Investigator) and S.C.R.E., M.I.K., P.J.P. and V.P. (co-Principal Investigators), administered under Department of Energy contract no. DE-AC02-05CH11231. Additional funding came from RC2 HG005639, U01 HG004279, R01 GM082798, R37 GM45744, RC1 HG005334, R01 GM071923, U54 HG004592 and NSF 0905968.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anders S, 2009, BIOINFORMATICS, V25, P1231, DOI 10.1093/bioinformatics/btp152; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	46	606	622	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					480	+		10.1038/nature09725	http://dx.doi.org/10.1038/nature09725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21179089	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000288702200055
J	Matsuoka, RL; Nguyen-Ba-Charvet, KT; Parray, A; Badea, TC; Chedotal, A; Kolodkin, AL				Matsuoka, Ryota L.; Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Badea, Tudor C.; Chedotal, Alain; Kolodkin, Alex L.			Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina	NATURE			English	Article							GANGLION-CELLS; PLEXIN-A4; RESPONSES; REQUIREMENT; EXPRESSION; DSCAM	In the vertebrate retina, establishment of precise synaptic connections among distinct retinal neuron cell types is critical for processing visual information and for accurate visual perception. Retinal ganglion cells (RGCs), amacrine cells and bipolar cells establish stereotypic neurite arborization patterns to form functional neural circuits in the inner plexiform layer (IPL)(1-3), a laminar region that is conventionally divided into five major parallel sublaminae(1,2). However, the molecular mechanisms governing distinct retinal subtype targeting to specific sublaminae within the IPL remain to be elucidated. Here we show that the transmembrane semaphorin Sema6A signals through its receptor PlexinA4 (PlexA4) to control lamina-specific neuronal stratification in the mouse retina. Expression analyses demonstrate that Sema6A and PlexA4 proteins are expressed in a complementary fashion in the developing retina: Sema6A in most ON sublaminae and PlexA4 in OFF sublaminae of the IPL. Mice with null mutations in PlexA4 or Sema6A exhibit severe defects in stereotypic lamina-specific neurite arborization of tyrosine hydroxylase (TH)-expressing dopaminergic amacrine cells, intrinsically photosensitive RGCs (ipRGCs) and calbindin-positive cells in the IPL. Sema6A and PlexA4 genetically interact in vivo for the regulation of dopaminergic amacrine cell laminar targeting. Therefore, neuronal targeting to subdivisions of the IPL in the mammalian retina is directed by repulsive transmembrane guidance cues present on neuronal processes.	[Matsuoka, Ryota L.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Badea, Tudor C.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Matsuoka, Ryota L.; Badea, Tudor C.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] INSERM, UMR S968, Inst Vis, F-75012 Paris, France; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] CNRS, UMR 7210, Inst Vis, F-75012 Paris, France	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Chedotal, Alain/F-2750-2017; Nguyen-Ba-Charvet, Kim/J-3507-2017; Matsuoka, Ryota L./K-5439-2019; Badea, Tudor Constantin/B-1654-2018	Chedotal, Alain/0000-0001-7577-3794; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; Matsuoka, Ryota L./0000-0001-6214-2889; Badea, Tudor Constantin/0000-0003-3086-6713	Nakajima Foundation; Fondation pour la Recherche Medicale (FRM); Fondation Retina France; Paris School of Neuroscience (ENP);  [R01 NS35165]; NATIONAL EYE INSTITUTE [ZIAEY000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165, R37NS035165] Funding Source: NIH RePORTER	Nakajima Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Retina France; Paris School of Neuroscience (ENP); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K.-W. Yau for the C-terminal melanopsin antibody, F. Suto for the PlexA4 antibody, B. Howell for the Dab-1 antibody, Y. Yoshida for the PlexA1<SUP>-/-</SUP> eyes, P. Mombaerts for the PlexB1<SUP>-/-</SUP> and PlexB3<SUP>-/-</SUP> mice (unpublished), C. Gu for the PlexD1<SUP>-/flox</SUP>; nestin cre (unpublished) eyes and M. Tessier-Lavigne for the PlexA4<SUP>-/-</SUP> mice. We also thank J. Nathans, S. Hattar, K. Mandai and M. Riccomagno for comments on the manuscript and discussions, and members of the Kolodkin laboratory for assistance. This work was supported by R01 NS35165 to A. L. K., a predoctoral fellowship from the Nakajima Foundation to R. L. M., the Fondation pour la Recherche Medicale (Programme equipe FRM) to A. C., the Fondation Retina France to K. T. N.-B.-C., and a PhD fellowship from the Paris School of Neuroscience (ENP) to A. P. A. L. K. is an investigator of the Howard Hughes Medical Institute.	Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; de Winter F, 2004, INVEST OPHTH VIS SCI, V45, P4554, DOI 10.1167/iovs.04-0173; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	30	149	149	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					259	+		10.1038/nature09675	http://dx.doi.org/10.1038/nature09675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21270798	Green Accepted			2022-12-24	WOS:000287144200044
J	Jones, CE; Naidoo, S; De Beer, C; Esser, M; Kampmann, B; Hesseling, AC				Jones, Christine E.; Naidoo, Shalena; De Beer, Corena; Esser, Monika; Kampmann, Beate; Hesseling, Anneke C.			Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PLACENTAL MALARIA; MEASLES-VIRUS; PERTUSSIS ANTIBODIES; CHILD-MORTALITY; IMMUNIZATION; PREVALENCE; MORBIDITY; AVIDITY; SERUM	Context Altered immune responses might contribute to the high morbidity and mortality observed in human immunodeficiency virus (HIV)-exposed uninfected infants. Objective To study the association of maternal HIV infection with maternal-and infant-specific antibody levels to Haemophilus influenzae type b (Hib), pneumococcus, Bordetella pertussis antigens, tetanus toxoid, and hepatitis B surface antigen. Design, Setting, and Participants A community-based cohort study in Khayelitsha, Western Cape Province, South Africa, between March 3, 2009, and April 28, 2010, of 109 HIV-infected and uninfected women and their infants. Serum samples from 104 women and 100 infants were collected at birth and samples from 93 infants were collected at 16 weeks. Main Outcome Measure Level of specific antibody in mother-infant pairs at delivery and in infants at 16 weeks, determined by enzyme-linked immunosorbent assays. Results At birth, HIV-exposed uninfected infants (n=46) had lower levels of specific antibodies than unexposed infants (n=54) did to Hib (0.37 [interquartile range {IQR}, 0.22-0.67] mg/L vs 1.02 [IQR, 0.34-3.79] mg/L; P<.001), pertussis (16.07 [IQR, 8.87-30.43] Food and Drug Administration [FDA] U/mL vs 36.11 [IQR, 20.41-76.28] FDA U/mL; P<.001), pneumococcus (17.24 [IQR, 11.33-40.25] mg/L vs 31.97 [IQR, 18.58-61.80] mg/L; P=.02), and tetanus (0.08 [IQR, 0.03-0.39] IU/mL vs 0.24 [IQR, 0.08-0.92] IU/mL; P=.006). Compared with HIV-uninfected women (n=58), HIV-infected women (n=46) had lower specific antibody levels to Hib (0.67 [IQR, 0.16-1.54] mg/L vs 1.34 [IQR, 0.15-4.82] mg/L; P=.009) and pneumococcus (33.47 [IQR, 4.03-69.43] mg/L vs 50.84 [IQR, 7.40-118.00] mg/L; P=.03); however, no differences were observed for antipertussis or antitetanus antibodies. HIV-exposed uninfected infants (n=38) compared with HIV-unexposed infants (n=55) had robust antibody responses following vaccination, with higher antibody responses to pertussis (270.1 [IQR, 84.4-355.0] FDA U/mL vs 91.7 [IQR, 27.9-168.4] FDA U/mL; P=.006) and pneumoccocus (47.32 [IQR, 32.56-77.80] mg/L vs 14.77 [IQR, 11.06-41.08] mg/L; P=.001). Conclusion Among South African infants, antenatal HIV exposure was associated with lower specific antibody responses in exposed uninfected infants compared with unexposed infants at birth, but with robust responses following routine vaccination. JAMA. 2011; 305(6): 576-584	[Jones, Christine E.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, London W2 1PG, England; [Jones, Christine E.; Kampmann, Beate] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kampmann, Beate] Med Res Council UK Gambia, Fajara, Gambia; [Naidoo, Shalena; De Beer, Corena; Esser, Monika] Univ Stellenbosch, Dept Pathol, Cape Town, South Africa; [De Beer, Corena; Esser, Monika] Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Hesseling, Anneke C.] Univ Stellenbosch, Dept Pediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa	Imperial College London; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; University of Cape Town; Tygerberg Hospital; Stellenbosch University	Jones, CE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, St Marys Campus,Norfolk Pl, London W2 1PG, England.	christine.jones@imperial.ac.uk	Jones, Chrissie/GXG-4400-2022	Jones, Christine/0000-0003-1523-2368	European Society for Pediatric Infectious Diseases; Thrasher Research Foundation; Wellcome Trust; National Institute for Health Research, England; Elizabeth Glaser Pediatric AIDS Foundation; Medical Research Council [MC_UP_A900_1115, MC_UP_A900_1122] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: UKRI	European Society for Pediatric Infectious Diseases; Thrasher Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research, England(National Institute for Health Research (NIHR)); Elizabeth Glaser Pediatric AIDS Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Society for Pediatric Infectious Diseases (Dr Jones), the Thrasher Research Foundation (Dr Jones), the Wellcome Trust (Dr Kampmann), National Institute for Health Research, England (Dr Kampmann), and Elizabeth Glaser Pediatric AIDS Foundation (Dr Hesseling).	AGBARAKWE AE, 1995, J CLIN PATHOL, V48, P206, DOI 10.1136/jcp.48.3.206; ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1283; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1050; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; DUCLOS P, 2009, J AM COLL CARDIOL, V9, pS2; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; ENGLUND JA, 1995, PEDIATRICS, V96, P580; Farquhar C, 2005, JAIDS-J ACQ IMM DEF, V40, P494, DOI 10.1097/01.qai.0000168179.68781.95; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Joint United Nations Programme on HIV/AIDS, 2011, GLOB REP UNAIDS REP; KNUF M, 2008, J PEDIAT, V152, pE1; KNUF M, 2008, J PEDIAT, V152, P660; Knuf M, 2008, J PEDIATR-US, V152, P655, DOI 10.1016/j.jpeds.2007.09.034; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kurikka S, 1996, PEDIATR INFECT DIS J, V15, P530, DOI 10.1097/00006454-199606000-00011; Madhi SA, 2005, VACCINE, V23, P5517, DOI 10.1016/j.vaccine.2005.07.038; Madhi SA, 2005, PEDIATR INFECT DIS J, V24, P410, DOI 10.1097/01.inf.0000160942.84169.14; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; MUSHER DM, 1990, J INFECT DIS, V161, P728, DOI 10.1093/infdis/161.4.728; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; Nuttall JJ, 2008, INT J INFECT DIS, V12, pE99, DOI 10.1016/j.ijid.2008.06.014; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; SARVAS H, 1992, J INFECT DIS, V165, P977, DOI 10.1093/infdis/165.5.977; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; *U CAP TOWN CTR IN, COMPR TB HIV SERV PR; *U CAP TOWN CTR IN, PROV HIV TB CAR PRIM; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P198	43	170	172	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					576	584		10.1001/jama.2011.100	http://dx.doi.org/10.1001/jama.2011.100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304083				2022-12-24	WOS:000287080500022
J	Edgeworth, JA; Farmer, M; Sicilia, A; Tavares, P; Beck, J; Campbell, T; Lowe, J; Mead, S; Rudge, P; Collinge, J; Jackson, GS				Edgeworth, Julie Ann; Farmer, Michael; Sicilia, Anita; Tavares, Paul; Beck, Jonathan; Campbell, Tracy; Lowe, Jessica; Mead, Simon; Rudge, Peter; Collinge, John; Jackson, Graham S.			Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay	LANCET			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; PROTEIN; TRANSFUSION; COMPONENTS; DIAGNOSIS; PATIENT	Background Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder originating from exposure to bovine-spongiform-encephalopathy-like prions. Prion infections are associated with long and clinically silent incubations. The number of asymptomatic individuals with vCJD prion infection is unknown, posing risk to others via blood transfusion, blood products, organ or tissue grafts, and contaminated medical instruments. We aimed to establish the sensitivity and specificity of a blood-based assay for detection of vCJD prion infection. Methods We developed a solid-state binding matrix to capture and concentrate disease-associated prion proteins and coupled this method to direct immunodetection of surface-bound material. Quantitative assay sensitivity was assessed with a serial dilution series of 10(-7) to 10(-10) of vCJD prion-infected brain homogenate into whole human blood, with a baseline control of normal human brain homogenate in whole blood (10(-6)). To establish the sensitivity and specificity of the assay for detection of endogenous vCJD, we analysed a masked panel of 190 whole blood samples from 21 patients with vCJD, 27 with sporadic CJD, 42 with other neurological diseases, and 100 normal controls. Samples were masked and numbered by individuals independent of the assay and analysis. Each sample was tested twice in independent assay runs; only samples that were reactive in both runs were scored as positive overall. Findings We were able to distinguish a 10(-10) dilution of exogenous vCJD prion-infected brain from a 10(-6) dilution of normal brain (mean chemiluminescent signal, 1.3x10(5) [SD 1.1x10(4)] for vCJD vs 9.9x10(4)[4.5x10(3)] for normal brain; p<0.0001)-an assay sensitivity that was orders of magnitude higher than any previously reported. 15 samples in the masked panel were scored as positive. All 15 samples were from patients with vCJD, showing an assay sensitivity for vCJD of 71.4% (95% CI 47.8-88.7) and a specificity of 100% (95% Cis between 97.8% and 100%). Interpretation These initial studies provide a prototype blood test for diagnosis of vCJD in symptomatic individuals, which could allow development of large-scale screening tests for asymptomatic vCJD prion infection.	[Edgeworth, Julie Ann; Farmer, Michael; Sicilia, Anita; Tavares, Paul; Beck, Jonathan; Campbell, Tracy; Lowe, Jessica; Mead, Simon; Collinge, John; Jackson, Graham S.] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England; [Mead, Simon; Rudge, Peter; Collinge, John] Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London WC1N 3BG, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Collinge, J (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk; g.s.jackson@prion.ucl.ac.uk	Mead, Simon/E-9414-2011	Mead, Simon/0000-0002-4326-1468; Jackson, Graham/0000-0002-3125-2011	UK Medical Research Council; Department of Health (England); University College London Hospital NHS Foundation Trust; Department of Health's NIHR Biomedical Research Centres; MRC [MC_U123170362, MC_U123160657] Funding Source: UKRI; Medical Research Council [MC_U123160657, MC_U123170362] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); University College London Hospital NHS Foundation Trust; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients and families affected by prion and other neurodegenerative diseases for their kind and generous support of these studies; our neurological and other clinical colleagues across the UK for referring patients, particularly colleagues at the National CJD Surveillance Centre in Edinburgh with whom we coordinate patient referral and research under a national protocol; present and past staff of the National Prion Clinic and Dementia Research Centre at the National Hospital for Neurology and Neurosurgery and of the MRC Prion Unit for many years of work collecting, documenting, and curating our sample collections (in particular, we thank Andrew Thompson, Ana Lukic, Chris Carswell, Michelle Gorham, Liz Ford, Imogen Eastwood, Steve Wroe, Daffyd Thomas, Angus Kennedy, Tom Webb, Dune Siddique, Suvankar Pal, Gary Adamson, James Uphill, Mark Poulter, Huda Al-Doujaily, Sabeena Chaudary, Gosala Gopalakrishnan, Nick Fox, Jason Warren, Martin Rossor, Jonathan Rohrer, Natalie Ryan, Colin Mahoney, and Suzie Barker); Paul Bassett of the UCL Biomedical Research Unit for statistical advice and analysis; Ray Young for preparation of the figures; and Jonathan Wadsworth for his critical reading of the report and assistance with preparing the panel of masked samples. This research was funded by the UK Medical Research Council. The Department of Health (England) funds the National Prion Monitoring Cohort study. Some of the work was undertaken at University College London Hospital NHS Foundation Trust, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	BARCIKOWSKA M, 1995, HISTOPATHOLOGY, V26, P445; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Duncan RE, 2005, J MED ETHICS, V31, P625, DOI 10.1136/jme.2005.011965; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Ghani AC, 2002, CR BIOL, V325, P37, DOI 10.1016/S1631-0691(02)01389-6; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Health Protection Analytical Team Department of Health, 2008, 1006 SEAC DEP HLTH H; Hewitt PE, 2006, VOX SANG, V91, P348, DOI 10.1111/j.1423-0410.2006.00837.x; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Minor PD, 2004, VOX SANG, V86, P164, DOI 10.1111/j.0042-9007.2004.00411.x; National Prion Clinic, 2009, NATL PRION CLIN; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spongiform Encephalopathy Advisory Committee, 2010, 1042 SEAC; Spongiform Encephalopathy Advisory Committee, 2008, 1002 SEAC; Tattum MH, 2010, TRANSFUSION, V50, P2619, DOI 10.1111/j.1537-2995.2010.02731.x; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2007, GUT, V56, P90, DOI 10.1136/gut.2006.091637; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	41	130	135	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					487	493		10.1016/S0140-6736(10)62308-2	http://dx.doi.org/10.1016/S0140-6736(10)62308-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21295339				2022-12-24	WOS:000287381800029
J	Garfield, AS; Cowley, M; Smith, FM; Moorwood, K; Stewart-Cox, JE; Gilroy, K; Baker, S; Xia, J; Dalley, JW; Hurst, LD; Wilkinson, LS; Isles, AR; Ward, A				Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Gilroy, Kerry; Baker, Sian; Xia, Jing; Dalley, Jeffrey W.; Hurst, Laurence D.; Wilkinson, Lawrence S.; Isles, Anthony R.; Ward, Andrew			Distinct physiological and behavioural functions for parental alleles of imprinted Grb10	NATURE			English	Article							GENE-EXPRESSION; MOUSE; ACETYLCHOLINE; METHYLATION; DISRUPTION; DOMINANCE; GROWTH; MODEL; LEADS; MICE	Imprinted genes, defined by their preferential expression of a single parental allele, represent a subset of the mammalian genome and often have key roles in embryonic development(1), but also postnatal functions including energy homeostasis(2) and behaviour(3,4). When the two parental alleles are unequally represented within a social group (when there is sex bias in dispersal and/or variance in reproductive success)(5,6), imprinted genes may evolve to modulate social behaviour, although so far no such instance is known. Predominantly expressed from the maternal allele during embryogenesis, Grb10 encodes an intracellular adaptor protein that can interact with several receptor tyrosine kinases and downstream signalling molecules(7). Here we demonstrate that within the brain Grb10 is expressed from the paternal allele from fetal life into adulthood and that ablation of this expression engenders increased social dominance specifically among other aspects of social behaviour, a finding supported by the observed increase in allogrooming by paternal Grb10-deficient animals. Grb10 is, therefore, the first example of an imprinted gene that regulates social behaviour. It is also currently alone in exhibiting imprinted expression from each of the parental alleles in a tissue-specific manner, as loss of the peripherally expressed maternal allele leads to significant fetal and placental overgrowth. Thus Grb10 is, so far, a unique imprinted gene, able to influence distinct physiological processes, fetal growth and adult behaviour, owing to actions of the two parental alleles in different tissues.	[Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Hurst, Laurence D.; Ward, Andrew] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Hurst, Laurence D.; Ward, Andrew] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Garfield, Alastair S.; Gilroy, Kerry; Baker, Sian; Wilkinson, Lawrence S.; Isles, Anthony R.] Cardiff Univ, Sch Med, Neurosci & Mental Hlth Res Inst, MRC,Ctr Neuropsychiat Genet & Genom,Behav Genet G, Cardiff CF14 4XN, S Glam, Wales; [Garfield, Alastair S.; Gilroy, Kerry; Baker, Sian; Wilkinson, Lawrence S.; Isles, Anthony R.] Cardiff Univ, Sch Psychol, Neurosci & Mental Hlth Res Inst, MRC,Ctr Neuropsychiat Genet & Genom,Behav Genet G, Cardiff CF14 4XN, S Glam, Wales; [Xia, Jing; Dalley, Jeffrey W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Xia, Jing; Dalley, Jeffrey W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England	University of Bath; University of Bath; Cardiff University; Cardiff University; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ward, A (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	bssaw@bath.ac.uk	Cowley, Mike/B-9425-2013; Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Moorwood, Kim/0000-0003-0943-6161; Dalley, Jeffrey/0000-0002-2282-3660; Isles, Anthony/0000-0002-7587-5712; Garfield, Alastair/0000-0002-9628-6140; Ward, Andrew/0000-0001-8311-5695; Cowley, Michael/0000-0001-8564-4224	Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Medical Research Council [G0001354B, G0300415, G1000183B, G0001354, G0801418B] Funding Source: researchfish; MRC [G0300415] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Wonnacott for reagents, the University of Bath Biological Services Unit and S. Routley for technical assistance, I. Jones and P. Mitchell for advice and C. Tickle for comments on the manuscript. We acknowledge funding of the work from the Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and external benefactors.	Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Haig D, 2000, ANN NY ACAD SCI, V907, P149, DOI 10.1111/j.1749-6632.2000.tb06621.x; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Isles AR, 2006, PHILOS T R SOC B, V361, P2229, DOI 10.1098/rstb.2006.1942; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Kaplan JR, 2002, NEUROPSYCHOPHARMACOL, V26, P431, DOI 10.1016/S0893-133X(01)00344-X; Keverne B, 2009, BIOESSAYS, V31, P1318, DOI 10.1002/bies.200900074; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; MORALES MA, 1995, P NATL ACAD SCI USA, V92, P11819, DOI 10.1073/pnas.92.25.11819; Nagy A., 2003, MANIPULATING MOUSE E; Nevison CM, 2003, P ROY SOC B-BIOL SCI, V270, P1957, DOI 10.1098/rspb.2003.2452; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; Przydzial MJ, 2010, BEHAV BRAIN RES, V206, P313, DOI 10.1016/j.bbr.2009.09.017; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Ubeda F, 2010, EVOLUTION, V64, P2587, DOI 10.1111/j.1558-5646.2010.01015.x; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Yamasaki-Ishizaki Y, 2007, MOL CELL BIOL, V27, P732, DOI 10.1128/MCB.01329-06	36	141	144	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					534	U101		10.1038/nature09651	http://dx.doi.org/10.1038/nature09651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270893	Green Accepted			2022-12-24	WOS:000286596500033
J	Churchman, LS; Weissman, JS				Churchman, L. Stirling; Weissman, Jonathan S.			Nascent transcript sequencing visualizes transcription at nucleotide resolution	NATURE			English	Article							RNA-POLYMERASE-II; ACTIVE PROMOTERS; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; HUMAN GENOME; HISTONE H3; IN-VIVO; POL II; ELONGATION; METHYLATION	Recent studies of transcription have revealed a level of complexity not previously appreciated even a few years ago, both in the intricate use of post-initiation control and the mass production of rapidly degraded transcripts. Dissection of these pathways requires strategies for precisely following transcripts as they are being produced. Here we present an approach (native elongating transcript sequencing, NET-seq), based on deep sequencing of 3' ends of nascent transcripts associated with RNA polymerase, to monitor transcription at nucleotide resolution. Application of NET-seq in Saccharomyces cerevisiae reveals that although promoters are generally capable of divergent transcription, the Rpd3S deacetylation complex enforces strong directionality to most promoters by suppressing antisense transcript initiation. Our studies also reveal pervasive polymerase pausing and backtracking throughout the body of transcripts. Average pause density shows prominent peaks at each of the first four nucleosomes, with the peak location occurring in good agreement with in vitro biophysical measurements. Thus, nucleosome-induced pausing represents a major barrier to transcriptional elongation in vivo.	[Churchman, L. Stirling; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Churchman, L. Stirling; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Damon Runyon Cancer Research Foundation [DRG-1997-08]; Howard Hughes Medical Institute	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Guthrie, N. Krogan, S. Luo, G. Schroth, J. Steitz and K. Yamamoto for advice and discussions; D. Breslow, P. Fordyce, A. Frost, J. Huff, M. Kampmann and M. Pufall for critical comments on the manuscript; C. Chu and N. Ingolia for help with sequencing and analysis; and S. Rouskin for help developing the ligation protocol. This research was supported by the Damon Runyon Cancer Research Foundation (DRG-1997-08 to L.S.C.) and by the Howard Hughes Medical Institute (to J.S.W.)	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CAI H, 1987, J BIOL CHEM, V262, P298; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; LANGMEAD B, 2009, GENOME BIOL, V10, pR25, DOI DOI 10.1186/gb-2009-10-11-r134; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	45	531	537	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					368	+		10.1038/nature09652	http://dx.doi.org/10.1038/nature09652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248844	Green Accepted			2022-12-24	WOS:000286385600045
J	Bostrom, P; Mann, N; Wu, J; Quintero, PA; Plovie, ER; Panakova, D; Gupta, RK; Xiao, CY; MacRae, CA; Rosenzweig, A; Spiegelman, BM				Bostroem, Pontus; Mann, Nina; Wu, Jun; Quintero, Pablo A.; Plovie, Eva R.; Panakova, Daniela; Gupta, Rana K.; Xiao, Chunyang; MacRae, Calum A.; Rosenzweig, Anthony; Spiegelman, Bruce M.			C/EBP beta Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling	CELL			English	Article							SERUM RESPONSE FACTOR; HEART; MUSCLE; ROLES	The heart has the ability to growin size in response to exercise, but little is known about the transcriptional mechanisms underlying physiological hypertrophy. Adult cardiomyocytes have also recently been proven to hold the potential for proliferation, a process that could be of great importance for regenerative medicine. Using a unique RT-PCR-based screen against all transcriptional components, we showed that C/EBP beta was downregulated with exercise, whereas the expression of CITED4 was increased. Reduction of C/EBP beta in vitro and in vivo resulted in a phenocopy of endurance exercise with cardiomyocyte hypertrophy and proliferation. This proliferation was mediated, at least in part, by the increased CITED4. Importantly, mice with reduced cardiac C/EBP beta levels displayed substantial resistance to cardiac failure upon pressure overload. These data indicate that C/EBP beta represses cardiomyocyte growth and proliferation in the adult mammalian heart and that reduction in C/EBP beta is a central signal in physiologic hypertrophy and proliferation.	[Mann, Nina; Quintero, Pablo A.; Xiao, Chunyang; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Mann, Nina; Quintero, Pablo A.; Xiao, Chunyang; Rosenzweig, Anthony] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bostroem, Pontus; Wu, Jun; Gupta, Rana K.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bostroem, Pontus; Wu, Jun; Gupta, Rana K.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Plovie, Eva R.; Panakova, Daniela; MacRae, Calum A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rosenzweig, A (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, 330 Brookline Ave, Boston, MA 02215 USA.	arosenzw@bidmc.harvard.edu; bruce_spiegelman@dfci.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019	Panakova, Daniela/0000-0002-8739-6225; Gupta, Rana/0000-0002-9001-4531	NIH [R01 HL085593]; Swedish Heart and Lung foundation; SSMF; Wenner-Gren Foundation; American Heart Association [09POST2010078]; Howard Hughes Postdoctoral Fellowship; T32 training grant; Leducq Foundation Network of Research Excellence; Maxwell Hurston Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085593, R01HL109264, K08HL076361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); SSMF; Wenner-Gren Foundation; American Heart Association(American Heart Association); Howard Hughes Postdoctoral Fellowship; T32 training grant; Leducq Foundation Network of Research Excellence(Leducq Foundation); Maxwell Hurston Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shingo Kajimura for valuable discussion during the progression of the manuscript. This project was supported by NIH grant R01 HL085593. P. B. was supported by the Swedish Heart and Lung foundation, SSMF, and the Wenner-Gren Foundation. J.W. was supported by a postdoctoral fellowship from the American Heart Association (Founders Affiliate #09POST2010078). N.M. is a trainee the Harvard/MIT Health Sciences and Technology Program and is supported by a Howard Hughes Postdoctoral Fellowship. P. A. Q. is supported by a T32 training grant. This research was supported in part by a Leducq Foundation Network of Research Excellence (B. M. S. and A. R.) and grants from the NIH (A. R. and B. W. S.). A. R. also gratefully acknowledges support from Judith and David Ganz and the Maxwell Hurston Charitable Foundation. A. R. is a principal faculty member of the Harvard Stem Cell Institute.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, pA12; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Liao Ronglih, 2007, V139, P251; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Yahata T, 2002, GENOMICS, V80, P601, DOI 10.1006/geno.2002.7005	27	284	300	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1072	1083		10.1016/j.cell.2010.11.036	http://dx.doi.org/10.1016/j.cell.2010.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183071	Bronze, Green Accepted			2022-12-24	WOS:000285625400006
J	Song, JK; Rechkoblit, O; Bestor, TH; Patel, DJ				Song, Jikui; Rechkoblit, Olga; Bestor, Timothy H.; Patel, Dinshaw J.			Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation	SCIENCE			English	Article							CXXC DOMAIN; METHYLTRANSFERASE; LEUKEMIA	Maintenance of genomic methylation patterns is mediated primarily by DNA methyltransferase-1 (DNMT1). We have solved structures of mouse and human DNMT1 composed of CXXC, tandem bromo-adjacent homology (BAH1/2), and methyltransferase domains bound to DNA-containing unmethylated CpG sites. The CXXC specifically binds to unmethylated CpG dinucleotide and positions the CXXC-BAH1 linker between the DNA and the active site of DNMT1, preventing de novo methylation. In addition, a loop projecting from BAH2 interacts with the target recognition domain (TRD) of the methyltransferase, stabilizing the TRD in a retracted position and preventing it from inserting into the DNA major groove. Our studies identify an autoinhibitory mechanism, in which unmethylated CpG dinucleotides are occluded from the active site to ensure that only hemimethylated CpG dinucleotides undergo methylation.	[Song, Jikui; Rechkoblit, Olga; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Bestor, Timothy H.] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Columbia University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org		Rechkoblit, Olga/0000-0003-4270-7242	Abby Rockefeller Mauze Trust; Maloris Foundation; NIH; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by funds from the Abby Rockefeller Mauze Trust and Maloris Foundation to D.J.P. and from NIH to T.H.B. We thank S. Murakami for technical assistance and Z. Wang and H. Li for their assistance with x-ray data collection and structure determination. We would also like to thank the staff of NE-CAT beamlines at the Advanced Photon Source, Argonne National Laboratory, and the X-29 beamline at the Brookhaven National Laboratory, for access and assistance with data collection. The structures of the complexes have been deposited in the Protein Data Bank (PDB). The accession codes are mDNMT1(650-1602)-DNA complex with bound AdoHcy (3PT6), hDNMT1(646-1600)-DNA complex with bound AdoHcy (3PTA) and mDNMT1(731-1602) with bound AdoHcy (3PT9).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Zhang ZG, 2002, EMBO J, V21, P4600, DOI 10.1093/emboj/cdf468	17	294	305	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1036	1040		10.1126/science.1195380	http://dx.doi.org/10.1126/science.1195380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21163962	Green Accepted			2022-12-24	WOS:000287699000054
J	Choi, M; Scholl, UI; Yue, P; Bjorklund, P; Zhao, BX; Nelson-Williams, C; Ji, WZ; Cho, YS; Patel, A; Men, CJ; Lolis, E; Wisgerhof, MV; Geller, DS; Mane, S; Hellman, P; Westin, G; Akerstrom, G; Wang, WH; Carling, T; Lifton, RP				Choi, Murim; Scholl, Ute I.; Yue, Peng; Bjoerklund, Peyman; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Cho, Yoonsang; Patel, Aniruddh; Men, Clara J.; Lolis, Elias; Wisgerhof, Max V.; Geller, David S.; Mane, Shrikant; Hellman, Per; Westin, Gunnar; Akerstrom, Goran; Wang, Wenhui; Carling, Tobias; Lifton, Richard P.			K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension	SCIENCE			English	Article							REMEDIABLE ALDOSTERONISM; ADRENOCORTICAL-CELLS; COLORECTAL CANCERS; GLOMERULOSA CELLS; POTASSIUM CHANNEL; MOLECULAR-BASIS; HUMAN BREAST; SELECTIVITY; IDENTIFICATION; CONDUCTION	Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K+) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na+) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca2+) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na+ conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K+ channel selectivity in constitutive cell proliferation and hormone production.	[Choi, Murim; Scholl, Ute I.; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Patel, Aniruddh; Men, Clara J.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Choi, Murim; Scholl, Ute I.; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Patel, Aniruddh; Men, Clara J.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; [Yue, Peng; Wang, Wenhui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Bjoerklund, Peyman; Carling, Tobias] Yale Univ, Sch Med, Yale Endocrine Neoplasia Lab, Dept Surg, New Haven, CT 06510 USA; [Bjoerklund, Peyman; Carling, Tobias] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Bjoerklund, Peyman; Hellman, Per; Westin, Gunnar; Akerstrom, Goran] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Cho, Yoonsang; Lolis, Elias] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Wisgerhof, Max V.] Henry Ford Hosp, Div Endocrinol, Detroit, MI 48202 USA; [Geller, David S.] Yale Univ, Sch Med, Nephrol Sect, West Haven, CT 06516 USA; [Geller, David S.] Vet Affairs Med Ctr, Dept Med, West Haven, CT 06516 USA; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, West Haven, CT 06516 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; New York Medical College; Yale University; Yale University; Uppsala University; Yale University; Henry Ford Health System; Henry Ford Hospital; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Hellman, Per/AAL-9817-2021; Choi, Murim/AAP-9120-2021; Bjørklund, Geir/B-7319-2014; Björklund, Peyman/A-1509-2014	Hellman, Per/0000-0002-5322-5073; Bjørklund, Geir/0000-0003-2632-3935; Björklund, Peyman/0000-0002-9398-4496; Patel, Aniruddh/0000-0001-7871-9638; Scholl, Ute/0000-0002-0309-8045; Lolis, Elias/0000-0002-7902-7868; Zhao, Bixiao/0000-0002-1775-1690; Choi, Murim/0000-0002-9195-1455	National Institutes of Health (NIH) [DK54983]; Yale Center for Human Genetics and Genomics; Yale NIH O'Brien Center for Kidney Research; Yale NIH; Swedish Cancer Society; Swedish Research Council; Lions Cancer Fund, Uppsala; Fondation Leducq Transatlantic Network in Hypertension; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, R01DK054983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Human Genetics and Genomics; Yale NIH O'Brien Center for Kidney Research; Yale NIH; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Fund, Uppsala; Fondation Leducq Transatlantic Network in Hypertension(Leducq Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients whose participation made this study possible and the staff of the Yale West Campus Genomics Center and the Endocrine Surgical Laboratory, Clinical Research Centre, University Hospital, Uppsala. Supported in part by the Fondation Leducq Transatlantic Network in Hypertension, National Institutes of Health (NIH) grant DK54983, the Yale Center for Human Genetics and Genomics, Yale NIH O'Brien Center for Kidney Research, and the Yale NIH Clinical Translational Science Award, and by the Swedish Cancer Society, the Swedish Research Council, and the Lions Cancer Fund, Uppsala. U.I.S. is a fellow of the Deutsche Forschungsgemeinschaft; B.Z. is an investigator of the Yale Medical Scientist Training Program; T.C. is a Doris Duke-Damon Runyon Clinical Investigator; R.P.L. is a paid scientific advisor to Merck and is an investigator of the Howard Hughes Medical Institute.	Calvo-Romero JM, 2000, POSTGRAD MED J, V76, P160, DOI 10.1136/pmj.76.893.160; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; Geller DS, 2008, J CLIN ENDOCR METAB, V93, P3117, DOI 10.1210/jc.2008-0594; Ghose RP, 1999, ANN INTERN MED, V131, P105, DOI 10.7326/0003-4819-131-2-199907200-00005; Gregerson KA, 2001, ENDOCRINOLOGY, V142, P2820, DOI 10.1210/en.142.7.2820; HAJNOCZKY G, 1992, ENDOCRINOLOGY, V130, P1637, DOI 10.1210/en.130.3.1637; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUMAR V, 2009, ROBBINS COTRAN PATHO, pCH24; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pawlikowski M, 2001, Endocr Regul, V35, P139; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tanabe A, 1998, J ENDOCRINOL INVEST, V21, P668, DOI 10.1007/BF03350796; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	25	669	699	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					768	772		10.1126/science.1198785	http://dx.doi.org/10.1126/science.1198785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311022	Green Accepted, Green Published			2022-12-24	WOS:000287205700070
J	Schadt, E				Schadt, Eric			First Steps on a Long Road	SCIENCE			English	Editorial Material									Pacific Biosci Calif, Menlo Pk, CA USA		Schadt, E (corresponding author), Pacific Biosci Calif, Menlo Pk, CA USA.								0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					691	691		10.1126/science.1203235	http://dx.doi.org/10.1126/science.1203235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310999				2022-12-24	WOS:000287205700044
J	Mills, RE; Walter, K; Stewart, C; Handsaker, RE; Chen, K; Alkan, C; Abyzov, A; Yoon, SC; Ye, K; Cheetham, RK; Chinwalla, A; Conrad, DF; Fu, YT; Grubert, F; Hajirasouliha, I; Hormozdiari, F; Iakoucheva, LM; Iqbal, Z; Kang, SL; Kidd, JM; Konkel, MK; Korn, J; Khurana, E; Kural, D; Lam, HYK; Leng, J; Li, RQ; Li, YR; Lin, CY; Luo, RB; Mu, XJ; Nemesh, J; Peckham, HE; Rausch, T; Scally, A; Shi, XH; Stromberg, MP; Stutz, AM; Urban, AE; Walker, JA; Wu, JT; Zhang, YJ; Zhang, ZDD; Batzer, MA; Ding, L; Marth, GT; McVean, G; Sebat, J; Snyder, M; Wang, J; Ye, K; Eichler, EE; Gerstein, MB; Hurles, ME; Lee, C; McCarroll, SA; Korbel, JO				Mills, Ryan E.; Walter, Klaudia; Stewart, Chip; Handsaker, Robert E.; Chen, Ken; Alkan, Can; Abyzov, Alexej; Yoon, Seungtai Chris; Ye, Kai; Cheetham, R. Keira; Chinwalla, Asif; Conrad, Donald F.; Fu, Yutao; Grubert, Fabian; Hajirasouliha, Iman; Hormozdiari, Fereydoun; Iakoucheva, Lilia M.; Iqbal, Zamin; Kang, Shuli; Kidd, Jeffrey M.; Konkel, Miriam K.; Korn, Joshua; Khurana, Ekta; Kural, Deniz; Lam, Hugo Y. K.; Leng, Jing; Li, Ruiqiang; Li, Yingrui; Lin, Chang-Yun; Luo, Ruibang; Mu, Xinmeng Jasmine; Nemesh, James; Peckham, Heather E.; Rausch, Tobias; Scally, Aylwyn; Shi, Xinghua; Stromberg, Michael P.; Stuetz, Adrian M.; Urban, Alexander Eckehart; Walker, Jerilyn A.; Wu, Jiantao; Zhang, Yujun; Zhang, Zhengdong D.; Batzer, Mark A.; Ding, Li; Marth, Gabor T.; McVean, Gil; Sebat, Jonathan; Snyder, Michael; Wang, Jun; Ye, Kenny; Eichler, Evan E.; Gerstein, Mark B.; Hurles, Matthew E.; Lee, Charles; McCarroll, Steven A.; Korbel, Jan O.		1000 Genomes Project	Mapping copy number variation by population-scale genome sequencing	NATURE			English	Article							STRUCTURAL VARIATION; SEGMENTAL DUPLICATIONS; SHORT-READ; REARRANGEMENTS; COMMON; POLYMORPHISM; INSERTIONS; DELETIONS; SNPS	Genomic structural variants (SVs) are abundant in humans, differing from other forms of variation in extent, origin and functional impact. Despite progress in SV characterization, the nucleotide resolution architecture of most SVs remains unknown. We constructed a map of unbalanced SVs (that is, copy number variants) based on whole genome DNA sequencing data from 185 human genomes, integrating evidence from complementary SV discovery approaches with extensive experimental validations. Our map encompassed 22,025 deletions and 6,000 additional SVs, including insertions and tandem duplications. Most SVs (53%) were mapped to nucleotide resolution, which facilitated analysing their origin and functional impact. We examined numerous whole and partial gene deletions with a genotyping approach and observed a depletion of gene disruptions amongst high frequency deletions. Furthermore, we observed differences in the size spectra of SVs originating from distinct formation mechanisms, and constructed a map of SV hotspots formed by common mechanisms. Our analytical framework and SV map serves as a resource for sequencing-based association studies.	[Rausch, Tobias; Stuetz, Adrian M.; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany; [Mills, Ryan E.; Shi, Xinghua; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mills, Ryan E.; Shi, Xinghua; Lee, Charles] Harvard Univ, Sch Med, Boston, MA USA; [Walter, Klaudia; Conrad, Donald F.; Scally, Aylwyn; Zhang, Yujun; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Stewart, Chip; Kural, Deniz; Stromberg, Michael P.; Wu, Jiantao; Marth, Gabor T.] Boston Coll, Dept Biol, Boston, MA USA; [Handsaker, Robert E.; Korn, Joshua; Nemesh, James; McCarroll, Steven A.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Handsaker, Robert E.; Korn, Joshua; Nemesh, James; McCarroll, Steven A.] MIT, Cambridge, MA 02139 USA; [Chen, Ken; Chinwalla, Asif; Ding, Li] Washington Univ, Genome Ctr, St Louis, MO USA; [Alkan, Can; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Abyzov, Alexej; Khurana, Ekta; Leng, Jing; Mu, Xinmeng Jasmine; Zhang, Zhengdong D.; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Yoon, Seungtai Chris] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY USA; [Yoon, Seungtai Chris] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Cheetham, R. Keira] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Fu, Yutao; Peckham, Heather E.] Life Technol, Beverly, MA USA; [Grubert, Fabian; Lam, Hugo Y. K.; Urban, Alexander Eckehart; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hajirasouliha, Iman; Hormozdiari, Fereydoun] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Iakoucheva, Lilia M.; Kang, Shuli; Sebat, Jonathan] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, Dept Psychiat, La Jolla, CA 92093 USA; [Iqbal, Zamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Li, Ruiqiang; Li, Yingrui; Luo, Ruibang; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Lin, Chang-Yun; Ye, Kenny] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX3 7BN, England; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Urban, Alexander Eckehart] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Wellcome Trust Sanger Institute; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Illumina; Thermo Fisher Scientific; Stanford University; Simon Fraser University; University of California System; University of California San Diego; University of Oxford; Wellcome Centre for Human Genetics; Louisiana State University System; Louisiana State University; Yale University; Beijing Genomics Institute (BGI); Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); University of Oxford; University of Copenhagen; Yale University; Harvard University; Harvard Medical School; Stanford University	Korbel, JO (corresponding author), European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany.	jan.korbel@embl.de	Korbel, Jan O/G-6470-2012; Fang, Xiaodong/K-6743-2018; Handsaker, Bob/AAX-9095-2021; Chen, Wei/AAX-5994-2020; Rausch, Tobias/H-6511-2019; Mills, Ryan/F-4225-2010; Dahl, Andreas/E-3783-2017; Maestrini, Elena/K-7508-2012; Ye, Kai/GSD-9856-2022; Abyzov, Alexej/M-4284-2013; Khurana, Ekta/C-4933-2013; Abyzov, Alexej/AAT-4615-2020; Chen, Ken/A-1074-2009; Wilson, Richard K./AAF-4139-2019; Rosenstiel, Philip/A-5137-2009; Ye, Kai/B-3640-2012; Wang, Jun/A-7261-2013; Browning, Brian L/A-1178-2010; Cooper, David N/H-4384-2011; Li, Yingrui/K-1064-2015; Ye, Kenny/GSM-7731-2022; Sahinalp, Suleyman Cenk/X-7843-2018; Alkan, Can/D-2982-2009; Ye, Kenny/U-2341-2019; Chen, Ken/AAU-1432-2021; Mu, Xinmeng/P-2562-2016; Myers, Simon R/A-6792-2015; Tumian, Afidalina/J-4404-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Korbel, Jan O/0000-0002-2798-3794; Fang, Xiaodong/0000-0001-7061-3337; Handsaker, Bob/0000-0002-3128-3547; Chen, Wei/0000-0001-7196-8703; Rausch, Tobias/0000-0001-5773-5620; Mills, Ryan/0000-0003-3425-6998; Dahl, Andreas/0000-0002-2668-8371; Maestrini, Elena/0000-0001-5924-3179; Ye, Kai/0000-0002-2851-6741; Wilson, Richard K./0000-0002-1992-1358; Rosenstiel, Philip/0000-0002-9692-8828; Browning, Brian L/0000-0001-6454-6633; Cooper, David N/0000-0002-8943-8484; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Alkan, Can/0000-0002-5443-0706; Ye, Kenny/0000-0002-1466-855X; Chen, Ken/0000-0003-4013-5279; Mu, Xinmeng/0000-0002-8079-0828; Myers, Simon R/0000-0002-2585-9626; Tumian, Afidalina/0000-0003-2763-6677; Chinwalla, Asif/0000-0001-7831-3996; Wang, Jun/0000-0002-8540-8931; Palotie, Aarno/0000-0002-2527-5874; Keenan, Stephen/0000-0002-9141-7690; McLaren, William/0000-0001-6218-1116; Borodina, Tatiana/0000-0002-6978-016X; Iakoucheva, Lilia/0000-0002-4542-5219; Herrero, Javier/0000-0001-7313-717X; Kidd, Jeffrey/0000-0002-9631-1465; Keinan, Alon/0000-0002-9760-1122; Sebat, Jonathan/0000-0002-9087-526X; Abyzov, Alexej/0000-0001-5405-6729; Wang, Jun/0000-0002-2113-5874; Radhakrishnan, Rajesh/0000-0001-7170-699X; Haraksingh, Rajini/0000-0002-6644-8874; Zalunin, Vadim/0000-0002-7722-1958; Stuetz, Adrian/0000-0001-7650-3470; Keane, Thomas/0000-0001-7532-6898; Leinonen, Rasko/0000-0002-2639-7187; MCLELLAN, MICHAEL/0000-0002-2703-8784; Cibulskis, Kristian/0000-0003-1343-1582; Clarke, Laura/0000-0002-5989-6898; Sherry, Stephen/0000-0002-7982-076X; Iqbal, Zamin/0000-0001-8466-7547; MacArthur, Daniel/0000-0002-5771-2290; Kulesha, Eugene/0000-0002-4285-6232; Hinrichs, Angie/0000-0002-1697-1130; Hormozdiari, Fereydoun/0000-0003-2703-9274; Clark, Andrew/0000-0001-7159-8511; Kural, Deniz/0000-0002-8085-0771; Stone, Eric/0000-0002-2725-4209; Snyder, Michael/0000-0003-0784-7987; Schaffner, Stephen/0000-0001-6699-3568; Lin, Chang-Yun/0000-0001-7599-1214; Swerdlow, Harold/0000-0002-9510-160X; Walter, Klaudia/0000-0003-4448-0301; Balasubramanian, Shankar/0000-0002-0281-5815; Luo, Ruibang/0000-0001-9711-6533; Eberle, Michael/0000-0001-8965-1253; Bustamante, Carlos D./0000-0002-4187-7920	National Institutes of Health [RO1 GM59290, R01 HG004719, RC2 HG005552, P01 HG004120, U01 HG005209, P41 HG004221, RO1 GM081533, UO1 HG005209]; German Research Foundation (Deutsche Forschungsgemeinschaft); National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council; MRC [G0701805] Funding Source: UKRI; Medical Research Council [G1000758, G0701805, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005552, R01HG004719, U01HG005209, U54HG003273, ZIAHG000024, P41HG004221, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081533, R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We would like to acknowledge C. Hardy, R. Smith, A. De Witte and S. Giles for their assistance with validation. M.A.B.'s group was supported by a grant from the National Institutes of Health (RO1 GM59290) and G.T.M.'s group by grants R01 HG004719 and RC2 HG005552, also from the NIH. J.O.K.'s group was supported by an Emmy Noether Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft). J.W.'s group was supported by the National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004), the Chinese 863 program (2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A; JC200903190772A; ZYC200903240076A; CXB200903110066A; ZYC200903240077A; ZYC200903240076A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council. E.E.E.'s group was supported by grants P01 HG004120 and U01 HG005209 from the National Institutes of Health. C.L.'s group was supported by grants from the National Institutes of Health: P41 HG004221, RO1 GM081533 and UO1 HG005209 and X. S. was supported by a T32 fellowship award from the NIH. We thank the Genome Structural Variation Consortium (http://www.sanger.ac.uk/humgen/cnv/42mio/) and the International HapMap Consortium for making available microarray data. The authors acknowledge the individuals participating in the 1000 Genomes Project by providing samples, including the Yoruba people of Ibadan, Nigeria, the community at Beijing Normal University, the people of Tokyo, Japan, and the people of the Utah CEPH community. Furthermore, we thank R. Durbin and L. Steinmetz for comments on the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee S, 2008, BIOINFORMATICS, V24, pI59, DOI 10.1093/bioinformatics/btn176; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	44	771	824	5	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					59	65		10.1038/nature09708	http://dx.doi.org/10.1038/nature09708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293372	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000286886400033
J	Weisfeldt, ML; Everson-Stewart, S; Sitlani, C; Rea, T; Aufderheide, TP; Atkins, DL; Bigham, B; Brooks, SC; Foerster, C; Gray, R; Ornato, JP; Powell, J; Kudenchuk, PJ; Morrison, LJ				Weisfeldt, Myron L.; Everson-Stewart, Siobhan; Sitlani, Colleen; Rea, Thomas; Aufderheide, Tom P.; Atkins, Dianne L.; Bigham, Blair; Brooks, Steven C.; Foerster, Christopher; Gray, Randal; Ornato, Joseph P.; Powell, Judy; Kudenchuk, Peter J.; Morrison, Laurie J.		Resuscitation Outcomes Consortium	Ventricular Tachyarrhythmias after Cardiac Arrest in Public versus at Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; ACCESS DEFIBRILLATION; CARDIOPULMONARY-RESUSCITATION; OUTCOMES; SURVIVAL; CPR; COMPRESSION; POPULATION; LOCATIONS	BACKGROUND The incidence of ventricular fibrillation or pulseless ventricular tachycardia as the first recorded rhythm after out-of-hospital cardiac arrest has unexpectedly declined. The success of bystander-deployed automated external defibrillators (AEDs) in public settings suggests that this may be the more common initial rhythm when out-of-hospital cardiac arrest occurs in public. We conducted a study to determine whether the location of the arrest, the type of arrhythmia, and the probability of survival are associated. METHODS Between 2005 and 2007, we conducted a prospective cohort study of out-of-hospital cardiac arrest in adults in 10 North American communities. We assessed the frequencies of ventricular fibrillation or pulseless ventricular tachycardia and of survival to hospital discharge for arrests at home as compared with arrests in public. RESULTS Of 12,930 evaluated out-of-hospital cardiac arrests, 2042 occurred in public and 9564 at home. For cardiac arrests at home, the incidence of ventricular fibrillation or pulseless ventricular tachycardia was 25% when the arrest was witnessed by emergency-medical-services (EMS) personnel, 35% when it was witnessed by a bystander, and 36% when a bystander applied an AED. For cardiac arrests in public, the corresponding rates were 38%, 60%, and 79%. The adjusted odds ratio for initial ventricular fibrillation or pulseless ventricular tachycardia in public versus at home was 2.28 (95% confidence interval [CI], 1.96 to 2.66; P<0.001) for bystander-witnessed arrests and 4.48 (95% CI, 2.23 to 8.97; P<0.001) for arrests in which bystanders applied AEDs. The rate of survival to hospital discharge was 34% for arrests in public settings with AEDs applied by bystanders versus 12% for arrests at home (adjusted odds ratio, 2.49; 95% CI, 1.03 to 5.99; P=0.04). CONCLUSIONS Regardless of whether out-of-hospital cardiac arrests are witnessed by EMS personnel or bystanders and whether AEDs are applied by bystanders, the proportion of arrests with initial ventricular fibrillation or pulseless ventricular tachycardia is much greater in public settings than at home. The incremental value of resuscitation strategies, such as the ready availability of an AED, may be related to the place where the arrest occurs.	[Weisfeldt, Myron L.] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Everson-Stewart, Siobhan; Sitlani, Colleen; Rea, Thomas; Powell, Judy; Kudenchuk, Peter J.] Univ Washington, Seattle, WA 98195 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Atkins, Dianne L.] Univ Iowa, Iowa City, IA USA; [Bigham, Blair; Brooks, Steven C.; Foerster, Christopher; Morrison, Laurie J.] Univ Toronto, Toronto, ON, Canada; [Gray, Randal] Univ Alabama, Birmingham, AL USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Richmond, VA USA	Johns Hopkins University; University of Washington; University of Washington Seattle; Medical College of Wisconsin; University of Iowa; University of Toronto; University of Alabama System; University of Alabama Birmingham; Virginia Commonwealth University	Weisfeldt, ML (corresponding author), Johns Hopkins Univ, 1830 E Monument St,Suite 9026, Baltimore, MD 21287 USA.	mlw5@jhmi.edu	Morrison, Laurie Jean/A-6325-2012; Brooks, Steven/ABC-8078-2021; Atkins, Dianne/AFM-2981-2022; Brooks, Steven/N-4317-2015	Morrison, Laurie Jean/0000-0001-8369-9774; Brooks, Steven/0000-0002-4592-4974; Brown, Siobhan/0000-0002-4774-3122	National Heart, Lung, and Blood Institute [5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865]; National Institute of Neurological Disorders and Stroke; U.S. Army Medical Research & Materiel Command; Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; American Heart Association; Heart and Stroke Foundation of Canada; Philips and Physio-Control; Medtronic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077887, U01HL077873, U01HL077866, U01HL077865, U01HL077881, U01HL077872, U01HL077863, U01HL077867, U01HL077908, U01HL077885, U01HL077871] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Army Medical Research & Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Philips and Physio-Control; Medtronic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by cooperative agreements with 10 regional clinical centers and one data coordinating center (5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, and HL077865) from the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, the U.S. Army Medical Research & Materiel Command, the Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the American Heart Association, and the Heart and Stroke Foundation of Canada.; Dr. Atkins reports receiving support from the American Heart Association as the editor of the CPR Guidelines and having testified as an expert witness on pediatric defibrillation; Dr. Aufderheide, serving as a consultant for the Medtronic Foundation and Jolife; Dr. Ornato, being employed as the American editor of the journal Resuscitation; Dr. Rea, using AEDs supplied by Philips and Physio-Control and receiving funding on behalf of his institution, the University of Washington, from Philips and Physio-Control and the Medtronic Foundation; and Dr. Weisfeldt, receiving royalties both for himself and on behalf of his institution, the Johns Hopkins University School of Medicine, from a patent for a pacemaker. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2010, CIRCULATION, V121, pe46; Atkins DL, 2009, CIRCULATION, V120, P461, DOI 10.1161/CIRCULATIONAHA.109.883488; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Becker L, 2008, RESUSCITATION, V79, P22, DOI 10.1016/j.resuscitation.2008.06.019; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Ewy GA, 2007, CIRCULATION, V116, P2525, DOI 10.1161/CIRCULATIONAHA.107.711820; Folke F, 2010, CIRCULATION, V122, P623, DOI 10.1161/CIRCULATIONAHA.109.924423; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Investigators TPADT., 2004, NEW ENGL J MED, V351, P637, DOI [10.1056/NEJMoa040566, DOI 10.1056/NEJMOA040566]; Iwami T, 2006, RESUSCITATION, V69, P221, DOI 10.1016/j.resuscitation.2005.08.018; MacDonald RD, 2001, ANN EMERG MED, V38, P262, DOI 10.1067/mem.2001.117953; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; NICHOL G, 2008, JAMA-J AM MED ASSOC, V300, P1763; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; Stolzenberg Brett T, 2002, Prehosp Emerg Care, V6, P65, DOI 10.1080/10903120290938814; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Weisfeldt ML, 2010, NEW ENGL J MED, V363, P481, DOI 10.1056/NEJMe1006306; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077	26	216	227	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					313	321		10.1056/NEJMoa1010663	http://dx.doi.org/10.1056/NEJMoa1010663			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268723	Green Accepted, Green Published			2022-12-24	WOS:000286592600006
J	Hingorani, AD; Hemingway, H				Hingorani, Aroon D; Hemingway, Harry			How should we balance individual and population benefits of statins for preventing cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hingorani, Aroon D] UCL, Dept Epidemiol & Publ Hlth, Clin Epidemiol Grp, London, England; [Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England	University of London; University College London; University of London; University College London	Hingorani, AD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England.	a.hingorani@ucl.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; Hingorani, Aroon/0000-0001-8365-0081	British Heart Foundation [FS05/125] Funding Source: Medline; Department of Health [RP-PG-0407-10314] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Department of Health			0	12	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6244	10.1136/bmj.c6244	http://dx.doi.org/10.1136/bmj.c6244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270079				2022-12-24	WOS:000286887800015
J	Stewart, MP; Helenius, J; Toyoda, Y; Ramanathan, SP; Muller, DJ; Hyman, AA				Stewart, Martin P.; Helenius, Jonne; Toyoda, Yusuke; Ramanathan, Subramanian P.; Muller, Daniel J.; Hyman, Anthony A.			Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding	NATURE			English	Article							ATOMIC-FORCE MICROSCOPE; SHAPE; FLOW; MORPHOGENESIS; OSCILLATIONS; RETRACTION; MEMBRANE; RIGIDITY; DIVISION; MOESIN	During mitosis, adherent animal cells undergo a drastic shape change, from essentially flat to round(1-3). Mitotic cell rounding is thought to facilitate organization within the mitotic cell and be necessary for the geometric requirements of division(4-7). However, the forces that drive this shape change remain poorly understood in the presence of external impediments, such as a tissue environment(2). Here we use cantilevers to track cell rounding force and volume. We show that cells have an outward rounding force, which increases as cells enter mitosis. We find that this mitotic rounding force depends both on the actomyosin cytoskeleton and the cells' ability to regulate osmolarity. The rounding force itself is generated by an osmotic pressure. However, the actomyosin cortex is required to maintain this rounding force against external impediments. Instantaneous disruption of the actomyosin cortex leads to volume increase, and stimulation of actomyosin contraction leads to volume decrease. These results show that in cells, osmotic pressure is balanced by inwardly directed actomyosin cortex contraction. Thus, by locally modulating actomyosin-cortex-dependent surface tension and globally regulating osmotic pressure, cells can control their volume, shape and mechanical properties.	[Toyoda, Yusuke; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-1307 Dresden, Germany; [Stewart, Martin P.; Helenius, Jonne; Ramanathan, Subramanian P.; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Stewart, Martin P.] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-1307 Dresden, Germany.	daniel.muller@bsse.ethz.ch	Hyman, Anthony A/B-3917-2017; Ramanathan, Subramanian/AAE-9817-2020; Müller, Daniel J./A-5967-2010; Stewart, Martin Philip/E-8059-2011; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Müller, Daniel J./0000-0003-3075-0665; Stewart, Martin Philip/0000-0003-4112-6622; Ramanathan, Subu/0000-0002-2876-0322; Toyoda, Yusuke/0000-0003-0534-6898	DFG; BMBF; SNF; JSPS; Max Planck Society	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); SNF; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck SocietyFoundation CELLEX)	DFG, BMBF and SNF supported this project. JSPS supported Y.T. A. A. H. is funded by the Max Planck Society. We thank S. Bhakdi for toxins and advice on their use, T. J. Mitchison for extensive discussions on osmotic pressure and critical reading of the manuscript, M. Krieg for valuable insights into cell blebbing, and B. Baum, C. Brangwynne, S. Grill, A. Helenius, J. Howard, F. Julicher, Z. Maliga and E. Paluch for discussions and critical reading of the manuscript.	Bereiter-Hahn J, 2005, MED ENG PHYS, V27, P743, DOI 10.1016/j.medengphy.2005.04.021; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; HAROLD FM, 1990, MICROBIOL REV, V54, P381, DOI 10.1128/MMBR.54.4.381-431.1990; HARRIS A, 1973, DEV BIOL, V35, P97, DOI 10.1016/0012-1606(73)90009-2; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; HIRAMOTO Y, 1963, EXP CELL RES, V32, P59, DOI 10.1016/0014-4827(63)90069-7; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lang F., 2006, MECH SIGNIFICANCE CE; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; RUTA M, 1986, MOL CELL BIOL, V6, P1706, DOI 10.1128/MCB.6.5.1706; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Valeva A, 2000, MOL MICROBIOL, V36, P467, DOI 10.1046/j.1365-2958.2000.01865.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x	35	441	449	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					226	230		10.1038/nature09642	http://dx.doi.org/10.1038/nature09642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21196934				2022-12-24	WOS:000286143400041
J	Huttlin, EL; Jedrychowski, MP; Elias, JE; Goswami, T; Rad, R; Beausoleil, SA; Villen, J; Haas, W; Sowa, ME; Gygi, SP				Huttlin, Edward L.; Jedrychowski, Mark P.; Elias, Joshua E.; Goswami, Tapasree; Rad, Ramin; Beausoleil, Sean A.; Villen, Judit; Haas, Wilhelm; Sowa, Mathew E.; Gygi, Steven P.			A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression	CELL			English	Article							KINASE; PREDICTION; LIPOLYSIS; DATABASE	Although most tissues in an organism are genetically identical, the biochemistry of each is optimized to fulfill its unique physiological roles, with important consequences for human health and disease. Each tissue's unique physiology requires tightly regulated gene and protein expression coordinated by specialized, phosphorylation-dependent intracellular signaling. To better understand the role of phosphorylation in maintenance of physiological differences among tissues, we performed proteomic and phosphoproteomic characterizations of nine mouse tissues. We identified 12,039 proteins, including 6296 phosphoproteins harboring nearly 36,000 phosphorylation sites. Comparing protein abundances and phosphorylation levels revealed specialized, interconnected phosphorylation networks within each tissue while suggesting that many proteins are regulated by phosphorylation independently of their expression. Our data suggest that the "typical'' phosphoprotein is widely expressed yet displays variable, often tissue-specific phosphorylation that tunes protein activity to the specific needs of each tissue. We offer this dataset as an online resource for the biological research community.	[Huttlin, Edward L.; Jedrychowski, Mark P.; Elias, Joshua E.; Goswami, Tapasree; Beausoleil, Sean A.; Villen, Judit; Haas, Wilhelm; Sowa, Mathew E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rad, Ramin; Gygi, Steven P.] Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; [Sowa, Mathew E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu		Huttlin, Edward/0000-0002-1822-1173; Villen, Judit/0000-0002-1005-1739	NIH [HG3456]; ThermoFisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThermoFisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Xue Li and Abir Mukherjee for help with phosphorylation studies and acknowledge Julian Mintseris, Deepak Kolippikam, Noah Dephoure, Younghao Yu, and other Gygi lab members for insightful discussions. This work was funded in part by a grant from the NIH to S. P. G. (HG3456) and by an industry-sponsored research project with ThermoFisher Scientific.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Castellanos-Serra L, 2002, ELECTROPHORESIS, V23, P1745, DOI 10.1002/1522-2683(200206)23:11<1745::AID-ELPS1745>3.0.CO;2-A; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Dehmelt L, 2005, GENOME BIOL, V6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Duta F, 2006, HISTOCHEM CELL BIOL, V126, P495, DOI 10.1007/s00418-006-0188-z; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pasini EM, 2008, MOL CELL PROTEOMICS, V7, P1317, DOI 10.1074/mcp.M700458-MCP200; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; *ROCH APPL SCI, 2004, COMPL GUID PROT INH; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Watt MJ, 2008, BIOCHEM J, V414, P313, DOI 10.1042/BJ20080305; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040	51	1152	10079	17	383	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1174	1189		10.1016/j.cell.2010.12.001	http://dx.doi.org/10.1016/j.cell.2010.12.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183079	Green Accepted, Bronze			2022-12-24	WOS:000285625400014
J	Haigo, SL; Bilder, D				Haigo, Saori L.; Bilder, David			Global Tissue Revolutions in a Morphogenetic Movement Controlling Elongation	SCIENCE			English	Article							DROSOPHILA FOLLICULAR EPITHELIUM; OVARIAN FOLLICLES; PLANAR POLARITY; CELL-MIGRATION; AXIS; INTERCALATION; MECHANISMS; EXTENSION; INTEGRIN; PATHWAY	Polarized cell behaviors drive axis elongation in animal embryos, but the mechanisms underlying elongation of many tissues remain unknown. Eggs of Drosophila undergo elongation from a sphere to an ellipsoid during oogenesis. We used live imaging of follicles (developing eggs) to elucidate the cellular basis of egg elongation. We find that elongating follicles undergo repeated rounds of circumferential rotation around their long axes. Follicle epithelia mutant for integrin or collagen IV fail to rotate and elongate, which results in round eggs. We present evidence that polarized rotation is required to build a polarized, fibrillar extracellular matrix (ECM) that constrains tissue shape. Thus, global tissue rotation is a morphogenetic behavior that uses planar polarity information in the ECM to control tissue elongation.	[Haigo, Saori L.; Bilder, David] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bilder, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 379 Life Sci Addit 3200, Berkeley, CA 94720 USA.	bilder@berkeley.edu		Bilder, David/0000-0002-1842-4966	Berkeley Graduate Fellowship; American Heart Association; NIH [R01 GM068675]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675] Funding Source: NIH RePORTER	Berkeley Graduate Fellowship; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kimbrell, L. Cooley, A. Spradling, M. Buszczak, J. Lipsick, and the Bloomington Drosophila Stock Center for kindly providing fly stocks and M. Welch for providing reagents. We thank members of the Bilder laboratory, I. Hariharan, and R. Harland for providing feedback and S. Windler for comments on the manuscript. We apologize to those whose work could only be cited in review articles. This work is supported by a Berkeley Graduate Fellowship and an American Heart Association Predoctoral Fellowship to S.L.H. and by NIH grant R01 GM068675 to D.B.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bastock R, 2007, DEVELOPMENT, V134, P3055, DOI 10.1242/dev.010447; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; GUTZEIT HO, 1990, EUR J CELL BIOL, V53, P349; GUTZEIT HO, 1991, J CELL SCI, V100, P781; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; King R. C., 1970, OVARIAN DEV DROSOPHI; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; SHIH J, 1992, DEVELOPMENT, V116, P901; Spradling Allan C., 1993, P1; Viktorinova I, 2009, DEVELOPMENT, V136, P4123, DOI 10.1242/dev.039099; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; WENT DF, 1978, J EXP ZOOL, V205, P149, DOI 10.1002/jez.1402050118	30	210	213	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1071	1074		10.1126/science.1199424	http://dx.doi.org/10.1126/science.1199424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21212324	Green Accepted			2022-12-24	WOS:000287699000065
J	Sasaki, T; Matsuki, N; Ikegaya, Y				Sasaki, Takuya; Matsuki, Norio; Ikegaya, Yuji			Action-Potential Modulation During Axonal Conduction	SCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; ASTROCYTES; RECEPTORS	Once initiated near the soma, an action potential (AP) is thought to propagate autoregeneratively and distribute uniformly over axonal arbors. We challenge this classic view by showing that APs are subject to waveform modulation while they travel down axons. Using fluorescent patch-clamp pipettes, we recorded APs from axon branches of hippocampal CA3 pyramidal neurons ex vivo. The waveforms of axonal APs increased in width in response to the local application of glutamate and an adenosine A(1) receptor antagonist to the axon shafts, but not to other unrelated axon branches. Uncaging of calcium in periaxonal astrocytes caused AP broadening through ionotropic glutamate receptor activation. The broadened APs triggered larger calcium elevations in presynaptic boutons and facilitated synaptic transmission to postsynaptic neurons. This local AP modification may enable axonal computation through the geometry of axon wiring.	[Sasaki, Takuya; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo 1130033, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo 1130033, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Sasaki, Takuya/J-3283-2015	Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22115003, 22650080, 22680025]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Science Research (nos. 22115003, 22650080, and 22680025) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. T.S. collected experimental data and carried out the data analysis. Y.I. conceived the project and carried out the data analysis. T.S. and Y.I. wrote the manuscript. N.M. supervised the project and provided feedback on the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Ishikawa D, 2010, NEURAL NETWORKS, V23, P669, DOI 10.1016/j.neunet.2010.02.004; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Schicker K W, 2008, Curr Mol Pharmacol, V1, P106; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999	15	148	151	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					599	601		10.1126/science.1197598	http://dx.doi.org/10.1126/science.1197598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292979				2022-12-24	WOS:000286933600058
J	Wang, W; Barnaby, JY; Tada, Y; Li, H; Tor, M; Caldelari, D; Lee, DU; Fu, XD; Dong, XN				Wang, Wei; Barnaby, Jinyoung Yang; Tada, Yasuomi; Li, Hairi; Toer, Mahmut; Caldelari, Daniela; Lee, Dae-un; Fu, Xiang-Dong; Dong, Xinnian			Timing of plant immune responses by a central circadian regulator	NATURE			English	Article							DOWNY MILDEW RESISTANCE; PERONOSPORA-PARASITICA; CELL-DEATH; ARABIDOPSIS; RHYTHMS; GENES; TRANSCRIPTION; EXPRESSION; MUTANT; BAK1	The principal immune mechanism against biotrophic pathogens in plants is the resistance (R)-gene-mediated defence(1). It was proposed to share components with the broad-spectrum basal defence machinery(2). However, the underlying molecular mechanism is largely unknown. Here we report the identification of novel genes involved in R-gene-mediated resistance against downy mildew in Arabidopsis and their regulatory control by the circadian regulator, CIRCADIAN CLOCK-ASSOCIATED 1 (CCA1). Numerical clustering based on phenotypes of these gene mutants revealed that programmed cell death (PCD) is the major contributor to resistance. Mutants compromised in the R-gene-mediated PCD were also defective in basal resistance, establishing an interconnection between these two distinct defence mechanisms. Surprisingly, we found that these new defence genes are under circadian control by CCA1, allowing plants to 'anticipate' infection at dawn when the pathogen normally disperses the spores and time immune responses according to the perception of different pathogenic signals upon infection. Temporal control of the defence genes by CCA1 differentiates their involvement in basal and R-gene-mediated defence. Our study has revealed a key functional link between the circadian clock and plant immunity.	[Wang, Wei; Barnaby, Jinyoung Yang; Tada, Yasuomi; Caldelari, Daniela; Lee, Dae-un; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Toer, Mahmut] Univ Worcester, NPARU, Henwick Grove WR2 6AJ, Worcester, England	Duke University; University of California System; University of California San Diego; University of Worcester	Dong, XN (corresponding author), Duke Univ, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Wang, Wei/F-7425-2013; Tor, Mahmut/AAF-6449-2020; Wang, Wei/I-5230-2015; Tor, Mahmut/AAU-4624-2020; Tada, Yasuomi/M-5041-2014	Tor, Mahmut/0000-0002-4416-5048; Wang, Wei/0000-0002-3780-5158; LEE, DAEUN/0000-0002-8517-7010; Tada, Yasuomi/0000-0001-9900-069X; Barnaby, Jinyoung/0000-0001-6507-9985	NSF [MCB-0519898, HG004659]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Brady for performing mixed model ANOVA of the data and advice on data analyses; J. Li for sharing the protocol for elf18 treatment, E. Tobin for providing the CCA1<INF>OE</INF> transgenic line, R. McClung for CCA1:LUC, LHY:LUC, ztl-4 lines. H. Lu for helpful discussion of the work, F. Ausubel, P. Benfey, S. Brady, J. Siedow and R. Mohan for critiquing the manuscript. This work was supported by a grant from NSF (MCB-0519898) to X.D. and a grant (HG004659) to X.-D.F.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Donofrio NM, 2001, MOL PLANT MICROBE IN, V14, P439, DOI 10.1094/MPMI.2001.14.4.439; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tor M, 2002, PLANT CELL, V14, P993, DOI 10.1105/tpc.001123; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	27	307	326	9	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					110	U126		10.1038/nature09766	http://dx.doi.org/10.1038/nature09766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293378	Green Accepted			2022-12-24	WOS:000286886400044
J	Gibson, P; Tong, YA; Robinson, G; Thompson, MC; Currle, DS; Eden, C; Kranenburg, TA; Hogg, T; Poppleton, H; Martin, J; Finkelstein, D; Pounds, S; Weiss, A; Patay, Z; Scoggins, M; Ogg, R; Pei, YX; Yang, ZJ; Brun, S; Lee, Y; Zindy, F; Lindsey, JC; Taketo, MM; Boop, FA; Sanford, RA; Gajjar, A; Clifford, SC; Roussel, MF; McKinnon, PJ; Gutmann, DH; Ellison, DW; Wechsler-Reya, R; Gilbertson, RJ				Gibson, Paul; Tong, Yiai; Robinson, Giles; Thompson, Margaret C.; Currle, D. Spencer; Eden, Christopher; Kranenburg, Tanya A.; Hogg, Twala; Poppleton, Helen; Martin, Julie; Finkelstein, David; Pounds, Stanley; Weiss, Aaron; Patay, Zoltan; Scoggins, Matthew; Ogg, Robert; Pei, Yanxin; Yang, Zeng-Jie; Brun, Sonja; Lee, Youngsoo; Zindy, Frederique; Lindsey, Janet C.; Taketo, Makoto M.; Boop, Frederick A.; Sanford, Robert A.; Gajjar, Amar; Clifford, Steven C.; Roussel, Martine F.; McKinnon, Peter J.; Gutmann, David H.; Ellison, David W.; Wechsler-Reya, Robert; Gilbertson, Richard J.			Subtypes of medulloblastoma have distinct developmental origins	NATURE			English	Article							CELL; PROGENITORS; P53; HINDBRAIN; MODEL; MICE	Medulloblastoma encompasses a collection of clinically and molecularly diverse tumour subtypes that together comprise the most common malignant childhood brain tumour(1-4). These tumours are thought to arise within the cerebellum, with approximately 25% originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Sonic Hedgehog pathway (hereafter, SHH subtype)(3-8). The pathological processes that drive heterogeneity among the other medulloblastoma subtypes are not known, hindering the development of much needed new therapies. Here we provide evidence that a discrete subtype of medulloblastoma that contains activating mutations in the WNT pathway effector CTNNB1 (hereafter, WNT subtype) 1,3,4 arises outside the cerebellum from cells of the dorsal brainstem. We found that genes marking human WNT-subtype medulloblastomas are more frequently expressed in the lower rhombic lip (LRL) and embryonic dorsal brainstem than in the upper rhombic lip (URL) and developing cerebellum. Magnetic resonance imaging (MRI) and intra-operative reports showed that human WNT-subtype tumours infiltrate the dorsal brainstem, whereas SHH-subtype tumours are located within the cerebellar hemispheres. Activating mutations in Ctnnb1 had little impact on progenitor cell populations in the cerebellum, but caused the abnormal accumulation of cells on the embryonic dorsal brainstem which included aberrantly proliferating Zic1(+) precursor cells. These lesions persisted in all mutant adult mice; moreover, in 15% of cases in which Tp53 was concurrently deleted, they progressed to form medulloblastomas that recapitulated the anatomy and gene expression profiles of human WNT-subtype medulloblastoma. We provide the first evidence, to our knowledge, that subtypes of medulloblastoma have distinct cellular origins. Our data provide an explanation for the marked molecular and clinical differences between SHH- and WNT-subtype medulloblastomas and have profound implications for future research and treatment of this important childhood cancer.	[Gibson, Paul; Tong, Yiai; Robinson, Giles; Currle, D. Spencer; Eden, Christopher; Kranenburg, Tanya A.; Hogg, Twala; Poppleton, Helen; Martin, Julie; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Patay, Zoltan; Scoggins, Matthew; Ogg, Robert] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Lee, Youngsoo; Zindy, Frederique; Roussel, Martine F.; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Boop, Frederick A.; Sanford, Robert A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Thompson, Margaret C.] Cleveland Clin, Dept Pediat Hematol Oncol, Cleveland, OH 44195 USA; [Weiss, Aaron] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; [Pei, Yanxin; Yang, Zeng-Jie; Brun, Sonja; Wechsler-Reya, Robert] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lindsey, Janet C.; Clifford, Steven C.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Cleveland Clinic Foundation; Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University; Newcastle University - UK; Kyoto University; Washington University (WUSTL)	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Kranenburg, Tanya/F-7138-2012; Patay, Zoltan/N-6994-2018; Robinson, Giles/N-8095-2018; Pounds, Stanley/N-2480-2018	Gilbertson, Richard James/0000-0001-7539-9472; Kranenburg, Tanya/0000-0002-5329-4968; Patay, Zoltan/0000-0003-1479-9864; Robinson, Giles/0000-0001-7441-9486; Lee, Youngsoo/0000-0003-4773-6464; Gutmann, David/0000-0002-3127-5045; Pounds, Stanley/0000-0002-9167-2114; Clifford, Steve/0000-0003-4893-2184	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA129541, P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R.J.G. holds the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network and by the American Lebanese Syrian Associated Charities. We are grateful to A. Chenn, J. Johnson and C. Birchmeier for their gifts of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology and ARC at St Jude Children's Research Hospital for technical assistance.	Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dipietrantonio HJ, 2009, NEUROSCIENCE, V162, P560, DOI 10.1016/j.neuroscience.2009.02.082; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lee Y, 2003, CANCER RES, V63, P5428; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Storm R, 2009, DEVELOPMENT, V136, P295, DOI 10.1242/dev.027193; The WHO, 2020, CLASSIFICATION TUMOU; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Wetmore C, 2001, CANCER RES, V61, P513; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	29	538	553	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1095	1099		10.1038/nature09587	http://dx.doi.org/10.1038/nature09587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21150899	Green Accepted			2022-12-24	WOS:000285553800057
J	Oury, F; Sumara, G; Sumara, O; Ferron, M; Chang, HX; Smith, CE; Hermo, L; Suarez, S; Roth, BL; Ducy, P; Karsenty, G				Oury, Franck; Sumara, Grzegorz; Sumara, Olga; Ferron, Mathieu; Chang, Haixin; Smith, Charles E.; Hermo, Louis; Suarez, Susan; Roth, Bryan L.; Ducy, Patricia; Karsenty, Gerard			Endocrine Regulation of Male Fertility by the Skeleton	CELL			English	Article							MOUSE LEYDIG-CELLS; PROTEIN-COUPLED RECEPTOR; RAT SEMINIFEROUS TUBULES; RNA HELICASE GRTH/DDX25; BONE MASS; METABOLIC SYNDROME; ENERGY-METABOLISM; GENETIC-CONTROL; EXPRESSION; SERUM	Interactions between bone and the reproductive system have until now been thought to be limited to the regulation of bone remodeling by the gonads. We now show that, in males, bone acts as a regulator of fertility. Using coculture assays, we demonstrate that osteoblasts are able to induce testosterone production by the testes, though they fail to influence estrogen production by the ovaries. Analyses of cell-specific loss- and gain-of-function models reveal that the osteoblast-derived hormone osteocalcin performs this endocrine function. By binding to a G protein-coupled receptor expressed in the Leydig cells of the testes, osteocalcin regulates in a CREB-dependent manner the expression of enzymes that is required for testosterone synthesis, promoting germ cell survival. This study expands the physiological repertoire of osteocalcin and provides the first evidence that the skeleton is an endocrine regulator of reproduction.	[Oury, Franck; Sumara, Grzegorz; Sumara, Olga; Ferron, Mathieu; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Ducy, Patricia] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chang, Haixin; Suarez, Susan] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Smith, Charles E.; Hermo, Louis] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Roth, Bryan L.] Univ N Carolina, Dept Pharmacol Med Chem & Nat Prod, Sch Med, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Dept Pharmacol Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	Columbia University; Columbia University; Cornell University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Roth, Bryan L/F-3928-2010; Ferron, Mathieu/M-7794-2013; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Sumara, Grzegorz/0000-0003-1502-6265; Sumara, Olga/0000-0002-0845-3720; OURY, FRANCK/0000-0003-0562-9900	NIH; Fond de la recherche en sante du Quebec; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065439] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fond de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Drs. Behringer and Ko for generously providing the Amh-mis-Cre and Cyp17-iCre mice; Dr. Hampson for generously providing us Gprc6a antibody; Dr. A. F. Parlow for measurements of LH in serum (National Hormone and Peptide Program); Drs. Przedborski and Jackson-Lewis for gracious help with stereological analysis; Drs. Mark, Yadav, Yoshizawa, Allen, and Setola for critical experimental advice; and G. Ren for mouse genotyping. This work was supported by grants from the NIH (G. K.), Fond de la recherche en sante du Quebec (M. F.), and HFSP (G. S. and F. O.).	Basura GJ, 2008, HEARING RES, V244, P45, DOI 10.1016/j.heares.2008.07.009; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Dacquin R, 2004, DEV DYNAM, V229, P826, DOI 10.1002/dvdy.20003; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GRAY A, 1991, J CLIN EPIDEMIOL, V44, P671, DOI 10.1016/0895-4356(91)90028-8; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; Hikim APS, 1999, REV REPROD, V4, P38; HUNTER MG, 1982, MOL CELL ENDOCRINOL, V25, P35, DOI 10.1016/0303-7207(82)90167-8; Jamin SP, 2003, MOL CELL ENDOCRINOL, V211, P15, DOI 10.1016/j.mce.2003.09.006; KANAZAWA I, 2010, BONE IN PRESS, DOI DOI 10.1016/J.BONE.2010.12.020; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Powlin SS, 1998, TOXICOL SCI, V46, P61, DOI 10.1093/toxsci/46.1.61; Quigley CA, 2002, J CLIN ENDOCR METAB, V87, P24, DOI 10.1210/jc.87.1.24; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; SHARPE RM, 1992, J ANDROL, V13, P172; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Simpson E, 2000, TRENDS ENDOCRIN MET, V11, P184, DOI 10.1016/S1043-2760(00)00254-X; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; Tsai-Morris CH, 2007, MOL HUM REPROD, V13, P887, DOI 10.1093/molehr/gam065; Tsai-Morris CH, 2010, J CELL BIOCHEM, V109, P1142, DOI 10.1002/jcb.22493; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang GM, 2003, ENDOCRINOLOGY, V144, P5058, DOI 10.1210/en.2003-0563; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	52	419	451	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					796	809		10.1016/j.cell.2011.02.004	http://dx.doi.org/10.1016/j.cell.2011.02.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21333348	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000288007100017
J	Ege, MJ; Mayer, M; Normand, AC; Genuneit, J; Cookson, WOCM; Braun-Fahrlander, C; Heederik, D; Piarroux, R; von Mutius, E				Ege, Markus J.; Mayer, Melanie; Normand, Anne-Cecile; Genuneit, Jon; Cookson, William O. C. M.; Braun-Fahrlaender, Charlotte; Heederik, Dick; Piarroux, Renaud; von Mutius, Erika		GABRIELA Transregio 22 Study Grp	Exposure to Environmental Microorganisms and Childhood Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCHOOL-AGE-CHILDREN; IN-HOUSE DUST; ATOPIC SENSITIZATION; ALLERGIC DISEASES; FARM CHILDREN; MATTRESS DUST; ENDOTOXIN; BACTERIAL; INFLAMMATION; ASSOCIATION	BACKGROUND Children who grow up in environments that afford them a wide range of microbial exposures, such as traditional farms, are protected from childhood asthma and atopy. In previous studies, markers of microbial exposure have been inversely related to these conditions. METHODS In two cross-sectional studies, we compared children living on farms with those in a reference group with respect to the prevalence of asthma and atopy and to the diversity of microbial exposure. In one study - PARSIFAL (Prevention of Allergy - Risk Factors for Sensitization in Children Related to Farming and Anthroposophic Lifestyle) - samples of mattress dust were screened for bacterial DNA with the use of single-strand conformation polymorphism (SSCP) analyses to detect environmental bacteria that cannot be measured by means of culture techniques. In the other study - GABRIELA (Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma in the European Community [GABRIEL] Advanced Study) - samples of settled dust from children's rooms were evaluated for bacterial and fungal taxa with the use of culture techniques. RESULTS In both studies, children who lived on farms had lower prevalences of asthma and atopy and were exposed to a greater variety of environmental microorganisms than the children in the reference group. In turn, diversity of microbial exposure was inversely related to the risk of asthma (odds ratio for PARSIFAL, 0.62; 95% confidence interval [CI], 0.44 to 0.89; odds ratio for GABRIELA, 0.86; 95% CI, 0.75 to 0.99). In addition, the presence of certain more circumscribed exposures was also inversely related to the risk of asthma; this included exposure to species in the fungal taxon eurotium (adjusted odds ratio, 0.37; 95% CI, 0.18 to 0.76) and to a variety of bacterial species, including Listeria monocytogenes, bacillus species, corynebacterium species, and others (adjusted odds ratio, 0.57; 95% CI, 0.38 to 0.86). CONCLUSIONS Children living on farms were exposed to a wider range of microbes than were children in the reference group, and this exposure explains a substantial fraction of the inverse relation between asthma and growing up on a farm. (Funded by the Deutsche Forschungsgemeinschaft and the European Commission.)	[Ege, Markus J.; von Mutius, Erika] Univ Childrens Hosp Munich, Munich, Germany; [Mayer, Melanie] Tech Univ Munich, Inst Anim Hyg, D-8050 Freising Weihenstephan, Germany; [Genuneit, Jon] Univ Ulm, Inst Epidemiol, Ulm, Germany; [Normand, Anne-Cecile] Univ Franche Comte, Chronoenvironm Lab, F-25030 Besancon, France; [Piarroux, Renaud] Assistance Publ Hop Marseille, Dept Parasitol & Mycol, Marseille, France; [Piarroux, Renaud] Univ Aix Marseille 2, Marseille, France; [Cookson, William O. C. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Heederik, Dick] Univ Utrecht, Inst Risk Assessment, Div Environm Epidemiol, Utrecht, Netherlands	University of Munich; Technical University of Munich; Ulm University; Universite de Franche-Comte; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Utrecht University	Ege, MJ (corresponding author), Univ Munich, Childrens Hosp, Lindwurmstr 4, D-80337 Munich, Germany.	markus.ege@med.uni-muenchen.de	Normand, Anne-Cécile/V-4271-2018; Genuneit, Jon/I-9323-2012; Cookson, William/HHC-1790-2022; Loss, Georg/F-1557-2013; Fahimifar, Sepideh/M-5303-2019; Ege, Markus/C-1962-2012; Latzin, Philipp/F-2206-2017	Normand, Anne-Cécile/0000-0002-9589-4603; Genuneit, Jon/0000-0001-5764-1528; Ege, Markus/0000-0001-6643-3923; Pershagen, Goran/0000-0002-9701-1130; von Mutius, Erika/0000-0002-8893-4515; Wouters, Inge M./0000-0001-7834-9390; Latzin, Philipp/0000-0002-5239-1571; Loss, Georg/0000-0003-1090-812X; Heederik, Dick/0000-0002-4550-1437; piarroux, renaud/0000-0002-4151-4134	Deutsche Forschungsgemeinschaft [SFB Transregio 22, A1]; European Commission [LSH-2004-1.2.5-1, QLRT 1999-01391]; Medical Research Council [G1000758B, G0801056B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by grants from Deutsche Forschungsgemeinschaft (SFB Transregio 22 Pulmonary Allergies, Project A1) and the European Commission (LSH-2004-1.2.5-1 and QLRT 1999-01391).	Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kalliomaki M, 2008, ADV EXP MED BIOL, V635, P57, DOI 10.1007/978-0-387-09550-9_5; Korthals M, 2008, ENVIRON RES, V107, P299, DOI 10.1016/j.envres.2008.02.007; Korthals M, 2008, J MICROBIOL METH, V73, P49, DOI 10.1016/j.mimet.2008.01.010; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Normand AC, 2009, APPL ENVIRON MICROB, V75, P7617, DOI 10.1128/AEM.01414-09; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x; Sahakian NM, 2008, IMMUNOL ALLERGY CLIN, V28, P485, DOI 10.1016/j.iac.2008.03.009; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI 10.1016/j.jaci.2004.01.078; Vartiainen E, 2002, J ALLERGY CLIN IMMUN, V109, P643, DOI 10.1067/mai.2002.123307; Vogel K, 2008, J ALLERGY CLIN IMMUN, V122, P307, DOI 10.1016/j.jaci.2008.05.016; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0	27	1010	1051	8	229	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					701	709		10.1056/NEJMoa1007302	http://dx.doi.org/10.1056/NEJMoa1007302			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345099	Green Published			2022-12-24	WOS:000287652500004
J	Berry, JG; Hall, DE; Kuo, DZ; Cohen, E; Agrawal, R; Feudtner, C; Hall, M; Kueser, J; Kaplan, W; Neff, J				Berry, Jay G.; Hall, David E.; Kuo, Dennis Z.; Cohen, Eyal; Agrawal, Rishi; Feudtner, Chris; Hall, Matt; Kueser, Jacqueline; Kaplan, William; Neff, John			Hospital Utilization and Characteristics of Patients Experiencing Recurrent Readmissions Within Children's Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLEX CHRONIC CONDITIONS; DURABLE MEDICAL EQUIPMENT; WASHINGTON-STATE; CARE; PREVALENCE; EMERGENCY; PATTERNS	Context Early hospital readmission is emerging as an indicator of care quality. Some children with chronic illnesses may be readmitted on a recurrent basis, but there are limited data describing their rehospitalization patterns and impact. Objectives To describe the inpatient resource utilization, clinical characteristics, and admission reasons of patients recurrently readmitted to children's hospitals. Design, Setting, and Patients Retrospective cohort analysis of 317 643 patients (n=579 504 admissions) admitted to 37 US children's hospitals in 2003 with follow-up through 2008. Main Outcome Measure Maximum number of readmissions experienced by each child within any 365-day interval during the 5-year follow-up period. Results In the sample, 69 294 patients (21.8%) experienced at least 1 readmission within 365 days of a prior admission. Within a 365-day interval, 9237 patients (2.9%) experienced 4 or more readmissions; time between admissions was a median 37 days (interquartile range [IQR], 21-63). These patients accounted for 18.8% (109 155 admissions) of all admissions and 23.2% ($3.4 billion) of total inpatient charges for the study cohort during the entire follow-up period. Tests for trend indicated that as the number of readmissions increased from 0 to 4 or more, the prevalences increased for a complex chronic condition (from 22.3% [n=55 382/248 349] to 89.0% [n=8225/9237]; P<.001), technology assistance (from 5.3% [n=13 163] to 52.6% [n=4859]; P<.001), public insurance use (from 40.9% [n=101 575] to 56.3% [n=5202]; P<.001), and non-Hispanic black race (from 21.8% [n=54 140] to 34.4% [n=3181]; P<.001); and the prevalence decreased for readmissions associated with an ambulatory care-sensitive condition (from 23.1% [62 847/272 065] to 14.0% [15 282/109 155], P<.001). Of patients readmitted 4 or more times in a 365-day interval, 2633 (28.5%) were rehospitalized for a problem in the same organ system across all admissions during the interval. Conclusions Among a group of pediatric hospitals, 18.8% of admissions and 23.2% of inpatient charges were accounted for by the 2.9% of patients with frequent recurrent admissions. Many of these patients were rehospitalized recurrently for a problem in the same organ system. JAMA. 2011;305(7):682-690 www.jama.com	[Berry, Jay G.; Kaplan, William] Harvard Univ, Sch Med, Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Hall, David E.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Kuo, Dennis Z.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72205 USA; [Cohen, Eyal] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Agrawal, Rishi] Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Chicago, IL 60611 USA; [Feudtner, Chris] Childrens Hosp Philadelphia, Div Gen Pediat, PolicyLab, Philadelphia, PA 19104 USA; [Feudtner, Chris] Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA; [Hall, David E.; Kueser, Jacqueline] Child Hlth Corp Amer, Shawnee Mission, KS USA; [Neff, John] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Berry, JG (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	jay.berry@childrens.harvard.edu	Dalla Zuanna, Teresa/G-3133-2015; Cohen, Eyal/K-2575-2014; Feudtner, Chris/AAI-1126-2019; Hall, Matt/AAT-1349-2021	Cohen, Eyal/0000-0003-0112-7188; Feudtner, Chris/0000-0002-5879-0434; Hall, Matt/0000-0001-7778-5887	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23 HD058092]; Arkansas Biosciences Institute National Health Center for Research Resources [KL2RR029883]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD058092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029883] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Arkansas Biosciences Institute National Health Center for Research Resources; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Berry was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development career development award (K23 HD058092). Dr Kuo was supported by grant KL2RR029883 from the Arkansas Biosciences Institute National Health Center for Research Resources.	[Anonymous], CHILD HLTH CORPORATI; [Anonymous], PREV HOSP WIND PRIM; Beck Carolyn E, 2006, Paediatr Child Health, V11, P409; Berry JG, 2007, ARCH PEDIAT ADOL MED, V161, P38, DOI 10.1001/archpedi.161.1.38; Berry JG, 2009, PEDIATRICS, V124, P563, DOI 10.1542/peds.2008-3491; Berry SA, 2009, QUAL SAF HEALTH CARE, V18, P360, DOI 10.1136/qshc.2007.025056; Bhogal S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005306.pub2; Bowles EJA, 2009, MED CARE, V47, P1091, DOI 10.1097/MLR.0b013e3181a7e569; Buescher PA, 2006, MATERN CHILD HLTH J, V10, P461, DOI 10.1007/s10995-006-0081-3; Carrns Ann, 2010, US News World Rep, V147, P22; Consumer Price Index, CONS PRIC IND; COYE MJ, 2008, HOSP HEALTH NETWORK, V82, pA10; Curtis P, GUARDIAN; Czaja AS, 2009, PEDIATRICS, V123, P849, DOI 10.1542/peds.2008-0856; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V53, P401, DOI 10.1002/pbc.22048; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Goodman DM, 2002, PEDIATRICS, V110, P583, DOI 10.1542/peds.110.3.583; Guterman S, 2010, HEALTH AFFAIR, V29, P1188, DOI 10.1377/hlthaff.2010.0442; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kne T, 1998, AM J EMERG MED, V16, P648, DOI 10.1016/S0735-6757(98)90166-8; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Lubell Jennifer, 2007, Mod Healthc, V37, P37; Lye PS, 2010, PEDIATRICS, V126, P829, DOI 10.1542/peds.2010-1535; Mackie AS, 2008, AM HEART J, V155, P577, DOI 10.1016/j.ahj.2007.11.003; Massin MM, 2006, ACTA PAEDIATR, V95, P208, DOI 10.1080/08035250500346443; Medicare Payment Advisory Commission (U.S.), REP C PROM GREAT EFF; Millman M., 1993, ACCESS HLTH CARE AM; Moore Keith D, 2010, Healthc Financ Manage, V64, P57; Palfrey JS, 2004, PEDIATRICS, V113, P1507; PALFREY JS, 1994, PUBLIC HEALTH REP, V109, P226; Reynolds S, 1996, PEDIATR EMERG CARE, V12, P166, DOI 10.1097/00006565-199606000-00005; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Shah SS, 2008, NEUROSURGERY, V62, P1095, DOI 10.1227/01.neu.0000325871.60129.23; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Sneed RC, 2004, PEDIATRICS, V114, pE612, DOI 10.1542/peds.2004-1063; Sneed RC, 2001, PEDIATRICS, V107, P1283, DOI 10.1542/peds.107.6.1283; Srivastava R, 2005, PEDIATR CLIN N AM, V52, P1165, DOI 10.1016/j.pcl.2005.03.007; Srivastava R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4411; Stone BL, 2008, J PEDIATR REHAB MED, V1, P237; Turnock AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005074.pub2; Young NL, 2009, PHYS OCCUP THER PEDI, V29, P345, DOI 10.3109/01942630903245994	46	350	352	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					682	690		10.1001/jama.2011.122	http://dx.doi.org/10.1001/jama.2011.122			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325184	Bronze, Green Accepted			2022-12-24	WOS:000287361100019
J	Basu, U; Meng, FL; Keim, C; Grinstein, V; Pefanis, E; Eccleston, J; Zhang, TT; Myers, D; Wasserman, CR; Wesemann, DR; Januszyk, K; Gregory, RI; Deng, HT; Lima, CD; Alt, FW				Basu, Uttiya; Meng, Fei-Long; Keim, Celia; Grinstein, Veronika; Pefanis, Evangelos; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Januszyk, Kurt; Gregory, Richard I.; Deng, Haiteng; Lima, Christopher D.; Alt, Frederick W.			The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates	CELL			English	Article							CLASS SWITCH RECOMBINATION; CHROMOSOMAL R-LOOPS; PROTEIN-KINASE-A; POLYMERASE-II; SOMATIC HYPERMUTATION; MECHANISM; REGIONS; SEQUENCE; REPAIR; BREAKS	Activation-induced cytidine deaminase (AID) initiates immunoglobulin (Ig) heavy-chain (IgH) class switch recombination (CSR) and Ig variable region somatic hypermutation (SHM) in B lymphocytes by deaminating cytidines on template and nontemplate strands of transcribed DNA substrates. However, the mechanism of AID access to the template DNA strand, particularly when hybridized to a nascent RNA transcript, has been an enigma. We now implicate the RNA exosome, a cellular RNA-processing/degradation complex, in targeting AID to both DNA strands. In B lineage cells activated for CSR, the RNA exosome associates with AID, accumulates on IgH switch regions in an AID-dependent fashion, and is required for optimal CSR. Moreover, both the cellular RNA exosome complex and a recombinant RNA exosome core complex impart robust AID-and transcription-dependent DNA deamination of both strands of transcribed SHM substrates in vitro. Our findings reveal a role for noncoding RNA surveillance machinery in generating antibody diversity.	[Basu, Uttiya; Meng, Fei-Long; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Cellular & Mol Med,Dept Genet,Childrens H, Boston, MA 02115 USA; [Basu, Uttiya; Meng, Fei-Long; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Childrens Hosp Boston,Dept Genet, Boston, MA 02115 USA; [Basu, Uttiya; Keim, Celia; Grinstein, Veronika; Pefanis, Evangelos] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Deng, Haiteng] Rockefeller Univ, Prote Res Ctr, New York, NY 10065 USA; [Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Harvard Stem Cell Inst,Childrens Hosp Boston, Boston, MA 02115 USA; [Januszyk, Kurt; Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Columbia University; Rockefeller University; Harvard University; Boston Children's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Tsinghua University	Basu, U (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Cellular & Mol Med,Dept Genet,Childrens H, 300 Longwood Ave, Boston, MA 02115 USA.	ub2121@columbia.edu; alt@enders.tch.harvard.edu		Meng, Feilong/0000-0003-0333-6872; Wesemann, Duane/0000-0002-6690-944X; Deng, Haiteng/0000-0001-9496-1280; Lima, Christopher/0000-0002-9163-6092	National Institute of Health [AI31541, GM079196]; Columbia University; Regeneron Pharmaceuticals; Cancer Biology training grant [CA09503-23]; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI077595, R01AI077595, U19AI031541, U01AI031541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079196] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; Regeneron Pharmaceuticals(Regeneron); Cancer Biology training grant; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bjoern Schwer, Jason Rodriguez, Stephen Goff, Bruce Stillman, and Tasuku Honjo for providing reagents and/or protocols. We also thank Bjoern Schwer and Cosmas Giallourakis for critically reading the manuscript. This work was supported by National Institute of Health grants AI31541 (to F. W. A.) and GM079196 (to K.J. and C. D. L.); by Trustees of Columbia University Faculty startup funds (to U. B.); and by funds from Regeneron Pharmaceuticals (in support of E. P.). F.-L. M. is a fellow of Cancer Research Institute of New York. C. K. was supported by a Cancer Biology training grant CA09503-23. K.J. is a fellow of the American Cancer Society (PF-10-236-01-RMC). U. B. is a Special Fellow of the Leukemia and Lymphoma Society of America and the recipient of a New Investigator Award from the Leukemia Research Foundation. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Anderson JR, 2006, RNA, V12, P1810, DOI 10.1261/rna.144606; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Huang FT, 2006, P NATL ACAD SCI USA, V103, P5030, DOI 10.1073/pnas.0506548103; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Shen V, 2006, CELL, V127, P1093, DOI 10.1016/j.cell.2006.11.035; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	80	222	233	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					353	363		10.1016/j.cell.2011.01.001	http://dx.doi.org/10.1016/j.cell.2011.01.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21255825	Green Accepted, Bronze			2022-12-24	WOS:000286973100008
J	Wu, XY; Shen, QT; Oristian, DS; Lu, CP; Zheng, QS; Wang, HW; Fuchs, E				Wu, Xiaoyang; Shen, Qing-Tao; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Wang, Hong-Wei; Fuchs, Elaine			Skin Stem Cells Orchestrate Directional Migration by Regulating Microtubule-ACF7 Connections through GSK3 beta	CELL			English	Article							ACTIN; HOMEOSTASIS; NETWORKS; PLAKIN; CDC42; ACF7	Homeostasis and wound healing rely on stem cells (SCs) whose activity and directed migration are often governed by Wnt signaling. In dissecting how this pathway integrates with the necessary downstream cytoskeletal dynamics, we discovered that GSK3 beta, a kinase inhibited by Wnt signaling, directly phosphorylates ACF7, a > 500 kDa microtubule-actin crosslinking protein abundant in hair follicle stem cells (HF-SCs). We map ACF7's GSK3 beta sites to the microtubule-binding domain and show that phosphorylation uncouples ACF7 from microtubules. Phosphorylation-refractile ACF7 rescues overall microtubule architecture, but phosphorylation-constitutive mutants do not. Neither mutant rescues polarized movement, revealing that phospho-regulation must be dynamic. This circuitry is physiologically relevant and depends upon polarized GSK3 beta inhibition at the migrating front of SCs/progeny streaming from HFs during wound repair. Moreover, only ACF7 and not GSK beta-refractile-ACF7 restore polarized microtubule-growth and SC-migration to ACF7 null skin. Our findings provide insights into how this conserved spectraplakin integrates signaling, cytoskeletal dynamics, and polarized locomotion of somatic SCs.	[Wu, Xiaoyang; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Wu, Xiaoyang; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Shen, Qing-Tao; Wang, Hong-Wei] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Zheng, Qinsi] Weill Cornell Med Coll, Triinst Training Program Chem Biol, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Yale University; Cornell University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	ZHENG, Qin/T-2925-2019; Fuchs, Elaine/G-1565-2016	Lu, Catherine/0000-0003-4593-327X	National Institutes of Health [R01-AR27883]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R37AR027883, R01AR050452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to M. Schober, Y.C. Hsu, E. Ezratty, and T. Chen for discussions and helpful comments and to J. Fernandez and H. Deng (Proteomics Center) for their technical assistance in mass spectrometry analysis. Valuable technical assistance was provided by N. Stokes, L. Polak, E. Wong, M Nikolova, J. Racelis, A. North, and S. Bhuvanendran. All mice used in this study were bred and maintained at the Rockefeller University Association for Assessment and Accreditation of Laboratory Animal Care International-accredited Comparative Biology Center (CBC) in accordance with institutional and National Institutes of Health guidelines. This work was supported by Grant R01-AR27883 from the National Institutes of Health. E. F. is an investigator of the Howard Hughes Medical Institute. X. W. was an American Association for Cancer Research Anna D. Barker Fellow in Basic Cancer Research and the recipient of a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Schiller Martin R, 2007, Curr Protoc Protein Sci, VChapter 2, DOI 10.1002/0471140864.ps0212s48; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sun DM, 2001, J CELL SCI, V114, P161; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	35	140	147	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					341	352		10.1016/j.cell.2010.12.033	http://dx.doi.org/10.1016/j.cell.2010.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295697	Bronze, Green Accepted			2022-12-24	WOS:000286973100007
J	Jiao, YC; Shi, CJ; Edil, BH; de Wilde, RF; Klimstra, DS; Maitra, A; Schulick, RD; Tang, LH; Wolfgang, CL; Choti, MA; Velculescu, VE; Diaz, LA; Vogelstein, B; Kinzler, KW; Hruban, RH; Papadopoulos, N				Jiao, Yuchen; Shi, Chanjuan; Edil, Barish H.; de Wilde, Roeland F.; Klimstra, David S.; Maitra, Anirban; Schulick, Richard D.; Tang, Laura H.; Wolfgang, Christopher L.; Choti, Michael A.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Hruban, Ralph H.; Papadopoulos, Nickolas			DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE TUMORS; TUBEROUS SCLEROSIS; EXPRESSION; CANCER; ATRX; H3.3; LOCALIZATION; SUPPRESSOR; MUTATIONS	Pancreatic neuroendocrine tumors (PanNETs) are a rare but clinically important form of pancreatic neoplasia. To explore the genetic basis of PanNETs, we determined the exomic sequences of 10 nonfamilial PanNETs and then screened the most commonly mutated genes in 58 additional PanNETs. The most frequently mutated genes specify proteins implicated in chromatin remodeling: 44% of the tumors had somatic inactivating mutations in MEN1, which encodes menin, a component of a histone methyltransferase complex, and 43% had mutations in genes encoding either of the two subunits of a transcription/chromatin remodeling complex consisting of DAXX (death-domain-associated protein) and ATRX (alpha thalassemia/mental retardation syndrome X-linked). Clinically, mutations in the MEN1 and DAXX/ATRX genes were associated with better prognosis. We also found mutations in genes in the mTOR (mammalian target of rapamycin) pathway in 14% of the tumors, a finding that could potentially be used to stratify patients for treatment with mTOR inhibitors.	[Jiao, Yuchen; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA; [Jiao, Yuchen; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Shi, Chanjuan; de Wilde, Roeland F.; Maitra, Anirban; Hruban, Ralph H.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Edil, Barish H.; Schulick, Richard D.; Wolfgang, Christopher L.; Choti, Michael A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Klimstra, David S.; Tang, Laura H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Maitra, Anirban; Hruban, Ralph H.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Diaz, Luis A., Jr.] Johns Hopkins Univ, Swim Amer Lab, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Kinzler, KW (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; rhruban@jhmi.edu; npapado1@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; Wolfgang, Christopher/HGD-0863-2022; Velculescu, Victor/ABF-4846-2020; jiao, yuchen/H-6313-2011	Velculescu, Victor/0000-0003-1195-438X; Diaz, Luis/0000-0002-7079-8914; Jiao, Yuchen/0000-0001-7917-8810	Caring for Carcinoid Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Pancreatic Cancer Research Center; Joseph L. Rabinowitz Fund for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Raymond and Beverly Sackler Research Foundation; American Associatoion for Cancer Research; National Institutes of Health [CA121113, P50CA062924, P01CA134292, R01CA113669]; NATIONAL CANCER INSTITUTE [R01CA121113, R01CA113669, P01CA134292, R37CA057345, P50CA062924, R01CA057345] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Pancreatic Cancer Research Center; Joseph L. Rabinowitz Fund for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Raymond and Beverly Sackler Research Foundation; American Associatoion for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Whalen for expert technical assistance. This work was supported by a research grant from the Caring for Carcinoid Foundation, by the Lustgarten Foundation for Pancreatic Cancer Research, the Sol Goldman Pancreatic Cancer Research Center, the Joseph L. Rabinowitz Fund for Pancreatic Cancer Research, the Virginia and D. K. Ludwig Fund for Cancer Research, the Raymond and Beverly Sackler Research Foundation, the American Associatoion for Cancer Research Stand Up To Cancer-Dream Team Translational Cancer Research Grant, and by National Institutes of Health grants CA121113, P50CA062924, P01CA134292, and R01CA113669. N.P. B.V., L.D., V.E.V., and K.W.K. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N.P. B.V., L.D., V.E.V., and K.W.K. are co-founders of Inostics and Personal Genome Diagnostics and are members of their Scientific Advisory Boards. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. N.P., B.V., K.W.K., L.A.D., and V.E.V. own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict-of-interest policies. D.S.K. is a paid advisor for Novartis, which produces drugs for treatment of neuroendocrine tumors.	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Capelli P, 2009, ARCH PATHOL LAB MED, V133, P350, DOI 10.1043/1543-2165-133.3.350; Chung DC, 1998, CANCER RES, V58, P3706; Corbo V, 2010, ENDOCR-RELAT CANCER, V17, P771, DOI 10.1677/ERC-10-0028; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ekeblad S, 2008, CLIN CANCER RES, V14, P7798, DOI 10.1158/1078-0432.CCR-08-0734; Floridia G, 2005, CANCER GENET CYTOGEN, V156, P23, DOI 10.1016/j.cancergencyto.2004.04.015; Francalanci P, 2003, AM J SURG PATHOL, V27, P1386, DOI 10.1097/00000478-200310000-00012; Fredrich M, 2009, EXP BRAIN RES, V195, P241, DOI 10.1007/s00221-009-1776-7; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hruban RH, 2007, TUMORS PANCREAS ATLA, P191; Hu Wenwei, 2010, Genes Cancer, V1, P360; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim H, 2003, CANCER RES, V63, P6135; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yao JC, 2010, ANN ONCOL, V21, P4; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	29	1175	1226	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1199	1203		10.1126/science.1200609	http://dx.doi.org/10.1126/science.1200609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21252315	Green Accepted			2022-12-24	WOS:000287971200044
J	Gilbert, NC; Bartlett, SG; Waight, MT; Neau, DB; Boeglin, WE; Brash, AR; Newcomer, ME				Gilbert, Nathaniel C.; Bartlett, Sue G.; Waight, Maria T.; Neau, David B.; Boeglin, William E.; Brash, Alan R.; Newcomer, Marcia E.			The Structure of Human 5-Lipoxygenase	SCIENCE			English	Article							PURIFIED HUMAN 5-LIPOXYGENASE; CRYSTAL-STRUCTURE; SOYBEAN LIPOXYGENASE-1; C2-LIKE DOMAIN; PROTEIN; SPECIFICITY; OXYGENATION; 8R-LIPOXYGENASE; BIOSYNTHESIS; DETERMINANTS	The synthesis of both proinflammatory leukotrienes and anti-inflammatory lipoxins requires the enzyme 5-lipoxygenase (5-LOX). 5-LOX activity is short-lived, apparently in part because of an intrinsic instability of the enzyme. We identified a 5-LOX-specific destabilizing sequence that is involved in orienting the carboxyl terminus, which binds the catalytic iron. Here, we report the crystal structure at 2.4 angstrom resolution of human 5-LOX stabilized by replacement of this sequence.	[Gilbert, Nathaniel C.; Bartlett, Sue G.; Waight, Maria T.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Gilbert, Nathaniel/I-8223-2018	Gilbert, Nathaniel/0000-0002-6706-811X	American Heart Association [MCB 08553920E]; NSF [0818387]; NIH [GM-15431]; Louisiana Governors' Biotechnology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Governors' Biotechnology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by grants from the American Heart Association (MCB 08553920E) and NSF (0818387) to M.E.N. and from NIH (GM-15431) to A. R. B. Preliminary work was performed at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative. X-ray data were collected at Beam Line 24-ID-E of NE-CAT at the Advanced Photon Source. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession number 3O8Y. M.E.N., N.C.G., and S. G. B, have applied for a patent on the modified enzyme (Stable-5-LOX). For noncommercial use, the construct will be supplied subject to a material transfer agreement.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; AHARONY D, 1986, J BIOL CHEM, V261, P1512; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Chen XS, 1998, J BIOL CHEM, V273, P31237, DOI 10.1074/jbc.273.47.31237; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hammarberg T, 2002, ADV EXP MED BIOL, V507, P117; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kuhn H, 2003, ARTERIOSCL THROM VAS, V23, P1072, DOI 10.1161/01.ATV.0000074167.01184.48; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Neau DB, 2007, ACTA CRYSTALLOGR F, V63, P972, DOI 10.1107/S1744309107050993; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; PERCIVAL MD, 1992, EUR J BIOCHEM, V210, P109, DOI 10.1111/j.1432-1033.1992.tb17397.x; Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; Walther M, 2001, CHEM BIOL, V8, P779, DOI 10.1016/S1074-5521(01)00050-3; ZHANG YY, 1994, ANAL BIOCHEM, V220, P28, DOI 10.1006/abio.1994.1294	29	301	309	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					217	219		10.1126/science.1197203	http://dx.doi.org/10.1126/science.1197203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233389	Green Accepted, Green Submitted			2022-12-24	WOS:000286433100043
J	Khera, AV; Cuchel, M; de la Llera-Moya, M; Rodrigues, A; Burke, MF; Jafri, K; French, BC; Phillips, JA; Mucksavage, ML; Wilensky, RL; Mohler, ER; Rothblat, GH; Rader, DJ				Khera, Amit V.; Cuchel, Marina; de la Llera-Moya, Margarita; Rodrigues, Amrith; Burke, Megan F.; Jafri, Kashif; French, Benjamin C.; Phillips, Julie A.; Mucksavage, Megan L.; Wilensky, Robert L.; Mohler, Emile R.; Rothblat, George H.; Rader, Daniel J.			Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; METABOLIC SYNDROME; MACROPHAGE ABCA1; HDL; PLASMA; ABCG1; SERUM; ABILITY	BACKGROUND High-density lipoprotein (HDL) may provide cardiovascular protection by promoting reverse cholesterol transport from macrophages. We hypothesized that the capacity of HDL to accept cholesterol from macrophages would serve as a predictor of atherosclerotic burden. METHODS We measured cholesterol efflux capacity in 203 healthy volunteers who underwent assessment of carotid artery intima-media thickness, 442 patients with angiographically confirmed coronary artery disease, and 351 patients without such angiographically confirmed disease. We quantified efflux capacity by using a validated ex vivo system that involved incubation of macrophages with apolipoprotein B-depleted serum from the study participants. RESULTS The levels of HDL cholesterol and apolipoprotein A-I were significant determinants of cholesterol efflux capacity but accounted for less than 40% of the observed variation. An inverse relationship was noted between efflux capacity and carotid intima-media thickness both before and after adjustment for the HDL cholesterol level. Furthermore, efflux capacity was a strong inverse predictor of coronary disease status (adjusted odds ratio for coronary disease per 1-SD increase in efflux capacity, 0.70; 95% confidence interval [CI], 0.59 to 0.83; P<0.001). This relationship was attenuated, but remained significant, after additional adjustment for the HDL cholesterol level (odds ratio per 1-SD increase, 0.75; 95% CI, 0.63 to 0.90; P = 0.002) or apolipoprotein A-I level (odds ratio per 1-SD increase, 0.74; 95% CI, 0.61 to 0.89; P = 0.002). Additional studies showed enhanced efflux capacity in patients with the metabolic syndrome and low HDL cholesterol levels who were treated with pioglitazone, but not in patients with hypercholesterolemia who were treated with statins. CONCLUSIONS Cholesterol efflux capacity from macrophages, a metric of HDL function, has a strong inverse association with both carotid intima-media thickness and the likelihood of angiographic coronary artery disease, independently of the HDL cholesterol level.	[Cuchel, Marina; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Khera, Amit V.; Rodrigues, Amrith; Burke, Megan F.; Jafri, Kashif; French, Benjamin C.; Mucksavage, Megan L.; Wilensky, Robert L.; Mohler, Emile R.; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [French, Benjamin C.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Mucksavage, Megan L.; Rothblat, George H.] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Phillips, Julie A.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Rutgers State University New Brunswick	Cuchel, M (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 654 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mcuchel@mail.med.upenn.edu; rader@mail.med.upenn.edu			National Heart, Lung, and Blood Institute (NHLBI) [HL22633, P50 HL70128, HL077146]; National Center for Research Resources [M01 RR00040, UL1-RR-024134]; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, P50HL070128, K23HL077146] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (HL22633 and P50 HL70128) and the National Center for Research Resources (M01 RR00040 and UL1-RR-024134) and a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation. Dr. Khera was supported by a medical student research fellowship from the Howard Hughes Medical Institute, and Dr. Cuchel by a K23 award (HL077146) from the NHLBI.	Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Chirinos JA, 2005, CIRCULATION, V112, P2446, DOI 10.1161/CIRCULATIONAHA.104.521815; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Cui D, 2007, J LEUKOCYTE BIOL, V82, P1040, DOI 10.1189/jlb.0307192; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; de Vries R, 2008, ATHEROSCLEROSIS, V196, P733, DOI 10.1016/j.atherosclerosis.2006.12.027; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Dullaart RPF, 2008, EUR J ENDOCRINOL, V158, P53, DOI 10.1530/EJE-07-0451; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khera AV, 2010, CURR ATHEROSCLER REP, V12, P73, DOI 10.1007/s11883-009-0080-0; Ky B, 2008, J AM COLL CARDIOL, V51, P1653, DOI 10.1016/j.jacc.2008.01.026; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mikkola TS, 2003, ATHEROSCLEROSIS, V170, P31, DOI 10.1016/S0021-9150(03)00247-8; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Pajunen P, 2001, SCAND CARDIOVASC J, V35, P96; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P1516; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Syvanne M, 1996, ATHEROSCLEROSIS, V127, P245, DOI 10.1016/S0021-9150(96)05962-X; Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang LH, 2010, J LIPID RES, V51, P2211, DOI 10.1194/jlr.M004481; Zhou HL, 2008, DIABETES-METAB RES, V24, P617, DOI 10.1002/dmrr.895	39	1462	1516	5	168	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					127	135		10.1056/NEJMoa1001689	http://dx.doi.org/10.1056/NEJMoa1001689			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226578	Green Accepted			2022-12-24	WOS:000286142900006
J	Bastviken, D; Tranvik, LJ; Downing, JA; Crill, PM; Enrich-Prast, A				Bastviken, David; Tranvik, Lars J.; Downing, John A.; Crill, Patrick M.; Enrich-Prast, Alex			Freshwater Methane Emissions Offset the Continental Carbon Sink	SCIENCE			English	Article							LAKES		[Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden; [Tranvik, Lars J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Limnol, SE-75236 Uppsala, Sweden; [Downing, John A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Crill, Patrick M.] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, BR-68020 Rio De Janeiro, Brazil	Linkoping University; Uppsala University; Iowa State University; Stockholm University; Universidade Federal do Rio de Janeiro	Bastviken, D (corresponding author), Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden.	david.bastviken@liu.se	Enrich-Prast, Alex/H-5391-2012; Tranvik, Lars J/H-2222-2011; Prast, Alex Enrich/AAL-4722-2021; Crill, Patrick/ABC-1357-2021; Magaña, Felipe/B-6966-2013	Prast, Alex Enrich/0000-0003-3561-0936; Crill, Patrick/0000-0003-1110-3059; Tranvik, Lars J./0000-0003-3509-8266; Bastviken, David/0000-0003-0038-2152; Downing, John/0000-0001-8547-0789	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas); NSF [DEB-94-21535]; University of California at Santa Barbara; state of California	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas)(Swedish Research Council Formas); NSF(National Science Foundation (NSF)); University of California at Santa Barbara; state of California	We thank J. Cole, N. Than Duc, and H. Marotta for valuable input. This study was supported by the Swedish Research Council (VR) and the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas). Analyses of global surface water area come from the ITAC (Integrating the Terrestrial and Aquatic Carbon Cycle) Working Group supported by the National Center for Ecological Analysis and Synthesis, a center funded by NSF (grant DEB-94-21535), the University of California at Santa Barbara, and the state of California.	Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Downing J. A., 2009, ENCY INLAND WATERS, V1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Guerin F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027929; International Commission on Large Dams, 2006, DAMS NEWSL       MAY, P2; Kemenes A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029479; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298	13	904	968	66	841	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					50	50		10.1126/science.1196808	http://dx.doi.org/10.1126/science.1196808			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212349	Green Submitted			2022-12-24	WOS:000285974000030
J	Brenner, H; Chang-Claude, J; Seiler, CM; Rickert, A; Hoffmeister, M				Brenner, Hermann; Chang-Claude, Jenny; Seiler, Christoph M.; Rickert, Alexander; Hoffmeister, Michael			Protection From Colorectal Cancer After Colonoscopy A Population-Based, Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SIDED COLON-CANCER; SCREENING COLONOSCOPY; OUTPATIENT COLONOSCOPY; UNITED-STATES; RISK-FACTORS; PREVENTION; SIGMOIDOSCOPY; SURVEILLANCE; POLYPECTOMY; ENDOSCOPY	Background: Colonoscopy with detection and removal of adenomas is considered a powerful tool to reduce colorectal cancer (CRC) incidence. However, the degree of protection achievable in a population setting with high-quality colonoscopy resources remains to be quantified. Objective: To assess the association between previous colonoscopy and risk for CRC. Design: Population-based case-control study. Setting: Rhine-Neckar region of Germany. Patients: A total of 1688 case patients with colorectal cancer and 1932 control participants aged 50 years or older. Measurements: A detailed lifetime history of CRC risk factors and preventive factors, including history and results of previous colonoscopies, and of medical data obtained by self-reports and medical records. Odds ratios of CRC associated with colonoscopy in the preceding 10 years were estimated, after adjustment for sex, age, education level, participation in a general health screening examination, family history of CRC, smoking status, body mass index, and use of nonsteroidal anti-inflammatory drugs or hormone replacement therapy. Results: Overall, colonoscopy in the preceding 10 years was associated with 77% lower risk for CRC. Adjusted odds ratios for any CRC, right-sided CRC, and left-sided CRC were 0.23 (95% CI, 0.19 to 0.27), 0.44 (CI, 0.35 to 0.55), and 0.16 (CI, 0.12 to 0.20), respectively. Strong risk reduction was observed for all cancer stages and all ages, except for right-sided cancer in persons aged 50 to 59 years. Risk reduction increased over the years in both the right and the left colon. Limitation: The study was observational, with potential for residual confounding and selection bias. Conclusion: Colonoscopy with polypectomy can be associated with strongly reduced risk for CRC in the population setting. Aside from strong risk reduction with respect to left-sided CRC, risk reduction of more than 50% was also seen for right-sided colon cancer.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; Heidelberg Univ, Univ Clin Heidelberg, Heidelberg, Germany; Univ Hosp Mannheim, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@Dkfz-Heidelberg.de	Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/AAB-2321-2022; Hoffmeister, Michael/B-5745-2012; Seiler, Christoph/AAG-7056-2021	Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; 	German Research Council [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]	German Research Council(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Grant Support: By the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, and CH 117/1-1) and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814).	Ahmadi AA, 2007, SURG CLIN N AM, V87, P743, DOI 10.1016/j.suc.2007.03.013; Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2010, J NATL CANCER I, V102, P70, DOI 10.1093/jnci/djp469; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2001, BRIT J CANCER, V85, P972, DOI 10.1038/sj.bjc.6692023; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2007, AM J GASTROENTEROL, V102, P1739, DOI 10.1111/j.1572-0241.2007.01231.x; Brenner H, 2007, CANCER EPIDEM BIOMAR, V16, P494, DOI 10.1158/1055-9965.EPI-06-0460; Brenner H, 2010, ANN INTERN MED, V152, P697, DOI 10.7326/0003-4819-152-11-201006010-00002; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; Hoffmeister M, 2007, AM J EPIDEMIOL, V166, P130, DOI 10.1093/aje/kwm062; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Karlitz JJ, 2009, ANN INTERN MED, V150, P816, DOI 10.7326/0003-4819-150-11-200906020-00012; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Mulder SA, 2010, EUR J GASTROEN HEPAT, V22, P437, DOI 10.1097/MEG.0b013e328333fc6a; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pox C, 2008, Z GASTROENTEROL, V46, pS31, DOI 10.1055/s-2007-963563; Pox C, 2007, ENDOSCOPY, V39, P168, DOI 10.1055/s-2007-966182; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	42	587	602	1	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					22	U156		10.7326/0003-4819-154-1-201101040-00004	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200035				2022-12-24	WOS:000285830900003
J	Guizetti, J; Schermelleh, L; Mantler, J; Maar, S; Poser, I; Leonhardt, H; Muller-Reichert, T; Gerlich, DW				Guizetti, Julien; Schermelleh, Lothar; Maentler, Jana; Maar, Sandra; Poser, Ina; Leonhardt, Heinrich; Mueller-Reichert, Thomas; Gerlich, Daniel W.			Cortical Constriction During Abscission Involves Helices of ESCRT-III-Dependent Filaments	SCIENCE			English	Article							MEDIATED ABSCISSION; CYTOKINESIS; MIDBODY; MACHINERY; ALIX; SCISSION; SPASTIN; CELLS	After partitioning of cytoplasmic contents by cleavage furrow ingression, animal cells remain connected by an intercellular bridge, which subsequently splits by abscission. Here, we examined intermediate stages of abscission in human cells by using live imaging, three-dimensional structured illumination microscopy, and electron tomography. We identified helices of 17-nanometer-diameter filaments, which narrowed the cortex of the intercellular bridge to a single stalk. The endosomal sorting complex required for transport (ESCRT)-III co-localized with constriction zones and was required for assembly of 17-nanometer-diameter filaments. Simultaneous spastin-mediated removal of underlying microtubules enabled full constriction at the abscission site. The identification of contractile filament helices at the intercellular bridge has broad implications for the understanding of cell division and of ESCRT-III-mediated fission of large membrane structures.	[Mueller-Reichert, Thomas] Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Theoret Ctr, D-01307 Dresden, Germany; [Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Guizetti, Julien; Mueller-Reichert, Thomas; Gerlich, Daniel W.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol, D-82152 Planegg Martinsried, Germany; [Maentler, Jana; Poser, Ina] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Marine Biological Laboratory - Woods Hole; University of Munich; Max Planck Society	Muller-Reichert, T (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Theoret Ctr, Fetscherstr 74, D-01307 Dresden, Germany.	mueller-reichert@tu-dresden.de; daniel.gerlich@bc.biol.ethz.ch	Leonhardt, Heinrich/B-2791-2014; Gerlich, Daniel Wolfram W/A-6991-2016; Schermelleh, Lothar/H-4588-2019; Guizetti, Julien/AAF-3793-2020	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Schermelleh, Lothar/0000-0002-1612-9699; Guizetti, Julien/0000-0002-8762-4259; Guizetti, Julien/0000-0002-7735-4689	Swiss National Science Foundation [3100A0-114120]; ETH-TH; European Science Foundation; Evelyn and Melvin Spiegel Fund; Human Frontier Science Program [RGP 0034/2010]; Deutsche Forschungsgemeinschaft [MU 1423/2-1, MU 1423/3-1, SFB TR5]; BioImaging Network; Nanosystems Initiative Munich; European Commission [241548]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH-TH; European Science Foundation(European Science Foundation (ESF)European Commission); Evelyn and Melvin Spiegel Fund; Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioImaging Network; Nanosystems Initiative Munich; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. E. Smith, M. Petronczki, P. Steigemann, M. Glotzer, and Y. Barral for comments on the manuscript; S. Prugnaller, A. Boden, G. Fabig, E. Seemann, A. Maiser, J. Neumann, L. Kerr, G. Csucs, and the ETHZ Light Microscopy and RNAi Screening Centres for technical support; U. Rothbauer, J. Gertsch, I. Mellman, B. Pfeiffer, and K. H. Altmann for providing reagents; and A. A. Hyman for support and reagents. This work was supported by Swiss National Science Foundation research grant 3100A0-114120, an ETH-TH grant, a European Young Investigators award of the European Science Foundation to D. W. G., MBL Research Fellowships by the Evelyn and Melvin Spiegel Fund to D. W. G. and T. M. R., a Human Frontier Science Program grant (RGP 0034/2010) to T. M. R., and grants from the Deutsche Forschungsgemeinschaft (MU 1423/2-1 and MU 1423/3-1 to T. M. R. and SFB TR5 to H. L. and L. S.) and from the BioImaging Network and the Nanosystems Initiative Munich to L. S. and H. L. Work in the Hyman and Gerlich laboratories is supported by European Commission grant agreement 241548 (MitoSys).	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Darenfed H, 2005, BIOCHEM CELL BIOL, V83, P711, DOI 10.1139/O05-164; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	26	323	331	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1616	1620		10.1126/science.1201847	http://dx.doi.org/10.1126/science.1201847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21310966				2022-12-24	WOS:000288754500059
J	Nikolova, EN; Kim, E; Wise, AA; O'Brien, PJ; Andricioaei, I; Al-Hashimi, HM				Nikolova, Evgenia N.; Kim, Eunae; Wise, Abigail A.; O'Brien, Patrick J.; Andricioaei, Ioan; Al-Hashimi, Hashim M.			Transient Hoogsteen base pairs in canonical duplex DNA	NATURE			English	Article							DOUBLE-HELICAL DNA; NUCLEIC-ACIDS; TATA BOX; MOLECULAR-STRUCTURE; GENERALIZED BORN; SPIN RELAXATION; PROTEIN; NMR; DYNAMICS; PROTON	Sequence-directed variations in the canonical DNA double helix structure that retain Watson-Crick base-pairing have important roles in DNA recognition, topology and nucleosome positioning. By using nuclear magnetic resonance relaxation dispersion spectroscopy in concert with steered molecular dynamics simulations, we have observed transient sequence-specific excursions away from Watson-Crick base-pairing at CA and TA steps inside canonical duplex DNA towards low-populated and short-lived A.T and G.C Hoogsteen base pairs. The observation of Hoogsteen base pairs in DNA duplexes specifically bound to transcription factors and in damaged DNA sites implies that the DNA double helix intrinsically codes for excited state Hoogsteen base pairs as a means of expanding its structural complexity beyond that which can be achieved based on Watson-Crick base-pairing. The methods presented here provide a new route for characterizing transient low-populated nucleic acid structures, which we predict will be abundant in the genome and constitute a second transient layer of the genetic code.	[Nikolova, Evgenia N.; Wise, Abigail A.; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Kim, Eunae; Andricioaei, Ioan] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	andricio@uci.edu; hashimi@umich.edu		Nikolova, Evgenia/0000-0003-0365-2939	NSF [MCB 0644278, CHE-0918817]; NIH [R01GM089846]; Rackham International; University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham International; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. L. Hansen, S. Horowitz and J. Feigon for valuable discussions and suggestions, A. V. Kurochkin for NMR expertise, and C. L. Brooks III for access to a supercomputing cluster. We gratefully acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for support in the purchase of a 600 MHz spectrometer. This work was supported by NSF CAREER awards (MCB 0644278 to HMA and CHE-0918817 to I. A.) and an NIH grant (R01GM089846). E.N.N. acknowledges support by a Rackham International and Predoctoral Fellowship awarded by the University of Michigan.	Abrescia NGA, 2004, BIOCHEMISTRY-US, V43, P4092, DOI 10.1021/bi0355140; Abrescia NGA, 2002, P NATL ACAD SCI USA, V99, P2806, DOI 10.1073/pnas.052675499; Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chocholousova J, 2006, J PHYS CHEM B, V110, P17240, DOI 10.1021/jp0627675; Coman D, 2005, BIOPHYS J, V89, P3285, DOI 10.1529/biophysj.105.065763; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov VP, 1996, NAT STRUCT BIOL, V3, P505, DOI 10.1038/nsb0696-505; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; FERRY JD, 1953, J APPL PHYS, V24, P911, DOI 10.1063/1.1721401; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Frisch M., 2016, GAUSSIAN 16 REVISION; Ghosal G, 2006, BIOCHEM BIOPH RES CO, V343, P1, DOI 10.1016/j.bbrc.2006.02.148; GILBERT DE, 1989, P NATL ACAD SCI USA, V86, P3006, DOI 10.1073/pnas.86.9.3006; GREENE KL, 1995, J BIOMOL NMR, V5, P333; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoopes BC, 1998, J MOL BIOL, V277, P1015, DOI 10.1006/jmbi.1998.1651; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; IZATT RM, 1971, CHEM REV, V71, P439, DOI 10.1021/cr60273a002; Johnson JE, 2008, J AM CHEM SOC, V130, P16757, DOI 10.1021/ja805759z; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Koudelka GB, 2006, PROG NUCLEIC ACID RE, V81, P143, DOI 10.1016/S0079-6603(06)81004-4; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lu LH, 2010, NUCLEIC ACIDS RES, V38, P4415, DOI 10.1093/nar/gkq129; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; Miloushev VZ, 2005, J MAGN RESON, V177, P221, DOI 10.1016/j.jmr.2005.07.023; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; PARDI A, 1982, BIOCHEMISTRY-US, V21, P6567, DOI 10.1021/bi00268a038; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell SW, 2001, BIOCHEMISTRY-US, V40, P11065, DOI 10.1021/bi010890a; RECORD MT, 1981, ANNU REV BIOCHEM, V50, P997, DOI 10.1146/annurev.bi.50.070181.005025; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; Sau AK, 1995, FEBS LETT, V377, P301, DOI 10.1016/0014-5793(95)01362-8; SEAMAN FC, 1993, BIOCHEMISTRY-US, V32, P12577, DOI 10.1021/bi00210a005; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SegersNolten GMJ, 1997, BIOCHEMISTRY-US, V36, P13241, DOI 10.1021/bi971326w; Shajani Z, 2008, BIOCHEMISTRY-US, V47, P7617, DOI 10.1021/bi7020469; Shanmugam G, 2008, CHEM RES TOXICOL, V21, P1795, DOI 10.1021/tx8001466; Song K, 2009, J CHEM THEORY COMPUT, V5, P3105, DOI 10.1021/ct9001575; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; UGHETTO G, 1985, NUCLEIC ACIDS RES, V13, P2305, DOI 10.1093/nar/13.7.2305; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xu XP, 2000, J PHYS CHEM B, V104, P5641, DOI 10.1021/jp0007538; Yang H, 2008, FEBS LETT, V582, P1629, DOI 10.1016/j.febslet.2008.04.013	58	224	228	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					498	U84		10.1038/nature09775	http://dx.doi.org/10.1038/nature09775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21270796	Green Submitted, Green Accepted			2022-12-24	WOS:000287652900034
J	McKee, M; Cole, K; Hurst, L; Aldridge, RW; Horton, R				McKee, Martin; Cole, Katie; Hurst, Louise; Aldridge, Robert W.; Horton, Richard			Observations Medicine and the Media The other Twitter revolution: how social media are helping to monitor the NHS reforms	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin; Cole, Katie] London Sch Hyg & Trop Med, London, England; [Hurst, Louise] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Aldridge, Robert W.] UCL, Dept Infect & Populat Hlth, Ctr Infect Dis Epidemiol, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Aldridge, Robert/0000-0003-0542-0816	National Institute for Health Research [ACF-2009-18-028] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Appleby J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d566; COWPER A, 2010, SUPER WEDNESDAY POLI; COWPER A, 2011, ACCOUNTABILITY MATTE; Goldacre B., 2011, GUARDIAN; Organisation for Economic Co-operation and Development, 2010, IMPR VAL HLTH CAR ME; PEEDELL C, 2011, O LETWIN NEW POLL TA; 2011, HLTH IND LOBBYING TO	7	9	9	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d948	10.1136/bmj.d948	http://dx.doi.org/10.1136/bmj.d948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325389	Green Accepted			2022-12-24	WOS:000287656500022
J	Tsai, WW; Wang, ZX; Yiu, TT; Akdemir, KC; Xia, WY; Winter, S; Tsai, CY; Shi, XB; Schwarzer, D; Plunkett, W; Aronow, B; Gozani, O; Fischle, W; Hung, MC; Patel, DJ; Barton, MC				Tsai, Wen-Wei; Wang, Zhanxin; Yiu, Teresa T.; Akdemir, Kadir C.; Xia, Weiya; Winter, Stefan; Tsai, Cheng-Yu; Shi, Xiaobing; Schwarzer, Dirk; Plunkett, William; Aronow, Bruce; Gozani, Or; Fischle, Wolfgang; Hung, Mien-Chie; Patel, Dinshaw J.; Barton, Michelle Craig			TRIM24 links a non-canonical histone signature to breast cancer	NATURE			English	Article							GENE-EXPRESSION; PHD FINGER; NUCLEAR RECEPTORS; BINDING MODULES; CHROMATIN REGULATION; COACTIVATOR HTIF1; TRANSCRIPTION; ESTROGEN; COMPLEX; ALPHA	Recognition of modified histone species by distinct structural domains within 'reader' proteins plays a critical role in the regulation of gene expression. Readers that simultaneously recognize histones with multiple marks allow transduction of complex chromatin modification patterns into specific biological outcomes. Here we report that chromatin regulator tripartite motif-containing 24 (TRIM24) functions in humans as a reader of dual histone marks by means of tandem plant homeodomain (PHD) and bromodomain (Bromo) regions. The three-dimensional structure of the PHD-Bromo region of TRIM24 revealed a single functional unit for combinatorial recognition of unmodified H3K4 (that is, histone H3 unmodified at lysine 4, H3K4me0) and acetylated H3K23 (histone H3 acetylated at lysine 23, H3K23ac) within the same histone tail. TRIM24 binds chromatin and oestrogen receptor to activate oestrogen-dependent genes associated with cellular proliferation and tumour development. Aberrant expression of TRIM24 negatively correlates with survival of breast cancer patients. The PHD-Bromo of TRIM24 provides a structural rationale for chromatin activation through a non-canonical histone signature, establishing a new route by which chromatin readers may influence cancer pathogenesis.	[Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Tsai, Wen-Wei; Yiu, Teresa T.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Program Genes & Dev, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Yiu, Teresa T.; Akdemir, Kadir C.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Yiu, Teresa T.; Akdemir, Kadir C.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Xia, Weiya; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Akdemir, Kadir C.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Bioinformat, Houston, TX 77030 USA; [Winter, Stefan; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Tsai, Cheng-Yu; Plunkett, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Schwarzer, Dirk] Leibniz Inst Mol Pharmakol FMP, Dept Chem Biol Prot Chem, D-13125 Berlin, Germany; [Aronow, Bruce] Cincinnati Childrens Hosp Med Ctr, Computat Med Ctr, Cincinnati, OH 45229 USA; [Gozani, Or] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Max Planck Society; University of Texas System; UTMD Anderson Cancer Center; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Cincinnati Children's Hospital Medical Center; Stanford University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; mbarton@mdanderson.org	Wang, Zhanxin/A-7967-2012; Gozani, Or P/I-6157-2013; Hung, Mien-Chie/ABD-5911-2021; Aronow, Bruce J/F-8438-2012	Hung, Mien-Chie/0000-0003-4317-4740; Shi, Xiaobing/0000-0001-5242-8189; Schwarzer, Dirk/0000-0002-7477-3319; Barton, Michelle/0000-0002-4042-1374; Gozani, Or/0000-0002-1365-4463; Tsai, Cheng-Yu/0000-0002-6351-1858	National Institutes of Health (NIH) [GM081627, U54 RR025216, P30DK078392-01, GM079641]; George and Cynthia Mitchell Foundation; China Medical University and Hospital; MDACC; Starr Foundation; Leukemia and Lymphoma Society; Max Planck Society; NCI Cancer Center; Sowell-Huggins Foundation; EMBO; Center for Cancer Epigenetics;  [T32 HD07325]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641, P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Cynthia Mitchell Foundation; China Medical University and Hospital(China Medical University); MDACC; Starr Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Max Planck Society(Max Planck Society); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sowell-Huggins Foundation; EMBO(European Molecular Biology Organization (EMBO)); Center for Cancer Epigenetics; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health (NIH GM081627) and the George and Cynthia Mitchell Foundation (to M. C. B.), from NIH (U54 RR025216 and P30DK078392-01) to B. A., from NIH (GM079641) to O.G., from the Sister Institution Fund of China Medical University and Hospital and MDACC to M.-C. H., from the Starr Foundation and the Leukemia and Lymphoma Society to D.J.P., from the Max Planck Society to W. F., and from the NCI Cancer Center (Support Grant) to the UT MD Anderson Cancer Center. W.-W.T. was supported in part by the Sowell-Huggins Foundation; S. W. by a long-term EMBO fellowship; T.T.Y. by T32 HD07325; and K. C. A. by the Center for Cancer Epigenetics. We thank J. Song, D. C. Jamison, A. Dose, Z. Coban and Y. Wei for technical support and assistance. We are grateful to S. Stratton, M. Lee, M. Bedford, G. Lozano, S. Dent, A. Nardulli and members of our laboratories for advice, reagents and discussions.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Belloni E, 2005, GENE CHROMOSOME CANC, V42, P320, DOI 10.1002/gcc.20144; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; ECKERT RL, 1982, J BIOL CHEM, V257, P8840; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	54	295	301	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					927	U320		10.1038/nature09542	http://dx.doi.org/10.1038/nature09542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164480	Green Accepted, Green Published			2022-12-24	WOS:000285344600039
J	Ting, DT; Lipson, D; Paul, S; Brannigan, BW; Akhavanfard, S; Coffman, EJ; Contino, G; Deshpande, V; Iafrate, AJ; Letovsky, S; Rivera, MN; Bardeesy, N; Maheswaran, S; Haber, DA				Ting, David T.; Lipson, Doron; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Letovsky, Stan; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.			Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers	SCIENCE			English	Article							PERVASIVE TRANSCRIPTION; DIFFERENTIATION; ELEMENTS; DATABASE; RNAS	Satellite repeats in heterochromatin are transcribed into noncoding RNAs that have been linked to gene silencing and maintenance of chromosomal integrity. Using digital gene expression analysis, we showed that these transcripts are greatly overexpressed in mouse and human epithelial cancers. In 8 of 10 mouse pancreatic ductal adenocarcinomas (PDACs), pericentromeric satellites accounted for a mean 12% (range 1 to 50%) of all cellular transcripts, a mean 40-fold increase over that in normal tissue. In 15 of 15 human PDACs, alpha satellite transcripts were most abundant and HSATII transcripts were highly specific for cancer. Similar patterns were observed in cancers of the lung, kidney, ovary, colon, and prostate. Derepression of satellite transcripts correlated with overexpression of the long interspersed nuclear element 1 (LINE-1) retrotransposon and with aberrant expression of neuroendocrine-associated genes proximal to LINE-1 insertions. The overexpression of satellite transcripts in cancer may reflect global alterations in heterochromatin silencing and could potentially be useful as a biomarker for cancer detection.	[Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02114 USA; [Lipson, Doron; Letovsky, Stan] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	haber@helix.mgh.harvard.edu	Akhavanfard, Sara/R-2032-2017; Akhavanfard, Sara/AAP-6475-2020; Ting, David/F-4389-2017	Akhavanfard, Sara/0000-0003-1659-8185; Akhavanfard, Sara/0000-0003-1659-8185; Contino, Gianmarco/0000-0001-5874-0405; Ting, David/0000-0002-3261-2322	Pancreatic Cancer Action Network-American Association for Cancer Research; Warshaw Institute for Pancreatic Cancer Research; Fond. Veronesi; Howard Hughes Medical Institute; National Cancer Institute [CA129933]; NATIONAL CANCER INSTITUTE [R01CA129933, R01CA133557, P01CA117969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010023] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-American Association for Cancer Research; Warshaw Institute for Pancreatic Cancer Research; Fond. Veronesi(Fondazione Umberto Veronesi); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship and the Warshaw Institute for Pancreatic Cancer Research (D.T.T.); Fond. Veronesi (G.C.); Howard Hughes Medical Institute (D.A.H. and M.N.R.); and National Cancer Institute CA129933 (D.A.H). We thank T. Raz, P. Kapranov, E. Giladi, and J. Whetstine for helpful discussions and K. Haigis and K. Wong for providing mouse colon and lung tumors, respectively. Massachusetts General Hospital and the authors (D.A.H., D.L., S.M., D.T.T.) have filed a patent application relating to detection of satellite and LINE sequences in human cancers.	Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Cindolo L, 2007, UROL INT, V79, P287, DOI 10.1159/000109711; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Tezel E, 2000, CANCER, V89, P2230, DOI 10.1002/1097-0142(20001201)89:11<2230::AID-CNCR11>3.0.CO;2-X; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056	23	337	368	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					593	596		10.1126/science.1200801	http://dx.doi.org/10.1126/science.1200801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233348	Green Accepted			2022-12-24	WOS:000286933600056
J	Hess, M; Sczyrba, A; Egan, R; Kim, TW; Chokhawala, H; Schroth, G; Luo, SJ; Clark, DS; Chen, F; Zhang, T; Mackie, RI; Pennacchio, LA; Tringe, SG; Visel, A; Woyke, T; Wang, Z; Rubin, EM				Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Kim, Tae-Wan; Chokhawala, Harshal; Schroth, Gary; Luo, Shujun; Clark, Douglas S.; Chen, Feng; Zhang, Tao; Mackie, Roderick I.; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.			Metagenomic Discovery of Biomass-Degrading Genes and Genomes from Cow Rumen	SCIENCE			English	Article							IONIC LIQUIDS; PAN-GENOME; ONE-CELL; SWITCHGRASS; CELLULOSE; BACTERIAL; BIOFUELS; TIME	The paucity of enzymes that efficiently deconstruct plant polysaccharides represents a major bottleneck for industrial-scale conversion of cellulosic biomass into biofuels. Cow rumen microbes specialize in degradation of cellulosic plant material, but most members of this complex community resist cultivation. To characterize biomass-degrading genes and genomes, we sequenced and analyzed 268 gigabases of metagenomic DNA from microbes adherent to plant fiber incubated in cow rumen. From these data, we identified 27,755 putative carbohydrate-active genes and expressed 90 candidate proteins, of which 57% were enzymatically active against cellulosic substrates. We also assembled 15 uncultured microbial genomes, which were validated by complementary methods including single-cell genome sequencing. These data sets provide a substantially expanded catalog of genes and genomes participating in the deconstruction of cellulosic biomass.	[Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Chen, Feng; Zhang, Tao; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Chen, Feng; Zhang, Tao; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Kim, Tae-Wan; Chokhawala, Harshal; Clark, Douglas S.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schroth, Gary; Luo, Shujun] Illumina Inc, Hayward, CA 94545 USA; [Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Dept Anim Sci, Urbana, IL 61801 USA; [Mackie, Roderick I.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Illumina; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rubin, EM (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Visel, Axel/A-9398-2009; Wang, Zhong/J-3244-2019; Hess, Matthias/B-1783-2012; Wang, Zhong/E-7897-2011; Hess, Matthias/R-3006-2017	Visel, Axel/0000-0002-4130-7784; Wang, Zhong/0000-0002-6307-0458; Hess, Matthias/0000-0003-0321-0380; Pennacchio, Len/0000-0002-8748-3732; Sczyrba, Alexander/0000-0002-4405-3847	Office of Science of the U.S. Department of Energy [DE-AC02-05CH112]; U.S. Department of Energy [DE-AC02-05CH11231]; Energy Biosciences Institute at the University of California, Berkeley	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute at the University of California, Berkeley	We thank J. Bristow, P. Hugenholtz, F. Warnecke, and K. Mavrommatis for critical discussions and reading the manuscript. We acknowledge technical support by the JGI production team, L. M. Sczyrba, M. Harmon-Smith, J. Froula, J. Martin, C. Wright, A. Lipzen, J. Zhao, S. Malfatti and Stefan Bauer. We thank P. D'Haeseleer for sequences extracted from the CAZy database, Jonas Lovaas Gjerstad for the picture of the fistulated cow, T. Shinkei, T. Yannarell, J. Kim and staff at the Dairy Farm, Department of Animal Sciences for assistance with the maintenance of the fistulated cows, nylon bag experiments and lab procedures carried out at the University of Illinois. The work conducted by the U.S. Department of Energy Joint Genome Institute was supported in part by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH112 and U.S. Department of Energy under contract DE-AC02-05CH11231 (cow rumen metagenomics data analysis and informatics). Supported by a research grant from the Energy Biosciences Institute at the University of California, Berkeley (M.H.). Data are available at the NCBI Short Read Archive under accession number SRA023560 and GenBank accession numbers HQ706005-HQ706094. Complete data can also be accessed through the Web site of the DOE Joint Genome Institute (www.jgi.doe.gov).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MEYER JHF, 1986, APPL ENVIRON MICROB, V51, P622, DOI 10.1128/AEM.51.3.622-629.1986; Parrish DJ, 2009, METHODS MOL BIOL, V581, P27, DOI 10.1007/978-1-60761-214-8_2; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sanderson K, 2006, NATURE, V444, P673, DOI 10.1038/444673a; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; Wang FC, 2009, MICROBIOL RES, V164, P650, DOI 10.1016/j.micres.2008.12.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhao H, 2010, BIOTECHNOL PROGR, V26, P127, DOI 10.1002/btpr.331; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	30	851	947	20	545	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					463	467		10.1126/science.1200387	http://dx.doi.org/10.1126/science.1200387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273488				2022-12-24	WOS:000286635900054
J	Fewtrell, M; Wilson, DC; Booth, I; Lucas, A				Fewtrell, Mary; Wilson, David C.; Booth, Ian; Lucas, Alan			Six months of exclusive breast feeding: how good is the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRON-DEFICIENCY; DURATION; RISK; HOSPITALIZATION; INFANTS; HEALTH; CONSUMPTION; INFECTION; EXPOSURE; CHILDREN		[Fewtrell, Mary; Lucas, Alan] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England; [Wilson, David C.] Univ Edinburgh, Coll Med & Vet Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Booth, Ian] Univ Birmingham, Inst Child Hlth, Birmingham B15 2TT, W Midlands, England	University of London; University College London; University of Edinburgh; University of Birmingham	Fewtrell, M (corresponding author), UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England.	m.fewtrell@ich.ucl.ac.uk			Medical Research Council [G1002033] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Agostoni C, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1423; Bolling K, 2007, INFANT FEEDING SURVE; British Dietetic Association, 2010, BDA PAED GROUP POS S; Chantry CJ, 2007, BREASTFEED MED, V2, P63, DOI 10.1089/bfm.2007.0002; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Garza C, 2002, NUTRIENT ADEQUACY EX; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Kramer MS, 2009, AM J CLIN NUTR, V90, P1070, DOI 10.3945/ajcn.2009.28021; Kramer MS, 2003, AM J CLIN NUTR, V78, P291, DOI 10.1093/ajcn/78.2.291; KRAMER MS, 2002, OPTIMAL DURATION EXC; Lanigan JA, 2001, EUR J CLIN NUTR, V55, P309, DOI 10.1038/sj.ejcn.1601168; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; [OECD Directorate for Employment Labour and Social Affairs Social Policy Division], 2009, OECD FAM DAT CO1 5 B; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Talayero JMP, 2006, PEDIATRICS, V118, pE92, DOI 10.1542/peds.2005-1629; Platt MPW, 2009, ARCH DIS CHILD, V94, P79, DOI 10.1136/adc.2008.150011; Poole JA, 2006, J ALLERGY CLIN IMMUN, V117, pS42, DOI 10.1016/j.jaci.2005.12.174; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Quigley MA, 2009, ARCH DIS CHILD, V94, P148, DOI 10.1136/adc.2008.146126; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rebhan B, 2009, ACTA PAEDIATR, V98, P974, DOI 10.1111/j.1651-2227.2009.01281.x; Reilly JJ, 2005, BRIT J NUTR, V94, P56, DOI 10.1079/BJN20051464; Reilly JJ, 2005, BRIT J NUTR, V94, P869, DOI 10.1079/BJN20051601; Schack-Nielsen L, 2010, AM J CLIN NUTR, V91, P619, DOI 10.3945/ajcn.2008.27078; [Scientific Advisory Committee on Nutrition (SACN) Subgroup on Maternal and Child Nutrition (SMCN)], 2003, SMCN0308 SACN; [Scientific Advisory Committee on Nutrition (SACN) Subgroup on Maternal and Child Nutrition (SMCN)], 2003, 2 M SUBGR MAT CHILD; WHO, 1998, WHONUT981; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; World Health Organization (WHO), 2002, 55 WORLD HLTH ASS IN	34	79	80	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c5955	10.1136/bmj.c5955	http://dx.doi.org/10.1136/bmj.c5955			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233152	Green Published			2022-12-24	WOS:000286386600005
J	Zheng, W; McLerran, DF; Rolland, B; Zhang, XL; Inoue, M; Matsuo, K; He, JA; Gupta, PC; Ramadas, K; Tsugane, S; Irie, F; Tamakoshi, A; Gao, YT; Wang, RW; Shu, XO; Tsuji, I; Kuriyama, S; Tanaka, H; Satoh, H; Chen, CJ; Yuan, JM; Yoo, KY; Ahsan, H; Pan, WH; Gu, DF; Pednekar, MS; Sauvaget, C; Sasazuki, S; Sairenchi, T; Yang, G; Xiang, YB; Nagai, M; Suzuki, T; Nishino, Y; You, SL; Koh, WP; Park, SK; Chen, Y; Shen, CY; Thornquist, M; Feng, ZD; Kang, DH; Boffetta, P; Potter, JD				Zheng, Wei; McLerran, Dale F.; Rolland, Betsy; Zhang, Xianglan; Inoue, Manami; Matsuo, Keitaro; He, Jiang; Gupta, Prakash Chandra; Ramadas, Kunnambath; Tsugane, Shoichiro; Irie, Fujiko; Tamakoshi, Akiko; Gao, Yu-Tang; Wang, Renwei; Shu, Xiao-Ou; Tsuji, Ichiro; Kuriyama, Shinichi; Tanaka, Hideo; Satoh, Hiroshi; Chen, Chien-Jen; Yuan, Jian-Min; Yoo, Keun-Young; Ahsan, Habibul; Pan, Wen-Harn; Gu, Dongfeng; Pednekar, Mangesh Suryakant; Sauvaget, Catherine; Sasazuki, Shizuka; Sairenchi, Toshimi; Yang, Gong; Xiang, Yong-Bing; Nagai, Masato; Suzuki, Takeshi; Nishino, Yoshikazu; You, San-Lin; Koh, Woon-Puay; Park, Sue K.; Chen, Yu; Shen, Chen-Yang; Thornquist, Mark; Feng, Ziding; Kang, Daehee; Boffetta, Paolo; Potter, John D.			Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE COHORT; MORTALITY; OBESITY; OVERWEIGHT; WEIGHT; WOMEN; MEN	BACKGROUND Most studies that have evaluated the association between the body-mass index (BMI) and the risks of death from any cause and from specific causes have been conducted in populations of European origin. METHODS We performed pooled analyses to evaluate the association between BMI and the risk of death among more than 1.1 million persons recruited in 19 cohorts in Asia. The analyses included approximately 120,700 deaths that occurred during a mean follow-up period of 9.2 years. Cox regression models were used to adjust for confounding factors. RESULTS In the cohorts of East Asians, including Chinese, Japanese, and Koreans, the lowest risk of death was seen among persons with a BMI (the weight in kilograms divided by the square of the height in meters) in the range of 22.6 to 27.5. The risk was elevated among persons with BMI levels either higher or lower than that range - by a factor of up to 1.5 among those with a BMI of more than 35.0 and by a factor of 2.8 among those with a BMI of 15.0 or less. A similar U-shaped association was seen between BMI and the risks of death from cancer, from cardiovascular diseases, and from other causes. In the cohorts comprising Indians and Bangladeshis, the risks of death from any cause and from causes other than cancer or cardiovascular disease were increased among persons with a BMI of 20.0 or less, as compared with those with a BMI of 22.6 to 25.0, whereas there was no excess risk of either death from any cause or cause-specific death associated with a high BMI. CONCLUSIONS Underweight was associated with a substantially increased risk of death in all Asian populations. The excess risk of death associated with a high BMI, however, was seen among East Asians but not among Indians and Bangladeshis.	[Zheng, Wei; Zhang, Xianglan; Shu, Xiao-Ou; Yang, Gong] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Div Epidemiol, Nashville, TN 37203 USA; [McLerran, Dale F.; Rolland, Betsy; Thornquist, Mark; Feng, Ziding; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Matsuo, Keitaro; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Suzuki, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Irie, Fujiko] Ibaraki Prefectural Govt, Dept Hlth & Social Serv, Ibaraki, Japan; [Tamakoshi, Akiko] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan; [Tsuji, Ichiro; Kuriyama, Shinichi; Nagai, Masato] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Ishinomaki, Miyagi, Japan; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Gupta, Prakash Chandra; Pednekar, Mangesh Suryakant] Healis Sekhsaria Inst Publ Hlth, Bombay, Maharashtra, India; [Ramadas, Kunnambath] Reg Canc Ctr, Div Radiat Oncol, Trivandrum 695011, Kerala, India; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Wang, Renwei; Yuan, Jian-Min] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Chen, Chien-Jen; You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; [Pan, Wen-Harn] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichung, Taiwan; [Yoo, Keun-Young; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Inst Hlth Policy & Management, Seoul, South Korea; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies Med & Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng] China Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Sauvaget, Catherine] Int Agcy Res Canc, Prevent & Early Detect Sect, Screening Grp, F-69372 Lyon, France; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Chen, Yu] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	Vanderbilt University; Fred Hutchinson Cancer Center; National Cancer Center - Japan; Aichi Cancer Center; Nagoya City University; Aichi Medical University; Tohoku University; Dokkyo Medical University; Miyagi Cancer Center; Tulane University; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; China Medical University Taiwan; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Chicago; University of Chicago; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; World Health Organization; International Agency for Research on Cancer (IARC); National University of Singapore; New York University; Icahn School of Medicine at Mount Sinai	Zheng, W (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, 2525 W End Ave,8th Fl, Nashville, TN 37203 USA.	wei.zheng@vanderbilt.edu	Kang, Dae Hee/E-8631-2012; Gao, Yu/HGE-1937-2022; Chen, Chien-Jen/N-4723-2019; Tsugane, Shoichiro/A-2424-2015; Shen, CY/F-6271-2010; Park, Sue Kyung/J-2757-2012; Tamakoshi, Akiko/D-5105-2012; Nagai, Masato/ABC-6862-2020; He, Jiang/AAF-5303-2020; Yoo, Keun-Young/J-5548-2012; Gao, Y./GWZ-3665-2022; Boffetta, Paolo/AAI-7767-2021; gao, yi/HCI-8298-2022; zhang, weihua/GXV-1334-2022; Chen, Chien-Jen/C-6976-2008; Tanaka, Hideo/A-8145-2016; Zheng, Wei/O-3351-2013; Matsuo, Keitaro/H-6758-2019	Tsugane, Shoichiro/0000-0003-4105-2774; Nagai, Masato/0000-0003-0818-3158; He, Jiang/0000-0002-8286-9652; Boffetta, Paolo/0000-0002-3811-2791; Zheng, Wei/0000-0003-1226-070X; Matsuo, Keitaro/0000-0003-1761-6314; Potter, John/0000-0001-5439-1500; Yuan, Jian-Min/0000-0002-4620-3108; Sauvaget, Catherine/0000-0002-8053-4963; Kang, Daehee/0000-0003-4031-5878; Chen, Yu/0000-0002-1519-4894; Sairenchi, Toshimi/0000-0001-8896-6501; Pednekar, Mangesh/0000-0001-6266-5356	CDC Foundation for Global Adult Tobacco Survey; World Lung Foundation for advancing tobacco control in India; Institute for Community Research; NATIONAL CANCER INSTITUTE [R37CA070867, R01CA082729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017541] Funding Source: NIH RePORTER	CDC Foundation for Global Adult Tobacco Survey; World Lung Foundation for advancing tobacco control in India; Institute for Community Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Dr. Gupta reports receiving consulting fees from the CDC Foundation for Global Adult Tobacco Survey. His institution, Healis-Sekhsaria Institute for Public Health, has received grants from the World Lung Foundation for advancing tobacco control in India and consulting fees from the Institute for Community Research for a project on the use of smokeless tobacco in an urban slum in Mumbai, India. No other potential conflict of interest relevant to this article was reported.	Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	21	581	616	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					719	729		10.1056/NEJMoa1010679	http://dx.doi.org/10.1056/NEJMoa1010679			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345101	Green Accepted, Green Submitted			2022-12-24	WOS:000287652500006
J	Tang, YC; Williams, BR; Siegel, JJ; Amon, A				Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika			Identification of Aneuploidy-Selective Antiproliferation Compounds	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; AUTOPHAGY; HSP90; PROLIFERATION; TUMORIGENESIS; INSTABILITY; METABOLISM; PHENOTYPES; INHIBITORS	Aneuploidy, an incorrect chromosome number, is a hallmark of cancer. Compounds that cause lethality in aneuploid, but not euploid, cells could therefore provide new cancer therapies. We have identified the energy stress-inducing agent AICAR, the protein folding inhibitor 17-AAG, and the autophagy inhibitor chloroquine as exhibiting this property. AICAR induces p53-mediated apoptosis in primary mouse embryonic fibroblasts (MEFs) trisomic for chromosome 1, 13, 16, or 19. AICAR and 17-AAG, especially when combined, also show efficacy against aneuploid human cancer cell lines. Our results suggest that compounds that interfere with pathways that are essential for the survival of aneuploid cells could serve as a new treatment strategy against a broad spectrum of human tumors.	[Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Tang, Yun-Chi/GRE-8205-2022	tang, yun qi/0000-0001-9385-2787; Amon, Angelika/0000-0001-9837-0314	Howard Hughes Medical Institute; Curt W. and Kathy Marble Cancer Research Fund; Human Frontier Science Program Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Curt W. and Kathy Marble Cancer Research Fund; Human Frontier Science Program Fellowship(Human Frontier Science Program)	We thank H.-C. Chang and M. vander Heiden for discussions; M. Hemann for the LMS vectors and shp53.1224; D. Sabatini for torin1; J.M. van Deursen for Bub1b<SUP>H/H</SUP> mice; P. Zhang for Cdc20<SUP>AAA</SUP> MEF cells; and E. Vazile in the Koch Institute Microscopy facility for assistance. We are grateful to M. Dunham, M. Hemann, J. Lees, D. Sabatini, F. Solomon, and members of the Amon lab for their critical reading of the manuscript. This work was supported by grants from the Howard Hughes Medical Institute and the Curt W. and Kathy Marble Cancer Research Fund. Y.-C.T. is supported by the Human Frontier Science Program Fellowship.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Georgakis GV, 2006, EXP HEMATOL, V34, P1670, DOI 10.1016/j.exphem.2006.07.002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Larson PS, 2006, J PATHOL, V209, P307, DOI 10.1002/path.1973; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Lin HY, 2006, AM J MED GENET A, V140A, P945, DOI 10.1002/ajmg.a.31173; LINDSLEY DL, 1972, GENETICS, V71, P157; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; MOERMAN P, 1988, HUM GENET, V80, P349, DOI 10.1007/BF00273650; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Shih IM, 2001, CANCER RES, V61, P818; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	44	245	249	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					499	512		10.1016/j.cell.2011.01.017	http://dx.doi.org/10.1016/j.cell.2011.01.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21315436	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000287473100006
J	Eden, E; Geva-Zatorsky, N; Issaeva, I; Cohen, A; Dekel, E; Danon, T; Cohen, L; Mayo, A; Alon, U				Eden, Eran; Geva-Zatorsky, Naama; Issaeva, Irina; Cohen, Ariel; Dekel, Erez; Danon, Tamar; Cohen, Lydia; Mayo, Avi; Alon, Uri			Proteome Half-Life Dynamics in Living Human Cells	SCIENCE			English	Article							ASSISTED LIGHT INACTIVATION; UBIQUITIN; OVEREXPRESSION; PROTEASOME; LIBRARY; CANCER; GENES; YEAST	Cells remove proteins by two processes: degradation and dilution due to cell growth. The balance between these basic processes is poorly understood. We addressed this by developing an accurate and noninvasive method for measuring protein half-lives, called "bleach-chase," that is applicable to fluorescently tagged proteins. Assaying 100 proteins in living human cancer cells showed half-lives that ranged between 45 minutes and 22.5 hours. A variety of stresses that stop cell division showed the same general effect: Long-lived proteins became longer-lived, whereas short-lived proteins remained largely unaffected. This effect is due to the relative strengths of degradation and dilution and suggests a mechanism for differential killing of rapidly growing cells by growth-arresting drugs. This approach opens a way to understand proteome half-life dynamics in living cells.	[Eden, Eran; Geva-Zatorsky, Naama; Issaeva, Irina; Cohen, Ariel; Dekel, Erez; Danon, Tamar; Cohen, Lydia; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Eden, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	eraneden@gmail.com; urialon@weizmann.ac.il	mayo, avi/N-3756-2019; Geva-Zatorsky, Naama/AAP-9176-2021; MAYO, AVI E/K-1736-2012	mayo, avi/0000-0002-4479-3423; Geva-Zatorsky, Naama/0000-0002-7303-854X; 	European Research Council; Israel Science Foundation; Kahn Family Foundation	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Kahn Family Foundation	We thank Z. Yakhini, Z. Kam, R. Milo, S. Sela, and A. Ciechanover for discussions and P. Choukroun for technical assistance. We acknowledge support by the European Research Council, the Israel Science Foundation, and the Kahn Family Foundation. The Weizmann Institute of Science has filed for a patent on the technology described in this report for measuring protein half-lives.	Alon U., 2007, INTRO SYSTEMS BIOL; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; LIU HP, 1992, GENETICS, V132, P665; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	17	219	220	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					764	768		10.1126/science.1199784	http://dx.doi.org/10.1126/science.1199784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21233346				2022-12-24	WOS:000287205700069
J	Philippe, H; Brinkmann, H; Copley, RR; Moroz, LL; Nakano, H; Poustka, AJ; Wallberg, A; Peterson, KJ; Telford, MJ				Philippe, Herve; Brinkmann, Henner; Copley, Richard R.; Moroz, Leonid L.; Nakano, Hiroaki; Poustka, Albert J.; Wallberg, Andreas; Peterson, Kevin J.; Telford, Maximilian J.			Acoelomorph flatworms are deuterostomes related to Xenoturbella	NATURE			English	Article							PHYLOGENETIC DISTRIBUTION; BASAL POSITION; SEQUENCES; PHYLUM; NEMERTODERMATIDA; MICRORNAS; EVOLUTION; ALIGNMENT; SUPPORTS; PACKAGE	Xenoturbellida and Acoelomorpha are marine worms with contentious ancestry. Both were originally associated with the flatworms (Platyhelminthes), but molecular data have revised their phylogenetic positions, generally linking Xenoturbellida to the deuterostomes(1,2) and positioning the Acoelomorpha as the most basally branching bilaterian group(s)(3-6). Recent phylogenomic data suggested that Xenoturbellida and Acoelomorpha are sister taxa and together constitute an early branch of Bilateria(7). Here we assemble three independent data sets-mitochondrial genes, a phylogenomic data set of 38,330 amino-acid positions and new microRNA (miRNA) complements-and show that the position of Acoelomorpha is strongly affected by a long-branch attraction (LBA) artefact. When we minimize LBA we find consistent support for a position of both acoelomorphs and Xenoturbella within the deuterostomes. The most likely phylogeny links Xenoturbella and Acoelomorpha in a clade we call Xenacoelomorpha. The Xenacoelomorpha is the sister group of the Ambulacraria (hemichordates and echinoderms). We show that analyses of miRNA complements(8) have been affected by character loss in the acoels and that both groups possess one miRNA and the gene Rsb66 otherwise specific to deuterostomes. In addition, Xenoturbella shares one miRNA with the ambulacrarians, and two with the acoels. This phylogeny makes sense of the shared characteristics of Xenoturbellida and Acoelomorpha, such as ciliary ultrastructure and diffuse nervous system, and implies the loss of various deuterostome characters in the Xenacoelomorpha including coelomic cavities, through gut and gill slits.	[Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Philippe, Herve; Brinkmann, Henner] Univ Montreal, Dept Biochim, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Copley, Richard R.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, Gainesville, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, Gainesville, FL 32080 USA; [Nakano, Hiroaki] Univ Gothenburg, Dept Marine Ecol Kristineberg, S-45034 Fiskebackskil, Sweden; [Poustka, Albert J.] Max Planck Inst Mol Genet, Evolut & Dev Grp, D-14195 Berlin, Germany; [Wallberg, Andreas] Uppsala Univ, Dept Systemat Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	University of London; University College London; Universite de Montreal; University of Oxford; Wellcome Centre for Human Genetics; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Gothenburg; Max Planck Society; Uppsala University; Dartmouth College	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008; Peterson, Kevin J/A-2188-2009	Telford, Maximilian J/0000-0002-3749-5620; Wallberg, Andreas/0000-0002-9081-9663; Moroz, Leonid/0000-0002-1333-3176	Canada Research Chairs; Natural Sciences and Engineering Research Council; Reseau Quebecois de Calcul de Haute Performance; Biotechnology and Biological Sciences Research Council; National Science Foundation; NASA Ames; Wellcome Trust [075491/Z/04]; Max-Planck Society for the Advancement of Sciences; Division Of Computer and Network Systems [0821622] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030118] Funding Source: NIH RePORTER	Canada Research Chairs(Canada Research ChairsCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois de Calcul de Haute Performance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); NASA Ames(National Aeronautics & Space Administration (NASA)); Wellcome Trust(Wellcome TrustEuropean Commission); Max-Planck Society for the Advancement of Sciences; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Lartillot for reading the manuscript, W. Sterrer for helping collect material, and E. Sperling for help with small RNA library construction. H. P. is funded by Canada Research Chairs, Natural Sciences and Engineering Research Council and Reseau Quebecois de Calcul de Haute Performance for computational resources: more than 220,000 central processing unit (CPU)-hours were used producing at least 7 tonnes of CO<INF>2</INF> excluding grey energy. R. R. C. and M.J.T. were part-funded by the Biotechnology and Biological Sciences Research Council SYNTAX scheme. K.J.P. is supported by the National Science Foundation and NASA Ames. R. R. C. was also supported by a Wellcome Trust core award, grant number 075491/Z/04. A.J.P. was supported by the Max-Planck Society for the Advancement of Sciences e. V. A. W. was funded by Inez Johanssons Stiftelse and Stiftelsen Lars Hiertas Minne.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Baguna J, 2008, PHILOS T R SOC B, V363, P1481, DOI 10.1098/rstb.2007.2238; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lundin K, 2001, BELG J ZOOL, V131, P153; Nielsen C, 2010, EVOL DEV, V12, P241, DOI 10.1111/j.1525-142X.2010.00408.x; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Roure B., BMC EVOL BI IN PRESS; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sempere LF, 2007, EVOL DEV, V9, P409, DOI 10.1111/j.1525-142X.2007.00180.x; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sperling EA, 2008, ANIMAL EVOLUTION: GENOMES, FOSSILS, AND TREES, P157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2008, GENESIS, V46, P580, DOI 10.1002/dvg.20414; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Tyler S, 2001, INTERRELATIONSHIPS P, P3; Westblad E., 1949, ARK ZOOL, V1, P3; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	47	303	322	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					255	+		10.1038/nature09676	http://dx.doi.org/10.1038/nature09676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307940	Green Accepted			2022-12-24	WOS:000287144200043
J	Croucher, NJ; Harris, SR; Fraser, C; Quail, MA; Burton, J; van der Linden, M; Mcgee, L; von Gottberg, A; Song, JH; Ko, KS; Pichon, B; Baker, S; Parry, CM; Lambertsen, LM; Shahinas, D; Pillai, DR; Mitchell, TJ; Dougan, G; Tomasz, A; Klugman, KP; Parkhill, J; Hanage, WP; Bentley, SD				Croucher, Nicholas J.; Harris, Simon R.; Fraser, Christophe; Quail, Michael A.; Burton, John; van der Linden, Mark; McGee, Lesley; von Gottberg, Anne; Song, Jae Hoon; Ko, Kwan Soo; Pichon, Bruno; Baker, Stephen; Parry, Christopher M.; Lambertsen, Lotte M.; Shahinas, Dea; Pillai, Dylan R.; Mitchell, Timothy J.; Dougan, Gordon; Tomasz, Alexander; Klugman, Keith P.; Parkhill, Julian; Hanage, William P.; Bentley, Stephen D.			Rapid Pneumococcal Evolution in Response to Clinical Interventions	SCIENCE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; INTERCONTINENTAL SPREAD; UNITED-STATES; SEROTYPE 19A; 23F CLONE; EMERGENCE; DISEASE; TRANSFORMATION; SEQUENCE	Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain(23F)-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.	[Croucher, Nicholas J.; Harris, Simon R.; Quail, Michael A.; Burton, John; Dougan, Gordon; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fraser, Christophe; Hanage, William P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [van der Linden, Mark] Rhein Westfal TH Aachen, Univ Hosp, Inst Med Microbiol, Natl Reference Ctr Streptococci, D-52074 Aachen, Germany; [McGee, Lesley; Klugman, Keith P.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [von Gottberg, Anne; Klugman, Keith P.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Resp & Meningeal Pathogens Res Unit, ZA-2000 Johannesburg, South Africa; [von Gottberg, Anne; Klugman, Keith P.] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Song, Jae Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Song, Jae Hoon] Asia Pacific Fdn Infect Dis, Seoul, South Korea; [Ko, Kwan Soo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Pichon, Bruno] Hlth Protect Agcy Ctr Infect, Resp & Syst Infect Lab, London NW9 5HT, England; [Baker, Stephen; Parry, Christopher M.] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lambertsen, Lotte M.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen S, Denmark; [Shahinas, Dea; Pillai, Dylan R.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1V2, Canada; [Shahinas, Dea; Pillai, Dylan R.] Ontario Agcy Hlth Protect & Promot, Toronto, ON M5G 1V2, Canada; [Mitchell, Timothy J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Hanage, William P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; Imperial College London; RWTH Aachen University; RWTH Aachen University Hospital; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Health Protection Agency; Statens Serum Institut; University of Toronto; University of Glasgow; Rockefeller University; Emory University; Rollins School Public Health; Emory University; Harvard University; Harvard T.H. Chan School of Public Health	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	sdb@sanger.ac.uk	Quail, michael/ABE-6131-2020; van der Linden, Mark/B-9305-2009; Harris, Simon R/K-1318-2013; Parkhill, Julian/G-4703-2011; Fraser, Christophe/A-8109-2008; Song, Jae Hoon/C-9602-2011; Hanage, Bill/CAF-1813-2022; Tomasz, Alexander/B-9939-2011	van der Linden, Mark/0000-0002-6574-4313; Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Fraser, Christophe/0000-0003-2399-9657; Baker, Stephen/0000-0003-1308-5755; Tomasz, Alexander/0000-0003-1520-1983; Croucher, Nicholas/0000-0001-6303-8768; von Gottberg, Anne/0000-0002-0243-7455; Ko, Kwan Soo/0000-0002-0978-1937; Lambertsen, Lotte/0000-0001-6409-6337; Mitchell, Timothy/0000-0002-8309-5556	Wellcome Trust; MRC [G0800596] Funding Source: UKRI; Medical Research Council [G0600719B, G0800596] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the participating surveillance networks, listed in table S1, and the core informatics, library-making, and sequencing teams at the Wellcome Trust Sanger Institute. Attending authors were grateful for the opportunity to discuss this project at the Permafrost conference. Sequence accession codes are given in tables S1 and S2. This work was funded by the Wellcome Trust.	Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BUUHOI A, 1980, J BACTERIOL, V143, P313; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; Corso A, 1998, MICROB DRUG RESIST, V4, P325, DOI 10.1089/mdr.1998.4.325; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Del Grosso M, 2007, ANTIMICROB AGENTS CH, V51, P4184, DOI 10.1128/AAC.00598-07; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Feil EJ, 2000, GENETICS, V154, P1439; Ferrandiz MJ, 2005, ANTIMICROB AGENTS CH, V49, P2237, DOI 10.1128/AAC.49.6.2237-2245.2005; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; KLUGMAN KP, 1994, EUR J CLIN MICROBIOL, V13, P171, DOI 10.1007/BF01982193; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; McGee L, 1997, MICROB DRUG RESIST, V3, P253, DOI 10.1089/mdr.1997.3.253; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Parry CM, 2002, ANTIMICROB AGENTS CH, V46, P3512, DOI 10.1128/AAC.46.11.3512-3517.2002; Pestova EV, 1998, J BACTERIOL, V180, P2701, DOI 10.1128/JB.180.10.2701-2710.1998; Pletz MWR, 2006, EMERG INFECT DIS, V12, P1462, DOI 10.3201/eid1209.051400; Romero P, 2007, PLASMID, V58, P51, DOI 10.1016/j.plasmid.2006.12.006; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; SHAW JH, 1985, J BACTERIOL, V164, P782, DOI 10.1128/JB.164.2.782-796.1985; Tarasi A, 1997, MICROB DRUG RESIST, V3, P105, DOI 10.1089/mdr.1997.3.105; Trzcinski K, 2004, J BACTERIOL, V186, P3447, DOI 10.1128/JB.186.11.3447-3452.2004	31	642	660	0	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					430	434		10.1126/science.1198545	http://dx.doi.org/10.1126/science.1198545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273480	Green Accepted			2022-12-24	WOS:000286635900044
J	Varela, I; Tarpey, P; Raine, K; Huang, D; Ong, CK; Stephens, P; Davies, H; Jones, D; Lin, ML; Teague, J; Bignell, G; Butler, A; Cho, J; Dalgliesh, GL; Galappaththige, D; Greenman, C; Hardy, C; Jia, MM; Latimer, C; Lau, KW; Marshall, J; McLaren, S; Menzies, A; Mudie, L; Stebbings, L; Largaespada, DA; Wessels, LFA; Richard, S; Kahnoski, RJ; Anema, J; Tuveson, DA; Perez-Mancera, PA; Mustonen, V; Fischer, A; Adams, DJ; Rust, A; Chan-on, W; Subimerb, C; Dykema, K; Furge, K; Campbell, PJ; Teh, BT; Stratton, MR; Futreal, PA				Varela, Ignacio; Tarpey, Patrick; Raine, Keiran; Huang, Dachuan; Ong, Choon Kiat; Stephens, Philip; Davies, Helen; Jones, David; Lin, Meng-Lay; Teague, Jon; Bignell, Graham; Butler, Adam; Cho, Juok; Dalgliesh, Gillian L.; Galappaththige, Danushka; Greenman, Chris; Hardy, Claire; Jia, Mingming; Latimer, Calli; Lau, King Wai; Marshall, John; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Stebbings, Lucy; Largaespada, David A.; Wessels, L. F. A.; Richard, Stephane; Kahnoski, Richard J.; Anema, John; Tuveson, David A.; Perez-Mancera, Pedro A.; Mustonen, Ville; Fischer, Andrej; Adams, David J.; Rust, Alistair; Chan-on, Waraporn; Subimerb, Chutima; Dykema, Karl; Furge, Kyle; Campbell, Peter J.; Teh, Bin Tean; Stratton, Michael R.; Futreal, P. Andrew			Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; CELL CARCINOMA; CANCER; MUTAGENESIS; BAF180; ARID1A; MOUSE; INACTIVATION; SENESCENCE; INDUCTION	The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large-scale screen of similar to 3,500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A)(1), JARID1C (also known as KDM5C) and SETD2 (ref. 2). These genes encode enzymes that demethylate (UTX, JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control(3). However, together these mutations are present in fewer than 15% of ccRCC, suggesting the existence of additional, currently unidentified cancer genes. Here, we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI/SNF chromatin remodelling complex gene PBRM1 (ref. 4) as a second major ccRCC cancer gene, with truncating mutations in 41% (92/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology.	[Huang, Dachuan; Ong, Choon Kiat; Chan-on, Waraporn; Subimerb, Chutima; Teh, Bin Tean] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 169610, Singapore; [Varela, Ignacio; Tarpey, Patrick; Raine, Keiran; Stephens, Philip; Davies, Helen; Jones, David; Lin, Meng-Lay; Teague, Jon; Bignell, Graham; Butler, Adam; Cho, Juok; Dalgliesh, Gillian L.; Galappaththige, Danushka; Greenman, Chris; Hardy, Claire; Jia, Mingming; Latimer, Calli; Lau, King Wai; Marshall, John; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Stebbings, Lucy; Campbell, Peter J.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wessels, L. F. A.] Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Richard, Stephane] Fac Med Paris Sud, INSERM, U753, Genet Oncol EPHE, F-94805 Villejuif, France; [Richard, Stephane] Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Richard, Stephane] Hop Bicetre, AP HP, Serv Urol, Ctr Expert Natl Canc Rares INCa PREDIR, F-94276 Le Kremlin Bicetre, France; [Kahnoski, Richard J.; Anema, John] Spectrum Hlth Hosp, Dept Urol, Grand Rapids, MI 49503 USA; [Tuveson, David A.; Perez-Mancera, Pedro A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Mustonen, Ville; Fischer, Andrej; Adams, David J.; Rust, Alistair] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Fischer, Andrej] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany; [Dykema, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] DUKE NUS Grad Med Sch, Lab Canc Therapeut, Singapore, Singapore; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	National Cancer Centre Singapore (NCCS); Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Saclay; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Cologne; Van Andel Institute; National University of Singapore; Van Andel Institute; University of London; Institute of Cancer Research - UK	Teh, BT (corresponding author), Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, 11 Hosp Dr, Singapore 169610, Singapore.	Bin.Teh@vai.org; mrs@sanger.ac.uk; paf@sanger.ac.uk	Largaespada, David/C-9832-2014; Mustonen, Ville/X-1599-2019; Mustonen, Ville/J-1155-2018; Varela, Ignacio/AAA-7680-2021; Varela, Ignacio/G-1699-2016; Dalgliesh, Gillian/B-7799-2008	Mustonen, Ville/0000-0002-7270-1792; Mustonen, Ville/0000-0002-7270-1792; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Raine, Keiran/0000-0002-5634-1539; Teh, Bin Tean/0000-0003-1514-1124; Dalgliesh, Gillian/0000-0001-8526-5064; HUANG, DACHUAN/0000-0002-7518-4081; Adams, David/0000-0001-9490-0306; Ong, Choon Kiat/0000-0001-6402-4288; Rust, Alistair/0000-0001-7287-192X	Wellcome Trust [077012/Z/05/Z]; Lee Foundation; International Human Frontier Science Program Organization; Cancer Research UK; University of Cambridge; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R01CA113636, R01CA134759] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Lee Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P.A.F. and M.R.S. would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z and A. Coffey, D. Turner and L. Mamanova for assistance with the exon capture. K.F., K.D. and B.T.T. acknowledge the support of the Van Andel Research Institute. B.T.T. would like to acknowledge support from the Lee Foundation. I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. D.J.A. acknowledges the support of Cancer Research UK. D.A.T. and P.A.P.-M. acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampo and thank W. Howatt, A. Hazelhurst and colleagues in the CRI core facilities for their support. B.T.T. would like to dedicate this work to Tat Hock Teh.	Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Sekine I, 2005, ONCOGENE, V24, P2735, DOI 10.1038/sj.onc.1207694; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong AKC, 2000, CANCER RES, V60, P6171; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	30	914	1029	0	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					539	542		10.1038/nature09639	http://dx.doi.org/10.1038/nature09639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21248752	Green Submitted, Green Accepted			2022-12-24	WOS:000286596500034
J	Novershtern, N; Subramanian, A; Lawton, LN; Mak, RH; Haining, WN; McConkey, ME; Habib, N; Yosef, N; Chang, CY; Shay, T; Frampton, GM; Drake, ACB; Leskov, I; Nilsson, B; Preffer, F; Dombkowski, D; Evans, JW; Liefeld, T; Smutko, JS; Chen, JZ; Friedman, N; Young, RA; Golub, TR; Regev, A; Ebert, BL				Novershtern, Noa; Subramanian, Aravind; Lawton, Lee N.; Mak, Raymond H.; Haining, W. Nicholas; McConkey, Marie E.; Habib, Naomi; Yosef, Nir; Chang, Cindy Y.; Shay, Tal; Frampton, Garrett M.; Drake, Adam C. B.; Leskov, Ilya; Nilsson, Bjorn; Preffer, Fred; Dombkowski, David; Evans, John W.; Liefeld, Ted; Smutko, John S.; Chen, Jianzhu; Friedman, Nir; Young, Richard A.; Golub, Todd R.; Regev, Aviv; Ebert, Benjamin L.			Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; ERYTHROID-DIFFERENTIATION; EXPRESSION PROFILES; MODULE NETWORKS; T-CELLS; GENE; BINDING; LINE; ERYTHROPOIESIS	Though many individual transcription factors are known to regulate hematopoietic differentiation, major aspects of the global architecture of hematopoiesis remain unknown. Here, we profiled gene expression in 38 distinct purified populations of human hematopoietic cells and used probabilistic models of gene expression and analysis of cis-elements in gene promoters to decipher the general organization of their regulatory circuitry. We identified modules of highly coexpressed genes, some of which are restricted to a single lineage but most of which are expressed at variable levels across multiple lineages. We found densely interconnected cis-regulatory circuits and a large number of transcription factors that are differentially expressed across hematopoietic states. These findings suggest a more complex regulatory system for hematopoiesis than previously assumed.	[Novershtern, Noa; Subramanian, Aravind; Mak, Raymond H.; Yosef, Nir; Chang, Cindy Y.; Shay, Tal; Nilsson, Bjorn; Liefeld, Ted; Golub, Todd R.; Regev, Aviv; Ebert, Benjamin L.] Broad Inst, Cambridge, MA 02142 USA; [Novershtern, Noa; Frampton, Garrett M.; Drake, Adam C. B.; Leskov, Ilya; Chen, Jianzhu; Young, Richard A.; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Novershtern, Noa; Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci, IL-91904 Jerusalem, Israel; [Lawton, Lee N.; Frampton, Garrett M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Haining, W. Nicholas; Evans, John W.; Golub, Todd R.; Ebert, Benjamin L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [McConkey, Marie E.; Chang, Cindy Y.; Nilsson, Bjorn; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Drake, Adam C. B.; Leskov, Ilya; Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Dombkowski, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Smutko, John S.] Nugen Technol, San Carlos, CA 94070 USA; [Golub, Todd R.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Regev, A (corresponding author), Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; bebert@partners.org	Friedman, Nir/H-9692-2012; Young, Richard A/F-6495-2012; Shay, Tal/J-4028-2016; Habib, Naomi/AAA-8937-2020	Friedman, Nir/0000-0002-9678-3550; Young, Richard A/0000-0001-8855-8647; Shay, Tal/0000-0003-0755-1350; Frampton, Garrett/0000-0002-2361-2750; Mak, Raymond/0000-0002-8754-0565; Novershtern, Noa/0000-0002-2244-6877	NIH [R01 HL082945, P01 CA108631]; Burroughs-Wellcome Fund; Landon and Lavinia Clay; HHMI; NATIONAL CANCER INSTITUTE [P01CA108631, P01CA066996, RC1CA145229] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL082448, R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Landon and Lavinia Clay; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Lander, I. Amit, and I. Gat-Viks for critical review of the manuscript; D. Scadden for helpful discussions; L. Gaffney and S. Hart for assistance with figure generation; and D. Peck, J. Lamb, R. Onofrio, and the Broad Genetic Analysis Platform for assistance with expression arrays. The work was funded by the NIH (grants R01 HL082945 and P01 CA108631 to B.L.E. and the PIONEER award to A.R.), the Burroughs-Wellcome Fund (CAMS to B.L.E. and CASI to A.R.), funds from Landon and Lavinia Clay (R.A.Y.) and HHMI (T.R.G. and A.R.). A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. J.S.S. is an employee of NuGEN Technologies, Inc.	Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Davidson E. H., 2001, DEV EVOLUTION; Ebert BL, 2004, BLOOD, V104, P923, DOI 10.1182/blood-2004-01-0274; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lee HM, 2010, BLOOD, V116, P720, DOI 10.1182/blood-2009-11-253872; Li QZ, 1998, BLOOD, V92, P3841, DOI 10.1182/blood.V92.10.3841.422k02_3841_3847; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitelman F, 2010, MITELMAN DATABASE CH; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; QUESENBERRY PJ, 2005, WILLIAMS HEMATOLOGY, P153; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Segal E, 2005, J MACH LEARN RES, V6, P557; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	624	640	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					296	309		10.1016/j.cell.2011.01.004	http://dx.doi.org/10.1016/j.cell.2011.01.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241896	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000286459900013
J	Levy, O; Kaniewska, P; Alon, S; Eisenberg, E; Karako-Lampert, S; Bay, LK; Reef, R; Rodriguez-Lanetty, M; Miller, DJ; Hoegh-Guldberg, O				Levy, O.; Kaniewska, P.; Alon, S.; Eisenberg, E.; Karako-Lampert, S.; Bay, L. K.; Reef, R.; Rodriguez-Lanetty, M.; Miller, D. J.; Hoegh-Guldberg, O.			Complex Diel Cycles of Gene Expression in Coral-Algal Symbiosis	SCIENCE			English	Article							ACROPORA-MILLEPORA; LIGHT		[Bay, L. K.; Miller, D. J.; Hoegh-Guldberg, O.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Levy, O.; Karako-Lampert, S.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Levy, O.; Kaniewska, P.; Reef, R.; Rodriguez-Lanetty, M.; Hoegh-Guldberg, O.] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Alon, S.] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Eisenberg, E.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Reef, R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Rodriguez-Lanetty, M.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	James Cook University; Bar Ilan University; University of Queensland; Tel Aviv University; Tel Aviv University; University of Queensland; University of Louisiana Lafayette	Miller, DJ (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	David.Miller@jcu.edu.au; oveh@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Eisenberg, Eli/D-2587-2009; Bay, Line/D-4037-2009; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Eisenberg, Eli/0000-0001-8681-3202; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Reef, Ruth/0000-0001-6639-520X	Australian Research Council; Israel Science Foundation [699/06]; Division Of Ocean Sciences [1321500] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); Israel Science Foundation(Israel Science Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Y. Gothilf for critical discussions and N. Simon-Blecher for assistance in collecting coral samples. This work was supported by the Australian Research Council (O.H.-G. and D.J.M.) and Israel Science Foundation grant no. 699/06. Microarray data are Minimum Information About a Microarray Experiment (MIAME)-compliant and deposited under accession number GSE21658 (National Center for Biotechnology Information GEO). HIF ortholog present in A. millepora (GenBank identification EZ037157).	Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241	9	97	97	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					175	175		10.1126/science.1196419	http://dx.doi.org/10.1126/science.1196419			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233378				2022-12-24	WOS:000286433100031
J	Chell, JM; Brand, AH				Chell, James M.; Brand, Andrea H.			Nutrition-Responsive Glia Control Exit of Neural Stem Cells from Quiescence	CELL			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA INSULIN-RECEPTOR; ADULT MAMMALIAN BRAIN; PHOSPHOINOSITIDE 3-KINASE; LARVAL BRAIN; POSTEMBRYONIC NEUROBLASTS; PROLIFERATION ACTIVATION; TRANSCRIPTION FACTORS; TEMPORAL IDENTITY	The systemic regulation of stem cells ensures that they meet the needs of the organism during growth and in response to injury. A key point of regulation is the decision between quiescence and proliferation. During development, Drosophila neural stem cells (neuroblasts) transit through a period of quiescence separating distinct embryonic and postembryonic phases of proliferation. It is known that neuroblasts exit quiescence via a hitherto unknown pathway in response to a nutrition-dependent signal from the fat body. We have identified a population of glial cells that produce insulin/IGF-like peptides in response to nutrition, and we show that the insulin/IGF receptor pathway is necessary for neuroblasts to exit quiescence. The forced expression of insulin/IGF-like peptides in glia, or activation of PI3K/Akt signaling in neuroblasts, can drive neuroblast growth and proliferation in the absence of dietary protein and thus uncouple neuroblasts from systemic control.	[Chell, James M.; Brand, Andrea H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chell, James M.; Brand, Andrea H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Brand, AH (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ahb@mole.bio.cam.ac.uk	Brand, Andrea H/F-8220-2014	Brand, Andrea H/0000-0002-2089-6954	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank H. Stocker, E. Hafen, S. Bray, S. Leevers, T. Xu, E. Rulifson, C. Doe, J. Skeath, S. Baumgartner, Y. Bellaiche, S. Gronke, L. Partridge, L. Cooley, I. Miguel-Aliaga, the DSHB, and the Bloomington Drosophila Stock Center for reagents. We thank K. Edoff for assistance with confocal microscopy, T. Southall for assistance with microinjection, and Pao-Shu Wu for Q-PCR wisdom. This work was funded by a Wellcome Trust four-year PhD studentship to J. M. C. and a Wellcome Trust Programme Grant to A.H.B.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alam S, 2004, BIOTECHNOL BIOENG, V88, P332, DOI 10.1002/bit.20246; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; DATTA S, 1995, DEVELOPMENT, V121, P1173; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Dumstrei K, 2003, J NEUROSCI, V23, P3325; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Friedrich MVK, 2000, EUR J BIOCHEM, V267, P3149, DOI 10.1046/j.1432-1327.2000.01337.x; GARCIAESTRADA J, 1992, BRAIN RES, V592, P343, DOI 10.1016/0006-8993(92)91695-B; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lindner JR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-121; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nern C, 2006, STEM CELL REV, V2, P233, DOI 10.1007/s12015-006-0051-6; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2002, DEVELOPMENT, V129, P4103; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yan YP, 2006, EUR J NEUROSCI, V24, P45, DOI 10.1111/j.1460-9568.2006.04872.x; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	79	256	261	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1161	1173		10.1016/j.cell.2010.12.007	http://dx.doi.org/10.1016/j.cell.2010.12.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183078	Green Published, hybrid			2022-12-24	WOS:000285625400013
J	Fakhri, N; MacKintosh, FC; Lounis, B; Cognet, L; Pasquali, M				Fakhri, Nikta; MacKintosh, Frederick C.; Lounis, Brahim; Cognet, Laurent; Pasquali, Matteo			Brownian Motion of Stiff Filaments in a Crowded Environment	SCIENCE			English	Article							WALLED CARBON NANOTUBES; SEMIFLEXIBLE POLYMERS; AGAROSE GELS; DYNAMICS; DIFFUSION; MICROSCOPY; CHAIN; FLUORESCENCE; REPTATION; ROD	The thermal motion of stiff filaments in a crowded environment is highly constrained and anisotropic; it underlies the behavior of such disparate systems as polymer materials, nanocomposites, and the cell cytoskeleton. Despite decades of theoretical study, the fundamental dynamics of such systems remains a mystery. Using near-infrared video microscopy, we studied the thermal diffusion of individual single-walled carbon nanotubes (SWNTs) confined in porous agarose networks. We found that even a small bending flexibility of SWNTs strongly enhances their motion: The rotational diffusion constant is proportional to the filament-bending compliance and is independent of the network pore size. The interplay between crowding and thermal bending implies that the notion of a filament's stiffness depends on its confinement. Moreover, the mobility of SWNTs and other inclusions can be controlled by tailoring their stiffness.	[Fakhri, Nikta; Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [MacKintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Lounis, Brahim; Cognet, Laurent] Univ Bordeaux, CNRS, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France	Rice University; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Pasquali, M (corresponding author), Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	mp@rice.edu	MacKintosh, Frederick/AAB-9332-2021; Cognet, Laurent/M-4505-2019; Fakhri, Nikta/B-4657-2008; MacKintosh, Fred C/A-9450-2008; Cognet, Laurent/F-4163-2011; Pasquali, Matteo/A-2489-2008; Lounis, Brahim/I-7862-2016	MacKintosh, Frederick/0000-0002-2607-9541; Fakhri, Nikta/0000-0003-1261-7465; MacKintosh, Fred C/0000-0002-2607-9541; Cognet, Laurent/0000-0002-3573-5387; Pasquali, Matteo/0000-0001-5951-395X; Lounis, Brahim/0000-0001-7501-0236	NSF Center for Biological and Environmental Nanotechnology [EEC-0118007, EEC-0647452]; Welch Foundation [C-1668]; Advanced Energy Consortium; Region Aquitaine; Agence Nationale pour la Recherche (ANR PNANO); European Research Council [232942]; Foundation for Fundamental Research on Matter (FOM); Netherlands Organisation for Scientific Research (NWO)	NSF Center for Biological and Environmental Nanotechnology(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Advanced Energy Consortium; Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale pour la Recherche (ANR PNANO)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the NSF Center for Biological and Environmental Nanotechnology (EEC-0118007 and EEC-0647452), the Welch Foundation (grant C-1668), the Advanced Energy Consortium (www.beg.utexas.edu/aec), the Region Aquitaine, the Agence Nationale pour la Recherche (ANR PNANO), the European Research Council (grant n 232942), and the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO).	ATTWOOD TK, 1988, BIOPOLYMERS, V27, P201, DOI 10.1002/bip.360270204; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Dogic Z, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125503; DOI M, 1985, J POLYM SCI POL SYM, P93; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Duggal R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246104; Duque JG, 2008, J AM CHEM SOC, V130, P2626, DOI 10.1021/ja0777234; EDWARDS SF, 1967, P PHYS SOC LOND, V92, pR1; Fakhri N, 2009, P NATL ACAD SCI USA, V106, P14219, DOI 10.1073/pnas.0904148106; FARGE E, 1993, MACROMOLECULES, V26, P5041, DOI 10.1021/ma00071a009; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Granek R, 1997, J PHYS II, V7, P1761, DOI 10.1051/jp2:1997214; Green MJ, 2009, POLYMER, V50, P4979, DOI 10.1016/j.polymer.2009.07.044; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Hofling F, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060904; Munk T, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/30003; ODIJK T, 1983, MACROMOLECULES, V16, P1340, DOI 10.1021/ma00242a015; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Ramanathan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010501; SATO T, 1991, MACROMOLECULES, V24, P6220, DOI 10.1021/ma00023a025; TRACY MA, 1992, ANNU REV PHYS CHEM, V43, P525, DOI 10.1146/annurev.physchem.43.1.525; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; WIJMENGA SS, 1986, BIOPOLYMERS, V25, P2173, DOI 10.1002/bip.360251110; ZERO KM, 1982, MACROMOLECULES, V15, P87, DOI 10.1021/ma00229a017	27	97	97	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1804	1807		10.1126/science.1197321	http://dx.doi.org/10.1126/science.1197321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205665				2022-12-24	WOS:000285603700035
J	Cheung, ACM; Cramer, P				Cheung, Alan C. M.; Cramer, Patrick			Structural basis of RNA polymerase II backtracking, arrest and reactivation	NATURE			English	Article							CLEAVAGE FACTOR TFIIS; TRANSCRIPT-CLEAVAGE; ELONGATION COMPLEX; DNA HYBRID; ANGSTROM RESOLUTION; TRIGGER LOOP; MECHANISM; SITE; TRANSLOCATION; ARCHITECTURE	During gene transcription, RNA polymerase (Pol) II moves forwards along DNA and synthesizes messenger RNA. However, at certain DNA sequences, Pol II moves backwards, and such backtracking can arrest transcription. Arrested Pol II is reactivated by transcription factor IIS (TFIIS), which induces RNA cleavage that is required for cell viability(1). Pol II arrest and reactivation are involved in transcription through nucleosomes(2,3) and in promoter-proximal gene regulation(4-6). Here we present X-ray structures at 3.3 angstrom resolution of an arrested Saccharomyces cerevisiae Pol II complex with DNA and RNA, and of a reactivation intermediate that additionally contains TFIIS. In the arrested complex, eight nucleotides of backtracked RNA bind a conserved 'backtrack site' in the Pol II pore and funnel, trapping the active centre trigger loop and inhibiting mRNA elongation. In the reactivation intermediate, TFIIS locks the trigger loop away from backtracked RNA, displaces RNA from the backtrack site, and complements the polymerase active site with a basic and two acidic residues that may catalyse proton transfers during RNA cleavage. The active site is demarcated from the backtrack site by a 'gating tyrosine' residue that probably delimits backtracking. These results establish the structural basis of Pol II backtracking, arrest and reactivation, and provide a framework for analysing gene regulation during transcription elongation.	[Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Gene Ctr, D-81377 Munich, Germany; [Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de		Cheung, Alan/0000-0001-6430-5127	Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; NIM; Bioimaging Network BIN; Jung-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIM; Bioimaging Network BIN; Jung-Stiftung	We thank F. Brueckner, G. Damsma, K. Kinkelin, D. Kostrewa, L. Lariviere, E. Lehmann, F. Martinez, S. Sainsbury and J. Sydow. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. P.C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, NIM, Bioimaging Network BIN, and the Jung-Stiftung.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GU WG, 1993, J BIOL CHEM, V268, P25604; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; SLUDER AE, 1988, J BIOL CHEM, V263, P9917; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	30	240	242	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					249	253		10.1038/nature09785	http://dx.doi.org/10.1038/nature09785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21346759				2022-12-24	WOS:000288170200044
J	Axon, RN; Williams, MV				Axon, R. Neal; Williams, Mark V.			Hospital Readmission as an Accountability Measure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INPATIENT CARE; QUALITY; ASSOCIATION		[Axon, R. Neal] Ralph H Johnson VAMC, Ctr Dis Prevent & Hlth Intervent Diverse Populat, Charleston, SC USA; [Axon, R. Neal] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Charleston, SC USA; [Williams, Mark V.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Northwestern University; Feinberg School of Medicine	Axon, RN (corresponding author), 135 Rutledge Ave,MSC 591, Charleston, SC 29425 USA.	axon@musc.edu		Williams, Mark V/0000-0001-6107-0457				[Anonymous], HOSP CAR OUTC EFF ME; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; *MED PAYM ADV COMM, 2007, MED PAYM POL	10	298	299	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					504	505		10.1001/jama.2011.72	http://dx.doi.org/10.1001/jama.2011.72			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285430				2022-12-24	WOS:000286810700026
J	Janic, A; Mendizabal, L; Llamazares, S; Rossell, D; Gonzalez, C				Janic, Ana; Mendizabal, Leire; Llamazares, Salud; Rossell, David; Gonzalez, Cayetano			Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila	SCIENCE			English	Article							TRANSCRIPTIONAL REPRESSOR; CANCER/TESTIS ANTIGENS; STEM-CELLS; COMPLEX; PROTEIN; IDENTIFICATION; MELANOGASTER; INTERACTS; DIVISION; MUTANTS	Model organisms such as the fruit fly Drosophila melanogaster can help to elucidate the molecular basis of complex diseases such as cancer. Mutations in the Drosophila gene lethal (3) malignant brain tumor cause malignant growth in the larval brain. Here we show that l(3)mbt tumors exhibited a soma-to-germline transformation through the ectopic expression of genes normally required for germline stemness, fitness, or longevity. Orthologs of some of these genes were also expressed in human somatic tumors. In addition, inactivation of any of the germline genes nanos, vasa, piwi, or aubergine suppressed l(3) mbt malignant growth. Our results demonstrate that germline traits are necessary for tumor growth in this Drosophila model and suggest that inactivation of germline genes might have tumor-suppressing effects in other species.	[Janic, Ana; Mendizabal, Leire; Llamazares, Salud; Gonzalez, Cayetano] PCB, IRB Barcelona, Cell Div Grp, Barcelona, Spain; [Rossell, David] PCB, IRB Barcelona, Bioinformat & Biostat Unit, Barcelona, Spain; [Gonzalez, Cayetano] Passeig Lluis Co 23, ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; ICREA	Gonzalez, C (corresponding author), PCB, IRB Barcelona, Cell Div Grp, C Baldiri Reixac 10-12, Barcelona, Spain.	gonzalez@irbbarcelona.org	Gonzalez, Cayetano/K-3933-2019; Janic, Ana/AAR-4783-2020; Rossell, David/AAM-4292-2021; Gonzalez, Cayetano/K-3055-2019	Janic, Ana/0000-0002-4200-2560; Rossell, David/0000-0002-7104-5789; Gonzalez, Cayetano/0000-0002-5259-3608; Llamazares, Salud/0000-0002-8771-2312	Consolider-Ingenio [CSD2006-23]; Ministerio de Ciencia e Innovacion Formacion de Personal;  [ONCASYM-037398];  [BFU2006-05813];  [BFU2009-07975];  [SGR2005];  [SRG200];  [CEN-20091016]; ICREA Funding Source: Custom	Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion Formacion de Personal; ; ; ; ; ; ; ICREA(ICREA)	We thank E. Gateff, R. Lehmann, P. Zamore, A. Spradling, F. Azorin, P. Lasko, S. Hawley, M. Siomi, T. Kai, T. Orr-Weaver, H. White-Cooper, D. McKearin, T. Schupbach, Hybridoma Bank, and Bloomington and Tubingen Drosophila Stock centers for antibodies and fly stocks; H. Auer, the IRB Functional Genomics Facility, and the European Molecular Biology Laboratory Genomics Core Facility for invaluable technical guidance; J. Januschke and members of our laboratory for discussions; and M. Llamazares for proofreading. Work in our laboratory is supported by ONCASYM-037398, BFU2006-05813, BFU2009-07975, SGR2005, SRG200, CEN-20091016, and Consolider-Ingenio CSD2006-23. A.J. is a recipient of a Ministerio de Ciencia e Innovacion Formacion de Personal Investigador fellowship. Array data sets are deposited at Gene Expression Omnibus (accession no. GSE24917).	Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bonnomet A, 2008, ONCOGENE, V27, P3692, DOI 10.1038/sj.onc.1211035; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Jager E, 2002, CURR OPIN IMMUNOL, V14, P178, DOI 10.1016/S0952-7915(02)00318-7; Joyce EF, 2009, GENETICS, V181, P335, DOI 10.1534/genetics.108.093104; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lee LA, 2003, GENE DEV, V17, P2979, DOI 10.1101/gad.1132603; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Perezgasga L, 2004, DEVELOPMENT, V131, P1691, DOI 10.1242/dev.01032; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Svensson MJ, 2003, CHROMOSOMA, V112, P133, DOI 10.1007/s00412-003-0253-5; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; Tavosanis G, 1997, EMBO J, V16, P1809, DOI 10.1093/emboj/16.8.1809; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Yohn CB, 2003, GENETICS, V165, P1889	32	195	199	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1824	1827		10.1126/science.1195481	http://dx.doi.org/10.1126/science.1195481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205669				2022-12-24	WOS:000285603700041
J	Miyamichi, K; Amat, F; Moussavi, F; Wang, C; Wickersham, I; Wall, NR; Taniguchi, H; Tasic, B; Huang, ZJ; He, ZG; Callaway, EM; Horowitz, MA; Luo, LQ				Miyamichi, Kazunari; Amat, Fernando; Moussavi, Farshid; Wang, Chen; Wickersham, Ian; Wall, Nicholas R.; Taniguchi, Hiroki; Tasic, Bosiljka; Huang, Z. Josh; He, Zhigang; Callaway, Edward M.; Horowitz, Mark A.; Luo, Liqun			Cortical representations of olfactory input by trans-synaptic tracing	NATURE			English	Article							PIRIFORM CORTEX; RABIES VIRUS; TOPOGRAPHIC ORGANIZATION; GENE-EXPRESSION; MOSAIC ANALYSIS; BULB GLOMERULI; DOUBLE MARKERS; PARS EXTERNA; DROSOPHILA; NUCLEUS	In the mouse, each class of olfactory receptor neurons expressing a given odorant receptor has convergent axonal projections to two specific glomeruli in the olfactory bulb, thereby creating an odour map. However, it is unclear how this map is represented in the olfactory cortex. Here we combine rabies-virus-dependent retrograde mono-trans-synaptic labelling with genetics to control the location, number and type of 'starter' cortical neurons, from which we trace their presynaptic neurons. We find that individual cortical neurons receive input from multiple mitral cells representing broadly distributed glomeruli. Different cortical areas represent the olfactory bulb input differently. For example, the cortical amygdala preferentially receives dorsal olfactory bulb input, whereas the piriform cortex samples the whole olfactory bulb without obvious bias. These differences probably reflect different functions of these cortical areas in mediating innate odour preference or associative memory. The trans-synaptic labelling method described here should be widely applicable to mapping connections throughout the mouse nervous system.	[Miyamichi, Kazunari; Tasic, Bosiljka; Luo, Liqun] Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA; [Amat, Fernando; Moussavi, Farshid; Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Wang, Chen; He, Zhigang] Childrens Hosp, Dept Neurosci, Boston, MA 02115 USA; [Wickersham, Ian; Wall, Nicholas R.; Callaway, Edward M.] Univ Calif San Diego, Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Wickersham, Ian; Wall, Nicholas R.; Callaway, Edward M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92037 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, New York, NY 11724 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA.	lluo@stanford.edu	Callaway, Edward/D-4336-2011; Miyamichi, Kazunari/AAO-3705-2021	Callaway, Edward/0000-0002-6366-5267; Wall, Nicholas/0000-0003-2039-8258; Luo, Liqun/0000-0001-5467-9264; Huang, Z. Josh/0000-0003-0592-028X	JSPS; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Stanford Transgenic Facility for help in generating transgenic mice, F. Zhang and K. Deisseroth for teaching us stereotactic injection, Y. Yoshihara and H. Zeng for reagents, C. Manalac and M. Shu for technical assistance, R. Axel, L. Buck, and L. Stryer, R. Yuste and members of the L.L. laboratory for discussion and critical reading of the manuscript. K.M. was supported by the JSPS program for Research Abroad and Human Frontier Science Program. K.M. is currently a research associate and L.L. is an investigator of the Howard Hughes Medical Institute. This work was also supported by an NIH grant.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CONG G, 1998, P 4 IEEE WORKSH APPL, V140; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; NEVELLE KR, 2004, SYNAPTIC ORG BRAIN; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHOENFELD TA, 1984, J COMP NEUROL, V227, P121, DOI 10.1002/cne.902270113; Schroeder W., 1997, VISUALIZATION TOOLKI; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	58	343	349	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					191	196		10.1038/nature09714	http://dx.doi.org/10.1038/nature09714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21179085	Green Accepted			2022-12-24	WOS:000289469100036
J	Thuiller, W; Lavergne, S; Roquet, C; Boulangeat, I; Lafourcade, B; Araujo, MB				Thuiller, Wilfried; Lavergne, Sebastien; Roquet, Cristina; Boulangeat, Isabelle; Lafourcade, Bruno; Araujo, Miguel. B.			Consequences of climate change on the tree of life in Europe	NATURE			English	Article							PHYLOGENETIC SIGNAL; EXTINCTION RISK; BIODIVERSITY; PREDICTORS; TRAITS; NICHE	Many species are projected to become vulnerable to twenty-first-century climate changes(1,2), with consequent effects on the tree of life. If losses were not randomly distributed across the tree of life, climate change could lead to a disproportionate loss of evolutionary history(3-5). Here we estimate the consequences of climate change on the phylogenetic diversities of plant, bird and mammal assemblages across Europe. Using a consensus across ensembles of forecasts for 2020, 2050 and 2080 and high-resolution phylogenetic trees, we show that species vulnerability to climate change clusters weakly across phylogenies. Such phylogenetic signal in species vulnerabilities does not lead to higher loss of evolutionary history than expected with a model of random extinctions. This is because vulnerable species have neither fewer nor closer relatives than the remaining clades. Reductions in phylogenetic diversity will be greater in southern Europe, and gains are expected in regions of high latitude or altitude. However, losses will not be offset by gains and the tree of life faces a trend towards homogenization across the continent.	[Thuiller, Wilfried; Lavergne, Sebastien; Roquet, Cristina; Boulangeat, Isabelle; Lafourcade, Bruno] Univ Grenoble 1, Lab Ecol Alpine, CNRS, UMR 5553, FR-38041 Grenoble 9, France; [Araujo, Miguel. B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Araujo, Miguel. B.] Univ Evora, CIBIO, Rui Nabeiro Biodivers Chair, P-7000 Evora, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora	Thuiller, W (corresponding author), Univ Grenoble 1, Lab Ecol Alpine, CNRS, UMR 5553, BP 53, FR-38041 Grenoble 9, France.	wilfried.thuiller@ujf-grenoble.fr	Thuiller, Wilfried/G-3283-2010; Roquet, Cristina/AAB-4031-2019; Araújo, Miguel B/B-6117-2008	Thuiller, Wilfried/0000-0002-5388-5274; Araújo, Miguel B/0000-0002-5107-7265; Roquet, Cristina/0000-0001-8748-3743	EU [GOCE-CT-2007-036866, ANR-2007-BDIV-014]; Fundacion Ramon Areces; Rhone-Alpes region [CPER07-13 CIRA]	EU(European Commission); Fundacion Ramon Areces; Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	This research was funded by the EU ECOCHANGE (GOCE-CT-2007-036866) and DIVERSITALP (ANR-2007-BDIV-014) projects. C. R. was supported by a grant from Fundacion Ramon Areces. We thank P. Pearman and A. Mooers for comments on earlier drafts. Computations were performed using the CIMENT infrastructure (https://ciment.ujf-grenoble.fr), supported by the Rhone-Alpes region (GRANT CPER07-13 CIRA).	[Anonymous], 2000, SPECIAL REPORT EMISS; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Nee S., 1997, SCIENCE, V288, P328; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	26	374	394	5	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					531	534		10.1038/nature09705	http://dx.doi.org/10.1038/nature09705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326204				2022-12-24	WOS:000287652900041
J	Pellegrini, M; Calzascia, T; Toe, JG; Preston, SP; Lin, AE; Elford, AR; Shahinian, A; Lang, PA; Lang, KS; Morre, M; Assouline, B; Lahl, K; Sparwasser, T; Tedder, TF; Paik, JH; DePinho, RA; Basta, S; Ohashi, PS; Mak, TW				Pellegrini, Marc; Calzascia, Thomas; Toe, Jesse G.; Preston, Simon P.; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Morre, Michel; Assouline, Brigitte; Lahl, Katharina; Sparwasser, Tim; Tedder, Thomas F.; Paik, Ji-hye; DePinho, Ronald A.; Basta, Sameh; Ohashi, Pamela S.; Mak, Tak W.			IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology	CELL			English	Article							CD4(+) T-CELLS; IN-VIVO; LYMPHOID-TISSUE; HOST-DEFENSE; INTERLEUKIN-22; ACTIVATION; EXPANSION; INFLAMMATION; PERSISTENCE; HEPATOCYTES	Understanding the factors that impede immune responses to persistent viruses is essential in designing therapies for HIV infection. Mice infected with LCMV clone-13 have persistent high-level viremia and a dysfunctional immune response. Interleukin-7, a cytokine that is critical for immune development and homeostasis, was used here to promote immunity toward clone-13, enabling elucidation of the inhibitory pathways underlying impaired antiviral immune response. Mechanistically, IL-7 down-regulated a critical repressor of cytokine signaling, Socs3, resulting in amplified cytokine production, increased T cell effector function and numbers, and viral clearance. IL-7 enhanced thymic output to expand the naive T cell pool, including T cells that were not LCMV specific. Additionally, IL-7 promoted production of cytoprotective IL-22 that abrogated liver pathology. The IL-7-mediated effects were dependent on endogenous IL-6. These attributes of IL-7 have profound implications for its use as a therapeutic in the treatment of chronic viral diseases.	[Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Dept Med Biophys, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Dept Immunol, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Pellegrini, Marc; Toe, Jesse G.; Preston, Simon P.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Pellegrini, Marc] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Morre, Michel; Assouline, Brigitte] Cytheris Inc, F-92130 Issy Les Moulineaux, France; [Lahl, Katharina] Stanford Univ, Lab Immunol & Vasc Biol, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, D-30625 Hannover, Germany; [Tedder, Thomas F.] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27708 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol,Dept Med,Dana Farber Canc Inst, Boston, MA 02115 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Basta, Sameh] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 396, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Walter & Eliza Hall Institute; University of Melbourne; Stanford University; Duke University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Queens University - Canada	Ohashi, PS (corresponding author), Univ Hlth Network, Dept Med Biophys, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada.	pohashi@uhnres.utoronto.ca	Sparwasser, Tim/AAF-7085-2019; Pellegrini, Marc/F-7670-2014; Sparwasser, Tim D/AAA-4306-2022; Yang, Chen/G-1379-2010; Lin, Amy Erica/ABG-4745-2020; Lahl, Katharina/AAA-1909-2021; Lang, Karl S/R-2505-2016	Sparwasser, Tim/0000-0001-5645-902X; Lin, Amy Erica/0000-0002-0554-2832; Lahl, Katharina/0000-0003-4919-331X; Pellegrini, Marc/0000-0003-3627-3126; Ohashi, Pamela S./0000-0003-2915-9317; Lang, Karl/0000-0001-9783-7605; Preston, Simon/0000-0001-8969-8297; DePinho, Ronald/0000-0002-5625-577X; Calzascia, Thomas/0000-0001-8225-6744	Canadian Institute for Health Research [CIHR-MOP-106529]; Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada; Irvington Institute with the Cancer Research Institute (New York, NY); Australian National Health and Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Irvington Institute with the Cancer Research Institute (New York, NY); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	Dr. Mandana Nikpour assisted with statistical analyses. Marina Zaitseva contributed to the analysis of thymic emigrants; Alain Lamarre, Paul Jolicoeur, and Michel Nussenzweig provided reagents and mice. This work was supported by a Canadian Institute for Health Research grant to T. W. M. and P.S.O. (CIHR-MOP-106529) and a Terry Fox Cancer Foundation National Cancer Institute of Canada grant to T. W. M. T. C. was supported by the Boninchi Foundation (Geneva, Switzerland) and The Terry Fox Foundation through an award from the National Cancer Institute of Canada. M. P. was supported through an Irvington Institute Fellowship with the Cancer Research Institute (New York, NY) and an Australian National Health and Medical Research Council Fellowship. S. B receives support from the Natural Sciences and Engineering Research Council of Canada. P.S.O. holds a Canada Research Chair in autoimmunity and tumor immunity. This research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brender C, 2007, BLOOD, V110, P2528, DOI 10.1182/blood-2006-08-041541; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Nugeyre MT, 2003, J IMMUNOL, V171, P4447, DOI 10.4049/jimmunol.171.8.4447; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	48	239	253	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					601	613		10.1016/j.cell.2011.01.011	http://dx.doi.org/10.1016/j.cell.2011.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21295337	Bronze			2022-12-24	WOS:000287473100014
J	Losina, E; Walensky, RP; Reichmann, WM; Holt, HL; Gerlovin, H; Solomon, DH; Jordan, JM; Hunter, DJ; Suter, LG; Weinstein, AM; Paltiel, AD; Katz, JN				Losina, Elena; Walensky, Rochelle P.; Reichmann, William M.; Holt, Holly L.; Gerlovin, Hanna; Solomon, Daniel H.; Jordan, Joanne M.; Hunter, David J.; Suter, Lisa G.; Weinstein, Alexander M.; Paltiel, A. David; Katz, Jeffrey N.			Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; NUTRITION EXAMINATION SURVEY; HEALTH-STATE UTILITIES; BODY-MASS INDEX; NATIONAL-HEALTH; METABOLIC SYNDROME; PROSPECTIVE COHORT; UNITED-STATES; RISK-FACTORS; OVERWEIGHT	Background: Obesity and knee osteoarthritis are among the most frequent chronic conditions affecting Americans aged 50 to 84 years. Objective: To estimate quality-adjusted life-years lost due to obesity and knee osteoarthritis and health benefits of reducing obesity prevalence to levels observed a decade ago. Design: The U.S. Census and obesity data from national data sources were combined with estimated prevalence of symptomatic knee osteoarthritis to assign persons aged 50 to 84 years to 4 subpopulations: nonobese without knee osteoarthritis (reference group), nonobese with knee osteoarthritis, obese without knee osteoarthritis, and obese with knee osteoarthritis. The Osteoarthritis Policy Model, a computer simulation model of knee osteoarthritis and obesity, was used to estimate quality-adjusted life-year losses due to knee osteoarthritis and obesity in comparison with the reference group. Setting: United States. Participants: U.S. population aged 50 to 84 years. Measurements: Quality-adjusted life-years lost owing to knee osteoarthritis and obesity. Results: Estimated total losses of per-person quality-adjusted life-years ranged from 1.857 in nonobese persons with knee osteoarthritis to 3.501 for persons affected by both conditions, resulting in a total of 86.0 million quality-adjusted life-years lost due to obesity, knee osteoarthritis, or both. Quality-adjusted life-years lost due to knee osteoarthritis and/or obesity represent 10% to 25% of the remaining quality-adjusted survival of persons aged 50 to 84 years. Hispanic and black women had disproportionately high losses. Model findings suggested that reversing obesity prevalence to levels seen 10 years ago would avert 178 071 cases of coronary heart disease, 889 872 cases of diabetes, and 111 206 total knee replacements. Such a reduction in obesity would increase the quantity of life by 6 318 030 years and improve life expectancy by 7 812 120 quality-adjusted years in U. S. adults aged 50 to 84 years. Limitations: Comorbidity incidences were derived from prevalence estimates on the basis of life expectancy of the general population, potentially resulting in conservative underestimates. Calibration analyses were conducted to ensure comparability of model-based projections and data from external sources. Conclusion: The number of quality-adjusted life-years lost owing to knee osteoarthritis and obesity seems to be substantial, with black and Hispanic women experiencing disproportionate losses. Reducing mean body mass index to the levels observed a decade ago in this population would yield substantial health benefits.	[Losina, Elena] Boston Univ, Sch Publ Hlth, Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res,Dept Orthopa, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Sydney, Sydney, NSW 2006, Australia; Yale Univ, Sch Med, New Haven, CT USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of Sydney; Yale University	Losina, E (corresponding author), Boston Univ, Sch Publ Hlth, Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res,Dept Orthopa, 75 Francis St,BC-4, Boston, MA 02115 USA.	Elosina@partners.org	Hunter, David J/A-4622-2010	Hunter, David J/0000-0003-3197-752X; Gerlovin, Hanna/0000-0002-6700-2129; Losina, ELENA/0000-0002-3424-0892; /0000-0002-1283-6329; Walensky, Rochelle P./0000-0002-8795-379X	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR053112, K24 AR057827, K23 AR054095, P60 AR47782, T32 AR 055885, K24 AR 02123]; Arthritis Foundation; Arthritis Investigator Award; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827, P60AR047782, K23AR054095, R01AR053112, T32AR055885, K24AR002123] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; Arthritis Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	By the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR053112, K24 AR057827, K23 AR054095, P60 AR47782, T32 AR 055885, and K24 AR 02123); an Arthritis Foundation Innovative Research grant (Dr. Losina); and an Arthritis Investigator Award (Dr. Suter).; Primary Funding Source: The National Institutes of Health and the Arthritis Foundation.	Abbate LM, 2006, OBESITY, V14, P1274, DOI 10.1038/oby.2006.145; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ammar KA, 2008, AM HEART J, V156, P975, DOI 10.1016/j.ahj.2008.06.018; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; BOULT C, 1994, J GERONTOL, V49, pM28, DOI 10.1093/geronj/49.1.M28; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1997, HLTH DAT INT CHRON C; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2006, NAT HLTH NUTR EX SUR; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Das UN, 2007, EUR HEART J, V28, P2953, DOI 10.1093/eurheartj/ehm472; DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878; Diehr P, 2001, MED CARE, V39, P670, DOI 10.1097/00005650-200107000-00004; Dieppe P, 1999, RHEUMATOLOGY, V38, P73, DOI 10.1093/rheumatology/38.1.73; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Harvey E L, 2002, Obes Rev, V3, P45, DOI 10.1046/j.1467-789X.2002.00053.x; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Jordan JM, 2007, J RHEUMATOL, V34, P172; KEYFITZ N, 1975, BIOMETRICS, V31, P889, DOI 10.2307/2529814; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lean MEJ, 1999, ARCH INTERN MED, V159, P837, DOI 10.1001/archinte.159.8.837; Lloyd A, 2006, BRIT J CANCER, V95, P683, DOI 10.1038/sj.bjc.6603326; Mann DM, 2006, PREV MED, V42, P66, DOI 10.1016/j.ypmed.2005.09.011; Mathers CD, 2002, GLOBAL BURDEN DIS 20; Mathias SD, 1997, QUAL LIFE RES, V6, P311, DOI 10.1023/A:1018475108460; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Parmet Sharon, 2003, JAMA, V289, P1068; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Quintana JM, 2006, ARCH INTERN MED, V166, P220, DOI 10.1001/archinte.166.2.220; Reichmann WM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1046, DOI 10.1002/art.24839; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Shirai K, 2004, CURR MED RES OPIN, V20, P295, DOI 10.1185/030079903125003008; Sowers M, 2000, OSTEOARTHR CARTILAGE, V8, P69, DOI 10.1053/joca.1999.0273; Todd Miller M, 2008, J Cardiometab Syndr, V3, P162, DOI 10.1111/j.1559-4572.2008.00004.x; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; *US BUR CENS, 2010, NCEST200904HISPWANHB; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Winkelmayer WC, 2006, MED DECIS MAKING, V26, P247, DOI 10.1177/0272989X06288685; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	60	174	179	2	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					217	W74		10.7326/0003-4819-154-4-201102150-00001	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00001			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320937	Green Accepted, Green Published			2022-12-24	WOS:000287310000013
J	Benning, A; Dixon-Woods, M; Nwulu, U; Ghaleb, M; Dawson, J; Barber, N; Franklin, BD; Girling, A; Hemming, K; Carmalt, M; Rudge, G; Naicker, T; Kotecha, A; Derrington, MC; Lilford, R				Benning, Amirta; Dixon-Woods, Mary; Nwulu, Ugochi; Ghaleb, Maisoon; Dawson, Jeremy; Barber, Nick; Franklin, Bryony Dean; Girling, Alan; Hemming, Karla; Carmalt, Martin; Rudge, Gavin; Naicker, Thirumalai; Kotecha, Amit; Derrington, M. Clare; Lilford, Richard			Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE-NATIONAL-AUDIT; FRAMEWORK; ADMISSIONS; MORTALITY; ADULT; UNITS; WORK	Objective To independently evaluate the impact of the second phase of the Health Foundation's Safer Patients Initiative (SPI2) on a range of patient safety measures. Design A controlled before and after design. Five substudies: survey of staff attitudes; review of case notes from high risk (respiratory) patients in medical wards; review of case notes from surgical patients; indirect evaluation of hand hygiene by measuring hospital use of handwashing materials; measurement of outcomes (adverse events, mortality among high risk patients admitted to medical wards, patients' satisfaction, mortality in intensive care, rates of hospital acquired infection). Setting NHS hospitals in England. Participants Nine hospitals participating in SPI2 and nine matched control hospitals. Intervention The SPI2 intervention was similar to the SPI1, with somewhat modified goals, a slightly longer intervention period, and a smaller budget per hospital. Results One of the scores (organisational climate) showed a significant (P=0.009) difference in rate of change over time, which favoured the control hospitals, though the difference was only 0.07 points on a five point scale. Results of the explicit case note reviews of high risk medical patients showed that certain practices improved over time in both control and SPI2 hospitals (and none deteriorated), but there were no significant differences between control and SPI2 hospitals. Monitoring of vital signs improved across control and SPI2 sites. This temporal effect was significant for monitoring the respiratory rate at both the six hour (adjusted odds ratio 2.1, 99% confidence interval 1.0 to 4.3; P=0.010) and 12 hour (2.4, 1.1 to 5.0; P=0.002) periods after admission. There was no significant effect of SPI for any of the measures of vital signs. Use of a recommended system for scoring the severity of pneumonia improved from 1.9% (1/52) to 21.4% (12/56) of control and from 2.0% (1/50) to 41.7% (25/60) of SPI2 patients. This temporal change was significant (7.3, 1.4 to 37.7; P=0.002), but the difference in difference was not significant (2.1, 0.4 to 11.1; P=0.236). There were no notable or significant changes in the pattern of prescribing errors, either over time or between control and SPI2 hospitals. Two items of medical history taking (exercise tolerance and occupation) showed significant improvement over time, across both control and SPI2 hospitals, but no additional SPI2 effect. The holistic review showed no significant changes in error rates either over time or between control and SPI2 hospitals. The explicit case note review of perioperative care showed that adherence rates for two of the four perioperative standards targeted by SPI2 were already good at baseline, exceeding 94% for antibiotic prophylaxis and 98% for deep vein thrombosis prophylaxis. Intraoperative monitoring of temperature improved over time in both groups, but this was not significant (1.8, 0.4 to 7.6; P=0.279), and there were no additional effects of SPI2. A dramatic rise in consumption of soap and alcohol hand rub was similar in control and SPI2 hospitals (P=0.760 and P=0.889, respectively), as was the corresponding decrease in rates of Clostridium difficile and meticillin resistant Staphylococcus aureus infection (P=0.652 and P=0.693, respectively). Mortality rates of medical patients included in the case note reviews in control hospitals increased from 17.3% (42/ 243) to 21.4% (24/112), while in SPI2 hospitals they fell from 10.3% (24/233) to 6.1% (7/114) (P=0.043). Fewer than 8% of deaths were classed as avoidable; changes in proportions could not explain the divergence of overall death rates between control and SPI2 hospitals. There was no significant difference in the rate of change in mortality in intensive care. Patients' satisfaction improved in both control and SPI2 hospitals on all dimensions, but again there were no significant changes between the two groups of hospitals. Conclusions Many aspects of care are already good or improving across the NHS in England, suggesting considerable improvements in quality across the board. These improvements are probably due to contemporaneous policy activities relating to patient safety, including those with features similar to the SPI, and the emergence of professional consensus on some clinical processes. This phenomenon might have attenuated the incremental effect of the SPI, making it difficult to detect. Alternatively, the full impact of the SPI might be observable only in the longer term. The conclusion of this study could have been different if concurrent controls had not been used.	[Benning, Amirta; Girling, Alan; Hemming, Karla; Rudge, Gavin; Naicker, Thirumalai; Lilford, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Nwulu, Ugochi] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Clin Invest Unit, Birmingham B15 2TH, W Midlands, England; [Franklin, Bryony Dean] Univ London, Sch Pharm, Dept Practice & Policy, Ctr Medicat Safety & Serv Qual, London WC1N 1AX, England; [Ghaleb, Maisoon] Univ Hertfordshire, Sch Pharm, Hatfield AL10 9AB, Herts, England; [Dawson, Jeremy] Aston Univ, Aston Business Sch, Work & Org Psychol Grp, Birmingham B4 7ET, W Midlands, England; [Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Ctr Medicat Safety & Serv Qual, London W2 1NY, England; [Carmalt, Martin; Kotecha, Amit] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England	University of Birmingham; University of Leicester; University of Birmingham; University of London; University College London; University of London School of Pharmacy; University of Hertfordshire; Aston University; Imperial College London; Royal Orthopaedic Hospital	Lilford, R (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk	Hemming, karla/AAB-3391-2021; Girling, Alan J/A-7843-2012; Nwulu, Ugochi/G-9245-2011	Hemming, karla/0000-0002-2226-6550; Nwulu, Ugochi/0000-0002-4720-4751; Nwulu, Ugochi/0000-0001-6372-176X; Franklin, Bryony/0000-0002-2892-1245; Girling, Alan/0000-0003-2022-045X; Dixon-Woods, Mary/0000-0002-5915-0041	Health Foundation; National Patient Safety Agency; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare; National Institute of Health Research; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	Health Foundation; National Patient Safety Agency; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Health Foundation and the National Patient Safety Agency. KH was funded by the National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country, and AG by the Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare programme. The Centre for Medication Safety and Service Quality is affiliated with the Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. The evaluation was sponsored for research governance purposes by the University of Birmingham. The study was designed independently by the researchers. The researchers acted independently but worked collaboratively with the funder. The researchers independently collected, analysed and interpreted the data. The researchers wrote this article independently. The funders were given the opportunity to provide comments before submission. All researchers (apart from CD) had the opportunity to access participant anonymised data.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bate P., 2008, ORG QUALITY IMPROVEM; Benning A, 2010, CONTROLLED EVALUATIO; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Borrill C, 2000, BRIT J HLTH CARE, V6, P364, DOI DOI 10.12968/BJHC.2000.6.8.19300; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; British Orthopaedic Association, 2006, PRIM TOT HIP REPL GU; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Campbell SE, 2001, INT J QUAL HEALTH C, V13, P309, DOI 10.1093/intqhc/13.4.309; Davidoff F, 2009, JAMA-J AM MED ASSOC, V302, P2580, DOI 10.1001/jama.2009.1845; Department of Health, 2010, BEDS OP OV ENGL; Department of Health, 2007, SAV LIV RED INF DEL; Dixon-Woods M, 2010, QUAL SAF HEALTH CARE, V19, P74, DOI 10.1136/qshc.2008.029504; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; Gallivan S, 2008, DRUG SAFETY, V31, P637, DOI 10.2165/00002018-200831080-00001; GUZZO RA, 1985, PERS PSYCHOL, V38, P275, DOI 10.1111/j.1744-6570.1985.tb00547.x; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Healthcare Commission, 2006, MAK SENS YOUR STAFF; Hillman K, 2005, LANCET, V365, P2091; House of Commons Health Committee, 2009, 6 HOUS COMM HLTH COM; Institute for Healthcare Improvement, 2007, GUID PREV SURG SIT I; Keogh-Brown M, 2007, HEALTH TECHNOL ASSES, V11, P1; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; LILFORD RJ, 2010, BMJ-BRIT MED J, V341, pC4413, DOI DOI 10.1136/BMJ.C4413; Michie S, 2004, INT J MANAG REV, V5-6, P91, DOI 10.1111/j.1460-8545.2004.00098.x; National Institute for Health and Clinical Excellence, 2008, 65 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2010, 74 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2007, CG50  NAT I HLTH CLI; National Patient Safety Agency, 2010, CLEAN CAMP; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Slaughter MJ, 2001, J INT ECON, V55, P203, DOI 10.1016/S0022-1996(00)00087-8; Stone S, 2007, J HOSP INFECT, V66, P293, DOI 10.1016/j.jhin.2007.04.011; West MA, 2006, J ORGAN BEHAV, V27, P983, DOI 10.1002/job.396	36	75	78	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								d199	10.1136/bmj.d199	http://dx.doi.org/10.1136/bmj.d199			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PW	21292720	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-24	WOS:000287138500003
J	Letessier, A; Millot, GA; Koundrioukoff, S; Lachages, AM; Vogt, N; Hansen, RS; Malfoy, B; Brison, O; Debatisse, M				Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Hansen, R. Scott; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle			Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site	NATURE			English	Article							DNA-REPLICATION; MOLECULAR-BASIS; ORIGIN CHOICE; COMMON; GENOME; FORK; CANCER; CHROMOSOMES; INSTABILITY; INDUCTION	Common fragile sites have long been identified by cytogeneticists as chromosomal regions prone to breakage upon replication stress(1). They are increasingly recognized to be preferential targets for oncogene-induced DNA damage in pre-neoplastic lesions(2) and hotspots for chromosomal rearrangements in various cancers(3). Common fragile site instability was attributed to the fact that they contain sequences prone to form secondary structures that may impair replication fork movement, possibly leading to fork collapse resulting in DNA breaks(4). Here we show, in contrast to this view, that the fragility of FRA3B-the most active common fragile site in human lymphocytes-does not rely on fork slowing or stalling but on a paucity of initiation events. Indeed, in lymphoblastoid cells, but not in fibroblasts, initiation events are excluded from a FRA3B core extending approximately 700 kilobases, which forces forks coming from flanking regions to cover long distances in order to complete replication. We also show that origins of the flanking regions fire in mid-S phase, leaving the site incompletely replicated upon fork slowing. Notably, FRA3B instability is specific to cells showing this particular initiation pattern. The fact that both origin setting(5,6) and replication timing are highly plastic(7,8) in mammalian cells explains the tissue specificity of common fragile site instability we observed. Thus, we propose that common fragile sites correspond to the latest initiation-poor regions to complete replication in a given cell type. For historical reasons, common fragile sites have been essentially mapped in lymphocytes(1). Therefore, common fragile site contribution to chromosomal rearrangements in tumours should be reassessed after mapping fragile sites in the cell type from which each tumour originates.	[Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] Inst Curie, Ctr Rech, F-75248 Paris, France; [Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] Univ Paris 06, F-75005 Paris, France; [Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] CNRS, UMR 3244, F-75248 Paris, France; [Hansen, R. Scott] Univ Washington, Div Med Genet, Dept Med, Sch Med, Seattle, WA 98195 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Washington; University of Washington Seattle	Debatisse, M (corresponding author), Inst Curie, Ctr Rech, 26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr	Millot, Gael/AAO-7115-2020; Letessier, Anne/M-3431-2017	Letessier, Anne/0000-0002-1894-4072; Lachages, Anne-Marie/0000-0003-1771-1880	ARC(Association pour la recherche sur le cancer); La Ligue Nationale contre le Cancer (LNCC); INCa (Institut National du Cancer) [2009-1-PLBIO-10-IC-1]; PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie)	ARC(Association pour la recherche sur le cancer)(Fondation ARC pour la Recherche sur le Cancer); La Ligue Nationale contre le Cancer (LNCC); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie)	We thank E. Blackburn for critical reading of the manuscript. We thank Genomic Vision for making the DNA combing technology available to us. We acknowledge the Nikon Imaging Centre at Institut Curie-CNRS. We thank C. Rouzaud for help in combing experiments. A.L. is supported by a grant from the ARC(Association pour la recherche sur le cancer). The M.D. team is supported by La Ligue Nationale contre le Cancer (LNCC) (Equipe Labellisee EL2008. LNCC/MD), INCa (Institut National du Cancer) (2009-1-PLBIO-10-IC-1) and the PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie).	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bielinsky AK, 2003, CELL CYCLE, V2, P307, DOI 10.4161/cc.2.4.435; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Dazy S, 2006, EMBO REP, V7, P806, DOI 10.1038/sj.embor.7400736; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Gregoire D, 2006, EMBO REP, V7, P812, DOI 10.1038/sj.embor.7400758; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Labit H, 2008, BIOTECHNIQUES, V45, P649, DOI 10.2144/000113002; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; Palumbo E., 2010, CHROMOSOMA; Pichiorri F, 2008, J CELL BIOCHEM, V104, P1525, DOI 10.1002/jcb.21560; R Development Core Team, 2006, R LANG ENV STAT COMP; Rothstein R, 2000, GENE DEV, V14, P1; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989	32	303	304	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					120	U138		10.1038/nature09745	http://dx.doi.org/10.1038/nature09745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21258320				2022-12-24	WOS:000286886400046
J	Fukuda, S; Toh, H; Hase, K; Oshima, K; Nakanishi, Y; Yoshimura, K; Tobe, T; Clarke, JM; Topping, DL; Suzuki, T; Taylor, TD; Itoh, K; Kikuchi, J; Morita, H; Hattori, M; Ohno, H				Fukuda, Shinji; Toh, Hidehiro; Hase, Koji; Oshima, Kenshiro; Nakanishi, Yumiko; Yoshimura, Kazutoshi; Tobe, Toru; Clarke, Julie M.; Topping, David L.; Suzuki, Tohru; Taylor, Todd D.; Itoh, Kikuji; Kikuchi, Jun; Morita, Hidetoshi; Hattori, Masahira; Ohno, Hiroshi			Bifidobacteria can protect from enteropathogenic infection through production of acetate	NATURE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; SMOOTH-MUSCLE-CELLS; SHIGA-TOXIN; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; GENE-EXPRESSION; LONGUM NCC2705; GUT MICROBIOTA; PPAR-ALPHA; MICE	The human gut is colonized with a wide variety of microorganisms, including species, such as those belonging to the bacterial genus Bifidobacterium, that have beneficial effects on human physiology and pathology(1-3). Among the most distinctive benefits of bifidobacteria are modulation of host defence responses and protection against infectious diseases(4-6). Nevertheless, the molecular mechanisms underlying these effects have barely been elucidated. To investigate these mechanisms, we used mice associated with certain bifidobacterial strains and a simplified model of lethal infection with enterohaemorrhagic Escherichia coli O157:H7, together with an integrated 'omics' approach. Here we show that genes encoding an ATP-binding-cassette-type carbohydrate transporter present in certain bifidobacteria contribute to protecting mice against death induced by E. coli O157:H7. We found that this effect can be attributed, at least in part, to increased production of acetate and that translocation of the E. coli O157:H7 Shiga toxin from the gut lumen to the blood was inhibited. We propose that acetate produced by protective bifidobacteria improves intestinal defence mediated by epithelial cells and thereby protects the host against lethal infection.	[Fukuda, Shinji; Hase, Koji; Nakanishi, Yumiko; Ohno, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Shinji; Nakanishi, Yumiko; Kikuchi, Jun; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Toh, Hidehiro; Taylor, Todd D.] RIKEN Adv Sci Inst, MetaSyst Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Nakanishi, Yumiko; Kikuchi, Jun] RIKEN Plant Sci Ctr, Adv NMR Metab Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yoshimura, Kazutoshi; Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Tobe, Toru] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Clarke, Julie M.; Topping, David L.] CSIRO Food & Nutr Sci, Adelaide, SA 5000, Australia; [Suzuki, Tohru] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Kanagawa 2298501, Japan; [Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	RIKEN; Yokohama City University; RIKEN; University of Tokyo; RIKEN; University of Tokyo; Osaka University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Gifu University; Nagoya University; Azabu University; Chiba University	Ohno, H (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hattori@k.u-tokyo.ac.jp; ohno@rcai.riken.jp	Taylor, Todd/A-7121-2009; Kikuchi, Jun/M-5512-2015; Hattori, Masahira/AAD-3785-2019; Clarke, Julie M/H-6762-2013; Ohno, Hiroshi/L-7899-2014; topping, david l/H-7969-2013; Hattori, Masahira/C-6958-2016; Kikuchi, Jun/O-4725-2019	Taylor, Todd/0000-0003-4247-6253; Kikuchi, Jun/0000-0002-6809-394X; Clarke, Julie M/0000-0003-4676-0366; Ohno, Hiroshi/0000-0001-8776-9661; topping, david l/0000-0002-8481-9384; Hattori, Masahira/0000-0001-9467-0344; Kikuchi, Jun/0000-0002-6809-394X; Fukuda, Shinji/0000-0001-5161-9880; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Danone Institute of Japan; Institute for Fermentation, Osaka; Kieikai Research Foundation; Naito Foundation; Nestle Nutrition Council, Japan; Japan Science Society; Yakult Bio-Science Foundation; Academic Frontier Project for Private Universities (Matching Fund Subsidy); Private University Scientific Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Danone Institute of Japan(Danone Nutricia); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Kieikai Research Foundation(Kieikai Research Foundation); Naito Foundation(Naito Memorial Foundation); Nestle Nutrition Council, Japan; Japan Science Society; Yakult Bio-Science Foundation; Academic Frontier Project for Private Universities (Matching Fund Subsidy)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Private University Scientific Foundation	We thank H. Kitamura and M. E. Mariotti-Ferrandiz for discussions and for reading the manuscript; T. Morita for suggestions; and C. Nishigaki, M. Ohmae, Y. Chiba, T. Kato, H. Shima, A. Nakano, K. Sakaguchi, K. Furuya, C. Yoshino, H. Inaba, E. Iioka, K. Motomura and Y. Hattori for technical support. This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan: a Grant-in-Aid for Scientific Research on Priority Areas 'Comprehensive Genomics' (M.H.), 'Membrane Traffic' (H.O.) and 'Matrix of Infectious Phenomena' (K.H.); Young Scientists (S.F., K.H. and J.K.); Challenging Exploratory Research (J.K.); Scientific Research (H.O.); and Scientific Research on Innovative Areas 'Intracellular Logistics' (H.O.). This work was also supported in part by a RIKEN President's Special Research Grant (J.K.); a RIKEN DRI Research Grant (S.F.); a CREST grant from the Japan Science and Technology Agency (J.K.); the Danone Institute of Japan (H.O.); the Institute for Fermentation, Osaka (S.F.); the Kieikai Research Foundation (S.F.); the Naito Foundation (S.F.); the Nestle Nutrition Council, Japan (S.F.); the Sasakawa Scientific Research Grant from the Japan Science Society (S.F. and Y.N.); the Yakult Bio-Science Foundation (S.F.); the Academic Frontier Project for Private Universities (Matching Fund Subsidy (H.M.)); and the Private University Scientific Foundation (H.M.).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016/j.ijfoodmicro.2006.04.041; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hase K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003033; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kitajima H, 2002, ARCH DIS CHILD, V87, P335, DOI 10.1136/adc.87.4.335; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; KONGMUANG U, 1987, J CLIN MICROBIOL, V25, P115, DOI 10.1128/JCM.25.1.115-118.1987; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Morita T, 2004, J GASTROEN HEPATOL, V19, P303, DOI 10.1111/j.1440-1746.2003.03208.x; Nakamura T, 2002, BIOSCI BIOTECH BIOCH, V66, P2362, DOI 10.1271/bbb.66.2362; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Saulnier DMA, 2009, CURR OPIN BIOTECH, V20, P135, DOI 10.1016/j.copbio.2009.01.002; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schuller S, 2004, CELL MICROBIOL, V6, P289, DOI 10.1046/j.1462-5822.2004.00370.x; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; Yoshimura K, 2010, ANTON LEEUW INT J G, V97, P107, DOI 10.1007/s10482-009-9391-y; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	47	1398	1695	21	433	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					543	U791		10.1038/nature09646	http://dx.doi.org/10.1038/nature09646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270894				2022-12-24	WOS:000286596500035
J	Bantignies, F; Roure, V; Comet, I; Leblanc, B; Schuettengruber, B; Bonnet, J; Tixier, V; Mas, A; Cavalli, G				Bantignies, Frederic; Roure, Virginie; Comet, Itys; Leblanc, Benjamin; Schuettengruber, Bernd; Bonnet, Jerome; Tixier, Vanessa; Mas, Andre; Cavalli, Giacomo			Polycomb-Dependent Regulatory Contacts between Distant Hox Loci in Drosophila	CELL			English	Article							BITHORAX COMPLEX; NUCLEAR-ORGANIZATION; RESPONSE ELEMENTS; HOMEOTIC MUTATION; MCP ELEMENT; GENE; DOMAIN; EXPRESSION; EVOLUTION; LADYBIRD	In Drosophila melanogaster, Hox genes are organized in an anterior and a posterior cluster, called Antennapedia complex and bithorax complex, located on the same chromosome arm and separated by 10 Mb of DNA. Both clusters are repressed by Polycomb group (PcG) proteins. Here, we show that genes of the two Hox complexes can interact within nuclear PcG bodies in tissues where they are corepressed. This colocalization increases during development and depends on PcG proteins. Hox gene contacts are conserved in the distantly related Drosophila virilis species and they are part of a large gene interaction network that includes other PcG target genes. Importantly, mutations on one of the loci weaken silencing of genes in the other locus, resulting in the exacerbation of homeotic phenotypes in sensitized genetic backgrounds. Thus, the three-dimensional organization of Polycomb target genes in the cell nucleus stabilizes the maintenance of epigenetic gene silencing.	[Bantignies, Frederic; Roure, Virginie; Comet, Itys; Leblanc, Benjamin; Schuettengruber, Bernd; Bonnet, Jerome; Tixier, Vanessa; Cavalli, Giacomo] CNRS, Inst Genet Humaine, UPR 1142, F-34396 Montpellier 5, France; [Mas, Andre] Univ Montpellier 2, Inst Modelisat Math Montpellier, CNRS, UMR 5149, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Montpellier	Bantignies, F (corresponding author), CNRS, Inst Genet Humaine, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 5, France.	frederic.bantignies@igh.cnrs.fr; giacomo.cavalli@igh.cnrs.fr	Cavalli, Giacomo/A-7958-2008; cavalli, giacomo/Z-2754-2019; Bonnet, Jerome/AAT-5600-2020; Bonnet, Jerome/D-3041-2014	Cavalli, Giacomo/0000-0003-3709-3469; cavalli, giacomo/0000-0003-3709-3469; Bonnet, Jerome/0000-0002-8420-9359; Bonnet, Jerome/0000-0002-8420-9359; Leblanc, Benjamin/0000-0002-8657-2821; Schuettengruber, Bernd/0000-0001-7338-4648; Comet, Itys/0000-0001-7265-2284	CNRS; Ministere de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Fondation de la Recherche Medicale; Human Frontier Science Program Organization; European Union; European Research Council [ERC-2008-AdG No 232947]; Indo-French Centre for Promotion of Advanced Research; Ministere de l'Enseignement Superieur, ACI BCMS	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program Organization(Human Frontier Science Program); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Indo-French Centre for Promotion of Advanced Research(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, ACI BCMS	We would like to thank W. Gehring, F. Karch, H. Gyurkovics, J.M. Dura, and Alain Pelisson for fly lines and plasmids. We also thank T. Sexton and D. Cribbs for stimulating discussions; B. Pfeiffer and S. Celniker for sharing the D. virilis BX-C sequence before publication; Chantal Cazevieille for electron microscopy at the Centre de Ressources en Imagerie Cellulaire of Montpellier. F.B. is supported by the CNRS; V.R. and I.C. were supported by the Ministere de l'Enseignement Superieur, the Association pour la Recherche sur le Cancer, and the Agence Nationale de la Recherche. B.L. was supported by the Ministere de l'Enseignement Superieur. B.S. was supported by the Fondation de la Recherche Medicale. G.C. was supported by grants of the CNRS, the Human Frontier Science Program Organization, the European Union FP6 (Network of Excellence, The Epigenome, and STREP 3D Genome), the European Research Council (ERC-2008-AdG No 232947), by the Indo-French Centre for Promotion of Advanced Research, by the Agence Nationale de la Recherche, and by the Ministere de l'Enseignement Superieur, ACI BCMS.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Castelli-Gair J, 1998, INT J DEV BIOL, V42, P437; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; Fedorova E, 2008, CHROMOSOME RES, V16, P649, DOI 10.1007/s10577-008-1218-6; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; GALLONI M, 1993, EMBO J, V12, P1087, DOI 10.1002/j.1460-2075.1993.tb05750.x; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jagla K, 1997, DEVELOPMENT, V124, P3471; Jagla K, 1997, DEVELOPMENT, V124, P91; Jagla T, 1998, DEVELOPMENT, V125, P3699; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; Kaufman T C, 1990, Adv Genet, V27, P309; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIORA MA, 1993, MECH DEVELOP, V42, P125, DOI 10.1016/0925-4773(93)90002-F; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Merdes G, 2009, DEV CELL, V17, P440, DOI 10.1016/j.devcel.2009.10.001; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Miele Adriana, 2008, V464, P105; Mihaly J, 1997, DEVELOPMENT, V124, P1809; MORATA P, 1994, CANCER LETT, V81, P209, DOI 10.1016/0304-3835(94)90204-6; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Muller M, 1999, GENETICS, V153, P1333; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; PATTATUCCI AM, 1991, GENETICS, V129, P423; PIRROTTA V, 1995, GENETICS, V141, P1439; Ranz JM, 1997, GENETICS, V145, P281; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Southworth JW, 2002, GENETICS, V161, P733; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; TALBERT PB, 1994, GENETICS, V138, P709; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; Vazquez M, 1999, DEVELOPMENT, V126, P733; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007	56	298	308	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					214	226		10.1016/j.cell.2010.12.026	http://dx.doi.org/10.1016/j.cell.2010.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241892	Bronze			2022-12-24	WOS:000286459900007
J	Wan, XH; Nakatani, H; Ueno, K; Asamizuya, T; Cheng, K; Tanaka, K				Wan, Xiaohong; Nakatani, Hironori; Ueno, Kenichi; Asamizuya, Takeshi; Cheng, Kang; Tanaka, Keiji			The Neural Basis of Intuitive Best Next-Move Generation in Board Game Experts	SCIENCE			English	Article							BASAL GANGLIA; CORTICOSTRIATAL PROJECTIONS; EPISODIC MEMORY; PARIETAL CORTEX; ABACUS EXPERTS; CHESS EXPERTS; BRAIN; CONNECTIONS; ACTIVATION; AREAS	The superior capability of cognitive experts largely depends on quick automatic processes. To reveal their neural bases, we used functional magnetic resonance imaging to study brain activity of professional and amateur players in a board game named shogi. We found two activations specific to professionals: one in the precuneus of the parietal lobe during perception of board patterns, and the other in the caudate nucleus of the basal ganglia during quick generation of the best next move. Activities at these two sites covaried in relevant tasks. These results suggest that the precuneus-caudate circuit implements the automatic, yet complicated, processes of board-pattern perception and next-move generation in board game experts.	[Wan, Xiaohong; Nakatani, Hironori; Cheng, Kang; Tanaka, Keiji] RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; [Ueno, Kenichi; Asamizuya, Takeshi; Cheng, Kang] RIKEN Brain Sci Inst, Support Unit Funct Magnet Resonance Imaging, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Tanaka, K (corresponding author), RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji@riken.jp	Cheng, Kang/A-6448-2016; Wan, Xiaohong/B-3753-2013; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Asamizuya, Takeshi/0000-0003-1004-6435	Fujitsu Laboratories; Ministry of Education, Culture, Sports, Science and Technology of Japan [19700312]	Fujitsu Laboratories; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Fujitsu Laboratories and a grant-in-aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19700312, X.W.). We thank the Japan Shogi Association for cooperation and T. Ito, K. Okuma, and T. Kawatsuma for discussion.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Atherton M, 2003, COGNITIVE BRAIN RES, V16, P26, DOI 10.1016/S0926-6410(02)00207-0; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Campitelli G, 2007, INT J NEUROSCI, V117, P1641, DOI 10.1080/00207450601041955; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; CHARNESS N, 1981, J EXP PSYCHOL HUMAN, V7, P467, DOI 10.1037/0096-1523.7.2.467; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; de Groot A. D., 1946, DENKEN VANDENSCHAKER; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Gaser C, 2003, J NEUROSCI, V23, P9240; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gobet F, 2004, MOVES IN MIND: THE PSYCHOLOGY OF BOARD GAMES; Gobet F, 1994, ADV COMPUTER CHESS, V7, P35; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han S, 2010, J NEUROSCI, V30, P4767, DOI 10.1523/JNEUROSCI.3077-09.2010; Hanakawa T, 2003, NEUROIMAGE, V19, P296, DOI 10.1016/S1053-8119(03)00050-8; HOLDING DH, 1989, AM J PSYCHOL, V102, P103, DOI 10.2307/1423119; HOLDING DH, 1979, SIMULAT GAMING, V10, P207, DOI 10.1177/104687817901000205; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mishkin M., 1984, NEUROBIOL LEARN MEM, P65, DOI DOI 10.1523/JNEUROSCI.0840-16.2016; NICHELLI P, 1994, NATURE, V369, P191, DOI 10.1038/369191a0; ONOFRJ M, 1995, NEUROSCI LETT, V198, P169, DOI 10.1016/0304-3940(95)11985-6; Ouchi Y, 2005, COGNITIVE BRAIN RES, V23, P164, DOI 10.1016/j.cogbrainres.2004.10.004; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Saariluoma P, 2004, EUR J COGN PSYCHOL, V16, P753, DOI 10.1080/09541440340000501; SAARILUOMA P, 1992, PSYCHOL RES-PSYCH FO, V54, P17, DOI 10.1007/BF01359219; Saariluoma P., 1995, CHESS PLAYERS THINKI; SELEMON LD, 1985, J NEUROSCI, V5, P776; Tanaka S, 2002, NEUROREPORT, V13, P2187, DOI 10.1097/00001756-200212030-00005; Volke HJ, 2002, J PSYCHOPHYSIOL, V16, P23, DOI 10.1027//0269-8803.16.1.23; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; YETERIAN EH, 1995, J COMP NEUROL, V352, P436, DOI 10.1002/cne.903520309; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	42	84	86	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					341	346		10.1126/science.1194732	http://dx.doi.org/10.1126/science.1194732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BF	21252348				2022-12-24	WOS:000286636300040
J	Hopkins, R; Rausher, MD				Hopkins, Robin; Rausher, Mark D.			Identification of two genes causing reinforcement in the Texas wildflower Phlox drummondii	NATURE			English	Article							CHARACTER DISPLACEMENT; REPRODUCTIVE ISOLATION; SPECIATION GENETICS; HYBRIDIZATION; EVOLUTION	Species formation generates biological diversity and occurs when traits evolve that prevent gene flow between populations. Discerning the number and distribution of genes underlying these traits and, in a few cases, identifying the genes involved, has greatly enhanced our understanding over the past 15 years of species formation (reviewed by Noor and Feder(1) and Wolf et al.(2)). However, this work has almost exclusively focused on traits that restrict gene flow between populations that have evolved as a by-product of genetic divergence between geographically isolated populations. By contrast, little is known about the characteristics of genes associated with reinforcement, the process by which natural selection directly favours restricted gene flow during the formation of species. Here we identify changes in two genes that appear to cause a flower colour change in Phlox drummondii, which previous work has shown contributes to reinforcement. Both changes involve cis-regulatory mutations to genes in the anthocyanin biosynthetic pathway (ABP). Because one change is recessive whereas the other is dominant, hybrid offspring produce an intermediate flower colour that is visited less by pollinators, and is presumably maladaptive. Thus genetic change selected to increase prezygotic isolation also appears to result in increased postzygotic isolation.	[Hopkins, Robin; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Hopkins, R (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	robin.hopkins@duke.edu; mrausher@duke.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank D. Des Marais, J. Tung, S. Johnsen and T. Juenger for technical advice, D. Levin for assistance in locating natural populations, and M. Noor for comments on the manuscript. This work was supported by a National Science Foundation grant to M. D. R. and a National Science Foundation Doctoral Dissertation Research Improvement Grant to R. H. R. H. was supported in part by the National Science Foundation Graduate Research Fellowship Program.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Dambroski HR, 2005, EVOLUTION, V59, P1953, DOI 10.1111/j.0014-3820.2005.tb01065.x; Des Marais DL, 2010, EVOLUTION, V64, P2044, DOI 10.1111/j.1558-5646.2010.00972.x; Dobzhansky T., 1937; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; GONNET JF, 1993, J HORTIC SCI, V68, P499, DOI 10.1080/00221589.1993.11516378; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Kelly AJ, 1998, MOL ECOL, V7, P769, DOI 10.1046/j.1365-294x.1998.00328.x; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; LEVIN DA, 1970, EVOLUTION, V24, P367, DOI 10.1111/j.1558-5646.1970.tb01768.x; LEVIN DA, 1975, EVOLUTION, V29, P37, DOI 10.1111/j.1558-5646.1975.tb00812.x; LEVIN DA, 1967, AM J BOT, V54, P1122, DOI 10.2307/2440537; LEVIN DA, 1985, EVOLUTION, V39, P1275, DOI 10.1111/j.1558-5646.1985.tb05693.x; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Mouritzen P, 2004, BIOTECHNIQUES, V37, P492, DOI 10.2144/04373AF02; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Nosil P, 2005, EVOLUTION, V59, P705; Orr HA, 2001, GENETICS, V157, P875; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Ruane LG, 2008, EVOL ECOL, V22, P229, DOI 10.1007/s10682-007-9174-8; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	34	130	132	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					411	+		10.1038/nature09641	http://dx.doi.org/10.1038/nature09641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21217687				2022-12-24	WOS:000286385600055
J	Rosenbaum, DM; Zhang, C; Lyons, JA; Holl, R; Aragao, D; Arlow, DH; Rasmussen, SGF; Choi, HJ; DeVree, BT; Sunahara, RK; Chae, PS; Gellman, SH; Dror, RO; Shaw, DE; Weis, WI; Caffrey, M; Gmeiner, P; Kobilka, BK				Rosenbaum, Daniel M.; Zhang, Cheng; Lyons, Joseph A.; Holl, Ralph; Aragao, David; Arlow, Daniel H.; Rasmussen, Soren G. F.; Choi, Hee-Jung; DeVree, Brian T.; Sunahara, Roger K.; Chae, Pil Seok; Gellman, Samuel H.; Dror, Ron O.; Shaw, David E.; Weis, William I.; Caffrey, Martin; Gmeiner, Peter; Kobilka, Brian K.			Structure and function of an irreversible agonist-beta(2) adrenoceptor complex	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTALLIZING MEMBRANE-PROTEINS; MOLECULAR-DYNAMICS SIMULATIONS; LIPIDIC MESOPHASES; ADRENERGIC-RECEPTOR; BINDING-SITE; FORCE-FIELDS; RHODOPSIN; ACTIVATION; AGONISTS	G-protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that modulate biological function by initiating cellular signalling in response to chemically diverse agonists. Despite recent progress in the structural biology of GPCRs(1), the molecular basis for agonist binding and allosteric modulation of these proteins is poorly understood. Structural knowledge of agonist-bound states is essential for deciphering the mechanism of receptor activation, and for structure-guided design and optimization of ligands. However, the crystallization of agonist-bound GPCRs has been hampered by modest affinities and rapid off-rates of available agonists. Using the inactive structure of the human beta(2) adrenergic receptor (beta(2)AR) as a guide, we designed a beta(2)AR agonist that can be covalently tethered to a specific site on the receptor through a disulphide bond. The covalent beta(2)AR-agonist complex forms efficiently, and is capable of activating a heterotrimeric G protein. We crystallized a covalent agonist-bound beta(2)AR-T4L fusion protein in lipid bilayers through the use of the lipidic mesophase method(2), and determined its structure at 3.5 angstrom resolution. A comparison to the inactive structure and an antibody-stabilized active structure (companion paper(3)) shows how binding events at both the extracellular and intracellular surfaces are required to stabilize an active conformation of the receptor. The structures are in agreement with long-timescale (up to 30 mu s) molecular dynamics simulations showing that an agonist-bound active conformation spontaneously relaxes to an inactive-like conformation in the absence of a G protein or stabilizing antibody.	[Rosenbaum, Daniel M.; Zhang, Cheng; Rasmussen, Soren G. F.; Choi, Hee-Jung; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lyons, Joseph A.] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Lyons, Joseph A.; Aragao, David; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Membrane Struct & Funct Biol Grp, Dublin 2, Ireland; [Holl, Ralph; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91052 Erlangan, Germany; [Arlow, Daniel H.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [DeVree, Brian T.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Stanford University; University of Limerick; Trinity College Dublin; University of Erlangen Nuremberg; D. E. Shaw Research; Stanford University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	martin.caffrey@tcd.ie; peter.gmeiner@medchem.uni-erlangen.de; kobilka@stanford.edu	Weis, William I/G-1437-2011; Gmeiner, Peter/N-5275-2015; Lyons, Joseph/AAA-2528-2020; Aragao, David/A-1695-2012; Sunahara, Roger/AAJ-8667-2020; Aragao, David/AAV-5514-2021; DeVree, Brian T/F-6205-2011; Zhang, Cheng/O-4372-2015	Weis, William I/0000-0002-5583-6150; Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; Zhang, Cheng/0000-0001-9042-4007; DeVree, Brian/0000-0003-0582-8125; Rasmussen, Soren/0000-0002-1853-1841; Choi, Hee-Jung/0000-0002-1167-1526; Gmeiner, Peter/0000-0002-4127-197X; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990; Lyons, Joseph/0000-0003-0218-4862	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, GM75915, P50GM073210, P60DK-20572]; Mathers Foundation; Lundbeck Foundation; Science Foundation Ireland [07/IN.1/B1836]; FP7 COST Action [CM0902]; Bavaria California Technology Center; University of Michigan; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075915, P50GM073210, P01GM075913, R01GM056169, R01GM068603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 COST Action; Bavaria California Technology Center; University of Michigan(University of Michigan System); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), GM75915 and P50GM073210 (M. C), and P60DK-20572 (R. K. S.), the Mathers Foundation (B. K. K and W. I. W), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), Science Foundation Ireland (07/IN.1/B1836) and FP7 COST Action CM0902 (M. C.), the Bavaria California Technology Center (P. G.), and the University of Michigan Biomedical Sciences Scholars Program(R. K. S). We thank Stefan Lober, Harald Hubner, Albert Pan and Paul Maragakis for discussion and suggestions. We thank Foon Sun Thian for help with insect cell expression.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Buck E, 2005, P NATL ACAD SCI USA, V102, P2719, DOI 10.1073/pnas.0500016102; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinelli MJ, 2002, J AM CHEM SOC, V124, P3578, DOI 10.1021/ja016031r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; TOTA MR, 1991, TRENDS PHARMACOL SCI, V12, P4, DOI 10.1016/0165-6147(91)90479-C; TU T, 2008, P 2008 ACM IEEE C SU; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	52	624	644	1	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					236	240		10.1038/nature09665	http://dx.doi.org/10.1038/nature09665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228876	Green Accepted			2022-12-24	WOS:000286143400043
J	Bevilacqua, L; Doly, S; Kaprio, J; Yuan, QP; Tikkanen, R; Paunio, T; Zhou, ZF; Wedenoja, J; Maroteaux, L; Diaz, S; Belmer, A; Hodgkinson, CA; Dell'Osso, L; Suvisaari, J; Coccaro, E; Rose, RJ; Peltonen, L; Virkkunen, M; Goldman, D				Bevilacqua, Laura; Doly, Stephane; Kaprio, Jaakko; Yuan, Qiaoping; Tikkanen, Roope; Paunio, Tiina; Zhou, Zhifeng; Wedenoja, Juho; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud; Hodgkinson, Colin A.; Dell'Osso, Liliana; Suvisaari, Jaana; Coccaro, Emil; Rose, Richard J.; Peltonen, Leena; Virkkunen, Matti; Goldman, David			A population-specific HTR2B stop codon predisposes to severe impulsivity	NATURE			English	Article							MONOAMINE-OXIDASE; MOLECULAR-GENETICS; SEROTONIN; VULNERABILITY; DOPAMINE; MUTATION; POLYMORPHISM; AGGRESSION; MECHANISMS; RECEPTORS	Impulsivity, describing action without foresight, is an important feature of several psychiatric diseases, suicidality and violent behaviour. The complex origins of impulsivity hinder identification of the genes influencing it and the diseases with which it is associated. Here we perform exon-focused sequencing of impulsive individuals in a founder population, targeting fourteen genes belonging to the serotonin and dopamine domain. A stop codon in HTR2B was identified that is common (minor allele frequency >1%) but exclusive to Finnish people. Expression of the gene in the human brain was assessed, as well as the molecular functionality of the stop codon, which was associated with psychiatric diseases marked by impulsivity in both population and family-based analyses. Knockout of Htr2b increased impulsive behaviours in mice, indicative of predictive validity. Our study shows the potential for identifying and tracing effects of rare alleles in complex behavioural phenotypes using founder populations, and indicates a role for HTR2B in impulsivity.	[Bevilacqua, Laura; Yuan, Qiaoping; Zhou, Zhifeng; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Doly, Stephane; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud] INSERM, UMR S 839, F-75654 Paris, France; [Doly, Stephane; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud] Univ Paris 06, Inst du Fer Moulin, F-75654 Paris, France; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med, FI-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Unit Child & Adolescent Psychiat, FI-00271 Helsinki, Finland; [Tikkanen, Roope; Virkkunen, Matti] Univ Helsinki, Inst Clin Med, Dept Psychiat, FI-00014 Helsinki, Finland; [Paunio, Tiina; Suvisaari, Jaana] Univ Helsinki, Dept Psychiat, Cent Hosp, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Inst Mol Med Finland, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Natl Inst Hlth & Welf, FI-00014 Helsinki, Finland; [Dell'Osso, Liliana] Univ Pisa, Dept Psychiat, I-56100 Pisa, Italy; [Coccaro, Emil] Univ Chicago, Pritzker Sch Med, Dept Psychiat, Chicago, IL 60637 USA; [Rose, Richard J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Virkkunen, Matti] Kellokoski Psychiat Hosp, FI-04500 Kellokoski, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Pisa; University of Chicago; Indiana University System; Indiana University Bloomington	Goldman, D (corresponding author), NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA.	davidgoldman@mail.nih.gov	Belmer, Arnauld/AAE-2554-2019; Kaprio, Jaakko/A-1820-2008; Maroteaux, Luc/H-4585-2019; Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010; doly, stephane/Y-2318-2019; Wedenoja, Juho/AAX-7008-2020	Belmer, Arnauld/0000-0001-6640-5631; Kaprio, Jaakko/0000-0002-3716-2455; Maroteaux, Luc/0000-0002-9499-8603; Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; doly, stephane/0000-0002-3517-8605; Wedenoja, Juho/0000-0002-6155-0378; Yuan, Qiaoping/0000-0002-5880-8702; Suvisaari, Jaana/0000-0001-7167-0990; , Laura/0000-0002-6460-0852	National Institute on Alcohol Abuse and Alcoholism, NIH; Academy of Finland Centre of Excellence in Complex Disease Genetics; National Institute on Alcohol Abuse and Alcoholism [AA-12502, AA-09203]; Academy of Finland [100499, 205585, 118555]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; French Ministry of Research (Agence Nationale pour la Recherche); European Union; IBRO; Region Ile de France DIM STEM; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301, R01AA012502, R01AA009203, R37AA012502] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland(Academy of Finland); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Union(European Commission); IBRO; Region Ile de France DIM STEM(Region Ile-de-France); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is dedicated to the memory of L.P. and M. Linnoila. We thank L. Akhtar for assistance with tissue culture, C. Marietta for assistance with measurement of receptor protein levels, V. Srivastava and G. Yamini for discussions, and P.-H. Shen for contributions to ancestry analyses. M. Eggert and L. Brown assisted with clinical ascertainment and assessment of the University of Helsinki sample. We thank M. Linnoila for his contributions to the collection of the University of Helsinki sample. E. Kempas assisted with genotyping. J.-M. Launay measured plasma testosterone levels in Htr2b<SUP>-/-</SUP> mice. We also thank A. Tuulio-Henriksson, E. Vuoksimaa, A. Happola and L. Arala. This work was supported by the Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, NIH and the Academy of Finland Centre of Excellence in Complex Disease Genetics. The FinnTwin12 and FinnTwin16 studies were supported by the National Institute on Alcohol Abuse and Alcoholism (AA-12502 and AA-09203 to R.J.R.), and by the Academy of Finland (100499, 205585 and 118555 to J.K.). The studies on Htr2b<SUP>-/-</SUP> mice were supported by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, the French Ministry of Research (Agence Nationale pour la Recherche), and the European Union. L.M.'s team is an "Equipe Fondation pour la Recherche Medicale''. S. Diaz is supported by a fellowship from IBRO and Region Ile de France DIM STEM.	Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Cases O, 1998, J NEUROSCI, V18, P6914; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chiavegatto S, 2010, GENES BRAIN BEHAV, V9, P110, DOI 10.1111/j.1601-183X.2009.00544.x; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COCCARO EF, 1993, PSYCHIAT RES, V48, P229, DOI 10.1016/0165-1781(93)90074-Q; DEJONG J, 1992, J NERV MENT DIS, V180, P543, DOI 10.1097/00005053-199209000-00001; Doly S, 2008, J NEUROSCI, V28, P2933, DOI 10.1523/JNEUROSCI.5723-07.2008; Ducci F, 2008, MOL PSYCHIATR, V13, P334, DOI 10.1038/sj.mp.4002034; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P1438, DOI 10.1001/archpsyc.65.12.1438; Kim SJ, 2000, MOL CELL PROBE, V14, P47, DOI 10.1006/mcpr.1999.0281; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Lin ZC, 2004, PHARMACOGENETICS, V14, P805, DOI 10.1097/00008571-200412000-00003; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Misener VL, 2004, MOL PSYCHIATR, V9, P500, DOI 10.1038/sj.mp.4001440; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Roy A, 2007, NEUROPSYCHOPHARMACOL, V32, P2046, DOI 10.1038/sj.npp.1301331; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sjoberg RL, 2008, NEUROPSYCHOPHARMACOL, V33, P425, DOI 10.1038/sj.npp.1301417; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P20; VIRKKUNEN M, 1993, J STUD ALCOHOL, P163, DOI 10.15288/jsas.1993.s11.163; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001	39	173	187	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1061	U460		10.1038/nature09629	http://dx.doi.org/10.1038/nature09629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179162	Green Accepted			2022-12-24	WOS:000285553800050
J	Gerstein, MB; Lu, ZJ; Van Nostrand, EL; Cheng, C; Arshinoff, BI; Liu, T; Yip, KY; Robilotto, R; Rechtsteiner, A; Ikegami, K; Alves, P; Chateigner, A; Perry, M; Morris, M; Auerbach, RK; Feng, X; Leng, J; Vielle, A; Niu, W; Rhrissorrakrai, K; Agarwal, A; Alexander, RP; Barber, G; Brdlik, CM; Brennan, J; Brouillet, JJ; Carr, A; Cheung, MS; Clawson, H; Contrino, S; Dannenberg, LO; Dernburg, AF; Desai, A; Dick, L; Dose, AC; Du, JA; Egelhofer, T; Ercan, S; Euskirchen, G; Ewing, B; Feingold, EA; Gassmann, R; Good, PJ; Green, P; Gullier, F; Gutwein, M; Guyer, MS; Habegger, L; Han, T; Henikoff, JG; Henz, SR; Hinrichs, A; Holster, H; Hyman, T; Iniguez, AL; Janette, J; Jensen, M; Kato, M; Kent, WJ; Kephart, E; Khivansara, V; Khurana, E; Kim, JK; Kolasinska-Zwierz, P; Lai, EC; Latorre, I; Leahey, A; Lewis, S; Lloyd, P; Lochovsky, L; Lowdon, RF; Lubling, Y; Lyne, R; MacCoss, M; Mackowiak, SD; Mangone, M; Mckay, S; Mecenas, D; Merrihew, G; Miller, DM; Muroyama, A; Murray, JI; Ooi, SL; Pham, H; Phippen, T; Preston, EA; Rajewsky, N; Ratsch, G; Rosenbaum, H; Rozowsky, J; Rutherford, K; Ruzanov, P; Sarov, M; Sasidharan, R; Sboner, A; Scheid, P; Segal, E; Shin, HJ; Shou, C; Slack, FJ; Slightam, C; Smith, R; Spencer, WC; Stinson, EO; Taing, S; Takasaki, T; Vafeados, D; Voronina, K; Wang, GL; Washington, NL; Whittle, CM; Wu, BJ; Yan, KK; Zeller, G; Zha, Z; Zhong, M; Zhou, XL; Ahringer, J; Strome, S; Gunsalus, KC; Micklem, G; Liu, XS; Reinke, V; Kim, SK; Hillier, LW; Henikoff, S; Piano, F; Snyder, M; Stein, L; Lieb, JD; Waterston, RH				Gerstein, Mark B.; Lu, Zhi John; Van Nostrand, Eric L.; Cheng, Chao; Arshinoff, Bradley I.; Liu, Tao; Yip, Kevin Y.; Robilotto, Rebecca; Rechtsteiner, Andreas; Ikegami, Kohta; Alves, Pedro; Chateigner, Aurelien; Perry, Marc; Morris, Mitzi; Auerbach, Raymond K.; Feng, Xin; Leng, Jing; Vielle, Anne; Niu, Wei; Rhrissorrakrai, Kahn; Agarwal, Ashish; Alexander, Roger P.; Barber, Galt; Brdlik, Cathleen M.; Brennan, Jennifer; Brouillet, Jeremy Jean; Carr, Adrian; Cheung, Ming-Sin; Clawson, Hiram; Contrino, Sergio; Dannenberg, Luke O.; Dernburg, Abby F.; Desai, Arshad; Dick, Lindsay; Dose, Andrea C.; Du, Jiang; Egelhofer, Thea; Ercan, Sevinc; Euskirchen, Ghia; Ewing, Brent; Feingold, Elise A.; Gassmann, Reto; Good, Peter J.; Green, Phil; Gullier, Francois; Gutwein, Michelle; Guyer, Mark S.; Habegger, Lukas; Han, Ting; Henikoff, Jorja G.; Henz, Stefan R.; Hinrichs, Angie; Holster, Heather; Hyman, Tony; Iniguez, A. Leo; Janette, Judith; Jensen, Morten; Kato, Masaomi; Kent, W. James; Kephart, Ellen; Khivansara, Vishal; Khurana, Ekta; Kim, John K.; Kolasinska-Zwierz, Paulina; Lai, Eric C.; Latorre, Isabel; Leahey, Amber; Lewis, Suzanna; Lloyd, Paul; Lochovsky, Lucas; Lowdon, Rebecca F.; Lubling, Yaniv; Lyne, Rachel; MacCoss, Michael; Mackowiak, Sebastian D.; Mangone, Marco; Mckay, Sheldon; Mecenas, Desirea; Merrihew, Gennifer; Miller, David M., III; Muroyama, Andrew; Murray, John I.; Ooi, Siew-Loon; Pham, Hoang; Phippen, Taryn; Preston, Elicia A.; Rajewsky, Nikolaus; Raetsch, Gunnar; Rosenbaum, Heidi; Rozowsky, Joel; Rutherford, Kim; Ruzanov, Peter; Sarov, Mihail; Sasidharan, Rajkumar; Sboner, Andrea; Scheid, Paul; Segal, Eran; Shin, Hyunjin; Shou, Chong; Slack, Frank J.; Slightam, Cindie; Smith, Richard; Spencer, William C.; Stinson, E. O.; Taing, Scott; Takasaki, Teruaki; Vafeados, Dionne; Voronina, Ksenia; Wang, Guilin; Washington, Nicole L.; Whittle, Christina M.; Wu, Beijing; Yan, Koon-Kiu; Zeller, Georg; Zha, Zheng; Zhong, Mei; Zhou, Xingliang; Ahringer, Julie; Strome, Susan; Gunsalus, Kristin C.; Micklem, Gos; Liu, X. Shirley; Reinke, Valerie; Kim, Stuart K.; Hillier, LaDeana W.; Henikoff, Steven; Piano, Fabio; Snyder, Michael; Stein, Lincoln; Lieb, Jason D.; Waterston, Robert H.		modENCODE Consortium	Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project	SCIENCE			English	Article							TRANSCRIPTION; REVEALS; DNA; MOTIFS; ROLES; IDENTIFICATION; ORGANIZATION; EXPRESSION; LANDSCAPE; GERMLINE	We systematically generated large-scale data sets to improve genome annotation for the nematode Caenorhabditis elegans, a key model organism. These data sets include transcriptome profiling across a developmental time course, genome-wide identification of transcription factor-binding sites, and maps of chromatin organization. From this, we created more complete and accurate gene models, including alternative splice forms and candidate noncoding RNAs. We constructed hierarchical networks of transcription factor-binding and microRNA interactions and discovered chromosomal locations bound by an unusually large number of transcription factors. Different patterns of chromatin composition and histone modification were revealed between chromosome arms and centers, with similarly prominent differences between autosomes and the X chromosome. Integrating data types, we built statistical models relating chromatin, transcription factor binding, and gene expression. Overall, our analyses ascribed putative functions to most of the conserved genome.	[Gerstein, Mark B.; Lu, Zhi John; Cheng, Chao; Yip, Kevin Y.; Robilotto, Rebecca; Alves, Pedro; Auerbach, Raymond K.; Leng, Jing; Alexander, Roger P.; Habegger, Lukas; Lochovsky, Lucas; Rozowsky, Joel; Sboner, Andrea; Shou, Chong; Yan, Koon-Kiu] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Lu, Zhi John; Cheng, Chao; Yip, Kevin Y.; Agarwal, Ashish; Alexander, Roger P.; Rozowsky, Joel; Sasidharan, Rajkumar; Sboner, Andrea; Yan, Koon-Kiu] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.; Agarwal, Ashish; Du, Jiang] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Van Nostrand, Eric L.; Brdlik, Cathleen M.; Brouillet, Jeremy Jean; Kim, Stuart K.; Snyder, Michael] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Arshinoff, Bradley I.; Perry, Marc; Feng, Xin; Kephart, Ellen; Lloyd, Paul; Ruzanov, Peter; Zha, Zheng; Stein, Lincoln] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Arshinoff, Bradley I.; Stein, Lincoln] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Liu, Tao; Shin, Hyunjin; Taing, Scott; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Shin, Hyunjin; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Ikegami, Kohta; Brennan, Jennifer; Ercan, Sevinc; Jensen, Morten; Whittle, Christina M.; Zhou, Xingliang; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Ikegami, Kohta; Brennan, Jennifer; Ercan, Sevinc; Jensen, Morten; Whittle, Christina M.; Zhou, Xingliang; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Chateigner, Aurelien; Carr, Adrian; Contrino, Sergio; Gullier, Francois; Lyne, Rachel; Rutherford, Kim; Smith, Richard; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Chateigner, Aurelien; Carr, Adrian; Contrino, Sergio; Gullier, Francois; Lyne, Rachel; Rutherford, Kim; Smith, Richard; Micklem, Gos] Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Morris, Mitzi; Rhrissorrakrai, Kahn; Gutwein, Michelle; Khurana, Ekta; Mangone, Marco; Mecenas, Desirea; Scheid, Paul; Gunsalus, Kristin C.; Piano, Fabio] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Vielle, Anne; Cheung, Ming-Sin; Kolasinska-Zwierz, Paulina; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Niu, Wei; Euskirchen, Ghia; Zhong, Mei; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06824 USA; [Niu, Wei; Janette, Judith; Wang, Guilin; Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Dannenberg, Luke O.; Holster, Heather; Iniguez, A. Leo; Rosenbaum, Heidi] Roche NimbleGen, Madison, WI 53719 USA; [Dernburg, Abby F.; Dose, Andrea C.; Pham, Hoang] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dernburg, Abby F.; Dose, Andrea C.; Pham, Hoang] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Desai, Arshad; Gassmann, Reto; Muroyama, Andrew; Voronina, Ksenia] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Ewing, Brent; Green, Phil; Leahey, Amber; MacCoss, Michael; Merrihew, Gennifer; Murray, John I.; Preston, Elicia A.; Vafeados, Dionne; Hillier, LaDeana W.; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Feingold, Elise A.; Good, Peter J.; Guyer, Mark S.; Lowdon, Rebecca F.] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Feng, Xin] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Han, Ting; Khivansara, Vishal; Kim, John K.] Univ Michigan, Inst Life Sci, Dept Human Genet, Ann Arbor, MI 48109 USA; [Henikoff, Jorja G.; Ooi, Siew-Loon; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Raetsch, Gunnar; Zeller, Georg] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Hyman, Tony; Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Miller, David M., III; Spencer, William C.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Kato, Masaomi; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Henz, Stefan R.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Lewis, Suzanna; Stinson, E. O.; Washington, Nicole L.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Lubling, Yaniv; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Mackowiak, Sebastian D.; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Div Syst Biol, D-13125 Berlin, Germany; [Mckay, Sheldon; Stein, Lincoln] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11542 USA; [Slightam, Cindie; Wu, Beijing; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Zeller, Georg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Gunsalus, Kristin C.; Piano, Fabio] NYU, Abu Dhabi, U Arab Emirates; [Dick, Lindsay] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10065 USA	Yale University; Yale University; Yale University; Stanford University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of Cambridge; New York University; University of Cambridge; Yale University; Yale University; University of California System; University of California Santa Cruz; Roche Holding; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society; Vanderbilt University; Yale University; Max Planck Society; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Weizmann Institute of Science; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Cold Spring Harbor Laboratory; Stanford University; European Molecular Biology Laboratory (EMBL); Rockefeller University	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	modencode.worm.pi@gersteinlab.org	Spencer, William/E-8529-2010; Zeller, Georg/M-6484-2013; Yan, Koon-Kiu/A-5940-2009; Hyman, Anthony A/B-3917-2017; Mackowiak, Sebastian D/S-3266-2017; Segal, Eran/AAF-4855-2019; Chateigner, Aurelien/AAC-9143-2020; Yip, Kevin/AAT-4771-2020; Alexander, Roger/A-8643-2008; Lai, Eric C/A-3412-2008; Liu, Tao/AAO-6310-2021; Rutherford, Kim/Y-7995-2018; Lai, Eric/AAO-1143-2021; Khurana, Ekta/C-4933-2013; Sboner, Andrea/C-6487-2008; Hinrichs, Angie S./H-9159-2019; Lyne, Rachel/AAE-2189-2020; Hyman, Tony/F-1923-2011; NUI, WEI/B-8300-2011; Clawson, Hiram/ABE-6101-2020; KHIVANSARA, VISHAL/P-7702-2019; Gassmann, Reto/M-6488-2013; Liu, Tao/G-3585-2010; Mangone, Marco/H-2462-2016	Zeller, Georg/0000-0003-1429-7485; Hyman, Anthony A/0000-0003-3664-154X; Mackowiak, Sebastian D/0000-0003-1673-5389; Yip, Kevin/0000-0001-5516-9944; Alexander, Roger/0000-0002-2967-7395; Liu, Tao/0000-0002-8818-8313; Rutherford, Kim/0000-0001-6277-726X; Lai, Eric/0000-0002-8432-5851; Sboner, Andrea/0000-0001-6915-3070; Hinrichs, Angie S./0000-0002-1697-1130; Lyne, Rachel/0000-0001-8050-402X; KHIVANSARA, VISHAL/0000-0003-2574-5298; Gassmann, Reto/0000-0002-0360-2977; Liu, Tao/0000-0002-8818-8313; Rechtsteiner, Andreas/0000-0001-6031-1087; Clawson, Hiram/0000-0002-0480-0545; Ratsch, Gunnar/0000-0001-5486-8532; Slack, Frank/0000-0001-8263-0409; Dernburg, Abby/0000-0001-8037-1079; Ahringer, Julie/0000-0002-7074-4051; contrino, sergio/0000-0003-3409-5231; Snyder, Michael/0000-0003-0784-7987; Henikoff, Steven/0000-0002-7621-8685; Lloyd, Paul/0000-0003-3508-5553; Van Nostrand, Eric/0000-0002-5188-0082; Muroyama, Andrew/0000-0003-0701-212X; Micklem, Gos/0000-0002-6883-6168; Rozowsky, Joel/0000-0002-3565-0762; Rajewsky, Nikolaus/0000-0002-4785-4332; Lubling, Yaniv/0000-0003-3461-9621; Mangone, Marco/0000-0001-7551-8793; McKay, Sheldon/0000-0002-4011-3160; Segal, Eran/0000-0002-6859-1164; Latorre, Isabel/0000-0003-0638-1783; Liu, Tao/0000-0003-0446-9001; Lewis, Suzanna/0000-0002-8343-612X	NHGRI of the NIH [R01GM088565]; Muscular Dystrophy Association; Pew Charitable Trusts; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); Wellcome Trust; William H. Gates III Endowed Chair of Biomedical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565] Funding Source: NIH RePORTER	NHGRI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); Wellcome Trust(Wellcome TrustEuropean Commission); William H. Gates III Endowed Chair of Biomedical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from the NHGRI of the NIH as part of the modENCODE project, NIH (grant R01GM088565), Muscular Dystrophy Association, and the Pew Charitable Trusts (J.K.K.); the Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network) (S.D.M.); the Wellcome Trust (J.A.); the William H. Gates III Endowed Chair of Biomedical Sciences (R.H.W.); and the A. L. Williams Professorship (M.B.G.). M. Snyder has an advisory role with DNANexus, a DNA sequence storage and analysis company. Transfer of GFP-tagged fosmids requires a Materials Transfer Agreement with the Max Planck Institute of Molecular Cell Biology and Genetics. Raw microarray data are available from the Gene Expression Omnibus archive, and raw sequencing data are available from the SRA archive (accessions are in table S18). We appreciate help from S. Anthony, K. Bell, C. Davis, C. Dieterich, Y. Field, A. S. Hammonds, J. Jo, N. Kaplan, A. Manrai, B. Mathey-Prevot, R. McWhirter, S. Mohr, S. Von Stetina, J. Watson, K. Watkins, C. Xue, and Y. Zhang, and B. Carpenter. We thank C. Jan and D. Bartel for sharing data on poly(A) sites before publication, WormBase curator G. Williams for assistance in quality checking and preparing the transcriptomics data sets for publication, as well as his fellow curator P. Davis for reviewing and hand-checking the list of pseudogenes.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARNES TM, 1995, GENETICS, V141, P159; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bickel P. J., 2010, ANN APPL STAT, V0, P1; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Ercan S, 2009, CURR BIOL, V19, P1777, DOI 10.1016/j.cub.2009.09.047; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ikegami K., GENOME RES, DOI [10.1186/gb-2010-11-12-r120, DOI 10.1186/GB-2010-11-12-R120]; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jans J, 2009, GENE DEV, V23, P602, DOI 10.1101/gad.1751109; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Lu ZJ, 2011, GENOME RES, V21, P276, DOI 10.1101/gr.110189.110; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Riddle D. L, 1997, C ELEGANS, P47; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stoeckius M, 2009, NAT METHODS, V6, P745, DOI [10.1038/nmeth.1370, 10.1038/NMETH.1370]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	76	685	691	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1775	1787		10.1126/science.1196914	http://dx.doi.org/10.1126/science.1196914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21177976	Green Accepted, Green Submitted			2022-12-24	WOS:000285603700031
J	Sahin, E; Colla, S; Liesa, M; Moslehi, J; Muller, FL; Guo, MR; Cooper, M; Kotton, D; Fabian, AJ; Walkey, C; Maser, RS; Tonon, G; Foerster, F; Xiong, R; Wang, YA; Shukla, SA; Jaskelioff, M; Martin, ES; Heffernan, TP; Protopopov, A; Ivanova, E; Mahoney, JE; Kost-Alimova, M; Perry, SR; Bronson, R; Liao, RL; Mulligan, R; Shirihai, OS; Chin, L; DePinho, RA				Sahin, Erguen; Colla, Simona; Liesa, Marc; Moslehi, Javid; Mueller, Florian L.; Guo, Mira; Cooper, Marcus; Kotton, Darrell; Fabian, Attila J.; Walkey, Carl; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Xiong, Robert; Wang, Y. Alan; Shukla, Sachet A.; Jaskelioff, Mariela; Martin, Eric S.; Heffernan, Timothy P.; Protopopov, Alexei; Ivanova, Elena; Mahoney, John E.; Kost-Alimova, Maria; Perry, Samuel R.; Bronson, Roderick; Liao, Ronglih; Mulligan, Richard; Shirihai, Orian S.; Chin, Lynda; DePinho, Ronald A.			Telomere dysfunction induces metabolic and mitochondrial compromise	NATURE			English	Article							HEART-FAILURE; STEM-CELLS; DAMAGE; LEADS; PGC-1-ALPHA; MICE; COACTIVATORS; HOMEOSTASIS; BIOGENESIS; CARCINOMA	Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues. The broader adverse impact of telomere dysfunction across many tissues including more quiescent systems prompted transcriptomic network analyses to identify common mechanisms operative in haematopoietic stem cells, heart and liver. These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1 alpha and PGC-1 beta, also known as Ppargc1a and Ppargc1b, respectively) and the downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RNA component (Terc) genes. Consistent with PGCs as master regulators of mitochondrial physiology and metabolism, telomere dysfunction is associated with impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species. In the setting of telomere dysfunction, enforced Tert or PGC-1a expression or germline deletion of p53 (also known as Trp53) substantially restores PGC network expression, mitochondrial respiration, cardiac function and gluconeogenesis. We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1 alpha and PGC-1 beta promoters, thereby forging a direct link between telomere and mitochondrial biology. We propose that this telomere-p53-PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.	[Sahin, Erguen; Colla, Simona; Mueller, Florian L.; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Xiong, Robert; Wang, Y. Alan; Shukla, Sachet A.; Jaskelioff, Mariela; Martin, Eric S.; Heffernan, Timothy P.; Protopopov, Alexei; Ivanova, Elena; Mahoney, John E.; Kost-Alimova, Maria; Perry, Samuel R.; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Sahin, Erguen; Colla, Simona; Moslehi, Javid; Mueller, Florian L.; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Jaskelioff, Mariela; Martin, Eric S.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liesa, Marc; Kotton, Darrell; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Moslehi, Javid; Liao, Ronglih; DePinho, Ronald A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Guo, Mira] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Cooper, Marcus] Univ Massachusetts, Div Cardiovasc Med, Worcester, MA 01605 USA; [Fabian, Attila J.; Mulligan, Richard; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Walkey, Carl] Univ Melbourne, St Vincents Hosp, St Vincents Inst, Victoria 3065, Australia; [Walkey, Carl] Univ Melbourne, St Vincents Hosp, Dept Med, Victoria 3065, Australia; [Bronson, Roderick] Harvard Univ, Sch Med, Rodent Histopathol Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Liesa, Marc/K-8590-2019; Tonon, Giovanni/J-9804-2018; Maser, Richard/B-2970-2012; Walkley, Carl/AAO-6021-2020	Liesa, Marc/0000-0002-5909-8570; Tonon, Giovanni/0000-0003-2973-5038; Walkley, Carl/0000-0002-4784-9031; Colla, Simona/0000-0001-6583-8910; DePinho, Ronald/0000-0002-5625-577X; Mahoney, John (Jed)/0000-0001-9414-9110; Ivanova, Elena/0000-0002-5069-4974; Kotton, Darrell/0000-0002-9604-8476; Muller, Florian/0000-0001-7568-2948; Shirihai, Orian/0000-0002-9502-2661	Deutsche Forschungsgemeinschaft; NIH National Cancer Institute; Robert A. and Renee E. Belfer Foundation; Ellison Foundation; American Cancer Society; Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE [R01CA084628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, P30DK046200, U24DK059635, R01DK063356, R01DK089185, P30DK079638, R01DK056690] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A. and Renee E. Belfer Foundation; Ellison Foundation(Lawrence Ellison Foundation); American Cancer Society(American Cancer Society); Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Bianchi, J. Moriarty, K. Marmon and E. Thompson for excellent mouse husbandry and care. We are grateful to B. Spiegelman, P. Puigserver, J. E. Dominy and J. L. Estall for providing Ad-PGC-1 alpha and Ad-GFP virus and helpful comments on the manuscript. We thank G. I. Evan for the p53-ER construct. We appreciate input, critical comments and helpful discussions from many DePinho/Chin lab members, in particular A.-J. Chen, C. Khoo, R. Carrasco, A. Kimmelman, S. Quayle, D. Liu and R. Wiedemeyer. We acknowledge the services of the Mouse Metabolism Cores at Yale (NIH/NIDDK U24 DK-59635) and at Baylor College of Medicine (BCM) and the BCM Diabetes & Endocrinology Research Center (DERC) grant (P30 DK079638). E.S. was supported by the Deutsche Forschungsgemeinschaft and this work and R.A.D. are supported by R01 and U01 grants from the NIH National Cancer Institute and the Robert A. and Renee E. Belfer Foundation. R.A.D. was supported by an Ellison Foundation for Medical Research Senior Scholar and an American Cancer Society Research Professor award. M.L. is a recipient of a postdoctoral fellowship from Fundacion Ramon Areces.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Farazi PA, 2003, CANCER RES, V63, P5021; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Miyagawa K, 2010, HYPERTENSION, V55, P738, DOI 10.1161/HYPERTENSIONAHA.109.141903; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	45	882	903	4	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					359	365		10.1038/nature09787	http://dx.doi.org/10.1038/nature09787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21307849	Green Accepted			2022-12-24	WOS:000287409100034
J	Stefan, CJ; Manford, AG; Baird, D; Yamada-Hanff, J; Mao, YX; Emr, SD				Stefan, Christopher J.; Manford, Andrew G.; Baird, Daniel; Yamada-Hanff, Jason; Mao, Yuxin; Emr, Scott D.			Osh Proteins Regulate Phosphoinositide Metabolism at ER-Plasma Membrane Contact Sites	CELL			English	Article							OXYSTEROL-BINDING-PROTEIN; SAC1 LIPID PHOSPHATASE; ENDOPLASMIC-RETICULUM; YEAST SAC1; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; GOLGI-COMPLEX; TRANSPORT; REQUIRES; 4-KINASE; MUTANTS	Sac1 phosphoinositide (PI) phosphatases are essential regulators of PI-signaling networks. Yeast Sac1, an integral endoplasmic reticulum (ER) membrane protein, controls PI4P levels at the ER, Golgi, and plasma membrane (PM). Whether Sac1 can act in trans and turn over PI4P at the Golgi and PM from the ER remains a paradox. We find that Sac1-mediated PI4P metabolism requires the oxysterol-binding homology (Osh) proteins. The PH domain-containing family member, Osh3, localizes to PM/ER membrane contact sites dependent upon PM PI4P levels. We reconstitute Osh protein-stimulated Sac1 PI phosphatase activity in vitro. We also show that the ER membrane VAP proteins, Scs2/Scs22, control PM PI4P levels and Sac1 activity in vitro. We propose that Osh3 functions at ER/PM contact sites as both a sensor of PM PI4P and an activator of the ER Sac1 phosphatase. Our findings further suggest that the conserved Osh proteins control PI metabolism at additional membrane contact sites.	[Stefan, Christopher J.; Manford, Andrew G.; Baird, Daniel; Yamada-Hanff, Jason; Mao, Yuxin; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	sde26@cornell.edu		Mao, Yuxin/0000-0002-5064-1397; Stefan, Christopher/0000-0002-4118-5721; Manford, Andrew/0000-0003-4472-9509	Weill Institute for Cell and Molecular Biology	Weill Institute for Cell and Molecular Biology	We thank C. Beh for strains and plasmids. We are grateful to S. Weys for technical assistance. We thank members of the S. D. E. laboratory, C. McMaster, and S. Henry for discussions, and A. Bretscher, C. Fromme, and D. Teis for comments on the manuscript. This work was supported by funds from the Weill Institute for Cell and Molecular Biology (S.D.E.).	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kagiwada S, 2007, BIOCHEM BIOPH RES CO, V364, P870, DOI 10.1016/j.bbrc.2007.10.079; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Konrad G, 2002, J BIOL CHEM, V277, P10547, DOI 10.1074/jbc.M200090200; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Nemoto Y, 2000, J BIOL CHEM, V275, P34293, DOI 10.1074/jbc.M003923200; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wei HC, 2003, CURR BIOL, V13, P1882, DOI 10.1016/j.cub.2003.09.056	35	330	341	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					389	401		10.1016/j.cell.2010.12.034	http://dx.doi.org/10.1016/j.cell.2010.12.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295699	Bronze			2022-12-24	WOS:000286973100011
J	Ukai-Tadenuma, M; Yamada, RG; Xu, HY; Ripperger, JA; Liu, AC; Ueda, HR				Ukai-Tadenuma, Maki; Yamada, Rikuhiro G.; Xu, Haiyan; Ripperger, Juergen A.; Liu, Andrew C.; Ueda, Hiroki R.			Delay in Feedback Repression by Cryptochrome 1 Is Required for Circadian Clock Function	CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTION; PROTEINS; CRY1; PAR; COMPONENTS; BINDING; LIMB	Direct evidence for the requirement of delay in feedback repression in the mammalian circadian clock has been elusive. Cryptochrome 1 (Cry1), an essential clock component, displays evening-time expression and serves as a strong repressor at morning-time elements (E box/E' box). In this study, we reveal that a combination of day-time elements (D box) within the Cry1-proximal promoter and night-time elements (RREs) within its intronic enhancer gives rise to evening-time expression. A synthetic composite promoter produced evening-time expression, which was further recapitulated by a simple phase-vector model. Of note, coordination of day-time with night-time elements can modulate the extent of phase delay. A genetic complementation assay in Cry1(-/-):Cry2(-/-) cells revealed that substantial delay of Cry1 expression is required to restore circadian rhythmicity, and its prolonged delay slows circadian oscillation. Taken together, our data suggest that phase delay in Cry1 transcription is required for mammalian clock function.	[Ukai-Tadenuma, Maki; Yamada, Rikuhiro G.; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Xu, Haiyan; Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Ripperger, Juergen A.] Univ Fribourg, Dept Med, Biochem Unit, CH-1700 Fribourg, Switzerland; [Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan; [Ueda, Hiroki R.] Kyoto Univ, Dept Math, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	RIKEN; RIKEN; RIKEN; University of Memphis; University of Fribourg; Osaka University; Kyoto University	Ueda, HR (corresponding author), RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Liu, Andrew C/B-3548-2009; Ueda, Hiroki R/C-5037-2014	Liu, Andrew C/0000-0003-1927-0900; Ueda, Hiroki R/0000-0001-8342-9176	RIKEN Center for Developmental Biology (CDB); Uehara Memorial Foundation; Mitsubishi Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Science Foundation [IOS-0920417]; SNF/FNS; Direct For Biological Sciences [0920417] Funding Source: National Science Foundation	RIKEN Center for Developmental Biology (CDB); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science Foundation(National Science Foundation (NSF)); SNF/FNS(Swiss National Science Foundation (SNSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology (CDB) (H.R.U.), Uehara Memorial Foundation (H.R.U.), The Mitsubishi Foundation (H.R.U.), the President's Fund from RIKEN (H.R.U.), KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H.R.U.), the National Science Foundation (IOS-0920417) (A.C.L.), and the SNF/FNS (J.A.R.). We thank Ueli Schibler, Urs Albrecht, and Frederic Gachon for their valuable reagents; Akira Yasui and Gijsbertus T.J. van der Horst for Cry1<SUP>-/-</SUP>:Cry2<SUP>-/-</SUP> double-knockout mice; Hideki Ukai and Koh-hei Masumoto for technical support in establishment of Cry1<SUP>-/-</SUP>:Cry2<SUP>-/-</SUP> cells; Yohei Koyama for critical comments on the theoretical analysis of delayed negative feedback loop; Hajime Tei for Cry1 and Cry2 expression vectors; and David K. Welsh for critical reading of the manuscript.	Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Falvey E, 1996, BIOL CHEM, V377, P797; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Fustin JM, 2009, J BIOL RHYTHM, V24, P16, DOI 10.1177/0748730408329267; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	39	183	188	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					268	281		10.1016/j.cell.2010.12.019	http://dx.doi.org/10.1016/j.cell.2010.12.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21236481	Green Submitted, Bronze			2022-12-24	WOS:000286459900011
J	Leonard, TA; Rozycki, B; Saidi, LF; Hummer, G; Hurley, JH				Leonard, Thomas A.; Rozycki, Bartosz; Saidi, Layla F.; Hummer, Gerhard; Hurley, James H.			Crystal Structure and Allosteric Activation of Protein Kinase C beta II	CELL			English	Article							MEMBRANE-BINDING; CATALYTIC DOMAIN; BIOLOGICAL MACROMOLECULES; INDUCED TRANSLOCATION; SOLUTION SCATTERING; PKC; ALPHA; PHOSPHORYLATION; ROLES; SIMULATIONS	Protein kinase C (PKC) isozymes are the paradigmatic effectors of lipid signaling. PKCs translocate to cell membranes and are allosterically activated upon binding of the lipid diacylglycerol to their C1A and C1B domains. The crystal structure of full-length protein kinase C beta II was determined at 4.0 angstrom, revealing the conformation of an unexpected intermediate in the activation pathway. Here, the kinase active site is accessible to substrate, yet the conformation of the active site corresponds to a low-activity state because the ATP-binding side chain of Phe629 of the conserved NFD motif is displaced. The C1B domain clamps the NFD helix in a low-activity conformation, which is reversed upon membrane binding. A low-resolution solution structure of the closed conformation of PKC beta II was derived from small-angle X-ray scattering. Together, these results show how PKC beta II is allosterically regulated in two steps, with the second step defining a novel protein kinase regulatory mechanism.	[Leonard, Thomas A.; Saidi, Layla F.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Rozycki, Bartosz; Hummer, Gerhard] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Leonard, Thomas/A-5143-2013; Hummer, Gerhard/A-2546-2013; Rozycki, Bartosz/B-7005-2009	Leonard, Thomas/0000-0001-6853-666X; Hummer, Gerhard/0000-0001-7768-746X; Rozycki, Bartosz/0000-0001-5938-7308	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; EMBO; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036127, ZIADK029033] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Chang for technical assistance, J. Lloyd and D. E. Anderson for assistance with mass spectrometry, J. F. Mushinski and A. Toker for DNAs, E. Boura for assistance with SAXS data collection, H. Tsuruta and T. Weiss for user support at BL4-2, SSRL, M. Becker for user support at GM/CA-CAT, APS, H. Mischak and M. Pearson for early efforts, A. Newton for discussions, and A. Brunger for a prerelease version of CNS 1.3. GM/CA-CAT has been funded in whole or in part with Federal funds from the NCI (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357. SAXS data were collected at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. T.A.L. was supported in part by an EMBO long term fellowship. B.R. was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme. This research was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health to J.H.H. and G.H.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; Hurley JH, 1997, PROTEIN SCI, V6, P477; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kim YC, 2008, J MOL BIOL, V375, P1416, DOI 10.1016/j.jmb.2007.11.063; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Littler DR, 2006, BIOCHEM BIOPH RES CO, V349, P1182, DOI 10.1016/j.bbrc.2006.08.160; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; ORR JW, 1994, J BIOL CHEM, V269, P8383; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; TSUTAKAWA SE, 1995, J BIOL CHEM, V270, P26807, DOI 10.1074/jbc.270.45.26807; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	56	148	149	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					55	66		10.1016/j.cell.2010.12.013	http://dx.doi.org/10.1016/j.cell.2010.12.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215369	Green Accepted, Bronze			2022-12-24	WOS:000285993600007
J	Roy, S; Ernst, J; Kharchenko, PV; Kheradpour, P; Negre, N; Eaton, ML; Landolin, JM; Bristow, CA; Ma, LJ; Lin, MF; Washietl, S; Arshinoff, BI; Ay, F; Meyer, PE; Robine, N; Washington, NL; Di Stefano, L; Berezikov, E; Brown, CD; Candeias, R; Carlson, JW; Carr, A; Jungreis, I; Marbach, D; Sealfon, R; Tolstorukov, MY; Will, S; Alekseyenko, AA; Artieri, C; Booth, BW; Brooks, AN; Dai, Q; Davis, CA; Duff, MO; Feng, X; Gorchakov, AA; Gu, TT; Henikoff, JG; Kapranov, P; Li, RH; MacAlpine, HK; Malone, J; Minoda, A; Nordman, J; Okamura, K; Perry, M; Powell, SK; Riddle, NC; Sakai, A; Samsonova, A; Sandler, JE; Schwartz, YB; Sher, N; Spokony, R; Sturgill, D; van Baren, M; Wan, KH; Yang, L; Yu, C; Feingold, E; Good, P; Guyer, M; Lowdon, R; Ahmad, K; Andrews, J; Berger, B; Brenner, SE; Brent, MR; Cherbas, L; Elgin, SCR; Gingeras, TR; Grossman, R; Hoskins, RA; Kaufman, TC; Kent, W; Kuroda, MI; Orr-Weaver, T; Perrimon, N; Pirrotta, V; Posakony, JW; Ren, B; Russell, S; Cherbas, P; Graveley, BR; Lewis, S; Micklem, G; Oliver, B; Park, PJ; Celniker, SE; Henikoff, S; Karpen, GH; Lai, EC; MacAlpine, DM; Stein, LD; White, KP; Kellis, M				Roy, Sushmita; Ernst, Jason; Kharchenko, Peter V.; Kheradpour, Pouya; Negre, Nicolas; Eaton, Matthew L.; Landolin, Jane M.; Bristow, Christopher A.; Ma, Lijia; Lin, Michael F.; Washietl, Stefan; Arshinoff, Bradley I.; Ay, Ferhat; Meyer, Patrick E.; Robine, Nicolas; Washington, Nicole L.; Di Stefano, Luisa; Berezikov, Eugene; Brown, Christopher D.; Candeias, Rogerio; Carlson, Joseph W.; Carr, Adrian; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Tolstorukov, Michael Y.; Will, Sebastian; Alekseyenko, Artyom A.; Artieri, Carlo; Booth, Benjamin W.; Brooks, Angela N.; Dai, Qi; Davis, Carrie A.; Duff, Michael O.; Feng, Xin; Gorchakov, Andrey A.; Gu, Tingting; Henikoff, Jorja G.; Kapranov, Philipp; Li, Renhua; MacAlpine, Heather K.; Malone, John; Minoda, Aki; Nordman, Jared; Okamura, Katsutomo; Perry, Marc; Powell, Sara K.; Riddle, Nicole C.; Sakai, Akiko; Samsonova, Anastasia; Sandler, Jeremy E.; Schwartz, Yuri B.; Sher, Noa; Spokony, Rebecca; Sturgill, David; van Baren, Marijke; Wan, Kenneth H.; Yang, Li; Yu, Charles; Feingold, Elise; Good, Peter; Guyer, Mark; Lowdon, Rebecca; Ahmad, Kami; Andrews, Justen; Berger, Bonnie; Brenner, Steven E.; Brent, Michael R.; Cherbas, Lucy; Elgin, Sarah C. R.; Gingeras, Thomas R.; Grossman, Robert; Hoskins, Roger A.; Kaufman, Thomas C.; Kent, William; Kuroda, Mitzi I.; Orr-Weaver, Terry; Perrimon, Norbert; Pirrotta, Vincenzo; Posakony, James W.; Ren, Bing; Russell, Steven; Cherbas, Peter; Graveley, Brenton R.; Lewis, Suzanna; Micklem, Gos; Oliver, Brian; Park, Peter J.; Celniker, Susan E.; Henikoff, Steven; Karpen, Gary H.; Lai, Eric C.; MacAlpine, David M.; Stein, Lincoln D.; White, Kevin P.; Kellis, Manolis		modENCODE Consortium	Identification of Functional Elements and Regulatory Circuits by Drosophila modENCODE	SCIENCE			English	Article							PREDICTIVE CHROMATIN SIGNATURES; TRANSCRIPTION FACTORS; SOMATIC-CELLS; HUMAN GENOME; DNA-BINDING; RNA PATHWAY; MELANOGASTER; SEQUENCE; REGIONS; NETWORK	To gain insight into how genomic information is translated into cellular and developmental programs, the Drosophila model organism Encyclopedia of DNA Elements (modENCODE) project is comprehensively mapping transcripts, histone modifications, chromosomal proteins, transcription factors, replication proteins and intermediates, and nucleosome properties across a developmental time course and in multiple cell lines. We have generated more than 700 data sets and discovered protein-coding, noncoding, RNA regulatory, replication, and chromatin elements, more than tripling the annotated portion of the Drosophila genome. Correlated activity patterns of these elements reveal a functional regulatory network, which predicts putative new functions for genes, reveals stage-and tissue-specific regulators, and enables gene-expression prediction. Our results provide a foundation for directed experimental and computational studies in Drosophila and related species and also a model for systematic data integration toward comprehensive genomic and functional annotation.	[Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Washietl, Stefan; Ay, Ferhat; Meyer, Patrick E.; Di Stefano, Luisa; Candeias, Rogerio; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Will, Sebastian; Berger, Bonnie; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Berger, Bonnie; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02140 USA; [Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Berger, Bonnie; Kellis, Manolis] Harvard Univ, Cambridge, MA 02140 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Schwartz, Yuri B.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Negre, Nicolas; Ma, Lijia; Brown, Christopher D.; Spokony, Rebecca; Grossman, Robert; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Eaton, Matthew L.; MacAlpine, Heather K.; Powell, Sara K.; MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Landolin, Jane M.; Carlson, Joseph W.; Booth, Benjamin W.; Minoda, Aki; Sandler, Jeremy E.; Wan, Kenneth H.; Yu, Charles; Hoskins, Roger A.; Celniker, Susan E.; Karpen, Gary H.] Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Arshinoff, Bradley I.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Robine, Nicolas; Dai, Qi; Henikoff, Jorja G.; Okamura, Katsutomo; Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Washington, Nicole L.; Lewis, Suzanna] LBNL, Genome Sci Div, Berkeley, CA 94720 USA; [Carr, Adrian; Russell, Steven; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Carr, Adrian; Russell, Steven; Micklem, Gos] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England; [Alekseyenko, Artyom A.; Gorchakov, Andrey A.; Kuroda, Mitzi I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Gorchakov, Andrey A.; Kuroda, Mitzi I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; [Artieri, Carlo; Malone, John; Sturgill, David; Oliver, Brian] NIDDK, Sect Dev Genom, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Davis, Carrie A.; Feng, Xin; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Duff, Michael O.; Yang, Li; Graveley, Brenton R.] Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Gu, Tingting; Riddle, Nicole C.; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA; [Li, Renhua; Feingold, Elise; Good, Peter; Guyer, Mark; Lowdon, Rebecca] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Arshinoff, Bradley I.; Feng, Xin; Perry, Marc; Stein, Lincoln D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Samsonova, Anastasia; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Samsonova, Anastasia; Perrimon, Norbert] Harvard Univ, Sch Med, Drosophila RNAi Screening Ctr, Boston, MA 02115 USA; [van Baren, Marijke; Brent, Michael R.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [Andrews, Justen; Cherbas, Lucy; Kaufman, Thomas C.; Cherbas, Peter] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Nordman, Jared; Sher, Noa; Orr-Weaver, Terry] Whitehead Inst, Cambridge, MA 02142 USA; [Berezikov, Eugene] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Berezikov, Eugene] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Cherbas, Lucy; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Posakony, James W.; Ren, Bing] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Brooks, Angela N.; Brenner, Steven E.; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sakai, Akiko; Ahmad, Kami] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Meyer, Patrick E.] Univ Libre Bruxelles, Machine Learning Grp, B-1050 Brussels, Belgium; [Di Stefano, Luisa] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ay, Ferhat] Univ Florida, Gainesville, FL 32611 USA; [Kent, William] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Kent, William] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Feng, Xin] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; University of Chicago; Duke University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Toronto; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Cambridge; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cold Spring Harbor Laboratory; University of Connecticut; Washington University (WUSTL); Affymetrix; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Massachusetts Institute of Technology (MIT); Whitehead Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Indiana University System; Indiana University Bloomington; Fred Hutchinson Cancer Center; University of California System; University of California San Diego; Rutgers State University New Brunswick; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Universite Libre de Bruxelles; Harvard University; Massachusetts General Hospital; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	celniker@fruitfly.org; steveh@fhcrc.org; karpen@fruitfly.org; laie@mskcc.org; david.macalpine@duke.edu; lincoln.stein@gmail.com; kpwhite@uchicago.edu; manoli@mit.edu	Sakai, Akiko/A-8929-2010; Lai, Eric C/A-3412-2008; Rutherford, Kim/Y-7995-2018; Venken, Koen/B-9909-2013; Gorchakov, Andrey A/N-5840-2015; Kellis, Manolis/ABE-7385-2020; White, Rob A H/G-4835-2012; Minoda, Aki/Q-4454-2019; Brent, Michael/AAK-3702-2020; Brenner, Steven E/A-8729-2008; Graveley, Brenton R/C-3108-2013; jiang, lichun/F-3776-2012; Berezikov, Eugene/D-3363-2013; Chateigner, Aurelien/AAC-9143-2020; Samsonova, Anastasia/Q-7591-2016; Eaton, Matthew/C-4408-2011; Spokony, Rebecca/AAD-3014-2020; Hirst, Martin/B-7684-2016; dai, qi/AAB-6637-2020; Russell, Steve/A-4072-2011; Marra, Marco A/B-5987-2008; Brooks, Angela/B-6173-2011; Hinrichs, Angie S./H-9159-2019; Samsonova, Anastasia/AAU-7269-2021; Lai, Eric/AAO-1143-2021; Eng, Thomas/AAV-5157-2020; Minoda, Aki/D-5335-2017; Hansen, Kasper D/E-6094-2011; Di Stefano, Luisa/ABB-6457-2020; Ay, Ferhat/J-7800-2019; Grossman, Robert/B-1865-2009	Sakai, Akiko/0000-0003-3120-0104; Rutherford, Kim/0000-0001-6277-726X; Venken, Koen/0000-0003-0741-4698; Gorchakov, Andrey A/0000-0003-2830-4236; Kellis, Manolis/0000-0001-7113-9630; Minoda, Aki/0000-0002-2927-5791; Brent, Michael/0000-0002-8689-0299; Brenner, Steven E/0000-0001-7559-6185; jiang, lichun/0000-0003-2462-7636; Berezikov, Eugene/0000-0002-1145-2884; Samsonova, Anastasia/0000-0002-9353-9173; Russell, Steve/0000-0003-0546-3031; Marra, Marco A/0000-0001-7146-7175; Hinrichs, Angie S./0000-0002-1697-1130; Samsonova, Anastasia/0000-0002-9353-9173; Lai, Eric/0000-0002-8432-5851; Eng, Thomas/0000-0002-4974-3863; Minoda, Aki/0000-0002-2927-5791; Hansen, Kasper D/0000-0003-0086-0687; Di Stefano, Luisa/0000-0003-3437-9066; Ay, Ferhat/0000-0002-0708-6914; Lewis, Suzanna/0000-0002-8343-612X; Elgin, Sarah C. R./0000-0002-5176-2510; Perrimon, Norbert/0000-0001-7542-472X; Bellen, Hugo/0000-0001-5992-5989; Dobin, Alexander/0000-0002-4115-9128; Negre, Nicolas/0000-0001-9727-3416; contrino, sergio/0000-0003-3409-5231; Graveley, Brenton/0000-0001-5777-5892; Lloyd, Paul/0000-0003-3508-5553; Sturgill, David/0000-0002-7902-3605; Henikoff, Steven/0000-0002-7621-8685; Lin, Wei/0000-0002-7506-3466; Meyer, Folker/0000-0003-1112-2284; Fagegaltier, Delphine/0000-0001-9154-6786; Park, Peter/0000-0001-9378-960X; Washington, Nicole/0000-0001-8936-9143; Clawson, Hiram/0000-0002-0480-0545; Robine, Nicolas/0000-0001-5698-8183; Gingeras, Thomas/0000-0001-9106-3573; Micklem, Gos/0000-0002-6883-6168; yang, li/0000-0001-8833-7473; Kapranov, Philipp/0000-0003-2647-4856; McKay, Sheldon/0000-0002-4011-3160; Brown, Christopher/0000-0002-3785-5008; Zieba, Jennifer/0000-0003-1650-1830; Dai, Qi/0000-0002-2082-0693; Grossman, Robert/0000-0003-3741-5739	National Human Genome Research Institute [RC2HG005639, U01HG004271, U01HG004258, U01HG004264, U01HG004279, U01HG004261, U01HG004274, U41HG004269]; LBNL [DE-AC02-05CH11231]; NSF [0937060, 0905968, 0644282]; Natural Sciences and Engineering Research Council of Canada (NSERC); Japan Society for the Promotion of Science; Swedish Research Council; NIH National Research Service; National Defense Science and Engineering; Austrian Fonds zur Forderung der wissenschaftlichen Forschung; Leukemia and Lymphoma Society; Lilly-Life Sciences Research Foundation; Affymetrix; Swiss National Science Foundation; German Research Foundation [WI 3628/1-1]; HHMI; Indiana Genomics Initiative; NIDDK genomics core laboratory; NIH [R01HG004037]; Sloan Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004279, RC2HG005639, U01HG004264, U01HG004274, U01HG004258, R01HG004037, U41HG004269, U01HG004261, U01HG004271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); LBNL; NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering; Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lilly-Life Sciences Research Foundation; Affymetrix; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); HHMI(Howard Hughes Medical Institute); Indiana Genomics Initiative; NIDDK genomics core laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute as part of the modENCODE project under RC2HG005639 (M.K.), U01HG004271 (S.E.C.), U01HG004258 (G.H.K.), U01HG004264 (K.P.W.), U01HG004279 (D.M.M.), U01HG004261 (E.L.), U01HG004274 (S.H.), and U41HG004269 (L.S.). Awards to S.E.C. and G.H.K. were carried out at LBNL under contract no. DE-AC02-05CH11231. Additional support was provided by the NSF under grant 0937060 to the Computing Research Association for the CIFellows Project (S.R.) and under award no. 0905968 (J.E.), a Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship (B.A.), T. Kahveci (F.A.), the Japan Society for the Promotion of Science (K.O.), the Swedish Research Council (Q.D.), a NIH National Research Service Award postdoctoral fellowship (C.A.B.), a National Defense Science and Engineering Graduate Fellowship (R.S.), an Erwin Schrodinger Fellowship of the Austrian Fonds zur Forderung der wissenschaftlichen Forschung (S.W.), a Leukemia and Lymphoma Society fellowship (S.W.), a Lilly-Life Sciences Research Foundation fellowship (C.D.B.), a NSERC postdoctoral fellowship (C. G. A.), Affymetrix (T.G.R.), a fellowship from the Swiss National Science Foundation (D.M.), a German Research Foundation grant WI 3628/1-1 (S.W.), a HHMI Damon Runyon Cancer Research fellowship (J.T.N.), the Indiana Genomics Initiative (T.C.K.), H. Smith and the NIDDK genomics core laboratory (B.O.), NIH R01HG004037, NSF CAREER award 0644282, and the Sloan Foundation (M.K.). A full list of author contributions is available in the SOM.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; [Anonymous], 2008, COMP FLYB REL 5 12, DOI http://fb2008_09.flybase.org/; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; GRAVELEY BR, 2010, NATURE, V471, P473, DOI DOI 10.1038/NATURE09715; HARRISON DA, 1993, GENE DEV, V7, P1966, DOI 10.1101/gad.7.10.1966; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spradling AC, 2006, GENETICS, V174, P1; STAPLETON M, 2002, GENOME BIOL, V0003; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wan KH, 2006, NAT PROTOC, V1, P624, DOI 10.1038/nprot.2006.90; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	69	854	864	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1787	1797		10.1126/science.1198374	http://dx.doi.org/10.1126/science.1198374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21177974	Green Accepted, Green Published			2022-12-24	WOS:000285603700032
J	Hansen, CS; Faerch, LH; Kristensen, PL				Hansen, Christian Stevns; Faerch, Louise Holmsgaard; Kristensen, Peter Lommer			CHRISTMAS 2010: RESEARCH Testing the validity of the Danish urban myth that alcohol can be absorbed through feet: open labelled self experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To determine the validity of the Danish urban myth that it is possible to get drunk by submerging feet in alcohol. Design Open labelled, self experimental study, with no control group. Setting Office of a Danish hospital. Participants Three adults, median age 32 (range 31-35), free of chronic skin and liver disease and non-dependent on alcohol and psychoactive drugs. Main outcome measures The primary end point was the concentration of plasma ethanol (detection limit 2.2 mmol/L (10 mg/100 mL)), measured every 30 minutes for three hours while feet were submerged in a washing-up bowl containing the contents of three 700 mL bottles of vodka. The secondary outcome was self assessment of intoxication related symptoms (self confidence, urge to speak, and number of spontaneous hugs), scored on a scale of 0 to 10. Results Plasma ethanol concentrations were below the detection limit of 2.2 mmol/L (10 mg/100 mL) throughout the experiment. No significant changes were observed in the intoxication related symptoms, although self confidence and urge to speak increased slightly at the start of the study, probably due to the setup. Conclusion Our results suggest that feet are impenetrable to the alcohol component of vodka. We therefore conclude that the Danish urban myth of being able to get drunk by submerging feet in alcoholic beverages is just that; a myth. The implications of the study are many though.	[Hansen, Christian Stevns; Faerch, Louise Holmsgaard; Kristensen, Peter Lommer] Hillerod Hosp, Dept Cardiol & Endocrinol, Endocrinol Sect, DK-3400 Hillerod, Denmark	University of Copenhagen	Kristensen, PL (corresponding author), Hillerod Hosp, Dept Cardiol & Endocrinol, Endocrinol Sect, Dyrehavevej 29, DK-3400 Hillerod, Denmark.	pelk@hih.regionh.dk	Kristensen, Peter L/B-4218-2009; Kristensen, Peter/V-5630-2019	Kristensen, Peter/0000-0001-5431-824X; Hansen, Christian Stevns/0000-0002-5782-3476	Department of Clinical Biochemistry, Hillerod Hospital	Department of Clinical Biochemistry, Hillerod Hospital	The measurement of ethanol concentrations was funded by the Department of Clinical Biochemistry, Hillerod Hospital.	Miller MA, 2006, AM J EMERG MED, V24, P815, DOI 10.1016/j.ajem.2006.05.006; Saghir SA, 2010, INT J TOXICOL, V29, P268, DOI 10.1177/1091581810366604; Yu CY, 2009, APPL ERGON, V40, P767, DOI 10.1016/j.apergo.2008.08.004	3	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6812	10.1136/bmj.c6812	http://dx.doi.org/10.1136/bmj.c6812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XD	21156749	Green Published, hybrid			2022-12-24	WOS:000285552200015
J	Domazet-Loso, T; Tautz, D				Domazet-Loso, Tomislav; Tautz, Diethard			A phylogenetically based transcriptome age index mirrors ontogenetic divergence patterns	NATURE			English	Article							CONSERVED EMBRYONIC STAGE; DROSOPHILA-MELANOGASTER; PHYLOTYPIC STAGE; GENE-EXPRESSION; DEVELOPMENTAL HOURGLASS; ZEBRAFISH DEVELOPMENT; LIFE-CYCLE; EVOLUTION; VERTEBRATES; HISTORY	Parallels between phylogeny and ontogeny have been discussed for almost two centuries, and a number of theories have been proposed to explain such patterns(1). Especially elusive is the phylotypic stage, a phase during development where species within a phylum are particularly similar to each other(2-6). Although this has formerly been interpreted as a recapitulation of phylogeny(1), it is now thought to reflect an ontogenetic progression phase(2), where strong constraints on developmental regulation and gene interactions exist(2,3). Several studies have shown that genes expressed during this stage evolve at a slower rate, but it has so far not been possible to derive an unequivocal molecular signature associated with this stage(7-15). Here we use a combination of phylostratigraphy(16) and stage-specific gene expression data to generate a cumulative index that reflects the evolutionary age of the transcriptome at given ontogenetic stages. Using zebrafish ontogeny and adult development as a model, we find that the phylotypic stage does indeed express the oldest transcriptome set and that younger sets are expressed during early and late development, thus faithfully mirroring the hourglass model of morphological divergence(2,3). Reproductively active animals show the youngest transcriptome, with major differences between males and females. Notably, ageing animals express increasingly older genes. Comparisons with similar data sets from flies and nematodes show that this pattern occurs across phyla. Our results indicate that an old transcriptome marks the phylotypic phase and that phylogenetic differences at other ontogenetic stages correlate with the expression of newly evolved genes.	[Domazet-Loso, Tomislav; Tautz, Diethard] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Div Mol Biol, Lab Evolutionary Genet, Zagreb 10002, Croatia	Max Planck Society; Rudjer Boskovic Institute	Domazet-Loso, T (corresponding author), Max Planck Inst Evolut Biol, August Thienemannstr 2, D-24306 Plon, Germany.	tdomazet@irb.hr	Tautz, Diethard/D-4304-2011; Tautz, Diethard/H-8436-2014	Tautz, Diethard/0000-0002-0460-5344	Adris Foundation [49]; Max-Planck Society	Adris Foundation; Max-Planck Society(Max Planck Society)	We thank B. Walderich for providing zebrafish, A. Nolte, E. Blohm-Sievers, B. Kleinhenz, L. Turner and J. Bryk for laboratory support, R. Bakaric has provided the phylostratigraphic map of C. elegans, and M. Domazet-Loso and V. Dunjko have helped with statistics. L. Boell, F. Chang and A. Pozhitkov have made suggestions on the manuscript. This work was supported by Unity Through Knowledge Fund (grant No. 49), Adris Foundation and funds of the Max-Planck Society. Computational resources were provided by CSTMB and RBI (Phylostrat Cluster).	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Artieri CG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-42; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Comte A, 2010, EVOL DEV, V12, P144, DOI 10.1111/j.1525-142X.2010.00400.x; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-66; DUBOULE D, 1994, DEVELOPMENT, P135; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Flatt T, 2006, INTEGR COMP BIOL, V46, P777, DOI 10.1093/icb/icl034; Gould S. J., 1977, ONTOGENY PHYLOGENY; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hazkani-Covo E, 2005, J EXP ZOOL PART B, V304B, P150, DOI 10.1002/jez.b.21033; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Leys SP, 2005, INTEGR COMP BIOL, V45, P342, DOI 10.1093/icb/45.2.342; Nolte AW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-59; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Sander K., 1983, DEV EVOLUTION, P137; Yassin A, 2010, EVOL DEV, V12, P288, DOI 10.1111/j.1525-142X.2010.00414.x	32	249	254	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					815	U107		10.1038/nature09632	http://dx.doi.org/10.1038/nature09632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150997				2022-12-24	WOS:000285093700044
J	St Hilaire, C; Ziegler, SG; Markello, TC; Brusco, A; Groden, C; Gill, F; Carlson-Donohoe, H; Lederman, RJ; Chen, MY; Yang, D; Siegenthaler, MP; Arduino, C; Mancini, C; Freudenthal, B; Stanescu, HC; Zdebik, AA; Chaganti, RK; Nussbaum, RL; Kleta, R; Gahl, WA; Boehm, M				St Hilaire, Cynthia; Ziegler, Shira G.; Markello, Thomas C.; Brusco, Alfredo; Groden, Catherine; Gill, Fred; Carlson-Donohoe, Hannah; Lederman, Robert J.; Chen, Marcus Y.; Yang, Dan; Siegenthaler, Michael P.; Arduino, Carlo; Mancini, Cecilia; Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Chaganti, R. Krishna; Nussbaum, Robert L.; Kleta, Robert; Gahl, William A.; Boehm, Manfred			NT5E Mutations and Arterial Calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; VASCULAR CALCIFICATION; MINERALIZATION; ADENOSINE; INFANCY; ENPP1; CELLS	BACKGROUND Arterial calcifications are associated with increased cardiovascular risk, but the genetic basis of this association is unclear. METHODS We performed clinical, radiographic, and genetic studies in three families with symptomatic arterial calcifications. Single-nucleotide-polymorphism analysis, targeted gene sequencing, quantitative polymerase-chain-reaction assays, Western blotting, enzyme measurements, transduction rescue experiments, and in vitro calcification assays were performed. RESULTS We identified nine persons with calcifications of the lower-extremity arteries and hand and foot joint capsules: all five siblings in one family, three siblings in another, and one patient in a third family. Serum calcium, phosphate, and vitamin D levels were normal. Affected members of Family 1 shared a single 22.4-Mb region of homozygosity on chromosome 6 and had a homozygous nonsense mutation (c.662C -> A, p.S221X) in NT5E, encoding CD73, which converts AMP to adenosine. Affected members of Family 2 had a homozygous missense mutation (c.1073G -> A, p.C358Y) in NT5E. The proband of Family 3 was a compound heterozygote for c.662C -> A and c.1609dupA (p.V537fsX7). All mutations found in the three families result in nonfunctional CD73. Cultured fibroblasts from affected members of Family 1 showed markedly reduced expression of NT5E messenger RNA, CD73 protein, and enzyme activity, as well as increased alkaline phosphatase levels and accumulated calcium phosphate crystals. Genetic rescue experiments normalized the CD73 and alkaline phosphatase activity in patients' cells, and adenosine treatment reduced the levels of alkaline phosphatase and calcification. CONCLUSIONS We identified mutations in NT5E in members of three families with symptomatic arterial and joint calcifications. This gene encodes CD73, which converts AMP to adenosine, supporting a role for this metabolic pathway in inhibiting ectopic tissue calcification.	[Markello, Thomas C.; Groden, Catherine; Gahl, William A.] NHGRI, NIH Undiagnosed Dis Program, NIH, Bethesda, MD 20892 USA; [St Hilaire, Cynthia; Lederman, Robert J.; Chen, Marcus Y.; Yang, Dan; Siegenthaler, Michael P.; Boehm, Manfred] NHLBI, NIH, Bethesda, MD 20892 USA; [Gill, Fred] NIH, Off Rare Dis Res, Ctr Clin, Bethesda, MD 20892 USA; [Brusco, Alfredo; Arduino, Carlo; Mancini, Cecilia] Direz Univ Med Genet, Azienda Osped Univ San Giovanni Battista, Turin, Italy; [Brusco, Alfredo; Arduino, Carlo; Mancini, Cecilia] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Med, London WC1E 6BT, England; [Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Physiol, London WC1E 6BT, England; [Chaganti, R. Krishna] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Center for Advancing Translational Sciences (NCATS); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Turin; University of London; University College London; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gahl, WA (corresponding author), NHGRI, NIH Undiagnosed Dis Program, NIH, 10 Ctr Dr,Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Riksen, Niels P/G-8260-2015; St. Hilaire, Cynthia/R-8205-2017; Mancini, Cecilia/AAB-7442-2019; St. Hilaire, Cynthia/I-4713-2014; Hofbauer, Lorenz C/G-2490-2010; Brusco, Alfredo/A-1811-2013; Rongen, Gerard A/C-1578-2018; lederman, robert j/C-6305-2009; Rongen, Gerard/AAJ-9694-2021	Riksen, Niels P/0000-0001-9197-8124; St. Hilaire, Cynthia/0000-0003-1871-6915; Hofbauer, Lorenz C/0000-0002-8691-8423; Brusco, Alfredo/0000-0002-8318-7231; lederman, robert j/0000-0003-1202-6673; Freudenthal, Bernard/0000-0003-4669-918X; Mancini, Cecilia/0000-0003-1282-0404	National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006079, ZICHL006019, ZIAHL006077, ZIAHL005062, ZIDHL006061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007309] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Intramural Research Programs of the National Human Genome Research Institute (NHGRI) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.	Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delomenede M, 2009, ACTA BIOCHIM POL, V56, P301; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HAYASHI E, 1985, BRIT J PHARMACOL, V84, P765, DOI 10.1111/j.1476-5381.1985.tb16159.x; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; LEVITIN J, 1945, RADIOLOGY, V44, P489, DOI 10.1148/44.5.489; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Magnus-Levy A, 1914, DEUT MED WOCHENSCHR, V40, P1305, DOI 10.1055/s-0029-1190517; Mori Hideki, 1992, Heart and Vessels, V7, P211, DOI 10.1007/BF01744607; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; NOSAKA H, 1974, YONAGO ACTA MED, V18, P191; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; SHARP J, 1954, ANN RHEUM DIS, V13, P15, DOI 10.1136/ard.13.1.15; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933	29	304	315	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					432	442		10.1056/NEJMoa0912923	http://dx.doi.org/10.1056/NEJMoa0912923			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288095	Green Accepted, Green Published			2022-12-24	WOS:000286885900008
J	Riksen, NP; Rongen, GA				Riksen, Niels P.; Rongen, Gerard A.			NT5E Mutations and Arterial Calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							ECTO-5'-NUCLEOTIDASE		[Riksen, Niels P.; Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Riksen, NP (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	n.riksen@aig.umcn.nl	Riksen, Niels P/G-8260-2015; St. Hilaire, Cynthia/R-8205-2017; Mancini, Cecilia/AAB-7442-2019; St. Hilaire, Cynthia/I-4713-2014; Hofbauer, Lorenz C/G-2490-2010; Brusco, Alfredo/A-1811-2013; Rongen, Gerard A/C-1578-2018; lederman, robert j/C-6305-2009; Rongen, Gerard/AAJ-9694-2021	Riksen, Niels P/0000-0001-9197-8124; St. Hilaire, Cynthia/0000-0003-1871-6915; Hofbauer, Lorenz C/0000-0002-8691-8423; Brusco, Alfredo/0000-0002-8318-7231; lederman, robert j/0000-0003-1202-6673; Freudenthal, Bernard/0000-0003-4669-918X; Mancini, Cecilia/0000-0003-1282-0404	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006079, ZICHL006019, ZIAHL006077, ZIAHL005062, ZIDHL006061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007309] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Meijer P, 2010, HYPERTENSION, V56, P722, DOI 10.1161/HYPERTENSIONAHA.110.155689; Sanada S, 2004, CIRCULATION, V110, P2143, DOI 10.1161/01.CIR.0000143830.59419.73; Zernecke A, 2006, CIRCULATION, V113, P2120, DOI 10.1161/CIRCULATIONAHA.105.595249	4	304	315	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1579	1579		10.1056/NEJMoa0912923	http://dx.doi.org/10.1056/NEJMoa0912923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21288095	Green Published, Green Accepted			2022-12-24	WOS:000289722700025
